Citrus Sinensis ID: 022706
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 293 | 2.2.26 [Sep-21-2011] | |||||||
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.986 | 0.816 | 0.827 | 1e-143 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 0.989 | 0.794 | 0.809 | 1e-137 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.962 | 0.781 | 0.695 | 1e-112 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.965 | 0.693 | 0.670 | 1e-110 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.819 | 0.655 | 0.772 | 1e-109 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.969 | 0.778 | 0.625 | 1e-106 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.771 | 0.313 | 0.527 | 7e-63 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.778 | 0.306 | 0.5 | 1e-62 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.972 | 0.625 | 0.449 | 3e-61 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.771 | 0.314 | 0.519 | 9e-61 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 506 bits (1304), Expect = e-143, Method: Compositional matrix adjust.
Identities = 240/290 (82%), Positives = 264/290 (91%), Gaps = 1/290 (0%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CC++DDMH+A DNG +M +SAG +G A+E+A + Q V +QPI VP+I+VD
Sbjct: 1 MSCFSCCDDDDMHRATDNG-PFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELK+IT+NFG+ ALIGEGSYGRVY+G+LKSG AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 60 ELKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLK 119
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
EN V+LLGYCVDG RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRVKIAVGA
Sbjct: 120 DENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGA 179
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKA PHIIHRDIKSSN+L+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 180 AKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 239
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQL++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 240 GYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 238/294 (80%), Positives = 259/294 (88%), Gaps = 4/294 (1%)
Query: 1 MSCFGCC-EEDDMHKAADNGNAYMVKS--SAGTDGAYH-ASEAAPKGAQAVKVQPIEVPA 56
MSCFGCC E+DDMHK AD G + G D +H ASE A KG VK+QPIEVP
Sbjct: 1 MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARHHQASETAQKGPPVVKLQPIEVPI 60
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
I ELKE T++FG+N+LIGEGSYGRVYYG+L + +AIKKLD++KQPD EFLAQVSMV
Sbjct: 61 IPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNKQPDNEFLAQVSMV 120
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SRLKH+NFVQLLGYCVDG SR+L+YEFA+NGSLHDILHGRKGVKGAQPGPVLSW QRVKI
Sbjct: 121 SRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQRVKI 180
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
AVGAA+GLEYLHEKA+PHIIHRDIKSSNVL+F+DDVAKIADFDLSNQAPDMAARLHSTRV
Sbjct: 181 AVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHSTRV 240
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH LPRGQQSLVTW
Sbjct: 241 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTW 294
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1039), Expect = e-112, Method: Compositional matrix adjust.
Identities = 203/292 (69%), Positives = 228/292 (78%), Gaps = 10/292 (3%)
Query: 3 CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQ--PIEVPAISVD 60
C C ED N + S +D + S+ AP VK + PIEVP +S+D
Sbjct: 6 CCTCQIEDS------NEEQQLKSSQQQSDANHKNSKPAPVAKHEVKKEALPIEVPPLSLD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSR 118
E+KE TENFG+ ALIGEGSYGRVYY L G A A+KKLD + + D EFL+QVSMVSR
Sbjct: 60 EVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVSMVSR 119
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
LKHEN +QLLG+CVDG RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RVKIAV
Sbjct: 120 LKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRVKIAV 179
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
AA+GLEYLHEK+ P +IHRDI+SSNVL+F+D AKIADF+LSNQAPD AARLHSTRVLG
Sbjct: 180 EAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHSTRVLG 239
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
TFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTW
Sbjct: 240 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 291
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1021), Expect = e-110, Method: Compositional matrix adjust.
Identities = 197/294 (67%), Positives = 231/294 (78%), Gaps = 11/294 (3%)
Query: 3 CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGA---QAVKVQP-IEVPAIS 58
C C E+ H + N ++ D +H + P+ A A+K P I+VPA+S
Sbjct: 48 CCACHVEEPYHSSE---NEHLRSPKHHNDFGHHTRK--PQAAVKPDALKEPPSIDVPALS 102
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMV 116
+DELKE T+NFG+ +LIGEGSYGR YY LK G A A+KKLD + +P+ EFL QVS V
Sbjct: 103 LDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRV 162
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
S+LKH+NFV+L GYCV+G R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+I
Sbjct: 163 SKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRI 222
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
AV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AKIADF+LSNQ+PDMAARLHSTRV
Sbjct: 223 AVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRV 282
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
LGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTW
Sbjct: 283 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 336
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1010), Expect = e-109, Method: Compositional matrix adjust.
Identities = 187/242 (77%), Positives = 208/242 (85%), Gaps = 2/242 (0%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEE 108
PIEVP +SVDE+KE T+NFG+ +LIGEGSYGRVYY L G A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
FL QVSMVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
W RVKIAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AK+ADF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
ARLHSTRVLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292
Query: 289 TW 290
TW
Sbjct: 293 TW 294
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (985), Expect = e-106, Method: Compositional matrix adjust.
Identities = 184/294 (62%), Positives = 226/294 (76%), Gaps = 10/294 (3%)
Query: 6 CCEEDDMHKAADNGNAYMVKSS-------AGTDGAYHASEAAPKGAQAVKVQPIEVPAIS 58
CC D A N Y + G + + AP+ KV PIE+P+++
Sbjct: 3 CCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPSVA 62
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQPDEEFLAQVSMV 116
+DEL + NFG ALIGEGSYGRV+ G K G A AIKKLDAS ++PD +F +Q+S+V
Sbjct: 63 LDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLSVV 121
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SRLKH++FV+LLGYC++ +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRVKI
Sbjct: 122 SRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRVKI 181
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A GAAKGLE+LHEK P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHSTRV
Sbjct: 182 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHSTRV 241
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
LGTFGYHAPEYAMTGQ+ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTW
Sbjct: 242 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW 295
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 7e-63, Method: Compositional matrix adjust.
Identities = 124/235 (52%), Positives = 163/235 (69%), Gaps = 9/235 (3%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSM 115
S +EL EIT+ F ++GEG +G VY G L+ G A+K+L A S Q D EF A+V +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+SR+ H + V L+GYC+ R+L YE+ SN +L LHG KG+ PVL W +RV+
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG-KGL------PVLEWSKRVR 471
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
IA+G+AKGL YLHE P IIHRDIKS+N+L+ D+ A++ADF L+ + D STR
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVSTR 530
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
V+GTFGY APEYA +G+L +SDV+SFGVVLLEL+TGRKPVD T P G++SLV W
Sbjct: 531 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEW 585
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (611), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 120/240 (50%), Positives = 164/240 (68%), Gaps = 12/240 (5%)
Query: 52 IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-DEEFL 110
+ V ++ EL++ T+ F ++GEG +GRVY G ++ G A+K L Q D EF+
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFI 391
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
A+V M+SRL H N V+L+G C++G +R L YE NGS+ LH +G L W
Sbjct: 392 AEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-----EG-----TLDW 441
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
R+KIA+GAA+GL YLHE ++P +IHRD K+SNVL+ DD K++DF L+ +A + +
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 501
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
+ STRV+GTFGY APEYAMTG L KSDVYS+GVVLLELLTGR+PVD + P G+++LVTW
Sbjct: 502 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (600), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 139/309 (44%), Positives = 174/309 (56%), Gaps = 24/309 (7%)
Query: 1 MSCFGCCEEDDMHK--AADNGNAYMVKSSAGT---------DGAYHASEAAPKGAQAVKV 49
M CF C + D K D N K S T G S G++ +
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 50 QP------IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDAS 102
P I + EL T NF + +GEG +GRVY G L S G A+K+LD +
Sbjct: 61 LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120
Query: 103 K-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG 161
Q + EFL +V M+S L H N V L+GYC DG R+L YEF GSL D LH K
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180
Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A L W R+KIA GAAKGLE+LH+KA+P +I+RD KSSN+L+ + K++DF L+
Sbjct: 181 A-----LDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLA 235
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
P STRV+GT+GY APEYAMTGQL KSDVYSFGVV LEL+TGRK +D +P
Sbjct: 236 KLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMP 295
Query: 282 RGQQSLVTW 290
G+Q+LV W
Sbjct: 296 HGEQNLVAW 304
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 9e-61, Method: Compositional matrix adjust.
Identities = 122/235 (51%), Positives = 160/235 (68%), Gaps = 9/235 (3%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSM 115
+ +EL +ITE F + ++GEG +G VY GIL G AIK+L + S + EF A+V +
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+SR+ H + V L+GYC+ R L YEF N +L LHG+ PVL W +RV+
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-------PVLEWSRRVR 470
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
IA+GAAKGL YLHE P IIHRDIKSSN+L+ D+ A++ADF L+ + D A STR
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQSHISTR 529
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
V+GTFGY APEYA +G+L +SDV+SFGVVLLEL+TGRKPVD + P G++SLV W
Sbjct: 530 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEW 584
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 293 | ||||||
| 255548287 | 362 | Serine/threonine-protein kinase PBS1, pu | 0.989 | 0.801 | 0.937 | 1e-160 | |
| 224130874 | 362 | predicted protein [Populus trichocarpa] | 0.989 | 0.801 | 0.917 | 1e-155 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 0.989 | 0.609 | 0.889 | 1e-153 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 0.989 | 0.803 | 0.889 | 1e-153 | |
| 224064746 | 362 | predicted protein [Populus trichocarpa] | 0.989 | 0.801 | 0.9 | 1e-153 | |
| 359811321 | 361 | pto-interacting protein 1-like [Glycine | 0.989 | 0.803 | 0.886 | 1e-151 | |
| 351725893 | 361 | serine/threonine protein kinase [Glycine | 0.989 | 0.803 | 0.872 | 1e-149 | |
| 225437716 | 362 | PREDICTED: pto-interacting protein 1 [Vi | 0.989 | 0.801 | 0.862 | 1e-149 | |
| 356505673 | 361 | PREDICTED: pto-interacting protein 1-lik | 0.989 | 0.803 | 0.862 | 1e-146 | |
| 449508412 | 299 | PREDICTED: pto-interacting protein 1-lik | 0.996 | 0.976 | 0.842 | 1e-144 |
| >gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1465), Expect = e-160, Method: Compositional matrix adjust.
Identities = 272/290 (93%), Positives = 280/290 (96%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEEDDMHKAAD+G Y VKSSAG G YHASE AP+GAQAVK+QPIEVP+ISVD
Sbjct: 1 MSCFGCCEEDDMHKAADSGGPYPVKSSAGNVGGYHASETAPRGAQAVKIQPIEVPSISVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG N+LIGEGSYGRVYYGILKSG AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGINSLIGEGSYGRVYYGILKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130874|ref|XP_002320946.1| predicted protein [Populus trichocarpa] gi|222861719|gb|EEE99261.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1424), Expect = e-155, Method: Compositional matrix adjust.
Identities = 266/290 (91%), Positives = 275/290 (94%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEEDD+ KAADNG Y VKSSAG G YHASE AP+G QAVK+QPIEVPAISVD
Sbjct: 1 MSCFGCCEEDDVQKAADNGGPYAVKSSAGHVGNYHASETAPRGPQAVKIQPIEVPAISVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T NFGT++LIGEGSYGRVYYG+LKS AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTVNFGTDSLIGEGSYGRVYYGVLKSEQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYCVDG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKADP IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPRIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1410), Expect = e-153, Method: Compositional matrix adjust.
Identities = 258/290 (88%), Positives = 274/290 (94%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEED+ HKAA++G Y+VK+ AG DG YHAS+ A +GAQ VKVQPIEVP I D
Sbjct: 116 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 175
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 176 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 235
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 236 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 295
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 296 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 355
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 356 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 405
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-153, Method: Compositional matrix adjust.
Identities = 258/290 (88%), Positives = 274/290 (94%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEED+ HKAA++G Y+VK+ AG DG YHAS+ A +GAQ VKVQPIEVP I D
Sbjct: 1 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064746|ref|XP_002301545.1| predicted protein [Populus trichocarpa] gi|222843271|gb|EEE80818.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1404), Expect = e-153, Method: Compositional matrix adjust.
Identities = 261/290 (90%), Positives = 273/290 (94%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CCEEDD+HKAAD G Y VKSSAG G YHASE APKGAQA K+QPIEVP IS D
Sbjct: 1 MSCFCCCEEDDIHKAADYGGQYTVKSSAGNLGNYHASETAPKGAQAFKIQPIEVPEISGD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFGT++LIGEGSYGRVYYG+LKSG A+IKKLDASKQPD+EFL+QVSMVSRLK
Sbjct: 61 ELKEVTDNFGTSSLIGEGSYGRVYYGVLKSGQDASIKKLDASKQPDDEFLSQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYCVDG SRVL YEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLIYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHEKADPHI+HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIVHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1390), Expect = e-151, Method: Compositional matrix adjust.
Identities = 257/290 (88%), Positives = 272/290 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CCEEDD+HKAA++G Y+VK+ AG DG Y ASE A +G Q VK QPIEVP IS D
Sbjct: 1 MSCFSCCEEDDLHKAAESGGPYVVKNPAGNDGNYLASETAKQGTQPVKPQPIEVPNISAD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKE+T+NFG +ALIGEGSYGRVYYG+LKS AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDALIGEGSYGRVYYGVLKSELAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HENFVQLLGYC+DG+SR+LAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725893|ref|NP_001237620.1| serine/threonine protein kinase [Glycine max] gi|223452365|gb|ACM89510.1| serine/threonine protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 534 bits (1375), Expect = e-149, Method: Compositional matrix adjust.
Identities = 253/290 (87%), Positives = 270/290 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCEEDD K A++G ++VK+S G DG ASE A +G QAVK+QPIEVP + VD
Sbjct: 1 MSCFGCCEEDDYQKTAESGGQHVVKNSTGNDGNSRASETAKQGTQAVKIQPIEVPELQVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKEIT+ FG ++LIGEGSYGRVYYG+LKSG AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDGFGESSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437716|ref|XP_002280340.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297744052|emb|CBI37022.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1370), Expect = e-149, Method: Compositional matrix adjust.
Identities = 250/290 (86%), Positives = 270/290 (93%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCCE+DD+H A ++GN + K+ AG DG Y ++ APKG QAVKVQPI VP I D
Sbjct: 1 MSCFGCCEDDDIHTAPESGNPFAAKNPAGNDGGYRHTDPAPKGTQAVKVQPIAVPPIPFD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKEIT+NFGT+ALIGEGSYGRVYYG+LK+G AAAIKKLDASKQPDEEFLAQVSMVSRLK
Sbjct: 61 ELKEITDNFGTSALIGEGSYGRVYYGLLKNGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFV+L+GYCVDG SR+LAYEFASNGSLHDILHGRKGVKGAQPGP+LSW QRVKIAVGA
Sbjct: 121 HDNFVELIGYCVDGGSRILAYEFASNGSLHDILHGRKGVKGAQPGPILSWAQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GL+YLHEKA PHIIHRDIKSSNVL+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLDYLHEKASPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505673|ref|XP_003521614.1| PREDICTED: pto-interacting protein 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1352), Expect = e-146, Method: Compositional matrix adjust.
Identities = 250/290 (86%), Positives = 268/290 (92%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CCEEDD KA+++G ++VK+S G G ASE A +G QAVK+QPIEVP + VD
Sbjct: 1 MSCFSCCEEDDYQKASESGGQHVVKNSTGNHGNGRASETAKQGTQAVKIQPIEVPELPVD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
ELKEIT+ FG ++LIGEGSYGRVYYG+LKS AAAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDGFGESSLIGEGSYGRVYYGVLKSRQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+NFVQLLGYC+DG SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL+W QRVKIAVGA
Sbjct: 121 HDNFVQLLGYCIDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWTQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AKGLEYLHE+ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 AKGLEYLHERADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449508412|ref|XP_004163306.1| PREDICTED: pto-interacting protein 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1334), Expect = e-144, Method: Compositional matrix adjust.
Identities = 246/292 (84%), Positives = 265/292 (90%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCF CCEED++ KAADNG Y K + G +G YH EAAP QAVK+QPI VP I ++
Sbjct: 1 MSCFSCCEEDEIQKAADNGGMYAGKQNTGNNGGYHKPEAAPAVTQAVKMQPILVPTIPIE 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
EL E+T+NFG +ALIGEGSYGRVYYG+LK+G AAIKKLDASKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELSEVTDNFGNDALIGEGSYGRVYYGMLKNGQPAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H NFVQLLGYCVDG+SR+L YE+ASNGSLHDILHGRKGVKGAQPGPVLSW QRVKIAVGA
Sbjct: 121 HGNFVQLLGYCVDGSSRILVYEYASNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKA+ HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKAESHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD TLPRGQQSLVTWV+
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDPTLPRGQQSLVTWVI 292
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 293 | ||||||
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.989 | 0.803 | 0.817 | 4.8e-126 | |
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.986 | 0.793 | 0.766 | 7.7e-119 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.986 | 0.796 | 0.727 | 2.5e-113 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.935 | 0.759 | 0.724 | 5.4e-102 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.969 | 0.696 | 0.675 | 6.2e-101 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.986 | 0.793 | 0.652 | 5.6e-100 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.863 | 0.691 | 0.741 | 5.8e-98 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.969 | 0.778 | 0.636 | 5.2e-97 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.843 | 0.730 | 0.718 | 2.1e-93 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.802 | 0.324 | 0.534 | 7.1e-61 |
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1238 (440.9 bits), Expect = 4.8e-126, P = 4.8e-126
Identities = 237/290 (81%), Positives = 258/290 (88%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFGCC EDD+ A D G M K S G DG + SE A KGAQ+VKVQPIEV AI D
Sbjct: 1 MSCFGCCREDDLPGANDYGGHNMTKQSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILAD 60
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
EL E T +FGTN+LIGEGSY RVY+G+LK+G AAIKKLD++KQP+EEFLAQVSMVSRLK
Sbjct: 61 ELIEATNDFGTNSLIGEGSYARVYHGVLKNGQRAAIKKLDSNKQPNEEFLAQVSMVSRLK 120
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H NFV+LLGY VDG SR+L +EFA NGSLHDILHGRKGVKGA+PGP+LSW QRVKIAVGA
Sbjct: 121 HVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGA 180
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEKA+PH+IHRDIKSSNVLIFD+DVAKIADFDLSNQAPDMAARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTGQL+AKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
|
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1170 (416.9 bits), Expect = 7.7e-119, P = 7.7e-119
Identities = 223/291 (76%), Positives = 251/291 (86%)
Query: 1 MSCFGCCEE-DDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISV 59
M CFGCC +D + ++ G V ++ G +G +H PK +++QPI V AI
Sbjct: 1 MGCFGCCGGGEDFRRVSETGPK-PVHNTGGYNGGHHQRADPPKNLPVIQMQPISVAAIPA 59
Query: 60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL 119
DEL++IT+N+G+ +LIGEGSYGRV+YGILKSG AAAIKKLD+SKQPD+EFLAQVSMVSRL
Sbjct: 60 DELRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSKQPDQEFLAQVSMVSRL 119
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+ EN V LLGYCVDG RVLAYE+A NGSLHDILHGRKGVKGAQPGPVLSW QRVKIAVG
Sbjct: 120 RQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVG 179
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
AA+GLEYLHEKA+PH+IHRDIKSSNVL+FDDDVAKIADFDLSNQAPDMAARLHSTRVLGT
Sbjct: 180 AARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
FGYHAPEYAMTG L+ KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS+VTW
Sbjct: 240 FGYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTW 290
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
Identities = 211/290 (72%), Positives = 241/290 (83%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFG C +D A D G + AG +G ++ P + +QPI VPAI VD
Sbjct: 1 MSCFGWCGSEDFRNATDTGPR-PAHNPAGYNGGHYQRADPPMNQPVIPMQPISVPAIPVD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
EL++IT+N+G+ LIGEGSYGRV+YG+LKSG AAAIKKLD+SKQPD+EFL+Q+SMVSRL+
Sbjct: 60 ELRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSKQPDQEFLSQISMVSRLR 119
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H+N L+GYCVDG RVLAYEFA GSLHD LHG+KG KGA GPV++WQQRVKIAVGA
Sbjct: 120 HDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRVKIAVGA 179
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+GLEYLHEK P +IHRDIKSSNVL+FDDDVAKI DFDLS+QAPDMAARLHSTRVLGTF
Sbjct: 180 ARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHSTRVLGTF 239
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GYHAPEYAMTG L++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 240 GYHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
Identities = 202/279 (72%), Positives = 226/279 (81%)
Query: 17 DNGNAYMVKSSAGTDGAYHA-SEAAPKGAQAVKVQ--PIEVPAISVDELKEITENFGTNA 73
D+ +KSS A H S+ AP VK + PIEVP +S+DE+KE TENFG+ A
Sbjct: 13 DSNEEQQLKSSQQQSDANHKNSKPAPVAKHEVKKEALPIEVPPLSLDEVKEKTENFGSKA 72
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYC 131
LIGEGSYGRVYY L G A A+KKLD + + D EFL+QVSMVSRLKHEN +QLLG+C
Sbjct: 73 LIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFC 132
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
VDG RVLAYEFA+ GSLHDILHGRKGV+GAQPGP L W RVKIAV AA+GLEYLHEK+
Sbjct: 133 VDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKS 192
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
P +IHRDI+SSNVL+F+D AKIADF+LSNQAPD AARLHSTRVLGTFGYHAPEYAMTG
Sbjct: 193 QPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTG 252
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
QL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTW
Sbjct: 253 QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 291
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
Identities = 198/293 (67%), Positives = 231/293 (78%)
Query: 3 CFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHAS--EAAPKGAQAVKVQP-IEVPAISV 59
C C E+ H + N ++ D +H +AA K A+K P I+VPA+S+
Sbjct: 48 CCACHVEEPYHSSE---NEHLRSPKHHNDFGHHTRKPQAAVK-PDALKEPPSIDVPALSL 103
Query: 60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVS 117
DELKE T+NFG+ +LIGEGSYGR YY LK G A A+KKLD + +P+ EFL QVS VS
Sbjct: 104 DELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVS 163
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+LKH+NFV+L GYCV+G R+LAYEFA+ GSLHDILHGRKGV+GAQPGP L W QRV+IA
Sbjct: 164 KLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIA 223
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
V AA+GLEYLHEK P +IHRDI+SSNVL+F+D AKIADF+LSNQ+PDMAARLHSTRVL
Sbjct: 224 VDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVL 283
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
GTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTW
Sbjct: 284 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 336
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 5.6e-100, P = 5.6e-100
Identities = 190/291 (65%), Positives = 229/291 (78%)
Query: 1 MSCFGCCEEDDMHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVD 60
MSCFG C +D+ AD G + +S G +G +H P V +QPI VPAI VD
Sbjct: 1 MSCFGWCGSEDVRNPADTGPS-QAHNSIGYNGRHHQRADPPMNQPVVNMQPIAVPAIPVD 59
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
EL++ITENF + L+G+GSYGRV+YG+LKSG AAIKKL +KQPD+EFL+QVSMVSRL
Sbjct: 60 ELEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTKQPDQEFLSQVSMVSRLH 119
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HEN V L+ YCVDG RVLAYEFA+ G+LHD+LHG+ GV GA GPV++WQ+RVKIA+GA
Sbjct: 120 HENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRVKIALGA 179
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV-LGT 239
A+GLEYLH+K +P +IHRDIK+SN+L+FDDD+AKI DFDL +QAP+MA RLHS R+ LG
Sbjct: 180 ARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSCRMALGA 239
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
H PE+AMTG L KSDVYSFGVVLLELLTGRKPVD TLPRGQQ+LVTW
Sbjct: 240 SRSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNLVTW 290
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 189/255 (74%), Positives = 212/255 (83%)
Query: 38 EAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIK 97
+A K + PIEVP +SVDE+KE T+NFG+ +LIGEGSYGRVYY L G A A+K
Sbjct: 40 QAVVKPEAQKEALPIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALK 99
Query: 98 KLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
KLD + + + EFL QVSMVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHG
Sbjct: 100 KLDVAPEAETNTEFLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHG 159
Query: 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215
RKGV+GAQPGP L W RVKIAV AA+GLEYLHEK P +IHRDI+SSNVL+F+D AK+
Sbjct: 160 RKGVQGAQPGPTLDWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKV 219
Query: 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
ADF+LSNQAPD AARLHSTRVLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKP
Sbjct: 220 ADFNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 279
Query: 276 VDHTLPRGQQSLVTW 290
VDHT+PRGQQSLVTW
Sbjct: 280 VDHTMPRGQQSLVTW 294
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 5.2e-97, P = 5.2e-97
Identities = 187/294 (63%), Positives = 228/294 (77%)
Query: 6 CCEEDDMHKAADNGNAYMVK-SSAGTD--GAYHASEA----APKGAQAVKVQPIEVPAIS 58
CC D A N Y + AG G + E AP+ KV PIE+P+++
Sbjct: 3 CCGGADEEPAGPPANQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAKVLPIEIPSVA 62
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQPDEEFLAQVSMV 116
+DEL + NFG ALIGEGSYGRV+ G K G A AIKKLDAS ++PD +F +Q+S+V
Sbjct: 63 LDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQLSVV 121
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SRLKH++FV+LLGYC++ +R+L Y+FA+ GSLHD+LHGRKGV+GA+PGPVL+W QRVKI
Sbjct: 122 SRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQRVKI 181
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A GAAKGLE+LHEK P I+HRD++SSNVL+FDD VAK+ADF+L+N + D AARLHSTRV
Sbjct: 182 AYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLHSTRV 241
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
LGTFGYHAPEYAMTGQ+ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTW
Sbjct: 242 LGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW 295
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 930 (332.4 bits), Expect = 2.1e-93, P = 2.1e-93
Identities = 179/249 (71%), Positives = 208/249 (83%)
Query: 44 AQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK 103
A+ ++ PI VP++SVDE+ E T+NFG N+LIGEGSYGRVYY L G A A+KKLD +
Sbjct: 22 AKPKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALKKLDLAP 81
Query: 104 QPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG 161
+ + EFL+QVSMVSRLKHEN +QL+GYCVD RVLAYEFA+ GSLHDILHGRKGV+
Sbjct: 82 EDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQD 141
Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A PGP L W RVKIAV AA+GLEYLHEK P +IHRDI+SSN+L+FDD AKIADF+LS
Sbjct: 142 ALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNLS 201
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
NQ+PD AARL STRVLG+FGY++PEYAMTG+L KSDVY FGVVLLELLTGRKPVDHT+P
Sbjct: 202 NQSPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKPVDHTMP 261
Query: 282 RGQQSLVTW 290
RGQQSLVTW
Sbjct: 262 RGQQSLVTW 270
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 7.1e-61, P = 7.1e-61
Identities = 130/243 (53%), Positives = 166/243 (68%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS-KQPDEEF 109
P +S +ELKE T NF + +++GEG +G+VY GIL G A AIKKL + Q D+EF
Sbjct: 362 PASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEF 421
Query: 110 LAQVSMVSRLKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
++ M+SRL H N V+L+GY D + +L YE NGSL LHG G+ P
Sbjct: 422 QVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNC--P--- 476
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
L W R+KIA+ AA+GL YLHE + P +IHRD K+SN+L+ ++ AK+ADF L+ QAP+
Sbjct: 477 LDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEG 536
Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
STRV+GTFGY APEYAMTG L KSDVYS+GVVLLELLTGRKPVD + P GQ++L
Sbjct: 537 RGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 596
Query: 288 VTW 290
VTW
Sbjct: 597 VTW 599
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.8275 | 0.9863 | 0.8163 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 293 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-40 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-24 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 5e-51
Identities = 70/200 (35%), Positives = 99/200 (49%), Gaps = 18/200 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
+GEG +G VY K+G AIK + EE L ++ ++ +L H N V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
D L E+ GSL D+L +G LS + ++I + +GLEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN- 111
Query: 192 DPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-YAM 249
IIHRD+K N+L+ D+ K+ADF LS + L + GT Y APE
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLG 167
Query: 250 TGQLNAKSDVYSFGVVLLEL 269
G + KSD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-49
Identities = 75/221 (33%), Positives = 107/221 (48%), Gaps = 44/221 (19%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G VY G LK A+K L DAS+Q EEFL + ++ +L H N V+L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C + + E+ G L L + P LS + A+ A+G+EYL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR--------PKLSLSDLLSFALQIARGMEYL 118
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
K + IHRD+ + N L+ ++ V KI+DF LS R L Y+
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLS-------------RDLYDDDYYRKRG 162
Query: 244 --------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE G+ +KSDV+SFGV+L E+ T G +P
Sbjct: 163 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-48
Identities = 75/210 (35%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G VY G LK A+K L AS++ EEFL + S++ +L H N V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C G + E+ G L D L + G L+ + +++A+ AKG+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPE 246
K + +HRD+ + N L+ ++ V KI+DF LS D R L APE
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
G+ +KSDV+SFGV+L E+ T G +P
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-48
Identities = 75/209 (35%), Positives = 109/209 (52%), Gaps = 12/209 (5%)
Query: 75 IGEGSYGRVYYGILKSG----HAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+GEG++G VY G LK A+K L DAS++ ++FL + ++ +L H N V+LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C + L E+ G L D L + V + LS + + A+ AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHSTRVLGTFGYHAPEY 247
K +HRD+ + N L+ +D V KI+DF LS + D R + L + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPES 178
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
G +KSDV+SFGV+L E+ T G P
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-48
Identities = 73/210 (34%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 75 IGEGSYGRVYYGILKSGHA-----AAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G VY G LK A+K L DAS+Q EEFL + ++ +L H N V+L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C + ++ E+ G L D L + LS + A+ A+G+EYL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSFALQIARGMEYL 119
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPE 246
K + IHRD+ + N L+ ++ V KI+DF LS D ++ ++ + APE
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPE 174
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
G+ +KSDV+SFGV+L E+ T G +P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-45
Identities = 70/205 (34%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGY 130
+GEGS+G+VY K+G AIK + K E L ++ ++ +LKH N V+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
D L E+ G L D+L R LS + LEYLH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
I+HRD+K N+L+ +D K+ADF L+ Q +T V GT Y APE +
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPEVLLG 170
Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
D++S GV+L ELLTG+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-45
Identities = 75/219 (34%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
+G GS+G VY K G A+K L + D+ ++ ++ RL H N V+L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
D L E+ G L D L LS + KIA+ +GLEYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
IIHRD+K N+L+ ++ V KIADF L+ + ++ +T V GT Y APE +
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLG 172
Query: 251 GQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
G K DV+S GV+L ELLTG+ P Q L+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-41
Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
L+G GS+G VY + K +G A+K ++ S +EE ++ ++S L+H N V+ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 130 YCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEY 186
D L E+ S GSL +L + P PV+ ++ + I +GL Y
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVI--RKYTRQI----LEGLAY 116
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH I+HRDIK +N+L+ D V K+ADF + + D+ + V GT + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ +D++S G ++E+ TG+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-40
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
IG+G +G VY ++G AIK + + +E + + ++ + KH N V+ G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ EF S GSL D+L L+ Q + KGLEYLH
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN-- 117
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
IIHRDIK++N+L+ D K+ DF LS Q ++ ++GT + APE
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 253 LNAKSDVYSFGVVLLELLTGRKP 275
+ K+D++S G+ +EL G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-37
Identities = 75/223 (33%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
A IG+G +G V G + G A+K L + FLA+ S+++ L+H N VQLLG +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D L R G V++ Q++ A+ +G+EYL EK
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSR----GRA---VITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMT 250
+ +HRD+ + NVL+ +D VAK++DF L+ +A + G + APE
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-------SQGQDSGKLPVKWTAPEALRE 173
Query: 251 GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR-GQQSLVTWV 291
+ + KSDV+SFG++L E+ + GR P PR + +V V
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP----YPRIPLKDVVPHV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 32/213 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE---EFLAQVSMVSRLKHENFVQLLG 129
LIG G++G VY G+ L++G AIK++ K +E + ++ ++ LKH N V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDIL--HGRKG-----VKGAQPGPVLSWQQRVKIAVGAAK 182
S + E+A NGSL I+ G V Q VL +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ---VL-------------Q 110
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL YLHE+ +IHRDIK++N+L D V K+ADF ++ + D++ S V+GT +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + SD++S G ++ELLTG P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 71/217 (32%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHE-NFVQLL 128
+GEGS+G VY + A+K L + E FL ++ +++ L H N V+L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ D S L E+ GSL D+L LS + + I LEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKI------GRKGPLSESEALFILAQILSALEYLH 118
Query: 189 EKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTR----VLGTFGYH 243
K IIHRDIK N+L+ D V K+ DF L+ PD + +GT GY
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 244 APEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVD 277
APE + ++ SD++S G+ L ELLTG P +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-33
Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 31/222 (13%)
Query: 75 IGEGSYGRVYYGILKSG------HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
+GEG++G+V+ G A+K L + D ++F + +++ +HEN V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV---LSWQQRVKIAVGAA 181
G C +G ++ +E+ +G L+ L HG P L+ Q ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST---RVLG 238
G+ YL A H +HRD+ + N L+ D V KI DF +S +++T RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD-------VYTTDYYRVGG 182
Query: 239 T----FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ PE M + +SDV+SFGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 74 LIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
IG+GS+G+VY G +K++D S ++E L +V ++ +L H N ++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ + E+A G L + +K + G +Q + V L+YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQK-----KEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGYHA 244
+ I+HRDIK N+ + + + K+ DF +S L ST V+GT Y +
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKTVVGTPYYLS 171
Query: 245 PE------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
PE Y N KSD++S G VL EL T + P
Sbjct: 172 PELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G+ + A+K L ++FLA+ ++ +L+H +QL C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E GSL + L G G L Q + +A A G+ YL + +
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ---N 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTF--GYHAPEY 247
IHRD+ + NVL+ ++++ K+ADF L AR+ + R F + APE
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGL--------ARVIKEDIYEAREGAKFPIKWTAPEA 175
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
A+ + + KSDV+SFG++L E++T GR P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G A+K L E FL + ++ +L+H+ VQL C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ S GSL D L +G K L Q V +A A+G+ YL + +
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR---N 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTF--GYHAPEY 247
IHRD+ + N+L+ ++ V KIADF L ARL ++ R F + APE
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGL--------ARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
A G+ KSDV+SFG++L E++T GR P
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-30
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
IG+GS+G V+ + K+ A+K++D +++ EE + + ++++L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+D + E+A NG LH +L Q G L Q + + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK-------MQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
I+HRDIKS N+ + D KI D ++ D + ++GT Y +PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCED 175
Query: 251 GQLNAKSDVYSFGVVLLELLTGRKPVD 277
N KSDV++ GVVL E TG+ P D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 69/208 (33%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 75 IGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSM----VSRLKHENFVQLLG 129
+G G+ G V +G A+K + +E Q+ + + V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ + E+ GSL IL K V+G P +L KIAV KGL YLHE
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
K IIHRD+K SN+L+ K+ DF +S Q + A+ T V GT Y APE
Sbjct: 119 KH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPERIQ 172
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPVD 277
+ KSD++S G+ L+EL TGR P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 75 IGEGSYGRVYYGIL------KSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
+GEG++G+VY G L S + AIK L + +P +EF + ++S L+H N V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKIAVG 179
LLG C + +E+ ++G LH+ L L + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVL 237
A G+EYL + H +HRD+ + N L+ + KI+DF LS + D R+ S +L
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLL 188
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ PE + G+ +SD++SFGVVL E+ + G +P
Sbjct: 189 -PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
+ ++G+GS G VY K +G A+KK+ + ++ L ++ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 124 FVQLLG-YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
V+ G + +G + E+ GSL D+L + P PVL+ IA K
Sbjct: 61 VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQILK 110
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL+YLH K HIIHRDIK SN+LI KIADF +S + + +T V GT Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVTY 166
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+PE + +D++S G+ LLE G+ P
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
E F +GEGSYG VY I ++G AIK + ++ +E + ++S++ + V
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIV 61
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ G T + E+ GS+ DI+ L+ ++ I KGLE
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLE 113
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH IHRDIK+ N+L+ ++ AK+ADF +S Q D A+ ++ V+GT + AP
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAP 168
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
E N K+D++S G+ +E+ G+ P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-28
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIK--KLDASKQPDEEFLAQ----VSMVSRLKHENFVQ 126
L+G GS+G VY G+ L G A+K L Q +E + Q ++++S+L+H N VQ
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LG + + + E GSL +L G+ P PV+ R + GLEY
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL-----LGLEY 117
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH++ + +HRDIK +N+L+ + V K+ADF ++ Q + + + G+ + APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPE 171
Query: 247 YAM-TGQLNAKSDVYSFGVVLLELLTGRKP 275
G +D++S G +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 30/218 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKL---------DASKQPD--EEFLAQVSMVSRLKH 121
LIG+G+YGRVY + + +G A+K++ S+Q D + +++ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVG 179
N VQ LG+ + E+ GS+ L +GR + V + ++V
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV----- 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
+GL YLH K I+HRD+K+ N+L+ D + KI+DF +S ++ D+ + + G+
Sbjct: 118 -LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 240 FGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 275
+ APE + +AK D++S G V+LE+ GR+P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG+G++G VY G+LK A+K ++ PD +FL + ++ + H N V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
V + E GSL L +K L+ ++ +++++ AA G+EYL K
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK- 112
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
+ IHRD+ + N L+ +++V KI+DF +S + + + APE G
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 252 QLNAKSDVYSFGVVLLELLTG 272
+ ++SDV+S+G++L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-26
Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G+G +G V+ G AIK L E FL + ++ +L+HE VQL Y V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 71
Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ + E+ S GSL D L G + G L Q V +A A G+ Y+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG-------EMGKYLRLPQLVDMAAQIASGMAYVERM--- 121
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
+ +HRD++++N+L+ ++ V K+ADF L+ D ++ R F + APE A+ G
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYG 178
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKP 275
+ KSDV+SFG++L EL T GR P
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G +G V+ G+ K+ AIK L + ++F +V + RL+H++ + L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
G + E GSL L + G VL + +A A+G+ YL E+
Sbjct: 74 GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL 253
+ IHRD+ + N+L+ +D V K+ADF L+ + ++ + + APE A G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 254 NAKSDVYSFGVVLLELLT 271
+ KSDV+SFG++L E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
+GEG +G+V +G A+K L+ S + +F ++ ++ L HEN V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C G S L E+ +GSL D L + ++ ++ + + KG++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMD 123
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP--DMAARLHSTRVLGTFGYH 243
YL + IHRD+ + N+L+ +D+ KI+DF L+ P + F Y
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
APE T + ++ SDV+SFGV L EL T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G + AIK + +++F+ + ++ +L H N VQL G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ +NG L + L RKG G + + + + +EYL
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKGKLGT--------EWLLDMCSDVCEAMEYLESNG--- 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT---FGYHAPEYAMTG 251
IHRD+ + N L+ +D+V K++DF L+ D T GT + PE
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKFPVKWAPPEVFDYS 176
Query: 252 QLNAKSDVYSFGVVLLELLTGRK 274
+ ++KSDV+SFGV++ E+ + K
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 28/221 (12%)
Query: 74 LIGEGSYGRVYYG----ILKSGHA---AAIKKLD--ASKQPDEEFLAQVSMVSRLKHENF 124
+G G++G VY G IL G A+K L A+ Q +EFL + ++S H N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
V+LLG C+ + + E G L L R P+L+ ++ + I + AKG
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFDLSNQAPDMAA----RLHSTR 235
YL H IHRD+ + N L+ + V KI DF L A D+ R
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL---ARDIYKSDYYRKEGEG 173
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+L + APE + G+ +SDV+SFGV++ E+LT G++P
Sbjct: 174 LL-PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G YG VY G+ K A+K L EEFL + +++ +KH N VQLLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ EF + G+L D L R+ + VL + +A + +EYL +K
Sbjct: 74 EPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISSAMEYLEKK--- 123
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
+ IHRD+ + N L+ ++ + K+ADF LS M ++ F + APE
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 252 QLNAKSDVYSFGVVLLELLT 271
+ + KSDV++FGV+L E+ T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 72/214 (33%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG G+ VY I L + AIK++D K +E +V +S+ H N V+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
V G L + S GSL DI +K + P L + KGLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR--VLGTFGYHAPEYAM 249
IHRDIK+ N+L+ +D KIADF +S D R R +GT + APE M
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VM 178
Query: 250 TGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
+ K+D++SFG+ +EL TG P P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY-SKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 75 IGEGSYGRVYYGI--LKSGH--AAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G++G V G+ +KSG A+K L + +EFL + S++++L H V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C G +L E A G L L R+ + + + +V A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG------Y 242
K H +HRD+ + NVL+ + AKI+DF +S A S T +
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPLKW 164
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+APE G+ ++KSDV+S+GV L E + G KP
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLG-YCV 132
IGEG+ G VY +G AIKK+ KQ E + ++ ++ KH N V Y V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
V E+ GSL DI+ Q ++ Q + +GLEYLH +
Sbjct: 87 GDELWV-VMEYMDGGSLTDII--------TQNFVRMNEPQIAYVCREVLQGLEYLHSQ-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---HSTR--VLGTFGYHAPEY 247
++IHRDIKS N+L+ D K+ADF AA+L S R V+GT + APE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGF-------AAQLTKEKSKRNSVVGTPYWMAPEV 187
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
K D++S G++ +E+ G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-26
Identities = 71/215 (33%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 74 LIGEGSYGRVYYGILKS--GH--AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
+G+GS+G V G + G A+K L + K D ++FL + +++ L HEN ++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + ++ E A GSL D L RK G L V+IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRL--RKDALGHFLISTL-CDYAVQIA----NGMRYL 113
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------MAARLHSTRVLGTFG 241
K IHRD+ + N+L+ DD KI DF L P M L +V F
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL---KV--PFA 165
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ APE T + SDV+ FGV L E+ T G +P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 70/205 (34%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G A+K L E FL + ++ +L+H+ VQL Y V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVS 71
Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ + E+ S GSL D L + G G L V +A A G+ Y+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KDG-----EGRALKLPNLVDMAAQVAAGMAYIERM--- 121
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTG 251
+ IHRD++S+N+L+ D V KIADF L+ D ++ R F + APE A+ G
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYG 178
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKP 275
+ KSDV+SFG++L EL+T GR P
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
I EL + E IG G +G V+ G AIK + +E+F+ + ++
Sbjct: 1 IHPSELTLVQE-------IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVM 53
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
+L H VQL G C + + L +EF +G L D L ++G S + + +
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGM 105
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTR 235
+ +G+ YL +IHRD+ + N L+ ++ V K++DF ++ D T+
Sbjct: 106 CLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDH 278
+ +PE + ++KSDV+SFGV++ E+ + G+ P ++
Sbjct: 163 F--PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 68/206 (33%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
IG G+YG VY + +G AIK + D E + Q +SM+ +H N V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ E+ GSL DI GP LS Q + KGL YLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIAYVCRETLKGLAYLHET-- 120
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA---M 249
IHRDIK +N+L+ +D K+ADF +S Q A+ S +GT + APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVER 177
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKP 275
G + K D+++ G+ +EL + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 75 IGEGSYGRVYYGILK---SGHA---AAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
+G+GS+G VY G+ K G AIK ++ + E EFL + S++ + V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
LLG G ++ E + G L L R + + Q+ +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQ---APDMAARLHSTRVLG 238
YL K +HRD+ + N ++ +D KI DF D+ L R
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR--- 186
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ APE G KSDV+SFGVVL E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE-EFLAQ-VSMVSRLKHENFVQLLGY 130
IG+GS+G VY I ++ AIK +D + DE E + Q + +S+ + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ G+ + E+ GS D+L +PG L I GLEYLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL---------KPGK-LDETYIAFILREVLLGLEYLHEE 117
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
IHRDIK++N+L+ ++ K+ADF +S Q ++ ++ +GT + APE
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVIKQ 172
Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
+ K+D++S G+ +EL G P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
IGEG+YG+VY K+G A+KK+ + E F + ++ ++ +L+H N V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 130 YCVD--GTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
S + +E+ HD+ L VK + Q +GL+
Sbjct: 66 IVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVK-------FTESQIKCYMKQLLEGLQ 114
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH I+HRDIK SN+LI +D V K+ADF L+ + ++ RV+ T Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 246 EYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
E + + + D++S G +L EL G+
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-24
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V YG + + AIK + ++EF+ + ++ +L HE VQL G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ SNG L + L R+ K QP Q +++ +G+ YL K
Sbjct: 72 RPIYIVTEYMSNGCLLNYL--REHGKRFQP------SQLLEMCKDVCEGMAYLESK---Q 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
IHRD+ + N L+ D K++DF LS D +++ V F + PE + +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 253 LNAKSDVYSFGVVLLELLT-GRKPVD 277
++KSDV++FGV++ E+ + G+ P +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-24
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 75 IGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
+G G++G VY G+ + A+K L S+Q + +FL + ++S+ H+N V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
L+G + R + E + G L L R + +P L+ + + A AKG +
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRP--RPERPSS-LTMKDLLFCARDVAKGCK 130
Query: 186 YLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDLSNQAPDMAARLHST-------R 235
YL E H IHRDI + N L+ VAKIADF MA ++ R
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF-------GMARDIYRASYYRKGGR 180
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ + PE + G +K+DV+SFGV+L E+ + G P
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-24
Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 23/205 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG+G +G V G + G+ A+K K DA+ Q FLA+ S++++L+H N VQLLG V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 133 -DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ + E+ + GSL D L R VL +K ++ + +EYL
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEAN- 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
+ +HRD+ + NVL+ +D+VAK++DF L+ + A+ T L + APE
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKL-PVKWTAPEALREK 174
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKP 275
+ + KSDV+SFG++L E+ + GR P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-24
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 23/206 (11%)
Query: 73 ALIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
+IGEG +G V G +G A+K K D + Q FL + +++++L H+N V+LLG
Sbjct: 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ ++ E S G+L + L R + Q ++ ++ A+G+EYL K
Sbjct: 68 ILHNGLYIVM-ELMSKGNLVNFLRTRG--RALVSVI-----QLLQFSLDVAEGMEYLESK 119
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
++HRD+ + N+L+ +D VAK++DF L+ + ++++ + APE
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL--PVKWTAPEALKH 171
Query: 251 GQLNAKSDVYSFGVVLLELLT-GRKP 275
+ ++KSDV+S+GV+L E+ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 73 ALIGEGSYGRVYYGIL-----KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFV 125
++G G++G VY G+ K AIK L + S + ++E L + +++ + H + V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
+LLG C+ +S+V L + G L D + K G+Q +L+W V AKG+
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNW------CVQIAKGM 122
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
YL EK ++HRD+ + NVL+ KI DF L+ H+ + A
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
E + KSDV+S+GV + EL+T G KP +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 19/213 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
E+ + +G+G +G V+ G AIK L E FL + ++ +L+H+ V
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
L Y V + + EF GSL D L ++G G L Q V +A A G+
Sbjct: 66 L--YAVVSEEPIYIVTEFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMA 116
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYH 243
Y+ + IHRD++++N+L+ D+ V KIADF L+ D ++ R F +
Sbjct: 117 YIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWT 170
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE A+ G+ KSDV+SFG++L EL+T GR P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-24
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 68 NFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHEN 123
+F +G+GSYG VY L A+K++D E+ + ++ +++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
+ +DG + E+A G L + K + ++ Q+ +I + +G
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLS-----KAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
L+ LHE+ I+HRD+KS+N+L+ +D+ KI D +S A+ +GT Y
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPHYM 168
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + KSD++S G +L E+ T P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 6e-24
Identities = 71/221 (32%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
+GEG+ G V LK +G A+K + PD ++ L ++ + K V+ G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 132 VDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--KIAVGAAKGLEYL 187
+D +S + A E+ GSL D ++ + +G + G ++V KIA KGL YL
Sbjct: 69 LDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGKIAESVLKGLSYL 121
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H + IIHRDIK SN+L+ K+ DF +S + + A T GT Y APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT-GTSFYMAPER 174
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
+ SDV+S G+ LLE+ R P P G+ L
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 7e-24
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 19/216 (8%)
Query: 75 IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ + A+K L +AS+ ++F + +++ L+H++ V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGR-----KGVKGAQPGPVLSWQQRVKIAVGA 180
G C +G ++ +E+ +G L+ L HG G + PG L+ Q + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQI 131
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A G+ YL A H +HRD+ + N L+ V KI DF +S R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ PE + + +SD++SFGVVL E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 7e-24
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 72 NALIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFV 125
+IG G +G V G L K AIK L A + +FL + S++ + H N +
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+L G ++ E+ NGSL L G + Q V + G A G++
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGMK 120
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTF 240
YL ++ + +HRD+ + N+L+ + V K++DF LS + D A ++T+ + T
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWT- 175
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + + SDV+SFG+V+ E+++ G +P
Sbjct: 176 ---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 9e-24
Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 36/227 (15%)
Query: 75 IGEGSYGRVYYGILKSGH-------------------AAAIKKLDASKQPDEEFLAQVSM 115
+GEG +G V+ + + A I + DA+K +FL +V +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL----------HGRKGVKGAQPG 165
+SRLK N ++LLG CVD + E+ NG L+ L +G V A
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-- 223
P +S+ + +A+ A G++YL + + +HRD+ + N L+ ++ KIADF +S
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
A D R+ VL + A E + G+ SDV++FGV L E+L
Sbjct: 190 AGDY-YRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 1e-23
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 75 IGEGSYGRVY----YGILKSGHA--AAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ Y + A+K L DAS ++F + +++ L+HE+ V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPV--LSWQQRVKIAVGAAKG 183
G CV+G ++ +E+ +G L+ L HG V A+ L+ Q + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
+ YL A H +HRD+ + N L+ ++ + KI DF +S + +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
PE M + +SDV+S GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-23
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 74 LIGEGSYGRV----YYGILKSGH--AAAIKKL--DASKQPDEEFLAQVSMVSRL-KHENF 124
+GEG++G+V G+ A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIA 177
+ LLG C + E+A++G+L D L R P L+ + V A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
A+G+E+L K IHRD+ + NVL+ +D V KIADF L+ + +T
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ APE +SDV+SFGV+L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-23
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 27/209 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G AIK L E FLA+ +++ +L+H V+L V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVTQ 72
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ NGSL D L +G+K L+ + + +A A+G+ ++ K +
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERK---N 122
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL-----HSTRVLGTF--GYHAPEY 247
IHRD++++N+L+ + KIADF L ARL ++ R F + APE
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGL--------ARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
G KSDV+SFG++L E++T GR P
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-23
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
L+G+G++G V+ G LK A+K K D ++ +FL++ ++ + H N V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ E G L +K L +Q VK A+ AA G+ YL K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYHAPEYAM 249
+ IHRD+ + N L+ +++V KI+DF +S Q D ++S+ L + APE
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD---GIYSSSGLKQIPIKWTAPEALN 167
Query: 250 TGQLNAKSDVYSFGVVLLELLT 271
G+ +++SDV+S+G++L E +
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-22
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKL-------DASKQPDEEFLAQVSMVSRLKHENFVQ 126
++G+G+YG VY G+ G A+K++ A+++ E+ +V ++ LKH N VQ
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LG C+D + + EF GS+ IL+ G P PV K G+ Y
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL----GTFGY 242
LH ++HRDIK +NV++ + + K+ DF + + + + +L GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE KSD++S G + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-22
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+GEG+YG VY K+G A+KK LD +E L ++S++ LKH N V+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L L +E+ L L R G P + S ++ +GL Y
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL------LRGLAYC 114
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTFG 241
H I+HRD+K N+LI D V K+ADF L AR T + T
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTLW 163
Query: 242 YHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
Y APE L +K D++S G + E++TG+
Sbjct: 164 YRAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 23/227 (10%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL- 119
L + T F +IGEG+YG+VY K+G AIK +D + +EE + +++ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 120 KHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
H N G + L E GS+ D++ G + +++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
I +GL YLHE +IHRDIK N+L+ + K+ DF +S Q R ++
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 234 TRVLGTFGYHAPE-----YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+GT + APE +A+SDV+S G+ +EL G+ P
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRL-K 120
E+ +IGEG++G+V ++K AAIK L AS+ +F ++ ++ +L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQR 173
H N + LLG C + +A E+A G+L D L + + K L+ QQ
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
++ A A G++YL EK IHRD+ + NVL+ ++ +KIADF LS R
Sbjct: 122 LQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLS--------RGEE 170
Query: 234 TRVLGTFGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 271
V T G + LN KSDV+SFGV+L E+++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKL---------DASKQPDEEFLA-QVSMVSRLKH 121
ALIG GS+G VY G+ SG A+K++ K+ + LA +++++ L+H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
EN VQ LG +D + E+ GS+ +L+ GA ++ R +
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQIL----- 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP----DMAARLHSTRVL 237
KGL YLH + IIHRDIK +N+L+ + KI+DF +S + +
Sbjct: 117 KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
G+ + APE K+D++S G +++E+LTG+ P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 5e-22
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 43/223 (19%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIK-------KLDASKQPDEEFLAQVSMVSRLKHENF 124
IG G++G+VY + L +G A+K K+ +E + ++ LKH N
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE----MKVLELLKHPNL 61
Query: 125 VQLLGYCVDGTSRVLAY-EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA-- 181
V+ G V +V + E+ S G+L ++L G +L + V I V
Sbjct: 62 VKYYGVEVH-REKVYIFMEYCSGGTLEELLEH---------GRIL--DEHV-IRVYTLQL 108
Query: 182 -KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD----LSNQAPDMAARLHSTRV 236
+GL YLH I+HRDIK +N+ + + V K+ DF L N M + S
Sbjct: 109 LEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA- 164
Query: 237 LGTFGYHAPEY----AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT Y APE G A +D++S G V+LE+ TG++P
Sbjct: 165 -GTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 8e-22
Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 75 IGEGSYGR-VYYGILKSGHAAAIKKLDASK-QPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
+G+G++G Y + K+++ ++ E A + ++S L+H N + +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+D + ++ E+A+ G+L+D + +KG + + + + Y+H+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
I+HRDIK+ N+ + + K+ DF +S + V+GT Y +PE
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPELCQG 175
Query: 251 GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
+ N KSD+++ G VL ELLT ++ D T P
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 68/221 (30%), Positives = 113/221 (51%), Gaps = 33/221 (14%)
Query: 75 IGEGSYGRVY----YGILKS--GHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V YGI KS A+K L +A+ + + ++++ ++ + KH+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 124 FVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP------------VLSW 170
+ LLG C +G V+ E+A+ G+L + L R+ PGP LS+
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSF 133
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
+ V A A+G+EYL + IHRD+ + NVL+ +D+V KIADF L+ D+
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
++ + APE +SDV+SFG+++ E+ T
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-21
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 75 IGEGSYGRVYYGILKSGHA-AAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG G++G V+ G L++ + A+K + PD +FL + ++ + H N V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ E G L GP L ++ +++ AA G+EYL K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESK- 113
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
H IHRD+ + N L+ + +V KI+DF +S + D + APE G
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 252 QLNAKSDVYSFGVVLLE 268
+ +++SDV+SFG++L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 75 IGEGSYGRVYY----GILKSGH----AAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
IG+G++GRV+ G+L A + K +AS +F + ++++ H N V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR-------------KGVKGAQPGPVLSWQQR 173
LLG C G L +E+ + G L++ L R K LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
+ IA A G+ YL E+ +HRD+ + N L+ ++ V KIADF LS S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ PE + +SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-21
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G ++ AIK ++ +E+F+ + ++ +L H VQL G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ EF NG L + L R+G +LS Q V +G+EYL +
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV------CEGMEYLERNS--- 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG------YHAPEYA 248
IHRD+ + N L+ V K++DF ++ D + G + PE
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-------DEYTSSSGAKFPVKWSPPEVF 173
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ ++KSDV+SFGV++ E+ T G+ P
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 75 IGEGSYGRVYY----GILKSGHA----AAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V GI K A+K L DA+ + + ++++ M+ + KH+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVKGA-----QPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ G+ + P L+++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A A+G+EYL A IHRD+ + NVL+ +D+V KIADF L+ ++ +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ APE +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 75 IGEGSYGRVYY-GILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
IGEG++G V+ ++G A+KK+ + + L ++ + +H V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
G+ VL E+ L ++L + +P L Q KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE-----RP---LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
I+HRD+K +N+LI D V KIADF L+ + RL+S +V T Y APE
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 251 GQ-LNAKSDVYSFGVVLLELLTGR 273
+ + D+++ G + ELL G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-21
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSR-LKHENFVQLLGYCV 132
IG+G+ G VY I + +G AIK+++ +QP +E + +V R KH N V L +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ +G Q + + LE+LH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 134
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
+IHRDIKS N+L+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 190
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
K D++S G++ +E++ G P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-21
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 75 IGEGSYGRVY----YGI--LKSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ Y + K A+K L D + ++F + +++ L+HE+ V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGV-----KGAQPGPVLSWQQRVKIAVGA 180
G C DG ++ +E+ +G L+ L HG + + Q L Q + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A G+ YL A H +HRD+ + N L+ + + KI DF +S +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ PE M + +SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-21
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G + A+K L + FL + +++ L+H+ V+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ + GSL D L +G K P + + + A+G+ Y+ K +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK---N 123
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
IHRD++++NVL+ + + KIADF L+ D ++ R F + APE G
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 180
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
KSDV+SFG++L E++T G+ P
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-21
Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 75 IGEGSYGRVYY----GILK---------SGHA--AAIKKL--DASKQPDEEFLAQVSMVS 117
+GEG +G V+ G+ + G A+K L D +K +FL ++ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK---GVKGAQPGPVLSWQQRV 174
RLK+ N ++LLG CV + E+ NG L+ L R+ A P +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLHS 233
+AV A G++YL A + +HRD+ + N L+ + KIADF +S N R+
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
VL + A E + G+ SDV++FGV L E+ T K ++L +Q
Sbjct: 190 RAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-21
Identities = 72/234 (30%), Positives = 115/234 (49%), Gaps = 26/234 (11%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVY-YGILKSGHAAAIKKLDASKQPDEEFLAQVSM 115
+ ++ L + T+ + IG+G+YG+VY K G AA+K LD DEE A+ ++
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI 71
Query: 116 VSRL-KHENFVQLLG--YCVD---GTSRVLAYEFASNGSLHDILHG--RKGVKGAQPGPV 167
+ L H N V+ G Y D G L E + GS+ +++ G G + + +
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA--M 129
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
+S+ I GA GL++LH IIHRD+K +N+L+ + K+ DF +S Q
Sbjct: 130 ISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--T 179
Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 276
+ RL +GT + APE Q +A+ DV+S G+ +EL G P+
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-21
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENF 124
IGEGS G V KS G A+KK+D KQ E L +V ++ +H N
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V++ + G + EF G+L DI+ H R ++ +Q + + K
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLAVLKA 127
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
L +LH + +IHRDIKS ++L+ D K++DF Q R S ++GT +
Sbjct: 128 LSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWM 182
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + D++S G++++E++ G P
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-21
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKH---ENFVQL 127
LIG G+YG VY G + +G A+K ++ D+ + +V+++S+L+ N +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + G + E+A GS+ ++ + GP+ V I L+Y+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKYISV-IIREVLVALKYI 117
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGY 242
H+ +IHRDIK++N+L+ + K+ DF + AA L+ +GT +
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGV-------AALLNQNSSKRSTFVGTPYW 167
Query: 243 HAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKP 275
APE G+ + K+D++S G+ + E+ TG P
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-21
Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 74 LIGEGSYGRVYYG-ILKSG--HAAAIKKLD--ASKQPDEEFLAQVSMVSRL-KHENFVQL 127
+IGEG++G+V I K G AAIK++ ASK +F ++ ++ +L H N + L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGA 180
LG C LA E+A +G+L D L + ++ LS QQ + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS R V T
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTM 182
Query: 241 GYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 271
G + LN SDV+S+GV+L E+++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-20
Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 31/217 (14%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
+IGEG++G+V +K AAIK++ ASK +F ++ ++ +L H N + L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG--------PVLSWQQRVKIAVG 179
LG C LA E+A +G+L D L + V P LS QQ + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS R V T
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKT 169
Query: 240 FGYHAPEYAMTGQLN-----AKSDVYSFGVVLLELLT 271
G + LN SDV+S+GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
+ +I + +I G G Y G +K+G +K+++ +A + +L+
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG---KLQ 741
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H N V+L+G C L +E+ +L ++L LSW++R KIA+G
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------LSWERRRKIAIGI 789
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
AK L +LH + P ++ ++ ++I D LS P + T+ +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLRLS--LPGLLCT--DTKCFISS 842
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
Y APE T + KSD+Y FG++L+ELLTG+ P D S+V W
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 75 IGEGSYGRVYY----GILK------SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V G+ K + A + K DA+++ + ++++ M+ + KH+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK--GVK-----GAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ G++ P LS++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+ + +T
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ APE +SDV+SFGV+L E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-20
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 27/222 (12%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKL----DASKQPDEEFLAQVSMVSR 118
E EN G ++G+G+YG VY S AIK++ QP E ++++ S
Sbjct: 6 EYDEN-GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSY 61
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
LKH N VQ LG + + E GSL +L + G ++ + +++
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAARLH--STR 235
+GL+YLH+ I+HRDIK NVL+ V KI+DF S + A ++ +
Sbjct: 118 --LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR----LAGINPCTET 168
Query: 236 VLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKP 275
GT Y APE G A +D++S G ++E+ TG+ P
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-20
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 75 IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENF 124
+GEG +G+V L +G A+K L + +Q + +++++ L HEN
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 125 VQLLGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
V+ G C + + L E+ GSL D L P L+ Q + A +
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICE 118
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTF 240
G+ YLH + H IHRD+ + NVL+ +D + KI DF L+ P+ R+ F
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
Y A E + + SDV+SFGV L ELLT
Sbjct: 176 WY-AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-20
Identities = 68/215 (31%), Positives = 113/215 (52%), Gaps = 17/215 (7%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDEEFLA---QVSMVSRLKHEN 123
+ IGEGS+G++Y KS IK++D +K P +E A +V +++++KH N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V + + E+ G L ++ ++GV ++ +LSW V+I++G
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSW--FVQISLG---- 113
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L+++H D I+HRDIKS N+ + + VAK+ DF ++ Q D + L T +GT Y
Sbjct: 114 LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYT-CVGTPYY 168
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
+PE N K+D++S G VL EL T + P +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 2e-20
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 39/219 (17%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G+GS+G+V K +G A+K L ++ E L + +++SR+ H V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 130 YCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK----- 182
+ L E+A G L L + + + A+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL-----------------SKEGRFSEERARFYAAE 101
Query: 183 ---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
LEYLH II+RD+K N+L+ D K+ DF L+ + +R ++ GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
Y APE + D +S GV+L E+LTG+ P
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 31/216 (14%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IG G+YGRVY K+G AIKK K+ +++++ LKHEN V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 128 LGYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPV---LSWQQRVKIAVGAAK 182
+ ++ + L +++A + I R+ + + P + L WQ
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------ILN 119
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN--QAPDMAARLHSTRV 236
G+ YLH ++HRD+K +N+L+ + V KI D L+ AP + V
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPLADLDPV 175
Query: 237 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLT 271
+ T Y APE + + K+ D+++ G + ELLT
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 37/214 (17%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ +++ AIKK+ S KQ +E++ + +V + +L+H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 130 YCVDGTSRVLAYEFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLE 185
+ + L E+ GS DIL +K + Q V+IA GA +GL
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHKKPL------------QEVEIAAICHGALQGLA 129
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHSTRVLGTFGYHA 244
YLH IHRDIK+ N+L+ + K+ADF S +P + +GT + A
Sbjct: 130 YLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMA 179
Query: 245 PE--YAM-TGQLNAKSDVYSFGVVLLELLTGRKP 275
PE AM GQ + K DV+S G+ +E L RKP
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-20
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
IGEGS G V +KS G A+KK+D KQ E L +V ++ +HEN V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
G + EF G+L DI+ H R ++ +Q + + K L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLKALSVLHAQG 136
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
+IHRDIKS ++L+ D K++DF Q R S ++GT + APE
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRL 191
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
+ D++S G++++E++ G P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-20
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 74 LIGEGSYGRVYYGILKSG----HAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
+IG G +G V G LK AIK L + +++ +FL++ S++ + H N + L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ EF NG+L L G Q + Q V + G A G++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVI----QLVGMLRGIAAGMKYL 122
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGYHA 244
++ + +HRD+ + N+L+ + V K++DF LS D + T LG + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
PE + + SDV+S+G+V+ E+++ G +P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-20
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKLDASKQPDE----EFLA 111
L+EIT +G G +G V+ K +K L K DE EF
Sbjct: 7 LQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRR 57
Query: 112 QVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++ M +L H+N V+LLG C + + E+ G L L K P LS +
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
Q+V + A G+++L ++ +HRD+ + N L+ K++ LS +
Sbjct: 118 QKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
++ + APE + KSDV+SFGV++ E+ T
Sbjct: 175 LRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 71/217 (32%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA---QVSMVSRLKHE 122
E+F IG G+YG VY + +G AAIK + +P E+F ++ M+ KH
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHS 66
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
N V G + + EF GSL DI H GP LS Q ++ +
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQ 117
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL YLH K +HRDIK +N+L+ D+ K+ADF +S Q A+ S +GT +
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYW 172
Query: 243 HAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPV 276
APE A G N D+++ G+ +EL + P+
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 75 IGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G VY GI ++ AIK +D + DE + +++++S+ + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ GT + E+ GS D+L +PGP L I KGL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSER 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
+ K+D++S G+ +EL G P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-20
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 27/214 (12%)
Query: 74 LIGEGSYGRVYYGILK----SGHAAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
+IG G +G V+ GILK A AIK L +++ ++FL++ S++ + H N ++L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ E+ NG+L L G S Q V + G A G++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL 123
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG-----Y 242
+D + +HRD+ + N+L+ + K++DF LS D ++T + G +
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRW 176
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + + SDV+SFG+V+ E+++ G +P
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-20
Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 41/248 (16%)
Query: 43 GAQAVKVQPIEVPAISVDELKEITEN---FGTNALIGEGSYGRVY----YGILKSGHA-- 93
G + V + P ++P D E N FG +G G++G+V YG+ KS
Sbjct: 13 GNEYVYIDPTQLP---YDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMK 67
Query: 94 AAIKKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150
A+K L + E ++++ ++S L HEN V LLG C G ++ E+ G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210
+ L RK +LS+ +V AKG+ +L K + IHRD+ + NVL+
Sbjct: 128 NFLR-RKRESFLTLEDLLSFSYQV------AKGMAFLASK---NCIHRDLAARNVLLTHG 177
Query: 211 DVAKIADFDL-------SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFG 263
+ KI DF L SN ARL + APE +SDV+S+G
Sbjct: 178 KIVKICDFGLARDIMNDSNYVVKGNARL-------PVKWMAPESIFNCVYTFESDVWSYG 230
Query: 264 VVLLELLT 271
++L E+ +
Sbjct: 231 ILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 8e-20
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G V+ GI ++ AIK +D + DE + +++++S+ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ T + E+ GS D+L +PGP L Q I KGL+YLH +
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
++K+D++S G+ +EL G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 69/210 (32%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 75 IGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDE---EFLAQVSMVSRLKHENFVQLLGY 130
IGEG+YG VY SG A+KK+ + D L +++++ L+H N V+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 131 CVDG--TSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLE 185
V S L E+ SL D + P P Q VK + + +GL+
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNM----------PTPFSESQ--VKCLMLQLLRGLQ 122
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLHE IIHRD+K SN+L+ D KIADF L+ A T + T Y AP
Sbjct: 123 YLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAP 177
Query: 246 E--YAMTGQLNAKSDVYSFGVVLLELLTGR 273
E T A D+++ G +L ELL +
Sbjct: 178 ELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 63/218 (28%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKH 121
+ ++GEG+YG V K +G AIKK S+ DE+ L +V ++ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRH 59
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV--LSWQQRVKIAVG 179
EN V L L +E+ +L ++L G G P V WQ
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG--GLPPDAVRSYIWQ-------- 108
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
+ + Y H +IIHRDIK N+L+ + V K+ DF + A T + T
Sbjct: 109 LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVAT 164
Query: 240 FGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGR 273
Y APE G DV++ G ++ ELL G
Sbjct: 165 RWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 75 IGEGSYGRVYY----GI----LKSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V GI K A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P ++++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A+G+EYL A IHRD+ + NVL+ +++V KIADF L+ ++ +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ APE +SDV+SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 72 NALIGEGSYGRVYYGILKSGH----AAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFV 125
IGEG +G VY G+ S A A+K K S E+FL + ++ + H + V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+L+G + ++ E A G L L K L + + + L
Sbjct: 71 KLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YL K +HRDI + NVL+ D K+ DF LS + + + +++ + AP
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAP 177
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
E + + SDV+ FGV + E+L G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLL-GYC 131
+G+G++G+VY K +G AA K + + + E+F+ ++ ++S KH N V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ +L EF G+L I L +G+ Q V + L +LH
Sbjct: 73 YENKLWIL-IEFCDGGALDSIMLELERGLTEPQIRYVCRQ---------MLEALNFLHSH 122
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
+IHRD+K+ N+L+ D K+ADF +S + + + +GT + APE
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVAC 177
Query: 251 GQL-----NAKSDVYSFGVVLLELLTGRKP 275
+ K+D++S G+ L+EL P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
+GE ++G++Y G L AIK L P + EF + S+++ L H N V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL-----HGRKGVKGAQPGPV---LSWQQRVKIAVG 179
LG + +E+ + G LH+ L H G + G V L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
A G+EYL + +H+D+ + N+LI + KI+D LS + + L
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ PE M G+ ++ SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-19
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G V+ GI ++ AIK +D + DE + +++++S+ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ GT + E+ GS D+L + GP +Q + KGL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------RAGPFDEFQIATMLK-EILKGLDYLHSEK 121
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
IHRDIK++NVL+ + K+ADF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
++K+D++S G+ +EL G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-19
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
IGEGS G V K +G A+KK+D KQ E L +V ++ HEN V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 133 DGTSRVLAYEFASNGSLHDIL-HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
G + EF G+L DI+ H R ++ +Q + + + L YLH +
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR-----------MNEEQIATVCLSVLRALSYLHNQG 138
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
+IHRDIKS ++L+ D K++DF Q + S ++GT + APE
Sbjct: 139 ---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRL 193
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
+ D++S G++++E++ G P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-19
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ A+K + E FLA+ +++ L+H+ V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
++ EF + GSL D L +G K QP P L + + A+G+ ++ ++ +
Sbjct: 74 PIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR---N 122
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQ 252
IHRD++++N+L+ V KIADF L+ D ++ R F + APE G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 179
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
KSDV+SFG++L+E++T GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-19
Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 26/245 (10%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF 109
P+ I D + ++ + IG+G+YG+V+ + K +G AA+K LD DEE
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61
Query: 110 LAQVSMVSRLK-HENFVQLLGY-----CVDGTSRVLAYEFASNGSLHDILHG--RKGVKG 161
A+ +++ L H N V+ G +G L E + GS+ D++ G ++G +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 162 AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
+P ++++ I A GL++LH IHRD+K +N+L+ + K+ DF +S
Sbjct: 122 EEP--IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPEY-AMTGQL----NAKSDVYSFGVVLLELLTGRKPV 276
Q + RL +GT + APE A QL +A+ DV+S G+ +EL G P+
Sbjct: 172 AQL--TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
Query: 277 DHTLP 281
P
Sbjct: 230 ADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-19
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 75 IGEGSYGRVYY----GILK-------------SGHAAAIKKL--DASKQPDEEFLAQVSM 115
+GEG +G V+ G+ K A+K L DA+K +FL ++ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 173
+SRLK N ++LL C+ + E+ NG L+ L H + +S+
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARLH 232
+ +A A G++YL + + +HRD+ + N L+ + KIADF +S N R+
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
VL + + E + G+ SDV++FGV L E+LT
Sbjct: 190 GRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF------LAQVSMVSRLKHENFVQL 127
IGEG+YG VY +G AIKK+ K E L ++ ++ L H N ++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L L +EF I ++G+ + L +Q +GL +
Sbjct: 64 LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-YQ--------LLQGLAFC 114
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLH--STRVLGTFGYHA 244
H I+HRD+K N+LI + V K+ADF L+ + H TR Y A
Sbjct: 115 HSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRA 166
Query: 245 PEYAMT-GQLNAKSDVYSFGVVLLELLTGR 273
PE + + D++S G + ELL+ R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 70/224 (31%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 75 IGEGSYGRVYYGIL------KSGHAAAIKKL-DASKQP-DEEFLAQVSMVSRLKHENFVQ 126
+GE +G+VY G L + A AIK L D ++ P EEF + M SRL+H N V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR------------KGVKGAQPGPVLSWQQRV 174
LLG + + + S+ LH+ L R K VK V
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-----V 127
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLH 232
I A G+E+L + H++H+D+ + NVL+FD KI+D L + A D +
Sbjct: 128 HIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
++ L + +PE M G+ + SD++S+GVVL E+ + G +P
Sbjct: 185 NS--LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-18
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 74 LIGEGSYGRVYYGILKSGH----AAAIKKLDA--SKQPDEEFLAQVSMVSRLKHENFVQL 127
+IG G +G V G LK AIK L A +++ +FL++ S++ + H N + L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ E+ NGSL L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGYHA 244
+D +HRD+ + N+L+ + V K++DF LS D ++TR G + A
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIPIRWTA 177
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
PE + + SDV+S+G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-18
Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 36/226 (15%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM----VSRLK-HENFVQL 127
+IGEGS+ V K + AIK LD + E+ + V + ++RL H ++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
D + E+A NG L + L + A LEYL
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---------LDEKCTRFYAAEILLALEYL 118
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADF--------DLSNQAPDMAARLHSTR---- 235
H K IIHRD+K N+L+ D KI DF + S ++ A ++
Sbjct: 119 HSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 236 ------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+GT Y +PE SD+++ G ++ ++LTG+ P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGY 130
IG+GS+G V KS G K++D + ++ +++V+++ LKH N V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 131 CVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+D +++ L Y E+ G L ++ K + + W+ ++ + L
Sbjct: 68 IIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLA----LYEC 121
Query: 188 HEKADPH--IIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGY 242
H ++DP ++HRD+K +N+ + ++ K+ DF L+ A T V GT Y
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA----KTYV-GTPYY 176
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+PE + KSD++S G ++ EL P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 2e-18
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYC 131
L+G G+YG+VY G +K+G AAIK +D + +EE +++M+ + H N G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 132 VDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ L EF GS+ D++ KG L + I +GL
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLS 125
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+LH+ +IHRDIK NVL+ ++ K+ DF +S Q R ++ +GT + AP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 180
Query: 246 EYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 276
E + + KSD++S G+ +E+ G P+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-18
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 32/209 (15%)
Query: 75 IGEGSYGRVYYGIL----KSGHAAAIKKLDASK-QPDE--EFLAQVSMVSRLKHENFVQL 127
IGEGS+G+ IL + G IK+++ SK P E E +V+++S +KH N VQ
Sbjct: 8 IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+ + + ++ G L+ ++ ++GV +L W ++ +A L+++
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLA------LKHV 117
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-----GTFGY 242
H D I+HRDIKS N+ + D K+ DF + A L+ST L GT Y
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYY 167
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+PE N KSD+++ G VL E+ T
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSM 115
I + L++ F ++G G+YG+VY G +K+G AAIK +D ++ +EE +++M
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 116 VSRLKHE-NFVQLLGYCVDGT------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
+ + H N G + + L EF GS+ D++ KG L
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NAL 118
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
I +GL +LH +IHRDIK NVL+ ++ K+ DF +S Q
Sbjct: 119 KEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQ-----LNAKSDVYSFGVVLLELLTGRKPV 276
R ++ +GT + APE + + +SD++S G+ +E+ G P+
Sbjct: 176 GRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-18
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 75 IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDEE--FLAQVSMVSRLKHENFVQLLG 129
IG G +G+V G G + A +K+L AS PDE+ FL +V L H N +Q LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C++ +L EF G L + L +G+ + QR +A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MACEVASGLLWLHQ 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA- 248
IH D+ N + D KI D+ L+ + + + APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 249 ------MTGQLNAKSDVYSFGVVLLELLT 271
+ KS+++S GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-18
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK---SGHA---AAIKKLDASKQPD 106
EV + L+E+ G+GS+G VY G + G A A+K ++ S
Sbjct: 2 EVSREKITLLREL----------GQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 51
Query: 107 E--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
E EFL + S++ + V+LLG G ++ E ++G L L + P
Sbjct: 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 111
Query: 165 G-PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
G P + Q+ +++A A G+ YL+ K +HRD+ + N ++ D KI DF ++
Sbjct: 112 GRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ + L + APE G SD++SFGVVL E+ +
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 60/220 (27%), Positives = 84/220 (38%), Gaps = 39/220 (17%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---------NF 124
I +G+YGRV+ KS G AIK + + + + + V ++ E +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD------MIRKNQVDQVLTERDILSQAQSPY 54
Query: 125 VQLLGYCVDGTSRV-LAYEFASNGSLHDILH--GRKGVKGAQPGPVLSWQQRVKIAVGAA 181
V L Y G + L E+ G L +L G L
Sbjct: 55 VVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-----------SLDEDVARIYIAEIV 103
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------NQAPDMAARLHSTR 235
LEYLH IIHRD+K N+LI + K+ DF LS Q R
Sbjct: 104 LALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
++GT Y APE + + D +S G +L E L G P
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKL-----DASKQPD--EEFLAQVSMVSRLKHENF 124
+G G++ Y +K+G A+K++ +S+Q + E ++ +++RL H +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV--GAAK 182
+++LG + + L E+ + GS+ +L + G +++ V I +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS--------KYGA---FKEAVIINYTEQLLR 114
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHST----- 234
GL YLHE IIHRD+K +N+LI D +IADF A +AA+
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLI--DSTGQRLRIADF---GAAARLAAKGTGAGEFQG 166
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
++LGT + APE Q DV+S G V++E+ T + P
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYG-ILKSGHAAAIKKLDASKQPDE--EFLAQV 113
+++L+ + E IG G+ G+VY K+GH A+K++ + +E L +
Sbjct: 12 ADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL 64
Query: 114 SMVSRLKHE--NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+V H+ V+ GY + + + E S + D L K ++G P +L
Sbjct: 65 DVVL-KSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKL--LKRIQGPIPEDILG-- 117
Query: 172 QRVKIAVGAAKGLEYLHEKADPH-IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
K+ V K L YL EK H +IHRD+K SN+L+ K+ DF +S + D A+
Sbjct: 118 ---KMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171
Query: 231 LHSTRVLGTFGYHAPEY----AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
TR G Y APE + + ++DV+S G+ L+EL TG+ P
Sbjct: 172 ---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-18
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA-QVSMVSRLKHENFVQLLGYCV 132
IG+G+ G V+ I + +G AIK+++ KQP +E + ++ ++ LK+ N V L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ + Q + + LE+LH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV----------TETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
+IHRDIKS NVL+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 190
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
K D++S G++ +E++ G P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 5e-18
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
IG+G+ G VY + + +G AI++++ +QP +E + +V R K+ N V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ +G Q + + LE+LH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLHSN-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
+IHRDIKS N+L+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 191
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
K D++S G++ +E++ G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-18
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
IG+G+ G VY I + +G AIK+++ +QP +E + +V R K+ N V L +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ +G Q + + L++LH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALDFLHSN-- 134
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
+IHRDIKS N+L+ D K+ DF Q P+ + R + ++GT + APE
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 190
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
K D++S G++ +E++ G P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
+G G+YG VY L +G AA+K + D + Q + MV KH N V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ E+ GSL DI H GP LS Q + +GL YLH K
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--- 249
+HRDIK +N+L+ D+ K+ADF ++ + A+ S +GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEK 182
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKPV 276
G N D+++ G+ +EL + P+
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 66 TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD----ASKQPDEEFLAQVSMVSRLK 120
NF IG+G + VY I L G A+KK+ + ++ L ++ ++ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H N ++ L ++ + E A G L I H +K K P + W+ V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYFVQLC-- 116
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
LE++H K I+HRDIK +NV I V K+ D L HS ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y +PE N KSD++S G +L E+ + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 50/119 (42%), Positives = 63/119 (52%), Gaps = 16/119 (13%)
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
P +L KIAV K LEYLH K +IHRD+K SNVLI + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-----KSDVYSFGVVLLELLTGRKPVD 277
D A+ T G Y APE + +LN KSDV+S G+ ++EL TGR P D
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIK------KLDASKQPD-EEFLAQVSMVSRLKHENFVQ 126
++GEG +G V G L + +K KLD + EEFL++ + + H N ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 127 LLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
L+G C + +S ++ F +G LH L + + P+ Q +K V
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QTLLKFMVDI 122
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLG 238
A G+EYL + + IHRD+ + N ++ +D +ADF LS + + D + ++
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-- 177
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ A E +KSDV++FGV + E+ T G+ P
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAA----AIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126
++G G++G VY GI + G AIK L+ + P + EF+ + +++ + H + V+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C+ T + L + +G L D +H K G+Q +L+W V AKG+ Y
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL--LLNW------CVQIAKGMMY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
L E+ ++HRD+ + NVL+ + KI DF L+ ++ + A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
+ +SDV+S+GV + EL+T G KP D
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDE--EFLA--QVSMVSRLKHENFV 125
+GEG+Y VY ++G AIKK L K+ + F A ++ ++ LKH N +
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
LL ++ L +EF L ++ + V P + S+ +GLE
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM------TLRGLE 116
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH I+HRD+K +N+LI D V K+ADF L+ R + +V+ T Y AP
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAP 171
Query: 246 EYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
E A+ D++S G + ELL R P
Sbjct: 172 ELLF----GARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 32/213 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ +++ AIKK+ S KQ +E++ + +V + R+KH N ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
+ + L E+ GS D+L K P+ Q V+IA GA +GL Y
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAITHGALQGLAY 140
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH ++IHRDIK+ N+L+ + K+ADF + +A+ +S +GT + APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFG----SASIASPANS--FVGTPYWMAPE 191
Query: 247 YAMT---GQLNAKSDVYSFGVVLLELLTGRKPV 276
+ GQ + K DV+S G+ +EL + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 38/219 (17%)
Query: 74 LIGEGSYGRVYYGILKSG-----HAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
L+ EG++GR++YGIL +K + AS+ L + ++ L H+N +
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 127 LLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+L C+ DG + Y + + G+L L + A LS QQ V +A+ A G+
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG-EANNPQALSTQQLVHMAIQIACGMS 131
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH-- 243
YLH++ +IH+DI + N +I ++ KI D LS R L YH
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALS-------------RDLFPMDYHCL 175
Query: 244 -----------APEYAMTGQLNAKSDVYSFGVVLLELLT 271
A E + + ++ SDV+SFGV+L EL+T
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-17
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 75 IGEGSYGRVYYGILKS------GHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
+G+GS+G VY GI K AIK ++ + E EFL + S++ + V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL-SWQQRVKIAVGAAKGLE 185
LLG G ++ E + G L L + P S ++ +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YL+ +HRD+ + N ++ +D KI DF ++ + + L + +P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLT 271
E G SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 74 LIGEGSYGRV---YYGILK--SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQL 127
+G+G++G V Y L+ +G A+KKL S +F ++ ++ L+H+N V+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 128 LGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C R L E+ GSL D L + + + + Q KG+E
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGME 122
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG---TFGY 242
YL K +HRD+ + N+L+ ++ KI DF L+ P + R G F Y
Sbjct: 123 YLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWY 178
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
APE + + SDV+SFGVVL EL T
Sbjct: 179 -APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 33/212 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ + A+KK+ S KQ +E++ + +V + +LKH N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEY 186
+ + L E+ GS D+L K P+ Q V+IA GA +GL Y
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKK-------PL----QEVEIAAITHGALQGLAY 136
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH +IHRDIK+ N+L+ + K+ADF ++++ + +GT + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPE 187
Query: 247 YAMT---GQLNAKSDVYSFGVVLLELLTGRKP 275
+ GQ + K DV+S G+ +E L RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-17
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRLK 120
N+ L+G+G++GRVY + +G A+K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
HE VQ G D + + E+ GS+ D L G + R K
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR-KYTRQI 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST---RVL 237
+G+EYLH I+HRDIK +N+L K+ DF S + T V
Sbjct: 114 LEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVT 168
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT + +PE K+DV+S G ++E+LT + P
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-17
Identities = 50/142 (35%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV--KIAVGAAKGLEYLHEKADPHI 195
+ EF GSL I +KG GP+ + KIAV +GL YL+ I
Sbjct: 79 CMCMEFMDCGSLDRIY--KKG------GPI---PVEILGKIAVAVVEGLTYLYNVH--RI 125
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA 255
+HRDIK SN+L+ K+ DF +S + + A T V GT Y +PE G+
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTSTYMSPERIQGGKYTV 181
Query: 256 KSDVYSFGVVLLELLTGRKPVD 277
KSDV+S G+ ++EL G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-17
Identities = 38/113 (33%), Positives = 52/113 (46%), Gaps = 14/113 (12%)
Query: 171 QQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
Q+VK + K LEYLH K IIHRDIK N+L+ + I DF+++
Sbjct: 92 SQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT 148
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ +T GT GY APE + D +S GV E L G++P
Sbjct: 149 KVTP---DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 34/231 (14%)
Query: 75 IGEGSYGRVYY-------GILKSGHAA----------AIKKL--DASKQPDEEFLAQVSM 115
+GEG +G V+ + A A+K L DAS E+FL +V +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--GPVLSWQQR 173
+SRL N +LLG C + E+ NG L+ L LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
+ +A A G+ YL + +HRD+ + N L+ + KIADF +S ++ + +
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY 186
Query: 234 TRVLGT----FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDH 278
RV G + A E + G+ KSDV++FGV L E+LT +P +H
Sbjct: 187 -RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 51/219 (23%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQ---- 126
+G+GSYG V ++ G IKKL+ AS++ + + ++S+LKH N V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 127 ----------LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
++G+C G D+ H K Q G +L Q V+
Sbjct: 68 WEGEDGLLYIVMGFCEGG----------------DLYHKLK----EQKGKLLPENQVVEW 107
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD----LSNQAPDMAARLH 232
V A L+YLHEK HI+HRD+K+ NV + ++ K+ D L NQ DMA+ L
Sbjct: 108 FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL- 162
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+GT Y +PE N KSDV++ G + E+ T
Sbjct: 163 ----IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-17
Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 29/210 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEF---LAQVSMVSRLKHENFVQLLG 129
IG GS+G VY+ +++ AIKK+ S KQ +E++ + +V + +L+H N +Q G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ + L E+ GS D+L K +P L + + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP---LQEVEIAAVTHGALQGLAYLHS 133
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADF-DLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
++IHRD+K+ N+L+ + + K+ DF S AP + +GT + APE
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183
Query: 249 MT---GQLNAKSDVYSFGVVLLELLTGRKP 275
+ GQ + K DV+S G+ +E L RKP
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAA-AIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQ 126
+GEG +G+V ++G+ A+K L + E + L++ +++ ++ H + ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR------------- 173
L G C +L E+A GSL L + V P + S R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKV---GPSYLGSDGNRNSSYLDNPDERAL 124
Query: 174 -----VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
+ A ++G++YL E ++HRD+ + NVL+ + KI+DF LS +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ + ++ + A E +SDV+SFGV+L E++T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL-AQVSMVSRLKHENFVQLLGYCV 132
IGEGS G V K SG A+K +D KQ E L +V ++ +H+N V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + EF G+L DI+ + L+ +Q + + L YLH +
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG- 137
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTG 251
+IHRDIKS ++L+ D K++DF Q + D+ R ++GT + APE
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISRT 192
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
+ D++S G++++E++ G P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 75 IGEGSYGRVYYGILKSGHA---AAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ K AIK K + K +E + + ++ +L + V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + + +L E AS G L+ L G+K ++ V++ + G++YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPEY 247
K + +HRD+ + NVL+ + AKI+DF LS +A + R G + ++APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ +++SDV+S+G+ + E + G+KP
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 42/104 (40%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
KIAV K L YL K + IIHRD+K SN+L+ + K+ DF +S Q D A+ T
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---T 165
Query: 235 RVLGTFGYHAPEYAMTGQLNA---KSDVYSFGVVLLELLTGRKP 275
R G Y APE + +SDV+S G+ L E+ TG+ P
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL---DASKQPDEEFLAQVSMVSRL 119
E EN G L+GEGSYG V K +G AIKK + K + + ++ M+ +L
Sbjct: 1 EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+HEN V L+ L +EF + L D+ G L + K
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESRVRKYLFQ 108
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-TRVLG 238
+G+E+ H +IIHRDIK N+L+ V K+ DF A +AA T +
Sbjct: 109 ILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF---ARTLAAPGEVYTDYVA 162
Query: 239 TFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTG 272
T Y APE + ++ D+++ G ++ E+LTG
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
E GSL +L +K G P +L KI++ +GL YL EK I+HRD+K
Sbjct: 79 EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLREKHK--IMHRDVK 127
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
SN+L+ K+ DF +S Q D A +GT Y +PE +SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 262 FGVVLLELLTGRKPV 276
G+ L+E+ GR P+
Sbjct: 184 LGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 22/224 (9%)
Query: 62 LKEITENFGTNALIGEGSYGRVYYGI-LKSGH----AAAIKKLDASKQP--DEEFLAQVS 114
LKE TE F ++G G++G VY G+ + G AIK+L + P ++E L +
Sbjct: 4 LKE-TE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+++ + + + +LLG C+ T +++ + G L D + K G+Q +L+W
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW---- 114
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
V AKG+ YL E+ ++HRD+ + NVL+ KI DF L+ H+
Sbjct: 115 --CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
+ A E + +SDV+S+GV + EL+T G KP D
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-16
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQL 127
+GEG +G+V +G A+K L + + ++ ++ L HEN V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 128 LGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C + G L EF +GSL + L K ++ +Q++K AV KG++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--------INLKQQLKYAVQICKGMD 123
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH 243
YL + +HRD+ + NVL+ + KI DF L+ L + F Y
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY- 179
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
APE + + SDV+SFGV L ELLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-16
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 75 IGEGSYGRV---YYGILKSGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G++G V Y + KS A+K L + +E L + +++ +L + V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C + S +L E A G L+ L K V + ++ + G++YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE---------KNITELVHQVSMGMKYLE 112
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF--GYHAPE 246
E + +HRD+ + NVL+ AKI+DF LS +A + + G + ++APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALGADENYYKAKTHGKWPVKWYAPE 168
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ ++KSDV+SFGV++ E + G+KP
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 74 LIGEGSYGRVYYGI-LKSGHA----AAIKKLD--ASKQPDEEFLAQVSMVSRLKHENFVQ 126
L+G G +G V+ GI + G + AIK + + +Q +E + + L H V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C G S L + + GSL D + + P +L+W V AKG+ Y
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNW------CVQIAKGMYY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
L E ++HR++ + N+L+ D + +IADF +++ + + + A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ G+ +SDV+S+GV + E+++ G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF-----LAQVSMVSRLKHENFVQLL 128
IGEGSYG V+ + +G AIKK S+ D+ L ++ M+ +LKH N V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 129 GYCVDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
V R L +E+ + L+++ +GV KI + + +
Sbjct: 67 E--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE---------HLIKKIIWQTLQAVNF 115
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTF 240
H+ + IHRD+K N+LI K+ DF AR+ + T + T
Sbjct: 116 CHKH---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATR 164
Query: 241 GYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTG 272
Y APE + G Q DV++ G V ELLTG
Sbjct: 165 WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-15
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+ G VY L + A+K LD + + ++ ++++ ++ + + G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ EF GSL V P VL +IAV KGL YL
Sbjct: 69 FVENRISICTEFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL- 114
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
I+HRD+K SN+L+ K+ DF +S Q + A+ + +GT Y APE
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISGE 168
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
Q SDV+S G+ +EL GR P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF--LAQVSMVSRLK-HENFVQLLGY 130
IGEG++ V K+G AIK + + E+ L ++ + RL H N ++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 131 CVDGTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYLH 188
D + LA F + +L++++ GRK +P P ++RVK K L+++H
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRK-----RPLP----EKRVKSYMYQLLKSLDHMH 117
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
I HRDIK N+LI DD+ K+ADF + ++ T + T Y APE
Sbjct: 118 RNG---IFHRDIKPENILI-KDDILKLADF---GSCRGIYSKPPYTEYISTRWYRAPECL 170
Query: 249 MT-GQLNAKSDVYSFGVVLLELLT 271
+T G K D+++ G V E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-15
Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 52/223 (23%)
Query: 74 LIGEGSYGRVYYGIL----KSGHAAAIKKLD--ASKQPDEEFLAQVSMVSRLKHENFVQL 127
+IG+G +G VY+G L A+K L+ + E+FL + ++ H N + L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDIL----HG--RKGVKGAQPGPVLSWQQRVKIAVG-- 179
LG C+ S GS +L HG R ++ P VK +G
Sbjct: 62 LGICLP-----------SEGSPLVVLPYMKHGDLRNFIRSETHNPT------VKDLIGFG 104
Query: 180 --AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD---------MA 228
AKG+EYL K +HRD+ + N ++ + K+ADF L+ D
Sbjct: 105 LQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
A+L + A E T + KSDV+SFGV+L EL+T
Sbjct: 162 AKL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 25/200 (12%)
Query: 90 SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA-YEFA 144
+GH AIK L +E F + ++ +RL H N V LL + A +E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
+L ++L A G L + ++ + L H + I+HRD+K N
Sbjct: 62 PGRTLREVL--------AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQN 109
Query: 205 VLIFDDDV---AKIADFDLSNQAPDM--AARLHSTR---VLGTFGYHAPEYAMTGQLNAK 256
+++ V AK+ DF + P + A TR VLGT Y APE +
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 257 SDVYSFGVVLLELLTGRKPV 276
SD+Y++G++ LE LTG++ V
Sbjct: 170 SDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 74 LIGEGSYGRVYYGI-LKSGH----AAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
++G G++G VY GI + G AIK L + S + ++E L + +++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C+ T + L + G L D + K G+Q +L+W V AKG+ Y
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNW------CVQIAKGMSY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
L E ++HRD+ + NVL+ + KI DF L+ H+ + A E
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLT-GRKPVD 277
+ + +SDV+S+GV + EL+T G KP D
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+GEG+Y VY G + +G A+K LDA + + ++S++ LKHEN V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 132 VDGTSRVLAYEFASNG--SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+L +E+ D HG +G P V S+ ++ KG+ + HE
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDT-HGVRG--ALDPNTVKSFTYQL------LKGIAFCHE 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
++HRD+K N+LI K+ADF L+ +A + S V+ T Y AP+ +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 250 TGQLNAKS-DVYSFGVVLLELLTGR 273
+ + S D++S G ++ E++TGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 72 NALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF---------------LAQVSM 115
A +GEG+YG+V +G AIKK+ + ++ L ++ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
++ +KHEN + L+ V+G L + + L ++ + L+ Q
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKC 123
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQ 223
I + GL LH+ + +HRD+ +N+ I + KIADF L+ ++
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKP 275
M R T + T Y APE M + + D++S G + ELLTG KP
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP 232
|
Length = 335 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 75 IGEGSYGRVYYGILKSGHA---AAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+GEG +G V G L + A+K + ++ E+FL++ + H N ++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 129 GYCVDGTSR------VLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
G C+ V+ F +G LH +L+ R G P L Q VK A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR---LGDCP-QYLPTQMLVKFMTDIA 122
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD----MAARLHSTRVL 237
G+EYL K IHRD+ + N ++ ++ +ADF LS + + R+ V
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV- 178
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ A E KSDV+SFGV + E+ T G+ P
Sbjct: 179 ---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLKHENFVQLL 128
IGEG+YG VY G K+G A+KK+ + +EE + ++S++ L+H N V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL--ESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + L +EF S L L + V S+ ++ +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCH 118
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
+ ++HRD+K N+LI + V K+ADF L+ +A + R+++ V+ T Y APE
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPEVL 173
Query: 249 MTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
+ + D++S G + E+ T +KP+ H
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 48/228 (21%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
+GEG++G VY +K+G A+KK+ + D F L ++ ++ +LKH N V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLID 74
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV-----LSWQQRVKIAVGAAK-- 182
+A E R V P L VK+ K
Sbjct: 75 ---------MAVERPDK-----SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 183 ------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPDM 227
G+ YLHE HI+HRDIK++N+LI + + KIADF L + +
Sbjct: 121 MLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKS--DVYSFGVVLLELLTGR 273
T ++ T Y PE + G+ + D++ G V E+ T R
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 3e-14
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLA--QVSMVSRLK-HENFVQLLGY 130
+G+G++G VY K G AIKK+ EE + +V + +L H N V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ +E+ G+L+ ++ RKG + S ++ +GL ++H+
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQI------LQGLAHIHKH 118
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE---- 246
HRD+K N+L+ +V KIADF L A ++ +R T + T Y APE
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 247 ---YAMTGQLNAKSDVYSFGVVLLELLTGR 273
Y ++ D+++ G ++ EL T R
Sbjct: 173 STSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-14
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 75 IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDEE--FLAQVSMVSRLKHENFVQLLG 129
IG G +G+V G + SG+ A +K+L S E+ FL + L+H N +Q LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + T +L EF G L L + + P P + Q+ +A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP-TTLQR---MACEIALGLLHLHK 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA- 248
+ IH D+ N L+ D KI D+ LS+ + ++ + APE
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 249 -MTGQL-----NAKSDVYSFGVVLLELLT-GRKPVDH 278
+ G L +S+V+S GV + EL G +P H
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 53/228 (23%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK---HEN 123
A IGEG+YG VY L +G A+KK+ EE L +++++ +L+ H N
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 124 FVQLLGYCV-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG--PV----LSWQQ 172
V+LL C L +E L L K +PG P L Q
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-----KCPKPGLPPETIKDLMRQ- 115
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
+G+++LH I+HRD+K N+L+ D KIADF L AR++
Sbjct: 116 -------LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL--------ARIY 157
Query: 233 S-----TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
S T V+ T Y APE + D++S G + EL R+P
Sbjct: 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-14
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQ--VSMVSRLKHENFVQLLG 129
++G G++G V+ K+ I K +Q DE AQ ++ L H N ++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
++ + ++ E+A G+L + + R +L + ++ +A L ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLA------LHHVHT 119
Query: 190 KADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
K I+HRD+K+ N+L+ V KI DF +S ++++ + V+GT Y +PE
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELC 173
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
N KSD+++ G VL EL + ++ +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 67/230 (29%), Positives = 112/230 (48%), Gaps = 37/230 (16%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQ 112
SVDE +++ I EG+YG VY K+G A+KKL K+ E F L +
Sbjct: 3 SVDEYEKLNR-------IEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLRE 54
Query: 113 VSMVSRLKHENFVQL----LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
++++ +L+H N V + +G +D V+ Y + H K + P L
Sbjct: 55 INILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY----------VEHDLKSLMETMKQPFL 104
Query: 169 SWQQRVK-IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
Q VK + + G+ +LH+ I+HRD+K+SN+L+ + + KI DF L+ +
Sbjct: 105 --QSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
Query: 228 AARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPV 276
T+++ T Y APE + + + D++S G + ELLT +KP+
Sbjct: 160 LKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-14
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 74 LIGEGSYGRVYYGIL----KSGHAAAIKKLDASKQPDEE--FLAQVSMVSRLKHENFVQL 127
++G G +G + G L K AI L A + FLA+ + + H N V+L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G G + ++ E+ SNG+L L +G L Q + + G A G++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYL 123
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
E +H+ + + VL+ D V KI+ F Q A + + APE
Sbjct: 124 SEMG---YVHKGLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 248 AMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
++ SDV+SFG+V+ E+++ G +P
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-14
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 24/204 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG-YC 131
+G+G++G+VY K A A K+ +K +E +++ ++ +++ H V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 132 VDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
DG ++ EF G++ I L +G+ +P Q +V I + L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLT--EP------QIQV-ICRQMLEALQYLHSM 129
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
IIHRD+K+ NVL+ D K+ADF +S + R S +GT + APE M
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMC 184
Query: 251 GQL-----NAKSDVYSFGVVLLEL 269
+ + K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-14
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK------LDASKQPDEEFLAQVSMVSRLK 120
NF IG G + VY L G A+KK +DA + D + ++ ++ +L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLN 60
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H N ++ ++ + E A G L ++ K K P + W+ V++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLC--- 116
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
LE++H + ++HRDIK +NV I V K+ D L HS ++GT
Sbjct: 117 -SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 170
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y +PE N KSD++S G +L E+ + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE----NFVQLLG 129
+G+G+YG VY + + +G A+K++ DE Q+ M + H+ V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ + E+ GSL D L+ P VL +I KGL++L
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL-- 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
K + +IIHRD+K +NVL+ + K+ DF +S + A L T + G Y APE
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIK 174
Query: 250 TGQLNA------KSDVYSFGVVLLELLTGRKP 275
+G N +SDV+S G+ +LE+ GR P
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHE 122
NF IG G + VY L A+KK+ + D ++ + ++ ++ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
N ++ L ++ + E A G L ++ K K P + W+ V++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLC----S 117
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
+E++H + ++HRDIK +NV I V K+ D L HS ++GT Y
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+PE N KSD++S G +L E+ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
E GSL +L K + P +L K+++ +GL YL EK I+HRD+K
Sbjct: 83 EHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAVLRGLAYLREKH--QIMHRDVK 131
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
SN+L+ K+ DF +S Q D A +GT Y +PE + +SD++S
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWS 187
Query: 262 FGVVLLELLTGRKPV 276
G+ L+EL GR P+
Sbjct: 188 MGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKH 121
F IGEG+YG+VY K +G A+KK LD K E F + ++ ++ +L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNH 65
Query: 122 ENFVQLLGYCVDGTSRV----------LAYEFASNGSLHDILHGRKGVKGAQPGPV-LSW 170
N V L D + L +E+ HD++ G+ + G V S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLM----GL--LESGLVHFSE 115
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
+GL Y H+K + +HRDIK SN+L+ + K+ADF L+ +R
Sbjct: 116 DHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
++ +V+ T Y PE + + + DV+S G +L EL T +KP+
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
+G+G++G+VY K +G AA K +D + + E+++ ++ +++ H N V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ + EF + G++ ++ + P+ Q RV + + L YLHE
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER-------PLTEPQIRV-VCKQTLEALNYLHEN-- 122
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
IIHRD+K+ N+L D K+ADF +S + R S +GT + APE M
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCET 179
Query: 253 -----LNAKSDVYSFGVVLLEL 269
+ K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 50/230 (21%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
A IG+G++G V+ K+ A+KK+ + E F L ++ ++ LKHEN V L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 128 LGYC---VDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+ C +R L +EF HD L G L + VK +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCE----HD-LAG------------LLSNKNVKFTLS 119
Query: 180 AAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMA 228
K GL Y+H I+HRD+K++N+LI D + K+ADF L+ + + +
Sbjct: 120 EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLN--AKSDVYSFGVVLLELLTGRKPV 276
++ RV+ T Y PE + G+ + D++ G ++ E+ T R P+
Sbjct: 177 PNRYTNRVV-TLWYRPPEL-LLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
I +G++G VY + +G AIK L K+ D QV+ V + +Q
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL---KKSDMIAKNQVTNVKAERAIMMIQGES---P 57
Query: 134 GTSRVLAYEFASNGSLH---DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
++ L Y F S L+ + L+G + L + G+E LH++
Sbjct: 58 YVAK-LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
IIHRDIK N+LI K+ DF LS L + + +GT Y APE +
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPETILG 167
Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
+ SD +S G V+ E L G P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHE 122
+F ++G+GS+G+V K +A I K D Q D E + + +++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 123 NFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
F+ L C R+ E+ + G L + H ++ K +P Q V A +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------QAVFYAAEIS 111
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
GL +LH + II+RD+K NV++ + KIADF + + M + + GT
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPD 166
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
Y APE D +++GV+L E+L G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 37/102 (36%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
K+++ KGL YL EK I+HRD+K SN+L+ K+ DF +S Q D A
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
+GT Y +PE + +SD++S G+ L+E+ GR P+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 34/212 (16%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL----KHENFVQLLG 129
+G G+YG+V +G AIKKL Q + RL HEN + LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 130 -YCVDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
+ + L L++I+ +K LS + +G
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRG 130
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGY 242
L+Y+H IIHRD+K SN+ + +D KI DF L+ D M T + T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWY 181
Query: 243 HAPEYAMT-GQLNAKSDVYSFGVVLLELLTGR 273
APE + N D++S G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQ--PDEEFLAQVSMVSRLKHE 122
NF IGEG+YG VY +G A+KK LD + P + ++S++ L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP-----VLSWQQRVKIA 177
N V+LL L +EF LH L +K + + + S+ ++
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSGIPLPLIKSYLFQL--- 109
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
+GL + H ++HRD+K N+LI + K+ADF L+ +A + R ++ V+
Sbjct: 110 ---LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV 162
Query: 238 GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
T Y APE + + + + D++S G + E++T R
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 46/217 (21%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEGSY VY GI + +G A+K + + F A + S++ LKH N V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIA 177
HDI+H ++ + PG + + R+
Sbjct: 69 ------------------HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FM 109
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
+GL Y+H + HI+HRD+K N+LI K+ADF L+ +A + ++ +S+ V+
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV 165
Query: 238 GTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
T Y P+ + ++ D++ G + +E+L G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
E+ E + + +G G+YG V K+G A+KKL Q + ++ ++ +
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
KHEN + LL S ++ + H + GA ++ Q+ V
Sbjct: 74 KHENVIGLLDVFTPARS------LEEFNDVYLVTH----LMGADLNNIVKCQKLTDDHVQ 123
Query: 180 -----AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
+GL+Y+H AD IIHRD+K SN+ + +D KI DF L+ D T
Sbjct: 124 FLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMT 175
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
+ T Y APE + N D++S G ++ ELLTGR
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 68 NFGTNALIGEGSYGRVY--YGILKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRL 119
N+ L+G+G++GRVY Y + +G A K++ S + +E A ++ ++ L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 120 KHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+HE VQ G D + L E+ GS+ D L GA V R +
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQIL- 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-V 236
+G+ YLH I+HRDIK +N+L K+ DF S + + R V
Sbjct: 117 ----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT + +PE K+DV+S G ++E+LT + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQVSMVSR------LKHENF 124
++G+GS+G+V+ LK + AIK L D D+ + +MV + +H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VECTMVEKRVLSLAWEHPFL 58
Query: 125 VQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
L YC T L + E+ + G L + H + K P A
Sbjct: 59 THL--YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATF-------YAAEIIC 107
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL++LH K I++RD+K N+L+ D KIADF + + +M + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDY 162
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + + N D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 68 NFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRLK 120
N+ L+G+G++GRVY +G A+K++ S + +E A ++ ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 121 HENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
HE VQ G D R L+ E GS+ D L GA L+ K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY----GA-----LTENVTRKYTR 113
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST---R 235
+G+ YLH I+HRDIK +N+L K+ DF S + + L T
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC--LSGTGMKS 168
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
V GT + +PE K+D++S G ++E+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 56/241 (23%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF------LAQVSMVSRLKHENFVQ 126
L+G+G GRV+ LK +G A+K LD K+ + L + +++ L H
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLD--KKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 127 LLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQ-RVKIA-VGAAK 182
L Y T L ++ G L +L QPG LS + R A V A
Sbjct: 66 L--YASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVARFYAAEVLLA- 115
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA---------------PDM 227
LEYLH I++RD+K N+L+ + ++DFDLS Q+
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 228 AARLHSTRVL------------GTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRK 274
+ + GT Y APE ++G + D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 275 P 275
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 69 FGTNALIGEGSYGRVYYGILKSGHA-AAIKKLDASKQPDE---EFLAQVSMVSRLKHENF 124
F ++GEG+YG V K AIKK S++ +E L ++ M+ LK EN
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
V+L L +E+ L + + G P V S+ ++ K +
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL------IKAI 113
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+ H+ I+HRDIK N+LI +DV K+ DF + + + + T + T Y +
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRS 169
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
PE + D++S G +L EL G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA-----QVSMVS 117
E+ E + + +G G+YG V I ++G AIKKL S+ E A +++++
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLK 69
Query: 118 RLKHENFVQLLGYCVDGTS--------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
++HEN + LL S V+ Y L I+ G LS
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIM-----------GHPLS 115
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMA 228
+ + GL+Y+H IIHRD+K N+ + +D KI DF L+ A +M
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM- 171
Query: 229 ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
T + T Y APE + N D++S G ++ E+LTG+
Sbjct: 172 -----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 3e-12
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVSRLKHENFVQL 127
IG G+YG V + ++G AIKK+ S D+ A+ + ++ L+HEN + L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGL 64
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGPVLSWQQRVKIA 177
L +L S +D+ LH K +K QP L+
Sbjct: 65 L--------DILRPP--SPEDFNDVYIVTELMETDLH--KVIKSPQP---LTDDHIQYFL 109
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRV 236
+GL+YLH ++IHRD+K SN+L+ + KI DF L+ PD + T
Sbjct: 110 YQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 237 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
+ T Y APE ++ K+ D++S G + ELLT +
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 74 LIGEGSYGRVYYGILK----SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQ 126
++G+G +G V LK S A+K L A S EEFL + + + H N ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 127 LLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
L+G + ++ ++ F +G LH L + G +P L Q V+ +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVRFMIDI 122
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLG 238
A G+EYL K + IHRD+ + N ++ ++ +ADF LS + + D + ++++
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-- 177
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ A E SDV++FGV + E++T G+ P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 70/253 (27%), Positives = 107/253 (42%), Gaps = 45/253 (17%)
Query: 36 ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAA 94
+S ++ + A P ++S EL+ + IG G+ G VY I + +G
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLS--ELERVNR-------IGSGAGGTVYKVIHRPTGRLY 102
Query: 95 AIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLG-YCVDGTSRVLAYEFASNGSLHD 151
A+K + + + + ++ ++ + H N V+ + +G +VL EF GSL
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL-LEFMDGGSLE- 160
Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
G + Q +A G+ YLH + HI+HRDIK SN+LI
Sbjct: 161 ---GTH---------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAK 205
Query: 212 VAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA------KSDVYSF 262
KIADF +S Q D +GT Y +PE T LN D++S
Sbjct: 206 NVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPERINT-DLNHGAYDGYAGDIWSL 259
Query: 263 GVVLLELLTGRKP 275
GV +LE GR P
Sbjct: 260 GVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 70/245 (28%), Positives = 108/245 (44%), Gaps = 45/245 (18%)
Query: 64 EITENFGTNALIGEGSYGRV--YYGILKSGHAAAIKKL-------DASKQPDEEFLAQVS 114
EIT + +G G++G V L +G AIKK+ +K+ E +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRE----LK 61
Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
++ L+HEN + L + + E LH +L R L Q
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP----------LEKQFI 110
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLH 232
+GL+Y+H ++HRD+K SN+LI ++ KI DF L+ Q P M +
Sbjct: 111 QYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV- 166
Query: 233 STRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV----DHTLPRGQQSL 287
STR Y APE +T Q + + D++S G + E+L G KP+ DH Q S+
Sbjct: 167 STRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHV---NQFSI 217
Query: 288 VTWVL 292
+T +L
Sbjct: 218 ITDLL 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-12
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G+G +G V +K +G A KKLD ++ ++ L + ++ ++ F+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 130 YCVDGTSRV-LAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
Y + + L + G L + G P + + A GLE+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGE---------PGFPEARAIFYAAQIICGLEH 110
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH++ I++RD+K NVL+ D +I+D L A ++ GT GY APE
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKGRAGTPGYMAPE 164
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ D ++ G L E++ GR P
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK------HENFV 125
A IG G+YG VY SGH A+K + D L+ V V+ LK H N V
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 126 QLLGYC----VDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
+L+ C D ++V L +E D+ + P P L + +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVD----QDL----RTYLDKVPPPGLPAETIKDLMRQF 117
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TR 235
+GL++LH I+HRD+K N+L+ K+ADF L AR++S T
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTP 166
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
V+ T Y APE + D++S G + E+ RKP+
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IGEG+YG VY +G A+KK L+ DE + ++S++ L H N V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE---TEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL----SWQQRVKIAVGAAKG 183
L L +EF D+ P L +Q +G
Sbjct: 64 LDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQG 111
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
+ Y H ++HRD+K N+LI + K+ADF L+ +A + R ++ V+ T Y
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYR 166
Query: 244 APEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
APE + Q + D++S G + E++ R+P
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-12
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 74 LIGEGSYGR---VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLL-G 129
++GEGS+GR V + +A +L S E+ + +++++KH N V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ DG ++ E+ G L + ++G K +L W ++ + V +++HE
Sbjct: 67 FEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGV------QHIHE 118
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV------LGTFGYH 243
K ++HRDIKS N+ + + K+ DF +ARL ++ +GT Y
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDFG--------SARLLTSPGAYACTYVGTPYYV 167
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
PE N KSD++S G +L EL T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 29/233 (12%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDAS-----KQPDEEFLAQVSMVSR 118
NF ++G G+YG+V+ GH A A+K L + + E + ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
++ F+ L Y +++ L ++ + G L L+ R+ + V++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----------ESEVRVY 110
Query: 178 VGA-AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
+ L++LH+ II+RDIK N+L+ + + DF LS + + R +S
Sbjct: 111 IAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165
Query: 236 VLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
GT Y APE G + D +S GV+ ELLTG P + QS
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQ-------PDEEFLAQV--SMVSRLKHENFV 125
+G+GS+G VY ++K A A ++L K+ P+E A ++S+L H V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ ++ + + E+ L L K G LS Q + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVH 120
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
Y+H++ I+HRD+K+ N+ + +++ KI DF +S M + +T GT Y +P
Sbjct: 121 YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSP 174
Query: 246 EYAMTGQLNAKSDVYSFGVVLLEL 269
E ++KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEG+Y V+ G K + + A+K++ + A +VS++ LKH N V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV-GAAKGLEYLHEK 190
L +E+ + + + G ++S VKI + +GL Y H++
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNC---------GNLMS-MHNVKIFMFQLLRGLSYCHKR 122
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM- 249
I+HRD+K N+LI + K+ADF L+ +A + + +S V+ T Y P+ +
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLLG 177
Query: 250 TGQLNAKSDVYSFGVVLLELLTGR 273
+ + + D++ G +L E+ TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 73 ALIGEGSYGRVYYGILK-SGHAAAIK--KLDASKQPDE--------EFLAQVSMVSRLKH 121
++G+GS+G+V LK + A+K K D Q D+ LA KH
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KH 55
Query: 122 ENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
QL C R+ E+ + G L + H ++ + +P + A
Sbjct: 56 PFLTQLHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEP-------RARFYAAEI 105
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
GL++LHE+ II+RD+K NVL+ + KIADF + + + + ++ GT
Sbjct: 106 VLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTFCGTP 160
Query: 241 GYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVD 277
Y APE ++ Q + D ++ GV+L E+L G+ P +
Sbjct: 161 DYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG----Y 242
+H H+IHRDIKS+N+L+ + + K+ DF S M A S V TF Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAATVSDDVGRTFCGTPYY 211
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
APE + K+D++S GV+L ELLT ++P D
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 58/237 (24%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE------FLAQVSMV 116
++ + + IGEG+YG V K +G AIKK+ P E L ++ ++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKIL 57
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGP 166
R KHEN + +L R ++E S +D+ L+ K +K Q
Sbjct: 58 RRFKHENIIGILD-----IIRPPSFE-----SFNDVYIVQELMETDLY--KLIK-TQH-- 102
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
LS +GL+Y+H A+ ++HRD+K SN+L+ + KI DF L
Sbjct: 103 -LSNDHIQYFLYQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGL------ 152
Query: 227 MAARLHS---------TRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
AR+ T + T Y APE + + K+ D++S G +L E+L+ R
Sbjct: 153 --ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 74 LIGEGSYGRVYYGILKSGH---AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLL 128
++G+GS+G+V LK A + K D Q D E + + ++S ++ F+ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 129 GYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGLEY 186
C R+ EF + G L + H +K + + R + A L +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA--------RARFYAAEITSALMF 111
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH+K II+RD+K NVL+ + K+ADF + + + ++ GT Y APE
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPE 166
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
D ++ GV+L E+L G P +
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 19/178 (10%)
Query: 97 KKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHG 155
K L + + F S++S+L H++ V+L G CV D V E+ G L LH
Sbjct: 36 KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHR 93
Query: 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVA 213
K L W ++ +A A L YL +K ++H ++ N+L+ + +
Sbjct: 94 EKN------NVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEG 142
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLEL 269
+ LS+ + RV + APE GQ L +D +SFG LLE+
Sbjct: 143 YVPFIKLSDPGIPITVLSREERVERI-PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 60 DELKEITENFGTNAL--IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVS 117
+ +E+ + G + + GS GRV+ K G + L ++ L + ++
Sbjct: 57 QKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVV-LKIGQKGTT--LIEAMLLQ 112
Query: 118 RLKHENFVQLLGYCVDG--TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+ H + +++ V G T VL + + L+ L R L Q +
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPH---YSSDLYTYLTKRSRP--------LPIDQALI 161
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
I +GL YLH + IIHRD+K+ N+ I D D I D + Q P +A
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG-- 215
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
+ GT +APE + N+K+D++S G+VL E+L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEGSY VY G K +G A+K + ++ F A + S++ LKH N V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ L +E+ L + G G P V + ++ +GL Y+H++
Sbjct: 73 HTKETLTLVFEYVHT-DLCQYMDKHPG--GLHPENVKLFLFQL------LRGLSYIHQR- 122
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-T 250
+I+HRD+K N+LI D K+ADF L+ +A + + +S V+ T Y P+ + +
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-TLWYRPPDVLLGS 178
Query: 251 GQLNAKSDVYSFGVVLLELLTG 272
+ + D++ G + +E++ G
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 61/208 (29%), Positives = 85/208 (40%), Gaps = 26/208 (12%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKHENFVQLL 128
+G GS+GRV K +G AIK L KQ + S++ L H V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSHPFIVNMM 84
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS-WQQRVKIAVGAAKGLEYL 187
D EF G L H RK G P V + + +A EYL
Sbjct: 85 CSFQDENRVYFLLEFVVGGEL--FTHLRKA--GRFPNDVAKFYHAELVLA------FEYL 134
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H K II+RD+K N+L+ + K+ DF + + PD L GT Y APE
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTPEYLAPEV 186
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ D ++ GV+L E + G P
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL++LH+K II+RD+K NVL+ D KIADF + + +M ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + N D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
IGEG+YG V+ + + A+K++ D + L ++ ++ LKH+N V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
L +E+ L G + +Q KGL + H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAFCHSH 118
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
+++HRD+K N+LI + K+ADF L+ +A + R +S V+ T Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVLFG 173
Query: 251 GQLNAKS-DVYSFGVVLLELLTGRKPV 276
+L + S D++S G + EL +P+
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 64/254 (25%), Positives = 99/254 (38%), Gaps = 62/254 (24%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKL--DASKQP--DEEFLAQVSMVSRLKHENFVQLL 128
LIG+G G VY A+KK+ D S+ P + FL + + + L H V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-------KIAVGA- 180
C DG + +L +L K V WQ+ K +VGA
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLL---KSV----------WQKESLSKELAEKTSVGAF 115
Query: 181 -------AKGLEYLHEKADPHIIHRDIKSSNVL--------IFDDDVAKIADF---DLSN 222
+EY+H K ++HRD+K N+L I D A DL +
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 223 QAPDMAARLHST-----RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT------ 271
D +S+ +++GT Y APE + + +D+Y+ GV+L ++LT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 272 ---GRK-PVDHTLP 281
GRK +
Sbjct: 233 RKKGRKISYRDVIL 246
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV-- 125
NF ++G G+YG+V+ SGH D+ K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-------DSGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 126 --QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR-----VKIA 177
Q+L + V L Y F ++ LH IL + G + LS ++R V+I
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIY 110
Query: 178 VGA-AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
G LE+LH+ II+RDIK N+L+ + + DF LS + D R +S
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165
Query: 236 VLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKP 275
GT Y AP+ G + D +S GV++ ELLTG P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 1e-10
Identities = 65/219 (29%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
++F +G GS+GRV K SG A+K L KQ E L + ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H V L G D ++ L E+ G L L RK G P PV A
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RK--SGRFPEPV--------ARFYA 107
Query: 181 AK---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
A+ LEYLH I++RD+K N+L+ D KI DF + + T L
Sbjct: 108 AQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTL 158
Query: 238 -GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT Y APE ++ D ++ G+++ E+L G P
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 73 ALIGEGSYGRVYYG--ILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK------HENF 124
A IGEG+YG+V+ + G A+K++ + L+ + V+ L+ H N
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 125 VQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V+L C V T R D+ V P P + + + +G
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRG 122
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----TRVLG 238
L++LH ++HRD+K N+L+ K+ADF L AR++S T V+
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSVVV 171
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276
T Y APE + D++S G + E+ RKP+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLHSTRVLGTF 240
+GL+YLH I+HRDIK N+L+ + V KI DF L+ + PD H T+ + T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQ 168
Query: 241 GYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGR 273
Y APE M + + D++S G + ELL R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD---ASKQPDEEFLA---QVSMVSRL 119
N+ L+G G++G VY +G A+K++ S++ +E A ++ ++ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 120 KHENFVQLLGYCVDGTSRVLA--YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+H+ VQ G D + L+ E+ GS+ D L GA V R +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQIL- 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-V 236
+G+ YLH I+HRDIK +N+L K+ DF S + + + V
Sbjct: 117 ----QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT + +PE K+DV+S ++E+LT + P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 28/220 (12%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRL 119
E+ E + +G G+YG V + A+KKL Q ++ ++ +
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71
Query: 120 KHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
KHEN + LL TS V L++I+ +K LS +
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----------LSDEHVQ 121
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
+ +GL+Y+H IIHRD+K SNV + +D +I DF L+ QA D T
Sbjct: 122 FLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMT 173
Query: 235 RVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGR 273
+ T Y APE + N D++S G ++ ELL G+
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 8/140 (5%)
Query: 139 LAYEFASNGSLHDILHGRKG--VKGAQPGPVLSWQQRVKIAVGA-AKGLEYLHEKADPHI 195
L Y F + G L+ IL +G + V+ ++ VK + A L++LH I
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---I 119
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA 255
I+RD+K N+L+ ++ K+ DF LS ++ D + +S GT Y APE
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQ 177
Query: 256 KSDVYSFGVVLLELLTGRKP 275
+D +SFGV++ E+LTG P
Sbjct: 178 SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLL 128
++G+GS+G+V K +A I K D Q D E + + +++ F+ L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
C R+ E+ + G L + H ++ K +P V A A GL +L
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEP-------HAVFYAAEIAIGLFFL 117
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL--SNQAPDMAARLHSTRVLGTFGYHAP 245
H K II+RD+K NV++ + KIADF + N R GT Y AP
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCGTPDYIAP 170
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
E D ++FGV+L E+L G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 57/216 (26%), Positives = 87/216 (40%), Gaps = 33/216 (15%)
Query: 73 ALIGEGSYGRV----------YYGI--LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
A++G G +G+V Y I LK G A ++++ F + +
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----ANSER 60
Query: 121 HENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H V L C V E+A+ G L ++H V S + V A
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV--------FSEPRAVFYAAC 109
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
GL+YLHE I++RD+K N+L+ + KIADF L + M ++ GT
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTSTFCGT 164
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ APE D + GV++ E+L G P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
+G G+YG V + ++G AIKKL Q + + ++ ++ +KHEN + LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 131 CVDGTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQ----RVKIAV-GAAKG 183
F + SL + G G ++ ++ R++ V KG
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
L+Y+H IIHRD+K N+ + +D KI DF L+ Q TR Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182
Query: 244 APEYAMTGQLNAKS-DVYSFGVVLLELLTGR---KPVDH 278
APE + ++ D++S G ++ E+LTG+ K DH
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKL-DASKQPD--EEFLAQVS 114
V + EN IG G+YG V I +SG AIKK+ A P + L ++
Sbjct: 3 VGSRYKPIEN------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 115 MVSRLKHENFVQLLGYCV----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
++ KH+N + + D + + + LH I+H QP L+
Sbjct: 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD------QP---LTE 106
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDM 227
+ +GL+Y+H A+ +IHRD+K SN+L+ +D +I DF ++ +P
Sbjct: 107 EHIRYFLYQLLRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
Query: 228 AARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPV 276
T + T Y APE ++ + D++S G + E+L GR+ +
Sbjct: 164 HKY-FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 74 LIGEGSYGRVYYGILKSGHAA--AIKKLD--------ASKQPDEEFLAQVSMVS----RL 119
+G G++G VY K+ A+K+++ ++ D+ VS V+ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV-KIAV 178
+H N V+ ++ + + L + + K K ++R+ I V
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT------EERIWNIFV 120
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
L YLH+ + I+HRD+ +N+++ +DD I DF L+ Q + T V+G
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVG 175
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
T Y PE K+DV++FG +L ++ T + P
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAAA---IKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLG 129
IG G +G+V + + A +K+L A+ E EFL Q L+H N +Q LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
CV+ +L +E+ G L L + + +L Q ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN--SQLLLLQ---RMACEIAAGVTHMHK 117
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDL--SNQAPDMAARLHSTRVLGTFGYHAPEY 247
+ +H D+ N + D K+ D+ + S D + APE
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET--EDDKCVPLRWLAPEL 172
Query: 248 A-------MTGQLNAKSDVYSFGVVLLELL 270
+T + S+V++ GV L EL
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 66/214 (30%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQVSMVSR----LKHEN-FV 125
++G+GS+G+V LK G A+K L D D+ + +MV + L EN F+
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTMVEKRVLALAWENPFL 58
Query: 126 QLLGYCVDGTSRVLAY--EFASNGSL--HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
L YC T L + EF + G L H GR + A
Sbjct: 59 THL-YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-----------FDLYRATFYAAEIV 106
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
GL++LH K II+RD+K NV++ D KIADF + + ++ ++ GT
Sbjct: 107 CGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPD 161
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y APE + D +SFGV+L E+L G+ P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G +GRV +KS A+K + + Q E ++ ++ H V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
D + E+ G L IL R G + R IA EYLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR--------GLFDEYTARFYIA-CVVLAFEYLH 110
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
+ II+RD+K N+L+ + K+ DF + + + + GT Y APE
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWT--FCGTPEYVAPEII 164
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ + D +S G++L ELLTGR P
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKL--------DASKQPDEEFLAQVSMVSRLKHENFV 125
IG G+YG V ++ AIKK+ DA + L ++ ++ L HEN +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-----LREIKLLRHLDHENVI 67
Query: 126 QLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+ + R + YE LH I ++ +Q LS
Sbjct: 68 AIKD-IMPPPHREAFNDVYIVYELMDT-DLHQI------IRSSQT---LSDDHCQYFLYQ 116
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---SNQAPDMAARLHSTRV 236
+GL+Y+H +++HRD+K SN+L+ + KI DF L +++ D TR
Sbjct: 117 LLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR- 172
Query: 237 LGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPV 276
Y APE + + DV+S G + ELL GRKP+
Sbjct: 173 ----WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 63/270 (23%), Positives = 102/270 (37%), Gaps = 87/270 (32%)
Query: 75 IGEGSYGRVY----YGILKSG--HAAAIKKLDASKQPDEEFLAQVSMVSRLK-------H 121
+G G++G+V +GI KS A+K L E ++++ LK H
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE----YKALMTELKILIHIGHH 70
Query: 122 ENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGR---------KGVKGAQPGPVLSWQ 171
N V LLG C G ++ E+ G+L + L + K + + +
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 172 QR-------------------------------------------VKIAVGAAKGLEYLH 188
QR + + A+G+E+L
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL- 189
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMA----ARLHSTRVLGTFG 241
A IHRD+ + N+L+ +++V KI DF L+ + PD ARL
Sbjct: 190 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-------PLK 240
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ APE +SDV+SFGV+L E+ +
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 40/98 (40%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGT 239
GL+Y+H A+ ++HRD+K N+L+ D KI DF L+ ++ P A T + T
Sbjct: 117 GLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVAT 172
Query: 240 FGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPV 276
Y APE ++ Q K+ DV+S G +L ELL GRKPV
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 62/225 (27%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE--EFLA--QVSMVSRLKHENFVQLLG 129
+GEGSY VY G K +G A+K++ + +E F A + S++ LKH N V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLKHANIV---- 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGV-------------------KGAQPGPVLSW 170
+LHDI+H +K + G
Sbjct: 67 ------------------TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSM------ 102
Query: 171 QQRVKIAV-GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
V++ + +GL Y H++ ++HRD+K N+LI + K+ADF L+ +A + +
Sbjct: 103 -HNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPS 157
Query: 230 RLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
+ +S V+ T Y P+ + + + + D++ G + E+ TGR
Sbjct: 158 KTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
++HRD+KS+N+ + + K+ DF S Q D + ++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 255 AKSDVYSFGVVLLELLTGRKP 275
K+D++S GV+L ELLT +P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 75 IGEGSYGRVYYGI---LKSGHAA-----AIKKLDAS-KQPDEEFLAQVSMVSRLKHENFV 125
+G+G++ +++ GI + +K LD S + E F SM+S+L H++ V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G CV G ++ E+ GSL L K + SW+ V AK L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SWKLEV------AKQLA 110
Query: 186 Y-LHEKADPHIIHRDIKSSNVLIFDDDVAKIAD---FDLSNQAPDMAARLHSTRVL-GTF 240
+ LH D + H ++ + NVL+ ++ K + LS+ P ++ + +L
Sbjct: 111 WALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD--PGISITVLPKEILLERI 168
Query: 241 GYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTG-RKPV 276
+ PE Q L+ +D +SFG L E+ +G KP+
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 61/228 (26%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKL-DA-SKQPDEEFLAQ-----VSMVSRLK-HENFV 125
+G+G+YG V+ I ++ A+KK+ DA D AQ + + L H N V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIV 70
Query: 126 QLLG----------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+LL Y L +E+ LH ++ R + L +
Sbjct: 71 KLLNVIKAENDKDIY--------LVFEYMET-DLHAVI--RANI--------LEDVHKRY 111
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL---------SNQAPD 226
I K L+Y+H ++IHRD+K SN+L+ D K+ADF L + + P
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
+ T + T Y APE + K D++S G +L E+L G+
Sbjct: 169 L------TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEG+Y V+ G K + + A+K++ + A +VS++ LKH N V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--GPVLSWQQRVKIAVGAAKGLEYLHE 189
S L +E+ K +K G ++S +GL Y H
Sbjct: 74 HTDKSLTLVFEYLD-----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
+ ++HRD+K N+LI + K+ADF L+ +A + + +S V+ T Y P+ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLL 177
Query: 250 -TGQLNAKSDVYSFGVVLLELLTGR 273
+ + + + D++ G + E+ +GR
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 28/235 (11%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDAS-----KQPDEEFLAQVSMVSR 118
NF ++G G+YG+V+ +GH A+K L + + E + +++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
++ F+ L Y +++ L ++ S G + L+ R + V+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE----------VRFY 110
Query: 178 VGAA-KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR 235
G LE+LH+ I++RDIK N+L+ + + DF LS + + R +S
Sbjct: 111 SGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-- 165
Query: 236 VLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289
GT Y APE + K+ D +S G+++ ELLTG P R QS V+
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 31/219 (14%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGH--AAAIKKLDASK-----QPDEEFLAQVSMVSRL 119
E+F +G GS+GRV K+ AIK+ + SK Q D F ++ +++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYI 88
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H V L G D + L EF G L K P V + + +
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF----PNDVGCFYAAQIVLI- 143
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR---V 236
EYL +I++RD+K N+L+ D K+ DF A++ TR +
Sbjct: 144 ----FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTL 188
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT Y APE + +D ++ G+ + E+L G P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLKHENF-VQL 127
IGEG+YG+VY +G A+KK + DEE L ++S++ L + V+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK--TRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 128 LGYCVDGT-------SRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
L V+ S L +E+ S+ +GR + + S+ ++
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL----- 119
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMAARLHSTRVLG 238
KG+ + H+ ++HRD+K N+L+ + KIAD L +A + + ++ ++
Sbjct: 120 -LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIPVKSYTHEIV- 173
Query: 239 TFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTG 272
T Y APE + + D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 39/179 (21%), Positives = 80/179 (44%), Gaps = 24/179 (13%)
Query: 107 EEFLAQVSMVSRLKHENFVQLLGY---CVDGTSRV-LAYEFASNGSLHDILHGRKGVKGA 162
+ ++ + R+ N +++ G+ VD R+ L E+ + G L ++L K
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---- 118
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKAD-PHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
LS++ ++ +A+ KGL L++ + P ++++ S + L+ ++ KI L
Sbjct: 119 -----LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLE 170
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDH 278
+ + V Y + + + K D+YS GVVL E+ TG+ P ++
Sbjct: 171 K----ILSSPPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLG 129
+G+G +G V ++ +G A KKL+ + + E + + +++++ H F+ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
Y + + NG D+ + V PG + GLE+LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGG--DLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQ 115
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-VLGTFGYHAPEYA 248
+ II+RD+K NVL+ +D +I+D L A ++ T+ GT G+ APE
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ + D ++ GV L E++ R P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLK 120
++ +G G++GRV+ + S H A+K + KQ ++ + ++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H ++L D + E+ G L L S + A
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEI 110
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
LEYLH K I++RD+K N+L+ + K+ DF + + D L GT
Sbjct: 111 VCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTP 162
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y APE + N D ++ G+++ E+L G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 44/216 (20%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLA--QVSMVSRLKHENFVQLLGYC 131
+GEG+Y VY G K + + A+K++ + A +VS++ LKH N V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGA-------------QPGPVLSWQQRVKIAV 178
+LHDI+H K + G ++
Sbjct: 68 ----------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF 111
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
+GL Y H + ++HRD+K N+LI + K+ADF L+ +A + + +S V+
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV- 166
Query: 239 TFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
T Y P+ + + + + D++ G + E+ TGR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
P LS+ V + A G+E+L K + +HRD+ + NVLI + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ + + APE SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMAARLHSTRVL 237
A+G+E+L A IHRD+ + N+L+ +++V KI DF L+ + PD R S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARL- 238
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ APE +SDV+SFGV+L E+ + G P
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 7e-09
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
+G GS G V+ + A+KK+ + Q + L ++ ++ RL H+N V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGV-----KGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
S L + S L+ + ++ + + GP+ R+ +GL+Y+
Sbjct: 73 PSGSD-LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKYI 130
Query: 188 HEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN-QAPDMAARLHSTRVLGTFGYHAP 245
H +++HRD+K +NV I +D V KI DF L+ P + + + + L T Y +P
Sbjct: 131 HSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 246 EYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
++ K+ D+++ G + E+LTG+
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 68 NFGTNALIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDEEFLAQVSMVSRL----- 119
+F ++G+GS+G+V K +A I K D Q D+ + +MV +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---VECTMVEKRVLALS 57
Query: 120 KHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
F+ L C R+ E+ + G L + ++ + +P V A
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVF-------YAA 108
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
A GL +LH K II+RD+K NV++ + KIADF + + +M + + G
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCG 163
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
T Y APE D ++FGV+L E+L G+ P +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-09
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 39/218 (17%)
Query: 74 LIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHEN--FV 125
+IG G +G VY G K +G A+K LD KQ + L + M+S + + F+
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+ Y ++ + + G LH L HG V S + A
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLG 238
GLE++H + +++RD+K +N+L+ + +I+D D S + P H++ +G
Sbjct: 109 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VG 157
Query: 239 TFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
T GY APE G ++ +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 74 LIGEGSYGRVYYGILKSG-HAAAIKKLDASKQPDEEFLAQVSMVSRLKH-------ENFV 125
+IG GSY +V LK A+K + D+E + V KH F+
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---DIDWVQTEKHVFEQASSNPFL 58
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
L C TSR+ L E+ + G L + H ++ K L + A L
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYAAEICIAL 109
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+LHE+ II+RD+K NVL+ D K+ D+ + + + ++ GT Y A
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIA 164
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
PE + D ++ GV++ E++ GR P D
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 44/206 (21%), Positives = 78/206 (37%), Gaps = 38/206 (18%)
Query: 89 KSGHAAAIKKLDASKQPDEEFL---AQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145
+ A+KK++ E+ ++ +L+H N + + + + + +
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 146 NGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAV---GAAKGLEYLHEKADPHIIHRDI 200
GS D+L H +G+ + IA L+Y+H K IHR +
Sbjct: 83 YGSCEDLLKTHFPEGLP------------ELAIAFILKDVLNALDYIHSK---GFIHRSV 127
Query: 201 KSSNVLIFDDDVAKIADFDLS--------NQAPDMAARLHSTRVLGTFGYHAPEY---AM 249
K+S++L+ D ++ S Q S + L + +PE +
Sbjct: 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLSPEVLQQNL 184
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKP 275
G N KSD+YS G+ EL G P
Sbjct: 185 QG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 74 LIGEGSYGRVYYGILK--SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHEN--FV 125
+IG G +G VY G K +G A+K LD KQ + L + M+S + + F+
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 126 QLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
+ Y ++ + + G LH L +Q G V S ++ A GL
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHL--------SQHG-VFSEKEMRFYATEIILGL 110
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----DLSNQAPDMAARLHSTRVLGTF 240
E++H + +++RD+K +N+L+ + +I+D D S + P H++ +GT
Sbjct: 111 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------HAS--VGTH 159
Query: 241 GYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKP 275
GY APE G ++ +D +S G +L +LL G P
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE LH++ I++RD+K N+L+ D +I+D L+ P+ + RV GT GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 37/103 (35%), Positives = 54/103 (52%), Gaps = 18/103 (17%)
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN---QAPDMA----ARLHS 233
AKG+E+L A IHRD+ + N+L+ +++V KI DF L+ + PD ARL
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ APE +SDV+SFGV+L E+ + G P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL-------SNQAPDMAARLHS 233
A+G+++L K + IHRD+ + NVL+ D VAKI DF L SN ARL
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL-- 276
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ APE +SDV+S+G++L E+ + G+ P
Sbjct: 277 -----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGY 130
+G+G +G V +K +G A KKLD K+ E+ + + F+ L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 131 CVDG-TSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ T L + G L + I + G +G + V+ + ++ G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQI------TCGILHLH 112
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
I++RD+K NVL+ D +++D L+ + D T+ GT GY APE
Sbjct: 113 SMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEIL 166
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ D ++ G + E++ GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE LH + + ++RD+K N+L+ D +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + D + G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+YG VY K G A+K+++ + +++++ LKH N + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVF 67
Query: 132 VDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYLH 188
+ + R L +++A + H I R A P+ + VK + G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHR--ASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 189 EKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
++HRD+K +N+L+ + KIAD + N A L V+ TF
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFW 180
Query: 242 YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
Y APE + + K+ D+++ G + ELLT +P+ H
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-08
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+YG VY K G A+K+++ + +++++ LKH N + L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 67
Query: 132 VDGTSRV--LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK------- 182
+ R L +++A + H I R +P V++ G K
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP---------VQLPRGMVKSLLYQIL 118
Query: 183 -GLEYLHEKADPHIIHRDIKSSNVLIFDDDV----AKIADFDLS---NQAPDMAARLHST 234
G+ YLH ++HRD+K +N+L+ + KIAD + N A L
Sbjct: 119 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP- 174
Query: 235 RVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
V+ TF Y APE + + K+ D+++ G + ELLT +P+ H
Sbjct: 175 -VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQLL 128
L+G+G++G+V K +G A+K L +K L + ++ +H F+ L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTAL 60
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
Y R+ E+A+ G L L + V S + L+YL
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYL 111
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H ++ ++++RD+K N+++ D KI DF L + A + + GT Y APE
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEV 167
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
D + GVV+ E++ GR P
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 74 LIGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKH-----ENFVQL 127
+IG GSY +V LK A+K + D+E + V KH N L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE---DIDWVQTEKHVFETASNHPFL 58
Query: 128 LGY--CVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
+G C SR+ EF S G L + H ++ K L + + + L
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRK-------LPEEHARFYSAEISLAL 109
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+LHE+ II+RD+K NVL+ + K+ D+ + + + ++ GT Y A
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIA 164
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
PE D ++ GV++ E++ GR P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 38/216 (17%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDAS----KQPDEEFLAQVS-MVSRLKHENFVQLL 128
IG+GS+G+V K+ G A+K L K+ + +A+ + ++ +KH V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK---------IAVG 179
Y F + L+ +L G G + QR + A
Sbjct: 62 -----------HYSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAE 104
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
A L YLH +II+RD+K N+L+ + DF L + + ++ GT
Sbjct: 105 IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y APE + D + G VL E+L G P
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKHENFVQLL 128
+IG GSY +V LK + A+K + D+E + V + + + F+ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 129 GYCVDGTSRVL-AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
C SR+ E+ + G L + H ++ K L + + + L YL
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-------LPEEHARFYSAEISLALNYL 112
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
HE+ II+RD+K NVL+ + K+ D+ + + + ++ GT Y APE
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEI 167
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
D ++ GV++ E++ GR P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL----KHENFVQLL 128
L+G+G++G+V K +G A+K L ++ +A SR+ +H F+ L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTAL 60
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
Y R+ E+A+ G L L + V + ++ LEYL
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYL 111
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H + +++RDIK N+++ D KI DF L + A + + GT Y APE
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
D + GVV+ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 32/213 (15%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDE--EFLAQVSMVSRLKHENFVQLLG 129
+G+G YG+V+ K +G A+K++ S + +E L + +++ K E V+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-----AVGAAKGL 184
D LA E+ G +L+ G + R + AV A
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNL--------GVLSEDHARFYMAEMFEAVDA---- 116
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
LHE IHRD+K N LI K+ DF LS A +S V+G+ Y A
Sbjct: 117 --LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA---NS--VVGSPDYMA 166
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
PE + D +S G +L E L G P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 44/231 (19%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKL--------DASKQPDEEFLAQVSMVSRLKHENF 124
+IG+GSYG V I +G AIKK+ DA++ L ++ ++ L+H +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDI 61
Query: 125 VQLLGYCVDGTSR-----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
V++ + + R + +E + LH ++ + + +Q
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLT-PEHHQFFLYQ-------- 111
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLG 238
+ L+Y+H ++ HRD+K N+L D KI DF L+ A D + T +
Sbjct: 112 LLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 239 TFGYHAPEYAMTGQLNAKS----DVYSFGVVLLELLTGR-----KPVDHTL 280
T Y APE + G +K D++S G + E+LTG+ K V H L
Sbjct: 169 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 3/108 (2%)
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
L +Q + I + L YLH + IIHRD+K+ N+ + + + A + DF + +
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT ++PE AK+D++S G+VL E+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE LH + I++RD+K N+L+ D +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + D + G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLL 128
L+G+G++G+V K+ +A I K + DE L + ++ +H F+ L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP-FLTAL 60
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA--AKGLE 185
Y R+ E+A+ G L H + V S + R + GA L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL--FFHLSRE-------RVFS-EDRARF-YGAEIVSALG 109
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH +++RD+K N+++ D KI DF L + A + + GT Y AP
Sbjct: 110 YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPV---DH 278
E D + GVV+ E++ GR P DH
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 25/126 (19%)
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
I GA +GL YLH+ IHR+IK+S++LI D + ++ + + +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGL---SHLYSLVRNGQKAK 159
Query: 236 VLGTFGYHAPEYAMTGQ--------------LNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
V+ Y P+++ + N KSD+YS G+ EL TGR P +
Sbjct: 160 VV----YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF-QDML 214
Query: 282 RGQQSL 287
R Q L
Sbjct: 215 RTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-07
Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLL 128
L+G+G++G+V K SG A+K L +K L + ++ +H F+ L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-FLTSL 60
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
Y R+ E+ + G L L + V S + L+YL
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYL 111
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H I++RD+K N+++ D KI DF L + AA + + GT Y APE
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEV 166
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
D + GVV+ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
APE + D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 49/220 (22%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
IGEG+YG VY + + A+KK+ +Q DE + ++S++ ++H N V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRL-- 66
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGV------------KGAQPGPVLSWQQR-VKI 176
D++H K + K P + R +K
Sbjct: 67 --------------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 177 AV-GAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHST 234
+ +G+ Y H ++HRD+K N+LI + K+ADF L+ +A + R +
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGIPVRTFTH 162
Query: 235 RVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
V+ T Y APE + + + D++S G + E++ +
Sbjct: 163 EVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GLE L + I++RD+K N+L+ D +I+D L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRV-GTVGY 167
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
LE+LH++ II+RD+K N+L+ K+ DF L ++ H+ GT Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYM 167
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE M D +S G ++ ++LTG P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 10/93 (10%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTF 240
G+++LH IIHRD+K SN+++ D KI DF L+ A M TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
Y APE + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 34/119 (28%), Positives = 45/119 (37%), Gaps = 30/119 (25%)
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS----------------NQAPDM 227
L+ +H+ IHRDIK N+LI D K+ADF L +
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 228 AARLHSTR-----------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
L R +GT Y APE + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 34/229 (14%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAA-AIKKLDAS----KQPDEEFLAQVSMVSRLKH 121
E+F T LI G+YG VY K A+KK++ + ++ + +++ ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 122 ENFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
V + +C T R L E+ G +L K PV + V
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETVL 112
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHS----- 233
A LEYLH I+HRD+K N+LI K+ DF LS + L+
Sbjct: 113 A---LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 234 -TR------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
TR V GT Y APE + D ++ G++L E L G P
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 2e-06
Identities = 64/227 (28%), Positives = 94/227 (41%), Gaps = 41/227 (18%)
Query: 59 VDELKEIT--ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE-FLAQVSM 115
V LK + +G +G+V +LK H +KL K + F A M
Sbjct: 10 VQFLKNCEIVKKLKLI----DGKFGKVS--VLK--HKPT-QKLFVQKIIKAKNFNAIEPM 60
Query: 116 VSRL--KHENFVQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
V +L + NF++L Y V T + VL ++ +G L D+L LS
Sbjct: 61 VHQLMKDNPNFIKLY-YSV-TTLKGHVLIMDYIKDGDLFDLLKKEGK---------LSEA 109
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAAR 230
+ KI + L LH+ +IIH DIK NVL D + D+ L
Sbjct: 110 EVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------I 159
Query: 231 LHSTRVL-GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
+ + GT Y +PE + G S D ++ GV+ ELLTG+ P
Sbjct: 160 IGTPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAIKKLDASKQPDEEFLAQVSMVSR------LKHENF 124
++G+GS+G+V LK +A + K D Q D+ +M + KH
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD---VDCTMTEKRILALAAKHPFL 58
Query: 125 VQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAA 181
L +C T L + E+ + G L + ++ K +P R + A
Sbjct: 59 TAL--HCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEP--------RSRFYAAEVT 106
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
L +LH +I+RD+K N+L+ + K+ADF + + + + +T GT
Sbjct: 107 LALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPD 161
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y APE + D ++ GV++ E++ G+ P
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL-------SNQAPDMAARLHS 233
AKG+ +L K + IHRD+ + N+L+ + KI DF L SN ARL
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ APE +SDV+S+G++L E+ + G P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
LE+LH+ I++RD+K N+L+ + DF LS ++ + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 244 APEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + + K D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
+ ++YLHE IIHRDIK+ N+ I + DF + D+ A + GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
+APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 103 KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
KQ D V M+ + + + D R +Y+ +++ + ++L G +G
Sbjct: 181 KQADT--TQYVPMLEIKEASKYSDIQRSNYD---RPASYKGSNDSEVKNLL-SDDGSEGL 234
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
+LS+ +V A+G+E+L K + +HRD+ + NVL+ + KI DF L+
Sbjct: 235 TTLDLLSFTYQV------ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR 285
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
+ + + APE SDV+S+G++L E+ +
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIK----KLDASKQPDEEFLAQVS-MVSRLKHENFVQL 127
+IG+GS+G+V K G A+K K+ +++ + +A+ + ++ +KH F+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP-FLVG 60
Query: 128 LGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGLE 185
L Y T ++ +F + G L H ++ +P R + A A L
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEP--------RARFYAAEIASALG 110
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YLH +I++RD+K N+L+ + DF L + + +T GT Y AP
Sbjct: 111 YLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAP 165
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
E + D + G VL E+L G P
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSR----LKH 121
E F I G++G+VY G K + A+K + + ++ + QV R L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQV-QAERDALALSK 62
Query: 122 ENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
F+ L Y + + V L E+ G + +LH + G + VK
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEM-----AVKYISEV 113
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
A L+YLH IIHRD+K N+LI ++ K+ DF LS
Sbjct: 114 ALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
APE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
G+++LH IIHRD+K SN+++ D KI DF L+ A T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLE------LLTGRKPVDH 278
APE + D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 5/84 (5%)
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----G 251
IHRD+K N+L+ K+ADF + D + +GT Y +PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
+ D +S GV L E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 31/86 (36%), Positives = 40/86 (46%), Gaps = 7/86 (8%)
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY--AMTGQL 253
+HRDIK NVLI K+ADF S ++S +GT Y APE M G
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 254 NAKSDV----YSFGVVLLELLTGRKP 275
V +S GV+ E++ GR P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 32/224 (14%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
E+F +IG G++G V A +K +A K + L + M+ R + F +
Sbjct: 1 EDFEILKVIGRGAFGEV----------AVVKLKNADKVFAMKILNKWEMLKRAETACFRE 50
Query: 127 LLGYCVDGTSR---VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V+G ++ L Y F +L+ ++ G G +L+ + + +
Sbjct: 51 ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG------GDLLTLLSKFEDRLPEDMA 104
Query: 184 LEYLHEKA-------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
YL E H +HRDIK N+L+ + ++ADF + + + S+
Sbjct: 105 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVA 163
Query: 237 LGTFGYHAPEY--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 275
+GT Y +PE AM G+ + D +S GV + E+L G P
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 37/228 (16%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKK-LDASKQPDEEFLAQVSMVSRLKHENFVQLLGY- 130
+IG GS+G VY I + + AIKK L + + E L ++ L H N + L Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYY 128
Query: 131 ---CVDGTSRVL----AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAK 182
C + + EF ++H + + + P+ VK+ + +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYM--KHYARNNHALPLF----LVKLYSYQLCR 181
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
L Y+H K I HRD+K N+LI + K+ DF A ++ A S + +
Sbjct: 182 ALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF---GSAKNLLAGQRSVSYICSRF 235
Query: 242 YHAPEYAMTGQLNAKS--DVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
Y APE M G N + D++S G ++ E++ G + + GQ S+
Sbjct: 236 YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG-----YPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 36/149 (24%), Positives = 50/149 (33%), Gaps = 45/149 (30%)
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF------------------------- 218
+E +H+ IHRDIK N+LI D K+ DF
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 219 --------DLSNQAPDMAARLH---STRVL-----GTFGYHAPEYAMTGQLNAKSDVYSF 262
++ R R L GT Y APE + D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 263 GVVLLELLTGRKPVDHTLPRG-QQSLVTW 290
GV+L E+L G+ P P Q ++ W
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 41/171 (23%), Positives = 64/171 (37%), Gaps = 24/171 (14%)
Query: 110 LAQVSMVSRLKHE-------NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
L + S SR + N V L Y V S L + A G L + +
Sbjct: 26 LRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEE 85
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
V W + +A L+ LH + I+ RD+ +N+L+ D ++ F +
Sbjct: 86 C---VKRWAAEMVVA------LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWS 133
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
+ D + Y APE + D +S G +L ELLTG+
Sbjct: 134 EVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 39/141 (27%), Positives = 52/141 (36%), Gaps = 46/141 (32%)
Query: 196 IHRDIKSSNVLIFDDDVAKIADF--------------------------DLSNQAPD--- 226
IHRDIK N+LI D K+ DF D SN+ D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 227 ------------MAARLH----STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
AAR H + ++GT Y APE + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 271 TGRKPVDHTLP-RGQQSLVTW 290
G+ P P Q ++ W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 23/226 (10%)
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPDEEFLAQVS 114
+ +L+ E++ +IG G++G V KS + K + K+ D F +
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 115 MVSRLKHENFV-QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
+ + +V QL D + E+ G L +++ + W +
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--------KWAKF 146
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
V A L+ +H +IHRD+K N+L+ K+ADF + D +
Sbjct: 147 YTAEVVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRC 200
Query: 234 TRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKP 275
+GT Y +PE + G + D +S GV L E+L G P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 31/225 (13%)
Query: 75 IGEGSYGRVYYGILK---------SGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK 120
+G G+ ++Y GIL + IK + P F SM+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H++ V L G CV ++ EF G L D+ RK VL+ + K+A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRK-------SDVLTTPWKFKVAKQL 114
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADF-DLSNQAPDMAARLHSTRVLG 238
A L YL +K ++H ++ + N+L+ + + + F LS+ + L +
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV-LSRQECVE 170
Query: 239 TFGYHAPEYAM-TGQLNAKSDVYSFGVVLLEL-LTGRKPV-DHTL 280
+ APE + L+ +D +SFG L E+ G P+ D TL
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 58/258 (22%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
++F + +IG G++G V K +GH A+K L + ++E +A + R + + V
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILV 56
Query: 126 QLLGYCV--------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+ G V D + L EF G + +L + + ++ +A
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA---ETVLA 113
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---------------- 221
+ A L + IHRDIK N+L+ K++DF L
Sbjct: 114 IDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 222 -NQAPDMAAR-LHSTR---------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
N D + + ++S R +GT Y APE M N D +S GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 265 VLLELLTGRKPVDHTLPR 282
++ E+L G P P+
Sbjct: 225 IMYEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 73 ALIGEGSYGRVYYGILKS-GHAAAIKKLDAS----KQPDEEFLAQVS-MVSRLKHENFVQ 126
+IG+GS+G+V KS G A+K L K+ +A+ + ++ LKH F+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP-FLV 59
Query: 127 LLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGL 184
L Y ++ ++ + G L H ++ +P R + A A +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEP--------RARFYAAEVASAI 109
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
YLH +II+RD+K N+L+ + DF L + + ++ GT Y A
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTFCGTPEYLA 164
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
PE + D + G VL E+L G P
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+H H +HRDIK NVL+ + ++ADF S + + S+ +GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 247 Y--AM---TGQLNAKSDVYSFGVVLLELLTGRKP 275
AM G+ + D +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 22/177 (12%)
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
F S++S++ H + + G CV G+ ++ EF +G L D+ ++ KG P +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKE--KGRVP---V 116
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD--FDLSNQAPD 226
+W ++ +A A L YL +K +++H ++ + N+L+ +A+ LS+
Sbjct: 117 AW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL-------LTGRKP 275
A RV + APE G L+ +D +SFG LLE+ L R P
Sbjct: 172 FTALSREERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 35/124 (28%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 43 GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY----YGILKSGHA--AAI 96
G + + V P+++P S E+ +N +G G++GRV +G+ S A+
Sbjct: 15 GHEYIYVDPMQLPYDSAWEMPR--DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAV 72
Query: 97 KKLDASKQPDEE--FLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
K L ++ + E+ ++++ ++S L H N V LLG C G + E+ G L D L
Sbjct: 73 KMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
Query: 154 HGRK 157
H K
Sbjct: 133 HRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 56/254 (22%), Positives = 97/254 (38%), Gaps = 50/254 (19%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
E+F + +IG G++G V K +GH A+K L + ++E + + + E
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 124 --FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
V++ D + L EF G + +L + L+ ++
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD---------TLTEEETQFYIAETV 111
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------------DLSNQAP 225
++ +H+ IHRDIK N+L+ K++DF +L++ P
Sbjct: 112 LAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 226 D--MAARLHSTR---------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 268
++S R +GT Y APE M N D +S GV++ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 269 LLTGRKPVDHTLPR 282
+L G P P+
Sbjct: 229 MLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
LE LH+ ++I+RD+K N+L+ D IA D +M + GT Y
Sbjct: 106 LENLHKF---NVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + D ++ GV+L E+LTG P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 9/88 (10%)
Query: 75 IGEGSYGRVY----YGILKSGHA--AAIKKLDASKQPDEE--FLAQVSMVSRL-KHENFV 125
+G G++G+V +G+ K + A+K L AS DE ++++ ++S L +H+N V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDIL 153
LLG C G ++ E+ G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 12/108 (11%)
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL---- 231
I G K L+Y+H +HR +K+S++LI D ++ + + RL
Sbjct: 106 ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 232 ----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+S +VL + + G +AKSD+YS G+ EL G P
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQG-YDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 18/112 (16%)
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
P+L Q R I +EY+H+K +IHRDIK N+ + D + DF
Sbjct: 264 PLL-KQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDF------- 311
Query: 226 DMAARLHSTRV------LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
A R +GT ++PE +D++S G++LL++L+
Sbjct: 312 GTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 36/116 (31%)
Query: 196 IHRDIKSSNVLIFDDDVAKIADFDL---------------------SNQAPDMAARLHST 234
IHRDIK N+L+ K++DF L SN ++ + S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 235 R---------------VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
R +GT Y APE + N + D +S GV++ E+L G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY--AM-- 249
+HRDIK NVL+ + ++ADF S + S +GT Y +PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 250 -TGQLNAKSDVYSFGVVLLELLTGRKP 275
G+ + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 74 LIGEGSYGRVYYGILKSG---HAAAI--KKLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+IG+GS+G+V K+ +A + KK K+ ++ +++ +++ + F+ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 129 GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI-AVGAAKGLEY 186
+ ++ ++ + G L H ++ +P R + A A L Y
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP--------RARFYAAEIASALGY 111
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH +I++RD+K N+L+ + DF L + ++ ++ GT Y APE
Sbjct: 112 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPE 166
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ D + G VL E+L G P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 23/226 (10%)
Query: 59 VDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPDEEFLAQVS 114
+ +L+ E++ +IG G++G V KS + K + K+ D F +
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 115 MVSRLKHENFVQLLGYCV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
+ + +V L Y D + E+ G L +++ P W +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPE---KWARF 146
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
V A L+ +H IHRD+K N+L+ K+ADF + + +
Sbjct: 147 YTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRC 200
Query: 234 TRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKP 275
+GT Y +PE + G + D +S GV L E+L G P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 4/108 (3%)
Query: 161 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
GA+ P L Q +A ++Y+H + IIHRDIK+ NVL+ + + DF
Sbjct: 251 GARLRP-LGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 268
+ A + + GT +APE D++S G+V+ E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 293 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.65 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.53 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.47 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.32 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.19 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.08 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 99.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.87 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.8 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.76 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.71 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.61 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.58 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.46 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.39 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| PLN02236 | 344 | choline kinase | 98.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.03 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 98.02 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.94 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.84 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.82 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.79 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.76 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.67 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.66 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 97.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.44 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.41 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.37 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.31 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.22 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.16 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 97.12 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.88 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.79 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.63 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=341.91 Aligned_cols=201 Identities=34% Similarity=0.513 Sum_probs=181.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
..+|.+.+.||+|+|++||+|+++ ++..||||.+...... .+.+..|+.+|+.++|||||.+++++.+.+.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 358999999999999999999987 7899999999766422 355789999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC------CceEE
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD------DVAKI 215 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~------~~~kl 215 (293)
|||.||+|.++++.++ .+++..++.++.|++.||++||+++ ||||||||.|||++.. -.+||
T Consensus 89 EyC~gGDLs~yi~~~~---------~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---------RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred EeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEe
Confidence 9999999999999886 3999999999999999999999999 9999999999999764 45899
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||+++.+.... ...+.+|+|-|||||++....|+.|+|+||+|+++|++++|+.||+..++
T Consensus 157 ADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 157 ADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred cccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9999999876433 34778999999999999999999999999999999999999999996554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=352.50 Aligned_cols=199 Identities=29% Similarity=0.486 Sum_probs=184.9
Q ss_pred hcCCCCceeeccCceEEEEEEe-CCCCeEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.+|...++||+|+|+.+|.+++ .+|+.||+|++.+ .....+.+.+|+++.++|+|||||+++++|+|.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 6899999999986 4555678999999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|+|..++|.+++++++ .+++.+++.+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|
T Consensus 98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence 9999999999999665 5999999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
..+.....+ ..+.+|||.|+|||++.+..++..+||||+||+||.||+|++||+..
T Consensus 166 t~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 166 TQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred eeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 987654333 36789999999999999999999999999999999999999999854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=331.37 Aligned_cols=202 Identities=27% Similarity=0.382 Sum_probs=183.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.++||+|+||+||+++.+ +++.||+|++++.. .......+|..+|.+++||+||+++-.|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 358999999999999999999977 79999999997653 2345678999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
+||+.||.|...|++.+ .+++..++.++.+|+.||.|||++| ||||||||+|||++.+|+++|+|||+
T Consensus 104 ld~~~GGeLf~hL~~eg---------~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---------RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred EeccCCccHHHHHHhcC---------CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999999998776 4999999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++..... ...+.+++||+.|||||++.+..|+..+|.||||+++|||++|.+||.+.+.
T Consensus 172 ~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 172 CKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred chhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 9854332 2234568999999999999999999999999999999999999999987654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=330.48 Aligned_cols=204 Identities=27% Similarity=0.439 Sum_probs=178.7
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--------hHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--------DEEFLAQVSMVSRLKHENFVQLLGYCVD 133 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 133 (293)
+.+.+.|.+.+.||+|+||.|-+|..+ +|+.||||++.++... ...+.+|+++|++|+||+||+++++++.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 336678899999999999999999976 8999999999754322 2346799999999999999999999999
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC---
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--- 210 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~--- 210 (293)
.++.|+||||++||.|.+.+-..+ .+.+.....+++|++.|+.|||++| |+||||||+|||+..+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk---------~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANK---------YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAED 315 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhcc---------ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcc
Confidence 999999999999999999987765 4888899999999999999999999 9999999999999876
Q ss_pred CceEEeccccCCCCCcccccccccccccCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
-.+||+|||+|+..... ....+++|||.|.|||++.+.. +..++|+||+||+||-+|+|.+||++...
T Consensus 316 ~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred eEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 57999999999987532 2347799999999999998654 33488999999999999999999997543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=323.62 Aligned_cols=196 Identities=31% Similarity=0.444 Sum_probs=176.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC--CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCC-eeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-SRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~ 143 (293)
+.+..+.||+|..|+||++.++ +++.+|+|++... ....+.+.+|+++++.++||+||++|+.|.+.. .+.++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4445667999999999999998 8999999999543 334567899999999999999999999999998 49999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|++|+|++++...+ .+++...-.++.+|++||.|||+ .+ ||||||||+|||++..|.|||||||.+.
T Consensus 160 MDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred cCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccH
Confidence 99999999998764 38999999999999999999996 66 9999999999999999999999999998
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.+... ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||...
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 76543 347789999999999999999999999999999999999999999763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=321.28 Aligned_cols=206 Identities=26% Similarity=0.409 Sum_probs=179.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEE-EE-eCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGY-CV-DGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~-~~-~~~~~~l 139 (293)
..+|++.+.||+|.||+||++.+. +|..+|.|.+.....+ .+++..|+.+|++|+||||++++++ +. +...++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 357889999999999999999866 8999999999865544 3568899999999999999999983 33 3444889
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCceEEcCCCceEEec
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH--IIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
|||+|.+|+|..+++..+..+ +.+++..+++++.|++.||..+|+. ..+ |+||||||.||+++.+|.+||+|
T Consensus 98 vmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred HHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence 999999999999998655322 4699999999999999999999983 223 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||+++.+..... ...+.+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+.
T Consensus 172 fGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 172 FGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred chhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 999998755333 346789999999999999999999999999999999999999999876
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=330.32 Aligned_cols=230 Identities=54% Similarity=0.949 Sum_probs=204.8
Q ss_pred ccCccCHHHHHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEE
Q 022706 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYC 131 (293)
Q Consensus 53 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~ 131 (293)
....++.+++...+++|.-...||+|+||.||+|...+++.||||++...... ..+|.+|+.++.+++|||+++++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 55678999999999999999999999999999999998899999988766655 66799999999999999999999999
Q ss_pred EeCC-eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC
Q 022706 132 VDGT-SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 132 ~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
.+.+ ..+||+||+++|+|.+.+...... .++|..+++|+.++++||+|||....++|+|||||++|||+|++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 9998 599999999999999999876532 48999999999999999999999887789999999999999999
Q ss_pred CceEEeccccCCCCCccccccccccc-ccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccccc
Q 022706 211 DVAKIADFDLSNQAPDMAARLHSTRV-LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~~~ 289 (293)
.++||+|||+++..+.. ....... .||..|++||....+..+.++||||||++|.||+||+.|.+...+.++..+.+
T Consensus 214 ~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~ 291 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE 291 (361)
T ss_pred CCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence 99999999999765541 1111222 79999999999999999999999999999999999999998777777777888
Q ss_pred cc
Q 022706 290 WV 291 (293)
Q Consensus 290 ~~ 291 (293)
|.
T Consensus 292 w~ 293 (361)
T KOG1187|consen 292 WA 293 (361)
T ss_pred HH
Confidence 85
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=311.44 Aligned_cols=199 Identities=29% Similarity=0.405 Sum_probs=183.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||.|+||+|.+++.+ +|..+|+|++.+... ..+...+|..+|+.+.||+++++++.+.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 358899999999999999999988 799999999976543 235577899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||++||.|.+++++.+ .+++..++.++.||+.||+|||+.+ |++||+||+|||+|++|.+||.|||.
T Consensus 123 meyv~GGElFS~Lrk~~---------rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---------RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred EeccCCccHHHHHHhcC---------CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccc
Confidence 99999999999999876 4999999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++...+. +.+.+|||.|+|||.+...+++.++|.||||+++|||+.|.+||.+..+
T Consensus 191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred eEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 9886543 4778999999999999999999999999999999999999999998776
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=328.11 Aligned_cols=205 Identities=28% Similarity=0.404 Sum_probs=183.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 138 (293)
-.++|..++.||+|+|++|++|+.+ +++.||||++.+.. ...+.+.+|-..|.+| .||.|++++-.|+|+..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3469999999999999999999977 89999999987543 3335577888999999 6999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+|+||+++|+|.++|++.+ .+++.-.+.++.||+.||+|||++| ||||||||+|||+|.+++++|.||
T Consensus 151 FvLe~A~nGdll~~i~K~G---------sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG---------SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred EEEEecCCCcHHHHHHHhC---------cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeec
Confidence 9999999999999999886 4999999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccc---------cc--ccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 219 DLSNQAPDMAAR---------LH--STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|.++.+...... .. ...++||..|.+||++.....++.+|+|+|||+||+|+.|.+||.+..+
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 999877554322 11 2569999999999999999999999999999999999999999987643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=323.22 Aligned_cols=204 Identities=25% Similarity=0.352 Sum_probs=180.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+++.||+|+||.||+|+-+ +|..+|+|+++++.. ..+.++.|-++|...++|.||+++-.|++..++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 48999999999999999999977 899999999987643 3456888999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++||++..+|.+.. .|++..++.++.+++.|+..+|+.| +|||||||+|+|||..|++||+|||++
T Consensus 221 EylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence 9999999999998765 4999999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccc---------------------ccc------------------------cccccccCcccccccccccCCCCCc
Q 022706 222 NQAPDMA---------------------ARL------------------------HSTRVLGTFGYHAPEYAMTGQLNAK 256 (293)
Q Consensus 222 ~~~~~~~---------------------~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 256 (293)
..+.... ... .....+|||.|+|||++++..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 5321100 000 0123679999999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 257 SDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 257 ~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
.|.||||||+||||.|.+||.+.+|.
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~ 394 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQ 394 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999988774
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=323.07 Aligned_cols=210 Identities=28% Similarity=0.421 Sum_probs=183.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeC--CeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 139 (293)
.+.|+.++.||+|.||.||+|++. +|+.||+|++..+.... ....+|+.+|++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356888889999999999999966 89999999998765433 4567999999999999999999998876 78999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
|+|||+. +|.-++.... ..|++.++..++.|++.||.|||++| |+|||||.+|||||++|.+||+|||
T Consensus 196 VFeYMdh-DL~GLl~~p~--------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG--------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred EEecccc-hhhhhhcCCC--------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccc
Confidence 9999987 8888876543 24999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccccccc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~~ 288 (293)
++..+...... .-+..+-|++|+|||++++. .|+..+|+||+||||.||+.|++.|.+.++.+|...+
T Consensus 264 LAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI 332 (560)
T KOG0600|consen 264 LARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI 332 (560)
T ss_pred ceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH
Confidence 99976543322 23566779999999999985 6999999999999999999999999999887766544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=308.60 Aligned_cols=208 Identities=29% Similarity=0.394 Sum_probs=180.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|+....+|+|+||+||+++++ +|+.||||++..+..+ .+-..+|+++|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46788889999999999999998 8999999999765544 3457899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
||+. ++.+-+.+... .++.+.+..++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||+|+
T Consensus 82 ~~dh-TvL~eLe~~p~--------G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPN--------GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ecch-HHHHHHHhccC--------CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 9988 55444554442 3899999999999999999999998 9999999999999999999999999998
Q ss_pred CCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCccccccc
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~~ 288 (293)
.+..... .-+..+.|.+|+|||++.+ ..|+..+||||+||++.||++|.+-|.+....++-.++
T Consensus 150 ~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 150 TLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLI 214 (396)
T ss_pred hhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHH
Confidence 8763221 2366788999999999988 57999999999999999999999999988776665544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=329.76 Aligned_cols=204 Identities=26% Similarity=0.386 Sum_probs=182.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.++||+|.||+|+++..+ +++.+|||+++++.. +.+....|.+++.... ||+++.++..|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 468999999999999999999988 799999999987642 3456778888888775 9999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+.||++..+.+... +++..++.++.+|+.||+|||++| |||||||.+|||+|.+|++||+|||
T Consensus 447 vmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred EEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccc
Confidence 999999999666655443 999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~ 284 (293)
+++.... ....+.+++|||.|+|||++.+..|+.++|.|||||+||||+.|+.||.+.++++.
T Consensus 514 lcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~ 576 (694)
T KOG0694|consen 514 LCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV 576 (694)
T ss_pred cccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9987543 23356889999999999999999999999999999999999999999998876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=318.01 Aligned_cols=203 Identities=30% Similarity=0.462 Sum_probs=179.8
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----C--CChHHHHHHHHHHhcCC-CCCceeEEEEEEeCC
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----K--QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGT 135 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 135 (293)
...++|.+++.||+|.||+|++|.+. +++.||+|++... . ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34579999999999999999999876 7899999977653 1 12356678999999999 999999999999999
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-CceE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAK 214 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-~~~k 214 (293)
.+++||||+.||.|.+++...+ .+.+.++..+++|++.|++|||+.| |+||||||+|||++.+ +++|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999999998844 4899999999999999999999999 9999999999999999 9999
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCC-CC-CccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LN-AKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+|||++.... .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||++..
T Consensus 162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 99999998763 1222346789999999999999876 75 68999999999999999999999754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=311.18 Aligned_cols=202 Identities=28% Similarity=0.450 Sum_probs=182.9
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEe-CCCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGIL-KSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
..+..+|.+.+.||+|.||.|-+|+. +.|+.||||.++++.... -.+++|+++|..|+||||++++++|++.+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34556899999999999999999986 589999999998765432 3578999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
.|||||..+|.|.+++.+++ .+++.+++.+++||+.|+.|+|.++ ++|||||.+|||+|+++++||+|
T Consensus 129 vivMEYaS~GeLYDYiSer~---------~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIAD 196 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERG---------SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIAD 196 (668)
T ss_pred EEEEEecCCccHHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeec
Confidence 99999999999999999886 4999999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||++..+.+. ..-.+++|+|.|.+||++.+.+| ++.+|-||||++||.|+.|.+||++.
T Consensus 197 FGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 197 FGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred cchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 9998765432 23467999999999999999887 67899999999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=313.76 Aligned_cols=200 Identities=39% Similarity=0.624 Sum_probs=173.7
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCC-eeEEEEEcccC
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT-SRVLAYEFASN 146 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~ 146 (293)
+.+.||+|+||+||++.++....||+|++...... ...|.+|+.+|.+++|||||++++++.+.. ...+||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 44459999999999999984444999999765544 348999999999999999999999999887 78999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEeccccCCCCC
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAP 225 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg~~~~~~ 225 (293)
|+|.+++..... ..+++..++.|+.||++|+.|||+.+ +|||||||++|||++.++ ++||+|||+++...
T Consensus 125 GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 125 GSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred CcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999987411 24999999999999999999999996 389999999999999997 99999999997654
Q ss_pred cccccccccccccCcccccccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAM--TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
... ...+...||+.|||||++. ...++.++||||||+++|||+||+.||.+..+
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 321 2224478999999999999 56899999999999999999999999998876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=319.49 Aligned_cols=197 Identities=32% Similarity=0.472 Sum_probs=180.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|.+.++||+|.||.||+|+.+ +.+.||+|.+.+..... ..+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57999999999999999999987 89999999998766555 447799999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+.| +|+.++.... .++++.+..++.+++.||.|||+++ |.|||+||.|||++.++++||||||+++
T Consensus 82 ~a~g-~L~~il~~d~---------~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---------KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred hhhh-hHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence 9987 9999998765 3999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
..... ....+...|||.|||||+..+++|+..+|+||+||++||+++|++||-.
T Consensus 149 ~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 149 AMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred hcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 76542 2234567799999999999999999999999999999999999999964
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=289.22 Aligned_cols=207 Identities=29% Similarity=0.402 Sum_probs=182.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.+|...+.||+|.||.||+|++. +|+.||||+++..... .....+|++.|+.++|+||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999966 8999999999866443 4568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|++. +|+..++... ..++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+++
T Consensus 82 fm~t-dLe~vIkd~~--------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred eccc-cHHHHhcccc--------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence 9976 9999998766 35999999999999999999999998 9999999999999999999999999999
Q ss_pred CCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccc
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~ 287 (293)
........ .+..+-|.+|+|||++.+. .|+..+||||.||++.||+-|.+-|.+.+.-+|.+.
T Consensus 150 ~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~ 213 (318)
T KOG0659|consen 150 FFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK 213 (318)
T ss_pred ccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH
Confidence 87654332 2334679999999999875 699999999999999999999999998876655443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=315.55 Aligned_cols=209 Identities=33% Similarity=0.519 Sum_probs=182.5
Q ss_pred cCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
.+.+.+.||+|.||.||+|.++....||+|.++......+.|.+|+++|++|+|++||+++++|..+..++|||||++.|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 34456679999999999999997789999999988888899999999999999999999999999988999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
+|.++++...+ ..+...+.+.++.||++|++||++++ +|||||.+.||||+++..+||+|||+++...+.
T Consensus 287 sLl~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 287 SLLDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred cHHHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999987332 35899999999999999999999998 999999999999999999999999999955443
Q ss_pred cccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccc
Q 022706 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 287 (293)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~~~~~ 287 (293)
... ......-...|.|||.+....++.+|||||||++||||+| |+.||.+.+..+..+.
T Consensus 357 ~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~ 416 (468)
T KOG0197|consen 357 EYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL 416 (468)
T ss_pred cee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH
Confidence 322 1122223558999999999999999999999999999999 9999998876554433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=313.52 Aligned_cols=206 Identities=28% Similarity=0.423 Sum_probs=184.0
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHH--HHHHHHHHhcCC-CCCceeEEEEEEeCC-eeE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE--FLAQVSMVSRLK-HENFVQLLGYCVDGT-SRV 138 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~ 138 (293)
.+.++|.+.+.||.|.||.||+|+.+ ++..||||+++..-..-++ -+||++.|++|+ ||||+++.+++.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45679999999999999999999976 7999999999876555444 358999999999 999999999999988 999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+|||||+. +|.++++.+. +.+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+||
T Consensus 87 fVfE~Md~-NLYqLmK~R~--------r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRN--------RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eeHHhhhh-hHHHHHhhcC--------CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccc
Confidence 99999976 9999999885 46999999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~ 284 (293)
|+|+.+...... +..+.|.+|+|||+++. ..|+.+.|||++||+++|+.+-++-|-+..+.++
T Consensus 155 GLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq 218 (538)
T KOG0661|consen 155 GLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ 218 (538)
T ss_pred ccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence 999987554433 77889999999999876 5689999999999999999999999998766444
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=294.38 Aligned_cols=207 Identities=26% Similarity=0.382 Sum_probs=180.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEE--eCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCV--DGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 140 (293)
++|..+..|++|+||.||+|+++ +++.||+|+++.+.... -.-++|+.+|.+++|||||.+.++.. +-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46778888999999999999987 89999999998765332 24579999999999999999999876 45679999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
||||+. +|..++...+ ..+...++..++.|+++|++|||.+. |+|||||++|+|+...|.+|++|||+
T Consensus 156 Me~~Eh-DLksl~d~m~--------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred HHHHHh-hHHHHHHhcc--------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccch
Confidence 999987 9999998765 35999999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccc
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~ 287 (293)
|+.++.. ....+..+-|++|+|||++++. .|+.+.|+||+||++.||+++++-|.+..+.++-+.
T Consensus 224 AR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~ 289 (419)
T KOG0663|consen 224 AREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK 289 (419)
T ss_pred hhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH
Confidence 9987654 2234667889999999999985 599999999999999999999999998876655443
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=292.65 Aligned_cols=205 Identities=27% Similarity=0.377 Sum_probs=179.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++++.||+|.-|+||++..+ ++..+|+|++.+.... ..+.+.|.++|..++||.++.+|..++.....+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 57888899999999999999988 6799999999765432 346777899999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|||+||+|+.+++++.+ ..+++..++.++.+|+.||+|||..| ||+|||||+||||.++|++.|+||.++
T Consensus 157 eyCpGGdL~~LrqkQp~-------~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-------KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred ecCCCccHHHHHhhCCC-------CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccc
Confidence 99999999999987764 46999999999999999999999999 999999999999999999999999986
Q ss_pred CCCCcc---------------------------------cc---------------------cccccccccCcccccccc
Q 022706 222 NQAPDM---------------------------------AA---------------------RLHSTRVLGTFGYHAPEY 247 (293)
Q Consensus 222 ~~~~~~---------------------------------~~---------------------~~~~~~~~gt~~y~aPE~ 247 (293)
..+... .. ......++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 433110 00 011234789999999999
Q ss_pred cccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 248 AMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 248 ~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+.+..++.++|.|+||+++|||+.|..||.+.+.
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 9999999999999999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=297.78 Aligned_cols=207 Identities=29% Similarity=0.395 Sum_probs=182.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|.+...||.|..++||+|+.. .++.||||++..+.-. .+.+++|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 368999999999999999999976 7899999999755433 4689999999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+.+|++.++++..... .+++..+..|++++++||.|||.+| .||||||+.||||+++|.|||+|||.+.
T Consensus 105 fMa~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred hhcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence 99999999999876532 3999999999999999999999999 9999999999999999999999999887
Q ss_pred CCCcccccc-cc-cccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 223 QAPDMAARL-HS-TRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 223 ~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
.+.+...+. .. ..++|||+|||||+++. ..|+.|+||||||++..||.+|..||+...|.
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 664433211 11 56789999999999664 46899999999999999999999999988663
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=308.84 Aligned_cols=203 Identities=26% Similarity=0.381 Sum_probs=176.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||++.++ +++.||+|++.... .....+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999977 78999999986532 22346778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred cCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccc---------------------------------cccccccccCcccccccccccCCCCCccchhhHHHHHHH
Q 022706 222 NQAPDMAA---------------------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 268 (293)
Q Consensus 222 ~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e 268 (293)
........ .......+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 75432110 000123579999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCC
Q 022706 269 LLTGRKPVDHTLP 281 (293)
Q Consensus 269 l~~g~~Pf~~~~~ 281 (293)
|++|+.||.+.++
T Consensus 229 ll~G~~Pf~~~~~ 241 (363)
T cd05628 229 MLIGYPPFCSETP 241 (363)
T ss_pred HHhCCCCCCCCCH
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=310.55 Aligned_cols=199 Identities=27% Similarity=0.372 Sum_probs=178.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.-|++++.||.|+.|.|-+|++. +|+.+|||++.+.. .....+.+|+-+|+.+.|||+++++++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 46889999999999999999976 89999999997652 22356889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++||.|++++-..+ .+.+.++.++++||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|
T Consensus 92 Eyv~gGELFdylv~kG---------~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---------PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred EecCCchhHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecccee
Confidence 9999999999998776 4999999999999999999999998 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..-. ....-.+.+|+|.|.+||++.+.+| +.++||||.||+||.||||++||++..
T Consensus 160 sLe~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 160 SLEV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred eccc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 6532 2223356789999999999999887 568999999999999999999998653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=296.54 Aligned_cols=206 Identities=33% Similarity=0.477 Sum_probs=170.4
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---------------ChHHHHHHHHHHhcCCCCCcee
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------------PDEEFLAQVSMVSRLKHENFVQ 126 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~ 126 (293)
....++|.+.+.||+|.||.|-+|++. +++.||||++.+... .-+.+++|+.+|++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999977 899999999864321 1257899999999999999999
Q ss_pred EEEEEEe--CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 022706 127 LLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (293)
Q Consensus 127 ~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 204 (293)
++++..+ .+.+|||+|||..|.+...=... +-+++.+++.+++.++.||.|||.+| |+||||||+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN 240 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence 9999876 46789999999887775432111 22899999999999999999999999 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCcc---cccccccccccCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCC
Q 022706 205 VLIFDDDVAKIADFDLSNQAPDM---AARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 205 ilv~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
+|++++|++||+|||.+...... .....-..-+|||.|+|||+..++. .+.+.||||+||+||.|+.|++||-
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 99999999999999998755221 1111123367999999999887632 3567899999999999999999998
Q ss_pred CCC
Q 022706 278 HTL 280 (293)
Q Consensus 278 ~~~ 280 (293)
+..
T Consensus 321 ~~~ 323 (576)
T KOG0585|consen 321 DDF 323 (576)
T ss_pred cch
Confidence 653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.66 Aligned_cols=204 Identities=29% Similarity=0.490 Sum_probs=185.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh-HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
..|...+.||+|+.|.||.+... +++.||||++....+.. +-+.+|+.+|+..+|+|||.+++.+...+.+++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888899999999999999865 79999999998777665 45779999999999999999999998889999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+||+|.+.+.... +++.++..|++++++||+|||.+| |+|||||.+|||+..+|.+||+|||++..+
T Consensus 353 ~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred CCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 9999999998775 999999999999999999999999 999999999999999999999999999877
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~ 285 (293)
..... ...+.+|||.|||||+.....|+++.||||||++++||+-|++||-...|....
T Consensus 420 ~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl 478 (550)
T KOG0578|consen 420 SEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 478 (550)
T ss_pred ccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH
Confidence 55432 357789999999999999999999999999999999999999999876664433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=296.81 Aligned_cols=202 Identities=32% Similarity=0.520 Sum_probs=172.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCC--eeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 142 (293)
.+|...+.||+|+||+||++.+. +|+..|||.+...... .+.+.+|+++|++++|||||++++...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 46788899999999999999977 5999999998654222 456889999999999999999999744333 6889999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~~ 221 (293)
|+++|+|.+++.+.++ .+++..++.+++|+++||.|||++| |+|+||||+|||++. ++.+||+|||++
T Consensus 97 y~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred ccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccc
Confidence 9999999999987763 2999999999999999999999999 999999999999999 799999999998
Q ss_pred CCCCc-ccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 222 NQAPD-MAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 222 ~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
..... ...........||+.|||||++..+ ...+++|||||||++.||+||..||...
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 87653 1111223467899999999999853 3445999999999999999999999873
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=305.78 Aligned_cols=202 Identities=24% Similarity=0.312 Sum_probs=174.1
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.|.+++.||+|+||+||+|.++ +++.||+|++..... ....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999976 789999999865322 23467889999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.+++++|+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 999999999987543 3889999999999999999999998 9999999999999999999999999875
Q ss_pred CCCcccc---------------------------------------------cccccccccCcccccccccccCCCCCcc
Q 022706 223 QAPDMAA---------------------------------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKS 257 (293)
Q Consensus 223 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 257 (293)
....... .......+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 3311000 0001235799999999999988899999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCC
Q 022706 258 DVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 258 DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||||||++|||++|+.||...++
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTP 253 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCH
Confidence 999999999999999999986554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.44 Aligned_cols=203 Identities=25% Similarity=0.375 Sum_probs=175.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||++.++ +++.||||++.... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999987 78999999996432 22345778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence 9999999999987543 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccc------------------------------------ccccccccCcccccccccccCCCCCccchhhHHHH
Q 022706 222 NQAPDMAAR------------------------------------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 265 (293)
Q Consensus 222 ~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 265 (293)
......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 654221100 00112468999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCC
Q 022706 266 LLELLTGRKPVDHTLP 281 (293)
Q Consensus 266 l~el~~g~~Pf~~~~~ 281 (293)
+|||++|..||.+.++
T Consensus 229 l~el~~G~~Pf~~~~~ 244 (364)
T cd05599 229 MYEMLVGYPPFCSDNP 244 (364)
T ss_pred HHHhhcCCCCCCCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=301.03 Aligned_cols=199 Identities=27% Similarity=0.397 Sum_probs=176.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||+++++ +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 358999999999999999999987 78999999986432 2335688999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred EcCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999987653 3889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+....... ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+..+
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 87653321 345789999999999988899999999999999999999999976543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.86 Aligned_cols=198 Identities=24% Similarity=0.372 Sum_probs=175.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||.||++.++ +++.+|+|++.... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 37899999999999999999987 79999999986432 22356788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..++.++.|++.||+|||+++ ++||||||+|||+++++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 81 EYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence 9999999999987654 3889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+..+
T Consensus 149 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 149 KKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred hhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 765331 1345689999999999988899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.29 Aligned_cols=203 Identities=27% Similarity=0.334 Sum_probs=174.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||.||++.++ +++.||+|++.... .....+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999976 79999999986432 12345778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999987543 3889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccc------------c---------------------------------ccccccccCcccccccccccCCCCCc
Q 022706 222 NQAPDMAA------------R---------------------------------LHSTRVLGTFGYHAPEYAMTGQLNAK 256 (293)
Q Consensus 222 ~~~~~~~~------------~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 256 (293)
........ . ......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 63221000 0 00012469999999999998899999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 257 SDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 257 ~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||||||++|||++|..||.+..+
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCH
Confidence 9999999999999999999986554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=306.35 Aligned_cols=202 Identities=24% Similarity=0.310 Sum_probs=173.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
+|.+.+.||+|+||+||+|.++ +++.+|+|++..... ....+.+|++++++++|+||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999976 789999999865322 23467889999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 999999999987543 3889999999999999999999999 9999999999999999999999999975
Q ss_pred CCCccc---------------------------------------------ccccccccccCcccccccccccCCCCCcc
Q 022706 223 QAPDMA---------------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKS 257 (293)
Q Consensus 223 ~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 257 (293)
...... ........+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 321100 00001235689999999999998999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCCC
Q 022706 258 DVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 258 DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||||||++|||++|+.||...++
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.13 Aligned_cols=204 Identities=24% Similarity=0.314 Sum_probs=175.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||.||+++++ +++.||+|++.... .....+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999976 78999999986432 23456788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 9999999999997653 3889999999999999999999999 999999999999999999999999997
Q ss_pred CCCCccc-----------------------------------------ccccccccccCcccccccccccCCCCCccchh
Q 022706 222 NQAPDMA-----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 260 (293)
Q Consensus 222 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 260 (293)
....... .........||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 5321000 00001235799999999999998999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCc
Q 022706 261 SFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 261 slG~~l~el~~g~~Pf~~~~~~ 282 (293)
||||++|||++|+.||.+..+.
T Consensus 229 SlGvilyell~G~~Pf~~~~~~ 250 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPA 250 (376)
T ss_pred eccceeeehhhCCCCCCCCCHH
Confidence 9999999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=299.94 Aligned_cols=198 Identities=29% Similarity=0.424 Sum_probs=176.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||.||+|.++ +++.||+|++.... .....+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999987 68999999987532 22356788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 9999999999997543 3889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|..||...++
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 76533 22456789999999999988999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=303.30 Aligned_cols=201 Identities=23% Similarity=0.336 Sum_probs=174.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||.||++.++ +++.+|+|++.... .....+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999987 78899999986421 2234577899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... +++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 122 ~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 122 MEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999997543 788999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 876532211 112356799999999998754 37889999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=290.37 Aligned_cols=201 Identities=23% Similarity=0.368 Sum_probs=173.9
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.|++.+.||+|+||.||++.++ +++.||+|.+..... ....+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999976 799999999864322 22457789999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 9999999888754321 13889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 151 QIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred EcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 6432211 2345689999999999998999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=298.83 Aligned_cols=199 Identities=26% Similarity=0.389 Sum_probs=175.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-C-CCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||.||+|.++ + +..+|+|++... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357999999999999999999865 3 368999988643 2234567889999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 109 v~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence 999999999999997654 3899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.++
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 98764321 2345789999999999988899999999999999999999999987654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=285.15 Aligned_cols=206 Identities=26% Similarity=0.382 Sum_probs=176.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCC-ceeEEEEEEeCC------
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGT------ 135 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------ 135 (293)
..|...+.||+|+||+||+|+.+ +|+.||+|++..... ......+|+.+++.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 35666677999999999999977 899999999976544 3456789999999999999 999999998877
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++|+||++. +|..++....... ..++...+..+++||+.||+|||+++ |+||||||.||||+++|.+||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEee
Confidence 78999999965 9999998765211 23677899999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
+|||+++...-... .-+..++|.+|+|||++.+. .|+...||||+||++.||++++.-|.+..+.+
T Consensus 162 aDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ 228 (323)
T KOG0594|consen 162 ADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID 228 (323)
T ss_pred eccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH
Confidence 99999986542211 13567789999999999986 69999999999999999999999999876543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.31 Aligned_cols=194 Identities=25% Similarity=0.340 Sum_probs=169.5
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
+.||+|+||.||++.++ +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 79999999987532 22345778999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 9999887543 3899999999999999999999999 999999999999999999999999998753221
Q ss_pred cccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 149 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 149 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred C--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 1 12244679999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=300.15 Aligned_cols=209 Identities=31% Similarity=0.509 Sum_probs=178.1
Q ss_pred ccCHHHHHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEE
Q 022706 56 AISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCV 132 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~ 132 (293)
..+..+.+...+.+.+...||+|.||+||+|.|.. .||||++...... .+.|++|+..+++-+|.||+-+.|++.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 34445555556778889999999999999999873 4999999755433 367999999999999999999999998
Q ss_pred eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 133 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
.... .||..+|+|.+|+.+++-... .|+..+.+.|++||++|+.|||.++ |||+|||..|||+.++++
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCc
Confidence 8777 999999999999999986652 4899999999999999999999998 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
|||+|||++................|...|||||++.. .+|++.+||||||+++|||++|.+||..
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 99999999865433333333344567889999999874 4689999999999999999999999993
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=300.63 Aligned_cols=204 Identities=26% Similarity=0.385 Sum_probs=176.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||++..+ +++.||+|++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999977 7899999998642 222356778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred eCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence 9999999999987553 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccc---------------------------------cccccccccCcccccccccccCCCCCccchhhHHHHHHH
Q 022706 222 NQAPDMAA---------------------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLE 268 (293)
Q Consensus 222 ~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~e 268 (293)
........ .......+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 65422110 001123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCc
Q 022706 269 LLTGRKPVDHTLPR 282 (293)
Q Consensus 269 l~~g~~Pf~~~~~~ 282 (293)
|++|+.||.+.++.
T Consensus 229 l~tG~~Pf~~~~~~ 242 (360)
T cd05627 229 MLIGYPPFCSETPQ 242 (360)
T ss_pred cccCCCCCCCCCHH
Confidence 99999999876553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=296.05 Aligned_cols=203 Identities=30% Similarity=0.483 Sum_probs=183.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..|+..+.||+|.||.||+|.+. +++.||+|++...... .+++.+|+.++.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35777789999999999999976 8999999999765543 36889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+.||++.+.++... .+.+..+..++++++.||.|||..+ .+|||||+.|||+..+|.+||+|||.+..
T Consensus 93 ~~gGsv~~lL~~~~---------~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---------ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred hcCcchhhhhccCC---------CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence 99999999998665 3588899999999999999999998 99999999999999999999999999987
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
+...... ..+++|||.|||||++....|+.++||||||++.+||++|.+||.+.+|..
T Consensus 161 l~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 161 LTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred eechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 7553332 377999999999999998899999999999999999999999999998844
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.68 Aligned_cols=202 Identities=22% Similarity=0.310 Sum_probs=174.5
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
..++|++.+.||+|+||.||++.++ +++.+|+|++.... .....+.+|+.+++.++||||+++++.+.+....++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3579999999999999999999987 78999999986422 223457789999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 121 v~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 121 VMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999987543 788999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++....... ........||+.|+|||++... .++.++|||||||++|||++|..||...+
T Consensus 188 ~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 188 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred ceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 987653221 1122356799999999998754 37889999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=287.26 Aligned_cols=205 Identities=27% Similarity=0.388 Sum_probs=170.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----eeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv 140 (293)
-.|.-.+++|.|+||.||+|... +++.+|||++-.+..-. -+|+++|+.++|||||++.-+|.... ...+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 36778889999999999999976 68999999986555422 36899999999999999998886432 33489
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-CceEEeccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFD 219 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-~~~kl~Dfg 219 (293)
|||++. +|.+.++.....+ ..++.-.++-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||
T Consensus 101 leymP~-tL~~~~r~~~~~~-----~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRAN-----QRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHhchH-HHHHHHHHHhhcC-----CCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence 999976 9999988532111 23788889999999999999999998 9999999999999976 899999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~ 286 (293)
.|+.+...... .+...|..|+|||++.+. .|+.+.||||.||++.||+-|++-|.+.+..++..
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~ 236 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV 236 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence 99987554433 556678999999999985 69999999999999999999999999876655543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=271.61 Aligned_cols=201 Identities=31% Similarity=0.442 Sum_probs=181.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+++.||+|-||.||+|+.+ ++..||+|++.++. .....+.+|+++-..|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 568999999999999999999976 78899999997654 2345688999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
+||...|+|...+...... .+++.....+..|++.||.|+|..+ ++||||||+|+|++..+.+|++|||-
T Consensus 101 lEya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred EEecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999855432 4889999999999999999999998 99999999999999999999999998
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+...+ .....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||....
T Consensus 171 sV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 171 SVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred eeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 87654 223477899999999999999999999999999999999999999998765
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=291.55 Aligned_cols=195 Identities=25% Similarity=0.350 Sum_probs=169.3
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
+.||+|+||.||++.++ +++.||+|++.... .....+.+|+++++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999976 79999999986532 22345678999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
+|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 9998886543 3899999999999999999999999 999999999999999999999999988653221
Q ss_pred cccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 149 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 200 (323)
T cd05595 149 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred C--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence 1 112345689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=290.95 Aligned_cols=195 Identities=26% Similarity=0.348 Sum_probs=169.9
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
+.||+|+||.||++.++ +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 79999999986532 22356778999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
+|..++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 9998886543 3899999999999999999999999 999999999999999999999999998753221
Q ss_pred cccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 149 A--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred c--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 1 112345789999999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=296.97 Aligned_cols=202 Identities=24% Similarity=0.325 Sum_probs=174.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||+++++ +++.||+|++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 458999999999999999999987 78999999986422 2234577899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... +++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 122 ~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999999987543 788999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 189 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 189 CMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred eeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 87543211 1122345789999999988653 478899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=296.38 Aligned_cols=202 Identities=24% Similarity=0.405 Sum_probs=182.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCe-eEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS-RVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 141 (293)
++|..++++|+|+||.+++++++ ++..+++|++...... .....+|+.+++++.||||+.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999987 7889999999755433 2457899999999999999999999998887 89999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
+||+||+|.+.+.++++ ..++++.+..|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||++
T Consensus 84 ~Y~eGg~l~~~i~~~k~-------~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGla 153 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG-------VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLA 153 (426)
T ss_pred eecCCCCHHHHHHHHhh-------ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhh
Confidence 99999999999988763 24999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+...... ....+.+|||.|++||++.+.+|+.++|||||||++|||++-+.+|.+.+
T Consensus 154 K~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 154 KILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred hhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 9876543 23467899999999999999999999999999999999999999998654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=289.33 Aligned_cols=192 Identities=23% Similarity=0.297 Sum_probs=168.2
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
||+|+||.||++.++ +++.||+|++... ......+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999987 6889999998643 22335677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 147 (312)
T cd05585 81 FHHLQREG---------RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD- 147 (312)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-
Confidence 99987543 3899999999999999999999999 9999999999999999999999999987542221
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 12244678999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.40 Aligned_cols=203 Identities=27% Similarity=0.379 Sum_probs=178.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||+||+|.+. +++.||+|++.... .....+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999987 79999999986432 33456788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence 9999999999997653 3899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCccc---------------------------ccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCC
Q 022706 222 NQAPDMA---------------------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 274 (293)
Q Consensus 222 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~ 274 (293)
....... .........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7654322 0112234568999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 022706 275 PVDHTLP 281 (293)
Q Consensus 275 Pf~~~~~ 281 (293)
||....+
T Consensus 229 Pf~~~~~ 235 (350)
T cd05573 229 PFYSDTL 235 (350)
T ss_pred CCCCCCH
Confidence 9987653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=290.00 Aligned_cols=197 Identities=27% Similarity=0.426 Sum_probs=169.2
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHH---hcCCCCCceeEEEEEEeCCeeEEE
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMV---SRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
|++.+.||+|+||.||++.++ +++.||+|++.... ...+.+.+|.+++ +.++||||+++++++.+....++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999977 78999999986432 2234566666554 566799999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|..++.... +++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 81 MEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence 99999999998886433 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+....... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 148 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 148 CKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 86532211 12245678999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=282.64 Aligned_cols=214 Identities=29% Similarity=0.394 Sum_probs=183.7
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCC---CCCChHHHHHHHHHHhcCCCCCceeEEEEEEe-----
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD----- 133 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 133 (293)
..+...|...+.||+|+||.|..+.++ +|+.||||++.. .....++..+|+++|+.++|+||+.+++++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 334567777899999999999999987 899999999973 23345788999999999999999999998865
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
-..+|+|+|+++ .+|..+++.+. .++...+..++.|++.||.|+|+.+ |+||||||.|++++.+..+
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCE
Confidence 345799999994 59999998775 3999999999999999999999998 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccccc
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~~~ 289 (293)
|++|||+++...........+..+.|.+|.|||++.. ..|+...||||+||++.||++|++-|.+.+...+-.++.
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~ 241 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL 241 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 9999999987754323333467788999999998865 579999999999999999999999999887766665543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.66 Aligned_cols=199 Identities=27% Similarity=0.331 Sum_probs=171.4
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCC-CCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 141 (293)
+|++.+.||+|+||.||+|.++ +++.||+|++.... .....+..|.+++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999977 68899999987532 233567788899999976 56888999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 9999999999887543 3889999999999999999999998 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+
T Consensus 149 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 149 KENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred eecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 6432111 12234568999999999999899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.22 Aligned_cols=212 Identities=24% Similarity=0.441 Sum_probs=171.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC-C
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG-T 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 135 (293)
.++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999741 3578999998754332 34688999999999 799999999988754 4
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCC-----------------------------------------------------
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGA----------------------------------------------------- 162 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~----------------------------------------------------- 162 (293)
..+++|||+++|+|.+++.........
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999998754211000
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCccc
Q 022706 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242 (293)
Q Consensus 163 ~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 242 (293)
.....+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++................+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 00134888999999999999999999998 999999999999999999999999998765332222222334456789
Q ss_pred ccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 243 ~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999998899999999999999999997 999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.65 Aligned_cols=201 Identities=25% Similarity=0.403 Sum_probs=172.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|+||+||+|.++ +++.||+|++.... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 47999999999999999999977 78999999986443 2335678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 85 ~~~-~l~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 85 LDS-DLKQYLDNCG--------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred CCc-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceee
Confidence 976 8988886543 23788999999999999999999998 99999999999999999999999999865
Q ss_pred CCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 153 KSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred ccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 432111 1234567899999998875 5688999999999999999999999987553
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=299.99 Aligned_cols=203 Identities=27% Similarity=0.349 Sum_probs=179.2
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-C-----CCceeEEEEEEeCCeeEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H-----ENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv 140 (293)
+|.+.++||+|+||.|.+|.+. +++.||||+++....-......|+++|..|+ | -|+|+++++|...++.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 6788999999999999999976 8999999999887766677778999999997 4 3899999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC--ceEEecc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADF 218 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~--~~kl~Df 218 (293)
+|.+. .+|.++++...-. .++...++.++.||+.+|..||..+ |||+||||+|||+.+.+ .||++||
T Consensus 267 fELL~-~NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ehhhh-hhHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 99995 5999999876532 4999999999999999999999999 99999999999997655 5999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~ 286 (293)
|++....... ...+.+..|+|||++++.+|+.+.||||||||+.||++|.+-|.+..+.++..
T Consensus 336 GSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 336 GSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred ccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 9987654322 35677889999999999999999999999999999999999999887765543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=284.65 Aligned_cols=200 Identities=25% Similarity=0.403 Sum_probs=170.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|+||.||+|.++ +++.+|+|++..... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 58999999999999999999987 789999999875432 234677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+. ++|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 85 ~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 85 VH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred CC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence 96 478777765431 3888999999999999999999999 99999999999999999999999999865
Q ss_pred CCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+..
T Consensus 153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 153 KSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred ccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 43211 11234567899999998875 457889999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=288.63 Aligned_cols=200 Identities=26% Similarity=0.327 Sum_probs=171.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+|.+.+.||+|+||.||++.++ +++.+|+|++..... ....+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999977 688999999875422 2234566777777774 899999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence 9999999999886543 3889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+
T Consensus 149 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 149 KENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred eecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 6532211 122456789999999999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.52 Aligned_cols=203 Identities=29% Similarity=0.415 Sum_probs=182.4
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCe
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 136 (293)
..+...|.+.+.||+|.||.||++..+ +|+.+|+|.+.+... +.+.+.+|+++|+++. ||||+.+++++++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 345568999999999999999999988 699999999976544 3468999999999998 9999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC----Cc
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DV 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~----~~ 212 (293)
.++|||++.||.|.+.+.... +++..+..+++|++.++.|||+.| |+||||||+|+|+... +.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~----------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKH----------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred EEEEEEecCCchHHHHHHHcc----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCc
Confidence 999999999999999987651 899999999999999999999999 9999999999999643 47
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.
T Consensus 178 ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred EEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 99999999988765 2234678899999999999999999999999999999999999999987764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=287.49 Aligned_cols=200 Identities=28% Similarity=0.425 Sum_probs=175.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|++.+.||+|+||.||++.++ ++..+|+|.+...... ...+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999987 7889999998754322 3568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+|+||||+||+++.++.++|+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 84 HMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 999999999997643 3889999999999999999999853 39999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 653321 234568999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=286.17 Aligned_cols=194 Identities=28% Similarity=0.379 Sum_probs=165.9
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||+|.++ +++.||+|+++... ...+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 68899999987532 2233455666666654 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 99999887543 3899999999999999999999998 99999999999999999999999999875432
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 149 GE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred CC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 21 22345678999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.17 Aligned_cols=202 Identities=23% Similarity=0.326 Sum_probs=172.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||+++.+ +++.||+|++.+. ......+.+|..++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999977 7899999998642 122345778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 81 e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred ecCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence 9999999999997532 13899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+..
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 150 LRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 65432211 11123468999999998863 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.28 Aligned_cols=201 Identities=26% Similarity=0.370 Sum_probs=172.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|+||+||+++++ +++.+|+|++..... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999987 788999999865432 23567899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|++++++..+..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 999877665543221 3889999999999999999999998 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 149 NLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred ccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 6543221 11234568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=288.11 Aligned_cols=193 Identities=24% Similarity=0.350 Sum_probs=167.6
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||++.++ +++.||+|+++.... ....+.+|..+++++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999977 789999999975422 224577899999888 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 99998886543 3899999999999999999999999 99999999999999999999999999864321
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
. ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 149 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred C--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 1 11224467899999999999989999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=289.91 Aligned_cols=194 Identities=28% Similarity=0.417 Sum_probs=165.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.+|...+.||+|+||.||++.++ +++.||+|++...... ...+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 46777889999999999999977 7899999998654332 35688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.... ...+..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 154 ~~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 154 MDGGSLEGTH-------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217 (353)
T ss_pred CCCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccccee
Confidence 9999986532 2567788899999999999999999 99999999999999999999999999876
Q ss_pred CCcccccccccccccCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
...... ......||+.|+|||.+.. ...+.++|||||||++|||++|+.||..
T Consensus 218 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 218 LAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 532211 1234578999999998743 2345689999999999999999999974
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=291.12 Aligned_cols=195 Identities=25% Similarity=0.349 Sum_probs=168.5
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
+.||+|+||.||++.++ +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 79999999986532 22345678999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
+|..++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9998886543 38999999999999999999997 67 99999999999999999999999999865322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 149 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred CC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 11 112345689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=293.43 Aligned_cols=203 Identities=25% Similarity=0.326 Sum_probs=174.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||+||++.++ +++.+|+|++..... ....+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999977 799999999875432 3345778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--------DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred CCCCCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence 9999999999997653 13899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
......... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.....
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 150 ARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred eECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 765432211 223356899999999886 45678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.18 Aligned_cols=202 Identities=22% Similarity=0.300 Sum_probs=172.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||+||+++++ +++.||+|++.... .....+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999977 78899999986422 22344778899999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 Ey~~gg~L~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred eCCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence 9999999999997632 13889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 150 LKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 75533211 11233568999999998875 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=286.94 Aligned_cols=194 Identities=26% Similarity=0.377 Sum_probs=167.8
Q ss_pred ceeeccCceEEEEEEeC----CCCeEEEEEcCCCC-----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 73 ALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.||+|+||.||+++.. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999852 58899999986432 2234567899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... .+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 82 LSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999987554 3788899999999999999999999 99999999999999999999999999864
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 150 SIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred cccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 32211 12234568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=274.79 Aligned_cols=201 Identities=24% Similarity=0.391 Sum_probs=176.1
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCC---CCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
+.+.|.+-+.||+|.|+.|+++.++ +|+.+++|++.. ...+.+++.+|+.+.+.|+||||+++++.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888899999999999999877 899999998863 334567899999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC---CceEEec
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIAD 217 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~---~~~kl~D 217 (293)
+|++.|+.|..-+-.+. .+++..+...++||+++|.|+|.++ |||||+||+|+++.+. .-+||+|
T Consensus 89 Fe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred EecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecc
Confidence 99999999965443332 3899999999999999999999999 9999999999999643 4599999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++..+.+. .....++|||.||+||++.+.+|+..+|||+.|++||-|+.|++||.+.+
T Consensus 157 FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 157 FGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred cceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 9999877632 22356789999999999999999999999999999999999999998743
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=287.57 Aligned_cols=195 Identities=23% Similarity=0.350 Sum_probs=167.9
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||+|+++ +++.||+|++.... .....+..|.+++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 68899999987532 2234566788888766 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 99998886543 3889999999999999999999999 99999999999999999999999999875322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 149 NG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred CC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 11 122445689999999999988999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=283.75 Aligned_cols=213 Identities=28% Similarity=0.438 Sum_probs=174.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC-----------------CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS-----------------GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~ 126 (293)
.++|.+.+.||+|+||.||++.+++ +..||+|.+...... ..++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3589999999999999999997532 336999998764332 356889999999999999999
Q ss_pred EEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 022706 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHII 196 (293)
Q Consensus 127 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iv 196 (293)
+++++.+.+..++||||+++++|.+++........ ......+++.+++.++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999998865431111 111234788999999999999999999998 99
Q ss_pred eCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh--CCC
Q 022706 197 HRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRK 274 (293)
Q Consensus 197 H~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~ 274 (293)
||||||+|||+++++.+||+|||++................++..|+|||.+....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876543322222233445788999999988889999999999999999986 678
Q ss_pred CCCCCCC
Q 022706 275 PVDHTLP 281 (293)
Q Consensus 275 Pf~~~~~ 281 (293)
||...+.
T Consensus 241 p~~~~~~ 247 (304)
T cd05096 241 PYGELTD 247 (304)
T ss_pred CCCcCCH
Confidence 8876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.64 Aligned_cols=202 Identities=19% Similarity=0.317 Sum_probs=166.5
Q ss_pred HHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC------CCceeEEEEEEeC
Q 022706 62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH------ENFVQLLGYCVDG 134 (293)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~ 134 (293)
+....++|++.+.||+|+||+||+|.+. +++.||||+++...........|+++++.++| .+++++++++...
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3334578999999999999999999976 68899999996544444556667777776654 4588898888754
Q ss_pred -CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCC-
Q 022706 135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDD- 211 (293)
Q Consensus 135 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~- 211 (293)
...++|||++ +++|.+++.... .+++.++..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDT 270 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCc
Confidence 5788999988 668888876543 38999999999999999999998 48 99999999999998765
Q ss_pred ---------------ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 022706 212 ---------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 212 ---------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf 276 (293)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998754221 224567999999999999999999999999999999999999999
Q ss_pred CCCCC
Q 022706 277 DHTLP 281 (293)
Q Consensus 277 ~~~~~ 281 (293)
.+.+.
T Consensus 346 ~~~~~ 350 (467)
T PTZ00284 346 DTHDN 350 (467)
T ss_pred CCCCh
Confidence 87654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=288.04 Aligned_cols=199 Identities=25% Similarity=0.334 Sum_probs=170.4
Q ss_pred cCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCC-----CChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCee
Q 022706 68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR 137 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 137 (293)
+|++.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|++++++++ |+||+++++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999999853 58899999986422 22345778999999995 99999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 99999999999999887543 3899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 149 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 149 FGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 999876432211 122346789999999998765 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=285.95 Aligned_cols=200 Identities=26% Similarity=0.338 Sum_probs=171.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+|+..+.||+|+||+||++.++ +++.||+|++.... .....+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999977 78999999987432 22345677888888886 577888999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++
T Consensus 81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence 9999999999887543 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..+
T Consensus 149 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 149 KEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred cccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 7542211 112345689999999999988899999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=285.39 Aligned_cols=195 Identities=27% Similarity=0.368 Sum_probs=168.0
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||+||++.++ +++.||+|++.... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 78999999986432 2334567788888776 599999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQKSR---------RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 99999887553 3899999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 149 NG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred CC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 11 122445789999999999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.11 Aligned_cols=217 Identities=29% Similarity=0.500 Sum_probs=186.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
..+....+.||+|+||+||+|... +...||||.++..... ..+|++|++++..++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566678999999999999832 4668999999865544 57899999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCC-C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQ-P----GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~-~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
++|+||+..|+|.++|..+....... . .+.++..+.+.|+.||+.|+.||-++. +|||||-..|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997654222211 1 234999999999999999999999998 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccc
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQ 285 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~~~ 285 (293)
|||+|||+++.+...+..+....-.-...|||||.++.++++.+|||||+||+|||+++ |+.||.+....+.-
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999998877666655544445779999999999999999999999999999999 99999988765443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=287.73 Aligned_cols=202 Identities=23% Similarity=0.313 Sum_probs=172.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||.||++.++ +++.+|+|++.+.. .....+.+|+.++..++|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999977 68889999986421 22344778899999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 ey~~~g~L~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred eccCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence 9999999999997643 13889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 150 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred eecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 65432211 1123356899999999886 3457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=299.32 Aligned_cols=206 Identities=20% Similarity=0.277 Sum_probs=175.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-C-CCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~-~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..|.+.+.||+|+||.||+|... + ++.+++|.+...... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 35999999999999999999865 4 678888877543322 34577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++...... ...+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 147 ~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred CCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 9999999887643211 124889999999999999999999998 99999999999999999999999999986
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..............||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 544332222345679999999999998899999999999999999999999997654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=277.68 Aligned_cols=207 Identities=25% Similarity=0.325 Sum_probs=182.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|..+++||+|.||.|.+++.+ +++.||+|++++...-. ...+.|-+.|+..+||.+..+.-.|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 468999999999999999999987 89999999998764322 3345688999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||..||.|.-.+.+.. .+++...+.+-.+|+.||.|||+.+ ||+||||.+|+|+|.+|++||.|||+
T Consensus 247 MeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred EEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeeccc
Confidence 99999999998887654 4999999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~ 286 (293)
++.-. .......+++|||.|+|||++....|+.++|.|.+||+||||++|++||.+.+-..-.+
T Consensus 315 CKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe 378 (516)
T KOG0690|consen 315 CKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE 378 (516)
T ss_pred chhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH
Confidence 97532 23334578999999999999999999999999999999999999999999876544333
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=286.17 Aligned_cols=194 Identities=24% Similarity=0.347 Sum_probs=167.7
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||++..+ +++.+|+|++..... ....+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 788999999975432 224577889988888 599999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 99998886543 3899999999999999999999999 99999999999999999999999999864322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 149 PG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred CC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 11 12245678999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=283.73 Aligned_cols=195 Identities=27% Similarity=0.360 Sum_probs=167.2
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||++.++ +++.||+|+++... ........|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999987 78999999987532 2334566777777654 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 99999887543 3889999999999999999999999 99999999999999999999999999864321
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 149 GD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred CC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 11 122456789999999999998999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=285.40 Aligned_cols=192 Identities=24% Similarity=0.358 Sum_probs=166.2
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||++.++ +++.+|+|++..... ....+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999977 788999999875422 224567888888777 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 99998886543 3899999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 149 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 11 122446789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=285.01 Aligned_cols=194 Identities=25% Similarity=0.365 Sum_probs=165.1
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHH-HHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||+++++ +++.||+|++.... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 78999999986432 12234455544 57888999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|...+.... .+++.++..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 99988886543 3889999999999999999999998 99999999999999999999999999865322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|..||...+
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 149 PE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 11 12244678999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=282.81 Aligned_cols=195 Identities=27% Similarity=0.394 Sum_probs=166.8
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||+|.++ +++.||+|++.... ........|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999987 68899999987542 2234566677777764 899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 99999987543 3889999999999999999999999 99999999999999999999999999864322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 149 GD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred CC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 11 122445689999999999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=284.91 Aligned_cols=194 Identities=25% Similarity=0.367 Sum_probs=165.7
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHH-HHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||+||++.++ +++.||+|++.... .....+.+|.. +++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999987 79999999986432 12234445544 56788999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 99999887543 3889999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 149 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 149 H--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred C--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 1 112244678999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=284.94 Aligned_cols=195 Identities=24% Similarity=0.340 Sum_probs=165.2
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHH-HHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQV-SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||+||++.++ +++.+|+|++.... .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 67889999986432 1223344444 356788999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+.+..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 99999987543 3788899999999999999999999 99999999999999999999999999875422
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 149 HN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred CC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 11 122456799999999999998999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=278.70 Aligned_cols=201 Identities=23% Similarity=0.376 Sum_probs=173.7
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
+|++.+.||+|+||+||++.+. +++.||+|++..... ....+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999976 789999999865322 22456789999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999988764331 23899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+...
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 151 EIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 6432211 1334689999999999888899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=285.87 Aligned_cols=200 Identities=25% Similarity=0.412 Sum_probs=168.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CeeE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSRV 138 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 138 (293)
+|++.+.||+|+||.||++.++ +++.||+|++.... .....+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999976 79999999986432 2234678999999999999999999987643 2479
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence 9999995 58988886543 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccc-cccccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|++........ ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99875432211 111234578999999998865 578899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.75 Aligned_cols=199 Identities=28% Similarity=0.431 Sum_probs=174.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|++.+.||+|+||.||++.++ ++..+|+|.+...... ...+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999987 7889999988654332 3568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|+++++|.+++.... .+++..+..++.|++.+|.|||+. + ++|+||||+||++++++.++|+|||++
T Consensus 84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 84 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 999999999987643 378899999999999999999975 5 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 152 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 7543321 134568999999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=290.29 Aligned_cols=188 Identities=35% Similarity=0.568 Sum_probs=169.1
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhh
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 151 (293)
++-||.|+.|.||+|+.+ ++.||||+++.-. ..+++-|++|+|+||+.+.++|.....++||||||..|.|.+
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 345999999999999998 8899999875322 235788999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccc
Q 022706 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231 (293)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (293)
+|+... .+.......|..+|+.++.|||.+. |||||||.-||||..+..|||+|||-++...+...
T Consensus 202 VLka~~---------~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-- 267 (904)
T KOG4721|consen 202 VLKAGR---------PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-- 267 (904)
T ss_pred HHhccC---------ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--
Confidence 998765 4888899999999999999999998 99999999999999999999999999987765532
Q ss_pred cccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.-.++||..|||||++.+.+.+.++|||||||+|||||||..||.+.+.
T Consensus 268 -kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 268 -KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred -hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 2568899999999999999999999999999999999999999987653
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=284.88 Aligned_cols=195 Identities=26% Similarity=0.358 Sum_probs=166.0
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHH-HHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||+||++.++ +++.+|+|++.... .....+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999976 79999999986432 12234455554 46778999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++.++..++.||+.||+|||+.| |+||||||+|||+++++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 99998886543 3899999999999999999999999 99999999999999999999999999865322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 149 QS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred CC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 11 122456789999999999998999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.13 Aligned_cols=193 Identities=22% Similarity=0.285 Sum_probs=168.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.+|.+.+.||+|+||.||++.+. +++.||+|... ...+.+|++++++++||||+++++++......++|||++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 57999999999999999999976 78999999753 2456789999999999999999999999999999999995
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
++|..++.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 167 -~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 167 -TDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred -CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 58888876543 3889999999999999999999998 9999999999999999999999999986533
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||-.
T Consensus 234 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 234 DINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 2211 122346799999999999988999999999999999999999987653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.75 Aligned_cols=208 Identities=24% Similarity=0.330 Sum_probs=175.9
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT----- 135 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 135 (293)
..++|.+.+.||+|+||+||++++. +++.||+|++...... ...+.+|+..+..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3569999999999999999999876 7999999998755433 245778999999999999999988765332
Q ss_pred ---eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 136 ---SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 136 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
..++||||+++++|.+++...... ...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 367999999999999998754321 134899999999999999999999998 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999876543322223345679999999999999899999999999999999999999997654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=275.98 Aligned_cols=196 Identities=24% Similarity=0.360 Sum_probs=167.5
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
||+|+||+||++.++ +++.+|+|++...... .+.+..|+++++.++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999977 7899999998654322 24567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
..++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 81 RYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 8877532211 124899999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 1234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=280.78 Aligned_cols=194 Identities=26% Similarity=0.373 Sum_probs=167.6
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||+||++.++ +++.||+|++.... .....+.+|..+++.+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 68899999987532 2234567888888888 599999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... .+++.++..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 99998887553 3899999999999999999999999 99999999999999999999999998864321
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 149 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 149 GG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred CC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 11 11234568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=276.56 Aligned_cols=200 Identities=25% Similarity=0.425 Sum_probs=166.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC--CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcC---CCCCceeEEEEEE-----e
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL---KHENFVQLLGYCV-----D 133 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 133 (293)
++|++.+.||+|+||+||+|.+. +++.+|+|.+..... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999874 468899998864432 224566777777665 6999999999875 3
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
....++||||+. ++|.+++..... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence 456889999996 489888865432 23889999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|+|||++...... .......|++.|+|||.+.+..++.++|||||||++|||++|++||.+..
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99999998754332 12244568999999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=265.78 Aligned_cols=202 Identities=27% Similarity=0.423 Sum_probs=177.6
Q ss_pred HHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-----Ch----HHHHHHHHHHhcCC-CCCceeEEEE
Q 022706 62 LKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-----PD----EEFLAQVSMVSRLK-HENFVQLLGY 130 (293)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-----~~----~~~~~e~~~l~~l~-h~~i~~~~~~ 130 (293)
...+-++|.-.+.||+|..++|.++.++ ++..+|+|++..... .. +..++|+.+|+++. ||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3556678999999999999999999877 899999999853221 11 34567899999996 9999999999
Q ss_pred EEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC
Q 022706 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 131 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
++.....++|+|.++.|.|.+++.... .+++.+.+.|++|+.+++.|||..+ ||||||||+|||++++
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn 159 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDN 159 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccc
Confidence 999999999999999999999998765 4999999999999999999999998 9999999999999999
Q ss_pred CceEEeccccCCCCCcccccccccccccCccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
.+++|+|||++..+..... -...+|||.|+|||.+.. ..|+..+|+|++|++||.|+.|.+||-+
T Consensus 160 ~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred cceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9999999999998765443 367899999999998853 3578899999999999999999999964
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=283.92 Aligned_cols=199 Identities=26% Similarity=0.332 Sum_probs=169.6
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCC----
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT---- 135 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 135 (293)
.+.++|.+.+.||+|+||.||++.++ ++..+|+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34679999999999999999999976 799999999865432 2356788999999999999999999886543
Q ss_pred --eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 136 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
..++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 46899999976 66666542 2788899999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987543211 1244568999999999999899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=277.19 Aligned_cols=201 Identities=34% Similarity=0.537 Sum_probs=182.3
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
|.++..||+|+||.||++.++ +|+.+|||++..+ .+.+++.+|+.++++++.|++|++|+.+.....+++|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 445667999999999999988 8999999998654 35578899999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
++.++++.+. ++++++++..+++..+++|+|||... -+|||||..|||++.+|+.||+|||.+..+.+.
T Consensus 114 SiSDI~R~R~--------K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 114 SISDIMRARR--------KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred cHHHHHHHhc--------CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 9999998776 35999999999999999999999997 899999999999999999999999999877654
Q ss_pred cccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
.. ...+..|||-|||||++..-.|+.++||||||++..||..|++||.+.+|..
T Consensus 183 MA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 183 MA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred HH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 33 2467889999999999999999999999999999999999999999988754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=285.12 Aligned_cols=212 Identities=25% Similarity=0.430 Sum_probs=173.6
Q ss_pred HhcCCCCceeeccCceEEEEEEe------CCCCeEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 136 (293)
.++|++.+.||+|+||.||+|++ .++..||+|+++.... ..+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999973 2466899999875433 235688999999999 79999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCC-------------------------------------------------------
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKG------------------------------------------------------- 161 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~------------------------------------------------------- 161 (293)
.++||||+++|+|.+++........
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999865431100
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccccc
Q 022706 162 -----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (293)
Q Consensus 162 -----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~ 230 (293)
......+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 001124788999999999999999999998 999999999999999999999999998765432221
Q ss_pred ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 11222334567999999999899999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=283.58 Aligned_cols=194 Identities=26% Similarity=0.372 Sum_probs=168.8
Q ss_pred ceeeccCceEEEEEEe----CCCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 73 ALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
+.||+|+||.||+++. .+++.+|+|++.... .....+.+|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 268899999987532 223456789999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 999999986543 3899999999999999999999999 9999999999999999999999999987643
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 150 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 150 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred CCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 321 12234678999999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=285.94 Aligned_cols=213 Identities=27% Similarity=0.475 Sum_probs=173.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||++.+. ++..||+|.+...... ...+.+|+++++.+ +|+||+++++.+.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 458999999999999999999843 3457999999754332 34678999999999 79999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCC---------------------------------------------------------
Q 022706 137 RVLAYEFASNGSLHDILHGRKGV--------------------------------------------------------- 159 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~--------------------------------------------------------- 159 (293)
.++||||+++++|.+++......
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999988643210
Q ss_pred ----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccc
Q 022706 160 ----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235 (293)
Q Consensus 160 ----~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (293)
........+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 00011134788999999999999999999998 99999999999999999999999999876533222111222
Q ss_pred cccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 334567999999988899999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=272.01 Aligned_cols=193 Identities=24% Similarity=0.352 Sum_probs=166.3
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
||+|+||.||++..+ +++.||+|.+..... ....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999977 799999999864321 233456799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 81 KYHIYNVGE-------RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred HHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence 988865432 23888999999999999999999999 99999999999999999999999999876543221
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 233568999999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=292.71 Aligned_cols=200 Identities=28% Similarity=0.457 Sum_probs=172.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC--CCChHHHHHHHHHHhcCCCCCceeEEEEEEeC------CeeE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSRV 138 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~ 138 (293)
.+...+.||+|+||.||+++++ +|+.||||.+... ....+..-+|++++++++|+|||+++++-++. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455678999999999999977 8999999999764 34456778999999999999999999985543 3457
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC--C--ceE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--D--VAK 214 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~--~--~~k 214 (293)
+|||||.||+|...++.-.+. ..+++.+.+.++..+..||.|||+++ |+||||||.||++..+ | ..|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~------~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENA------YGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred EEEeecCCCcHHHHhcCcccc------cCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEe
Confidence 999999999999999764432 24999999999999999999999998 9999999999999643 3 479
Q ss_pred EeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
|+|||.|+.+.+.. ...+++||+.|++||+..+ ..|+.-+|.|||||++|+++||..||...
T Consensus 165 LtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 165 LTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999887655 4578999999999998885 77888999999999999999999999754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=281.97 Aligned_cols=202 Identities=24% Similarity=0.403 Sum_probs=179.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
..-|.+.+.||+|.|.+|-+|++- +|+.||||++.+...+ ...+.+|++-|+.++|||||++|++...+..+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456889999999999999999976 8999999999876654 356889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~ 220 (293)
|+-++|+|+++|-+... .+.+..+.+++.||+.|+.|+|+.. +|||||||+||.+.+ -|.|||.|||+
T Consensus 97 ELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred EecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccc
Confidence 99999999998865442 3999999999999999999999998 999999999998864 68899999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+..+..... -++.+|++.|.|||++++..|+ +++|||||||+||.|++|++||+....
T Consensus 166 SNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 166 SNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred cccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 877654332 3678999999999999999886 578999999999999999999987654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=284.67 Aligned_cols=199 Identities=19% Similarity=0.276 Sum_probs=172.1
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC---CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+..+|.+.+.||+|+||.||++..+ .+..+++|.+... ....+|++++++++||||+++++++......+++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 3468999999999999999999754 4678999987543 24568999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|++. ++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 166 e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 166 PKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred hhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence 9996 58888884332 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
................||+.|+|||++....++.++|||||||++|||++|+.||.+..
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 76554333323345679999999999998899999999999999999999999997654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=298.58 Aligned_cols=207 Identities=23% Similarity=0.345 Sum_probs=170.4
Q ss_pred hcCCCCceeeccCceEEEEEEeCCC-CeEEEEEcCCC-CCChHHHHHHHHHHhcCC-CCCceeEEE-EEEe------CCe
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSG-HAAAIKKLDAS-KQPDEEFLAQVSMVSRLK-HENFVQLLG-YCVD------GTS 136 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~avK~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~-~~~~------~~~ 136 (293)
.++++.+.|.+|||+.||+|.+..+ ..||+|++-.. ......+.+|+.+|++|+ |+|||.+++ .... .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4778899999999999999997744 99999987543 344567889999999998 999999999 3221 134
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
++|.||||.||.|-++++.+... .|++.++++|+.|+++||++||... ++|||||||-+||||..+|++|||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence 57899999999999999876532 3999999999999999999999984 679999999999999999999999
Q ss_pred ccccCCCCCcccccc-------cccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARL-------HSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||.+.......... ......-|+.|++||++. +...+.|+|||+|||+||-|+....||++..+
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 999986432221110 011233589999999874 56789999999999999999999999997644
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=272.72 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=172.7
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
+|+..+.||+|+||.||++.++ +++.+|+|.+...... ...+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4778889999999999999977 7899999998654322 2346789999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence 9999999998864432 13889999999999999999999998 9999999999999999999999999986
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 151 HVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 5432211 123468999999999998889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.00 Aligned_cols=203 Identities=28% Similarity=0.497 Sum_probs=176.0
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|++.+.||+|+||.||++.++++..+++|.+.........+.+|++++++++||||+++++++.+....+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46888999999999999999988888999999876666677899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999875431 3789999999999999999999998 99999999999999999999999998876532
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... ......++..|+|||.+....++.++|+||||+++|+|++ |+.||...+.
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 2211 1122234567999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=301.38 Aligned_cols=211 Identities=23% Similarity=0.345 Sum_probs=175.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ..++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999977 7999999998754322 356889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 142 EFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||++|++|.+++........ ......++...++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864321110 011123667888999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccc----------------cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 220 LSNQAPDMAA----------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9876521100 001123569999999999999899999999999999999999999997643
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.91 Aligned_cols=194 Identities=23% Similarity=0.272 Sum_probs=166.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
...|.+.+.||+|+||.||++.+. +++.||+|... ...+.+|++++++++|+||+++++++......++|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 347999999999999999999987 68899999642 234578999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
. ++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 243 ~-~~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 243 R-SDLYTYLGARL--------RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred C-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 5 58888876543 14899999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf 276 (293)
.............||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 4322221223456899999999999989999999999999999999987654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=272.91 Aligned_cols=191 Identities=22% Similarity=0.382 Sum_probs=165.9
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEe----CCeeEEEEEcc
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAYEFA 144 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 144 (293)
..||+|+++.||+|.+. |+.||+|.+....... +.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 57999999999999984 8999999997654443 456799999999999999999999877 45678999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
++|+|.+++.... .+++...+.++.|++.+|.+||+. + ++||||||+||++++++.+||+|||++..
T Consensus 105 ~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 105 TRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 9999999997653 388899999999999999999985 6 88999999999999999999999999875
Q ss_pred CCcccccccccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.++
T Consensus 173 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 173 LSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred hcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 43221 23467899999999876 6789999999999999999999999987654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=285.01 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=170.2
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----eeE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 138 (293)
+|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999976 799999999865332 2356789999999999999999999998776 789
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+.+ +|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeecccc-CHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence 99999964 7877775433 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
|++........ .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.++.
T Consensus 148 g~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 148 GLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred cceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 99875432211 122344678999999988774 4788999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=272.02 Aligned_cols=212 Identities=30% Similarity=0.507 Sum_probs=175.9
Q ss_pred hcCCCCceeeccCceEEEEEEeCC-C-----CeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKS-G-----HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
++|++.+.||+|+||.||+|.... + ..+++|.+...... ...+.+|+..+++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478899999999999999998652 2 57999988654332 356889999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGA-------QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
++|||+++++|.+++......... .....+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999764321111 01135889999999999999999999998 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999875533322222334456788999999988889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=289.36 Aligned_cols=201 Identities=23% Similarity=0.338 Sum_probs=164.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeC--------Ce
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--------TS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~ 136 (293)
.++|.+.+.||+|+||+||+|.+. +++.||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 457999999999999999999976 78999999885433 2345799999999999999999876532 24
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEE
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKI 215 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl 215 (293)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceee
Confidence 6789999975 777766532111 124899999999999999999999999 99999999999998665 7999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+...
T Consensus 213 ~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 213 CDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred eccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999997654322 12345689999999988764 689999999999999999999999987543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=271.76 Aligned_cols=200 Identities=22% Similarity=0.362 Sum_probs=172.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.|+..+.||+|+||+||++.+. +++.+|+|.+..... ....+.+|++++++++|+||+.+++.+.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999976 789999999865432 22346789999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred eccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcce
Confidence 9999999988864331 13899999999999999999999999 9999999999999999999999999886
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 151 ~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 151 KIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5432211 133468999999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=276.71 Aligned_cols=201 Identities=23% Similarity=0.409 Sum_probs=171.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|+||.||+++++ +++.+|+|++..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999977 788999999864432 234677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 86 ~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 86 LDK-DLKQYMDDCG--------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred CCC-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccccee
Confidence 976 8888776543 23788999999999999999999999 99999999999999999999999999865
Q ss_pred CCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 154 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 154 KSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred cCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 432211 1233457899999998865 4688999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=282.09 Aligned_cols=199 Identities=24% Similarity=0.311 Sum_probs=170.1
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeC-----
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG----- 134 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 134 (293)
.+.++|.+.+.||+|+||.||++.+. +++.+|||++..... ....+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34679999999999999999999976 789999999875432 235678899999999999999999987543
Q ss_pred -CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 135 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcE
Confidence 357999999976 77776642 2788899999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999987653321 1234578999999999999899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=281.60 Aligned_cols=199 Identities=24% Similarity=0.302 Sum_probs=170.1
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC-----
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG----- 134 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 134 (293)
.+.++|++.+.||+|+||.||++.+. +++.+|+|++...... ...+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45679999999999999999999976 7899999998754332 35677899999999999999999988643
Q ss_pred -CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 135 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 346899999976 67666642 2788999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987653321 1234578999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.07 Aligned_cols=204 Identities=27% Similarity=0.433 Sum_probs=172.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|++.+.||+|+||.||+|.++ .+..+|+|.++..... ...+.+|+..+++++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357899999999999999999754 4668999998765432 3467899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++++|||
T Consensus 84 v~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCc
Confidence 999999999999987543 13889999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.+........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+..+
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 153 RLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred ccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 8755322111 11122334678999999998899999999999999999875 9999986654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=268.91 Aligned_cols=205 Identities=27% Similarity=0.476 Sum_probs=177.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||+|...++..+++|.+.......+.+.+|+.++++++|+||+++++.+.+....+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35789999999999999999998888899999987666566788999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 85 KGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence 9999999875432 23788999999999999999999998 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... ......++..|+|||.+....++.++||||||+++|+|++ |..||....+
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 32211 1122335668999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.39 Aligned_cols=203 Identities=28% Similarity=0.483 Sum_probs=174.7
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
.+|++.+.||+|+||.||++.++++..+++|.+.........+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 36888999999999999999988778999999876666667888999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..... .+++..++.++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++....+
T Consensus 84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999875431 3899999999999999999999999 99999999999999999999999998875532
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++
T Consensus 153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 2111 0111123457999999988889999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=276.97 Aligned_cols=203 Identities=29% Similarity=0.476 Sum_probs=169.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC----eEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.+|++.+.||+|+||+||+|.+. ++. .||+|.+..... ...++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999865 344 389999864432 235788899999999999999999998764 5679
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 86 v~e~~~~g~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--------DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred eeecCCCCCHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccc
Confidence 999999999999987643 23888999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++................++..|++||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9986543222111122234668999999998899999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=271.47 Aligned_cols=212 Identities=28% Similarity=0.493 Sum_probs=176.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
++|.+.+.||+|+||.||+|.+. +++.+++|.+...... ...+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 57888999999999999999864 3578999998765443 367889999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 139 LAYEFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
++|||+++++|.+++........ ......+++.++..++.|++.+|.+||+.+ ++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999976432110 112235889999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999875433222112233345778999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.98 Aligned_cols=203 Identities=28% Similarity=0.480 Sum_probs=175.5
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|.+.+.||+|+||+||++.++.+..+|+|.+.......+.+.+|+.++++++||||+++++++.+....+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 47888999999999999999988777899999886666677899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999875431 3899999999999999999999999 99999999999999999999999999875533
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... ......++..|++||.+.+..++.++||||||+++|+|++ |..||....+
T Consensus 153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 2211 1112234567999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=266.48 Aligned_cols=205 Identities=29% Similarity=0.506 Sum_probs=176.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|++|.||++.+.+++.|++|.+.........+.+|+.++++++|+||+++++++......+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45789999999999999999998777889999998766667789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.++..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 85 YGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999875431 24899999999999999999999998 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... .......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.++
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 155 EDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred CCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 22111 0111122457999999988889999999999999999999 9999987553
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=265.85 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=174.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|.+.+.||+|++|.||++... +++.+++|.+...... ...+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47899999999999999999976 7899999998644321 2457889999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
+|||+++++|.+++.... .+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999987543 3889999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccc-ccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++........... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 9875533221111 1234578899999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=270.51 Aligned_cols=199 Identities=28% Similarity=0.439 Sum_probs=165.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcC---CCCCceeEEEEEEe-----CC
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL---KHENFVQLLGYCVD-----GT 135 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 135 (293)
+|++.+.||+|+||+||+|.++ +++.+|+|.+..... ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999987 789999999875332 223456677766655 69999999998764 34
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..+++||++.+ +|.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 57899999975 88888865432 23899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++........ .....+++.|+|||++.+..++.++||||+||++|+|++|++||....
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 150 ADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred CccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 99999876533211 234567899999999988889999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=278.15 Aligned_cols=199 Identities=30% Similarity=0.430 Sum_probs=170.0
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeC----
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG---- 134 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 134 (293)
-.+.++|.+.+.||+|+||+||++.+. +++.||+|++..... ....+.+|++++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345679999999999999999999976 788999999875432 234577899999999999999999887543
Q ss_pred --CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 135 --TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 135 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
...+++|+++ +++|.+++.... +++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~ 156 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCE 156 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCC
Confidence 3468999998 679988876443 899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+||+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 157 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 157 LRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred EEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 999999998765332 234568999999999876 568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=280.12 Aligned_cols=192 Identities=24% Similarity=0.295 Sum_probs=161.8
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcC---CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL---KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
||+|+||+||+|+++ +++.||+|++..... .......|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999977 799999999864321 122344566666555 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 99998887543 3899999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 149 DN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred CC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 21 122446789999999998764 47899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=261.48 Aligned_cols=201 Identities=23% Similarity=0.331 Sum_probs=170.9
Q ss_pred HHHhcCCCC-ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEe----CCe
Q 022706 64 EITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVD----GTS 136 (293)
Q Consensus 64 ~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~~ 136 (293)
.++++|.+. ++||-|--|.|..+..+ +++++|+|++... ...++|+++.-..+ |||||.+++++.+ ...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 356788765 58999999999999987 8999999998533 45667887755554 9999999998764 355
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCce
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVA 213 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~ 213 (293)
+.+|||.++||.|.+.++.++.. .+++.++..|++||..|+.|||+.+ |.||||||+|+|... +..+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcce
Confidence 67999999999999999988753 4999999999999999999999998 999999999999974 4579
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
||+|||+++...... .-.+.+-||.|.|||++-...|+...|+||+||++|.|++|.+||.....
T Consensus 204 KLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 204 KLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred EecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 999999998754322 22456779999999999989999999999999999999999999987644
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=281.64 Aligned_cols=201 Identities=28% Similarity=0.384 Sum_probs=180.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
...|.+.+.||+|.|+.|.++++. ++..||||.+.+...+. ..+.+|+++++.++||||++++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 458999999999999999999977 89999999998766543 45789999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+.+|.+++++.+... ..+.++..++.|++.|++|||++. |+|||||++|||++.+.++||+|||++
T Consensus 135 eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccc
Confidence 99999999999987763 666889999999999999999998 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..+... ....+++|++.|.|||++.+..| ++..|+||+|+++|-|+.|.+||++.+-
T Consensus 203 ~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 203 TFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred eeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 876532 23467899999999999998765 6799999999999999999999997643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=266.96 Aligned_cols=193 Identities=26% Similarity=0.407 Sum_probs=169.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|++.+.||+|+||.||++.+. +++.+|+|.+...... ...+.+|++++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36888999999999999999976 7899999998654322 35688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 81 MDGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CCCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 9999986552 2788899999999999999999999 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 53321 23457899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=271.96 Aligned_cols=204 Identities=23% Similarity=0.377 Sum_probs=163.2
Q ss_pred CceeeccCceEEEEEEeC---CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeEEEEEcccC
Q 022706 72 NALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAYEFASN 146 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 146 (293)
.+.||+|+||+||+|+++ +++.+|+|.+..... ...+.+|++++++++||||+++++++.+ ....+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 457999999999999865 568899999865433 3457889999999999999999998864 4567899999965
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE----cCCCceEEeccccCC
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN 222 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv----~~~~~~kl~Dfg~~~ 222 (293)
+|.+++..............+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 88887754332211111234899999999999999999999999 9999999999999 456789999999987
Q ss_pred CCCcccc-cccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAA-RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... ........+|+.|+|||++.+ ..++.++||||+||++|+|++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6543211 112234678999999999877 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=265.12 Aligned_cols=204 Identities=32% Similarity=0.531 Sum_probs=174.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||+|.+.+...+++|++.......+.+.+|++++++++|+||+++++.+. ....++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3579999999999999999999876678999999876666678899999999999999999999874 456789999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++..++.++.|++.||++||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 84 KGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 9999999975421 23789999999999999999999998 9999999999999999999999999987554
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... ......++..|++||...+..++.++||||||+++|+|++ |..||.+..+
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred ccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 32211 1122335678999999888889999999999999999999 8999986644
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=264.57 Aligned_cols=205 Identities=32% Similarity=0.533 Sum_probs=178.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|.+.+.||+|+||.||++.++++..+++|.+........++.+|+.++++++|+||+++++++.+....+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46899999999999999999998878899999998777777889999999999999999999999998899999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.++..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 85 KGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred CCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999976432 23899999999999999999999998 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... .......+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.+...
T Consensus 155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 155 DDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred chhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 32111 1112224568999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=280.05 Aligned_cols=212 Identities=24% Similarity=0.425 Sum_probs=173.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||+|++. .+..||+|++...... .+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 568999999999999999999853 2346999999754332 356889999999996 9999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCC-------------------------------------------------------
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKG------------------------------------------------------- 161 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~------------------------------------------------------- 161 (293)
.++||||+++|+|.+++........
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865321000
Q ss_pred --------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 162 --------------------------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 162 --------------------------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
......+++.+++.++.|++.||+|||+.+ |+|+||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 001124788899999999999999999998 999999999999999
Q ss_pred CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999999999876533222212233456788999999988889999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=266.70 Aligned_cols=197 Identities=35% Similarity=0.561 Sum_probs=172.4
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHH---HHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~---~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
|++.+.||+|+||+||++.+. +++.+|+|++......... ..+|+.++++++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999988 6778999999766544332 345999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
.+++|.+++.... .+++.+++.++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccc---------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999998332 3899999999999999999999998 999999999999999999999999998653
Q ss_pred CcccccccccccccCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.. .........+++.|+|||++. +..++.++|+||+|+++|+|++|..||...
T Consensus 149 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 149 SE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11 122234567899999999988 788999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.17 Aligned_cols=193 Identities=25% Similarity=0.350 Sum_probs=164.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
..+|.+.+.||+|+||.||+|.++ +++.||+|+.... ....|+.++++++|+||+++++++.+....++|||++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 357999999999999999999987 6789999975432 2356899999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
. ++|.+++.... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 140 ~-~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 140 S-SDLYTYLTKRS--------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred C-CcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 6 48888876543 24899999999999999999999998 999999999999999999999999998643
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR-KPVDH 278 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~-~Pf~~ 278 (293)
.... ......||+.|+|||++.+..++.++|||||||++|||+++. .+|..
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 2211 123456899999999999989999999999999999999854 45543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=269.82 Aligned_cols=198 Identities=26% Similarity=0.419 Sum_probs=172.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|++.+.||+|+||.||++.+. ++..+++|.+...... ...+.+|++++++++||||+++++.+.+.+..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999977 7888999988654322 24578899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+++++|.+++.... .+++..+..++.|++.+|.|||+ .+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 81 MDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence 99999999997553 38899999999999999999997 46 9999999999999999999999999886
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 543221 234568899999999888888999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=283.56 Aligned_cols=203 Identities=33% Similarity=0.515 Sum_probs=172.8
Q ss_pred hcCCCCceeeccCceEEEEEEeCC--C--Ce-EEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKS--G--HA-AAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~--~--~~-~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
++-.+.+.||+|+||.||+|+.+. + .. ||+|..+... ....++.+|++++++++||||++++|++.+...+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455667899999999999999662 2 23 8999887522 2235788999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++|||+|.||+|.++|+.... .++..+.+.++.+.+.||+|||+++ ++||||-..|+|+..++.+||+|
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999998763 3899999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
||++.......... ....-...|+|||.+....++.++|||||||++||+++ |..||.+....
T Consensus 306 FGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred cccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence 99987654211111 11123568999999999999999999999999999999 89999877643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=302.83 Aligned_cols=202 Identities=26% Similarity=0.324 Sum_probs=178.9
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCC---C-CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---S-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~---~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
-..+|.++++||+|+||.|.+++.+ +++.||+|++.+ - .....-|..|-.+|..-+.+-|+.++-.|+|..++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3468999999999999999999987 799999999975 2 3344567888899999899999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||++||+|..++.+.. .+++.-++.++..|+.||..||+.| +|||||||+|||+|..|++||+|||
T Consensus 153 VMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred EEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999998765 3999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccc----c-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAM----T-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.+-.... +........+|||-|++||++. + +.|++..|.||+||++|||+.|..||...
T Consensus 221 sClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 221 SCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred hHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 8866542 2333446678999999999886 2 56899999999999999999999999754
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=262.80 Aligned_cols=198 Identities=28% Similarity=0.497 Sum_probs=166.5
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
+.||+|+||.||++.++ +++.+|+|.+..... ....+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999976 789999998864432 235688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 81 LTFLRTEG--------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred HHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 99986543 23889999999999999999999998 99999999999999999999999999875432211
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.........+..|+|||.+.+..++.++||||||+++|+|++ |..||....+
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 111111123456999999988889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=267.43 Aligned_cols=212 Identities=29% Similarity=0.448 Sum_probs=173.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.+|++.+.||+|+||+||+|.+. ++..+++|.+...... ...+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 47888999999999999999842 4678999998754332 2468889999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 140 AYEFASNGSLHDILHGRKGVK--------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
+|||+++++|.+++....... .......+++.+++.++.|++.||.|||+++ ++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999986432100 0001124788999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.+..+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999876543322222233445678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=274.05 Aligned_cols=202 Identities=25% Similarity=0.388 Sum_probs=179.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.|+.-++||+|+||.||-+..+ +|+-||+|.+.+.. ....-.++|..+|.+++.++||.+--.|+..+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46888899999999999999877 89999999986432 23345678999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
..|.||+|.-.|.+.+. +.++++.++.++.+|+.+|++||+.+ ||+||+||+|||+|+.|+++|+|+|++
T Consensus 265 tlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred EeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceE
Confidence 99999999988876653 45999999999999999999999998 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..+++... ....+||..|||||++.+..|+...|.|||||++|||+.|+.||.....
T Consensus 335 vei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 335 VEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred EecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 88765433 2445899999999999999999999999999999999999999986543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=267.87 Aligned_cols=197 Identities=28% Similarity=0.416 Sum_probs=175.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||.||++.+. +++.+|+|++.... .....+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999977 78999999986432 22356788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..+..++.|++.+|.+||+.+ ++|+||+|.||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 81 EYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999987653 3899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... .....+++.|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 765432 234568899999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=266.45 Aligned_cols=214 Identities=27% Similarity=0.430 Sum_probs=174.8
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
..++|++.+.||+|+||.||+|.++ ++..+|+|++..... ...++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3578999999999999999998753 356799998864332 23467889999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKG-AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
.++||||+++++|.+++........ ......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865332111 111234678899999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999876543322222223345778999999988889999999999999999999 7899986544
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=268.44 Aligned_cols=201 Identities=26% Similarity=0.453 Sum_probs=175.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..+|.+.+.||+|++|.||++.++ +++.+++|.+..... ....+.+|+.+++.++|+|++++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 358999999999999999999976 789999999875443 346688899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... +++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred cCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchh
Confidence 99999999986543 789999999999999999999999 99999999999999999999999998875
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+
T Consensus 166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred cccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 432211 12334688999999999888889999999999999999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=267.27 Aligned_cols=204 Identities=28% Similarity=0.462 Sum_probs=168.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC----eEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|++.+.||+|+||+||+|.+. +++ .+++|.+...... ..++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 47888999999999999999975 454 4777777533221 245677888899999999999999875 455788
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
++||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 86 i~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--------DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCc
Confidence 999999999999997543 23899999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
++................++..|++||.+.+..++.++||||||+++|||++ |..||.+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9876543322222233456778999999988889999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=262.82 Aligned_cols=204 Identities=30% Similarity=0.488 Sum_probs=175.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||+|..++++.+|+|.+.........+.+|+.++++++|+||+++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 5689999999999999999999888899999999877777788999999999999999999999864 456899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.+++.++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 84 NGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999998865432 23889999999999999999999998 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... ......++..|+|||.+....++.++||||||+++|||++ |+.||.+.+.
T Consensus 154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 154 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred CCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 21111 1122335678999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=263.42 Aligned_cols=203 Identities=31% Similarity=0.471 Sum_probs=174.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.+|.+.+.||+|++|.||++.++ +++.+++|.+.........+.+|++.+++++|+||+++++++......+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 46888899999999999999976 68899999987665556778999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++..++.++.|++.+|++||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 86 ~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 86 YGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred CCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999865432 23889999999999999999999998 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
..... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.+
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 156 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred cceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 32211 1112223567999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=263.08 Aligned_cols=204 Identities=32% Similarity=0.519 Sum_probs=174.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||++.++++..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4578999999999999999999888888999999876666778999999999999999999999875 456789999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 84 KGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 9999999875431 23889999999999999999999998 9999999999999999999999999987543
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 32211 1112234567999999888889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.06 Aligned_cols=202 Identities=30% Similarity=0.442 Sum_probs=173.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|++.+.||+|+||.||+|.++ +++.+++|++..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 458999999999999999999976 788999999865433 345677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... .+++..+..++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99999999886543 3889999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|+|||.+. ...++.++|+||+||++|||++|+.||....+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 156 ITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred eccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 532211 123356788999999874 34577899999999999999999999975543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=263.89 Aligned_cols=203 Identities=32% Similarity=0.541 Sum_probs=176.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
..+|++.+.||.|+||.||+|.++.+..+++|.+..... ....+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 357899999999999999999988899999999876554 4567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 85 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 85 EKGSLLAFLRSPEG-------QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred ccCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999976432 23889999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
...... .....++..|++||.+.+..++.++||||||+++|+|++ |+.||....
T Consensus 155 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 155 KEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred CCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 432211 123345678999999988889999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=276.09 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=174.5
Q ss_pred hcCCC--CceeeccCceEEEEEEeC-CCCeEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGT--NALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~--~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.-|++ .++||.|.||+||-|+++ +|+.||||++.+- ......+++|+++|+++.||.||.+...|+..+..|.|
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV 641 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV 641 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence 34544 478999999999999977 8999999998643 34457789999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC---ceEEec
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIAD 217 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~---~~kl~D 217 (293)
||.+.|.-|+-++...++ .+++.....++.||+.||.|||.++ |+|+||||+|||+.+.. .+||||
T Consensus 642 MEKl~GDMLEMILSsEkg--------RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKG--------RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred ehhhcchHHHHHHHhhcc--------cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecc
Confidence 999977555555554442 4899999999999999999999998 99999999999997654 599999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||.++.+++..- ....+|||.|+|||++.+..|+..-|+||+|+++|--++|..||....
T Consensus 711 FGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 711 FGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred ccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 999998876544 367899999999999999999999999999999999999999998653
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=265.36 Aligned_cols=204 Identities=30% Similarity=0.489 Sum_probs=173.8
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeC------Ce
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG------TS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~ 136 (293)
..+.|.+.+.||+|+||.||+|.++ +++.+|+|++.........+.+|+.+++++ +|+||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3567888899999999999999976 789999999977666667888999999998 699999999998753 46
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++|||+.+++|.+++..... ..+++..+..++.|++.+|+|||+.+ |+|+||+|+||++++++.++|+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEc
Confidence 7899999999999999876432 23889999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++....... .......|++.|+|||.+. ...++.++||||+||++|||++|..||....
T Consensus 154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred cCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999987543321 1224466899999999886 3357889999999999999999999997554
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.32 Aligned_cols=212 Identities=30% Similarity=0.501 Sum_probs=181.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC--CCC----eEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK--SGH----AAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~--~~~----~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.+..+...||+|.||.||.|... .+. .||+|.+.... ....+|.+|..+|+.++||||++++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34566788999999999999855 343 49999997654 34568999999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+++|||+||+|..+|++....... ...++..+.+.++.+|++|+.||++++ +|||||...|+|++....||++||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999877432222 346999999999999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 283 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~ 283 (293)
|+|+.+...+.........-...|||||.+....++.++|||||||++||+|| |..||.+.++.+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 99997665554433333344568999999999999999999999999999999 999999876644
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=265.30 Aligned_cols=213 Identities=28% Similarity=0.440 Sum_probs=176.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|.+.+.||+|+||.||++.++ ++..+++|.+...... ...+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 468999999999999999999865 2468999998655432 34678899999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGA-QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
++||||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998754321111 11234788999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.+.++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 9999876543322222234456788999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.18 Aligned_cols=201 Identities=27% Similarity=0.452 Sum_probs=176.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||.||++... +++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 468999999999999999999975 799999999875443 345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... +++.++..++.|++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred cCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceE
Confidence 99999999986543 789999999999999999999998 99999999999999999999999998865
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|++||.+.+..++.++|+||||+++|+|++|..||...++
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred ccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 432211 12345678899999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=298.07 Aligned_cols=208 Identities=23% Similarity=0.391 Sum_probs=170.5
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCee
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR 137 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 137 (293)
...++|.+.+.||+|+||+||++.++ ++..+++|++...... ...+..|+.++++|+||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34579999999999999999999987 6888999988754332 3568899999999999999999998864 4568
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCceEEcCC---
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD----PHIIHRDIKSSNVLIFDD--- 210 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~ivH~Dikp~Nilv~~~--- 210 (293)
||||||+++++|.++|...... ...+++..++.|+.||+.||.|||+.+. .+|+|+||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 9999999999999998753211 1248999999999999999999998431 139999999999999642
Q ss_pred --------------CceEEeccccCCCCCcccccccccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCC
Q 022706 211 --------------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRK 274 (293)
Q Consensus 211 --------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~ 274 (293)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 348999999987653322 1234578999999998864 458889999999999999999999
Q ss_pred CCCCC
Q 022706 275 PVDHT 279 (293)
Q Consensus 275 Pf~~~ 279 (293)
||...
T Consensus 242 PF~~~ 246 (1021)
T PTZ00266 242 PFHKA 246 (1021)
T ss_pred CCCcC
Confidence 99754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=260.29 Aligned_cols=201 Identities=32% Similarity=0.480 Sum_probs=175.1
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|.+.+.||+|++|.||++.++ +++.+++|.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999987 78999999986432 2345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence 999999999876421 24889999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 151 LSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 543221 1234567889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=272.61 Aligned_cols=212 Identities=24% Similarity=0.440 Sum_probs=171.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEe-CC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVD-GT 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 135 (293)
.++|++.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.+++++ +|+||+++++++.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 358999999999999999999632 3578999998754332 24577899999999 79999999998765 45
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCC----------------------------------------------------CC
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKG----------------------------------------------------AQ 163 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~----------------------------------------------------~~ 163 (293)
..+++|||+++++|.+++........ ..
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998864321100 00
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccc
Q 022706 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243 (293)
Q Consensus 164 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 243 (293)
....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0125889999999999999999999998 9999999999999999999999999997654332222223345567899
Q ss_pred cccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 244 APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 244 aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=261.50 Aligned_cols=202 Identities=27% Similarity=0.410 Sum_probs=170.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCceeEEEEEEeC--Cee
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 137 (293)
.+|++.+.||+|+||.||++.++ ++..|++|.+...... ...+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47899999999999999999976 6899999988543211 24677899999999999999999988763 567
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
+++|||+++++|.+++.... .+++..++.++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence 89999999999999987543 3788999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 9998754321111 11233458889999999988889999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.56 Aligned_cols=201 Identities=24% Similarity=0.398 Sum_probs=171.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|+||.||++.++ +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999977 78999999986443 2335677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 86 ~~~-~l~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 86 LDK-DLKQYLDDCG--------NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred ccc-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 975 8888886543 23889999999999999999999998 99999999999999999999999999865
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+.
T Consensus 154 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 154 KSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred cCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 432111 11234568899999988754 578899999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.81 Aligned_cols=213 Identities=26% Similarity=0.457 Sum_probs=174.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.++|.+.+.||+|+||.||++.+. ++..+++|.+..... ....+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357899999999999999999852 345689998865432 2456889999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGA----QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~k 214 (293)
++|||+++++|.+++......... .....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 999999999999998754321100 11124899999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||....+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999876533222112223345778999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=261.04 Aligned_cols=203 Identities=30% Similarity=0.493 Sum_probs=172.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|++.+.||+|+||+||+|.++ +...+++|.+...... ..++.+|+..+++++||||+++++++.+....+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 57899999999999999999875 2457999988754433 35688899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence 999999999999875432 3899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 887642222111122334678999999988889999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=253.65 Aligned_cols=210 Identities=27% Similarity=0.389 Sum_probs=175.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeC-----CeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 138 (293)
.++|++.+.||+|||+.||+++.- +++.||+|++.-.. .+.+..++|++..++++|||+++++++...+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 469999999999999999999954 89999999997655 4557789999999999999999998876543 3489
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
++++|...|+|.+.++..... +..+++.+++.|+.++++||++||+.. +++.||||||.|||+.+++.++|.||
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~k-----g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIK-----GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred EEeehhccccHHHHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 999999999999998866532 235999999999999999999999984 56999999999999999999999999
Q ss_pred ccCCCCCccccc-------ccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 219 DLSNQAPDMAAR-------LHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|.+....-.... ........|..|+|||++.- ...+.++|||||||+||+|+.|.-||+....
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 998765322111 11123456889999998863 4568899999999999999999999986544
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=264.33 Aligned_cols=211 Identities=28% Similarity=0.477 Sum_probs=173.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|.+.+.||+|++|.||+|.+. .+..+++|.+...... ...+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467999999999999999999875 3567899988654333 34688999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC---ceE
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAK 214 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~---~~k 214 (293)
+++|||+++++|.+++........ ....+++..++.++.||+.+|+|||+.+ ++|+||||+||++++++ .++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 999999999999999876542111 1124899999999999999999999998 99999999999998755 599
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|+|||++.................++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999876533222111122334568999999988889999999999999999997 9999987554
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=260.62 Aligned_cols=201 Identities=25% Similarity=0.392 Sum_probs=174.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
+|++.+.||+|+||.||++.++ +++.+++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999987 79999999885432 23467788999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... ..+++..++.++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 81 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 81 DGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence 99999998865332 23789999999999999999999998 999999999999999999999999998655
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 151 TSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 33211 1234568889999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=264.15 Aligned_cols=213 Identities=26% Similarity=0.431 Sum_probs=174.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|++.+.||+|+||.||+|..+ .+..||+|.+...... ...+.+|+..++.++||||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 468999999999999999999753 2457999988654332 24577899999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKG-AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
++||||+++++|.+++........ ....+.++...++.++.|++.||.|||+++ ++|+||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975432111 111234677889999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|||++................++..|+|||.+.+..++.++|+|||||++|||++ |..||.+...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999876543222222233345678999999988889999999999999999998 8899976543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.48 Aligned_cols=213 Identities=31% Similarity=0.478 Sum_probs=173.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
.++|.+.+.||+|+||.||++.+. ....+|+|.+..... ...++.+|+++++.+ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 468999999999999999999753 235799999875432 234677899999999 699999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
+..++||||+++++|.+++....... .......+++.+++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997643210 0112235889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999876543222111222234568999999988889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=264.29 Aligned_cols=204 Identities=29% Similarity=0.475 Sum_probs=169.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCC----eEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+...... ...+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357889999999999999999865 444 4899988654332 3567889999999999999999999875 4567
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
++|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+||
T Consensus 85 l~~~~~~~g~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK--------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCC
Confidence 9999999999999987543 13899999999999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|++................+++.|++||.+.+..++.++|||||||++|||++ |..||+....
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99876543222111122234678999999988889999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=260.17 Aligned_cols=201 Identities=29% Similarity=0.506 Sum_probs=173.2
Q ss_pred cCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC-------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
+|.+.+.||+|+||.||++...+++.+|+|.+...... ...+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47889999999999999999888999999998654322 14577899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++..+..++.|++.+|++||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 81 MEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 99999999999997543 3789999999999999999999998 99999999999999999999999998
Q ss_pred CCCCCcccc----cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAA----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ ........++..|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 865422111 111233568889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.72 Aligned_cols=202 Identities=32% Similarity=0.457 Sum_probs=173.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||.||++.+. +++.+++|+++..... ...+.+|+.+++.++||||+++++.+.+....+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999876 7899999998654332 34577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... .+++.+++.++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 88 CGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999987543 3899999999999999999999998 99999999999999999999999999865
Q ss_pred CCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... .......|++.|+|||.+. ...++.++|+|||||++|+|++|..||....+
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 43221 1123456899999999874 44578899999999999999999999975543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=265.36 Aligned_cols=200 Identities=29% Similarity=0.479 Sum_probs=175.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
++|++.+.||.|++|.||++.+. +++.+++|.+..... ..+.+.+|+..++.++||||+++++++.+....++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 47999999999999999999875 799999999865433 3467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++.... +++.+++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 99 ~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 99 AGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred CCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 9999999886543 899999999999999999999999 999999999999999999999999988754
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred ccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 33221 12334678899999999888899999999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=274.03 Aligned_cols=207 Identities=28% Similarity=0.433 Sum_probs=182.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.+...+.+.||+|.||.|.++....+..||+|.++..... ..+|.+|+++|.+|+||||+.++++|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4567888999999999999999887899999999876654 36899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++|+|.+++.+.... .+......+|+.||+.|++||.+.+ +|||||.+.|+|++.+.++||+|||+++.
T Consensus 617 mEnGDLnqFl~aheap-------t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP-------TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HhcCcHHHHHHhccCc-------ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 9999999999877521 1455667789999999999999998 99999999999999999999999999987
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCc
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTLPR 282 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~Pf~~~~~~ 282 (293)
+...+........+-...|||+|.+..++++.++|||+||+++||+++ ...||+..+.+
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 655555544556667789999999999999999999999999999765 88999987654
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.39 Aligned_cols=212 Identities=26% Similarity=0.435 Sum_probs=172.7
Q ss_pred cCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
+|++.+.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5788999999999999999853 2356888888654332 3468889999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 022706 140 AYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 204 (293)
+|||+.+++|.+++........ ......+++..++.++.|++.+|.|||+.+ ++|+||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999865321100 011235889999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 205 ilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999876533222111223345678999999988889999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=259.33 Aligned_cols=203 Identities=33% Similarity=0.530 Sum_probs=173.0
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|.+...||+|++|.||++.++.+..+++|.+.........+.+|++++++++|+|++++++++. ....+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 578899999999999999999887778999998766666678899999999999999999998875 4567899999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 85 GSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999975432 23789999999999999999999998 99999999999999999999999999875532
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... ......++..|++||...+..++.++|+||||+++|+|++ |..||.+..+
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2111 1122335678999999888889999999999999999999 9999987544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=259.95 Aligned_cols=200 Identities=30% Similarity=0.517 Sum_probs=172.4
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
+|.+.+.||+|++|.||+|.+. +++.+++|.+...... .+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999876 6899999988644322 1357789999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++|||+++++|.+++.... .+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence 999999999999999997653 3788999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccc----cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 217 DFDLSNQAPDMAA----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 217 Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
|||.+........ ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 9999876642111 11112345788999999998888899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=263.44 Aligned_cols=200 Identities=30% Similarity=0.448 Sum_probs=167.7
Q ss_pred hcC-CCCceeeccCceEEEEEEe-----CCCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeC--Ce
Q 022706 67 ENF-GTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TS 136 (293)
Q Consensus 67 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 136 (293)
++| .+.+.||+|+||+||++.. .++..+|+|.+..... ....+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8899999999999988652 2578899999875533 346788999999999999999999987653 46
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++|||+++++|.+++.... +++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEe
Confidence 789999999999999987543 899999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccc-cccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
|||++.......... ......++..|++||.+.+..++.++||||||+++|+|++|..||...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 999987654322111 112233466799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=266.19 Aligned_cols=212 Identities=30% Similarity=0.433 Sum_probs=173.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.+|++.+.||+|+||.||+|.+. .+..+|+|++...... ...+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35777888999999999999853 2578999999754432 256788999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 139 LAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
+++||+.+++|.+++....... .......+++..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985432100 0011134888899999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999876543332222233445788999999988889999999999999999998 8899987644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=274.10 Aligned_cols=201 Identities=22% Similarity=0.360 Sum_probs=175.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 141 (293)
...|++++.||+||.+.||++...+.+.||+|++.....+ ...+.+|+++|.+|+ |.+|+++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3579999999999999999999888889999988654444 356899999999997 999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|+=+. +|..+|+..... .....++.+-.|++.|+.++|..| |||.||||.|+|+-+ |.+||+|||++
T Consensus 440 E~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA 506 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIA 506 (677)
T ss_pred ecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechh
Confidence 99854 999999877643 343488899999999999999999 999999999999954 78999999999
Q ss_pred CCCCcccccccccccccCcccccccccccC-----------CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----------QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
..+............+||+.||+||.+... ..++++|||||||+||+|+.|++||...
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 988777777777888999999999988531 2568999999999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=266.76 Aligned_cols=204 Identities=28% Similarity=0.425 Sum_probs=175.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|++|+||++... +++.+++|.+...... ...+.+|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999977 6999999999765433 246788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+.+++|.+++..... ..+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred EecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence 99999999999875432 24899999999999999999999998 999999999999999999999999987
Q ss_pred CCCCccccc---------------------------ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCC
Q 022706 222 NQAPDMAAR---------------------------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 274 (293)
Q Consensus 222 ~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~ 274 (293)
......... .......|+..|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 654321100 01123467889999999998889999999999999999999999
Q ss_pred CCCCCC
Q 022706 275 PVDHTL 280 (293)
Q Consensus 275 Pf~~~~ 280 (293)
||...+
T Consensus 231 pf~~~~ 236 (316)
T cd05574 231 PFKGSN 236 (316)
T ss_pred CCCCCc
Confidence 997654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=263.39 Aligned_cols=212 Identities=26% Similarity=0.456 Sum_probs=174.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|.+.+.||+|+||.||++.+. ++..+++|.+...... ...+.+|+..+++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999743 3556888988644432 3568899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 140 AYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
||||+++++|.+++....... .......+++..++.++.|++.||+|||+++ ++|+||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997543110 0011124889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999876543322222234456788999999988889999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.64 Aligned_cols=215 Identities=31% Similarity=0.475 Sum_probs=177.2
Q ss_pred cCHHHHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEE--
Q 022706 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV-- 132 (293)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-- 132 (293)
+..+.+....++|++.+.||+|+||.||++.++ +++.+++|++.........+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 334455556789999999999999999999976 788999999876555556788899999999 6999999999874
Q ss_pred ---eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 133 ---DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 133 ---~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
+....++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~ 159 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTT 159 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECC
Confidence 345689999999999999987632211 124889999999999999999999998 999999999999999
Q ss_pred CCceEEeccccCCCCCcccccccccccccCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++.++|+|||++....... .......|++.|+|||.+.. ..++.++||||+||++|+|++|+.||....+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred CCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 9999999999987653221 11234468999999998753 4578899999999999999999999986644
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=262.06 Aligned_cols=199 Identities=30% Similarity=0.460 Sum_probs=175.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||.|++|.||++.+. +++.+++|.+..... ....+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999977 789999999865432 235678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++... .+++..++.++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 81 CGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999998754 2899999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......+++.|++||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 148 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 148 LTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred ecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 54321 12234567889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=260.85 Aligned_cols=203 Identities=25% Similarity=0.403 Sum_probs=173.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||.||+|+++ +++.+|+|.+..... ....+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47999999999999999999976 789999998754222 2245788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++....... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQK-----RLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCcHHHHHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 9999999998886432111 23789999999999999999999998 999999999999999999999999988
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 76543221 112346788999999998888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=266.14 Aligned_cols=209 Identities=32% Similarity=0.487 Sum_probs=169.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCC--eEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~--~~avK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||.||+|.++ ++. .+++|.+..... ....+.+|++++.++ +|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 358899999999999999999976 454 357777654322 234678899999999 79999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGA-------QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
||||+++++|.+++......... .....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 99999999999999755321110 11235899999999999999999999998 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 9999999986432111 1122233567999999888889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=266.46 Aligned_cols=204 Identities=23% Similarity=0.375 Sum_probs=162.3
Q ss_pred CceeeccCceEEEEEEeC---CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeEEEEEcccC
Q 022706 72 NALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAYEFASN 146 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 146 (293)
...||+|+||+||+|+.+ ++..+|+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 357999999999999865 45789999886543 23467889999999999999999998853 5677899999965
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE----cCCCceEEeccccCC
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIADFDLSN 222 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv----~~~~~~kl~Dfg~~~ 222 (293)
+|.+++..............+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 78777753322111111234889999999999999999999998 9999999999999 456789999999997
Q ss_pred CCCcccc-cccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAA-RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... ........+|+.|+|||.+.+ ..++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 6543221 111234568999999998876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=255.30 Aligned_cols=195 Identities=28% Similarity=0.450 Sum_probs=168.0
Q ss_pred ceeeccCceEEEEEE-eCCCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
+.||+|+++.|-.+. ..++..||||++.+.+. ...++.+|++++.+++ |+||++++++|++...+|||||.+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 479999999999887 45899999999987654 4578999999999997 99999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc---eEEeccccCCCCCc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIADFDLSNQAPD 226 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---~kl~Dfg~~~~~~~ 226 (293)
...|.++. .+++.++.+++.+|+.||.+||.+| |.|||+||+|||-.+.+. +|||||.+......
T Consensus 164 LshI~~~~---------~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 164 LSHIQKRK---------HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred HHHHHHhh---------hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99998776 5999999999999999999999999 999999999999976654 89999988654322
Q ss_pred c-----cccccccccccCcccccccccc---c--CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 227 M-----AARLHSTRVLGTFGYHAPEYAM---T--GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 227 ~-----~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
. .....-.+.+|+..|||||+.. + ..|+.+.|.||||++||.|++|++||.+.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1 1112234567888999999764 2 35889999999999999999999999875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=259.61 Aligned_cols=207 Identities=28% Similarity=0.424 Sum_probs=169.1
Q ss_pred CCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCe-----
Q 022706 69 FGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----- 136 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 136 (293)
|.+.+.||+|+||.||+|... .+..+|+|.+...... ...+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999865 2467999998754433 2467889999999999999999998866544
Q ss_pred -eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 137 -RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 137 -~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
.+++|||+++++|..++....... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence 789999999999999885543111 1124899999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+|||++.................+..|++||.+.+..++.++|||||||++|||++ |..||.+..+
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999876543322211222334678999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=264.45 Aligned_cols=206 Identities=26% Similarity=0.465 Sum_probs=173.8
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGT 135 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 135 (293)
..++|.+.+.||+|+||.||++.+. ++..+|+|.+...... .+.+.+|+++++++ +|+||+++++++....
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3468999999999999999999742 3557999988754332 35688999999999 7999999999999999
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..+++|||+.+++|.+++..... ..+++.+++.++.|++.+|+|||+++ ++|+||||+||++++++.++|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEE
Confidence 99999999999999999875432 13899999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+|||++................+++.|+|||.+.+..++.++||||+||++|+|++ |..||....
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 99999876543222111223345778999999998889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=261.94 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=169.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|.+.+.||+|++|.||+|+++ ++..|++|++..... ....+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788899999999999999976 799999999864432 235678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+. ++|.+++..... +..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 97 588888764331 124899999999999999999999998 99999999999999999999999999865
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+..
T Consensus 151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 151 FGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred cCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 43221 111334568899999988654 57889999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=262.96 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=171.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
+.|++.+.||+|+||.||++.++ ++..+++|.+..... ....+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 57999999999999999999987 689999999865432 2356788999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|..++.... ..+++..++.++.|++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 92 PGGAVDAIMLELD--------RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999988875433 13899999999999999999999998 999999999999999999999999987653
Q ss_pred CcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
... ........+++.|+|||.+. ...++.++|+|||||++|+|++|..||....
T Consensus 161 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 161 VKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 221 11123456788999999885 3446789999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=258.80 Aligned_cols=204 Identities=27% Similarity=0.479 Sum_probs=174.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||++.+..+..+++|.+.........+.+|++++++++|+||+++++.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46899999999999999999998777889999987665556778899999999999999999999887 77899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.+++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 84 KGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CCcHHHHHHhCCc-------cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999976432 23788899999999999999999998 9999999999999999999999999987553
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... ......++..|+|||.+....++.++|+||||+++|++++ |+.||...+.
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 154 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred CCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 32111 1122334567999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=257.09 Aligned_cols=206 Identities=34% Similarity=0.528 Sum_probs=174.3
Q ss_pred ceeeccCceEEEEEEeC-C---CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~---~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||++.+. . +..+++|.+...... ...+.+|++.++.++|+||+++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999976 3 889999999766544 46788999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..............+++.+++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999986521100011134899999999999999999999998 99999999999999999999999999987654
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 332222344557889999999988889999999999999999999 6999987643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=257.73 Aligned_cols=202 Identities=27% Similarity=0.422 Sum_probs=171.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCee
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR 137 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 137 (293)
.+|.+.+.||+|+||.||++.+. ++..+++|++...... ...+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 37899999999999999999976 7899999988643221 2457789999999999999999998875 3567
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
+++|||+++++|.+++.... .+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 89999999999999987543 3788999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCcccc-cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++........ ........++..|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 999875532211 111123457889999999988889999999999999999999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=261.09 Aligned_cols=201 Identities=28% Similarity=0.403 Sum_probs=172.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|++|.||++.++ +++.+++|++..... ..+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999987 689999998864322 23567889999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|..++.... .+++.+++.++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence 999988887765432 3899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... ......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||.+..+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 149 ILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred ecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6544321 1223457889999998876 4578899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=257.71 Aligned_cols=201 Identities=33% Similarity=0.527 Sum_probs=177.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
++|++.+.||+|+||.||++.++ +++.+++|.+..... .+.+.+|++++++++|+||+++++++.+....++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57899999999999999999987 589999999865543 6788999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 82 ~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 82 AGSVSDIMKITN--------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred CCcHHHHHHhCc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 999999986543 24899999999999999999999998 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.... ......++..|++||.+.+..++.++||||||+++|+|++|+.||....+
T Consensus 151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 151 DTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred cCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 3221 12334578899999999888899999999999999999999999986554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=259.58 Aligned_cols=201 Identities=28% Similarity=0.426 Sum_probs=161.3
Q ss_pred eeeccCceEEEEEEeC---CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCc
Q 022706 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
.||+|+||.||+|... ....+++|.+...... ...+.+|+..++.++|+||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5999999999999754 3457888877644322 2457889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccc
Q 022706 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (293)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~ 228 (293)
|.+++....... ....++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 82 LKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred HHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 999997654211 112567888999999999999999998 9999999999999999999999999986543222
Q ss_pred ccccccccccCccccccccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 229 ARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.........+++.|+|||++.. ..++.++|||||||++|||++ |..||....+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 1111223345678999998743 356789999999999999999 8899976643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=283.69 Aligned_cols=207 Identities=20% Similarity=0.295 Sum_probs=161.9
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC--CCCeEEEE------------------EcCCCCCChHHHHHHHHHHhcCCCC
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK--SGHAAAIK------------------KLDASKQPDEEFLAQVSMVSRLKHE 122 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK------------------~~~~~~~~~~~~~~e~~~l~~l~h~ 122 (293)
..+.++|++.+.||+|+||+||++..+ .+...++| .+.........+.+|+.++++++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345679999999999999999998754 22222222 1111112234578999999999999
Q ss_pred CceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 022706 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (293)
Q Consensus 123 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 202 (293)
||+++++++.+.+..+++++++.+ +|.+++....... .......+++.++.||+.||.|||+++ |+||||||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP 295 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKL 295 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 999999999999999999999954 7777665332110 012346778899999999999999998 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCC-CCCC
Q 022706 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK-PVDH 278 (293)
Q Consensus 203 ~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~-Pf~~ 278 (293)
+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++|.. ||..
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 999999999999999999976543221 12234679999999999999899999999999999999999875 5543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=258.67 Aligned_cols=202 Identities=27% Similarity=0.398 Sum_probs=164.1
Q ss_pred ceeeccCceEEEEEEeC---CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
+.||+|+||.||+|.+. ++..+++|.+...... ...+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999864 3567999988755432 246888999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
+|.+++....... ....++..++.++.|++.||.|||+.+ ++|+||||+||+++.+++++|+|||++......
T Consensus 81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999987543111 123667788899999999999999998 999999999999999999999999998654332
Q ss_pred cccccccccccCcccccccccccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 228 AARLHSTRVLGTFGYHAPEYAMTG-------QLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..........+++.|+|||.+.+. .++.++|+||||+++|||++ |+.||....+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 222222334567889999987642 35789999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=262.70 Aligned_cols=213 Identities=25% Similarity=0.412 Sum_probs=173.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-----------------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-----------------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~ 126 (293)
.++|++.+.||+|+||.||++.+. +...+|+|.+...... ...+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998643 2346899998754332 357889999999999999999
Q ss_pred EEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 022706 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (293)
Q Consensus 127 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 204 (293)
+++++.+.+..+++|||+++++|.+++........ ......+++.+++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999876432211 112235888999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCC
Q 022706 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTLP 281 (293)
Q Consensus 205 ilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~Pf~~~~~ 281 (293)
|++++++.++|+|||++................+++.|++||......++.++|+|||||++|||++ |..||....+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999876533221111222334678999998888889999999999999999998 7899976543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=263.36 Aligned_cols=212 Identities=29% Similarity=0.432 Sum_probs=172.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC---------------CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS---------------GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLL 128 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~ 128 (293)
.++|++.+.||+|+||.||++.+.. ...||+|.+...... ...+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3589999999999999999987642 224899998754332 34688999999999999999999
Q ss_pred EEEEeCCeeEEEEEcccCCchhhhhhcCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCce
Q 022706 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (293)
Q Consensus 129 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Ni 205 (293)
+++......++||||+++++|.+++....... .......+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532110 0111124788999999999999999999999 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 022706 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTL 280 (293)
Q Consensus 206 lv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~Pf~~~~ 280 (293)
++++++.+||+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999876543222222233345678999999988889999999999999999988 678987654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.27 Aligned_cols=211 Identities=29% Similarity=0.507 Sum_probs=175.6
Q ss_pred HHHHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEe---
Q 022706 59 VDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD--- 133 (293)
Q Consensus 59 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 133 (293)
..++....+.|++.+.||+|+||.||++.++ +++.+++|++.........+..|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 3344445578999999999999999999976 789999999876555556788899999998 69999999999853
Q ss_pred ---CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC
Q 022706 134 ---GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 134 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
....+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++++
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~ 157 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTEN 157 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence 4678999999999999999875432 13788899999999999999999998 9999999999999999
Q ss_pred CceEEeccccCCCCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+.++|+|||++........ ......+++.|+|||.+. ...++.++|+|||||++|+|++|..||....+
T Consensus 158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 9999999999875432211 123456889999999876 34578899999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=266.23 Aligned_cols=199 Identities=21% Similarity=0.305 Sum_probs=165.2
Q ss_pred CCceeecc--CceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 71 TNALIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 71 ~~~~lg~G--~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
++++||+| +|++||++..+ +++.||+|++...... ...+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999976 8999999998754332 245778999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.....
T Consensus 82 ~~~~l~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFM-------DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999999865431 13889999999999999999999998 999999999999999999999999865433
Q ss_pred Ccccccc-----cccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 225 PDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 225 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
....... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 2111100 0122346778999999876 45889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.76 Aligned_cols=201 Identities=36% Similarity=0.609 Sum_probs=166.7
Q ss_pred CCceeeccCceEEEEEEeC-----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 71 TNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.+.||.|.||.||+|.++ .+..|+||.+...... .+.+.+|++.+++++||||+++++++......++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4568999999999999866 3678999999654332 46789999999999999999999999988889999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++..... ..+++.+++.|+.|++.||.|||+.+ ++|+||+++||++++++.+||+|||++..
T Consensus 83 ~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp -TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999987621 24899999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..................|+|||.+....++.++||||||+++|||++ |+.||.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 532222222233446778999999988889999999999999999999 7899987643
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=263.60 Aligned_cols=213 Identities=28% Similarity=0.471 Sum_probs=174.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
..+|.+.+.||+|+||.||++++. ++..+++|.+..... ...++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 568999999999999999999741 245799998865432 235688999999999 799999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
...+++|||+++++|.+++........ ......+++.+++.++.|++.||.|||+++ ++|+||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999976432110 011235888999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999876644332222233445678999999988889999999999999999998 8899976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=256.71 Aligned_cols=202 Identities=25% Similarity=0.428 Sum_probs=175.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|+..+.||+|+||.||.++.. +++.+++|.+.... .....+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999866 78999999886443 2335688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++..... ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 999999999976531 24899999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+
T Consensus 151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 151 LGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred cccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 533221 22345689999999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=262.44 Aligned_cols=202 Identities=27% Similarity=0.428 Sum_probs=173.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
++|.+.+.||.|+||.||++.++ ++..+++|.+..... ..+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56889999999999999999976 789999999865432 2356888999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++.... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~~~~L~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 85 DGGALDSIMLELE--------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred CCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhh
Confidence 9999999987543 24899999999999999999999999 999999999999999999999999987654
Q ss_pred CcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... ......+++.|++||.+. ...++.++|+||||+++|+|++|+.||...++
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 154 KSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 33211 223456889999999875 34567899999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=262.31 Aligned_cols=213 Identities=30% Similarity=0.476 Sum_probs=174.7
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGT 135 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 135 (293)
..++|++.+.||+|+||.||++..+ ....+++|.+...... ..++.+|+.+++++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3568999999999999999999864 2367999988754332 24578899999999 7999999999999999
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 208 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~ 208 (293)
..+++|||+++++|.+++....... .......+++..++.++.|++.||.|||+.+ |+|+||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999987542100 0012245899999999999999999999998 99999999999999
Q ss_pred CCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999886544322221222334668999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=263.83 Aligned_cols=213 Identities=28% Similarity=0.476 Sum_probs=173.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
..+|.+.+.||+|+||.||++.+. ....+|+|.+...... ..++.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 468899999999999999999742 2457899988754332 24678899999999 599999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
...+++|||+++++|.+++....... .......+++.+++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999997643210 0111235899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999976643322211222234567999999988889999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=263.89 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=172.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||.||++.++ +++.|++|.+..... ....+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999987 688999999865432 2346778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 81 EYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred ecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCc
Confidence 9999999999997543 3889999999999999999999998 999999999999999999999999987
Q ss_pred CCCCccc-------------ccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMA-------------ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+...... .........++..|+|||.+....++.++|+||||+++|||++|..||.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6321000 00011224578889999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=279.07 Aligned_cols=194 Identities=31% Similarity=0.499 Sum_probs=170.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.|.-++.||.|+||.||.|++. +.+.||||++..+.... .++++|++.|++++|||++.+.+.|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4556678999999999999976 88999999997543322 579999999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
||-| +-.+++.-.+ +++.+-++..|+.+.+.||+|||+.+ .||||||..|||+.+.|.|||+|||.+.
T Consensus 107 YClG-SAsDlleVhk--------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHhc-cHHHHHHHHh--------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence 9965 8888776544 35899999999999999999999998 9999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.... ..+++|||.|||||+++ .+.|+-++||||||++-.||.-.++|+-++
T Consensus 175 i~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 175 IMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred hcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 5432 36789999999999886 467999999999999999999999998654
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=261.31 Aligned_cols=213 Identities=25% Similarity=0.445 Sum_probs=173.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.++|.+.+.||+|+||.||++... ++..+++|.+..... ....+.+|+++++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 357888999999999999999642 466889998764432 2457889999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 139 LAYEFASNGSLHDILHGRKGVK------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
++|||+++++|.+++....... .......+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 9999999999999987543210 0111134889999999999999999999998 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||....+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 99999999865432221111223335678999999998889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=256.23 Aligned_cols=202 Identities=28% Similarity=0.535 Sum_probs=174.6
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
.+|++.+.||+|+||.||++.+..+..+++|.+.........+.+|++++++++|||++++++++......+++|||+.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 36888899999999999999987788999999987666677899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..... .+++..++.++.|++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999875431 3789999999999999999999998 99999999999999999999999998865432
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 153 ~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 153 DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred Cccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 2111 1112234568999999988889999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=257.50 Aligned_cols=202 Identities=25% Similarity=0.399 Sum_probs=171.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC------CChHHHHHHHHHHhcCCCCCceeEEEEEEeC--Cee
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 137 (293)
.+|++.+.||+|+||.||++.++ ++..+++|.+.... .....+.+|++++++++|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999976 79999999875321 1124678899999999999999999998764 457
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
+++|||+++++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence 89999999999999987543 3788999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccc-cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 999876532111 111133568899999999988888999999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=259.00 Aligned_cols=207 Identities=28% Similarity=0.409 Sum_probs=166.5
Q ss_pred CCCCceeeccCceEEEEEEeCC-CC--eEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC------Ce
Q 022706 69 FGTNALIGEGSYGRVYYGILKS-GH--AAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG------TS 136 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~-~~--~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 136 (293)
|.+.+.||+|+||.||+|.+.. +. .+|+|.++..... .+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999763 33 6899988754322 35678899999999999999999987532 24
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++|||+.+++|.+++....... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.++|+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEEC
Confidence 689999999999998874332111 1124899999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|||++................+++.|++||.+.+..++.++||||||+++|||++ |+.||....+
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999886543222111223345678999999998889999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=262.63 Aligned_cols=201 Identities=25% Similarity=0.438 Sum_probs=170.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|++.+.||+|+||.||++.++ ++..+|+|.+...... ...+.+|++++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999987 8999999988654322 35688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+++++|.+++..... ...+++..+..++.|++.+|.|||+ .+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 81 MDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred cCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999998875421 1248999999999999999999997 47 9999999999999999999999999986
Q ss_pred CCCcccccccccccccCcccccccccccC------CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... .....+++.|++||.+.+. .++.++|+|||||++|+|++|+.||....
T Consensus 152 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 152 NLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred cccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 543221 2334578899999988543 35789999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=259.69 Aligned_cols=201 Identities=30% Similarity=0.479 Sum_probs=174.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..|+..+.||.|+||.||+|.++ ++..+|+|.+..... ....+.+|++++++++|+||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46778889999999999999976 689999998865432 235688899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... +++.++..++.|++.+|++||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 84 ~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 84 LGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999986543 788999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
..... .......++..|+|||.+.+..++.++|+||||+++|||++|..||...++.
T Consensus 151 ~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 151 LTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred ccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 54322 1123346788999999998888999999999999999999999999866543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=262.76 Aligned_cols=209 Identities=33% Similarity=0.480 Sum_probs=169.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC--eEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~~avK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.... ....+.+|++++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57899999999999999999876 343 468888764222 235688899999999 699999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 141 YEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
|||+++++|.+++........ ......+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965431110 011135889999999999999999999998 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+|+|||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+..+
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999864321111 111223457999999988889999999999999999997 9999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=258.26 Aligned_cols=204 Identities=28% Similarity=0.460 Sum_probs=171.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-C---CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~---~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.+|++.+.||+|+||.||+|.++ + +..+++|.+...... ...+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999865 2 337999998754332 35688999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... ..+++.+++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999999997543 13789999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccc-ccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 221 SNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+........... .....++..|++||.+.+..++.++|+||||+++||+++ |..||.+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 876643322111 112223567999999988889999999999999999886 9999986654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=261.16 Aligned_cols=212 Identities=28% Similarity=0.430 Sum_probs=175.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC-----------------CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCcee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS-----------------GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQ 126 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~ 126 (293)
.++|++.+.||+|+||.||++.+.. +..+|+|.+...... .+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3589999999999999999988642 245899988755432 456889999999999999999
Q ss_pred EEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 022706 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA--QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (293)
Q Consensus 127 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 204 (293)
+++++.+....+++||++.+++|.+++......... .....+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999998765421110 11124899999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 022706 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT--GRKPVDHTL 280 (293)
Q Consensus 205 ilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~--g~~Pf~~~~ 280 (293)
|++++++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999876543332222334456778999999988889999999999999999998 778987653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=271.19 Aligned_cols=212 Identities=29% Similarity=0.488 Sum_probs=173.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||+|+++ .+..||+|++...... ...+.+|++++.++. ||||+++++.+.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 457888999999999999999854 3468999999754333 246889999999997 9999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCC--------------------------------------------------------
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVK-------------------------------------------------------- 160 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~-------------------------------------------------------- 160 (293)
.++||||+++|+|.++++......
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999987543200
Q ss_pred ---------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 161 ---------------------------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 161 ---------------------------------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
.....+.+++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 0011235788889999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++++.++|+|||++................+++.|++||.+.+..++.++||||||+++|||++ |..||....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999875432221111223456788999999988889999999999999999998 899997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=256.30 Aligned_cols=202 Identities=32% Similarity=0.461 Sum_probs=175.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
++|.+.+.||+|+||.||++.+. +++.+++|++..... ....+.+|+.++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999976 688999999875433 3467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++.... ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 83 ~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 83 GGGSLQDIYQVTR--------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred CCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence 9999999887542 13899999999999999999999998 999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... ......++..|++||.+... .++.++|+||||+++|+|++|..||...++
T Consensus 152 ~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 152 TATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred hhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 43211 12345678899999998766 788899999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.47 Aligned_cols=200 Identities=31% Similarity=0.479 Sum_probs=172.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.|...+.||+|+||.||+|.+. +++.+|+|.+..... ....+.+|++++++++||||+++++.+......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34666778999999999999876 688999998864432 235688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 84 LGGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred cCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999886432 889999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||....+
T Consensus 151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 151 LTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred ccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 54322 112335678899999999888899999999999999999999999986543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=261.10 Aligned_cols=200 Identities=26% Similarity=0.426 Sum_probs=170.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|++|.||++..+ +++.|++|.+..... ....+.+|++++++++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57999999999999999999987 789999999865432 234567899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 85 ~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 85 LDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred CCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccc
Confidence 975 89888865431 3889999999999999999999998 99999999999999999999999999865
Q ss_pred CCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....
T Consensus 153 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 153 KSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 422111 1122346788999998875 457889999999999999999999997554
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=255.36 Aligned_cols=197 Identities=32% Similarity=0.554 Sum_probs=168.7
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEE-eCCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 145 (293)
++|.+.+.||+|+||.||++..+ +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. +....+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 57899999999999999999876 7889999886433 3457889999999999999999999764 5567899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++..++.++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 84 KGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence 9999999876542 23789999999999999999999998 9999999999999999999999999987543
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
... .....+..|+|||.+.+..++.++|||||||++|+|++ |+.||....
T Consensus 154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 221 22334567999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=281.34 Aligned_cols=193 Identities=31% Similarity=0.491 Sum_probs=169.2
Q ss_pred eeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhh
Q 022706 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 151 (293)
+||+|.||+||.|++. +..+.|||.++... ...+-+..|+.+.++|+|.|||+++|.+..++.+-|+||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999987 67789999997443 344568899999999999999999999988888889999999999999
Q ss_pred hhhcCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEeccccCCCCCccc
Q 022706 152 ILHGRKGVKGAQPGPVL--SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMA 228 (293)
Q Consensus 152 ~l~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~~~~~~~~~ 228 (293)
+++..=+ ++ ++..+-.+.+||++||.|||++. |||||||-+||||+. .|.+||+|||-++.+...
T Consensus 662 LLrskWG--------PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi- 729 (1226)
T KOG4279|consen 662 LLRSKWG--------PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI- 729 (1226)
T ss_pred HHHhccC--------CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-
Confidence 9975432 24 77888899999999999999998 999999999999975 789999999999876543
Q ss_pred ccccccccccCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 229 ARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
...+.++.||+.|||||++..+ .|+.++|||||||++.||.||++||-..
T Consensus 730 -nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 730 -NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred -CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 3345678899999999999864 5899999999999999999999999765
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=255.20 Aligned_cols=200 Identities=35% Similarity=0.583 Sum_probs=175.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||++... ++.+++|.+.......+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 357899999999999999999876 8899999997665556788999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||.+....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSRGR-------AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999875532 13899999999999999999999999 9999999999999999999999999987653
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
... .....+..|+|||.+....++.++||||||+++|+|++ |+.||.....
T Consensus 154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 221 12234567999999988889999999999999999997 9999976643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.89 Aligned_cols=203 Identities=30% Similarity=0.487 Sum_probs=170.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC----eEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.+|++.+.||+|+||.||+|.++ +++ .+++|.+...... ...+.+|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 57889999999999999999865 343 5899988655432 3568899999999999999999999887 78899
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
+|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 86 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred EEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCc
Confidence 9999999999999876432 3899999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++................++..|++||.+....++.++|+||||+++||+++ |+.||....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 9876543222111112223567999999888889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=259.67 Aligned_cols=200 Identities=28% Similarity=0.453 Sum_probs=170.0
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
|++.+.||+|+||.||++.+. ++..+++|.+..... ....+.+|+++++.++||||+++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677788999999999999977 688889998864432 235678899999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|..++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 87 ~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 87 GAVDAVMLELE--------RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred CcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 99988876432 23899999999999999999999998 99999999999999999999999999875433
Q ss_pred ccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
... ......+++.|+|||.+. +..++.++||||+||++|+|++|+.||...++
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 156 TIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred ccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 211 123456889999999874 34577899999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=259.24 Aligned_cols=204 Identities=30% Similarity=0.495 Sum_probs=170.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CC---CeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|++.+.||+|+||.||+|.++ ++ ..|++|.+..... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46889999999999999999976 33 3699999875432 235788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence 999999999999875431 3889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccccccccccc---cCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVL---GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+................ .+..|++||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 87553322111111111 1347999999988889999999999999999886 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=277.44 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=181.5
Q ss_pred hcCCCCceeeccCceEEEEEEeCC-CCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++.++..||-|+||.|=++..+. ...+|+|++++.. ...+.+..|-++|..++.|.||++|..|.+..+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 466677889999999999998773 3358999887543 33456888999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|-|-||.|..+++.++ .+++...+.++..+++|++|||+++ ||+|||||+|++++.+|-+||.|||++
T Consensus 500 EaClGGElWTiLrdRg---------~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---------SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred HhhcCchhhhhhhhcC---------CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhH
Confidence 9999999999999887 4899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
+.+.... .+.+++|||.|.|||++++..++.++|.||||+++|||++|.+||++.+|..
T Consensus 568 Kki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 568 KKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred HHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 9876433 3578999999999999999999999999999999999999999999988743
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.48 Aligned_cols=200 Identities=24% Similarity=0.367 Sum_probs=168.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|+||.||+|..+ +++.+++|.+...... ...+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 58999999999999999999876 7899999998654322 34677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+. ++|.+++.... ..+.+.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 85 ~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 85 MH-TDLAQYMIQHP--------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred cc-CCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccc
Confidence 96 57776665432 13778889999999999999999998 99999999999999999999999998875
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 153 KSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred cCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 432211 12334568899999988764 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.83 Aligned_cols=203 Identities=27% Similarity=0.427 Sum_probs=174.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||.||+|... +++.+++|.++... .....+.+|++++++++|+|++++++.+.+....+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999987 89999999886422 22457889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++...... ...+++.+++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred ecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 999999999988643211 124889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 65433211 123356788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=255.04 Aligned_cols=201 Identities=28% Similarity=0.407 Sum_probs=171.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEe-CCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 142 (293)
.|++.+.||+|++|.||++.++ +++.+++|++..... ..+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999977 688999999865432 23467889999999999999999998764 446789999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++..... ..+++.+++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 9999999999875332 24899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+
T Consensus 151 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 151 VLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred EecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 553221 12234568899999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.61 Aligned_cols=201 Identities=29% Similarity=0.494 Sum_probs=171.0
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-----------hHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-----------DEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 135 (293)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... .+.+.+|+.++++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999876 7899999987532110 135678999999999999999999999999
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+++++|.+++.... .+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence 9999999999999999987653 3889999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++................++..|++||.+.... ++.++|+||||+++|+|++|..||....
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 9999987654322222223455788999999887654 7889999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=253.26 Aligned_cols=197 Identities=31% Similarity=0.513 Sum_probs=167.0
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchh
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 150 (293)
+.||+|+||.||++..++++.+++|.+...... ...+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998754432 346889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccccc
Q 022706 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (293)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~ 230 (293)
+++..... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 98865431 3789999999999999999999998 999999999999999999999999988654322111
Q ss_pred ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
......++..|+|||.+.+..++.++||||||+++|++++ |..||.....
T Consensus 150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 1112234567999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=258.06 Aligned_cols=201 Identities=25% Similarity=0.428 Sum_probs=172.2
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
+|+..+.||+|++|.||++.+. +++.+++|++..... ....+.+|++++++++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999975 799999999864331 12567899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEecc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADF 218 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Df 218 (293)
||||+++++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 999999999999987543 3889999999999999999999999 99999999999998776 5999999
Q ss_pred ccCCCCCccccc--ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|.+......... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 998765432111 11123457889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=259.32 Aligned_cols=203 Identities=25% Similarity=0.401 Sum_probs=173.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.+|.+.+.||+|+||.||++.++ +++.+++|.+..... ...++.+|+++++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999975 899999998764322 2346788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++...... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 999999999988642211 124899999999999999999999999 999999999999999999999999988
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 765332211 12346788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.87 Aligned_cols=212 Identities=29% Similarity=0.458 Sum_probs=174.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC-----CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEe-CCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 137 (293)
.++|.+.+.||+|+||.||+|.+.. +..+++|.+...... ...+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4689999999999999999999764 688999988644322 3567889999999999999999998765 5678
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++++||+++++|.+++....... ......+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGE-ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999987543211 111235899999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||....+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 999876533222111122345678999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=260.68 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=173.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|++.+.||+|+||+||++.+. +++.+++|++..... ....+.+|+++++.++||||+++++.+.+....++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888899999999999999976 688999998764432 346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+++++|.+++.... .+++..+..++.|++.+|.|||+ .+ ++|+||+|+||++++++.++|+|||++.
T Consensus 85 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 85 MDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred CCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCccc
Confidence 99999999887543 38999999999999999999997 46 9999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+
T Consensus 153 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 153 ELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred chhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 542211 1345689999999999888899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=260.11 Aligned_cols=199 Identities=28% Similarity=0.383 Sum_probs=175.7
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
+|.+.+.||.|+||.||++.++ +++.+++|++.... .....+.+|++.+++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4888999999999999999987 79999999987543 234678899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+.+++|.+++.... .+++.++..++.|++++|.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999997652 3889999999999999999999998 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 149 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 149 KVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 654322 12345578899999999888899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=255.67 Aligned_cols=196 Identities=28% Similarity=0.494 Sum_probs=162.4
Q ss_pred eeeccCceEEEEEEeC---CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCc
Q 022706 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
.||+|+||.||+|.++ .+..+|+|++...... .+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 3557999998755332 356889999999999999999999875 457789999999999
Q ss_pred hhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccc
Q 022706 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (293)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~ 228 (293)
|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 999987543 13899999999999999999999998 9999999999999999999999999987543322
Q ss_pred ccc-cccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 229 ARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 229 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
... ......+++.|+|||.+....++.++||||||+++|+|++ |..||.+..+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 111 1111223568999999988889999999999999999996 9999987654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=266.55 Aligned_cols=203 Identities=27% Similarity=0.324 Sum_probs=177.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 140 (293)
.+|..+.+||+|+||.|.++..+ +.+.||||+++++... .+--..|-++|.... -|.+++++..|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 48999999999999999999977 7889999999876422 233445667776664 68899999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+.||+|--.++.-+ .+.+..+..++.+|+-+|-+||++| |++||||.+||+++.+|++||.|||+
T Consensus 429 MEyvnGGDLMyhiQQ~G---------kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGm 496 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG---------KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 496 (683)
T ss_pred EEEecCchhhhHHHHhc---------ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccc
Confidence 99999999988887665 3788889999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
++.--. ....+.+++|||.|+|||++...+|+.++|.||+||+||||+.|++||++.++.+
T Consensus 497 cKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 497 CKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred cccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 875322 3344578999999999999999999999999999999999999999999876543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=281.42 Aligned_cols=201 Identities=26% Similarity=0.442 Sum_probs=175.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.|.|+..||.|+||.||+|..+ ++-..|.|++.... ...+++.-|+.+|..++||+|+++++.|...+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 4567778999999999999988 56667788876433 345788999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
||..+.++-.-. ..+++.++..+++|++.||.|||++. |||||||..|||++.+|.++|+|||.+....
T Consensus 113 GGAVDaimlEL~--------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 113 GGAVDAIMLELG--------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred CchHhHHHHHhc--------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch
Confidence 999998886544 46999999999999999999999998 9999999999999999999999999986543
Q ss_pred cccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
. .......++|||+|||||+.+ ..+|++++||||||++|.||..+.+|.....|
T Consensus 182 ~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 182 S--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred h--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 2 333457899999999999775 46899999999999999999999999987765
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=257.18 Aligned_cols=210 Identities=27% Similarity=0.460 Sum_probs=174.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
++|.+.+.||+|+||.||+++.+ +.+.+++|.+...... ...+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 58899999999999999999964 3467999988654433 357889999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+++++|.+++..............+++..+..++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976542211111224899999999999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
|++....... ........++..|++||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 9886543211 111233345778999999888888999999999999999999 889997543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=255.07 Aligned_cols=206 Identities=33% Similarity=0.444 Sum_probs=176.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|++.+.||.|+||+||++... ++..+++|++..... ....+.+|++.++.++|+||+++++.+......+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999976 688999999865433 346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++..... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 999999999975431 023899999999999999999999998 99999999999999999999999999876
Q ss_pred CCccccc--ccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAAR--LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .......++..|++||.+... .++.++|+||||+++|+|++|+.||....+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 5443221 122344688899999988876 788999999999999999999999986543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=260.69 Aligned_cols=209 Identities=32% Similarity=0.466 Sum_probs=173.9
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeC-----C
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG-----T 135 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~ 135 (293)
....++|.+.+.||+|+||.||++..+ +++.+++|++.........+.+|+.+++++ +|||++++++++... .
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 334678999999999999999999976 789999999876555566788899999999 799999999998753 3
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+++++|.++++..... ...+++..++.++.|++.||.+||+.+ ++|+||||+||++++++.++|
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 579999999999999988642211 124889999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|+.||....+
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 99999876543221 11334678899999987643 367899999999999999999999986643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=262.58 Aligned_cols=199 Identities=29% Similarity=0.493 Sum_probs=170.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.|.....||+|+||.||++.+. ++..++||.+...... .+.+.+|+..++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999976 7899999998654332 3567899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... +++.++..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 103 ~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 103 GGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999886432 889999999999999999999998 9999999999999999999999999986543
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||....+
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 223 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223 (292)
T ss_pred cccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2211 12335688999999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.89 Aligned_cols=201 Identities=27% Similarity=0.458 Sum_probs=175.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999876 78899999986433 3346688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... +++.++..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred CCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 99999999987543 789999999999999999999999 99999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|++||.+....++.++|+||||+++|++++|+.||....+
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 433221 12334688899999999888889999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=262.59 Aligned_cols=197 Identities=29% Similarity=0.452 Sum_probs=170.2
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
|.....||+|+||.||++.++ +++.+++|.+.... ...+.+.+|+.+++.++|||++++++++..+...+++|||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334557999999999999976 78999999986433 3345688999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... +++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 99999876533 889999999999999999999998 99999999999999999999999998865432
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 170 DVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred ccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 1234568899999999988889999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=272.65 Aligned_cols=210 Identities=24% Similarity=0.346 Sum_probs=178.9
Q ss_pred CCCCceeeccCceEEEEEE-eCCCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 69 FGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~-~~~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
|..++.||-|+||.|.+++ ..+...||+|.+.+.. .....++.|..||...+.+-||++|-.|+|.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5667889999999999997 4468899999987543 2334577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
++||++-.+|-+.+ .|.+..++.++.++..|+++.|..| +|||||||+|||||.+|++||.|||++.-
T Consensus 711 IPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred cCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999998886654 4899999999999999999999999 99999999999999999999999999753
Q ss_pred CCcccc----------------------------------------cccccccccCcccccccccccCCCCCccchhhHH
Q 022706 224 APDMAA----------------------------------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFG 263 (293)
Q Consensus 224 ~~~~~~----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 263 (293)
+..... +......+||+.|+|||++.+..|+...|.||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 211000 0011247799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcc-ccccccc
Q 022706 264 VVLLELLTGRKPVDHTLPRG-QQSLVTW 290 (293)
Q Consensus 264 ~~l~el~~g~~Pf~~~~~~~-~~~~~~~ 290 (293)
|+||||+.|++||-+.+|.+ +..+++|
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 99999999999999988864 4456666
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=256.83 Aligned_cols=199 Identities=25% Similarity=0.458 Sum_probs=172.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.|++.+.||+|+||.||+|.+. +++.+++|.+.... ....++.+|++++++++ |||++++++++.+....+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5778889999999999999975 78999999986543 23456888999999986 999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... +++..++.++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 82 EYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred ecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence 9999999999986542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 149 ALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred eecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 76544321 1234568889999998875 4578899999999999999999999987654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=259.47 Aligned_cols=212 Identities=28% Similarity=0.451 Sum_probs=173.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|++.+.||+|+||.||++.++ ++..+++|++...... ...+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357999999999999999999863 4788999998754332 35688899999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCC-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKG-------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~-------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~N 204 (293)
+++|||+++++|.+++........ ......+++.+++.++.|++.||.+||+.+ ++|+||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975431110 111234788999999999999999999998 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 205 ilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
|++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999875432221111122334667999999888889999999999999999998 888996553
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=253.21 Aligned_cols=195 Identities=29% Similarity=0.481 Sum_probs=163.1
Q ss_pred eeeccCceEEEEEEeC---CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 74 LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
.||+|+||.||+|.++ ++..+|+|++...... .+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 6789999998654433 356888999999999999999999875 45678999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
+|.+++.... .+++..+..++.|++.||++||+++ ++|+||||.||++++++.++|+|||++......
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999986543 3889999999999999999999998 999999999999999999999999998765432
Q ss_pred cccc-cccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 228 AARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 228 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... ......++..|+|||.+....++.++|+||||+++|||++ |..||.....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2111 1122234578999999888889999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=276.08 Aligned_cols=197 Identities=27% Similarity=0.442 Sum_probs=168.5
Q ss_pred CCCceeeccCceEEEEEEeC-CCCeEEEEEcC-----CCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe--eEEEE
Q 022706 70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS--RVLAY 141 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~ 141 (293)
+....||+|+|-+||+|-+. +|-.||=-.++ ..+...+++..|+.+|+.|+||||++++++|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45668999999999999976 67666544332 233344789999999999999999999999998765 77999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~ 220 (293)
|.+..|+|..++++.+ .++...++.|++||++||.|||++ +++|+|||||-+||||+. .|.|||+|+|+
T Consensus 123 EL~TSGtLr~Y~kk~~---------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred ecccCCcHHHHHHHhc---------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence 9999999999998876 388899999999999999999998 678999999999999974 58999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|....... ....+|||.|||||+. ...|+..+||||||++|.||+|+..||+.-..
T Consensus 193 Atl~r~s~----aksvIGTPEFMAPEmY-EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 193 ATLLRKSH----AKSVIGTPEFMAPEMY-EENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred HHHhhccc----cceeccCccccChHHH-hhhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 97654332 3557899999999954 48899999999999999999999999986543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=260.34 Aligned_cols=196 Identities=22% Similarity=0.376 Sum_probs=166.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|.+.+.||+|+||.||++.++ +|+.+++|.+..... ....+.+|+.++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888899999999999999987 799999999864322 234677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+.+ +|.+++.... ..+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CDQ-DLKKYFDSCN--------GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CCC-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 975 7877775432 13899999999999999999999998 99999999999999999999999999875
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.
T Consensus 149 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 149 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 432211 11334578899999988764 47889999999999999999988864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=258.04 Aligned_cols=200 Identities=27% Similarity=0.400 Sum_probs=172.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|++.+.||+|++|.||+|.+. +++.+++|++..... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999976 789999999875432 245788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+ +++|.+++.... ..+++.+++.++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 81 ~-~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9 999999986543 24899999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||....
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 543221 112345688999999988754 46889999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=264.86 Aligned_cols=212 Identities=25% Similarity=0.433 Sum_probs=169.9
Q ss_pred HhcCCCCceeeccCceEEEEEEe------CCCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC-C
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG-T 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 135 (293)
.++|++.+.||+|+||+||+|.+ .+++.||||+++..... ...+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45899999999999999999973 25788999999754332 34678899999999 589999999987654 5
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCC------------------------------------------------------
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKG------------------------------------------------------ 161 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~------------------------------------------------------ 161 (293)
..+++|||+++++|.+++........
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999865321000
Q ss_pred ----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccc
Q 022706 162 ----AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237 (293)
Q Consensus 162 ----~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 237 (293)
......+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 000124788899999999999999999998 9999999999999999999999999987653322211122234
Q ss_pred cCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 238 gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5677999999988889999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=259.83 Aligned_cols=200 Identities=29% Similarity=0.427 Sum_probs=170.7
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
+|.+.+.||+|++|.||+|.++ +++.|++|++...... ...+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999976 7899999999754332 34567899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+ +++|.+++.... ..+++..++.++.||++||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence 9999 889999987543 13899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+........ ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+..+
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 149 ARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred eeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 876543221 1123356788999998865 4578899999999999999999888876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=263.81 Aligned_cols=212 Identities=30% Similarity=0.478 Sum_probs=173.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
..+|.+.+.||+|+||.||++.+. .+..+++|.+...... ...+.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 457999999999999999999753 1236899988754332 35688999999999 799999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
...+++|||+++++|.+++....... .......+++.+++.++.|++.||.|||+++ ++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999987543110 0112235888999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999876543222211222334567999999998899999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.61 Aligned_cols=200 Identities=29% Similarity=0.413 Sum_probs=176.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|++|.||++.++ +++.+++|++..... ....+.+|+..+.+++|+|++++++++......+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999987 699999999876543 346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+++++|.+++.... .+++..++.++.|++.+|.+||+ .+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999997643 38999999999999999999999 98 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 149 VLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 65432221 124557889999999988889999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=256.01 Aligned_cols=204 Identities=29% Similarity=0.486 Sum_probs=170.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CC---CeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|+..+.||+|+||.||++.++ ++ ..+++|.+...... ...+.+|++++++++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 57888999999999999999976 33 37999988654332 35688999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 85 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 85 TEYMENGALDKYLRDHD--------GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence 99999999999986543 13889999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccccccc-cccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 221 SNQAPDMAARLHS-TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+............ .....++.|++||.+....++.++||||||+++|||++ |+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 8765432211111 11223457999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=255.88 Aligned_cols=205 Identities=31% Similarity=0.510 Sum_probs=173.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCC------ee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGT------SR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~ 137 (293)
.++|++.+.||+|++|.||+|.++ +++.+++|++.......+.+.+|+.+++++ +|+||+++++++.+.. ..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 578999999999999999999986 688999999887666667889999999999 6999999999987644 48
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECC
Confidence 9999999999999988653210 124899999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++........ ......+++.|+|||.+.. ..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 157 FGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred Cccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 998865433221 1234568889999998753 346788999999999999999999997553
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=251.40 Aligned_cols=198 Identities=30% Similarity=0.544 Sum_probs=167.8
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchh
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 150 (293)
+.||+|+||.||++.+..++.+++|.+...... ...+.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998755443 357889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccccc
Q 022706 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (293)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~ 230 (293)
+++..... .+++..++.++.|++.+|.+||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 99865431 3788999999999999999999998 999999999999999999999999998755321111
Q ss_pred ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
........+..|+|||.+.+..++.++|+||||+++|+|++ |..||....+
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 11112223567999999988889999999999999999999 8999976653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=252.96 Aligned_cols=198 Identities=28% Similarity=0.472 Sum_probs=172.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
+|+..+.||+|++|.||+|..+ +++.+++|.+..... ....+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4788899999999999999987 799999998864331 235688899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999987543 3789999999999999999999998 99999999999999999999999998
Q ss_pred CCCCCcccccccccccccCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+....... ......+++.|++||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 87653322 123456788999999887766 8899999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.60 Aligned_cols=202 Identities=30% Similarity=0.513 Sum_probs=168.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC----eEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|+..+.||+|+||.||++.+. ++. .+++|.+...... ...+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 57888999999999999999865 444 4788888654332 23678899999999999999999998754 4678
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
++||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 86 v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred eehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccc
Confidence 9999999999999875431 3789999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++................++..|++||.+.+..++.++||||||+++|||++ |..||.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9876543222211222345678999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=243.72 Aligned_cols=197 Identities=29% Similarity=0.466 Sum_probs=166.4
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh--HHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEcc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
.+.+..||.|..|+|++++.+ +|...|||.+....+.. ++++..+.++.... +|+||+.+++|......++.||.+
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344567999999999999987 79999999997655443 46777777766665 899999999999999999999998
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
. .-++.++++.. .++++.-+-.+...+++||.||..+. .|+|||+||+|||+|+.|++||||||++-.+
T Consensus 174 s-~C~ekLlkrik--------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 174 S-TCAEKLLKRIK--------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred H-HHHHHHHHHhc--------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence 4 36677776555 24888888899999999999999875 5999999999999999999999999999877
Q ss_pred CcccccccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
-++... +...|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+.
T Consensus 243 vdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 243 VDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred eccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 655443 56679999999998863 46889999999999999999999999874
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=254.81 Aligned_cols=200 Identities=31% Similarity=0.478 Sum_probs=172.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+-|++.+.||+|+||.||++.++ ++..+|+|.+..... ....+.+|++.+++++||||+++++++.+....++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34778889999999999999876 789999998764432 235688899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... +++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 84 LGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999986432 889999999999999999999998 99999999999999999999999998865
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... .......++..|++||.+....++.++|+|||||++|+|++|..||....+
T Consensus 151 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 206 (277)
T cd06641 151 LTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP 206 (277)
T ss_pred cccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch
Confidence 53321 112335678899999999888889999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=256.35 Aligned_cols=192 Identities=26% Similarity=0.371 Sum_probs=159.4
Q ss_pred eeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHH---hcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMV---SRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.||+|+||.||++.+. +++.+|+|.+...... ...+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999976 6899999988654321 22334444333 33469999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999887543 3899999999999999999999999 9999999999999999999999999986543
Q ss_pred cccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
... .....|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.....
T Consensus 149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 149 KKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred ccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 221 133468999999998864 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=265.25 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=169.9
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeC-----
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG----- 134 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 134 (293)
.+.++|++.+.||+|+||.||++.+. +++.+|+|.+..... ....+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45689999999999999999999976 799999999864322 234677899999999999999999987643
Q ss_pred -CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 135 -TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 135 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 356899999965 888877532 788899999999999999999998 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|+|||++........ .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999876533211 233467889999999999899999999999999999999999997553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=252.17 Aligned_cols=196 Identities=31% Similarity=0.501 Sum_probs=164.0
Q ss_pred ceeeccCceEEEEEEeC-C---CCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~---~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||+|.+. . +..+++|.+..... ..+.+.+|++++++++|+||+++++++. ....+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999754 2 26899999876655 3467889999999999999999999875 4567999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+++..++.++.|++.+|.+||..+ ++|+||||+||++++++.++|+|||++.....
T Consensus 80 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 99999997654 3889999999999999999999998 99999999999999999999999999876533
Q ss_pred cccccc-ccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...++
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 221110 111223467999999988889999999999999999998 9999986544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=256.92 Aligned_cols=199 Identities=29% Similarity=0.449 Sum_probs=167.5
Q ss_pred hcCCCCceeeccCceEEEEEEe-----CCCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeC--Cee
Q 022706 67 ENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSR 137 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 137 (293)
+.|++.+.||+|+||.||++.. .++..+++|.+...... ...+.+|++++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 25889999998654322 35788999999999999999999998765 568
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence 89999999999999986543 13899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 022706 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 218 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf 276 (293)
||++......... .......++..|+|||.+.+..++.++||||||+++|+|+++..|+
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 9998765432221 1112344677899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=256.12 Aligned_cols=200 Identities=31% Similarity=0.419 Sum_probs=165.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHH-HhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|+||.||++.++ +++.||+|++...... ...+..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999987 7999999998765432 3455566664 566689999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|++ ++|.+++...... ...+++..++.++.|++.||+|||++ + ++|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred hhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 997 5888877643211 12489999999999999999999997 7 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCccccccccccc----CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 152 GYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 7653321 1133567889999998864 4468899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=253.55 Aligned_cols=191 Identities=26% Similarity=0.497 Sum_probs=163.1
Q ss_pred ceeeccCceEEEEEEeCC-C----------CeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 73 ALIGEGSYGRVYYGILKS-G----------HAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~-~----------~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.||+|+||.||++.++. + ..+++|.+.........+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 469999999999999873 3 257888776554446788899999999999999999999888 7789999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-------ceE
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-------VAK 214 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-------~~k 214 (293)
||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++ .++
T Consensus 80 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred EcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence 99999999999976542 3889999999999999999999998 99999999999999887 799
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccC--CCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|+|||++..... .....++..|+|||.+... .++.++||||||+++|+|++ |..||...++
T Consensus 149 l~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 149 LSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred eCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 999999876533 1234567789999998876 78899999999999999999 6889977654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=254.26 Aligned_cols=191 Identities=27% Similarity=0.387 Sum_probs=159.7
Q ss_pred eeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHH---HHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQV---SMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.||+|+||.||++.+. +++.||+|.+...... ...+..|. +.++...||+|+++++.+.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999876 6899999998654321 12233343 34445579999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
|++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999886543 4899999999999999999999998 9999999999999999999999999987543
Q ss_pred cccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
... .....|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 149 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred ccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 221 1334689999999998754 68899999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=256.93 Aligned_cols=200 Identities=27% Similarity=0.379 Sum_probs=172.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|++|.||+|.++ +++.|++|++..... ....+.+|++++++++|+||+++++++.+.+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999987 688999999865332 23678899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|++++.+..+..... .+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 81 YVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 999866666554332 3889999999999999999999998 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 149 ALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6544322 122345678899999999887 7889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=255.26 Aligned_cols=193 Identities=25% Similarity=0.364 Sum_probs=166.3
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
||+|+||+||++.++ +++.+++|.+.... .....+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999876 78999999986432 2234567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++..... ..+++.+++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 148 (277)
T cd05577 81 KYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-- 148 (277)
T ss_pred HHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--
Confidence 999875542 23899999999999999999999999 999999999999999999999999988654321
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.......++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 149 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 149 -KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred -CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 11233457889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=253.10 Aligned_cols=197 Identities=30% Similarity=0.557 Sum_probs=168.1
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|.+.+.||+|+||.||++.. +++.+++|.+.... ....+.+|+.++++++|||++++++++... ..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 5799999999999999999875 57889999986543 346788999999999999999999998654 47899999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 83 GNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred CCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 999999975432 23789999999999999999999998 99999999999999999999999998865432
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.. .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.
T Consensus 153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 11 12233567999999988889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.99 Aligned_cols=200 Identities=29% Similarity=0.436 Sum_probs=170.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|+||.||++.++ +++.+|+|++...... .+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36889999999999999999987 6899999998644322 3567889999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.++..... .+++.+++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 999988888765432 3899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 149 TLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred eccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 6533221 1233457889999998875 347789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=251.18 Aligned_cols=201 Identities=27% Similarity=0.427 Sum_probs=173.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|++.+.||+|+||.+|++..+ +++.+++|.+.... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999976 78999999986432 2335788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+.+++|.+++..... ..+++.+++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 81 CEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 999999998875432 13789999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 151 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 151 LNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred cCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 533221 1233457889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=250.38 Aligned_cols=200 Identities=24% Similarity=0.394 Sum_probs=172.7
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|++.+.||+|+||.||++... +++.+++|.+..... ....+.+|++++++++|||++++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999976 789999999865432 235688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg~~~ 222 (293)
+++++|.+++..... ..+++..++.++.|++.+|.+||+++ ++|+||+|+||++++++ .++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 999999999976432 23889999999999999999999998 99999999999998654 58999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 151 ILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred ecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 6543221 133567889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=251.30 Aligned_cols=200 Identities=28% Similarity=0.498 Sum_probs=173.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|.+.+.||+|+||.||++... +++.+++|.+..... ....+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999876 789999999876554 345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 81 CSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 99999999987543 3788999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccc--ccccccCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 224 APDMAARLH--STRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 224 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
......... .....+++.|++||.+.+.. ++.++||||||+++|++++|+.||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 543322110 12345788999999988765 788999999999999999999999755
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=252.09 Aligned_cols=198 Identities=32% Similarity=0.485 Sum_probs=167.3
Q ss_pred ceeeccCceEEEEEEeCC--C--CeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILKS--G--HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~--~--~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|++|.||++.+.+ + ..+|+|.+..... ....+.+|++.+++++||||+++++++.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998652 3 3689999876555 34578899999999999999999999988 889999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++..... ..+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999876531 23899999999999999999999998 99999999999999999999999999877643
Q ss_pred cccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 206 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG 206 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2211 11123446778999999988889999999999999999998 9999975543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=252.11 Aligned_cols=191 Identities=26% Similarity=0.398 Sum_probs=168.9
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
||.|++|.||++++. +++.+++|++..... ..+.+.+|++++++++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 689999999865432 235688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++.... .+++..+..++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 81 WTILRDRG---------LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred HHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 99997653 3889999999999999999999998 9999999999999999999999999987664432
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
......+++.|++||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1234567889999999888889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=253.23 Aligned_cols=199 Identities=23% Similarity=0.359 Sum_probs=175.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+..+||+|+|..|.+++++ +.+.||+|++++.-... .=.+.|...+.+.+ ||.+|-++..|+.++.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 368999999999999999999976 88999999997643222 23556777777774 9999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
|.||++||+|--.++++. .++++.++.+..+|..||.|||+.| |++||||.+|+|++..|++||.|+|
T Consensus 329 vieyv~ggdlmfhmqrqr---------klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred EEEEecCcceeeehhhhh---------cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccc
Confidence 999999999988877665 3999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
+++.--. ....+.+++|||.|+|||++.+..|+..+|.|+||++|+||+.|+.||+-
T Consensus 397 mcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 397 MCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9875322 23345789999999999999999999999999999999999999999974
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.31 Aligned_cols=200 Identities=25% Similarity=0.315 Sum_probs=167.6
Q ss_pred HHHHHHHHhcCCCCcee--eccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 59 VDELKEITENFGTNALI--GEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 59 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
..+.....++|.+.+.+ |+|+||.||++..+ ++..+++|.+........ |+.....+ +||||+++++.+...
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 34455566788888877 99999999999976 788999999865433221 22222222 699999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ce
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VA 213 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~ 213 (293)
+..++||||+++++|.+++.... .+++.+++.++.|+++||.+||+.+ ++|+||+|+||+++.++ .+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~ 149 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRI 149 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeE
Confidence 99999999999999999997653 3899999999999999999999999 99999999999999988 99
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|+|||++...... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....
T Consensus 150 ~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 150 YLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred EEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999988654321 23457889999999998889999999999999999999999998543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=263.03 Aligned_cols=201 Identities=27% Similarity=0.406 Sum_probs=168.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeC-----Ce
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 136 (293)
+.++|.+.+.||+|+||.||++.++ +++.||+|++.... .....+.+|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999976 79999999986432 2235678899999999999999999887644 35
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++|||+.+ +|.+++.... +++..+..++.|++.||.+||+.+ ++||||||+||+++.++.++|+
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 7899999965 8888776543 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccccc-cccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
|||++.......... ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987653322111 1133567899999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=255.45 Aligned_cols=198 Identities=30% Similarity=0.461 Sum_probs=173.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|+..+.||+|++|.||++.++ +++.+++|.+..... ....+.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999987 789999999876543 235688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+++++|.+++.... ..+++..+..++.|++.+|.+||+ .+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 81 MDGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred cCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 99999999997653 248899999999999999999999 88 9999999999999999999999999886
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
....... ....++..|++||.+.+..++.++||||||+++|+|++|..||...
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 5532211 2266788999999998888999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=255.96 Aligned_cols=200 Identities=32% Similarity=0.425 Sum_probs=170.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 142 (293)
+|...+.||.|++|.||++.++ +++.+++|.+..... ....+.+|++++++++||||+++++++.+ ....++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 6788899999999999999986 789999999875443 34568899999999999999999998865 346899999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++...... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 82 YCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred ecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccc
Confidence 99999999887643211 124889999999999999999999998 9999999999999999999999999976
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
....... ....++..|++||.+.+..++.++||||||+++|+|++|..||...
T Consensus 154 ~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 154 ELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 5432211 2345688899999998888999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=252.04 Aligned_cols=202 Identities=33% Similarity=0.505 Sum_probs=163.5
Q ss_pred ceeeccCceEEEEEEeC-CCC--eEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGH--AAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~--~~avK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||++.++ ++. .+++|.+..... ....+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999976 444 468888764322 235688999999999 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 147 GSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
++|.+++........ ......+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999875431110 011234889999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++........ ......+..|+|||.+....++.++||||||+++|||++ |..||.+.+
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 9753321111 112223567999999988889999999999999999997 999997653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=254.44 Aligned_cols=204 Identities=31% Similarity=0.470 Sum_probs=178.5
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..+.|...+.||+|++|.||++.++ ++..+++|++.........+.+|++.+++++|+|++++++.+......++++||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3457888899999999999999987 789999999976555566788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... ..+++.+++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 97 ~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 97 MDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred cCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 99999999998653 13899999999999999999999998 99999999999999999999999998765
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||....+
T Consensus 166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 433221 12334578899999998888899999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=255.50 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=169.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|++.+.||.|++|.||+|.++ +++.+++|++..... ....+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999976 789999999865432 235688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+. ++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 81 LH-QDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred cc-cCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 96 588888865432 23899999999999999999999998 99999999999999999999999999875
Q ss_pred CCcccccccccccccCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....
T Consensus 150 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 150 FGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred cccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 432211 123345688899999887644 6889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.21 Aligned_cols=201 Identities=34% Similarity=0.544 Sum_probs=171.8
Q ss_pred CCCCceeeccCceEEEEEEeC-CC----CeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SG----HAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~----~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.+.+.||+|+||.||++.+. .+ ..+|+|.+..... ....+.+|+..++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457789999999999999976 33 8899999976654 3567889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++...... .+++.++..++.|++.+|++||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence 999999999998764421 1899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
........... ....+++.|++||.+.+..++.++|+||+|+++|+|++ |..||....
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 151 RDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred eeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 76544322111 12236788999999988889999999999999999998 899997543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=254.03 Aligned_cols=202 Identities=31% Similarity=0.523 Sum_probs=166.7
Q ss_pred eeeccCceEEEEEEeCC-------CCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 74 LIGEGSYGRVYYGILKS-------GHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~-------~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
.||+|+||.||++++++ +..+++|.+.... .....+.+|+.+++.++||||+++++++.+....+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998652 2579999886543 23457889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-----ceEEeccc
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFD 219 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-----~~kl~Dfg 219 (293)
++++|.+++........ ....+++.+++.++.|++.+|.|||+.+ ++|+||+|+||+++.++ .++|+|||
T Consensus 82 ~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 82 EGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred CCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999875432110 1234788999999999999999999998 99999999999999877 89999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 9876533222212223345778999999998889999999999999999998 999997543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=253.55 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=168.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC----CCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||.||+|.+.+ ...+++|....... ..+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568899999999999999998652 34689998865442 23578899999999999999999998875 45789
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 84 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 84 VMELAPLGELRSYLQVNK--------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred EEEcCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCc
Confidence 999999999999997543 23899999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++......... ......+++.|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 98765432211 1122234567999999888889999999999999999986 9999976653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=257.92 Aligned_cols=202 Identities=31% Similarity=0.428 Sum_probs=169.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC--CeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 139 (293)
.++|++.+.||+|+||.||++.++ +++.||+|++...... ...+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 358999999999999999999986 7999999998643322 23466899999999999999999998755 56899
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+.+ +|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 86 v~e~~~~-~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEecCCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccc
Confidence 9999975 8888876543 23899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++........ ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.++
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred eeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9876543221 1123345788999998875 4578999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.15 Aligned_cols=200 Identities=24% Similarity=0.360 Sum_probs=159.7
Q ss_pred eeeccCceEEEEEEeCC---CCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCc
Q 022706 74 LIGEGSYGRVYYGILKS---GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~---~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
.||+|+||.||++...+ ...+++|.+..... ....+.+|+..++.++||||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 59999999999997543 33566776654432 34578899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccc
Q 022706 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228 (293)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~ 228 (293)
|.+++...... ....+...++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~ 153 (268)
T cd05086 82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED 153 (268)
T ss_pred HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch
Confidence 99999764321 123677788899999999999999998 9999999999999999999999999875432211
Q ss_pred ccccccccccCccccccccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 229 ARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.........++..|+|||++.. ..++.++||||||+++|||++ |..||....+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 1112234567889999998743 235778999999999999997 6789976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=233.72 Aligned_cols=209 Identities=23% Similarity=0.363 Sum_probs=176.4
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|.-.+.||+|.||+||+++++ +++.||+|.++.+..+ .....+|+-+++.++|.||++++++........+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999977 7899999998765544 36788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
|.. .|..+...-.+ .++.+.++.++.|++++|.++|+++ +.|||+||.|++++.+|.+||+|||+++.
T Consensus 83 cdq-dlkkyfdslng--------~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred hhH-HHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence 964 88888765543 3889999999999999999999998 99999999999999999999999999986
Q ss_pred CCcccccccccccccCcccccccccccCC-CCCccchhhHHHHHHHHHh-CCCCCCCCCCccccccccc
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 290 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~~~~~~~~ 290 (293)
.+-... -....+-|.+|.+|.++.+.. |+...|+||.||++.|+.. |++-|.+.+-.++.--+.|
T Consensus 151 fgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 151 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred cCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 543211 113345699999999999865 8889999999999999998 9999988765555444433
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=251.62 Aligned_cols=202 Identities=31% Similarity=0.459 Sum_probs=168.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.+++.....||+|+||.||++.++ ++..+++|.+..... ..+.+.+|+.++++++|+||+++++++..++..++++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 345555678999999999999976 688899998865443 345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEecccc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVL--SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL 220 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~ 220 (293)
+++++|.+++..... .+ ++..+..++.|++.||+|||+.+ |+|+||||+||+++. ++.++|+|||+
T Consensus 87 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 87 VPGGSLSALLRSKWG--------PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred CCCCCHHHHHHHhcc--------cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999875421 14 78889999999999999999998 999999999999976 67899999999
Q ss_pred CCCCCcccccccccccccCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 156 SKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred heecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 875532211 12334578899999988654 37889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=251.40 Aligned_cols=191 Identities=26% Similarity=0.471 Sum_probs=159.0
Q ss_pred ceeeccCceEEEEEEeCC-------------CCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 73 ALIGEGSYGRVYYGILKS-------------GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~-------------~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
+.||+|+||.||+|+..+ ...+++|.+...... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 225888887654333 346778899999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc------
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV------ 212 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~------ 212 (293)
++|||+++++|..++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred EEEecccCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence 9999999999988886543 13899999999999999999999998 999999999999987664
Q ss_pred -eEEeccccCCCCCcccccccccccccCcccccccccc-cCCCCCccchhhHHHHHHHHH-hCCCCCCCCC
Q 022706 213 -AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELL-TGRKPVDHTL 280 (293)
Q Consensus 213 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~-~g~~Pf~~~~ 280 (293)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||....
T Consensus 150 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 150 FIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred eeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 899999988654321 2345788899999886 466889999999999999997 5999997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=253.48 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=171.1
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
+|++.+.||+|++|.||+|+++ +++.+++|++..... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999987 789999999875432 3456778999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++ +|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 81 DK-DLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred Cc-cHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 86 88888765431 124899999999999999999999998 999999999999999999999999998654
Q ss_pred CcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... ......+++.|++||.+.+. .++.++|+||||+++|+|++|+.||.+.+.
T Consensus 151 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 151 GIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred cCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 32111 11234568899999988764 578899999999999999999999986653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.00 Aligned_cols=198 Identities=28% Similarity=0.472 Sum_probs=171.2
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.|...+.||+|++|.||++.++ +++.+++|++..... ..+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999976 789999998864433 23567889999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... +++.++..++.|++.+|++||+.+ ++||||+|+||++++++.++|+|||.+....
T Consensus 100 ~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 100 GGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999987632 889999999999999999999999 9999999999999999999999999876543
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 167 KEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred cCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 2211 1233568899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=253.63 Aligned_cols=200 Identities=29% Similarity=0.449 Sum_probs=165.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-----CCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 138 (293)
++|++.+.||+|+||+||++..+ ++..|++|.+...... ...+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47889999999999999999742 5889999998654332 3568899999999999999999998754 34678
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence 9999999999999986543 13889999999999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccc-cccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 219 DLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 219 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
|++.......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 9988654322111 1111223446999999988889999999999999999999877764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=256.72 Aligned_cols=206 Identities=27% Similarity=0.418 Sum_probs=169.8
Q ss_pred cCCCCceeeccCceEEEEEEeC---CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeC--CeeE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK---SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRV 138 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 138 (293)
+|.+.+.||+|+||.||+|.++ +++.||+|.+.... .....+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999975 37899999987633 2235678899999999999999999999988 8899
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC----CCceE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD----DDVAK 214 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~----~~~~k 214 (293)
+||||+++ +|.+++....... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEE
Confidence 99999975 6777665332111 124889999999999999999999999 999999999999999 89999
Q ss_pred EeccccCCCCCcccc-cccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.....
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999999876543322 1112345678899999988764 578899999999999999999999986654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.85 Aligned_cols=202 Identities=20% Similarity=0.231 Sum_probs=155.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC----CCeEEEEEcCCCCCCh--H----------HHHHHHHHHhcCCCCCceeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQPD--E----------EFLAQVSMVSRLKHENFVQLLG 129 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~i~~~~~ 129 (293)
.++|.+.+.||+|+||+||+|.+.+ +..+++|+........ + ....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999763 4566777543322111 1 1123334556678999999998
Q ss_pred EEEeCC----eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCce
Q 022706 130 YCVDGT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (293)
Q Consensus 130 ~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Ni 205 (293)
.+.... ..+++++++.. ++.+.+.... ..++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 765443 34678888744 6666665432 2567888999999999999999998 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCcccc-----cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 206 LIFDDDVAKIADFDLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 206 lv~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|++.++.++|+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999876532111 111233468999999999999999999999999999999999999998763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=250.75 Aligned_cols=207 Identities=26% Similarity=0.395 Sum_probs=173.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC---C--CCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEe-CCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK---S--GHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~---~--~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 136 (293)
...|++.+.||+|.||.||+|..+ + ...+|+|+++.... -.....+|+.+++.++|||++.+..++.. ...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 347999999999999999999633 2 33799999975532 23567799999999999999999998876 778
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC----Cc
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DV 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~----~~ 212 (293)
.++++||.+. +|.++|+.....+. +.++...+..|+.||+.++.|||++- |+||||||.||||..+ |.
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 9999999987 89888876554332 35889999999999999999999998 9999999999999877 89
Q ss_pred eEEeccccCCCCCccccc-ccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||+|||+++.+...-.. ......+-|.+|+|||++++. .|+++.|||++||++.||++-++-|.+..
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999999876443222 133556779999999999986 58999999999999999999999998654
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.67 Aligned_cols=201 Identities=22% Similarity=0.355 Sum_probs=167.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|++|+||++.++ +++.+++|.+..... ....+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47899999999999999999987 789999999865432 23567889999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~~ 221 (293)
|+++ +|.+++..... ..+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++
T Consensus 82 ~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 82 YLDL-DLKKHMDSSPD-------FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred cccc-cHHHHHHhCCC-------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 9964 78777754432 12678888999999999999999998 999999999999985 557999999998
Q ss_pred CCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ ......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...+
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 151 RAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred cccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 75432211 11334568899999988664 57889999999999999999999997543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=257.14 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=168.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 135 (293)
.++|.+.+.||+|+||.||++..+ +++.||+|.+..... ....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 458999999999999999999987 799999998864322 2335678999999999999999999987654
Q ss_pred --eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 136 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
..++||||+.+ +|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN--------VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL 158 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence 35999999965 7887776442 13899999999999999999999998 9999999999999999999
Q ss_pred EEeccccCCCCCccccc--ccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998765332211 111234578889999988764 478899999999999999999999986653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=245.60 Aligned_cols=198 Identities=33% Similarity=0.539 Sum_probs=176.2
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
+|.+.+.||+|++|.||++.++ +++.+++|++..... ....+.+|+..+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999987 789999999976554 45678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... ..+++..+..++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+....
T Consensus 81 ~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 81 GGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred CCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 999999987653 24899999999999999999999998 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.... .....++..|++||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 23456788999999998888899999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=253.43 Aligned_cols=202 Identities=30% Similarity=0.501 Sum_probs=171.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCee
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR 137 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 137 (293)
++|++.+.||+|+||.||++.+. ++..+|+|++...... ...+.+|++.++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 4789999999866554 5678999999999999999999999887 5678
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
+++|||+++++|.+++..... .+++..++.++.|++.||++||+.+ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999976542 3899999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 218 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||.+......... .......++..|++||.+.+..++.++||||||+++|||++|..||...
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 9998876422211 1111223456799999998888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=254.60 Aligned_cols=200 Identities=26% Similarity=0.406 Sum_probs=170.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC--CeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 140 (293)
++|.+.+.||+|+||.||+|.++ +++.+++|.++..... ...+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999987 6899999998644322 23567899999999999999999998877 889999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+.+ +|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 85 ~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred ehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCc
Confidence 999975 89888875431 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||....
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 153 AREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred eeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876544321 11334578899999988764 46889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=249.14 Aligned_cols=203 Identities=23% Similarity=0.363 Sum_probs=171.9
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 141 (293)
+|++.+.||.|+||.||++.+. +++.+++|.+...... .+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999999876 7899999998654332 3457789999999999999999998764 45678999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-----EKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
||+++++|.+++...... ...+++..++.++.|++.+|.+|| +.+ ++|+||+|+||++++++.++|+
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred hhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence 999999999998754211 124899999999999999999999 777 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++........ ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 153 d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 153 DFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 9999887643321 1234568999999999988889999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=259.26 Aligned_cols=202 Identities=30% Similarity=0.447 Sum_probs=170.1
Q ss_pred HHHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeC-
Q 022706 60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG- 134 (293)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 134 (293)
.++..+.++|.+.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 345556789999999999999999999865 799999999875432 235677899999999999999999987643
Q ss_pred -----CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 135 -----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 135 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
...+++++++ +++|.++++... +++..++.++.|++.||+|||+.+ ++|+||||+||++++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 3467888887 779988876543 899999999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++.++|+|||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999998754321 133567889999998876 468889999999999999999999997554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=259.91 Aligned_cols=203 Identities=27% Similarity=0.416 Sum_probs=169.8
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcC-CCCCceeEEEEEEeC--Ce
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDG--TS 136 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 136 (293)
.+.++|.+.+.||+|+||.||+|.++ +++.+++|++.... .....+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35678999999999999999999977 68899999885432 2234577899999999 999999999988653 46
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+.+ +|.+++.... +++..++.++.|++.+|.|||+.+ |+|+||+|+||+++.++.++|+
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred EEEEeccccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 7999999975 9988886542 788999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCccccc---ccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAAR---LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++......... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998765432211 12234568899999998765 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=248.94 Aligned_cols=207 Identities=27% Similarity=0.398 Sum_probs=167.4
Q ss_pred CCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 022706 69 FGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 135 (293)
|.+.+.||+|+||.||+|.++ ++..+|+|++...... .+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999854 4688999998765433 346788999999999999999999886532
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..+++++|+.+++|..++........ ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.++|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEE---PFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence 23688999999999888753321110 123788999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+|||++................+++.|++||.+....++.++||||||+++|+|++ |+.||.+.+.
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 99999876543222222233345678999999988889999999999999999999 9999986654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=246.35 Aligned_cols=201 Identities=30% Similarity=0.469 Sum_probs=176.4
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeC--CeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 141 (293)
+|++.+.||+|++|.||++..+ +++.+++|++..... ..+.+.+|+..+++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999987 799999999876542 346788999999999999999999999988 8899999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|++++++|.+++.... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999987653 3899999999999999999999998 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
................++..|++||.+.....+.++||||||+++|+|++|..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76654332111234567889999999988889999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=252.15 Aligned_cols=204 Identities=24% Similarity=0.343 Sum_probs=167.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCe-----
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS----- 136 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 136 (293)
++|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36889999999999999999977 789999998865432 2356788999999996 6999999999887665
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEE
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKI 215 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl 215 (293)
.+++|||+++ +|.+++...... ....+++..++.++.||+.||.|||+.+ ++|+||+|+||+++. ++.++|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence 7999999986 888887644321 0124899999999999999999999998 999999999999998 889999
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus 153 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 153 ADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred eecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999875432211 1123356888999998865 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=253.38 Aligned_cols=194 Identities=30% Similarity=0.483 Sum_probs=168.3
Q ss_pred CceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
...||+|+||.||++..+ +++.+++|++..... ....+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 457999999999999976 789999999864332 345688899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++.... +++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 105 ~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 105 TDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred HHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99876443 789999999999999999999998 99999999999999999999999998765533211
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
......+++.|++||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233567889999999888888999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=253.83 Aligned_cols=202 Identities=28% Similarity=0.402 Sum_probs=175.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 140 (293)
++|.+.+.||+|+||.||++..+ +++.+++|++.... .....+.+|.++++++. |+||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999977 79999999987532 22356788999999998 99999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
||++++++|.+++.... .+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence 99999999999997653 3899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccc------------------ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAAR------------------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+......... .......++..|++||.+....++.++|+||||++++++++|+.||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 8765432211 12234567889999999888888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=250.12 Aligned_cols=196 Identities=29% Similarity=0.413 Sum_probs=164.5
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCceeEEEEEEeC--CeeEEEEE
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDG--TSRVLAYE 142 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 142 (293)
|++.+.||+|+||.||++..+ +++.+|+|++...... .....+|+..++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999976 7899999998754322 234457888888885 99999999999987 88999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+.+ +|.+.+.... ..+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||++.
T Consensus 81 ~~~~-~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 81 LMDM-NLYELIKGRK--------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cCCc-cHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence 9975 7877776543 13899999999999999999999998 999999999999999 999999999987
Q ss_pred CCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .....+++.|+|||.+.. ..++.++||||+||++|||++|..||.+.+
T Consensus 148 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 148 GIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 6543222 133457889999997654 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=251.21 Aligned_cols=199 Identities=27% Similarity=0.372 Sum_probs=168.8
Q ss_pred cCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCC-----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 022706 68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 137 (293)
+|++.+.||+|+||.||++... +|+.||+|++.... ...+.+.+|+++++++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999863 68899999986432 2235678899999999 499999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++.... .+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 99999999999999987543 3789999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||++......... ......++..|++||.+... .++.++||||||+++|+|++|..||...
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 9998765332111 12345688899999988753 4678999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=257.88 Aligned_cols=199 Identities=29% Similarity=0.423 Sum_probs=169.2
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCC---
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT--- 135 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 135 (293)
..+.++|.+.+.||+|+||.||++.+. ++..||+|++...... ...+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999866 7999999998643322 346789999999999999999999887543
Q ss_pred ---eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 136 ---SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 136 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
..++||||+ +++|.+++.... +++..++.++.|++.||+|||+.+ |+|+||||+||++++++.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 358999999 679988886432 899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++|+|||++...... .....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+
T Consensus 157 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred EEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998765321 123456889999998876 457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=250.32 Aligned_cols=207 Identities=28% Similarity=0.407 Sum_probs=167.8
Q ss_pred ccCHHHHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcC-CCCCceeEEEEE
Q 022706 56 AISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRL-KHENFVQLLGYC 131 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 131 (293)
.++.+.++.+. .||.|.||+|++-.++ +|+..|||++..... ...+++.|.+...+- ++||||++++.+
T Consensus 60 ~F~~~~Lqdlg-------~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQDLG-------EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHHHH-------HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 44555555444 5999999999999887 899999999975543 346788888776655 599999999999
Q ss_pred EeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 132 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
..+...++.||+++ .||..+.+.-...+ ...++++-+-.|....+.||.||-..- +|+||||||+|||++..|
T Consensus 133 F~EGdcWiCMELMd-~SlDklYk~vy~vq----~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G 205 (361)
T KOG1006|consen 133 FSEGDCWICMELMD-ISLDKLYKRVYSVQ----KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHG 205 (361)
T ss_pred hcCCceeeeHHHHh-hhHHHHHHHHHHHH----hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCC
Confidence 99999999999995 47766554211100 124888888899999999999998765 699999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.+||||||++-.+.++... +...|...|||||.+.. ..|+.++||||||++|||+.||..||.+-
T Consensus 206 ~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred CEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 9999999998776554433 66789999999998864 35899999999999999999999999764
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=252.12 Aligned_cols=196 Identities=31% Similarity=0.478 Sum_probs=167.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.|.+.+.||+|+||+||++... +++.|++|++...... ..++.+|+++++.++||||+++++++.+....++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56889999999999999999976 7899999998643221 246789999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+.+ +|.+++.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 95 e~~~g-~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 95 EYCLG-SASDILEVHK--------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred HhhCC-CHHHHHHHcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence 99975 7777665332 13899999999999999999999998 999999999999999999999999988
Q ss_pred CCCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ....+++.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 163 SLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred eecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 654321 2346788999999874 3568889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=247.33 Aligned_cols=191 Identities=27% Similarity=0.367 Sum_probs=161.8
Q ss_pred ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHH-HhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||+|.+. +++.+|+|.+...... ...+..|..+ ....+|+|++++++++.+.+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999976 6899999998654321 1233444443 4455799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 99999997543 3889999999999999999999998 99999999999999999999999998865432
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.....+++.|++||.+.+..++.++||||||+++|+|++|..||...++
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 2345678899999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=251.10 Aligned_cols=192 Identities=26% Similarity=0.447 Sum_probs=158.1
Q ss_pred eeeccCceEEEEEEeC-------------------------CCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeE
Q 022706 74 LIGEGSYGRVYYGILK-------------------------SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQL 127 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~-------------------------~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~ 127 (293)
.||+|+||.||+|... ....+++|.+...... ...+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999742 1235888888644332 3467788999999999999999
Q ss_pred EEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
++++.+....++||||+++++|..++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill 150 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence 999999999999999999999999886533 23889999999999999999999998 9999999999999
Q ss_pred cCCC-------ceEEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHH-hCCCCCCC
Q 022706 208 FDDD-------VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELL-TGRKPVDH 278 (293)
Q Consensus 208 ~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~-~g~~Pf~~ 278 (293)
+..+ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||..
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred eccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 7644 3899999987543221 22356788999998875 56889999999999999985 69999987
Q ss_pred CCCc
Q 022706 279 TLPR 282 (293)
Q Consensus 279 ~~~~ 282 (293)
..+.
T Consensus 225 ~~~~ 228 (274)
T cd05076 225 RTPS 228 (274)
T ss_pred cChH
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=246.94 Aligned_cols=197 Identities=29% Similarity=0.476 Sum_probs=159.5
Q ss_pred ceeeccCceEEEEEEeC----CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEE-eCCeeEEEEEccc
Q 022706 73 ALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVLAYEFAS 145 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 145 (293)
+.||+|+||.||+|.+. ....+|+|.+..... ....+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999854 245799998854322 2356788999999999999999999775 4556789999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999875431 2677888999999999999999998 9999999999999999999999999987543
Q ss_pred ccccc--ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 226 DMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 226 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
..... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||....
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 22110 11122345678999999988889999999999999999999 567776543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=247.75 Aligned_cols=201 Identities=29% Similarity=0.496 Sum_probs=172.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|.+.+.||+|+||.||++..+ ++..+++|.+.... ...+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999987 68999999986532 2345678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc-eEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-AKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~-~kl~Dfg~~~ 222 (293)
+++++|.+++..... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++. ++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence 999999999875432 23789999999999999999999998 999999999999998864 6999999887
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 151 QLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred hccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 6543221 1123457889999999888889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.45 Aligned_cols=195 Identities=29% Similarity=0.424 Sum_probs=168.3
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
||.|+||.||++.+. +++.+++|.+..... ....+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 699999999865433 335688899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++.... .+++..++.++.|++.+|++||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 99997643 3899999999999999999999998 99999999999999999999999998765432211
Q ss_pred ------cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 230 ------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 230 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
........++..|++||.+.....+.++||||||+++|+|++|..||....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 1122345578899999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=243.94 Aligned_cols=199 Identities=33% Similarity=0.528 Sum_probs=174.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|++.+.||+|++|.||++.++ +++.+++|.+..... ....+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5888999999999999999877 688999999976553 335688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... .+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 99999999987653 3899999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .....++..|++||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 5443221 233567889999999887778899999999999999999999997543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=249.94 Aligned_cols=199 Identities=26% Similarity=0.384 Sum_probs=168.8
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
|++.+.||.|++|.||++.++ +|..|++|++..... ....+.+|++.+++++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999976 799999999865432 2356788999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+ ++|.+++..... ..+++..++.++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 5 589998875542 13899999999999999999999998 999999999999999999999999998754
Q ss_pred CcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus 150 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 150 GVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred CCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32211 11233568899999987664 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.19 Aligned_cols=202 Identities=25% Similarity=0.404 Sum_probs=169.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEE----eCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCV----DGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~ 137 (293)
.++|.+.+.||+|+||.||++..+ +++.|++|++.... .....+.+|+.++++++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999976 79999999987542 23356778999999999999999998875 34568
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 99999996 58988886543 3899999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCccccc--ccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 9998654322111 11134568899999998765 458899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=231.73 Aligned_cols=200 Identities=30% Similarity=0.376 Sum_probs=165.8
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
...+..||+|++|.|-+-++. +|...|+|.+...... ..+.++|+++..+. .+|++|.+++...+....++.||.+
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 334456999999999888876 8999999999765544 35677888877666 4999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
.. ||..+.++-... +..+++..+-+|+..++.||.|||++- .++|||+||+|||++.+|.+|+||||++-.+
T Consensus 128 ~t-Sldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred hh-hHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 54 887766543221 124888899999999999999999975 5999999999999999999999999998776
Q ss_pred CcccccccccccccCccccccccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMT----GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.++... +...|...|||||.+.. ..|+.++||||||+++.||.+++.||..-
T Consensus 200 ~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 200 VDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 655443 44678899999998753 36899999999999999999999999753
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=256.35 Aligned_cols=204 Identities=28% Similarity=0.417 Sum_probs=169.2
Q ss_pred HHhcCC-CCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---------------HHHHHHHHHHhcCCCCCceeE
Q 022706 65 ITENFG-TNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---------------EEFLAQVSMVSRLKHENFVQL 127 (293)
Q Consensus 65 ~~~~y~-~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~i~~~ 127 (293)
+.++|. +.+.||+|+||+||++.++ +++.||+|++....... ..+.+|++++++++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 346776 4578999999999999977 79999999986443221 246789999999999999999
Q ss_pred EEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
++++......+++|||+. ++|.+++.... .+++..+..++.|++.||++||+.+ ++|+||+|+||++
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill 152 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI 152 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence 999999999999999997 48998886543 3899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccc------------ccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMA------------ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRK 274 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~ 274 (293)
+.++.++|+|||++....... .........+++.|+|||.+.+. .++.++|+|||||++|+|++|..
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999987554110 01111233467889999988764 46889999999999999999999
Q ss_pred CCCCCCC
Q 022706 275 PVDHTLP 281 (293)
Q Consensus 275 Pf~~~~~ 281 (293)
||...++
T Consensus 233 p~~~~~~ 239 (335)
T PTZ00024 233 LFPGENE 239 (335)
T ss_pred CCCCCCH
Confidence 9986543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.80 Aligned_cols=192 Identities=27% Similarity=0.478 Sum_probs=160.1
Q ss_pred ceeeccCceEEEEEEeC-C-------CCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 73 ALIGEGSYGRVYYGILK-S-------GHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~-~-------~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.||+|+||.||+|.++ . ...+++|.+...... .+.+.+|..+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999865 2 234888877544322 35678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc--------eEE
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--------AKI 215 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~--------~kl 215 (293)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +++
T Consensus 81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence 999999999976542 3889999999999999999999998 999999999999987765 699
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhC-CCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTG-RKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g-~~Pf~~~~~ 281 (293)
+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++| .+||...++
T Consensus 150 ~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 150 SDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred cccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 99998765432 123457889999999876 4578899999999999999998 577776554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.29 Aligned_cols=204 Identities=26% Similarity=0.413 Sum_probs=176.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.-++.-...||.|.||.||.|.+. +|...|+|.+...... -..+.+|++++..++|||+|+++++-.+....+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346778889999999999999865 8999999998754433 245778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|||++|+|.+++.... ..++.....+..|++.|+.|||+.| ||||||||+||+++.+|.+|++|||.+
T Consensus 1314 EyC~~GsLa~ll~~gr---------i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---------IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHhccCcHHHHHHhcc---------hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence 9999999999998765 3677778889999999999999999 999999999999999999999999999
Q ss_pred CCCCccccc--ccccccccCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..+...... .......||+-|||||++.+. ....++|||||||++.||+||+-||...+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 877554321 222456799999999999763 467799999999999999999999987754
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=257.08 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=168.9
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCceeEEEEEEeC-----C
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-----T 135 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 135 (293)
+.++|.+.+.||+|+||+||++.+. +++.|++|.+... ......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3468999999999999999999976 7999999998643 22335677899999999999999999987644 3
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 4799999996 58888886543 3899999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+|||++....... .......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||.+.
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 9999987654321 11234567889999998765 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=247.65 Aligned_cols=202 Identities=25% Similarity=0.430 Sum_probs=168.4
Q ss_pred cCCCCceeeccCceEEEEEEeCC--CCeEEEEEcCCCC--------C---ChHHHHHHHHHHhc-CCCCCceeEEEEEEe
Q 022706 68 NFGTNALIGEGSYGRVYYGILKS--GHAAAIKKLDASK--------Q---PDEEFLAQVSMVSR-LKHENFVQLLGYCVD 133 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~--------~---~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 133 (293)
+|++.+.||+|+||.||++.++. ++.+++|.+.... . ...++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 7889999875321 1 12346678887765 689999999999999
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCc
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
.+..+++|||+++++|.+++...... ...+++..++.++.|++.+|.+||+ .+ ++|+||+|+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCc
Confidence 99999999999999999887542211 1248899999999999999999996 56 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++|+|||++....... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999999987654322 2244568889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=250.54 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=168.6
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCC----
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT---- 135 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 135 (293)
...++|++.+.||+|+||.||+|.++ +++.|++|++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999987 68999999986433 22356778999999999999999999887654
Q ss_pred ------eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 136 ------SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 136 ------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
..++++||+++ ++...+.... ..+++.+++.++.|++.||+|||+.+ |+|+||+|+||++++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~ 151 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNN 151 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 78999999986 6767665432 13899999999999999999999998 999999999999999
Q ss_pred CCceEEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
++.++|+|||++......... ......++..|++||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999998765432211 1122345778999998765 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=249.02 Aligned_cols=199 Identities=29% Similarity=0.460 Sum_probs=169.3
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeC--CeeEEEEE
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLAYE 142 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 142 (293)
|.+.+.||+|++|.||++.+. +++.+++|++.... .....+.+|+.++++++|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999987 68999999997653 2235678899999999999999999999888 88999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++ +|.+++.... ..+++.+++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 81 YMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cccc-cHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9975 8888886542 13899999999999999999999998 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 149 PYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred eccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6544321 11133456788999998765 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=254.15 Aligned_cols=199 Identities=27% Similarity=0.392 Sum_probs=169.4
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEe-CCee
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSR 137 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 137 (293)
..+.++|.+.+.||+|+||.||++.++ +++.+++|++.... .....+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999977 89999999886432 234567889999999999999999998875 5678
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
+++|||+ +++|.++++... +++..+..++.|++.||.|||+.+ ++|+||+|.||++++++.++|+|
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred EEEeehh-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence 8999999 558988886443 788889999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++...... .....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998754221 123456888999998765 568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=242.25 Aligned_cols=203 Identities=29% Similarity=0.470 Sum_probs=176.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|.+.+.||+|+||.||++.+. ++..+++|++..... ....+.+|++.++.++|+|++++++.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888899999999999999976 789999999875543 345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++..... ....+++.++..++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+..
T Consensus 81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 999999999876531 1124899999999999999999999998 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......+++.|+|||.+....++.++|+||+|+++|+|++|..||....
T Consensus 153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 54332 12234568889999999888889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=245.90 Aligned_cols=202 Identities=28% Similarity=0.441 Sum_probs=174.7
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|++.+.||+|++|.||++.++ +++.+++|.+..... ....+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788899999999999999876 788999999875432 234677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++...... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 81 APFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred cCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999988763211 124899999999999999999999999 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.... ......+++.|++||.+.+..++.++|+||+|+++|+|++|+.||...+.
T Consensus 153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5443 12334578899999999888899999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=252.76 Aligned_cols=204 Identities=26% Similarity=0.419 Sum_probs=166.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 135 (293)
.++|++.+.||+|+||.||++.++ +++.+++|++..... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999977 789999998864322 2346778999999999999999999875433
Q ss_pred --eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 136 --SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 136 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
..++||||+.+ +|...+.... ..+++.++..++.|+++||.|||+.+ ++|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 46899999965 6766665432 24899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccc---------ccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAAR---------LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|+|||++......... .......+++.|+|||.+.+. .++.++||||||+++|||++|++||.+...
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998754332211 111234568889999987654 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=249.01 Aligned_cols=195 Identities=32% Similarity=0.492 Sum_probs=166.4
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.|...+.||+|+||.||++++. ++..+++|++...... ...+.+|++++++++|+|++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999976 7899999998644222 2467889999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+.+ +|.+++.... ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 106 ~~~g-~l~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 106 YCLG-SASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred CCCC-CHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCcc
Confidence 9975 7777765433 23899999999999999999999998 9999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.... .....+++.|+|||.+. ...++.++|||||||++|+|++|..||....
T Consensus 174 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 174 IASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred ccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 5432 13346788999999874 3568889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=249.56 Aligned_cols=201 Identities=31% Similarity=0.418 Sum_probs=163.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+|...+.||+|+||.||++.+. +++.+|+|.+...... ...+.+|+.++.++. |+||+++++++.+....+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999977 7899999998754332 346788999999996 99999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+.. ++.++....... ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++.
T Consensus 85 ~~~-~l~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 85 MDI-SLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred ccC-CHHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhH
Confidence 864 665543211000 002489999999999999999999975 7 9999999999999999999999999986
Q ss_pred CCCcccccccccccccCcccccccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
....... .....+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 157 QLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred HhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 5432211 1334578899999998765 6889999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=246.00 Aligned_cols=198 Identities=30% Similarity=0.444 Sum_probs=166.0
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcC---CCCCceeEEEEEEeCCe-----
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRL---KHENFVQLLGYCVDGTS----- 136 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 136 (293)
|++.+.||+|+||.||++.++ +++.+|+|.+...... ...+.+|+.+++++ +|+|++++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999987 5899999999744322 23466777776665 59999999999988776
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++||++.+ +|.+++..... ..+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-------PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence 8999999975 88888865432 13899999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.+..
T Consensus 150 dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 150 DFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 9999876533221 123346888999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=252.21 Aligned_cols=213 Identities=20% Similarity=0.332 Sum_probs=180.5
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC--CCC----ceeEEEEEEeCCe
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK--HEN----FVQLLGYCVDGTS 136 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~--h~~----i~~~~~~~~~~~~ 136 (293)
.+.++|.+.+.+|+|.||.|-.+.++ ++..||+|+++.-....+..+-|++.+.++. .|+ ++++.++|...++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 35789999999999999999999876 6899999999766666667778999999994 333 7888889999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-------
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD------- 209 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~------- 209 (293)
.++|+|.+ |.|+.+++....- .+++..+++.|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y-------~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY-------IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc-------cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence 99999999 6699999987543 35899999999999999999999998 999999999999942
Q ss_pred -------------CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 022706 210 -------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 210 -------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf 276 (293)
+-.++++|||.+....+. ....+.|..|.|||++++-.++.+.||||+||+|+||++|..-|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 224899999998764332 26678899999999999999999999999999999999999999
Q ss_pred CCCCCccccccccccc
Q 022706 277 DHTLPRGQQSLVTWVL 292 (293)
Q Consensus 277 ~~~~~~~~~~~~~~~~ 292 (293)
+.-+..+...+++.++
T Consensus 310 qtHen~EHLaMMerIl 325 (415)
T KOG0671|consen 310 QTHENLEHLAMMERIL 325 (415)
T ss_pred ccCCcHHHHHHHHHhh
Confidence 9777666555555443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=246.68 Aligned_cols=198 Identities=28% Similarity=0.416 Sum_probs=170.1
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
|.+.+.||+|++|.||++... +++.+++|++...... ...+.+|++++++++|+||+++++++.++...+++|||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 667889999999999999976 7899999998654333 457788999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++ +|.+++.... ..+++.+++.++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~~-~l~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 81 DT-DLYKLIKDRQ--------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CC-CHHHHHHhhc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 76 8888876543 13899999999999999999999998 999999999999999999999999988765
Q ss_pred CcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.... .......++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus 149 ~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 149 GSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred CCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4332 112234578889999988876 78899999999999999999999997654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=250.64 Aligned_cols=211 Identities=27% Similarity=0.406 Sum_probs=178.2
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----eeE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 138 (293)
+.+-.+-||-|+||.||.+++. +|+.+++|++..-. ...+++.+|+++|...+|.|++..+++.+-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 5566778999999999999876 89999999986432 34578899999999999999999988765432 356
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
.+.|.+.. +|+.++-.-. .++.+.+.-++.||+++|.|||+.+ |.||||||.|+|++++..+|||||
T Consensus 134 V~TELmQS-DLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHHh-hhhheeccCC---------CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccc
Confidence 78888854 8888775432 4888999999999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccccccccccc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 292 (293)
|+++.... ....+.+..+-|..|+|||++++. .|+.+.||||+||++.||+..+.-|+...|..+.+++..|+
T Consensus 201 GLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL 274 (449)
T KOG0664|consen 201 GLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL 274 (449)
T ss_pred ccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence 99986543 344455667779999999999985 58999999999999999999999999999988887776554
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=252.48 Aligned_cols=195 Identities=29% Similarity=0.430 Sum_probs=164.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 135 (293)
.++|.+.+.||+|+||.||+|.+. +++.+|+|++..... ....+.+|+++++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999976 799999999865322 2345788999999999999999999887543
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++|+||+.. +|..++.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45899999964 67665421 2889999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+
T Consensus 159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998754321 123457889999998876 468889999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=250.55 Aligned_cols=197 Identities=25% Similarity=0.345 Sum_probs=161.2
Q ss_pred eeecc--CceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 74 LIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 74 ~lg~G--~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
.||+| +||+||++.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999986 8999999998754433 246788999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+......
T Consensus 85 ~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 85 SANSLLKTYFP-------EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred CHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhcc
Confidence 99999876532 13889999999999999999999998 999999999999999999999999854322111
Q ss_pred ccc-----ccccccccCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 228 AAR-----LHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 228 ~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
... .......++..|++||++.+. .++.++||||+||++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 100 000112245679999998764 47889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=253.41 Aligned_cols=200 Identities=27% Similarity=0.402 Sum_probs=171.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----eeE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-----SRV 138 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 138 (293)
+|.+.+.||+|++|.||++.+. +++.+++|++.... ...+.+.+|+.+++.++|+||+++++++.+.. ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999976 68999999987543 23457889999999999999999999988775 789
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
++|||+.+ +|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||||+||++++++.++|+||
T Consensus 81 lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 99999975 8888886543 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccc-cccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|++........ ........+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 99876544321 0112345678899999999887 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=276.88 Aligned_cols=197 Identities=29% Similarity=0.451 Sum_probs=161.3
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeC------
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------ 134 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 134 (293)
.-..+|...+.||+||||.||+++++ +|+.||||++.... .....+.+|++.|.+|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44568888999999999999999999 99999999998664 3345788999999999999999998643310
Q ss_pred --------------------------------------------------------------------------------
Q 022706 135 -------------------------------------------------------------------------------- 134 (293)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (293)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 022706 135 ---------------------------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181 (293)
Q Consensus 135 ---------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 181 (293)
..+||-||||+..+|.+++....-. -.....+++++||+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREIL 707 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHH
Confidence 0126789999887777877765410 14678899999999
Q ss_pred HHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC----cc------------cccccccccccCcccccc
Q 022706 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP----DM------------AARLHSTRVLGTFGYHAP 245 (293)
Q Consensus 182 ~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~----~~------------~~~~~~~~~~gt~~y~aP 245 (293)
.||.|+|+.| ||||||||.||++++++.|||+|||++.... .. ......+..+||.-|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999 9999999999999999999999999987621 00 111234668899999999
Q ss_pred cccccC---CCCCccchhhHHHHHHHHHh
Q 022706 246 EYAMTG---QLNAKSDVYSFGVVLLELLT 271 (293)
Q Consensus 246 E~~~~~---~~~~~~DvwslG~~l~el~~ 271 (293)
|++.+. .|+.|+|+||||++++||+.
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc
Confidence 998764 49999999999999999974
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=254.86 Aligned_cols=201 Identities=24% Similarity=0.358 Sum_probs=165.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeC---------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDG--------- 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------- 134 (293)
..+|.+.+.||.|+||.||+|.++ ++..|++|++..... ..+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999976 789999999865433 345688999999999999999999766543
Q ss_pred -----CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 135 -----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 135 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
...++||||+.+ +|.+++.... +++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 357899999974 8888876432 889999999999999999999999 999999999999974
Q ss_pred -CCceEEeccccCCCCCccccc-ccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 210 -DDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 210 -~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++.++|+|||++......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 557899999998654321111 11122357889999998764 567889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=253.53 Aligned_cols=205 Identities=28% Similarity=0.435 Sum_probs=172.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh--------HHHHHHHHHHhcCCCCCceeEEEEEE-eC
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--------EEFLAQVSMVSRLKHENFVQLLGYCV-DG 134 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 134 (293)
+.++|-++.+||+|+|+.||+|-+- ..+.||+|+-....... +..-+|.++.+.|+||.||++|+++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4457888899999999999999865 67888999765443332 23557899999999999999999986 67
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CC
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DD 211 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~ 211 (293)
+.++-|+|||+|.+|+-+++..+ .+++.+++.|+.||+.||.||... .++|||-||||.|||+.+ -|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 78889999999999999998776 489999999999999999999988 467999999999999965 46
Q ss_pred ceEEeccccCCCCCccccc-----ccccccccCcccccccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTG----QLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.+||.|||+++...+.... ..+....||-+|++||++.-+ ..+.++||||+||++|+++.|+.||.+.
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 7999999999877554332 123567799999999998643 3678999999999999999999999864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=245.90 Aligned_cols=195 Identities=31% Similarity=0.495 Sum_probs=165.7
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.|...+.||+|+||+||+|++. +++.+++|++...... ...+.+|+++++.++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3666778999999999999976 7899999998643322 2457789999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+.+ +|.+++.... ..+++.+++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 102 ~~~~-~l~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 102 YCLG-SASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred cCCC-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 9965 7777775433 23889999999999999999999998 9999999999999999999999999876
Q ss_pred CCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.... .....++..|+|||.+. ...++.++||||||+++|+|++|..||....
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 13456788999999874 3567889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=246.19 Aligned_cols=198 Identities=26% Similarity=0.355 Sum_probs=167.6
Q ss_pred cCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCC-----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 022706 68 NFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 137 (293)
+|++.+.||+|++|.||++... +++.+++|.+.... .....+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999998743 57889999986432 2235677899999999 499999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+.+++|.+++.... .+++..++.++.|++++|.+||+.+ ++|+||+|.||+++.++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 99999999999999886543 3889999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
||++........ .......++..|++||.+.+.. .+.++|+||||+++|+|++|..||..
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 149 FGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred Cccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 999876533221 1122345788999999887654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=245.75 Aligned_cols=198 Identities=27% Similarity=0.434 Sum_probs=167.9
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEcc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
|.+.+.||+|++|+||+|... +++.+++|++...... .....+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678889999999999999987 6889999998654332 234567899999999 999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+++|.+++..... ..+++.+++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence 6799888865431 23899999999999999999999998 999999999999999999999999998765
Q ss_pred CcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 150 RSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred cCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 33221 133557889999998754 457889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=248.88 Aligned_cols=197 Identities=19% Similarity=0.239 Sum_probs=159.2
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
+.+|.|+++.|+++.. +++.||+|++.... .....+.+|++.+++++|+||+++++++.+....+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344444444444433 69999999987542 2335788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++...... .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 87 ~~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 87 EDLLKTHFPE-------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred HHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 9999764321 3889999999999999999999998 99999999999999999999999998765432211
Q ss_pred -----cccccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 -----RLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 -----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........++..|+|||.+.. ..++.++|+||+||++|||++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111123456778999998876 358889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=262.39 Aligned_cols=203 Identities=29% Similarity=0.465 Sum_probs=173.0
Q ss_pred cCCCCceeeccCceEEEEEEeC--CCC--eEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK--SGH--AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~--~~~--~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+..+.++||+|.||.|++|.|. +|+ .||||.+..+... ..+|++|+.+|.+|+|+|++++|++..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3456678999999999999987 344 5899999876544 5789999999999999999999999877 6788999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|++++|+|.+.|++... ..|-....-.++.||+.|+.||.+++ +|||||...|+|+.....|||+|||++
T Consensus 190 ELaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred hhcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccce
Confidence 99999999999987321 24777788899999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccc-ccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 222 NQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+.+........ .....-...|.|||.+....++.++|||++||++||||+ |+.||-+...
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 98866543322 222223557999999999999999999999999999999 9999988654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=249.40 Aligned_cols=200 Identities=25% Similarity=0.334 Sum_probs=164.5
Q ss_pred cCCCCceeeccCceEEEEEEeC-C--CCeEEEEEcCCCCC---ChHHHHHHHHHHhcCC-CCCceeEEEEEEe----CCe
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-S--GHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLGYCVD----GTS 136 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~~ 136 (293)
+|++.+.||+|+||.||++.+. + +..+|+|++..... ....+.+|+.+++++. ||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999976 5 78999999864322 2356788999999994 9999999987543 245
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++++++. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence 688899986 58988886443 3899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccc--cccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++........ ........|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||....
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 9999876543221 111233568999999998765 468899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=263.46 Aligned_cols=205 Identities=31% Similarity=0.505 Sum_probs=183.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEE-----eCCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV-----DGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-----~~~~~~ 138 (293)
...|.+.+.||.|.+|.||+++.+ +++..|+|+.......++++..|.++++.+. |||++.+++++. .++.++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 457899999999999999999966 8999999999988888899999999999986 999999999987 357899
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
||||||.+||..++++...+ ..+.|..+..|++.++.||.+||.+. ++|||||=.|||++.++.|||+||
T Consensus 98 LVMEfC~gGSVTDLVKn~~g-------~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKG-------NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred EEeeccCCccHHHHHhhhcc-------cchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence 99999999999999987653 35999999999999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
|++..+.. ......+.+|||.|||||++.. ..|+.++|+||||++..||.-|.+|+-++.|.
T Consensus 168 GvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 168 GVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred eeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 99877643 3334567899999999999864 34777999999999999999999999988774
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=254.17 Aligned_cols=198 Identities=29% Similarity=0.457 Sum_probs=168.9
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe---
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS--- 136 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 136 (293)
.+.++|.+.+.||+|++|.||++.+. +++.+++|++..... ....+.+|+.++++++|+|++++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35678999999999999999999987 688999999865322 23557789999999999999999987765544
Q ss_pred ---eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 137 ---RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 137 ---~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
.++|+||+ +++|.+++... .+++..++.++.|++.+|++||+.+ ++|+||+|+||++++++.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 89999999 56999988753 2899999999999999999999998 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998765332 233467889999998765 367889999999999999999999997554
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=244.55 Aligned_cols=198 Identities=30% Similarity=0.495 Sum_probs=164.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|.+.+.||+|+||.||++.++ +++.+|+|.+...... ...+.+|+.++.++. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 357899999999999999999987 5999999998754332 345666777666665 999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
||+.+ +|.+++..... .+++..+..++.|++.+|+|||+ .+ |+|+||+|+||++++++.++|+|||+
T Consensus 94 e~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 94 ELMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred eccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcccc
Confidence 99854 77777655331 38999999999999999999997 47 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
+........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 162 SGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred chhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 876533221 12335778999999887543 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=238.39 Aligned_cols=192 Identities=31% Similarity=0.408 Sum_probs=168.1
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
||+|+||.||++.+. +++.+++|.+..... ....+.+|++++++++|+||+++++.+.++...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999977 689999999875433 234788899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022706 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229 (293)
Q Consensus 150 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~ 229 (293)
.+++.... .+++..+..++.|++++|.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~- 147 (250)
T cd05123 81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147 (250)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-
Confidence 99997653 3899999999999999999999998 9999999999999999999999999987653321
Q ss_pred cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.......++..|++||.+.+...+.++|+||||+++|+|++|..||...+
T Consensus 148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 11234567889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=259.66 Aligned_cols=216 Identities=30% Similarity=0.440 Sum_probs=185.2
Q ss_pred HHHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 60 DELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
++.+--..+......||-|.||.||.|.|+ -.-.||||.++.+....++|++|+.+|+.++|||+|+++++|..+..+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 455544556677789999999999999998 5778999999999999999999999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
||.|||..|+|.+++++.... -++.-..+.++.||..|+.||..++ +|||||...|+||.++..||++||
T Consensus 340 IiTEfM~yGNLLdYLRecnr~-------ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS-------EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred EEEecccCccHHHHHHHhchh-------hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence 999999999999999876533 2666677899999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 286 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~~~~ 286 (293)
|+++.........+... --...|.|||-+.-..++.++|||+|||+|||+.| |-.||-+.+-....+
T Consensus 410 GLsRlMtgDTYTAHAGA-KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~ 477 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGA-KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG 477 (1157)
T ss_pred chhhhhcCCceecccCc-cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH
Confidence 99987654333222111 12557999999998999999999999999999999 999999876443333
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=253.72 Aligned_cols=204 Identities=31% Similarity=0.478 Sum_probs=175.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC---C--CCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK---S--GHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~---~--~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
....+.+.||+|.||.||.|... . .-.||||..+.+. .+.+.|+.|.-++++++||||++++|+|.+. ..++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 34556678999999999999843 2 3468999887643 3457899999999999999999999998654 5789
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
|||+++.|.|..+++.++. .++......++.||+.||.|||+.. +|||||...||||....-|||+|||
T Consensus 468 vmEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred EEecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 9999999999999998774 4888999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRG 283 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~ 283 (293)
+++.+.+....... ...-...|||||.+.-+.++.++|||-|||++||++. |..||.+....+
T Consensus 537 LSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 537 LSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred hhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 99988776654333 3334568999999999999999999999999999888 999999876543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=267.20 Aligned_cols=144 Identities=28% Similarity=0.396 Sum_probs=130.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||+||+|.+. +++.||+|++...... ...+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 58999999999999999999987 7999999998754322 256788999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+.+++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++
T Consensus 84 Ey~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 9999999999987543 3788999999999999999999998 999999999999999999999999987
Q ss_pred C
Q 022706 222 N 222 (293)
Q Consensus 222 ~ 222 (293)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=255.67 Aligned_cols=196 Identities=24% Similarity=0.385 Sum_probs=169.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---------HHHHHHHHHHhcCC---CCCceeEEEEEEe
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---------EEFLAQVSMVSRLK---HENFVQLLGYCVD 133 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---------~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 133 (293)
.+|...+.+|+|+||.|++|.++ +...|+||.+.+...-. -.+--|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 36999999999999999999988 67789999886543221 12345899999997 9999999999999
Q ss_pred CCeeEEEEEcc-cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 134 GTSRVLAYEFA-SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 134 ~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
.+++||+||-- +|.+|.+++.... .+++.++..|++||+.++++||++| |||||||-+|++++.+|-
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---------~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---------RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF 708 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---------ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence 99999999974 4568999998765 4999999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
+||+|||.+..... .....++||..|.|||++.+..| +...|||++|++||.++...-||.+
T Consensus 709 ~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999998865432 23467899999999999998776 6678999999999999999999965
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=245.10 Aligned_cols=196 Identities=30% Similarity=0.495 Sum_probs=165.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.|...+.||+|+||.||+++++ ++..+++|.+..... ...++.+|+++++.++|+|++++++++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 35777788999999999999977 688999998864322 1245778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+. ++|.+++.... ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 95 e~~~-~~l~~~~~~~~--------~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 95 EYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred EccC-CCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence 9996 47877765433 23889999999999999999999998 999999999999999999999999987
Q ss_pred CCCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .....+++.|+|||.+. ...++.++|||||||++|+|++|..||....
T Consensus 163 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 163 SIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred eeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 65432 13346788999999875 3457889999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=242.49 Aligned_cols=198 Identities=30% Similarity=0.438 Sum_probs=170.1
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
|++.+.||+|++|.||++... +++.+++|++.... .....+.+|+.++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999977 69999999987643 23456788999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
.+ +|.+++.... ..+++..++.++.|++.+|.+||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 81 DM-DLKKYLDKRP--------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred Cc-CHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence 75 8999997653 13899999999999999999999998 999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 149 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 149 GIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred CCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 43221 12234457789999988766 78899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=243.37 Aligned_cols=210 Identities=26% Similarity=0.466 Sum_probs=172.7
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcC--CCCCceeEEEEEEeC----Ce
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL--KHENFVQLLGYCVDG----TS 136 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~ 136 (293)
..+.++..+.+.||+|.||.||+|.++ |+.||||++.. .++....+|.++.+.. +|+||+.+++.-... ..
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 445678889999999999999999998 99999999854 3456788888887765 799999999864322 25
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeCCCCCCceEEcCCC
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-----KADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-----~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
++||.+|-+.|||+++|++.. ++.+..++++..++.||++||. +|.+.|.|||||..||||.+++
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 789999999999999999864 9999999999999999999995 4567799999999999999999
Q ss_pred ceEEeccccCCCCCcc--cccccccccccCcccccccccccCC----C--CCccchhhHHHHHHHHHhC----------C
Q 022706 212 VAKIADFDLSNQAPDM--AARLHSTRVLGTFGYHAPEYAMTGQ----L--NAKSDVYSFGVVLLELLTG----------R 273 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~~l~el~~g----------~ 273 (293)
...|+|+|++...... .-.......+||..|||||++...- + -..+||||||.++||++.. +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999998765432 1223345678999999999887532 2 1368999999999998753 5
Q ss_pred CCCCCCCCcccc
Q 022706 274 KPVDHTLPRGQQ 285 (293)
Q Consensus 274 ~Pf~~~~~~~~~ 285 (293)
+||.+..|.++.
T Consensus 434 ~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 434 LPYYDVVPSDPS 445 (513)
T ss_pred CCcccCCCCCCC
Confidence 799888776543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=241.65 Aligned_cols=206 Identities=28% Similarity=0.469 Sum_probs=171.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEe--------C
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD--------G 134 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 134 (293)
+.|.-...||+|.||.||+|+.+ +++.||+|++-.... -....++|+++|..|+|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666678999999999999977 788899987754322 23567899999999999999999887653 3
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~k 214 (293)
..+|+||.+|+. +|.-++.... ..++..++..++.+++.+|.|+|++. |+|||+|++|+|++.+|.++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~--------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK--------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK 164 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc--------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence 457999999987 8988887664 24899999999999999999999998 99999999999999999999
Q ss_pred EeccccCCCCCccc--ccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 022706 215 IADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284 (293)
Q Consensus 215 l~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~ 284 (293)
|+|||+++...... ....-+..+-|++|++||.+++. .|+++.|||..||++.||+++.+-|++.++..+
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq 237 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ 237 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH
Confidence 99999997654332 22223456679999999999874 699999999999999999999999998776443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=235.48 Aligned_cols=181 Identities=23% Similarity=0.271 Sum_probs=154.5
Q ss_pred cCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcC
Q 022706 78 GSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR 156 (293)
Q Consensus 78 G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~ 156 (293)
|.+|.||++.++ +++.+|+|.+.... ...+|...+....||||+++++++.+....+++|||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999987 78999999986543 2334455555667999999999999999999999999999999988654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccccccccccc
Q 022706 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236 (293)
Q Consensus 157 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (293)
. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+....... ...
T Consensus 80 ~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~ 142 (237)
T cd05576 80 L---------NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE 142 (237)
T ss_pred c---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence 3 3899999999999999999999998 9999999999999999999999999876543321 223
Q ss_pred ccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 237 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.++..|+|||.+.+..++.++|+||+|+++|||++|+.||...
T Consensus 143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 4567899999988888899999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=239.41 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=165.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC------CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS------KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
+|.+.+.||+|+||.||++.+. .+..+++|.++.. ......+.+|+.++++++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999876 4555666665431 12234566789999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++...... ...+++.+++.++.|++.||.+||+.+ ++|+||+|+||++++ +.++|+|||+
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence 9999999999888642211 124899999999999999999999998 999999999999975 5699999998
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+........ ......+++.|++||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 876533211 123355788999999988888899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.56 Aligned_cols=196 Identities=35% Similarity=0.493 Sum_probs=163.7
Q ss_pred cCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcC--CCCCceeEEEEEEeCC----eeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL--KHENFVQLLGYCVDGT----SRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~ 141 (293)
...+.++||+|.||.||+|... ++.||||+++. ...+.+++|.++.+.. +|+||+++++.-...+ .++||+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4456678999999999999987 69999999864 3345677887777655 6999999999876555 789999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCceEEcCCCceEE
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------DPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
+|.+.|+|.++++... ++|....+|+..+++||+|||... .++|+|||||..||||.+|++..|
T Consensus 288 ~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred eeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 9999999999999876 999999999999999999999743 357999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCC-CC-----CccchhhHHHHHHHHHhCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LN-----AKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~~l~el~~g~~Pf 276 (293)
+|||++..+............+||..|||||++.+.. .. .+.||||+|.+|||+++.-.-+
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 9999998775444433344578999999999887642 22 3689999999999999875443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=252.08 Aligned_cols=194 Identities=24% Similarity=0.368 Sum_probs=166.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
+.+.|.+...+|.|+|+.|-.+.+. +++..++|++..... +..+|+.++... +||||+++.+++.++.+.|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4678888899999999999999877 799999999976632 234466555555 59999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE-cCCCceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv-~~~~~~kl~Dfg~~ 221 (293)
.+.|+.+.+.+.... ....++..|+.||+.|+.|||++| +|||||||+|||+ ++.++++|+|||.+
T Consensus 397 ~l~g~ell~ri~~~~----------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred hccccHHHHHHHhcc----------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 999998888776554 333788889999999999999999 9999999999999 68999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+..... ....+-|..|.|||++....|+.+.|+||||++||+|++|+.||...
T Consensus 464 ~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 464 SELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred hhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 876543 12345688999999999999999999999999999999999999754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=274.10 Aligned_cols=194 Identities=29% Similarity=0.554 Sum_probs=162.6
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
..+...|...+.||+|+||.||+|.++ ++..||+|++....... .+|++.+++++||||+++++++.+....++||
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 344567888889999999999999975 79999999986443322 34688899999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.++++. +++.++..++.|++.||+|||.....+|+||||||+||+++.++..++. |+..
T Consensus 763 Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 763 EYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred eCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 99999999999851 7899999999999999999994422239999999999999998887775 5554
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
..... .....+++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 830 GLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 33211 1233678999999999988999999999999999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=262.32 Aligned_cols=207 Identities=29% Similarity=0.470 Sum_probs=177.8
Q ss_pred cCCCCceeeccCceEEEEEEeC-C---CCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~---~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
...+.++||.|.||.|++|+.+ . ...||||.++.... ...+|+.|+.+|-+.+||||+++.++........||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4467889999999999999977 3 35799999986544 3467999999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|||++|+|+.+|+.+.+. ++..+...+++-|+.+++||.+.+ +|||||.+.||||+.+...|++|||++
T Consensus 710 EyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred hhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999877642 888999999999999999999998 999999999999999999999999999
Q ss_pred CCCCcccccccccccc--cCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 022706 222 NQAPDMAARLHSTRVL--GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQS 286 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~~~~ 286 (293)
+.+.+...... ++.- -...|.|||.+.-+.++.++||||+|++|||.++ |.-||=+.+..+...
T Consensus 779 Rvledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk 845 (996)
T KOG0196|consen 779 RVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK 845 (996)
T ss_pred eecccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH
Confidence 97755432111 1111 1458999999999999999999999999999777 999998887655443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=259.29 Aligned_cols=209 Identities=29% Similarity=0.433 Sum_probs=178.7
Q ss_pred CCCCceeeccCceEEEEEEeC-C----CCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 69 FGTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~----~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.+..++||+|+||+||+|.+- . +-+||+|++..... ...++++|+-+|.+++|||++++++++.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345679999999999999863 3 45789998865543 3678999999999999999999999997665 78999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
+|+++|+|.++++..++ .+..+..+.|..||++|+.|||.++ ++||||-..||||.+-.++|+.|||++
T Consensus 777 q~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HhcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence 99999999999987663 3889999999999999999999998 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccccc
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVT 289 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~~~~~~~ 289 (293)
+...............-.+.|||-|.+....|+.++|||||||++|||+| |..||.+...++..++.+
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 88765443333333334668999999999999999999999999999999 999999988777666543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=229.33 Aligned_cols=202 Identities=23% Similarity=0.429 Sum_probs=169.1
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEE-EEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGY-CVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~lv~ 141 (293)
+.+.|.+.+.||+|.||.+.++.++ +++.+++|.++.......+|.+|...--.|. |.||+.-|++ |+..+.++++|
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4567889999999999999999988 7899999999888888899999998877776 8999988875 55667788999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC--CCceEEeccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFD 219 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~--~~~~kl~Dfg 219 (293)
||++.|+|.+-+...+ +.+.....++.|+++|+.|+|+++ +||||||.+||||.+ .-++||||||
T Consensus 102 E~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred ccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence 9999999999887765 889999999999999999999998 999999999999964 3479999999
Q ss_pred cCCCCCcccccccccccccCccccccccccc---C--CCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---G--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~ 284 (293)
+....+..- .....+..|.+||.... + ...+.+|+|+||+++|.++||.+||+...-.++
T Consensus 169 ~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~ 233 (378)
T KOG1345|consen 169 LTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK 233 (378)
T ss_pred cccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence 987654322 22234567899997653 2 356789999999999999999999996544333
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=220.11 Aligned_cols=198 Identities=35% Similarity=0.511 Sum_probs=171.6
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
|.+.+.||+|++|.||++... +++.+++|.+..... ....+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567789999999999999987 589999999976544 35678899999999999999999999999899999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 81 GGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 9999999876541 1788999999999999999999998 9999999999999999999999999887654
Q ss_pred cccccccccccccCccccccccc-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYA-MTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
..... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 43211 12345677889999988 566778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=220.58 Aligned_cols=194 Identities=21% Similarity=0.358 Sum_probs=163.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCe--eEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS--RVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~--~~lv~ 141 (293)
.++|++.+.+|+|-++.||.|..- ++++++||++++ ...+.+.+|+++|+.|. +|||++++++..+..+ ..+|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 358999999999999999999854 789999999864 34568999999999997 9999999999887643 56999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg~ 220 (293)
|++.+.+...+.. .++..+++.++.|++.||.|+|+.| |+|||+||.|++++... .++|+|+|+
T Consensus 115 E~v~n~Dfk~ly~------------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP------------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred hhhccccHHHHhh------------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecch
Confidence 9998877766653 4888999999999999999999999 99999999999998654 699999999
Q ss_pred CCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+......... .-.+.+..|--||++-. ..|+.+-|+|||||++..|+..+-||-..
T Consensus 180 AEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 180 AEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred HhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 9876543322 33456778899998875 46889999999999999999988887543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=243.22 Aligned_cols=208 Identities=20% Similarity=0.257 Sum_probs=180.1
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC------CCceeEEEEEEeCC
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH------ENFVQLLGYCVDGT 135 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~ 135 (293)
+.+..+|.+....|+|-|++|.+|.+. .|+.||||++.....-...=++|+++|++|.. -|+++++..|...+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 445678999999999999999999976 68899999998877766777889999999962 48999999999999
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAK 214 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~k 214 (293)
+++||+|-+ ..+|.++++..+.. ..|....+..++.|+..||..|-..+ |+|.||||+||||++.. .+|
T Consensus 508 HLClVFE~L-slNLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999 45999999876633 24888999999999999999999998 99999999999998754 589
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~ 284 (293)
|||||.|-...+... +...-+.-|.|||++++-+|+...|+||+||+||||.||+.-|.+.+...+
T Consensus 578 LCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 578 LCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred eccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 999999877655432 344456679999999999999999999999999999999999998876544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=249.02 Aligned_cols=212 Identities=29% Similarity=0.467 Sum_probs=174.3
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC----C----CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK----S----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLK-HENFVQLLGYCVD 133 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~----~----~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 133 (293)
..++..+.+.||+|.||.|++|..+ . ...||||.++..... .+.+..|+++++.+. |+||+.+++.+..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3445567779999999999999833 1 457999998755444 567889999999996 9999999999999
Q ss_pred CCeeEEEEEcccCCchhhhhhcCC-CCCCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceE
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRK-GVKGAQPG------PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nil 206 (293)
....++|+||+..|+|.++++... .......+ ..++..+.+.++.||+.|++||++.. ++||||-..|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999998776 11111111 24899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeccccCCCCCcccccccc-cccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 022706 207 IFDDDVAKIADFDLSNQAPDMAARLHS-TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 279 (293)
Q Consensus 207 v~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~ 279 (293)
+..+..+|++|||+++........... ....-...|||||.+....++.++||||+|++|||+++ |..||.+.
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999865544332211 11112346999999999999999999999999999999 99999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=240.21 Aligned_cols=209 Identities=24% Similarity=0.382 Sum_probs=153.0
Q ss_pred HhcCCCCceeeccCceEEEEEEe-----------------CCCCeEEEEEcCCCCCC-hH--------------HHHHHH
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL-----------------KSGHAAAIKKLDASKQP-DE--------------EFLAQV 113 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~~avK~~~~~~~~-~~--------------~~~~e~ 113 (293)
.++|.+.+.||+|+||+||+|.. ..++.||||++...... .+ ....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999964 23568999998643321 12 223466
Q ss_pred HHHhcCCCCC-----ceeEEEEEEe--------CCeeEEEEEcccCCchhhhhhcCCCCC---------------CCCCC
Q 022706 114 SMVSRLKHEN-----FVQLLGYCVD--------GTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQPG 165 (293)
Q Consensus 114 ~~l~~l~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~---------------~~~~~ 165 (293)
.++.+++|.+ ++++++++.. ....++||||+++++|.++++...... .....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6677776554 3666776643 356799999999999999987532110 01112
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccc
Q 022706 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245 (293)
Q Consensus 166 ~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (293)
..+++..++.++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++........ .......+++.|++|
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 23577889999999999999999998 99999999999999999999999999865432211 111223347899999
Q ss_pred cccccCC--------------------CC--CccchhhHHHHHHHHHhCCC-CCCC
Q 022706 246 EYAMTGQ--------------------LN--AKSDVYSFGVVLLELLTGRK-PVDH 278 (293)
Q Consensus 246 E~~~~~~--------------------~~--~~~DvwslG~~l~el~~g~~-Pf~~ 278 (293)
|.+.... ++ .+.||||+||++|+|++|.+ ||.+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9875422 11 24699999999999999986 8764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=244.44 Aligned_cols=206 Identities=20% Similarity=0.266 Sum_probs=143.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-C----CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEE------EEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-S----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY------CVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~ 134 (293)
.++|.+.+.||+|+||.||+|++. + +..||+|++...... +....| .++...+.++..++.. ....
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 468999999999999999999976 5 789999987643221 111111 1122222222222111 2456
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-----------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~ 203 (293)
...++||||+.+++|.+++....... ............+..++.|++.||.|||+.+ |+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence 67899999999999999887542100 0000111234456789999999999999998 999999999
Q ss_pred ceEEcC-CCceEEeccccCCCCCcccccccccccccCcccccccccccC----------------------CCCCccchh
Q 022706 204 NVLIFD-DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----------------------QLNAKSDVY 260 (293)
Q Consensus 204 Nilv~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dvw 260 (293)
|||+++ ++.+||+|||++....... ........+++.|+|||.+... .++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999986 5789999999997653221 1123456789999999966432 133456999
Q ss_pred hHHHHHHHHHhCCCCCCC
Q 022706 261 SFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 261 slG~~l~el~~g~~Pf~~ 278 (293)
||||+||||+++..|++.
T Consensus 364 SlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred HHHHHHHHHHhCcCCCch
Confidence 999999999998877653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=215.20 Aligned_cols=185 Identities=37% Similarity=0.542 Sum_probs=163.9
Q ss_pred CceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhc
Q 022706 79 SYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155 (293)
Q Consensus 79 ~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 155 (293)
+||.||++.++ +++.+++|++...... .+.+.+|++.+++++|+|++++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 5899999998755433 47889999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccc
Q 022706 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235 (293)
Q Consensus 156 ~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (293)
.. .++...++.++.+++.++.+||+.+ ++|+||+|.||++++++.++|+|||.+....... ....
T Consensus 81 ~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 145 (244)
T smart00220 81 RG---------RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT 145 (244)
T ss_pred cc---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence 43 2788999999999999999999998 9999999999999999999999999987654432 2244
Q ss_pred cccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
..++..|++||.+....++.++|+||+|+++|+|++|..||..
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5678899999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=222.84 Aligned_cols=131 Identities=22% Similarity=0.372 Sum_probs=115.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-----C---CCceeEEEEEE----e
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----H---ENFVQLLGYCV----D 133 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~----~ 133 (293)
.+|.+.+.||-|.|++||++.+. +.+.||+|+.+....-.+....|+++|++++ | .+||++++.|. .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 68999999999999999999976 7889999999877777788899999999985 2 36999999987 4
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
+.++++|+|++ |.+|..+|....- +.++...++.|++||+.||.|||... +|||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~Y-------rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNY-------RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCC-------CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 67899999999 6789888876542 34899999999999999999999985 69999999999997
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=214.03 Aligned_cols=207 Identities=24% Similarity=0.337 Sum_probs=179.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.-+|++++.||+|.||.++.|++- +++.||||. .+.......+..|.+..+.|. .++|..++-+...+-+..||||+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf-EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF-EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEe-ccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 348999999999999999999965 899999995 445556677888999999986 79999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-----CceEEecc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-----DVAKIADF 218 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-----~~~kl~Df 218 (293)
+ |.+|+++..-.. +.++..++..++.|++.-++++|++. +|+|||||+|+||... ..+.++||
T Consensus 106 L-GPSLEDLFD~Cg--------R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--------RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred h-CcCHHHHHHHhc--------CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEec
Confidence 9 889999887655 35999999999999999999999998 9999999999999643 35899999
Q ss_pred ccCCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc
Q 022706 219 DLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285 (293)
Q Consensus 219 g~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~ 285 (293)
|+++.+.+.... .......||..||+-...+++.-+.+.|+-|||-++++.|.|.+||++.....-+
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK 245 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK 245 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence 999988766543 2345678999999999999999999999999999999999999999988654433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=222.60 Aligned_cols=225 Identities=24% Similarity=0.343 Sum_probs=186.1
Q ss_pred HHHHHHHHhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEE
Q 022706 59 VDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGY 130 (293)
Q Consensus 59 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~ 130 (293)
..++.....++++.-++-+|.||.||.|.++ +.+.+.+|.++.... ....++.|..++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3345555668888899999999999999654 245677777764433 23567889999999999999999998
Q ss_pred EE-eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 131 CV-DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 131 ~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
+. +....+.++.+..-|+|..++...++.. +...+.++..+...++.|++.|++|||+.+ +||.||...|.++++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 75 5567788899998899999998554332 222346888999999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccc
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSL 287 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~~~~~~ 287 (293)
...+||+|=.+++.+-..+....+........||+||.+.+..|+..+||||||++||||+| |+.||-..+|.++.-+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 99999999999988776666555566667789999999999999999999999999999999 9999999888765533
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-31 Score=237.89 Aligned_cols=202 Identities=28% Similarity=0.399 Sum_probs=163.9
Q ss_pred CCCCceeeccCceE-EEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 69 FGTNALIGEGSYGR-VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 69 y~~~~~lg~G~~g~-V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
|.-.+++|.|+-|+ ||+|... ++.||||.+-.... ....+|+..|+.-+ ||||+++++.-.+....||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 44556799998876 8999987 88999998753322 35678999999886 99999999999999999999999976
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---C--CceEEeccccC
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---D--DVAKIADFDLS 221 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~--~~~kl~Dfg~~ 221 (293)
+|.+++....... . .......+.+..|++.||++||+.+ ||||||||.||||.. + ..++|+|||++
T Consensus 588 -sL~dlie~~~~d~-~----~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 588 -SLQDLIESSGLDV-E----MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred -hHHHHHhccccch-h----hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 9999998741110 0 1111455788899999999999998 999999999999975 3 36899999999
Q ss_pred CCCCccc-ccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 222 NQAPDMA-ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 222 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
+.+.... .........||-+|+|||++.....+.++||+|+||++|+.++ |..||.+...+
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 9875433 3333456779999999999999888889999999999999988 59999876543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=211.75 Aligned_cols=196 Identities=24% Similarity=0.321 Sum_probs=165.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCceeEEEEEEeC------C
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------T 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 135 (293)
..+|.-.+.+|.|.- .|-.+.+. .+++|++|++... ....++..+|+..+..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357777888999988 66666665 7999999988533 23346788999999999999999999988632 3
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..|+|||++.. +|...+... ++-..+..++.|++.|++|||+.| |+||||||+||++..+..+|+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence 46899999965 998888733 777889999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.|||++...... ...+..+.|..|.|||++.+-.+...+||||+||++.||++|..-|.+.+
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 999998764322 23466788999999999999889999999999999999999999997554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=233.09 Aligned_cols=204 Identities=30% Similarity=0.461 Sum_probs=179.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh-HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..+|.+...+|.|.+|.||+++++ +++..|+|+++....+. ..++.|+-+++.++||||+.+++.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 458999999999999999999987 89999999998766543 5677899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
|.+|+|.++.+-.. ++++.++..++++.+++|+|||+.| -+|||||=.||++++.|.+||.|||.+..
T Consensus 94 cgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ 161 (829)
T ss_pred cCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh
Confidence 99999999877554 5999999999999999999999999 89999999999999999999999999876
Q ss_pred CCcccccccccccccCccccccccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYA---MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
+.... .....+.|||.|||||+- ..+.|....|+|++|++..|+-.-++|--+..|..
T Consensus 162 itati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr 222 (829)
T KOG0576|consen 162 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR 222 (829)
T ss_pred hhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH
Confidence 64322 234678999999999965 35679999999999999999999888877665543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=200.59 Aligned_cols=208 Identities=23% Similarity=0.331 Sum_probs=176.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 142 (293)
...+|.+++.||.|+||.+|+|..- +|..||||+-... .....+..|.++.+.|+ ...|..+.-+..+..+..+||+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578999999999999999999854 8999999976433 33356778899999997 4678888888888999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC---CceEEeccc
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIADFD 219 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~---~~~kl~Dfg 219 (293)
.+ |.+|+++.+-.. +.++..+++.++-|++.-++|+|..+ ++||||||+|+|..-+ ..+.|+|||
T Consensus 92 LL-GPsLEdLfnfC~--------R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--------RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred cc-CccHHHHHHHHh--------hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEecc
Confidence 99 889999887554 34899999999999999999999999 9999999999999643 458999999
Q ss_pred cCCCCCcccccc-----cccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc
Q 022706 220 LSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285 (293)
Q Consensus 220 ~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~ 285 (293)
+++...+..... ....+.||..|.+-..+.+-..+.+.|+-|+|.+|.++..|.+||++..+..++
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 999876654432 345678999999999888888899999999999999999999999998776544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=213.39 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=168.6
Q ss_pred HHHHHhcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCe
Q 022706 62 LKEITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTS 136 (293)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 136 (293)
+..+.+.|..+..||+|.|++||++.+. .++.||+|.+...... .++.+|+++|..+. +.||+++.+.+..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3456678999999999999999999854 4778999998654433 56899999999996 9999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEE
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKI 215 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl 215 (293)
..+|+||++.....++... ++..++..+++.++.||.++|.+| ||||||||.|+|.+. .+.-.|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred eEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence 9999999999988888753 778999999999999999999999 999999999999974 567899
Q ss_pred eccccCCCCCccc------c------------------------------------cccccccccCccccccccccc-CC
Q 022706 216 ADFDLSNQAPDMA------A------------------------------------RLHSTRVLGTFGYHAPEYAMT-GQ 252 (293)
Q Consensus 216 ~Dfg~~~~~~~~~------~------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~ 252 (293)
+|||++....... . ........||++|.|||++.+ ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999986210000 0 001123569999999999886 45
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 253 LNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 253 ~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
.++++||||.|+++..+++++.||-..
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred cCCccceeeccceeehhhccccccccC
Confidence 788999999999999999999999643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=194.26 Aligned_cols=182 Identities=36% Similarity=0.589 Sum_probs=158.0
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhh
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 151 (293)
||+|.+|.||++... +++.+++|++...... ...+.+|++.++.+.|++++++++++......+++||++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999986 5899999999766553 5678999999999999999999999999999999999999899999
Q ss_pred hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEeccccCCCCCccccc
Q 022706 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQAPDMAAR 230 (293)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~~~~~~~~~~~ 230 (293)
++.... ..++...+..++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 987652 13889999999999999999999998 999999999999999 89999999999875543221
Q ss_pred ccccccccCcccccccccccC-CCCCccchhhHHHHHHHH
Q 022706 231 LHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLEL 269 (293)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el 269 (293)
......+...|++||.+... .++.+.|+|++|+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 12335578889999988776 788899999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=207.50 Aligned_cols=203 Identities=24% Similarity=0.304 Sum_probs=167.3
Q ss_pred cCCCCceeeccCceEEEEEEeCC--CCeEEEEEcCCCCCC-hHHHHHHHHHHhcCC----CCCceeEEEEE-EeCCeeEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILKS--GHAAAIKKLDASKQP-DEEFLAQVSMVSRLK----HENFVQLLGYC-VDGTSRVL 139 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 139 (293)
+|.+.+.||+|+||.||++.+.. ...+|+|........ ...+..|..++..+. ..++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999774 357888877654222 226777888888886 36999999998 57888999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-----CceE
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-----DVAK 214 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-----~~~k 214 (293)
||+.+ |.+|.++...... ..++..+++.++.|++.+|.+||+.| ++||||||+|+++... ..+.
T Consensus 99 VM~l~-G~sL~dl~~~~~~-------~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPP-------GRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred EEecc-CccHHHHHHhCCC-------CCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence 99999 7899998865542 24999999999999999999999999 9999999999999865 3699
Q ss_pred EeccccCCCCC--cccc------cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 215 IADFDLSNQAP--DMAA------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~--~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|+|||+++... .... ......+.||..|.++.+..+...+++.|+||++.++.+|+.|.+||.+...
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 99999998322 1111 1112345699999999999999999999999999999999999999987654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=206.79 Aligned_cols=165 Identities=19% Similarity=0.218 Sum_probs=128.5
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC--CCCeEEEEEcCCCCC------ChHHHHHHHHHHhcCCCCCcee-EEEEEEe
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ------PDEEFLAQVSMVSRLKHENFVQ-LLGYCVD 133 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~ 133 (293)
..+..+|.+.+.||+|+||+||+|.++ +++.+|||++..... ....+.+|+++|++++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 445678999999999999999999875 577789998753311 1346889999999999999985 443
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCceEEcCCCc
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI-KSSNVLIFDDDV 212 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di-kp~Nilv~~~~~ 212 (293)
....++||||++|++|... . . .. ...++.|++++|.|||+.| |+|||| ||+|||++.++.
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~--~----------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-R--P----------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-C--c----------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCC
Confidence 2457999999999999632 1 0 11 1367889999999999999 999999 999999999999
Q ss_pred eEEeccccCCCCCccccccc------ccccccCccccccccccc
Q 022706 213 AKIADFDLSNQAPDMAARLH------STRVLGTFGYHAPEYAMT 250 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 250 (293)
++|+|||++........... -....+++.|++||.+..
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999999986644321111 135667888999998753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=186.53 Aligned_cols=170 Identities=14% Similarity=0.201 Sum_probs=134.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHH----------HHHHHHHHhcCCCCCceeEEEEEEeC
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE----------FLAQVSMVSRLKHENFVQLLGYCVDG 134 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~----------~~~e~~~l~~l~h~~i~~~~~~~~~~ 134 (293)
+.++|++.++||.|+||.||++.. ++..+|+|++.......+. +.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 567999999999999999999766 5778999999755443332 57899999999999999999886643
Q ss_pred --------CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceE
Q 022706 135 --------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206 (293)
Q Consensus 135 --------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nil 206 (293)
...+++|||++|.+|.++.. +++ ....+++.+|..+|+.| ++|+|++|+||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nil 167 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFI 167 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEE
Confidence 35789999999999988732 333 24569999999999999 999999999999
Q ss_pred EcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHH
Q 022706 207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270 (293)
Q Consensus 207 v~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 270 (293)
+++++ ++|+|||......+.... ...++...++.++|+|+||+++..+.
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988 999999987654221110 01345556778999999999987653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=219.72 Aligned_cols=149 Identities=21% Similarity=0.259 Sum_probs=112.5
Q ss_pred cCCC-CCceeEEEEE-------EeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022706 118 RLKH-ENFVQLLGYC-------VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189 (293)
Q Consensus 118 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 189 (293)
.++| .||+++++++ .+...++++||++ +++|.+++.... ..+++.+++.++.||+.||.|||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~ 98 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHS 98 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHh
Confidence 3445 5777777766 2234567788887 559999997432 248999999999999999999999
Q ss_pred CCCCCeeeCCCCCCceEEcCCC-------------------ceEEeccccCCCCCcccc--------------ccccccc
Q 022706 190 KADPHIIHRDIKSSNVLIFDDD-------------------VAKIADFDLSNQAPDMAA--------------RLHSTRV 236 (293)
Q Consensus 190 ~~~~~ivH~Dikp~Nilv~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~ 236 (293)
+| |+||||||+||||+..+ .+|++|||+++....... .......
T Consensus 99 ~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 99 QG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred CC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 99 99999999999996544 455666666543211000 0001124
Q ss_pred ccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 237 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
.||+.|+|||++.+..++.++|||||||+||||++|..||..
T Consensus 176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 578999999999999999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-24 Score=183.42 Aligned_cols=201 Identities=35% Similarity=0.540 Sum_probs=170.3
Q ss_pred CCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCC-CceeEEEEEEeCCeeEEEEEc
Q 022706 69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHE-NFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 143 (293)
|.+.+.||.|+|+.||++.+. ..+++|.+...... ...+.+|+..+..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999987 88999998755433 46788999999999988 799999999877778999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg~~~ 222 (293)
+.++++.+++...... ..+.......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.
T Consensus 80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 9999999777654311 13889999999999999999999999 99999999999999988 79999999987
Q ss_pred CCCcccccc----cccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARL----HSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
......... ......++..|++||.+.+ ...+...|+||+|++++++++|..||....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 544332211 2356779999999999887 578889999999999999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=175.14 Aligned_cols=138 Identities=20% Similarity=0.188 Sum_probs=107.3
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC----------hHH-----------------HHHHHHHHhcCCCCCc
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP----------DEE-----------------FLAQVSMVSRLKHENF 124 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~----------~~~-----------------~~~e~~~l~~l~h~~i 124 (293)
...||+|+||.||+|.+.+|+.||+|+++..... ... ..+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654211 011 2348999999987776
Q ss_pred eeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCC
Q 022706 125 VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADPHIIHRDIKSS 203 (293)
Q Consensus 125 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~ivH~Dikp~ 203 (293)
.....+... ..++||||++++++...+.... .++..++..++.|++.+|.++ |+.| |+||||||+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY 147 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 443333222 2389999999877655432221 388899999999999999999 6888 999999999
Q ss_pred ceEEcCCCceEEeccccCCCC
Q 022706 204 NVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 204 Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
||+++ ++.++|+|||++...
T Consensus 148 NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HEEEE-CCcEEEEEccccccC
Confidence 99998 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-24 Score=170.33 Aligned_cols=139 Identities=18% Similarity=0.167 Sum_probs=110.5
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---------------------------hHHHHHHHHHHhcCCCCC
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------DEEFLAQVSMVSRLKHEN 123 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~~ 123 (293)
+.+.||+|++|.||+|.+.+|+.||||++...... ...+.+|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999999999878999999998754211 112357889999999988
Q ss_pred ceeEEEEEEeCCeeEEEEEcccCCchhhh-hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCC
Q 022706 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDI-LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIK 201 (293)
Q Consensus 124 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dik 201 (293)
+.....+.... .++||||++|+++... +... .++..+...++.|++.++.++|+ .| |+|||||
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 75554443332 4899999998755433 3322 27788999999999999999999 88 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCC
Q 022706 202 SSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 202 p~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
|+||+++ ++.++|+|||++....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecC
Confidence 9999998 8899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=165.47 Aligned_cols=186 Identities=15% Similarity=0.125 Sum_probs=141.1
Q ss_pred CCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChH-----HHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEc
Q 022706 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDE-----EFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.+...|++|+||+||++.. .+.+++.+.+...+.... .+.+|+++|++|. ++++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4566899999999997766 588899888876665433 5789999999996 5889999886 346899999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCceEEcCCCceEEeccccCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI-KSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di-kp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+.|.+|.+.+.. ....++.|++.+|.++|+.| |+|||| ||+|||++.++.++|+|||++.
T Consensus 80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 999888653311 11357789999999999999 999999 7999999999999999999998
Q ss_pred CCCccccc----c-------cccccccCcccccccccccC-CCC-CccchhhHHHHHHHHHhCCCCCCCC
Q 022706 223 QAPDMAAR----L-------HSTRVLGTFGYHAPEYAMTG-QLN-AKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 223 ~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
........ . .......++.|+.|+...-. ..+ .+.+.++.|+-+|.++|+..|+-..
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 54432210 0 00112257788888754322 333 5778999999999999988776544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=195.73 Aligned_cols=196 Identities=24% Similarity=0.285 Sum_probs=157.5
Q ss_pred HHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 141 (293)
-...|.|.+.||+|+||+||+|...+|+.||+|+-++....+ |.--.+++.+|+ -+-|..+.....-.+..+||+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 356899999999999999999998889999999876655442 222234444554 234455555455566778999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-------CCceE
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-------DDVAK 214 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-------~~~~k 214 (293)
||.+.|+|.++++..+ .+++..+..++.|++..|+.||..+ |||+||||+|+|+.. ..-++
T Consensus 774 ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred eccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 9999999999998544 4889999999999999999999999 999999999999952 23489
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 274 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~ 274 (293)
|+|||.+....-..........++|-.+-.+|+..+.+|++..|.|.|+-+++.||.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999876544333334456678889999999999999999999999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=162.68 Aligned_cols=107 Identities=27% Similarity=0.295 Sum_probs=93.1
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
|+|.++++.+. ..+++.+++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRG--------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 58888887543 24999999999999999999999884 999999999999999 998865432
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 62 -------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 62 -------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred -------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1225789999999999999999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=159.22 Aligned_cols=136 Identities=16% Similarity=0.213 Sum_probs=105.1
Q ss_pred CCCceeeccCceEEEEEEeCCCCeEEEEEcCCCC-CChHHHHHHHHHHhcC-----CCCCceeEEEEEEeCC---eeE-E
Q 022706 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRL-----KHENFVQLLGYCVDGT---SRV-L 139 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-l 139 (293)
.-.+.||+|+|+.||. +......+||++.... ...+.+.+|+++++.+ +||||+++++++++.. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999995 4433334799886542 3456789999999999 5799999999998764 333 7
Q ss_pred EEEc--ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCceEEcC----CCc
Q 022706 140 AYEF--ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL-EYLHEKADPHIIHRDIKSSNVLIFD----DDV 212 (293)
Q Consensus 140 v~e~--~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~ivH~Dikp~Nilv~~----~~~ 212 (293)
|||| +.+++|.+++++.. +++. ..++.|++.++ +|||+++ |+||||||+||+++. +..
T Consensus 83 I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred EecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence 8999 55789999996532 5544 35677888777 9999999 999999999999974 337
Q ss_pred eEEec-cccCC
Q 022706 213 AKIAD-FDLSN 222 (293)
Q Consensus 213 ~kl~D-fg~~~ 222 (293)
++|+| ||...
T Consensus 148 ~~LiDg~G~~~ 158 (210)
T PRK10345 148 PVVCDNIGEST 158 (210)
T ss_pred EEEEECCCCcc
Confidence 99999 55433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.9e-24 Score=196.65 Aligned_cols=195 Identities=22% Similarity=0.246 Sum_probs=155.0
Q ss_pred cCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCC--CChHHH---HHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK--QPDEEF---LAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~--~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
+|...+.||.+.|=+|.+++++.|. |+||++-+.. .+-..+ ++|++ ...+++||.+++..+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778889999999999999998777 9999885433 222333 34444 555679999999888777888899999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|... +|++.+..+. .+...+.+.|+.|++.||..+|..| |+|||||.+||||+..+.+.|.||...+
T Consensus 102 yvkh-nLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHhh-hhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 9966 9999998764 6889999999999999999999999 9999999999999999999999998776
Q ss_pred CCCccccc-----ccccccccCcccccccccccC----------C-CCCccchhhHHHHHHHHHh-CCCCCC
Q 022706 223 QAPDMAAR-----LHSTRVLGTFGYHAPEYAMTG----------Q-LNAKSDVYSFGVVLLELLT-GRKPVD 277 (293)
Q Consensus 223 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~el~~-g~~Pf~ 277 (293)
...-...+ ....+...-.+|+|||.+... . .+++.||||+||++.||++ |++||.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 43211111 011222234589999987531 2 5788999999999999999 899997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=192.60 Aligned_cols=205 Identities=20% Similarity=0.337 Sum_probs=161.3
Q ss_pred hcC-CCCceeeccCceEEEEEEeC-CCCeEEEEEcCC----CCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 67 ENF-GTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 67 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~----~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
+.| ....++|.|++|.|+..... ....+..|.+.. ..... ..+..|..+-..+.|+|++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 46678999999988877644 444455554431 11111 1255677777888999998877777766666
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
.-+||||++ +|..++.... .+...++-.++.|++.||+|+|+.| |.|||+|++|+++..+|.+||+|
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~D 463 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIID 463 (601)
T ss_pred hhhhhcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEee
Confidence 666999999 9999988762 2888999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc--ccccccccCcccccccccccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 022706 218 FDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284 (293)
Q Consensus 218 fg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~~g~~Pf~~~~~~~~ 284 (293)
||.+......... ......+|+..|+|||.+.+..|.+ ..||||.|++++.|.+|+.||.-....++
T Consensus 464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 9988654333232 4456678999999999999998877 57999999999999999999986655544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-23 Score=186.24 Aligned_cols=185 Identities=28% Similarity=0.371 Sum_probs=157.8
Q ss_pred eeeccCceEEEEEE----eCCCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEccc
Q 022706 74 LIGEGSYGRVYYGI----LKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 74 ~lg~G~~g~V~~~~----~~~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.+|+|.||.|++++ ...+..+++|++.+.... ......|..++..++ ||.+++++..++.....++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 235888999988654321 224456777888887 9999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
|+.|...+.... .+.+.....+...++.+++++|+.+ ++|+|+|++||+++.+|++++.|||+++..-
T Consensus 81 gg~lft~l~~~~---------~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---------MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccCC---------chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence 999988887665 3788888899999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
+... .+||..|||||++. .+..++|.||+|++++||++|..||..
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 3222 28999999999888 678899999999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=166.34 Aligned_cols=206 Identities=20% Similarity=0.286 Sum_probs=131.6
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCC----------CCceeEEEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKH----------ENFVQLLGYCV 132 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h----------~~i~~~~~~~~ 132 (293)
.......||.|+++.||.+++. +++.+++|++...... .+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556778999999999999987 7999999998543322 2455555544433221 12222222221
Q ss_pred ---------eC---C-----eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 022706 133 ---------DG---T-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195 (293)
Q Consensus 133 ---------~~---~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 195 (293)
.. . ..+++|+.+.+ +|.+++..-...... ...+....++.+..|+++.+++||+.| +
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l 166 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG---L 166 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence 11 1 23677888854 887775421100000 112455566778899999999999999 9
Q ss_pred eeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccC--------CCCCccchhhHHHHHH
Q 022706 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--------QLNAKSDVYSFGVVLL 267 (293)
Q Consensus 196 vH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~~l~ 267 (293)
+|+||+|+|++++.+|.+.|+||+.......... . ...+..|.|||..... .++.+.|.|+||+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999999999987765443221 1 2345779999966432 4677899999999999
Q ss_pred HHHhCCCCCCCCCCccc
Q 022706 268 ELLTGRKPVDHTLPRGQ 284 (293)
Q Consensus 268 el~~g~~Pf~~~~~~~~ 284 (293)
.|++|+.||....+...
T Consensus 242 ~lWC~~lPf~~~~~~~~ 258 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEAD 258 (288)
T ss_dssp HHHHSS-STCCCGGGST
T ss_pred HHHHccCCCCCCCcccc
Confidence 99999999987765443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-22 Score=160.04 Aligned_cols=194 Identities=25% Similarity=0.381 Sum_probs=156.1
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
+...|.+...|..|+|+++ |..+++|++..+.. ...+|..|.-.|+...||||+.+++.|....+..++..|++.+
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3345888999999999998 66778888765433 3467888999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe--ccccCCCCC
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA--DFDLSNQAP 225 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~--Dfg~~~~~~ 225 (293)
+|+..++...+ ..++..++.+++.+++++++|||+.. +.|.---|....+++|++.+.+|. |--++-..
T Consensus 273 slynvlhe~t~-------vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 273 SLYNVLHEQTS-------VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE- 343 (448)
T ss_pred HHHHHHhcCcc-------EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec-
Confidence 99999987653 34788899999999999999999985 224444788999999999887654 32222111
Q ss_pred cccccccccccccCcccccccccccCCCC---CccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLN---AKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
....-.|.|++||.+.+.+-+ .+.|+|||++++|||.|...||.+..|.
T Consensus 344 --------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 344 --------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred --------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 112347889999999876533 4789999999999999999999988774
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=156.02 Aligned_cols=142 Identities=17% Similarity=0.172 Sum_probs=110.8
Q ss_pred cCCCCceeeccCceEEEEEE--eCCCCeEEEEEcCCCCCC-------------------------hHHHHHHHHHHhcCC
Q 022706 68 NFGTNALIGEGSYGRVYYGI--LKSGHAAAIKKLDASKQP-------------------------DEEFLAQVSMVSRLK 120 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~--~~~~~~~avK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 120 (293)
-|.+.+.||+|++|.||+|. ..+|+.||+|++...... ...+.+|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 458999999998643210 023568999999997
Q ss_pred CC--CceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 022706 121 HE--NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198 (293)
Q Consensus 121 h~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~ 198 (293)
+. .+.+++.+ ...++||||++|.+|........ .+...++..++.|++.+|++||+.+ .++|+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 53 34455543 23489999999988876542221 2566677899999999999999986 59999
Q ss_pred CCCCCceEEcCCCceEEeccccCCCCC
Q 022706 199 DIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 199 Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
||||+||+++ ++.++|+|||.+....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 8899999999876543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-20 Score=151.95 Aligned_cols=134 Identities=22% Similarity=0.335 Sum_probs=113.4
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.||+|++|.||+|.+ .+..+++|+....... ...+.+|++++..+.|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5788999986543221 13467899999999999988877777778888999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
++|++|.+++.... . ++..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 78899999999999999999 99999999999999 78899999998875
Q ss_pred C
Q 022706 224 A 224 (293)
Q Consensus 224 ~ 224 (293)
.
T Consensus 144 ~ 144 (211)
T PRK14879 144 S 144 (211)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=150.20 Aligned_cols=130 Identities=24% Similarity=0.389 Sum_probs=106.6
Q ss_pred eeeccCceEEEEEEeCCCCeEEEEEcCCCCC--C-------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--P-------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~--~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
.||+|++|.||++.+ ++..+++|+...... . ..++.+|++++..+.++++.....++.+....+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 478899998653321 1 145678999999999887665555566677789999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+|++|.+++.... . .++.|++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875321 1 78899999999999999 99999999999999 889999999988764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=147.92 Aligned_cols=136 Identities=16% Similarity=0.164 Sum_probs=108.2
Q ss_pred cCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC-----------------------hHHHHHHHHHHhcCCCC--
Q 022706 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-----------------------DEEFLAQVSMVSRLKHE-- 122 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~-- 122 (293)
.|.+.+.||+|+||.||++..++|+.+|||++...... .....+|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 48889999999999999999888999999987543211 12356788888888776
Q ss_pred CceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 022706 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (293)
Q Consensus 123 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 202 (293)
.++..++ ....+++|||++|++|..+... .....++.+++.++.++|+.+ ++|+||+|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 4444443 2445899999999988765321 234578899999999999998 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCC
Q 022706 203 SNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 203 ~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=167.95 Aligned_cols=138 Identities=22% Similarity=0.319 Sum_probs=112.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEc-CCCCC--------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL-DASKQ--------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~-~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
...|...+.||+|+||+||++.+... .+++|+. .+... ..+++.+|+++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44567789999999999999987643 3444432 22111 12457889999999999999988887777778
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||++|++|.+++. ....++.|++.+|.+||+.+ ++||||||+||++ +++.++|+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 899999999999988874 24578999999999999999 9999999999999 67889999
Q ss_pred ccccCCCCC
Q 022706 217 DFDLSNQAP 225 (293)
Q Consensus 217 Dfg~~~~~~ 225 (293)
|||++....
T Consensus 470 DFGla~~~~ 478 (535)
T PRK09605 470 DFGLGKYSD 478 (535)
T ss_pred eCcccccCC
Confidence 999987643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-20 Score=174.55 Aligned_cols=170 Identities=29% Similarity=0.439 Sum_probs=125.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
..+|..+++|..|++|.||+.+++ +.+++|+| +.++. .+.+ +++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~----lilR--nilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN----LILR--NILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc----hhhh--ccccccCCccee-------------------
Confidence 358999999999999999999988 68888884 43222 1111 133333445444
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
|+=...++..+ .++. +++.+++|||+.+ |+|||+||+|++|+.-|++|+.|||+++..
T Consensus 136 --gDc~tllk~~g---------~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --GDCATLLKNIG---------PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --chhhhhcccCC---------CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 23333333322 1221 2378999999999 999999999999999999999999998743
Q ss_pred Ccccc-------------cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 225 PDMAA-------------RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 225 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
..... .......+|||.|+|||++....|+..+|.|++|+++||.+.|..||.+.+|++
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 21110 111244689999999999999999999999999999999999999999987654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=139.32 Aligned_cols=135 Identities=17% Similarity=0.212 Sum_probs=98.4
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh---HH----------------------HHHHHHHHhcCCCC--C
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EE----------------------FLAQVSMVSRLKHE--N 123 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~---~~----------------------~~~e~~~l~~l~h~--~ 123 (293)
+.+.||+|+||+||+|.+.+++.||||++....... .. ...|...+.++.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 356899999999999998889999999886533211 11 13455566665433 3
Q ss_pred ceeEEEEEEeCCeeEEEEEcccCCchhh-hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCC
Q 022706 124 FVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIK 201 (293)
Q Consensus 124 i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dik 201 (293)
+.+.+.. ...+++|||++++.+.. .+... ....++..++.+++.++.++|. .+ |+|+|||
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----------~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~ 142 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----------RLLEDPEELYDQILELMRKLYREAG---LVHGDLS 142 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-----------hhcccHHHHHHHHHHHHHHHhhccC---cCcCCCC
Confidence 4455443 24589999999855422 11111 1115678899999999999999 88 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCC
Q 022706 202 SSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 202 p~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
|+||+++ ++.++|+|||.+...
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred hhhEEEE-CCcEEEEECcccccc
Confidence 9999999 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.6e-18 Score=138.80 Aligned_cols=135 Identities=15% Similarity=0.199 Sum_probs=104.4
Q ss_pred Cceee-ccCceEEEEEEeCCCCeEEEEEcCCCC--------------CChHHHHHHHHHHhcCCCCCc--eeEEEEEEeC
Q 022706 72 NALIG-EGSYGRVYYGILKSGHAAAIKKLDASK--------------QPDEEFLAQVSMVSRLKHENF--VQLLGYCVDG 134 (293)
Q Consensus 72 ~~~lg-~G~~g~V~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 134 (293)
...|| .|+.|+||.+... +..+++|.+.... .....+.+|++++.++.|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34687 7889999998875 7889999774311 123467889999999998775 6677664432
Q ss_pred Ce----eEEEEEcccC-CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 135 TS----RVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 135 ~~----~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
.. .++|||+++| .+|.+++.... ++.. .+.|++.+|.+||+.| |+|+||||+|||++.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~ 177 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDP 177 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcC
Confidence 22 2599999997 68988876432 4443 3578999999999999 999999999999999
Q ss_pred CCceEEeccccCCCC
Q 022706 210 DDVAKIADFDLSNQA 224 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~ 224 (293)
++.++|+|||.+...
T Consensus 178 ~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 178 DGKFWLIDFDRGELR 192 (239)
T ss_pred CCCEEEEECCCcccC
Confidence 899999999988764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-17 Score=126.89 Aligned_cols=135 Identities=20% Similarity=0.227 Sum_probs=112.5
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC--CCceeEEEEEEeCCeeEEEEEcccCCc
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|...++.+++ .++++++.+....+..+++|||+.+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 45679999999999999864 7899999865544 5678899999999976 589999988888788999999998876
Q ss_pred hhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+..+ +......++.+++.++..+|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 80 ~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 3455667889999999999985323399999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.3e-18 Score=141.91 Aligned_cols=145 Identities=25% Similarity=0.353 Sum_probs=111.1
Q ss_pred CCCCceeEEEEEEe---------------------------CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHH
Q 022706 120 KHENFVQLLGYCVD---------------------------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172 (293)
Q Consensus 120 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~ 172 (293)
+||||+++...|.+ +...|+||..++. +|.+++-.+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 49999999887653 2345899999976 9999997654 77788
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc--CCC--ceEEeccccCCCCCcccc----cccccccccCccccc
Q 022706 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDD--VAKIADFDLSNQAPDMAA----RLHSTRVLGTFGYHA 244 (293)
Q Consensus 173 ~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~--~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~a 244 (293)
..-|+.|+++|+.|||.+| |.|||+|.+|||+. +|+ .+.++|||++-......- ....-..-|.-..||
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 8899999999999999999 99999999999994 444 378999998753322110 001112336778899
Q ss_pred ccccccCC-----CC-CccchhhHHHHHHHHHhCCCCCCC
Q 022706 245 PEYAMTGQ-----LN-AKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 245 PE~~~~~~-----~~-~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
||+....+ .+ .++|.|+.|-+.||+++..-||.+
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 99775321 22 378999999999999999999986
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7e-19 Score=153.56 Aligned_cols=124 Identities=33% Similarity=0.464 Sum_probs=107.1
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
+.|+.|++|...+|.+++.++... ...+....+.++.|++.++.| ++ .+|+|+||.||+...+..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~------e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG------EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc------cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence 578999999999999999765422 236777889999999999999 66 999999999999999999999
Q ss_pred eccccCCCCCccc----ccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 022706 216 ADFDLSNQAPDMA----ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271 (293)
Q Consensus 216 ~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~ 271 (293)
.|||+........ .....+...||+.||+||++.+..|+.++||||||++|+||++
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9999976554333 2334567889999999999999999999999999999999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.2e-17 Score=144.66 Aligned_cols=153 Identities=32% Similarity=0.513 Sum_probs=126.5
Q ss_pred HhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 022706 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195 (293)
Q Consensus 116 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 195 (293)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.... ..+++.....++++++.+|+|||+.. |
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--------~~~d~~F~~s~~rdi~~Gl~ylh~s~---i 69 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--------IKLDYFFILSFIRDISKGLAYLHNSP---I 69 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--------cCccHHHHHHHHHHHHHHHHHHhcCc---c
Confidence 467889999999999999999999999999999999998743 24888999999999999999999885 4
Q ss_pred -eeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCC-------CCCccchhhHHHHHH
Q 022706 196 -IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-------LNAKSDVYSFGVVLL 267 (293)
Q Consensus 196 -vH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~~l~ 267 (293)
.|+.++..|.+++....+||.|||+.................-...|.|||.+.... .+.+.|+||+|++++
T Consensus 70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 999999999999999999999999987654311111111222345689999887531 456799999999999
Q ss_pred HHHhCCCCCCCC
Q 022706 268 ELLTGRKPVDHT 279 (293)
Q Consensus 268 el~~g~~Pf~~~ 279 (293)
|+++...||...
T Consensus 150 ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 150 EILFRSGPFDLR 161 (484)
T ss_pred HHHhccCccccc
Confidence 999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.5e-18 Score=157.06 Aligned_cols=205 Identities=26% Similarity=0.367 Sum_probs=164.1
Q ss_pred cCCCCceeeccCceEEEEEEeC--CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.|.+.+.||+|.|+.|-..... ....++.|.+...... ...+..|..+-+.+. |.|++.+++...+....++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 5677777999999999888754 3445666655443322 234445777777776 999999999999999999999
Q ss_pred EcccCCchhhhhh-cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCceEEcCCC-ceEEecc
Q 022706 142 EFASNGSLHDILH-GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKADPHIIHRDIKSSNVLIFDDD-VAKIADF 218 (293)
Q Consensus 142 e~~~~~sL~~~l~-~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Df 218 (293)
++..|+++.+.+. ... ...+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.||
T Consensus 101 ~~s~g~~~f~~i~~~~~--------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS--------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccccccccCCc--------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence 9999999998883 222 12556677789999999999999 888 99999999999999999 9999999
Q ss_pred ccCCCCCc-cccccccccccc-CcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 219 DLSNQAPD-MAARLHSTRVLG-TFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 219 g~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
|++..... ..........+| ++.|++||.+.+. ...+..|+||.|+++.-+++|..||+......
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 99988766 444444455678 9999999988874 56778999999999999999999998665433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=136.51 Aligned_cols=141 Identities=20% Similarity=0.245 Sum_probs=99.4
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh-----------------------------------------HHHH
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-----------------------------------------EEFL 110 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-----------------------------------------~~~~ 110 (293)
.+.||.|++|.||+|+.++|+.||||+.++..... -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542110 0234
Q ss_pred HHHHHHhcCC-----CCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHH-HH
Q 022706 111 AQVSMVSRLK-----HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK-GL 184 (293)
Q Consensus 111 ~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~-al 184 (293)
+|++.+.++. ++++.-..-+....+..++||||++|.+|.++...... ..+ ...++.+++. .+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--------~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--------GLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--------CCC---HHHHHHHHHHHHH
Confidence 4555555542 33332212222234557899999999999887653221 022 3356666665 47
Q ss_pred HHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 185 ~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
..+|..| ++|+|++|.||++++++.++|+|||++..+..
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8899998 99999999999999999999999999877654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.62 E-value=5e-15 Score=116.37 Aligned_cols=131 Identities=17% Similarity=0.113 Sum_probs=97.5
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcccCCchh
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLH 150 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~ 150 (293)
.+.|+.|.++.||+++.. +..+++|...........+.+|+++++.+.+.++ .+++.+ +....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 356889999999999876 7889999876554333456789999988865444 445544 333458999999998775
Q ss_pred hhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
... .. ...++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~--------------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 11 1245678999999999986 11249999999999998 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.8e-14 Score=126.98 Aligned_cols=167 Identities=18% Similarity=0.260 Sum_probs=126.6
Q ss_pred EEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCC
Q 022706 86 GILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163 (293)
Q Consensus 86 ~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 163 (293)
|..+ ++.++.|+..+.... ..+...+.++.|+.++||+|+++++.++.....|+|+|.+. .|..++++
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------- 100 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------- 100 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------
Confidence 4433 688888888765554 23456778899999999999999999999999999999984 67777764
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccc
Q 022706 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243 (293)
Q Consensus 164 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 243 (293)
+....+..-+.||+.||.+||+.+ +++|++|..+.|+|+..|.+||++|.++.......... ......-.|.
T Consensus 101 ----l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~ 172 (690)
T KOG1243|consen 101 ----LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFD 172 (690)
T ss_pred ----hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhccc
Confidence 445677788899999999999766 59999999999999999999999999875543322111 1111122355
Q ss_pred cccccccCCCCCccchhhHHHHHHHHHhC
Q 022706 244 APEYAMTGQLNAKSDVYSFGVVLLELLTG 272 (293)
Q Consensus 244 aPE~~~~~~~~~~~DvwslG~~l~el~~g 272 (293)
.|+.+.... -..|.|.|||++++++.|
T Consensus 173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 173 DPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 565433322 246999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.9e-15 Score=133.65 Aligned_cols=146 Identities=14% Similarity=0.201 Sum_probs=96.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC-CCeEEEEEcCCCCCC-----------------------------------h---
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQP-----------------------------------D--- 106 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~-----------------------------------~--- 106 (293)
...|.. +.||.|++|+||+|+.++ |+.||||+.++.... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999986 999999998754210 0
Q ss_pred ---HHHHHHHHHHhcCC----CCCceeEEEEEE-eCCeeEEEEEcccCCchhhhh--hcCCCCCCCCCCCCCCHHHHHHH
Q 022706 107 ---EEFLAQVSMVSRLK----HENFVQLLGYCV-DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKI 176 (293)
Q Consensus 107 ---~~~~~e~~~l~~l~----h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~l--~~~~~~~~~~~~~~l~~~~~~~i 176 (293)
-++.+|+..+.++. +.+.+.+-.++. -.+..++||||++|+.+.++- ...+. ....+....+..+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-----d~~~la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-----DMKLLAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-----CHHHHHHHHHHHH
Confidence 12344554444442 333333333332 255678999999999997742 22210 0011333344444
Q ss_pred HHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC----ceEEeccccCCCCCcc
Q 022706 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDM 227 (293)
Q Consensus 177 ~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~----~~kl~Dfg~~~~~~~~ 227 (293)
+.|+ ...| ++|+|+||.||+++.++ .++++|||++..+...
T Consensus 273 ~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 273 FTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4454 3577 99999999999999888 9999999998776543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.6e-13 Score=105.31 Aligned_cols=142 Identities=21% Similarity=0.258 Sum_probs=109.4
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
....|-+|+-+.|+++.+. |+...||.-..... ...+.++|++.+.++.--.|.-..-++.|...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999987 88888886543221 1246778999999998666666666677888888999
Q ss_pred EcccC-CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc---eEEec
Q 022706 142 EFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIAD 217 (293)
Q Consensus 142 e~~~~-~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---~kl~D 217 (293)
||++| .++.+++...... .........++++|-+.+.-||.++ |+|+||..+||++.+++. +.|+|
T Consensus 90 E~~~g~~~vk~~i~~~~~~-------~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-------ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EeccchhHHHHHHHHHccC-------cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence 99987 4777777654321 1233333688999999999999999 999999999999987653 58999
Q ss_pred cccCCC
Q 022706 218 FDLSNQ 223 (293)
Q Consensus 218 fg~~~~ 223 (293)
||++..
T Consensus 160 fgls~~ 165 (229)
T KOG3087|consen 160 FGLSSV 165 (229)
T ss_pred ecchhc
Confidence 999754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-13 Score=108.33 Aligned_cols=135 Identities=18% Similarity=0.182 Sum_probs=98.1
Q ss_pred CceeeccCceEEEEEEeCC-------CCeEEEEEcCCCC-----------------------CChHHH----HHHHHHHh
Q 022706 72 NALIGEGSYGRVYYGILKS-------GHAAAIKKLDASK-----------------------QPDEEF----LAQVSMVS 117 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~-------~~~~avK~~~~~~-----------------------~~~~~~----~~e~~~l~ 117 (293)
...||.|--+.||.|...+ +..+|||+.+... .....+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998542 4799999864210 001122 37899999
Q ss_pred cCCC--CCceeEEEEEEeCCeeEEEEEcccCCchh-hhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCC
Q 022706 118 RLKH--ENFVQLLGYCVDGTSRVLAYEFASNGSLH-DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL-HEKADP 193 (293)
Q Consensus 118 ~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~-~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~ 193 (293)
++.. -++.+++++ ...++||||+.+..+. ..++.. .++..+...+..+++.+|..+ |+.+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g-- 145 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN-- 145 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 9863 456666654 4567999999764332 222221 255566778889999999998 8888
Q ss_pred CeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 194 ~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++|+||++.||+++ ++.+.|+|||.+...
T Consensus 146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred -eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999999997 467999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-13 Score=105.09 Aligned_cols=131 Identities=20% Similarity=0.310 Sum_probs=103.2
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..+++|+-+.+|.+.+. |..+++|.-.+.... ..+..+|++++.++.-..|.-..-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 555777764332211 13466899999999876776666667788888999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
++|..|.+.+... ...+++.+-..+.-||..| |+|+||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888643 1357778888899999999 99999999999997765 89999999874
Q ss_pred C
Q 022706 224 A 224 (293)
Q Consensus 224 ~ 224 (293)
.
T Consensus 141 s 141 (204)
T COG3642 141 S 141 (204)
T ss_pred c
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.2e-14 Score=124.45 Aligned_cols=202 Identities=25% Similarity=0.263 Sum_probs=160.0
Q ss_pred HHHhcCCCCceeec--cCceEEEEEEe--C-CCCeEEEEEcCCC---CCChHHHHHHHHHHhcCC-CCCceeEEEEEEeC
Q 022706 64 EITENFGTNALIGE--GSYGRVYYGIL--K-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDG 134 (293)
Q Consensus 64 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~-~~~~~avK~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 134 (293)
.+.+.|.+.+.+|. |.+|.||.+.. + ++..+|+|.-+.. ......-.+|+....+++ |++.++.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34567888899999 99999999987 4 7888999974322 222334456777777776 99999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCceEEcCC
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK----GLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
+..|+-+|++. .+|.++..... ..++...++..+.+... ||.++|... ++|.|+||+||+...+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~--------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPC--------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSD 258 (524)
T ss_pred Ccceeeecccc-chhHHhhhccc--------ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccc
Confidence 99999999995 68888876554 23778888888889988 999999998 9999999999999998
Q ss_pred -CceEEeccccCCCCCcccc---cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 211 -DVAKIADFDLSNQAPDMAA---RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 211 -~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
...+++|||+...+.+..- ........|...|++|| +.+.-++..+|++++|.+..+..++..++..
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccC
Confidence 7899999999877655431 11123346788999999 5556788899999999999998888766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-12 Score=107.70 Aligned_cols=141 Identities=20% Similarity=0.277 Sum_probs=108.0
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCC--CCceeEEEEEEeCC---eeEEEEEccc
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKH--ENFVQLLGYCVDGT---SRVLAYEFAS 145 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~---~~~lv~e~~~ 145 (293)
+.|+.|..+.||++...+|+.+++|....... ....+.+|.++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887668999999765443 34578899999999975 34677777765532 5689999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA---------------------------------- 191 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 191 (293)
|.++.+.+... .++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 98887765321 2666777777888888888887521
Q ss_pred -------------------CCCeeeCCCCCCceEEcC--CCceEEeccccCCC
Q 022706 192 -------------------DPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQ 223 (293)
Q Consensus 192 -------------------~~~ivH~Dikp~Nilv~~--~~~~kl~Dfg~~~~ 223 (293)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.6e-11 Score=98.54 Aligned_cols=140 Identities=15% Similarity=0.054 Sum_probs=99.1
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCC------------CChHHHHHHHHHHhcCCCCC--ceeEEEEEEe-----
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASK------------QPDEEFLAQVSMVSRLKHEN--FVQLLGYCVD----- 133 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~------------~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~----- 133 (293)
+.+-......|++... +|+.+.||...... .....+.+|...+.+|...+ ++.++.+.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3454444455667655 47889999764322 11224778888888875333 3444555443
Q ss_pred CCeeEEEEEcccCC-chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---
Q 022706 134 GTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--- 209 (293)
Q Consensus 134 ~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~--- 209 (293)
....++|||++++. +|.+++..... ...+......++.+++..+..||..| |+|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-------~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~ 176 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-------NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFP 176 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecccc
Confidence 23468999999886 78888854221 12566778899999999999999999 999999999999985
Q ss_pred ----CCceEEeccccCCC
Q 022706 210 ----DDVAKIADFDLSNQ 223 (293)
Q Consensus 210 ----~~~~kl~Dfg~~~~ 223 (293)
+..+.|+||+.+..
T Consensus 177 ~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 177 GREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCCceEEEEECCcccc
Confidence 45799999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.1e-11 Score=95.60 Aligned_cols=123 Identities=21% Similarity=0.250 Sum_probs=82.1
Q ss_pred EEEEEEeCCCCeEEEEEcCCCC--------------C---------C----hHHHHHHHHHHhcCCCC--CceeEEEEEE
Q 022706 82 RVYYGILKSGHAAAIKKLDASK--------------Q---------P----DEEFLAQVSMVSRLKHE--NFVQLLGYCV 132 (293)
Q Consensus 82 ~V~~~~~~~~~~~avK~~~~~~--------------~---------~----~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 132 (293)
.||.|...++..+|+|..+... . . .....+|.+.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999864321 0 0 12466899999999855 566776552
Q ss_pred eCCeeEEEEEccc--CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeCCCCCCceEEcC
Q 022706 133 DGTSRVLAYEFAS--NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY-LHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 133 ~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
..++||||++ |..+..+.... ++..+...++.+++..+.. +|..| |+|+|+++.||++++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD 142 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence 3469999998 65555444322 2234456777888885554 57888 999999999999988
Q ss_pred CCceEEeccccCCC
Q 022706 210 DDVAKIADFDLSNQ 223 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~ 223 (293)
+ .+.++|||.+..
T Consensus 143 ~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 143 G-KVYIIDFGQAVD 155 (188)
T ss_dssp T-CEEE--GTTEEE
T ss_pred c-eEEEEecCccee
Confidence 7 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4e-12 Score=105.70 Aligned_cols=155 Identities=25% Similarity=0.366 Sum_probs=115.4
Q ss_pred HHHHhcCCCCCceeEEEEEEeCC-----eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 022706 113 VSMVSRLKHENFVQLLGYCVDGT-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187 (293)
Q Consensus 113 ~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 187 (293)
...+.++.|.||++++.||.+.. ...++.||+..|+|.++|++..... ..+......+|+.||+.||.||
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhh
Confidence 34566677999999999987644 4678999999999999998654322 3477888889999999999999
Q ss_pred HhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc---cccccccccccCcccccccccccCCCCCccchhhHHH
Q 022706 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM---AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264 (293)
Q Consensus 188 H~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 264 (293)
|+. .++|+|+++..+.|++..+|.+|+.- +........ ..........+.+.|.+||.=.....+.++|||+||.
T Consensus 193 hs~-~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hcc-CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 998 57799999999999999998888752 211111000 0011112234577899999544455667899999999
Q ss_pred HHHHHHhCCC
Q 022706 265 VLLELLTGRK 274 (293)
Q Consensus 265 ~l~el~~g~~ 274 (293)
...+|..+..
T Consensus 271 cAlemailEi 280 (458)
T KOG1266|consen 271 CALEMAILEI 280 (458)
T ss_pred HHHHHHHhee
Confidence 9999988765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-12 Score=123.26 Aligned_cols=205 Identities=23% Similarity=0.282 Sum_probs=148.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
..+.+.+.+-+|.++.++.+.-. .+...++|+..... .+.+....+-+++-.-.+|.++...--+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 35666778889999999988754 45555555443222 12233333333333334566665544445567788999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
+|..+++|...++.... .+.+-.+.....+.+++++||... +.|+|++|.|++...+++.++.||+..
T Consensus 884 ~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred HHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence 99999999999887652 444555566778889999999986 899999999999999999999999833
Q ss_pred CCCCcc---------------------------cc--cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhC
Q 022706 222 NQAPDM---------------------------AA--RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272 (293)
Q Consensus 222 ~~~~~~---------------------------~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g 272 (293)
...... .. ........+|+.|.+||.+.+......+|.|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 211110 00 0112346689999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc
Q 022706 273 RKPVDHTLPRG 283 (293)
Q Consensus 273 ~~Pf~~~~~~~ 283 (293)
.+||...++..
T Consensus 1032 ~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 1032 IPPFNAETPQQ 1042 (1205)
T ss_pred CCCCCCcchhh
Confidence 99999776643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-10 Score=99.34 Aligned_cols=197 Identities=18% Similarity=0.183 Sum_probs=129.4
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEE------EEEeCCe-eEEEEE
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLG------YCVDGTS-RVLAYE 142 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~------~~~~~~~-~~lv~e 142 (293)
....||+|+-+.+|..-.- .-.+.|++.......+.-+ +..|... .||-+..-+. +.-+.+. +-+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk--~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK--VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHHH--HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4567999999999954322 2245666654443322111 2222222 3443221011 1112222 567888
Q ss_pred cccCCc-hhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 143 FASNGS-LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~s-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
.+.+.. +..+++-. ......+...|...++.++.++.+.+.||..| .+-+|+.++|+||.+++.|.|.|=...
T Consensus 91 ~v~g~~pI~~~y~p~---tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 91 KVSGKEPIHMIYSPA---TRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred cCCCccchhhhcCch---hhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 887752 23333221 11223356899999999999999999999999 999999999999999999999986544
Q ss_pred CCCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTG-RKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g-~~Pf~~~~ 280 (293)
... .........+|.+.|.+||.-. +..-+..+|.|.||+++++|+.| +.||++..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 332 1222235567899999999543 23446679999999999999885 99999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.8e-12 Score=114.36 Aligned_cols=195 Identities=21% Similarity=0.217 Sum_probs=146.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--CCCeEEEEEcCCCCCC-hHH--HHHHHHHHhcCC-CCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQP-DEE--FLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~~-~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 139 (293)
..+|..+..||.|.|+.|+....+ ++..|++|.+...... ..+ -..|+-+...+. |.|++.+...|......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 347888999999999999987744 6888999987654332 222 235565666664 8889998888888888889
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-CceEEecc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADF 218 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-~~~kl~Df 218 (293)
--|||.++++...+.-. ..+++...+++..|++.++.++|+.. ++|+|++|.||++..+ +.-++.||
T Consensus 344 p~e~~~~~s~~l~~~~~---------~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS---------QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred chhhhcCcchhhhhHHH---------HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence 99999998887665322 23888899999999999999999998 9999999999999876 77889999
Q ss_pred ccCCCCCcccccccccccccCcccc--cccccccCCCCCccchhhHHHHHHHHHhCCC-CCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYH--APEYAMTGQLNAKSDVYSFGVVLLELLTGRK-PVD 277 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~~l~el~~g~~-Pf~ 277 (293)
|+...+.... ......-.+. +++......+..+.|++|||..+.+.+++.. +..
T Consensus 412 ~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~ 468 (524)
T KOG0601|consen 412 GCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES 468 (524)
T ss_pred ccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcc
Confidence 9876432211 1122233344 4444445678889999999999999999874 443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3e-10 Score=100.04 Aligned_cols=173 Identities=16% Similarity=0.195 Sum_probs=128.5
Q ss_pred ceEEEEEEeC-CCCeEEEEEcCCCCCCh-HHHHHHHHHHhcCCCCCceeEEEEEE----eCCeeEEEEEcccC-Cchhhh
Q 022706 80 YGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV----DGTSRVLAYEFASN-GSLHDI 152 (293)
Q Consensus 80 ~g~V~~~~~~-~~~~~avK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~sL~~~ 152 (293)
-.+.|++... +|..|++|++....... .....-+++++++.|+|+|++.+++. ....+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3568999866 89999999994332211 12334578899999999999999876 35678899999986 477665
Q ss_pred hhcCCC------CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 153 LHGRKG------VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 153 l~~~~~------~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
.-.... ...+..+...++..+|.++.|+..||.++|+.| +..+-|.+.+|+++.+.+++|...|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 432221 122344567889999999999999999999999 99999999999999999999998887654322
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRK 274 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~ 274 (293)
.. + |.+. --.+.|.=-||.++.-|.||..
T Consensus 446 d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC---------C-------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 11 0 1111 1335788899999999999954
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=94.01 Aligned_cols=134 Identities=17% Similarity=0.214 Sum_probs=99.1
Q ss_pred CCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCC-----------------------CChHHHHHHHHHHhcCCCC--C
Q 022706 69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------------------QPDEEFLAQVSMVSRLKHE--N 123 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~--~ 123 (293)
+.++..||-|--+.||.|....|.+++||.=+... ......++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45778999999999999999999999999532110 0113467899999999754 6
Q ss_pred ceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 022706 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (293)
Q Consensus 124 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~ 203 (293)
+.+.+++ +...+|||+++|..|...- ++....-.++..|+.-+..+-..| +||+|+++-
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSef 231 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEF 231 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence 7777765 4457999999996665432 123333445555666665555777 999999999
Q ss_pred ceEEcCCCceEEeccccCCC
Q 022706 204 NVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 204 Nilv~~~~~~kl~Dfg~~~~ 223 (293)
||+++++|.+.++||-.+..
T Consensus 232 NIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 232 NILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred eEEEecCCCEEEEeCccccc
Confidence 99999999999999976544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.7e-09 Score=85.25 Aligned_cols=137 Identities=13% Similarity=0.086 Sum_probs=102.2
Q ss_pred eeccCceEEEEEEeCCCCeEEEEEcCC----C---CCChHHHHHHHHHHhcCCC--CCceeEEEEEE-e----CCeeEEE
Q 022706 75 IGEGSYGRVYYGILKSGHAAAIKKLDA----S---KQPDEEFLAQVSMVSRLKH--ENFVQLLGYCV-D----GTSRVLA 140 (293)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~avK~~~~----~---~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~-~----~~~~~lv 140 (293)
-|+||.+-|++.... |..+-+|.-.. . +.....|.+|...+.+|.. -.+.++. ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467999999998766 55788887531 1 3456789999999988863 2244444 222 1 1235799
Q ss_pred EEcccC-CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc--eEEec
Q 022706 141 YEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIAD 217 (293)
Q Consensus 141 ~e~~~~-~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~--~kl~D 217 (293)
+|-+.+ .+|.+++...... ..+..+...+..+++.++..||+.| +.|+|+.+.||+++.++. +.++|
T Consensus 104 Te~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 998764 5888887654311 2577778899999999999999999 999999999999987677 99999
Q ss_pred cccCCC
Q 022706 218 FDLSNQ 223 (293)
Q Consensus 218 fg~~~~ 223 (293)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 986654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4e-10 Score=102.14 Aligned_cols=141 Identities=20% Similarity=0.232 Sum_probs=96.0
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---------------------------h--------------HHHHH
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------------------------D--------------EEFLA 111 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---------------------------~--------------~~~~~ 111 (293)
+-|+.++.|.||+|+.++|+.||||+..+.-.. - -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 578899999999999999999999997654111 0 02345
Q ss_pred HHHHHhcCC-----CCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHH-HH
Q 022706 112 QVSMVSRLK-----HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG-LE 185 (293)
Q Consensus 112 e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a-l~ 185 (293)
|...+.+++ .+++.-..-+++-.+..+|+|||++|..+.++...... .++...+ +..++.+ +.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--------g~d~k~i---a~~~~~~f~~ 279 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--------GIDRKEL---AELLVRAFLR 279 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--------CCCHHHH---HHHHHHHHHH
Confidence 555555552 34444334444556777899999999999887432221 1443332 2222222 23
Q ss_pred HHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022706 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 186 ~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~ 227 (293)
.+=..| ++|.|.+|.||+++.+|.+.+.|||+...+.+.
T Consensus 280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 333356 999999999999999999999999998776554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-09 Score=87.87 Aligned_cols=123 Identities=22% Similarity=0.204 Sum_probs=90.7
Q ss_pred CCCeEEEEEcCCC--------CCChHHHHHHHHHHhcCCC--CCceeEEEEEEeC----CeeEEEEEcccCC-chhhhhh
Q 022706 90 SGHAAAIKKLDAS--------KQPDEEFLAQVSMVSRLKH--ENFVQLLGYCVDG----TSRVLAYEFASNG-SLHDILH 154 (293)
Q Consensus 90 ~~~~~avK~~~~~--------~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~----~~~~lv~e~~~~~-sL~~~l~ 154 (293)
.++.+.+|..... ........+|...+..|.. -.+++.+.+.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4566666653211 1234567788888777753 3345566665542 2457999999884 7999887
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC---ceEEeccccCCCC
Q 022706 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQA 224 (293)
Q Consensus 155 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~---~~kl~Dfg~~~~~ 224 (293)
.... .+......++.+++..+.-||..| |+|+|+++.|||++.++ .+.|+||+-+...
T Consensus 111 ~~~~---------~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ---------LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc---------cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 6431 456677899999999999999999 99999999999999887 8999999976643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-08 Score=83.83 Aligned_cols=72 Identities=17% Similarity=0.159 Sum_probs=55.4
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC--CceeEEEEEEeCCeeEEEEEcccCCc
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..- .+.+.+.+..+.....+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999974 25578889876533 446678999999998643 35777888777777889999999963
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-08 Score=81.33 Aligned_cols=136 Identities=15% Similarity=0.188 Sum_probs=91.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHH----------HHHHHHHHhcC---CCCCceeEEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE----------FLAQVSMVSRL---KHENFVQLLGYC 131 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~----------~~~e~~~l~~l---~h~~i~~~~~~~ 131 (293)
+.++|.+.+++-......|.+.... |..+++|.........++ ..+++..+.++ ....+..++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3568888888888887878777665 789999987654322221 22333333333 223333333222
Q ss_pred E-----eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceE
Q 022706 132 V-----DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206 (293)
Q Consensus 132 ~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nil 206 (293)
. -....+++|||++|..|.+... +++ .+...+.+++..||..| +.|+|..|.|++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFl 167 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFL 167 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEE
Confidence 2 2344568999999988876542 332 24456778899999999 999999999999
Q ss_pred EcCCCceEEeccccCC
Q 022706 207 IFDDDVAKIADFDLSN 222 (293)
Q Consensus 207 v~~~~~~kl~Dfg~~~ 222 (293)
+++++ ++++||+..+
T Consensus 168 v~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKR 182 (229)
T ss_pred EECCc-EEEEECcccc
Confidence 98655 8999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.4e-08 Score=79.04 Aligned_cols=152 Identities=16% Similarity=0.215 Sum_probs=103.5
Q ss_pred ccCHHHHHHHHhcCCCCceee---ccCceEEEEEEeCCCCeEEEEEcCCCCCCh--------------------HH----
Q 022706 56 AISVDELKEITENFGTNALIG---EGSYGRVYYGILKSGHAAAIKKLDASKQPD--------------------EE---- 108 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~avK~~~~~~~~~--------------------~~---- 108 (293)
..+...+..+.++..+..+.| .|--+.||+|...++..+|+|++......- ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345555666666766666555 566778999998889999999986432111 11
Q ss_pred -HHHHHHHHhcCCC--CCceeEEEEEEeCCeeEEEEEcccCCc-hhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 022706 109 -FLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLAYEFASNGS-LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184 (293)
Q Consensus 109 -~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~s-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 184 (293)
..+|...|+++.. =.+.+.+.+. ...|||||+.... -.-.|+. ..+...+...+..++++.+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----------v~~e~~e~~~~~~~~v~~~ 179 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----------VPLELEEAEGLYEDVVEYM 179 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----------CCcCchhHHHHHHHHHHHH
Confidence 2467778888753 3345555543 3469999996531 1112221 1244446778888888888
Q ss_pred HHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 185 EYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 185 ~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
.-|-. .+ +||+||+.-|||+. ++.+.++||+.+....
T Consensus 180 ~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 180 RRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 87777 56 99999999999999 8899999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-07 Score=79.01 Aligned_cols=74 Identities=15% Similarity=0.069 Sum_probs=54.0
Q ss_pred eeccCc-eEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEcccCCchhh
Q 022706 75 IGEGSY-GRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151 (293)
Q Consensus 75 lg~G~~-g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 151 (293)
|..|.. +.||+.... +..+++|...... ...+.+|+++++.+. +--+.+++.+....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 789998765 4788889875443 345678888888875 4446678887776667899999999987764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-07 Score=78.49 Aligned_cols=77 Identities=16% Similarity=0.191 Sum_probs=56.5
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC--CceeEEEEEE---eCCeeEEEEEcccCC
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGYCV---DGTSRVLAYEFASNG 147 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~~~ 147 (293)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.... .....+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568999999999999886 69999987655 3456778888888888532 3566666433 234568999999998
Q ss_pred chhh
Q 022706 148 SLHD 151 (293)
Q Consensus 148 sL~~ 151 (293)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-07 Score=85.17 Aligned_cols=138 Identities=21% Similarity=0.244 Sum_probs=91.0
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh--------------------------------------HHHHHHHH
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD--------------------------------------EEFLAQVS 114 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~--------------------------------------~~~~~e~~ 114 (293)
+.||.-+.|.||+|+.++|+.||||+-++.-... -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999999999999999865431110 12445554
Q ss_pred HHhcC----CCCC------ceeEEEEEEeCCeeEEEEEcccCCchhhh--hhcCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 022706 115 MVSRL----KHEN------FVQLLGYCVDGTSRVLAYEFASNGSLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182 (293)
Q Consensus 115 ~l~~l----~h~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 182 (293)
...+. .|-+ |.+++ +.-....+|+|||++|..+.+. +.+.+ ++...+..-+.+...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYL 314 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHH
Confidence 43333 2434 33333 2334567899999999877654 44443 665544433333222
Q ss_pred HHHHHHhCCCCCeeeCCCCCCceEEcC----CCceEEeccccCCCCCcc
Q 022706 183 GLEYLHEKADPHIIHRDIKSSNVLIFD----DDVAKIADFDLSNQAPDM 227 (293)
Q Consensus 183 al~~LH~~~~~~ivH~Dikp~Nilv~~----~~~~kl~Dfg~~~~~~~~ 227 (293)
..+=..| ++|+|-+|.||++.. ++.+.+.|||+...+...
T Consensus 315 --~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 --EQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred --HHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2223345 999999999999984 567999999998776543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-07 Score=73.08 Aligned_cols=129 Identities=17% Similarity=0.239 Sum_probs=91.8
Q ss_pred CCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcccCCc
Q 022706 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
+..+.|++|.+|.||++.++ |..+|+|+-. .......+..|+++|..+.-.++ .+++.+.. .++.|||+.|..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 34567999999999999998 5688888654 34445678899999999985554 45665533 345699999988
Q ss_pred hhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CCceEEcCCCceEEeccccCCC
Q 022706 149 LHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK-SSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 149 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik-p~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
|.+.... .+.++ ...+++.---|-..| |-|+.|+ |...++..++.+.|+||..+..
T Consensus 99 L~~~~~~------------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG------------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc------------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8776532 12223 334455555666777 9999997 6666666666999999998763
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.4e-07 Score=87.18 Aligned_cols=78 Identities=14% Similarity=0.260 Sum_probs=57.8
Q ss_pred CceeeccCceEEEEEEeCCC---CeEEEEEcCCCC--CChHHHHHHHHHHhcCC-CCCc--eeEEEEEEeC---CeeEEE
Q 022706 72 NALIGEGSYGRVYYGILKSG---HAAAIKKLDASK--QPDEEFLAQVSMVSRLK-HENF--VQLLGYCVDG---TSRVLA 140 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~---~~~avK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv 140 (293)
.+.|+.|.++.+|+.....+ ..+++|+..... .....+.+|.++++.+. |.++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688899999999886643 478888765433 23457889999999996 6654 7778877664 457899
Q ss_pred EEcccCCch
Q 022706 141 YEFASNGSL 149 (293)
Q Consensus 141 ~e~~~~~sL 149 (293)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998653
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.8e-07 Score=73.00 Aligned_cols=73 Identities=14% Similarity=0.085 Sum_probs=49.1
Q ss_pred ceeeccCceEEEEEEeCC--CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEEEEEcccCCch
Q 022706 73 ALIGEGSYGRVYYGILKS--GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~--~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
+.|..|-...+|+....+ +..|++|+.........+..+|..+++.+...+ .++++.... ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999998764 678999987644332234457888888885333 344544332 2489999999766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-06 Score=69.36 Aligned_cols=130 Identities=17% Similarity=0.237 Sum_probs=93.1
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCC-----------------CChHHHHHHHHHHhcCC------CCCceeEE
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------------QPDEEFLAQVSMVSRLK------HENFVQLL 128 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~i~~~~ 128 (293)
...||+|+.=.|| .+..+....||+..... ....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 3579999998888 45566778999887655 22355667776665555 78999999
Q ss_pred EEEEeCCeeEEEEEcccC------CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 022706 129 GYCVDGTSRVLAYEFASN------GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (293)
Q Consensus 129 ~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 202 (293)
|+.++.-..-+|+|.+.. .+|.+++.... ++. ..... +-+-..+|-+.+ |+.+|++|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~ 146 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQA---LDEFKRYLLDHH---IVIRDLNP 146 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHH---HHHHHHHHHHcC---CeecCCCc
Confidence 999998888899998764 36788886554 554 33333 334455777777 99999999
Q ss_pred CceEEcCCC----ceEEec-ccc
Q 022706 203 SNVLIFDDD----VAKIAD-FDL 220 (293)
Q Consensus 203 ~Nilv~~~~----~~kl~D-fg~ 220 (293)
.||++.... .+.|+| ||.
T Consensus 147 ~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ccEEEEecCCCceEEEEEeCCCC
Confidence 999996432 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-08 Score=93.26 Aligned_cols=101 Identities=23% Similarity=0.409 Sum_probs=77.2
Q ss_pred HHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccc------cc-cccccccCcccccccccc
Q 022706 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA------RL-HSTRVLGTFGYHAPEYAM 249 (293)
Q Consensus 177 ~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~------~~-~~~~~~gt~~y~aPE~~~ 249 (293)
+.+++.|+.++|+.. ++||++|.|++|.++.++.+||+.|+.+........ .. ..........|.+||.+.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345568999999876 799999999999999999999999998765433111 10 011122456799999999
Q ss_pred cCCCCCccchhhHHHHHHHHH-hCCCCCCCC
Q 022706 250 TGQLNAKSDVYSFGVVLLELL-TGRKPVDHT 279 (293)
Q Consensus 250 ~~~~~~~~DvwslG~~l~el~-~g~~Pf~~~ 279 (293)
....+.++|++|+|+++|-+. .|+.-+...
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc
Confidence 888889999999999999998 466555443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=2e-06 Score=73.72 Aligned_cols=77 Identities=16% Similarity=0.042 Sum_probs=57.4
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC---CCceeEEEEEEeC---CeeEEEEEcc
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH---ENFVQLLGYCVDG---TSRVLAYEFA 144 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv~e~~ 144 (293)
-.+.||.|..+.||+....++ .+++|..+ .......+.+|.+.++.+.- -.+.++++++.++ +..+||||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 345799999999999876645 57777743 22244678899999988853 3678888877543 5689999999
Q ss_pred cCCch
Q 022706 145 SNGSL 149 (293)
Q Consensus 145 ~~~sL 149 (293)
+|.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.4e-07 Score=73.46 Aligned_cols=73 Identities=12% Similarity=0.127 Sum_probs=47.1
Q ss_pred ceeeccCce-EEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC---CceeEEEEEEeC---CeeEEEEEccc
Q 022706 73 ALIGEGSYG-RVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---NFVQLLGYCVDG---TSRVLAYEFAS 145 (293)
Q Consensus 73 ~~lg~G~~g-~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~~ 145 (293)
+.|+.|+.. .||+. +..+++|.... ......+.+|.++++.+... .+.+++...... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457766665 58875 24577886544 33455788999999888632 345555543332 23478999999
Q ss_pred CCchh
Q 022706 146 NGSLH 150 (293)
Q Consensus 146 ~~sL~ 150 (293)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.9e-06 Score=72.72 Aligned_cols=161 Identities=17% Similarity=0.202 Sum_probs=91.4
Q ss_pred HHHHHHHhcCCC-----CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC--CceeEEE---
Q 022706 60 DELKEITENFGT-----NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLG--- 129 (293)
Q Consensus 60 ~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~--- 129 (293)
+++..+.++|.+ .+.|..|....+|+.... +..+++|+... .....+..|++++..+... .+.+++.
T Consensus 2 ~~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~ 78 (296)
T cd05153 2 EELASFLADYDLGELLSFEGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRD 78 (296)
T ss_pred HHHHHHHHHcCCCchhheecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence 355666666765 345666777899998765 45789998764 3445677788877777532 2444433
Q ss_pred ---EEEeCCeeEEEEEcccCCchhh--------------hhhcCC-CCCCC-CCCCCCCHHHHH----------HHHHHH
Q 022706 130 ---YCVDGTSRVLAYEFASNGSLHD--------------ILHGRK-GVKGA-QPGPVLSWQQRV----------KIAVGA 180 (293)
Q Consensus 130 ---~~~~~~~~~lv~e~~~~~sL~~--------------~l~~~~-~~~~~-~~~~~l~~~~~~----------~i~~qi 180 (293)
+....+..++++++++|..+.. .++... ..... .......+.... .....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 1223456689999999876532 001100 00000 000011111110 011122
Q ss_pred HHHHHHHHh----CCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 181 AKGLEYLHE----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 181 ~~al~~LH~----~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
..++.++.. .-...++|+|+.|.||++++++.+.|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 333444443 1112399999999999999987788999987654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.3e-06 Score=71.79 Aligned_cols=138 Identities=12% Similarity=0.088 Sum_probs=77.8
Q ss_pred eeccCceEEEEEEeCCCCeEEEEEcCCCCCCh-HHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcccCCchhhh
Q 022706 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHDI 152 (293)
Q Consensus 75 lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~-~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~~ 152 (293)
+..|-.+.+|+... ++..+++|......... -+..+|.++++.+...++ .+++... . .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45677788998874 47789999765432221 235678888888864333 3444432 2 3689999998765421
Q ss_pred -----------------hhcCCCCCCCCCCCCCCHHH-HHHHHH---------HHHHHHHHHHhC-----CCCCeeeCCC
Q 022706 153 -----------------LHGRKGVKGAQPGPVLSWQQ-RVKIAV---------GAAKGLEYLHEK-----ADPHIIHRDI 200 (293)
Q Consensus 153 -----------------l~~~~~~~~~~~~~~l~~~~-~~~i~~---------qi~~al~~LH~~-----~~~~ivH~Di 200 (293)
++... ..+..++... +..+.. .+...+..+-.. ....++|+|+
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQP-----RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCC-----CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 11111 0111122211 111111 111112222111 0124899999
Q ss_pred CCCceEEcCCCceEEeccccCCC
Q 022706 201 KSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 201 kp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
.|.||++++++ +.|+||+.+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.9e-06 Score=71.65 Aligned_cols=165 Identities=17% Similarity=0.231 Sum_probs=88.6
Q ss_pred ccCHHHHHHHHhcCCCC-----ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC--CceeEE
Q 022706 56 AISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLL 128 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~ 128 (293)
.++.+++..+...|.+. +.|+.|....+|+....+| .+++|++. ....+.+..|..+++.|... .+.+++
T Consensus 6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 45667777777788662 4456677788999887644 78999875 22334444555655555311 133333
Q ss_pred E------EEEeCCeeEEEEEcccCCchhh-----------hh---hcC-CCCCCCCCC-CCCCH-HHHH-----------
Q 022706 129 G------YCVDGTSRVLAYEFASNGSLHD-----------IL---HGR-KGVKGAQPG-PVLSW-QQRV----------- 174 (293)
Q Consensus 129 ~------~~~~~~~~~lv~e~~~~~sL~~-----------~l---~~~-~~~~~~~~~-~~l~~-~~~~----------- 174 (293)
. +....+..+++++|++|..+.. .+ +.. ......... ..+.+ .+..
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1223556789999999864421 11 111 100000000 01111 1111
Q ss_pred -HHHHH-HHHHHHHHHhC----CCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 175 -KIAVG-AAKGLEYLHEK----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 175 -~i~~q-i~~al~~LH~~----~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
....+ +...++.+... -...++|+|+.+.||+++++...-++||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 11111 11122233211 012399999999999998766668999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.3e-08 Score=88.23 Aligned_cols=181 Identities=17% Similarity=0.140 Sum_probs=130.8
Q ss_pred eeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEEEEEcccCC-chhh
Q 022706 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEFASNG-SLHD 151 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-sL~~ 151 (293)
-+++++++.+++.+....+....+.+... ....-++++|.+++||| .+..++-+..++..++.|+++.++ +-..
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 47788889888877442222334443222 44556789999999999 677777777788889999999776 2222
Q ss_pred hhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccc
Q 022706 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231 (293)
Q Consensus 152 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (293)
.+... .-.+..-+...+.+.-.++++++|+.. -+|+| ||+..+ +..++.||+....+....
T Consensus 325 ~~~~s--------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 325 EMTVS--------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred cCChh--------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 11111 112455566677788889999999874 58888 776654 678999999887765433
Q ss_pred cccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
......+++.+++||......+....|+|++|.-..++.-|.+|=.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3366789999999999999999999999999987778877777654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.1e-06 Score=68.33 Aligned_cols=100 Identities=30% Similarity=0.364 Sum_probs=79.0
Q ss_pred HHHHHHhcCCC-CCceeEEEEEEeCCeeEEEEEcccCCchhhh---hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 022706 111 AQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEFASNGSLHDI---LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186 (293)
Q Consensus 111 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 186 (293)
.|.-+++.+.+ +++++++|+| ..+++.|+...+++... +... ...+|..+.+|+.++++.+.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~---------~~~~w~~R~~iA~~lL~~l~~ 74 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQF---------LQSPWEQRAKIALQLLELLEE 74 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccc---------cccCHHHHHHHHHHHHHHHHH
Confidence 47778888874 6999999998 34688999987665432 1110 127899999999999999999
Q ss_pred HHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 187 LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
|+..-...+...|++++|+-+++++++|++|......
T Consensus 75 l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 75 LDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred HhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 9985433588899999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.8e-06 Score=70.34 Aligned_cols=74 Identities=19% Similarity=0.148 Sum_probs=49.3
Q ss_pred ceeeccCceEEEEEEeCC-------CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEEEEEcc
Q 022706 73 ALIGEGSYGRVYYGILKS-------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~-------~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~ 144 (293)
+.|..|-...+|+....+ ++.+++|+.........+..+|.++++.+...+ ..+++..+.. .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 345566677899988654 578999997655444345678888888886333 3455555432 3689999
Q ss_pred cCCchh
Q 022706 145 SNGSLH 150 (293)
Q Consensus 145 ~~~sL~ 150 (293)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 987664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.2e-05 Score=68.55 Aligned_cols=74 Identities=15% Similarity=0.107 Sum_probs=54.5
Q ss_pred ceeeccCceEEEEEEeCCC-CeEEEEEcCCC--------CCChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEE
Q 022706 73 ALIGEGSYGRVYYGILKSG-HAAAIKKLDAS--------KQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~-~~~avK~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 140 (293)
+.||.|.++.||++...+| +.++||.-.+. +...++...|.+.|+.+. ..++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998866 58999985421 224466777888887764 3467777776 55667899
Q ss_pred EEcccCCc
Q 022706 141 YEFASNGS 148 (293)
Q Consensus 141 ~e~~~~~s 148 (293)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.3e-05 Score=65.93 Aligned_cols=166 Identities=17% Similarity=0.228 Sum_probs=92.8
Q ss_pred ccCHHHHHHHHhcCCCC-----ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC--ceeEE
Q 022706 56 AISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--FVQLL 128 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~ 128 (293)
..+.+++..+.+.|.+. +.++.|....+|+....++ .+++|+..... ....+..|.+++..|...+ +.+++
T Consensus 6 ~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 6 SVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred cCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 45667777777778663 4566677788999876544 68889775432 2345566777777774222 34444
Q ss_pred EE------EEeCCeeEEEEEcccCCchhh--------------hhhcC-CCCCCCCCC--CCCCHHHHH-----------
Q 022706 129 GY------CVDGTSRVLAYEFASNGSLHD--------------ILHGR-KGVKGAQPG--PVLSWQQRV----------- 174 (293)
Q Consensus 129 ~~------~~~~~~~~lv~e~~~~~sL~~--------------~l~~~-~~~~~~~~~--~~l~~~~~~----------- 174 (293)
.. ....+..+++++|++|..+.. .++.. .+-...... ..-.+....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 31 122455689999999855421 01111 100000000 000111000
Q ss_pred -HHHHHHHHHHHHHHh----CCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 175 -KIAVGAAKGLEYLHE----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 175 -~i~~qi~~al~~LH~----~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
.....+...++++.. .-...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 011123334444432 1112499999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-05 Score=62.18 Aligned_cols=124 Identities=25% Similarity=0.387 Sum_probs=85.3
Q ss_pred hcCCCCceeeccCc-eEEEEEEeCCCCeEEEEEcCC---CC-------------------CChHHHHHHHHHHhcCC---
Q 022706 67 ENFGTNALIGEGSY-GRVYYGILKSGHAAAIKKLDA---SK-------------------QPDEEFLAQVSMVSRLK--- 120 (293)
Q Consensus 67 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~avK~~~~---~~-------------------~~~~~~~~e~~~l~~l~--- 120 (293)
.+++.++.||.|.- |.||+++.. |+.||+|.+.. .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68888999999999 999999987 78999999321 00 00123667777766664
Q ss_pred CCCc--eeEEEEEEeC------------------CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHH
Q 022706 121 HENF--VQLLGYCVDG------------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180 (293)
Q Consensus 121 h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi 180 (293)
+.++ ++.++|..-. ....||.||++... .++. .-+.+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~----~~~~~~ 173 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQI----RDIPQM 173 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccch----hHHHHH
Confidence 5566 8888886422 01235555554322 1222 334567
Q ss_pred HHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 181 ~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
.+-+..+|..| |+-+|+++.|.. +| +|+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc---CC--EEEecccC
Confidence 77788899999 999999999986 22 88999854
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.8e-05 Score=65.30 Aligned_cols=143 Identities=15% Similarity=0.214 Sum_probs=80.2
Q ss_pred eeeccCceEEEEEEeCC-----CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcccCC
Q 022706 74 LIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~-----~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
.|-.|-...+|++...+ ++.+++|+........-+..+|..+++.+...++ .++++.+..+ .|.+|+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 44457778899987532 3689999876543322234678888888864333 3555554322 579999887
Q ss_pred chhhh-----------------hhcCCCCCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 022706 148 SLHDI-----------------LHGRKGVKGAQPGPVLSWQQRVKIAVGA-----------------AKGLEYL----HE 189 (293)
Q Consensus 148 sL~~~-----------------l~~~~~~~~~~~~~~l~~~~~~~i~~qi-----------------~~al~~L----H~ 189 (293)
+|... ++... .........+.++..+..++ ...+..| ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~---~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLD---MPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCC---CCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 76421 11110 00000011223332332221 1111122 21
Q ss_pred -CCCCCeeeCCCCCCceEEcC-CCceEEeccccCCC
Q 022706 190 -KADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQ 223 (293)
Q Consensus 190 -~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~~~~ 223 (293)
.....++|+|+++.||++++ ++.+.|+||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234899999999999986 46799999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.1e-06 Score=70.84 Aligned_cols=133 Identities=15% Similarity=0.173 Sum_probs=96.4
Q ss_pred CCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCC---------C--------------ChHHHHHHHHHHhcCC-C-CC
Q 022706 69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK---------Q--------------PDEEFLAQVSMVSRLK-H-EN 123 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~---------~--------------~~~~~~~e~~~l~~l~-h-~~ 123 (293)
+.++..||-|--+.||.+.+..|++.++|.-+... . +.-...+|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56788999999999999999999999999532110 0 0123457888888885 3 23
Q ss_pred ceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 022706 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (293)
Q Consensus 124 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~ 203 (293)
+.+.+++ +..++|||++.|-.|...-+-. ..-.+...++..+.-|-.+| +||+|+.--
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---------------d~~~ly~~lm~~Iv~la~~G---lIHgDFNEF 231 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVE---------------DPPTLYDDLMGLIVRLANHG---LIHGDFNEF 231 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeecC---------------ChHHHHHHHHHHHHHHHHcC---ceecccchh
Confidence 4555544 4557899999998886654322 12234455566667778888 999999999
Q ss_pred ceEEcCCCceEEeccccCCC
Q 022706 204 NVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 204 Nilv~~~~~~kl~Dfg~~~~ 223 (293)
||++++++.++++||--+..
T Consensus 232 Nimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eeEEecCCCEEEeechHhhc
Confidence 99999999999999975543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.5e-05 Score=63.35 Aligned_cols=136 Identities=16% Similarity=0.233 Sum_probs=81.8
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCC---CCChHHHHHHHHHHhcCCC--CCceeEEEEEEeCC--eeEEEEEccc
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKH--ENFVQLLGYCVDGT--SRVLAYEFAS 145 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~---~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e~~~ 145 (293)
+.+..|....+|..... +++++++ .+.. .....+..+|...++.+.- --+...++.|.++. ..|.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 33333333445655554 7889998 4321 1223456678888877753 33445566666655 6699999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHH-HHHHHHHHHHHh-----------------------------------
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA-VGAAKGLEYLHE----------------------------------- 189 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH~----------------------------------- 189 (293)
|..+.+.+.... .. .+++ ..+...|..||+
T Consensus 109 Ge~~~~~~~~~~----------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~ 174 (321)
T COG3173 109 GEVVWSALPPES----------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG 174 (321)
T ss_pred ceeccCcCCccc----------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence 843322221100 00 1111 234444444443
Q ss_pred ---------------C-----CCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 190 ---------------K-----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 190 ---------------~-----~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+ +...++|+|+++.||++++++.+=++||+++..-
T Consensus 175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 1246999999999999999998999999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=63.15 Aligned_cols=139 Identities=22% Similarity=0.232 Sum_probs=94.3
Q ss_pred CCCceeeccCceEEEEEEeCCCCeEEEEEcCCCC-----------------------CChH----HHHHHHHHHhcCCCC
Q 022706 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------------------QPDE----EFLAQVSMVSRLKHE 122 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-----------------------~~~~----~~~~e~~~l~~l~h~ 122 (293)
.+..+|.-|--+.||.+...+|..+|||+++.+. .+.. =..+|++.|+++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456777788899999998899999999875321 0111 134688888888755
Q ss_pred CceeEEEEEEeCCeeEEEEEcccCCch-hhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 022706 123 NFVQLLGYCVDGTSRVLAYEFASNGSL-HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (293)
Q Consensus 123 ~i~~~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik 201 (293)
.|.-.--+.. ...+|||+|+....- .-.|+. ..++...+..+-.|++..+.-|-+.. ++||.||+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd----------~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLS 292 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD----------ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLS 292 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccccc----------ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchh
Confidence 5432211111 133699999953211 122222 23777778888888888888887665 69999999
Q ss_pred CCceEEcCCCceEEeccccCCC
Q 022706 202 SSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 202 p~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
--|+|+. +|.+.++|.+-+..
T Consensus 293 EfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 293 EFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred hhhheEE-CCEEEEEEcccccc
Confidence 9999985 46788999887654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.5e-05 Score=63.13 Aligned_cols=73 Identities=14% Similarity=0.145 Sum_probs=47.5
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEEEEcccCC
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNG 147 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 147 (293)
.+.|+.|....+|+.. .+++.+.+|+-. ......+..|.+-|+.|. .-.+++++.+....+..+|+|||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999988 458899999865 222345777888777774 456788999988888889999999875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00047 Score=61.11 Aligned_cols=72 Identities=11% Similarity=0.166 Sum_probs=50.6
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCC-----CC---CChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEE
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDA-----SK---QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 140 (293)
.+.||.|....||+.... +..++||+-.. .. .+..+...|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 456899999999998875 56799998652 11 13344555667776664 347888888765 456789
Q ss_pred EEcccC
Q 022706 141 YEFASN 146 (293)
Q Consensus 141 ~e~~~~ 146 (293)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.002 Score=56.12 Aligned_cols=96 Identities=17% Similarity=0.162 Sum_probs=60.7
Q ss_pred cCccCHHHHHHHHhcCCCC--c--eeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC--ceeE
Q 022706 54 VPAISVDELKEITENFGTN--A--LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--FVQL 127 (293)
Q Consensus 54 ~~~~~~~~~~~~~~~y~~~--~--~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 127 (293)
.+.++++.+-.....+.+. . ..=.+.-..||+....++..+++|+..........+..|++.+..|.... ++..
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4566777776666665442 1 11224557899998887889999998765556677888888877774211 2221
Q ss_pred E---E--EEEeCCeeEEEEEcccCCch
Q 022706 128 L---G--YCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 128 ~---~--~~~~~~~~~lv~e~~~~~sL 149 (293)
. + +...++..+.++++++|..+
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 1 12234567789999988643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00041 Score=60.41 Aligned_cols=71 Identities=18% Similarity=0.158 Sum_probs=49.6
Q ss_pred eeeccCceEEEEEEeCCC-CeEEEEEcCC-----C---CCChHHHHHHHHHHhcCC--CC-CceeEEEEEEeCCeeEEEE
Q 022706 74 LIGEGSYGRVYYGILKSG-HAAAIKKLDA-----S---KQPDEEFLAQVSMVSRLK--HE-NFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~-~~~avK~~~~-----~---~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 141 (293)
.||.|....||++...++ +.++||.-.+ . +.+.++..-|...|+... .| ++++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478999999999997744 6899997531 1 233456667777777764 34 45666654 666777999
Q ss_pred EcccC
Q 022706 142 EFASN 146 (293)
Q Consensus 142 e~~~~ 146 (293)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0003 Score=59.62 Aligned_cols=31 Identities=19% Similarity=0.416 Sum_probs=25.6
Q ss_pred CeeeCCCCCCceEEcCCCc-eEEeccccCCCC
Q 022706 194 HIIHRDIKSSNVLIFDDDV-AKIADFDLSNQA 224 (293)
Q Consensus 194 ~ivH~Dikp~Nilv~~~~~-~kl~Dfg~~~~~ 224 (293)
.++|+|+++.||++++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 569999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00055 Score=59.65 Aligned_cols=72 Identities=14% Similarity=0.166 Sum_probs=44.9
Q ss_pred eeeccCceEEEEEEeCC----CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcccCCc
Q 022706 74 LIGEGSYGRVYYGILKS----GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
.|..|=...+|+....+ +..|++|+........-+..+|..+++.+..-++ .+++.++. +. +|.+|+++.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcCCC
Confidence 44446677899887542 2478999875443322234578888888864444 45555542 22 5899998876
Q ss_pred h
Q 022706 149 L 149 (293)
Q Consensus 149 L 149 (293)
|
T Consensus 97 l 97 (330)
T PLN02421 97 L 97 (330)
T ss_pred C
Confidence 5
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00026 Score=57.50 Aligned_cols=55 Identities=7% Similarity=0.053 Sum_probs=33.5
Q ss_pred CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcccCCch
Q 022706 91 GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 91 ~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
++.|++|+.......--+...|..+++.+...++ .++++.+ .+. .|.+|+++.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~--~~g--~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFF--ENG--RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEE--TTE--EEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEc--CCC--cEEEEeccccc
Confidence 4678888876665555667788888888864433 4555543 222 57799977665
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0027 Score=63.38 Aligned_cols=167 Identities=17% Similarity=0.242 Sum_probs=89.6
Q ss_pred cCccCHHHHHHH-HhcCCCC---ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-------CC
Q 022706 54 VPAISVDELKEI-TENFGTN---ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-------HE 122 (293)
Q Consensus 54 ~~~~~~~~~~~~-~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-------h~ 122 (293)
.|.++..++..+ .+.|.+. +.|+ |..-.+|+....++..+++|+..... .......|.+.+..|. .|
T Consensus 8 ~p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP 85 (1013)
T PRK06148 8 APEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVP 85 (1013)
T ss_pred CCCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcC
Confidence 345666666444 4567664 3443 45678899988788899999987643 3334445555665442 22
Q ss_pred CceeEE-----EEEEe-CC--eeEEEEEcccCCchhhhh-----------------hc-CCCCCCCCCCCCCCH------
Q 022706 123 NFVQLL-----GYCVD-GT--SRVLAYEFASNGSLHDIL-----------------HG-RKGVKGAQPGPVLSW------ 170 (293)
Q Consensus 123 ~i~~~~-----~~~~~-~~--~~~lv~e~~~~~sL~~~l-----------------~~-~~~~~~~~~~~~l~~------ 170 (293)
.+++-. ....+ .. ..+.+++|++|..+.+.. +. ..+...+...+.+.|
T Consensus 86 ~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~ 165 (1013)
T PRK06148 86 RLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAG 165 (1013)
T ss_pred eeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccch
Confidence 333211 11111 11 456789999997775411 00 000011111111111
Q ss_pred -----------HHHHHHHHHHHHHHH-----HHHhCCCCCeeeCCCCCCceEEcCCC--ceE-EeccccCCC
Q 022706 171 -----------QQRVKIAVGAAKGLE-----YLHEKADPHIIHRDIKSSNVLIFDDD--VAK-IADFDLSNQ 223 (293)
Q Consensus 171 -----------~~~~~i~~qi~~al~-----~LH~~~~~~ivH~Dikp~Nilv~~~~--~~k-l~Dfg~~~~ 223 (293)
...+.++.++++... .+.+. ...+||+|+.+.||+++.++ .+. |+|||-+..
T Consensus 166 ~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 166 RARDRLHFIDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 112223333333222 12111 11299999999999999775 555 999998754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00067 Score=59.86 Aligned_cols=73 Identities=14% Similarity=0.119 Sum_probs=51.8
Q ss_pred CceeeccCceEEEEEEeC-CCCeEEEEEcCC----C---CCChHHHHHHHHHHhcCC--CC-CceeEEEEEEeCCeeEEE
Q 022706 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDA----S---KQPDEEFLAQVSMVSRLK--HE-NFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~----~---~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 140 (293)
.+.||.|....||++.+. .++.++||.-.+ . +.+.++..-|.+.|+.+. .| ++++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 347899999999999975 356899997531 1 233467777888887774 34 56666654 66667789
Q ss_pred EEcccC
Q 022706 141 YEFASN 146 (293)
Q Consensus 141 ~e~~~~ 146 (293)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999964
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0013 Score=56.84 Aligned_cols=30 Identities=13% Similarity=0.217 Sum_probs=27.1
Q ss_pred CeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 194 ~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
.++|+|+.++|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00057 Score=66.81 Aligned_cols=152 Identities=21% Similarity=0.258 Sum_probs=109.7
Q ss_pred HHHHHHHHhcCCCCCceeEEEEEEeCCe----eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 022706 109 FLAQVSMVSRLKHENFVQLLGYCVDGTS----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184 (293)
Q Consensus 109 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 184 (293)
..-|+..+.++.|+|++.++.|...... ..+..+++...++...+.... .++....+.+..+++.+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---------~i~~~~~r~~~~~~~~GL 299 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---------SIPLETLRILHQKLLEGL 299 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---------ccCHHHHHHHHHHHhhhH
Confidence 3456778888899999999988654322 224567777778888777654 488899999999999999
Q ss_pred HHHHhCCCCCeeeCCCCCC---ceEEcCCCceEEe--ccccCCCCCcccccccccccccCcccccccccccCCCCC--cc
Q 022706 185 EYLHEKADPHIIHRDIKSS---NVLIFDDDVAKIA--DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA--KS 257 (293)
Q Consensus 185 ~~LH~~~~~~ivH~Dikp~---Nilv~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~ 257 (293)
.++|+.. +.|.-+... +.-++.++.+... ||+.++...+.... ........+.++|......... ..
T Consensus 300 ~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 300 AYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred HHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhh
Confidence 9999986 666655555 4445566666666 99988876654432 2333455677888776655444 47
Q ss_pred chhhHHHHHHHHHhCCCC
Q 022706 258 DVYSFGVVLLELLTGRKP 275 (293)
Q Consensus 258 DvwslG~~l~el~~g~~P 275 (293)
|+|.+|.++..+..|..+
T Consensus 374 dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHHHHHHhhhhhcCcc
Confidence 999999999999887643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0039 Score=54.07 Aligned_cols=143 Identities=20% Similarity=0.250 Sum_probs=83.7
Q ss_pred CceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC------ceeEEE----EEEeCCeeEEEEEcccCCc
Q 022706 79 SYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN------FVQLLG----YCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 79 ~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~----~~~~~~~~~lv~e~~~~~s 148 (293)
.-..+|+....+|+. ++|+.... ....++..|++.+..|.-.+ +...-| ....+...+-+++|++|..
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 556799998876655 99998887 77778888888888885221 111111 1111236778999999987
Q ss_pred hhh-h--------------hhc-CCCCC--CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhCC----C-
Q 022706 149 LHD-I--------------LHG-RKGVK--GAQPGPVLSWQQ-------------RVKIAVGAAKGLEYLHEKA----D- 192 (293)
Q Consensus 149 L~~-~--------------l~~-~~~~~--~~~~~~~l~~~~-------------~~~i~~qi~~al~~LH~~~----~- 192 (293)
+.. . ++. ..+.+ .+.......|.. -.....++...+..+.+.- .
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 772 0 010 01111 111111222220 0113334444444444321 1
Q ss_pred CC--eeeCCCCCCceEEcCCCc-eEEeccccCCC
Q 022706 193 PH--IIHRDIKSSNVLIFDDDV-AKIADFDLSNQ 223 (293)
Q Consensus 193 ~~--ivH~Dikp~Nilv~~~~~-~kl~Dfg~~~~ 223 (293)
.+ +||+|+.|.||+++.+.. .-++||+-+..
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 12 899999999999998874 88999997653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0096 Score=51.32 Aligned_cols=64 Identities=20% Similarity=0.255 Sum_probs=39.0
Q ss_pred EEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC--CceeEEEE------EEeCCeeEEEEEcccCCch
Q 022706 82 RVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE--NFVQLLGY------CVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 82 ~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e~~~~~sL 149 (293)
.||+....+| .+++|++.. ....+..|...+..|... .+++++.. ...++..+++++|++|.++
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~---~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY---PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4888876544 688998752 234455566666665422 33444332 2235678899999998554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0022 Score=55.59 Aligned_cols=85 Identities=18% Similarity=0.174 Sum_probs=61.6
Q ss_pred CCceeEEEEE-EeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 022706 122 ENFVQLLGYC-VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200 (293)
Q Consensus 122 ~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di 200 (293)
++..+.+-+- .++-+.|++|++- |++| ..++ .-.+++++.++.+.+..+.-+..+- +.-|||+
T Consensus 285 ~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik------------~~~~~e~lsff~s~~sil~~lekkf--~fehrnl 348 (488)
T COG5072 285 VFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIK------------ADRSEEELSFFWSCISILDILEKKF--PFEHRNL 348 (488)
T ss_pred hhhhcceEEecCCceEEEEEEecC-Ccee-eeee------------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccc
Confidence 4444433333 2334556777764 4344 3332 2567899999999999998888764 6899999
Q ss_pred CCCceEEcCCCceEEeccccCCC
Q 022706 201 KSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 201 kp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
...|||++ +|+|.|+||-+++.
T Consensus 349 t~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 349 TLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cccceeee-cCceEEEEeeeeec
Confidence 99999999 99999999999874
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0053 Score=54.51 Aligned_cols=74 Identities=19% Similarity=0.234 Sum_probs=44.1
Q ss_pred ceeeccCceEEEEEEeCCC--Ce-----EEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcc
Q 022706 73 ALIGEGSYGRVYYGILKSG--HA-----AAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~--~~-----~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 144 (293)
+.|..|-...+|++...++ .. |.++........--+-.+|.++++.+...++ .++++.+. .+++.||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 3455577788999875432 22 4444332211111234568899999875444 45565543 25899999
Q ss_pred cCCchh
Q 022706 145 SNGSLH 150 (293)
Q Consensus 145 ~~~sL~ 150 (293)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 997764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.16 E-value=6.5e-05 Score=75.08 Aligned_cols=159 Identities=12% Similarity=0.005 Sum_probs=112.1
Q ss_pred HHHHHHhcCCCCCceeEEEEEE--eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022706 111 AQVSMVSRLKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188 (293)
Q Consensus 111 ~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 188 (293)
.|...++.+.|+++.....-.. .....+..++++.+|.+.+.+-+..... +.+...-+...-.+.+....-+|
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-----~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-----PDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-----CcchhchHHHHHHHHHhccchhh
Confidence 3444556667888776655443 2344578899999999999886543221 23444444444444466666655
Q ss_pred hCC--CCCeeeCCCCCCceEEcCCCceEEeccccCC-CCCcccccccccccccCcccccccccccCCCCCccchhhHHHH
Q 022706 189 EKA--DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN-QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 265 (293)
Q Consensus 189 ~~~--~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~ 265 (293)
+.. ..--+|+++|+.|.++..+-++++.++|+.+ ...... .....++++.|+.|++...-.++.++|+|..++.
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s---f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS---FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHh---hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 432 2236899999999999999999999999988 322222 2345667888999998887788888999999999
Q ss_pred HHHHHhCCCCCC
Q 022706 266 LLELLTGRKPVD 277 (293)
Q Consensus 266 l~el~~g~~Pf~ 277 (293)
+|++.-|..+|-
T Consensus 1430 ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHhcccHHHH
Confidence 999988888775
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0051 Score=51.28 Aligned_cols=78 Identities=19% Similarity=0.111 Sum_probs=55.3
Q ss_pred ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc-cCCchhh
Q 022706 73 ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA-SNGSLHD 151 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~-~~~sL~~ 151 (293)
..+..|..+.|+.++..+|++.++|+..+......+... ...|+..+-...+++++. +.....+++|.+ ++.+|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g-~~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~L~~ 84 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARG-EAALRWWNGRGAVRLLAA--DPERGALLLERLDPGRSLAS 84 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhH-HhHhheeCCCCceeeecc--ccccchhhhhhccCCCchhh
Confidence 446678899999999889999999998755543333222 244777777788999986 344556889999 4557765
Q ss_pred hh
Q 022706 152 IL 153 (293)
Q Consensus 152 ~l 153 (293)
..
T Consensus 85 ~~ 86 (253)
T PF04655_consen 85 LP 86 (253)
T ss_pred cc
Confidence 54
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.017 Score=52.34 Aligned_cols=73 Identities=12% Similarity=0.060 Sum_probs=44.5
Q ss_pred ceeeccCceEEEEEEeCC---------CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCce-eEEEEEEeCCeeEEEEE
Q 022706 73 ALIGEGSYGRVYYGILKS---------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV-QLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~---------~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e 142 (293)
+.|..|=...+|++...+ ++.|++++.-.....--+..+|..+++.+...+|. ++++.+. -..|.|
T Consensus 111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~e 186 (442)
T PTZ00296 111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEE 186 (442)
T ss_pred EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEE
Confidence 445556667889887542 46788888754433322345677777777644443 4554432 246789
Q ss_pred cccCCch
Q 022706 143 FASNGSL 149 (293)
Q Consensus 143 ~~~~~sL 149 (293)
|++|.+|
T Consensus 187 fi~g~~l 193 (442)
T PTZ00296 187 WLYGDPL 193 (442)
T ss_pred eeCCccC
Confidence 9988644
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.009 Score=48.35 Aligned_cols=114 Identities=16% Similarity=0.178 Sum_probs=67.3
Q ss_pred CceEEEEEEeCCCCeEEEEEcCCCC-C-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcC
Q 022706 79 SYGRVYYGILKSGHAAAIKKLDASK-Q-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR 156 (293)
Q Consensus 79 ~~g~V~~~~~~~~~~~avK~~~~~~-~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~ 156 (293)
+-++.-.++.+-|. ..+|+++..+ . ...-+..+.+++.++. .|+++..- +...+-++.|+|.....
T Consensus 74 gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 33444444444333 3344443322 2 3445667777776653 56666632 33445588998853111
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 157 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
.. . .++.-=+++|.-.|+. +...+|+|..|+||+-|..|.+||.|-+.
T Consensus 142 -----------~~---~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -----------NF---S-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----------ch---h-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 11 1 1111224667788854 23599999999999999999999999875
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.019 Score=46.77 Aligned_cols=74 Identities=12% Similarity=0.110 Sum_probs=51.2
Q ss_pred eeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEEEEcccCCchh
Q 022706 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (293)
Q Consensus 74 ~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 150 (293)
.+.-|..-..|...+. ...+.+|+=. ......|..|+.-|+.+. .-.+.+++.+..+.++.|+||||++-+.+.
T Consensus 23 ~v~gG~inea~~v~dg-~~~~FvK~n~--~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 23 EVSGGDINEAWRLRDG-TDPFFVKCNQ--REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccCCccccceeEeecC-CcceEEEecc--hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3555666666666554 5678888632 222345677776666664 456788899988999999999999986664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 293 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-40 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 337 bits (867), Expect = e-116
Identities = 100/259 (38%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 36 ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAA 95
A+ + + + P E + + +L+E T NF LIG G +G+VY G+L+ G A
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 96 IKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILH 154
+K+ S Q EEF ++ +S +H + V L+G+C + +L Y++ NG+L L+
Sbjct: 68 LKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY 127
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214
G P +SW+QR++I +GAA+GL YLH +A IIHRD+KS N+L+ ++ V K
Sbjct: 128 GSDL-----PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 215 IADFDLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
I DF +S + ++ + H ST V GT GY PEY + G+L KSDVYSFGVVL E+L R
Sbjct: 180 ITDFGISKKGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 274 KPVDHTLPRGQQSLVTWVL 292
+ +LPR +L W +
Sbjct: 239 SAIVQSLPREMVNLAEWAV 257
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-112
Identities = 89/239 (37%), Positives = 139/239 (58%), Gaps = 12/239 (5%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQ-PDEEFLAQVSM 115
S+ EL+ ++NF ++G G +G+VY G L G A+K+L Q + +F +V M
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+S H N ++L G+C+ T R+L Y + +NGS+ L R + P L W +R +
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQR 135
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH-ST 234
IA+G+A+GL YLH+ DP IIHRD+K++N+L+ ++ A + DF L+ H +T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTT 193
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWV 291
V GT G+ APEY TG+ + K+DV+ +GV+LLEL+TG++ D L+ WV
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-107
Identities = 98/258 (37%), Positives = 144/258 (55%), Gaps = 24/258 (9%)
Query: 45 QAVKVQPIEVPAISVDELKEITENF------GTNALIGEGSYGRVYYGILKSGHAAAIKK 98
++++V + S ELK +T NF +GEG +G VY G + A+KK
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61
Query: 99 LDA-----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
L A +++ ++F ++ ++++ +HEN V+LLG+ DG L Y + NGSL D L
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
G P LSW R KIA GAA G+ +LHE H IHRDIKS+N+L+ + A
Sbjct: 122 SCLDG------TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTA 172
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
KI+DF L+ + A + ++R++GT Y APE + G++ KSD+YSFGVVLLE++TG
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGL 231
Query: 274 KPVDHTLPRGQQSLVTWV 291
VD R Q L+
Sbjct: 232 PAVDEH--REPQLLLDIK 247
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-73
Identities = 65/251 (25%), Positives = 97/251 (38%), Gaps = 27/251 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
+ + L + + G +G V+ L A+K + + +V +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 117 SRLKHENFVQLLGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
+KHEN +Q +G G L F GSL D L V+SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122
Query: 173 RVKIAVGAAKGLEYLHEKAD-------PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
IA A+GL YLHE P I HRDIKS NVL+ ++ A IADF L+ +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280
+ + +GT Y APE + D+Y+ G+VL EL + D +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 281 PRGQQSLVTWV 291
+
Sbjct: 243 DEYMLPFEEEI 253
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-65
Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMV 116
I E++ +G G++G V + AIK++++ + + F+ ++ +
Sbjct: 5 IDYKEIEVEEV-------VGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 55
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
SR+ H N V+L G C++ V+ E+A GSL+++LHG + P P + +
Sbjct: 56 SRVNHPNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAE------PLPYYTAAHAMSW 107
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTR 235
+ ++G+ YLH +IHRD+K N+L+ V KI DF + H T
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTN 162
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
G+ + APE + K DV+S+G++L E++T RKP
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 4e-63
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
I +L +T+ + E G ++ G + G+ +K L D S + +F +
Sbjct: 7 IDFKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+ H N + +LG C + + GSL+++LH V+
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
Q VK A+ A+G+ +LH +P I + S +V+I +D A+I+ D+
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------F 163
Query: 232 HSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKP 275
S + + APE A+ + +D++SF V+L EL+T P
Sbjct: 164 QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-62
Identities = 69/214 (32%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD-----EEFLAQVSMVSRLKHENFVQLLG 129
IG G +G+VY G A+K D E + + + LKH N + L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C+ + L EFA G L+ +L G++ + V AV A+G+ YLH+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHD 123
Query: 190 KADPHIIHRDIKSSNVLI--------FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
+A IIHRD+KSSN+LI + + KI DF L+ R G +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYA 179
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ APE + SDV+S+GV+L ELLTG P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-62
Identities = 66/240 (27%), Positives = 111/240 (46%), Gaps = 41/240 (17%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPD----- 106
+P ++ +E++ + IG+G +G V+ G L AIK L
Sbjct: 12 RLPTLADNEIEYEKQ-------IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 107 ---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
+EF +V ++S L H N V+L G + V+ EF G L+ L +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP---- 118
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADF 218
+ W ++++ + A G+EY+ + +P I+HRD++S N+ + D AK+ADF
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKP 275
LS Q+ + +LG F + APE + + K+D YSF ++L +LTG P
Sbjct: 174 GLSQQSVHS-----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-62
Identities = 73/222 (32%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
I +L + IG GS+G V+ G A+K L D + EFL +V
Sbjct: 34 IPWCDLNIKEK-------IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREV 85
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
+++ RL+H N V +G + + E+ S GSL+ +LH L ++R
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG------AREQLDERRR 139
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
+ +A AKG+ YLH + +P I+HR++KS N+L+ K+ DF LS S
Sbjct: 140 LSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT + APE N KSDVYSFGV+L EL T ++P
Sbjct: 199 AA--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-58
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 25/228 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
+G+G +G+ + +G +K+L + FL +V ++ L+H N ++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
E+ G+L I+ W QRV A A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ--------YPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLS------------NQAPDMAARLHSTRVLGTF 240
+IIHRD+ S N L+ ++ +ADF L+ ++ R V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
+ APE + K DV+SFG+VL E++ LPR +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-56
Identities = 53/216 (24%), Positives = 84/216 (38%), Gaps = 29/216 (13%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
IG+G +G+VY+G AI+ +D + + + F +V + +HEN V +G C
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ + +L+ ++ K VL + +IA KG+ YLH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAK- 149
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPEYA 248
I+H+D+KS NV D+ I DF L G + APE
Sbjct: 150 --GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 249 MTGQLNA---------KSDVYSFGVVLLELLTGRKP 275
+ SDV++ G + EL P
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-56
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 30/226 (13%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G+G YG V+ G + G A+K + + ++ L+HEN + + +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 134 GTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ GSL+D L L ++I + A GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHI 123
Query: 190 -----KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
+ P I HRD+KS N+L+ + IAD L+ +Q+ + ++ RV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKR 182
Query: 242 YHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
Y APE + D+++FG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-56
Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 31/236 (13%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---DASKQPDEEFLAQV 113
I ++ IG GS+G VY G G A +K L + Q + F +V
Sbjct: 21 IPDGQITVGQR-------IGSGSFGTVYKGKWH-GDVA-VKMLNVTAPTPQQLQAFKNEV 71
Query: 114 SMVSRLKHENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++ + +H N + +GY T+ LA ++ SL+ LH + +
Sbjct: 72 GVLRKTRHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHASE--------TKFEMK 120
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ + IA A+G++YLH K IIHRD+KS+N+ + +D+ KI DF L+ + +
Sbjct: 121 KLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 232 HSTRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
++ G+ + APE + + +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-55
Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 37/249 (14%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL 110
P+ V +++ + + IG+G YG V+ G + G A+K +++
Sbjct: 28 PLLVQRTIAKQIQMVKQ-------IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE 79
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGP 166
++ ++HEN + + + GT ++ NGSL+D L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------- 130
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
L + +K+A + GL +LH + P I HRD+KS N+L+ + IAD L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 222 --NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-------KSDVYSFGVVLLELLTG 272
+ + +GT Y PE + LN +D+YSFG++L E+
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
Query: 273 RKPVDHTLP 281
Sbjct: 249 CVSGGIVEE 257
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-54
Identities = 61/254 (24%), Positives = 92/254 (36%), Gaps = 46/254 (18%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFL 110
P++ +D LK + LIG G YG VY G L A+K S + F+
Sbjct: 4 AASEPSLDLDNLKLLE-------LIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFI 53
Query: 111 A--QVSMVSRLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQ 163
+ V ++H+N + + T+ L E+ NGSL L
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------ 107
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHE------KADPHIIHRDIKSSNVLIFDDDVAKIAD 217
W ++A +GL YLH P I HRD+ S NVL+ +D I+D
Sbjct: 108 ----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 218 FDLS------NQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLNAKSDVYSFGV 264
F LS + +GT Y APE + D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 265 VLLELLTGRKPVDH 278
+ E+ +
Sbjct: 224 IYWEIFMRCTDLFP 237
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-53
Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
IG+G +G V+ G + G A+K + ++ A++ L+HEN + +
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 134 GTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
++ +GSL D L+ ++ + +K+A+ A GL +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHM 157
Query: 190 KAD-----PHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
+ P I HRD+KS N+L+ + IAD L+ + A D + RV GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216
Query: 242 YHAPEYAMTGQLNA-------KSDVYSFGVVLLELLTGRKPVDHTLP 281
Y APE + +N ++D+Y+ G+V E+
Sbjct: 217 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 41/218 (18%)
Query: 75 IGEGSYGRVYYGILKSGHAA-AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
IG G++G V+ G L++ + A+K +FL + ++ + H N V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ E G L G L + +++ AA G+EYL K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH-------- 243
IHRD+ + N L+ + +V KI+DF +S R Y
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMS-------------REEADGVYAASGGLRQV 277
Query: 244 -----APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE G+ +++SDV+SFG++L E + G P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG G +G V+ G + AIK + +E+F+ + ++ +L H VQL G C++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
L EF +G L D L ++G + + + + + + +G+ YL E
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----------- 243
+IHRD+ + N L+ ++ V K++DF ++ R + Y
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMT-------------RFVLDDQYTSSTGTKFPVKW 171
Query: 244 -APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+PE + ++KSDV+SFGV++ E+ + G+ P
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-41
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 37/214 (17%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V G K + A+K + ++EF + + +L H V+ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ SNG L + L G L Q +++ +G+ +L
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----------- 243
IHRD+ + N L+ D K++DF ++ R + Y
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT-------------RYVLDDQYVSSVGTKFPVKW 171
Query: 244 -APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + ++KSDV++FG+++ E+ + G+ P
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-40
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V YG + + AIK + ++EF+ + ++ L HE VQL G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ +NG L + L + QQ +++ + +EYL K
Sbjct: 92 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----------- 243
+HRD+ + N L+ D V K++DF LS R + Y
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLS-------------RYVLDDEYTSSVGSKFPVRW 187
Query: 244 -APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
PE M + ++KSD+++FGV++ E+ + G+ P
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 75/257 (29%), Positives = 126/257 (49%), Gaps = 38/257 (14%)
Query: 33 AYHASEAAPKGAQAVKVQPIEVPAISVDELK----EIT-ENFGTNALIGEGSYGRVYYGI 87
++ ++A + +K + +E + DE + + IG+G +G V G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213
Query: 88 LKSGHAAAIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY---E 142
+ G+ A+K K DA+ + FLA+ S++++L+H N VQLLG V+ + Y E
Sbjct: 214 YR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL--YIVTE 267
Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
+ + GSL D L R VL +K ++ + +EYL + +HRD+ +
Sbjct: 268 YMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 317
Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYH--APEYAMTGQLNAKSDV 259
NVL+ +D+VAK++DF L + ST+ G APE + + KSDV
Sbjct: 318 RNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 260 YSFGVVLLELLT-GRKP 275
+SFG++L E+ + GR P
Sbjct: 370 WSFGILLWEIYSFGRVP 386
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 57/215 (26%), Positives = 87/215 (40%), Gaps = 28/215 (13%)
Query: 72 NALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQL 127
+ IG GS+ VY G+ ++ A +L K E F + M+ L+H N V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 128 LGYCVDGTSR----VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
VL E ++G+L L + +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----------MKIKVLRSWCRQIL 139
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
KGL++LH + P IIHRD+K N+ I KI D L+ A+ V+GT
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTP 194
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ APE + + DVY+FG+ +LE+ T P
Sbjct: 195 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 40/243 (16%)
Query: 57 ISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSG------HAAAIKKL--DASKQPDE 107
+ V + E+ E + +G+GS+G VY G+ K AIK + AS +
Sbjct: 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GP 166
EFL + S++ + V+LLG G ++ E + G L L + P
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
S + +++A A G+ YL+ +HRD+ + N ++ +D KI DF ++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----- 185
Query: 227 MAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-G 272
R + Y+ +PE G SDV+SFGVVL E+ T
Sbjct: 186 --------RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 273 RKP 275
+P
Sbjct: 238 EQP 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 44/229 (19%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ + A+K L D + ++F + +++ L+HE+ V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIAVGA 180
G C DG ++ +E+ +G L+ L + Q L Q + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A G+ YL + H +HRD+ + N L+ + + KI DF +S R + +
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDVYST 186
Query: 241 GYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
Y+ PE M + +SDV+SFGV+L E+ T G++P
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-40
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+G G++G VY G+ AIK+L S + ++E L + +++ + + + +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C+ T +++ + G L D + K + Q + V AKG+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
++ ++HRD+ + NVL+ KI DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
A E + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-40
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 75 IGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G YG VY G+ K A+K L EEFL + +++ +KH N VQLLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ EF + G+L D L +S + +A + +EYL +K
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK--- 130
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---------- 243
+ IHRD+ + N L+ ++ + K+ADF LS R++ Y
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIK 177
Query: 244 --APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + + KSDV++FGV+L E+ T G P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-40
Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
+GE +G+VY G L AIK L A EEF + + +RL+H N V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGR-------KGVKGAQPGPVLSWQQRVKIAVG 179
LLG + + + S+G LH+ L R L V +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
A G+EYL H++H+D+ + NVL++D KI+D L R +
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------------REVYA 180
Query: 240 FGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
Y+ APE M G+ + SD++S+GVVL E+ + G +P
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-40
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAA-AIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
+G G YG VY G+ K A+K L EEFL + +++ +KH N VQLLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ EF + G+L D L +S + +A + +EYL +K
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK--- 337
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH--APEYAMTG 251
+ IHR++ + N L+ ++ + K+ADF LS ++ F APE
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYN 394
Query: 252 QLNAKSDVYSFGVVLLELLT-GRKP 275
+ + KSDV++FGV+L E+ T G P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-40
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG+G +G V G + G+ A+K + + FLA+ S++++L+H N VQLLG V+
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 135 TSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADP 193
+ + E+ + GSL D L R VL +K ++ + +EYL
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 194 HIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR-LHSTRVLGTFGYH--APEYAMT 250
+ +HRD+ + NVL+ +D+VAK++DF L + ST+ G APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEALRE 188
Query: 251 GQLNAKSDVYSFGVVLLELLT-GRKP 275
+ + KSDV+SFG++L E+ + GR P
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 74/247 (29%), Positives = 113/247 (45%), Gaps = 16/247 (6%)
Query: 33 AYHASEAAPKGAQAVKVQPIEVPAIS--VDELKEIT-ENFGTNALIGEGSYGRVYYGILK 89
AY++ A + V P P + EI E+ +G+G +G V+ G
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 90 SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSL 149
AIK L E FL + ++ +L+HE VQL + ++ E+ S GSL
Sbjct: 207 GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSL 265
Query: 150 HDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209
D L G G L Q V +A A G+ Y+ + +HRD++++N+L+ +
Sbjct: 266 LDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGE 315
Query: 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLEL 269
+ V K+ADF L+ D + APE A+ G+ KSDV+SFG++L EL
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 270 LT-GRKP 275
T GR P
Sbjct: 375 TTKGRVP 381
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 4e-39
Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G+G +G V+ G AIK L E FL + ++ +L+HE VQL +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
++ E+ S GSL D L G G L Q V +A A G+ Y+ +
Sbjct: 335 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
+HRD++++N+L+ ++ V K+ADF L+ D + APE A+ G+
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 442
Query: 255 AKSDVYSFGVVLLELLT-GRKP 275
KSDV+SFG++L EL T GR P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP 464
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-39
Identities = 68/264 (25%), Positives = 105/264 (39%), Gaps = 23/264 (8%)
Query: 19 GNAYMVKSSAGT--DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIG 76
G A+ + S A T G+ P+ V E E +E +G
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVG 67
Query: 77 EGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135
GS+G V+ ++G A+KK+ EE + + L V L G +G
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAVREGP 123
Query: 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195
+ E GSL ++ ++ G P A +GLEYLH + I
Sbjct: 124 WVNIFMELLEGGSLGQLI--KQM--GCLPEDRAL-----YYLGQALEGLEYLHTR---RI 171
Query: 196 IHRDIKSSNVLIFDD-DVAKIADFDLSNQ-APDMAARLHSTR--VLGTFGYHAPEYAMTG 251
+H D+K+ NVL+ D A + DF + PD + T + GT + APE M
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
+AK D++S ++L +L G P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 6e-39
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ G A+K L + FLA+ +++ +L+H+ V+L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--- 77
Query: 135 TSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
++ Y E+ NGSL D L G L+ + + +A A+G+ ++ E+
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH--APEYAM 249
+ IHRD++++N+L+ D KIADF L+ D ++ R F APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAIN 183
Query: 250 TGQLNAKSDVYSFGVVLLELLT-GRKP 275
G KSDV+SFG++L E++T GR P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-39
Identities = 63/253 (24%), Positives = 101/253 (39%), Gaps = 47/253 (18%)
Query: 41 PKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AI 96
P+ QAV+ I ++ V + I G G +G VY+G L A+
Sbjct: 9 PELVQAVQHVVIGPSSLIVHFNEVI----------GRGHFGCVYHGTLLDNDGKKIHCAV 58
Query: 97 KKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA-YEFASNGSLHDIL 153
K L +FL + ++ H N + LLG C+ L + +G L + +
Sbjct: 59 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
+ + + + AKG++YL K +HRD+ + N ++ +
Sbjct: 119 RNET--------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV 167
Query: 214 KIADFDLSNQAPDMAAR-LHST---RVLGTFGYH------APEYAMTGQLNAKSDVYSFG 263
K+ADF L+ R ++ V G A E T + KSDV+SFG
Sbjct: 168 KVADFGLA--------RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 219
Query: 264 VVLLELLT-GRKP 275
V+L EL+T G P
Sbjct: 220 VLLWELMTRGAPP 232
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-39
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG++G+V+ + A+K L +AS+ ++F + +++ L+H++ V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV------LSWQQRVKIAVGAA 181
G C +G ++ +E+ +G L+ L G L Q + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
G+ YL H +HRD+ + N L+ V KI DF +S R + +
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS-------------RDIYSTD 212
Query: 242 YH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
Y+ PE + + +SDV+SFGVVL E+ T G++P
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 44/244 (18%)
Query: 58 SVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEE 108
S+ +LKE+ +N +G G++G VY G + A+K L S+Q + +
Sbjct: 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 109 FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVL 168
FL + ++S+ H+N V+ +G + R + E + G L L R+ L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL--RETRPRPSQPSSL 137
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAP 225
+ + +A A G +YL E H IHRDI + N L+ VAKI DF ++
Sbjct: 138 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---- 190
Query: 226 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT- 271
R + Y+ PE M G +K+D +SFGV+L E+ +
Sbjct: 191 ---------RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241
Query: 272 GRKP 275
G P
Sbjct: 242 GYMP 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 45/227 (19%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG +G V G LK A+K + ++S++ EEFL++ + + H N ++L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 128 LGYCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
LG C++ +S+ + F G LH L + + Q +K V A
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL---ETGPKHIPLQTLLKFMVDIAL 158
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
G+EYL + + +HRD+ + N ++ DD +ADF LS + + + Y
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSGDY 202
Query: 243 H-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ A E +KSDV++FGV + E+ T G P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ + AIK L K EE + + ++ +L + V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + +L E A G LH L G++ + ++ + G++YL E
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH---- 243
K + +HRD+ + NVL+ + AKI+DF LS + LG Y
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 172
Query: 244 --------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + +++SDV+S+GV + E L+ G+KP
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 71/272 (26%), Positives = 112/272 (41%), Gaps = 48/272 (17%)
Query: 27 SAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDEL-KEIT-ENFGTNALIGEGSYGRVY 84
S+G + Y + P+ + E P + +EI +IG G G V
Sbjct: 8 SSGRENLYFQGKL-PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVC 66
Query: 85 YGILKSGHAA----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138
YG L+ AIK L +++ +FL++ S++ + H N ++L G G +
Sbjct: 67 YGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126
Query: 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198
+ E+ NGSL L G + Q V + G G+ YL + +HR
Sbjct: 127 IVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLSDL---GYVHR 175
Query: 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG--TFGYH------------A 244
D+ + NVL+ + V K++DF LS RVL + A
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLS-------------RVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
PE ++ SDV+SFGVV+ E+L G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-38
Identities = 57/224 (25%), Positives = 89/224 (39%), Gaps = 47/224 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
IG+G +G VY+G AIK Q E FL + ++ L H N + L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 129 GYCVDGTSRVLA-YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + + +G L + P + + + + A+G+EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
E+ +HRD+ + N ++ + K+ADF L+ R + Y+
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLA-------------RDILDREYYSVQQ 184
Query: 244 -----------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
A E T + KSDV+SFGV+L ELLT G P
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 29/243 (11%)
Query: 47 VKVQPIEVPAISVDEL-KEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKL- 99
V E P +V E KE+ N + ++G G +G V G LK AIK L
Sbjct: 23 VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 100 -DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG 158
+++ +FL + S++ + H N ++L G ++ E+ NGSL L
Sbjct: 83 VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 159 VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
+ Q V + G A G++YL + +HRD+ + N+LI + V K++DF
Sbjct: 143 Q--------FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF 191
Query: 219 DLSNQAPDMAARLHSTR-----VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-G 272
L D ++TR + T +PE + + SDV+S+G+VL E+++ G
Sbjct: 192 GLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 273 RKP 275
+P
Sbjct: 248 ERP 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-38
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 46/222 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQL 127
+G G +G V+ G+ + IK + + +Q + + + L H + V+L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C + +++ ++ GSL D + +G L Q + V AKG+ YL
Sbjct: 81 LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYL 131
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
E ++HR++ + NVL+ ++ADF ++ +L
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVA-------------DLLPPDDKQLLYS 175
Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
A E G+ +SDV+S+GV + EL+T G +P
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-38
Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 57/258 (22%)
Query: 41 PKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAA----AI 96
P+ QAV+ I ++ V + I G G +G VY+G L A+
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVI----------GRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 97 KKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL-AYEFASNGSLHDIL 153
K L +FL + ++ H N + LLG C+ L + +G L + +
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
+ + + + AKG+++L K +HRD+ + N ++ +
Sbjct: 183 RNET--------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTV 231
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYH---------------APEYAMTGQLNAKSD 258
K+ADF L+ R + + A E T + KSD
Sbjct: 232 KVADFGLA-------------RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 259 VYSFGVVLLELLT-GRKP 275
V+SFGV+L EL+T G P
Sbjct: 279 VWSFGVLLWELMTRGAPP 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V+ A+K + E FLA+ +++ L+H+ V+L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
++ EF + GSL D L + G + + + A+G+ ++ ++ +
Sbjct: 256 PIYIIT-EFMAKGSLLDFLKSDE-------GSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH--APEYAMTGQ 252
IHRD++++N+L+ V KIADF L+ D ++ R F APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 253 LNAKSDVYSFGVVLLELLT-GRKP 275
KSDV+SFG++L+E++T GR P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-38
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+G G++G VY G+ AIK+L S + ++E L + +++ + + + +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
LG C+ T +++ + G L D + K + Q + V AKG+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH---- 243
++ ++HRD+ + NVL+ KI DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
A E + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-38
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 46/228 (20%)
Query: 75 IGEGSYGRVYYGILK----SGHAAAIK--KLDASKQPD-EEFLAQVSMVSRLKHENFVQL 127
+G+G +G V LK S A+K K D D EEFL + + + H + +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 128 LGYCVDGTSRVLAY------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
+G + ++ F +G LH L + + L Q V+ V A
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI---GENPFNLPLQTLVRFMVDIA 147
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
G+EYL + + IHRD+ + N ++ +D +ADF LS R + +
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYSGD 191
Query: 242 YH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
Y+ A E SDV++FGV + E++T G+ P
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-38
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 44/220 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+GEG +G VY G+ + A+K K D + E+F+++ ++ L H + V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G + + E G L L K L V ++ K + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAMAYLE 130
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----- 243
+ +HRDI N+L+ + K+ DF LS R + Y+
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVT 174
Query: 244 -------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+PE + SDV+ F V + E+L+ G++P
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-38
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 75 IGEGSYGRVYYGILKSGHAA-----AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
IG G +G VY G+LK+ AIK L +++ +FL + ++ + H N ++L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G ++ E+ NG+L L + G S Q V + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYL 163
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR-----VLGTFGY 242
+ +HRD+ + N+L+ + V K++DF LS D ++T + T
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT--- 217
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + + SDV+SFG+V+ E++T G +P
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 55 PAISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL--DASKQP 105
S+ +LKE+ +N +G G++G VY G + A+K L S+Q
Sbjct: 58 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 106 DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPG 165
+ +FL + ++S+ H+N V+ +G + R + E + G L L R+
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL--RETRPRPSQP 175
Query: 166 PVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSN 222
L+ + +A A G +YL E H IHRDI + N L+ VAKI DF ++
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA- 231
Query: 223 QAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLEL 269
R + GY+ PE M G +K+D +SFGV+L E+
Sbjct: 232 ------------RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279
Query: 270 LT-GRKP 275
+ G P
Sbjct: 280 FSLGYMP 286
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYC 131
++G+G+YG VY G L + AIK++ + L + +++ LKH+N VQ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ + E GSL +L + G + +GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIG-----FYTKQILEGLKYLHDN- 141
Query: 192 DPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE---Y 247
I+HRDIK NVLI V KI+DF S + + + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
G +D++S G ++E+ TG+ P
Sbjct: 198 GPRG-YGKAADIWSLGCTIIEMATGKPP 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ----VSMVSRLKHENFVQLL 128
IG G + VY L G A+KK+ D + A + ++ +L H N ++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
++ + E A G L ++ K + ++ + K V LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
+ ++HRDIK +NV I V K+ D L HS ++GT Y +PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
N KSD++S G +L E+ + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 30/230 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYC 131
+GEG + V L GH A+K++ +Q D E + M H N ++L+ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 132 VDGTSRVLAY----EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+ F G+L + + K G L+ Q + + +G +GLE +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEAI 150
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-------GTF 240
H HRD+K +N+L+ D+ + D NQA L T
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 241 GYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
Y APE + + + ++DV+S G VL ++ G P D +G
Sbjct: 208 SYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
IGEGS+G+ + G IK+++ S+ +E +V++++ +KH N VQ
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
+ S + ++ G L ++ +KGV Q + V L+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHD 143
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFGYHAPE 246
+ I+HRDIKS N+ + D ++ DF ++ N ++A + GT Y +PE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA----RACI-GTPYYLSPE 195
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
N KSD+++ G VL EL T +
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-37
Identities = 62/220 (28%), Positives = 89/220 (40%), Gaps = 44/220 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
IGEG +G V+ GI S AIK K S E+FL + + + H + V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G + ++ E + G L L RK L + A + L YL
Sbjct: 83 GVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLE 133
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH----- 243
K +HRDI + NVL+ +D K+ DF LS R + Y+
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKG 177
Query: 244 -------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + + SDV+ FGV + E+L G KP
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-37
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 53/238 (22%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
IGEG++GRV+ A+K L +AS +F + ++++ + N V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRK---------------GVKGAQPGPVLSWQ 171
LLG C G L +E+ + G L++ L + P LS
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+++ IA A G+ YL E+ +HRD+ + N L+ ++ V KIADF LS
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS---------- 221
Query: 232 HSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
R + + Y+ PE + +SDV+++GVVL E+ + G +P
Sbjct: 222 ---RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-37
Identities = 71/221 (32%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 74 LIGEGSYGRVYYGILKSGHA---AAIKKL--DASKQPDEEFLAQVSMVSRL-KHENFVQL 127
+IGEG++G+V +K AAIK++ ASK +F ++ ++ +L H N + L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKIAVGA 180
LG C LA E+A +G+L D L + LS QQ + A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+G++YL +K IHRD+ + N+L+ ++ VAKIADF LS R V T
Sbjct: 152 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKTM 200
Query: 241 G-----YHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
G + A E SDV+S+GV+L E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-37
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 47/222 (21%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKL---DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G G++G V G + A+K L +E LA+ +++ +L + V+++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C + S +L E A G L+ L + + + +++ + G++YL
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG--YH--- 243
E + +HRD+ + NVL+ AKI+DF LS + L Y
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-------------KALRADENYYKAQT 178
Query: 244 ---------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + ++KSDV+SFGV++ E + G+KP
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 69/255 (27%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK---- 89
+H + + P + LK+I + +GEG +G+V
Sbjct: 5 HHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRD-------LGEGHFGKVSLYCYDPTND 57
Query: 90 -SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY---EF 143
+G A+K L DA Q + ++ ++ L HE+ ++ G C D + L E+
Sbjct: 58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL-QLVMEY 116
Query: 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203
GSL D L + Q + A +G+ YLH + H IHRD+ +
Sbjct: 117 VPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAAR 163
Query: 204 NVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
NVL+ +D + KI DF L+ P+ R+ F Y APE + SDV+S
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWS 222
Query: 262 FGVVLLELLT-GRKP 275
FGV L ELLT
Sbjct: 223 FGVTLYELLTHCDSS 237
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 48/224 (21%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
+G+GS+G V G + A+K K D QP+ ++F+ +V+ + L H N ++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L G + + E A GSL D L +G + AV A+G+ Y
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 136
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG--YH- 243
L K IHRD+ + N+L+ D+ KI DF L R L Y
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLM-------------RALPQNDDHYVM 180
Query: 244 -----------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE T + SD + FGV L E+ T G++P
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-37
Identities = 49/227 (21%), Positives = 90/227 (39%), Gaps = 50/227 (22%)
Query: 75 IGEGSYGRVYYGILKSGHAA--------AIKKL-DASKQPDEEFLAQVSMVSRLKHENFV 125
+G+G++ +++ G+ + +K L A + E F SM+S+L H++ V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G CV G +L EF GSL L K ++ ++++A A +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMH 127
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDD--------VAKIADFDLSNQAPDMAARLHSTRVL 237
+L E +IH ++ + N+L+ ++ K++D +S +
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITV 171
Query: 238 GTFGYH-------APEYAMTGQL-NAKSDVYSFGVVLLELLT-GRKP 275
PE + N +D +SFG L E+ + G KP
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-37
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 50/226 (22%)
Query: 75 IGEGSYGRVYYGILK-----SGHAAAIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQL 127
+GEG +G+V +G A+K L ++ + ++ ++ L HEN V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 128 LGYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
G C + + EF +GSL + L K ++ +Q++K AV KG+
Sbjct: 89 KGICTEDGGNGI-KLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGM 139
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL--GTFGY 242
+YL + +HRD+ + NVL+ + KI DF L+ + + Y
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT-------------KAIETDKEYY 183
Query: 243 H------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE M + SDV+SFGV L ELLT
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
IG+G+ G VY + + +G AI++++ +QP +E + + ++ K+ N V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
G + E+ + GSL D++ + Q + + LE+LH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN-- 135
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
+IHRDIKS N+L+ D K+ DF Q ++ + ++GT + APE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 253 LNAKSDVYSFGVVLLELLTGRKP 275
K D++S G++ +E++ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 49/225 (21%)
Query: 75 IGEGSYGRVYYGILK-----SGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G+G++G V +G A+K+L + +F ++ ++ L + V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G + L E+ +G L D L + L + + + KG+E
Sbjct: 91 GVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHR--------ARLDASRLLLYSSQICKGME 141
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG--YH 243
YL + +HRD+ + N+L+ + KIADF L+ ++L Y
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLA-------------KLLPLDKDYYV 185
Query: 244 ------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + +SDV+SFGVVL EL T K
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 43/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
IG G +V+ + + AIK ++ + ++ + +++ +++L+ + ++L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
Y + + E N L+ L +K + +R + + +H
Sbjct: 76 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-- 246
+ I+H D+K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 126 QH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 247 ---------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
+++ KSDV+S G +L + G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
LIG G +G+V+ G IK++ + E+ +V +++L H N V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 133 DGTSRVLAY----------------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
EF G+L + R+G K L +++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALEL 127
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
KG++Y+H K +I+RD+K SN+ + D KI DF L + R TR
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRS 181
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT Y +PE + + D+Y+ G++L ELL
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-36
Identities = 63/208 (30%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 75 IGEGSYGRVYYGILKSGHAA----AIK--KLDASKQPDEEFLAQVSMVSRLKHENFVQLL 128
IGEG +G V+ GI S AIK K S E+FL + + + H + V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G + ++ E + G L L RK L + A + L YL
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE 508
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
K +HRDI + NVL+ +D K+ DF LS D S L APE
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI 564
Query: 249 MTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ + SDV+ FGV + E+L G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-36
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 48/220 (21%)
Query: 75 IGEGSYGRVYYGILK-----SGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G+G++G V +G A+KKL ++++ +F ++ ++ L+H+N V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C R L E+ GSL D L K + + ++ KG+E
Sbjct: 78 GVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL--GTFGYH 243
YL K IHRD+ + N+L+ +++ KI DF L+ +VL +
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLT-------------KVLPQDKEFFK 172
Query: 244 ------------APEYAMTGQLNAKSDVYSFGVVLLELLT 271
APE + + SDV+SFGVVL EL T
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 43/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
IG G +V+ + + AIK ++ + ++ + +++ +++L+ + ++L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
Y + + E N L+ L +K + +R + + +H
Sbjct: 95 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE-- 246
+ I+H D+K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 145 QH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 247 ---------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
+++ KSDV+S G +L + G+ P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 75 IGEGSYGRVYYGIL-----KSGHAAAIKKL-DASKQPDEEFLAQVSMVSRLKHENFVQLL 128
+G+G++G V +G A+KKL ++++ +F ++ ++ L+H+N V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 129 GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
G C R L E+ GSL D L K + + ++ KG+E
Sbjct: 109 GVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD--MAARLHSTRVLGTFGYH 243
YL K IHRD+ + N+L+ +++ KI DF L+ P ++ F Y
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY- 215
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLT 271
APE + + SDV+SFGVVL EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-36
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
+G G VY AIK + + EE L S+L H+N V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQNIV 74
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
++ + L E+ +L + + GP LS + G++
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIK 125
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+ H+ I+HRDIK N+LI + KI DF ++ +A + + VLGT Y +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
E A + +D+YS G+VL E+L G P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-36
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 74 LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGY 130
+G G +G V+ K AIK++ + + + +V +++L+H V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 131 CVDGTSRVLAY------------EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
++ + + +L D ++GR ++ + L +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI------FL 125
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------DLSNQAPDMA 228
A+ +E+LH K ++HRD+K SN+ DDV K+ DF + M
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 229 ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
A T +GT Y +PE + K D++S G++L ELL
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 42/223 (18%), Positives = 89/223 (39%), Gaps = 34/223 (15%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENF--VQLL 128
IG G +V+ + + AIK ++ + ++ + +++ +++L+ + ++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS--WQQRVKIAVGAAKGLEY 186
Y + + E N L+ L +K + W+ + + +
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKSI----DPWERKSYWKNML-------EAVHT 170
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+H+ I+H D+K +N L D + K+ DF ++NQ + +G Y PE
Sbjct: 171 IHQH---GIVHSDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 247 -----------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
+++ KSDV+S G +L + G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 21/235 (8%)
Query: 48 KVQPIEVPAISVDELKEI------TENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLD 100
VQ P + +L E E F +GEGSYG VY I ++G AIK++
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 101 ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK 160
+E + ++S++ + + V+ G T + E+ GS+ DI+ R
Sbjct: 64 VESDL-QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT- 121
Query: 161 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
L+ + I KGLEYLH IHRDIK+ N+L+ + AK+ADF +
Sbjct: 122 -------LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ Q D A+ ++ V+GT + APE N +D++S G+ +E+ G+ P
Sbjct: 172 AGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 74 LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHENFVQLLG 129
IG GSYGR KS G K+LD + E +++V+++ LKH N V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 130 YCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
+D T+ L Y E+ G L ++ KG + L + +++ L+
Sbjct: 73 RIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 187 LHEKADP--HIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHSTRVLGTFG 241
H ++D ++HRD+K +NV + K+ DF L+ N A T V GT
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTFV-GTPY 181
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y +PE N KSD++S G +L EL P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-35
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA---AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ + AIK L K EE + + ++ +L + V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + +L E A G LH L G++ + ++ + G++YL E
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT--FGYH---- 243
K + +HR++ + NVL+ + AKI+DF LS + LG Y
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 498
Query: 244 --------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
APE + +++SDV+S+GV + E L+ G+KP
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 27/254 (10%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDE----LKEI------TENFGTNALIGEGSYGRV 83
+H + + + ++ ++ L+ + + IGEGS G V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIV 61
Query: 84 YYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAY 141
SG A+K +D KQ E L V ++ +H N V++ + G +
Sbjct: 62 CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
EF G+L DI+ + L+ +Q + + L YLH + +IHRDIK
Sbjct: 122 EFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIK 168
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYS 261
S ++L+ D K++DF Q + S ++GT + APE + D++S
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 262 FGVVLLELLTGRKP 275
G++++E++ G P
Sbjct: 227 LGIMVIEMVDGEPP 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 48/233 (20%)
Query: 75 IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG++G+V K A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P ++++ V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A+G+EYL + IHRD+ + NVL+ +++V KIADF L+ R
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 206
Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ Y+ APE +SDV+SFGV++ E+ T G P
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 48/233 (20%)
Query: 75 IGEGSYGRVYYGIL--------KSGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG +G+V K A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGV-------KGAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P ++++ V
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A+G+EYL + IHRD+ + NVL+ +++V KIADF L+ R
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 252
Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ Y+ APE +SDV+SFGV++ E+ T G P
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-35
Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G+G +G VY +S A+K L ++ Q+ + S L+H N ++L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 129 GYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
GY D T L E+A G+++ L + Q+ A L Y
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSK-----------FDEQRTATYITELANALSY 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H K +IHRDIK N+L+ KIADF S AP + + GT Y PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD-LCGTLDYLPPE 177
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ K D++S GV+ E L G+ P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
++G G V+ L+ A+K L A D F AQ + L H V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIV 75
Query: 126 QLLGY-CVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
+ + + L Y E+ +L DI+H GP ++ ++ +++ A
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADAC 126
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST-RVLGTF 240
+ L + H+ IIHRD+K +N++I + K+ DF ++ D + T V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y +PE A ++A+SDVYS G VL E+LTG P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 48/233 (20%)
Query: 75 IGEGSYGRVYYGILKSGHAA--------AIKKL--DASKQPDEEFLAQVSMVSRL-KHEN 123
+GEG++G+V A+K L DA+++ + ++++ M+ + KH+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRK-------GVKGAQPGPVLSWQQRVKI 176
+ LLG C + E+AS G+L + L R+ P LS + V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+ R
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA-------------RD 240
Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ Y+ APE +SDV+SFGV+L E+ T G P
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG+GS+G V+ GI ++ AIK +D + D E+ +++++S+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+ T + E+ GS D+L +PGP L Q I KGL+YLH +
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSE- 138
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
IHRDIK++NVL+ + K+ADF ++ Q D + ++ +GT + APE
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194
Query: 252 QLNAKSDVYSFGVVLLELLTGRKP 275
++K+D++S G+ +EL G P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCV 132
+G+G++G+VY ++G AA K ++ + + E + +++ H V+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ EF G++ I+ L+ Q + + L +LH K
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
IIHRD+K+ NVL+ + ++ADF +S + + S +GT + APE M
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193
Query: 253 L-----NAKSDVYSFGVVLLELLTGRKP 275
+ + K+D++S G+ L+E+ P
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 75 IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V +G+ K A+K L A E ++++ ++S L +HEN V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-----GPVLSWQQRVKIAVGA 180
LLG C G ++ E+ G L + L + V P S + + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
A+G+ +L K + IHRD+ + NVL+ + VAKI DF L AR ++
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------ARD----IMNDS 218
Query: 241 GYH------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
Y APE +SDV+S+G++L E+ + G P
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 38/235 (16%)
Query: 65 ITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN 123
+F A++G+G++G+V AIKK+ +++ L++V +++ L H+
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQY 63
Query: 124 FVQLLGYCVDGTSRVLAY-------------EFASNGSLHDILHGRKGVKGAQPGPVLSW 170
V+ ++ + V E+ NG+L+D++H
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN--------QQR 115
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
+ ++ + L Y+H + IIHRD+K N+ I + KI DF L+
Sbjct: 116 DEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 231 LHS------------TRVLGTFGYHAPE-YAMTGQLNAKSDVYSFGVVLLELLTG 272
L T +GT Y A E TG N K D+YS G++ E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 41/222 (18%), Positives = 82/222 (36%), Gaps = 30/222 (13%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLD--------------ASKQPDEEFLAQV----SMV 116
+ +G + ++ K A+KK + K + ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 117 SRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
+ +K+E + G + + YE+ N S+ + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CI 156
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
Y+H + +I HRD+K SN+L+ + K++DF S D ++ +R
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR- 211
Query: 237 LGTFGYHAPEYAMTGQL---NAKSDVYSFGVVLLELLTGRKP 275
GT+ + PE + + AK D++S G+ L + P
Sbjct: 212 -GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 53/238 (22%)
Query: 75 IGEGSYGRVYYGILKSGHAA------AIKKL--DASKQPDEEFLAQVSMVSRLKHENFVQ 126
+GEG +G+V A+K L +AS + L++ +++ ++ H + ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ---------------PGPVLSWQ 171
L G C +L E+A GSL L + V L+
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ A ++G++YL E ++HRD+ + N+L+ + KI+DF LS
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS---------- 197
Query: 232 HSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
R + + A E +SDV+SFGV+L E++T G P
Sbjct: 198 ---RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 47/232 (20%)
Query: 75 IGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V + A+K L A+ ++++ ++ + H N V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 126 QLLGYCVD-GTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLSWQQRVKIA 177
LLG C G ++ EF G+L L ++ L+ + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
AKG+E+L + IHRD+ + N+L+ + +V KI DF L+ R +
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA-------------RDI 198
Query: 238 GTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ APE +SDV+SFGV+L E+ + G P
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 64/227 (28%), Positives = 90/227 (39%), Gaps = 26/227 (11%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE--EFLAQV 113
+ D+L+ I E +G G+YG V SG A+K++ A+ E L +
Sbjct: 4 VKADDLEPIME-------LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL 56
Query: 114 SMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
+ R V G + E + SL P +L
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--- 112
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
KIAV K LE+LH K +IHRD+K SNVLI K+ DF +S D A+
Sbjct: 113 --KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-- 166
Query: 233 STRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
G Y APE + KSD++S G+ ++EL R P
Sbjct: 167 -DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 71/238 (29%), Positives = 103/238 (43%), Gaps = 27/238 (11%)
Query: 47 VKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP 105
+K+ P + + ++LK++ E IG G+YG V + K SG A+K++ ++
Sbjct: 9 LKISPEQHWDFTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 106 DE--EFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
E + L + +V R VQ G + E + S V
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120
Query: 163 Q-PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221
P +L KI + K L +L E IIHRDIK SN+L+ K+ DF +S
Sbjct: 121 VIPEEILG-----KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS 173
Query: 222 NQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Q D A+ TR G Y APE A + +SDV+S G+ L EL TGR P
Sbjct: 174 GQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 48/233 (20%)
Query: 75 IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V YG++KS A A+K L A E ++++ ++S L H N V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ---------PGPVLSWQQRVKI 176
LLG C G ++ E+ G L + L ++ L + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
+ AKG+ +L K + IHRD+ + N+L+ + KI DF L+ R
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-------------RD 194
Query: 237 LGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ + APE +SDV+S+G+ L EL + G P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSM 115
I + L++ F L+G G+YG+VY G +K+G AAIK +D + +EE +++M
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 116 VSRL-KHENFVQLLG-YCVDGTSRVLAY-----EFASNGSLHDILHGRKGVKGAQPGPVL 168
+ + H N G + + EF GS+ D++ KG L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------L 126
Query: 169 SWQQRVKIAV---GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225
+ IA +GL +LH+ +IHRDIK NVL+ ++ K+ DF +S Q
Sbjct: 127 KEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQL-----NAKSDVYSFGVVLLELLTGRKP 275
R ++ +GT + APE + + KSD++S G+ +E+ G P
Sbjct: 181 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
L+G+GS+ VY + +G AIK +D + +V + +LKH + ++L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
Y D L E NG ++ L R S + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSENEARHFMHQIITGMLYLH 129
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA 248
I+HRD+ SN+L+ + KIADF L+ Q + ++ GT Y +PE A
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIA 184
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
+SDV+S G + LL GR P
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 29/244 (11%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAA 95
E K +A Q +V + D+ ++I+E +G G+ G V+ K SG A
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISE-------LGAGNGGVVFKVSHKPSGLVMA 62
Query: 96 IKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD 151
K + Q+ ++ V G + E GSL
Sbjct: 63 RKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 152 ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211
+L + P +L K+++ KGL YL EK I+HRD+K SN+L+
Sbjct: 121 VLKKAGRI----PEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRG 169
Query: 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271
K+ DF +S Q D A + V GT Y +PE + +SD++S G+ L+E+
Sbjct: 170 EIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 272 GRKP 275
GR P
Sbjct: 226 GRYP 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 63/209 (30%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G+G +G VY ++ A+K L S+ E Q+ + S L+H N +++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 129 GYCVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
Y D L EFA G L+ L HGR Q+ A L Y
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGR-----------FDEQRSATFMEELADALHY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
HE+ +IHRDIK N+L+ KIADF S AP R + GT Y PE
Sbjct: 130 CHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM--CGTLDYLPPE 182
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ K D++ GV+ E L G P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 56/250 (22%), Positives = 91/250 (36%), Gaps = 23/250 (9%)
Query: 32 GAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKS 90
G A GA A E+P + VD + +G+G + + + +
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADT 65
Query: 91 GHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146
A K + S ++ S+ L H++ V G+ D + E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 147 GSLHDILHGRKGVKGAQPGPVLSWQQRV-KIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205
SL ++ RK + + G +YLH +IHRD+K N+
Sbjct: 126 RSLLELHKRRKALT----------EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNL 172
Query: 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 265
+ +D KI DF L+ + R GT Y APE + + DV+S G +
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 266 LLELLTGRKP 275
+ LL G+ P
Sbjct: 231 MYTLLVGKPP 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 50/210 (23%), Positives = 77/210 (36%), Gaps = 22/210 (10%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFL------AQVSMVSRLKHENFV 125
L+G G G VY A+K + + D F A+ RL+ + V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEPHVV 97
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ + + + L +L + GP L+ + V I L+
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--------GP-LAPPRAVAIVRQIGSALD 148
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
H HRD+K N+L+ DD A + DF ++ A +GT Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
E ++D+Y+ VL E LTG P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 21/214 (9%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRL-KH 121
++F + +G GSYG V+ K G A+K+ + + ++ LA+V ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
V+L +G L E SL G L Q
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTL 167
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
L +LH + ++H D+K +N+ + K+ DF L + A + G
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPR 221
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y APE + G +DV+S G+ +LE+ +
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 51/231 (22%), Positives = 87/231 (37%), Gaps = 23/231 (9%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLA 111
E+P + VD + +G+G + + + + A K + S
Sbjct: 3 EIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 112 QV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
++ S+ L H++ V G+ D + E SL ++ RK +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT------- 113
Query: 168 LSWQQRV-KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
+ G +YLH +IHRD+K N+ + +D KI DF L+ +
Sbjct: 114 ---EPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
R GT Y APE + + DV+S G ++ LL G+ P +
Sbjct: 168 DGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 53/238 (22%)
Query: 75 IGEGSYGRVY----YGILKSGHAA--AIKKL--DASKQPDEEFLAQVSMVSRL-KHENFV 125
+G G++G+V YGI K+G + A+K L A E ++++ M+++L HEN V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDIL--------------HGRKGVKGAQPGPVLSWQ 171
LLG C L +E+ G L + L +K ++ + VL+++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ A AKG+E+L K +HRD+ + NVL+ V KI DF L+
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA---------- 219
Query: 232 HSTRVLGTFGYH-------------APEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
R + + + APE G KSDV+S+G++L E+ + G P
Sbjct: 220 ---RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-32
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 11/208 (5%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYC 131
IG G+ V AIK+++ K +E L ++ +S+ H N V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
V L + S GS+ DI+ + G L I +GLEYLH+
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEGLEYLHKN- 140
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTR--VLGTFGYHAPEYA 248
IHRD+K+ N+L+ +D +IADF +S A + R +GT + APE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 249 MTGQL-NAKSDVYSFGVVLLELLTGRKP 275
+ + K+D++SFG+ +EL TG P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 31/271 (11%)
Query: 13 HKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTN 72
H + + GA + P G +A ++ +V + + + + F
Sbjct: 5 HHHHHHDYDIPTTENLYFQGA---MDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDL 59
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ----VSMVSRLKHENFVQL 127
IG GS+G VY+ +++ AIKK+ S + E V + +L+H N +Q
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
G + + L E+ GS D+L K L + + GA +GL YL
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYL 170
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H ++IHRD+K+ N+L+ + + K+ DF ++ MA +GT + APE
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI---MAPA---NSFVGTPYWMAPEV 221
Query: 248 AMTGQL---NAKSDVYSFGVVLLELLTGRKP 275
+ + K DV+S G+ +EL + P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-31
Identities = 40/214 (18%), Positives = 73/214 (34%), Gaps = 23/214 (10%)
Query: 75 IGEG--SYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF---LAQVSMVSRLKHENFVQLL 128
IG+G V +G +++++ +E ++ + H N V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + F + GS D++ ++ I G K L+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIAYILQGVLKALDYIH 145
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-----GTFGYH 243
+HR +K+S++LI D ++ + R +
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 244 APEYAMTGQL--NAKSDVYSFGVVLLELLTGRKP 275
+PE +AKSD+YS G+ EL G P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 50/240 (20%), Positives = 92/240 (38%), Gaps = 35/240 (14%)
Query: 55 PAISVDELKEITE-------NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDAS--KQP 105
P++ D+ E T +F ++G G+ G + Y + A+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 106 DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
D E V ++ +H N ++ D + +A E + +L + + Q
Sbjct: 65 DRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQK 111
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-----VAKIADFD 219
+ + + GL +LH +I+HRD+K N+LI + A I+DF
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 220 LSNQ-APDMAARLHSTRVLGTFGYHAPEY---AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
L + A + + V GT G+ APE D++S G V +++
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-31
Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSM 115
+++L+ + E +G G+ G+V+ + +GH A+K++ S ++E ++ M
Sbjct: 22 AEINDLENLGE-------MGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILM 72
Query: 116 -----VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW 170
+ VQ G + T +A E + + + P +L
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG- 127
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
K+ V K L YL EK +IHRD+K SN+L+ + K+ DF +S + D A+
Sbjct: 128 ----KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181
Query: 231 LHSTRVLGTFGYHAPE-----YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
R G Y APE + ++DV+S G+ L+EL TG+ P
Sbjct: 182 ---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 47/250 (18%), Positives = 84/250 (33%), Gaps = 30/250 (12%)
Query: 47 VKVQPIEVPAISVD-ELKEITENFGTNALIGEGSYGRVYYGILKSGHAA------AIKKL 99
++PAI E + ++ + L+GEG++ +VY + A +K
Sbjct: 44 TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103
Query: 100 DASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGR 156
EF ++ RLK F++ + VL E S G+L + ++
Sbjct: 104 K--PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161
Query: 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--- 213
K P V+ + A+ +E +H+ IIH DIK N ++ + +
Sbjct: 162 K----NTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214
Query: 214 --------KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVV 265
+ D S T T G+ E N + D +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 266 LLELLTGRKP 275
+ +L G
Sbjct: 275 VYCMLFGTYM 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 32/283 (11%), Positives = 61/283 (21%), Gaps = 44/283 (15%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAA 95
AA A V P L + + G V+ ++ A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 96 IKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLLGYC-------------------- 131
+K + L ++ +RL E+ +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 132 ------VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+ +L AS L + + +
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAA 208
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
L K ++H N+ I D + D + Y
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPR 260
Query: 246 EYAM--TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 286
E+ T + + G+ + + P P + S
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 54/216 (25%), Positives = 82/216 (37%), Gaps = 24/216 (11%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQP-DEEFLAQ-VSMVSRLKHENFVQLL--- 128
+G G +G V I +G AIK+ P + E + ++ +L H N V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 129 ---GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
+LA E+ G L L+ + G L + + L
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG------LKEGPIRTLLSDISSALR 135
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
YLHE IIHRD+K N+++ + KI D + + L + V GT Y
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV-GTLQY 189
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
APE + D +SFG + E +TG +P
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGY 130
++G+G+ V+ G K +G AIK + +P + + + ++ +L H+N V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 131 CVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ T+R VL EF GSL+ +L G L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHLR 129
Query: 189 EKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
E I+HR+IK N++ V K+ DF + + D + S + GT Y
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LYGTEEYLH 183
Query: 245 PE--------YAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 287
P+ + A D++S GV TG P PR + +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGY 130
++G+G+ V+ G K +G AIK + +P + + + ++ +L H+N V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 131 CVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ T+R VL EF GSL+ +L G L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVLRDVVGGMNHLR 129
Query: 189 EKADPHIIHRDIKSSNVLIF----DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
E I+HR+IK N++ V K+ DF + + D + S + GT Y
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS--LYGTEEYLH 183
Query: 245 PE--------YAMTGQLNAKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 287
P+ + A D++S GV TG P PR + +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 40/221 (18%), Positives = 76/221 (34%), Gaps = 27/221 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE---FLAQVSMVSRL-KHENFVQLL 128
IG G +G V+ + G AIK+ + L +V + L +H + V+
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ ++ E+ + GSL D + + L + + +GL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLLQVGRGLRYIH 132
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD------------MAARLHSTRV 236
++H DIK SN+ I + A + R+ S +V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 237 L-GTFGYHAPE-YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
G + A E K+D+++ + ++
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 52/225 (23%), Positives = 85/225 (37%), Gaps = 30/225 (13%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK-HENFVQLLGY 130
++ EG + VY + SG A+K+L ++++ + Q V + +L H N VQ
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 131 CVDGTSR-------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
G L G L + L + LS +KI +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------LSCDTVLKIFYQTCRA 148
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF----------DLSNQAPDMAARLHS 233
++++H + P IIHRD+K N+L+ + K+ DF D S A A
Sbjct: 149 VQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 234 TRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
T Y PE + K D+++ G +L L + P
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 41/224 (18%), Positives = 79/224 (35%), Gaps = 35/224 (15%)
Query: 73 ALIGEGSYGRVYYG---ILKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
I G G +Y + +G +K L S + +A+ ++ + H + VQ+
Sbjct: 86 GCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 128 L--GYCVDGTSRVLAY---EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
D + Y E+ SL + L + + +
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEILP 193
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST-RVLGTFG 241
L YLH +++ D+K N+++ ++ + K+ D +R++S + GT G
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEEQL-KLIDLGA-------VSRINSFGYLYGTPG 242
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
+ APE +D+Y+ G L L + G
Sbjct: 243 FQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 46/236 (19%), Positives = 90/236 (38%), Gaps = 31/236 (13%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H 121
+ + + ++G GS G V + G A+K++ + L ++ +++ H
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH 68
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
N ++ +A E N +L D++ + + + + + A
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN--VSDENLKLQKEYNPISLLRQIA 125
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLI-------------FDDDVAKIADFDLSNQ--APD 226
G+ +LH IIHRD+K N+L+ ++ I+DF L + +
Sbjct: 126 SGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 227 MAARLHSTRVLGTFGYHAPE-------YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ R + GT G+ APE +L D++S G V +L+ K
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 31/297 (10%), Positives = 81/297 (27%), Gaps = 55/297 (18%)
Query: 35 HASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHA 93
++A + + P EL E ++G+ ++G +
Sbjct: 41 EYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 100
Query: 94 AAIKKLDASKQPDEE-----------------------------FLAQVSMVSRLKHENF 124
+ +++P F+ +V + +
Sbjct: 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160
Query: 125 VQLLGYCVDGT--SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+++ D SR Y +L G + + L R+++ + +
Sbjct: 161 IRVRLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L LH ++H ++ ++++ + F+ + + G+
Sbjct: 218 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGF 268
Query: 243 HAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
PE + D ++ G+V+ + P+ G +
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 64/245 (26%), Positives = 91/245 (37%), Gaps = 55/245 (22%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-----------------QPDEEFLAQVSM 115
IG+GSYG V A+K L K +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 116 VSR----------LKHENFVQLLGYCV-DGTSRVLAY---EFASNGSLHDIL-HGRKGVK 160
+ + L H N V+L V D + Y E + G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 161 GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220
LS Q KG+EYLH + IIHRDIK SN+L+ +D KIADF +
Sbjct: 134 -------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN---AKSDVYSFGVVLLELLTGRKP-V 276
SN+ A L +T GT + APE + DV++ GV L + G+ P +
Sbjct: 184 SNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 277 DHTLP 281
D +
Sbjct: 242 DERIM 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 26/281 (9%), Positives = 76/281 (27%), Gaps = 48/281 (17%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGH 92
++A + + P EL E ++G+ ++G
Sbjct: 45 SEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGE 104
Query: 93 AAAIKKLDASKQPDEEFLAQ--------------------------VSMVSRLKHENFVQ 126
+ + +++P + Q + +K +
Sbjct: 105 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164
Query: 127 LLGYCVDGTSRVLAYEF-------ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
++ +D + F ++ + ++L + L R+++ +
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQ 219
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
+ L LH ++H ++ ++++ + F+ +A R
Sbjct: 220 VIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAP 275
Query: 240 FGYHAPE-----YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
A + D ++ G+ + + P
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 21/142 (14%)
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200
+ +L D ++ R ++ + G L Q IA + +E+LH K ++HRD+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ---IA----EAVEFLHSK---GLMHRDL 190
Query: 201 KSSNVLIFDDDVAKIADF----------DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
K SN+ DDV K+ DF + M A T +GT Y +PE
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250
Query: 251 GQLNAKSDVYSFGVVLLELLTG 272
+ K D++S G++L ELL
Sbjct: 251 NNYSHKVDIFSLGLILFELLYS 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 31/220 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASK-QPDEEFLAQV----SMVSRLKHENFVQL 127
L+GEGSYG+V + ++ A+K L K + A V ++ RL+H+N +QL
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 128 LGYCVDGTSR--VLAYEFASNGS--LHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+ + + + E+ G + D + R V A + Q +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH----GYFCQLID------- 120
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA--RLHSTRVLGTF 240
GLEYLH + I+H+DIK N+L+ KI+ ++ AA +++ G+
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSP 175
Query: 241 GYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVDH 278
+ PE A K D++S GV L + TG P +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-24
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
+GEG+YG V + + A A+K +D + D + + + L HEN V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 131 CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+G + L E+ S G L D + AQ + Q + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA-------GVVYLH 122
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGYHAPEY 247
I HRDIK N+L+ + D KI+DF L+ RL + GT Y APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE- 177
Query: 248 AMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
+ + DV+S G+VL +L G P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-24
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G G++G+V G +GH A+K L+ K + + ++ + +H + ++L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
Y V T + E+ S G L D + HGR A +QQ + +
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----RRLFQQILS-------AV 124
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+Y H ++HRD+K NVL+ AKIADF LSN D L ++ G+ Y A
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNYAA 178
Query: 245 PEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
PE ++G+L + D++S GV+L LL G P D
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASK--QPDEEFLAQ-VSMVSRLKHENFVQLLGY 130
IG+G++ +V + +G AIK +D ++ + L + V ++ L H N V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 131 CVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
V T + L E+AS G + D L HGR K A+ ++Q V ++Y
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS----KFRQIVS-------AVQY 129
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
H+K I+HRD+K+ N+L+ D KIADF SN+ G Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPE 183
Query: 247 YAMTGQL--NAKSDVYSFGVVLLELLTGRKP-VDHTLP 281
G+ + DV+S GV+L L++G P L
Sbjct: 184 -LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGY 130
+GEG+YG V + + A A+K +D + D + + + L HEN V+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 131 CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+G + L E+ S G L D + AQ + Q + G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----RFFHQLMA-------GVVYLH 122
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD-MAARLHSTRVLGTFGYHAPE- 246
I HRDIK N+L+ + D KI+DF L+ RL + GT Y APE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 247 -----YAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
+ DV+S G+VL +L G P D
Sbjct: 179 LKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 34/260 (13%)
Query: 35 HASEAAPKGAQAVKVQPIEVPAISVDELKEITE-NFGTNALIGEGSYGRVYYGI-LKSGH 92
H+S P+G+ + ++ + KE E + L+G G +G VY GI +
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 93 AAAIKKLDASKQPDEEFLAQVSMVSR-------LKHE--NFVQLLGYCVDGTSRVLAYEF 143
AIK ++ + D L + V + ++LL + S VL E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 144 ASN-GSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200
L D G L + + + + H ++HRDI
Sbjct: 130 PEPVQDLFDFITERGA-----------LQEELARSFFWQVLEAVRHCHNC---GVLHRDI 175
Query: 201 KSSNVLIFDDDV-AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA-KSD 258
K N+LI + K+ DF D +++ GT Y PE+ + + +
Sbjct: 176 KDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRVYSPPEWIRYHRYHGRSAA 231
Query: 259 VYSFGVVLLELLTGRKPVDH 278
V+S G++L +++ G P +H
Sbjct: 232 VWSLGILLYDMVCGDIPFEH 251
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-23
Identities = 66/234 (28%), Positives = 96/234 (41%), Gaps = 40/234 (17%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG G++G + A+K ++ DE ++ L+H N V+ V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84
Query: 133 DGTSRVLAY--EFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
T LA E+AS G L++ + GR A+ +QQ + G+ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR----FFFQQLL-------SGVSYCH 133
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
I HRD+K N L+ D A KI DF S + ++ ST +GT Y AP
Sbjct: 134 SM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL-HSQPKST--VGTPAYIAP 186
Query: 246 E------YAMTGQLNAKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWVL 292
E Y G +DV+S GV L +L G P D PR + + +L
Sbjct: 187 EVLLRQEYD--G---KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 63/251 (25%), Positives = 101/251 (40%), Gaps = 25/251 (9%)
Query: 34 YHASEAAPKGAQAVKVQPIEVPAISVDELKE--ITENFGTNALIGEGSYGRVYYGILK-S 90
+H + ++ K+ ++E + +G G+YG V K +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 91 GHAAAIK---KLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNG 147
AIK K S + + L +V+++ L H N ++L + D + L E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
L D + R + I G+ YLH+ +I+HRD+K N+L+
Sbjct: 122 ELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLL 169
Query: 208 FDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
+ + KI DF LS + LGT Y APE + + + K DV+S GV
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGV 225
Query: 265 VLLELLTGRKP 275
+L LL G P
Sbjct: 226 ILFILLAGYPP 236
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+G G++G+V G +GH A+K L+ K + + ++ + +H + ++L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
Y V T + E+ S G L D + +GR K + +QQ + G+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----RRLFQQILS-------GV 129
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+Y H ++HRD+K NVL+ AKIADF LSN D L ++ G+ Y A
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNYAA 183
Query: 245 PEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
PE ++G+L + D++S GV+L LL G P D
Sbjct: 184 PE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-22
Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 75 IGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC 131
+G G+YG VY K A+K+++ + +++++ LKH N + L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87
Query: 132 VDGTSR--VLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
+ R L +++A HD I+ + K + L + G+ Y
Sbjct: 88 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARL---------HS 233
LH ++HRD+K +N+L+ + KIAD ARL
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADL 192
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
V+ TF Y APE L A+ D+++ G + ELLT
Sbjct: 193 DPVVVTFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 7e-22
Identities = 62/263 (23%), Positives = 84/263 (31%), Gaps = 47/263 (17%)
Query: 57 ISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK-----KLDASKQPDEEFL 110
L E+ + + IG+GSYG V I + AIK K+ D E +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 111 AQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
V ++ +L H N +L D L E G L D L+ + +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 170 WQQRVKIAVG------------------------AAK-------GLEYLHEKADPHIIHR 198
Q + L YLH + I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192
Query: 199 DIKSSNVLIFDDDVA--KIADFDLSN--QAPDMAARLHSTRVLGTFGYHAPE--YAMTGQ 252
DIK N L + K+ DF LS + T GT + APE
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 253 LNAKSDVYSFGVVLLELLTGRKP 275
K D +S GV+L LL G P
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-22
Identities = 53/255 (20%), Positives = 103/255 (40%), Gaps = 18/255 (7%)
Query: 25 KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY 84
G + ++ + P + + +++ + +G G++G V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 85 YGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142
++ G+ A K + + D+E + + + +S L+H V L D V+ YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
F S G L + + +S + V+ KGL ++HE + +H D+K
Sbjct: 235 FMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKP 283
Query: 203 SNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY 260
N++ + K+ DF L+ + + GT + APE A + +D++
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340
Query: 261 SFGVVLLELLTGRKP 275
S GV+ LL+G P
Sbjct: 341 SVGVLSYILLSGLSP 355
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-22
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 18/219 (8%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD--ASKQPDEEFLAQVSMVSRL 119
I + F +G G++G V+ + SG IK ++ S+ P E+ A++ ++ L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
H N +++ D + + E G L + + + LS ++
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQ 132
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLSNQAPDMAARLHSTRV 236
L Y H + H++H+D+K N+L D KI DF L+ +
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA 187
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT Y APE + K D++S GVV+ LLTG P
Sbjct: 188 -GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 9e-22
Identities = 46/222 (20%), Positives = 75/222 (33%), Gaps = 35/222 (15%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSR-----------LKH 121
L+G+G +G V+ G L AIK + ++ L+ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGS-LHD--ILHGRKGVKGAQPGPVLSWQQRVKIAV 178
++LL + +L E L D G L
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----------LGEGPSRCFFG 146
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVL 237
+++ H + ++HRDIK N+LI AK+ DF D
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDF--D 199
Query: 238 GTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDH 278
GT Y PE+ Q + V+S G++L +++ G P +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 24/221 (10%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASKQPDEEFLAQVSMVS 117
++ + ++G+GS+G V K +G A+K + K E L +V ++
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
+L H N ++L + D L E + G L D + RK S +I
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARII 132
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHST 234
G+ Y+H+ I+HRD+K N+L+ +I DF LS
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---K 186
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+GT Y APE + G + K DV+S GV+L LL+G P
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-21
Identities = 27/208 (12%), Positives = 51/208 (24%), Gaps = 48/208 (23%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVS----MVSRLKHENFVQL 127
G + + + A+ +D ++ L + +SR+ ++
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L ++ E+ GSL ++ P P ++ A +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIRAMQSLAAAADAA 145
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H + S V + D L
Sbjct: 146 HRA---GVALSIDHPSRVRVSIDGDVV----------------------LAYPATMPDA- 179
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
N + D+ G L LL R P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVSRLKHENFVQLL 128
+GEGS+G+V K+ A+K + + +V S + L+H + ++L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 129 GYCVDGTSR--VLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
Y V T V+ E+A G L D + R +QQ + +
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEG----RRFFQQIIC-------AI 121
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
EY H I+HRD+K N+L+ D+ KIADF LSN D L ++ G+ Y A
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNYAA 175
Query: 245 PEYAMTGQL--NAKSDVYSFGVVLLELLTGRKPVD 277
PE + G+L + DV+S G+VL +L GR P D
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 67/259 (25%), Positives = 102/259 (39%), Gaps = 37/259 (14%)
Query: 35 HASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHA 93
H+S Q + + P + +I E++ +G G+YG V K
Sbjct: 7 HSSGRENLYFQGIAINP---GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 94 AAIKKLD--------------ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139
AIK + ++ EE ++S++ L H N ++L D L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRD 199
EF G L + + R I G+ YLH+ +I+HRD
Sbjct: 124 VTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKH---NIVHRD 171
Query: 200 IKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAK 256
IK N+L+ + + KI DF LS+ +L LGT Y APE + + N K
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLRD--RLGTAYYIAPE-VLKKKYNEK 227
Query: 257 SDVYSFGVVLLELLTGRKP 275
DV+S GV++ LL G P
Sbjct: 228 CDVWSCGVIMYILLCGYPP 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 47/272 (17%)
Query: 50 QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIK-----KLDASK 103
+ +E+ ++ E E ++ + T + +G G++G V+ + + +K K+
Sbjct: 8 KAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 104 QPDEEFLAQV----SMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGS-LHD--ILHGR 156
++ L +V +++SR++H N +++L + L E +G L H R
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR 126
Query: 157 KGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216
L I + YL K IIHRDIK N++I +D K+
Sbjct: 127 -----------LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172
Query: 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL--NAKSDVYSFGVVLLELLTGRK 274
DF + +L T GT Y APE + G + +++S GV L L+
Sbjct: 173 DFGSAAYLER--GKLFYTFC-GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEEN 228
Query: 275 PVD-------------HTLPRGQQSLVTWVLD 293
P + + + SLV+ +L
Sbjct: 229 PFCELEETVEAAIHPPYLVSKELMSLVSGLLQ 260
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 23/220 (10%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIK---KLDASKQPDEEFLAQVSMVSR 118
E + ++G+GS+G V + + A+K K A + L +V ++ +
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
L H N ++L D +S + E + G L D + RK S +I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIK 128
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTR 235
G+ Y+H+ +I+HRD+K N+L+ + KI DF LS ++
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKD-- 182
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+GT Y APE + G + K DV+S GV+L LL+G P
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-20
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 20/218 (9%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK 120
+ + + +G G++G V+ + K+ G K ++ D+ + +S++++L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H + L D VL EF S G L D + +S + + A
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQA 158
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQA-PDMAARLHSTRVL 237
+GL+++HE I+H DIK N++ + KI DF L+ + PD ++
Sbjct: 159 CEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TT 211
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
T + APE + +D+++ GV+ LL+G P
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 59/261 (22%), Positives = 97/261 (37%), Gaps = 41/261 (15%)
Query: 32 GAYHASEAAPKGAQAVKVQP----IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI 87
G++ S A G + + I+V A ++ + +IG GS+G V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 88 LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV------LAY 141
L AIKK+ Q ++ ++ +KH N V L + + L
Sbjct: 61 LVESDEVAIKKV---LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 142 EFASNGSLHDILHGRKGVKGAQPGPVL-----SWQQRVKIAVGAAKGLEYLHEKADPHII 196
E+ +++ R K Q P+L +Q + L Y+H I
Sbjct: 118 EYVPE-TVYRAS--RHYAKLKQTMPMLLIKLYMYQ--------LLRSLAYIHSI---GIC 163
Query: 197 HRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYHAPEYAMTGQL 253
HRDIK N+L+ V K+ DF + + +R Y APE
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATN 218
Query: 254 -NAKSDVYSFGVVLLELLTGR 273
D++S G V+ EL+ G+
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 8e-20
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 23/218 (10%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKH 121
I + F ++G G++ V+ + G A+K + S + L ++++ ++KH
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
EN V L T L + S G L D IL +GV + + +
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGV--------YTEKDASLVIQQV 115
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVL 237
++YLHE I+HRD+K N+L ++ I DF LS + + +
Sbjct: 116 LSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMST--AC 168
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT GY APE + D +S GV+ LL G P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-19
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKH 121
+I + + IG GS+G V + K + A KK+ D + Q + ++ L H
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
N ++L D T L E + G L + + A + +K +
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLS 117
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRV 236
A + Y H+ ++ HRD+K N L D K+ DF L+ + ++ T+V
Sbjct: 118 A---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV 169
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT Y +P+ + G + D +S GV++ LL G P
Sbjct: 170 -GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-19
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IGEG+YG V+ ++ A+K+ LD E L ++ ++ LKH+N V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRL 66
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEY 186
L +EF L G P V S+ Q +K GL +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLK-------GLGF 116
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTRVLGTFGYHA 244
H + +++HRD+K N+LI + K+A+F L+ P R +S V+ T Y
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVV-TLWYRP 169
Query: 245 PEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
P+ AK D++S G + EL +P
Sbjct: 170 PDVL----FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQLL 128
+GEG+YG VY G A+K+ LD DE + ++S++ L H N V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLD---AEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGLEYL 187
L +EF L +L K G Q + + Q ++ G+ +
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLR-------GVAHC 135
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
H+ I+HRD+K N+LI D K+ADF L+ +A + R ++ V+ T Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSYTHEVV-TLWYRAPDV 190
Query: 248 AMTGQLNAKS-----DVYSFGVVLLELLTGR 273
+ +K D++S G + E++TG+
Sbjct: 191 L----MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 38/213 (17%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQLL 128
IGEG+YG VY G A+KK L+ E + ++S++ LKH N V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLY 66
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK-IAVGAAKGLEYL 187
VL +E D+ K + G + S K + G+ Y
Sbjct: 67 DVIHTKKRLVLVFEHLD----QDL----KKLLDVCEGGLESVT--AKSFLLQLLNGIAYC 116
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN--QAPDMAARLHSTRVLGTFGYHAP 245
H++ ++HRD+K N+LI + KIADF L+ P R ++ ++ T Y AP
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIV-TLWYRAP 169
Query: 246 EYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
+ + +K D++S G + E++ G
Sbjct: 170 DVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 46/218 (21%), Positives = 87/218 (39%), Gaps = 21/218 (9%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
KE+ E + +G G +G V+ + S K + ++S+++ +H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
N + L V+ +EF S + + I L+ ++ V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQV 111
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQ-APDMAARLHSTRVL 237
+ L++LH +I H DI+ N++ + KI +F + Q P RL +
Sbjct: 112 CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LF 164
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y+APE ++ +D++S G ++ LL+G P
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-19
Identities = 59/247 (23%), Positives = 96/247 (38%), Gaps = 21/247 (8%)
Query: 43 GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIK---- 97
G+ + + ++ D+ + + +IG+G + V I + G A+K
Sbjct: 1 GSPGISGGGGGILDMADDD-VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDV 59
Query: 98 -KLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHG 155
K +S E L + S+ LKH + V+LL + +EF L +
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-- 117
Query: 156 RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA-- 213
VK A G V S + L Y H+ +IIHRD+K VL+ + +
Sbjct: 118 ---VKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAP 171
Query: 214 -KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
K+ F ++ Q + +GT + APE DV+ GV+L LL+G
Sbjct: 172 VKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 273 RKPVDHT 279
P T
Sbjct: 230 CLPFYGT 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-19
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLK---HENF 124
IG G+YG VY SGH A+K + + +V+++ RL+ H N
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 125 VQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
V+L+ C + L +E D+ + P P L + +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS-----T 234
+GL++LH I+HRD+K N+L+ K+ADF L AR++S T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
V+ T Y APE + D++S G + E+ +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-19
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+G G+Y VY G+ +G A+K+ LD+ +E + ++S++ LKHEN V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLMKELKHENIVRL 68
Query: 128 LGYCVDGTSRVLAYEFASN--GSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKGL 184
L +EF N D +G + V + Q +GL
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-------LLQGL 121
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
+ HE I+HRD+K N+LI K+ DF L+ +A + S+ V+ T Y A
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLWYRA 176
Query: 245 PEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
P+ + +++ D++S G +L E++TG+
Sbjct: 177 PDVL----MGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-19
Identities = 52/231 (22%), Positives = 84/231 (36%), Gaps = 36/231 (15%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ--------- 112
K + + + + +G G+ G V + AI+ + K
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSW 170
+ ++ +L H +++ + D + E G L D + + R +
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------- 242
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDM 227
++YLHE IIHRD+K NVL+ + + KI DF S +
Sbjct: 243 ----LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 228 AARLHSTRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ L T GT Y APE T N D +S GV+L L+G P
Sbjct: 296 S--LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 47/224 (20%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
IG+G++G V+ K+G A+KK ++ K E F L ++ ++ LKHEN V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNL 81
Query: 128 LGYCVDGTSRV--------LAYEFASNGSLHDILHGRKGVKG--AQPGPVLSWQQRVKIA 177
+ C S L ++F HD+ G + + + ++
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE----HDL-------AGLLSNVLVKFTLSEIKRVM 130
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQAPDMAARLHST 234
GL Y+H I+HRD+K++NVLI D V K+ADF L+ + A + ++
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 235 RVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
RV+ T Y PE L + D++ G ++ E+ T
Sbjct: 188 RVV-TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 60/240 (25%), Positives = 92/240 (38%), Gaps = 64/240 (26%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
+ ++ +IG GS+G VY L SG AIKK+ Q ++ ++ +L H
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNRELQIMRKLDH 106
Query: 122 ENFVQLLGYCVDGTSRV-------LAYEFASNGSLHDILHGRKGVKGAQPGPVL-----S 169
N V+L Y + L ++ +++ + R + Q PV+
Sbjct: 107 CNIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTLPVIYVKLYM 162
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIADFDLSNQAPDMA 228
+Q + L Y+H I HRDIK N+L+ D V K+ DF
Sbjct: 163 YQ--------LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS-------- 203
Query: 229 ARLHS----------TRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
A+ +R Y APE + A DV+S G VL ELL G+
Sbjct: 204 AKQLVRGEPNVSYICSRY-----YRAPE-LI---FGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-18
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 42/217 (19%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+GEG + VY + AIKK L + + L ++ ++ L H N + L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 128 LGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQRVKIAVGAAKG 183
L ++ L ++F D I+ V P + ++ +G
Sbjct: 78 LDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLT--PSHIKAYMLM-------TLQG 124
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLGTFG 241
LEYLH+ I+HRD+K +N+L+ ++ V K+ADF L+ +P+ R ++ +V+ T
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYTHQVV-TRW 177
Query: 242 YHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
Y APE A+ D+++ G +L ELL
Sbjct: 178 YRAPELL----FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
E + ++G+GS+G V + A+K ++ + D + + V ++ +
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKI 176
L H N ++L D +S + E + G L D I R S +I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----------FSEHDAARI 126
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHS 233
G+ Y+H+ +I+HRD+K N+L+ + KI DF LS
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMK 181
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
R+ GT Y APE + G + K DV+S GV+L LL+G P
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 65/270 (24%), Positives = 101/270 (37%), Gaps = 27/270 (10%)
Query: 12 MHKAADNGNAYMVKSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGT 71
MH + + + + + + A + I +++ F
Sbjct: 1 MHH---HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEV 57
Query: 72 NALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFVQLLG 129
+ +G G+ VY K A+K L K D++ + + ++ RL H N ++L
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 130 YCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
T L E + G L D I+ KG S + + + YLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIV--EKGY--------YSERDAADAVKQILEAVAYLH 165
Query: 189 EKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
E I+HRD+K N+L D KIADF LS L T GT GY AP
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAP 219
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
E + D++S G++ LL G +P
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 68 NFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ-VSMVSRLKHENFV 125
++G G +G+V+ + G A K + D+E + +S++++L H N +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
QL VL E+ G L D I+ L+ + +G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---------DESYNLTELDTILFMKQICEGI 200
Query: 185 EYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLSNQAPDMAARLHSTRVL----G 238
++H+ +I+H D+K N+L D KI DF L+ R L G
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLA-------RRYKPREKLKVNFG 250
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
T + APE ++ +D++S GV+ LL+G P
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 57/236 (24%), Positives = 87/236 (36%), Gaps = 37/236 (15%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK---------QPDEEFLAQ 112
EN+ ++G G V I K A+K +D + Q E +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 113 -VSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVL 168
V ++ ++ H N +QL T L ++ G L D L
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----------L 121
Query: 169 SWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMA 228
S ++ KI + + LH+ +I+HRD+K N+L+ DD K+ DF S Q
Sbjct: 122 SEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176
Query: 229 ARLHSTRVLGTFGYHAPE------YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
GT Y APE + D++S GV++ LL G P H
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-18
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE-----FLAQVSMVSRLK 120
E + +GEG+Y VY G K + + A+K++ + EE + +VS++ LK
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHD---ILHGRKGVKGAQPGPVLSW-QQRVKI 176
H N V L S L +E+ D L V + Q ++
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGN--IINMHNVKLFLFQLLR- 111
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
GL Y H + ++HRD+K N+LI + K+ADF L+ +A + + + V
Sbjct: 112 ------GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYDNEV 161
Query: 237 LGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
+ T Y P+ L + D++ G + E+ TGR
Sbjct: 162 V-TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKH 121
E + L+GEGSYG V +G AIKK S D+ + ++ ++ +L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRH 83
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW-QQRVKIAVGA 180
EN V LL C L +EF + ++ D L G V + Q +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQII------ 134
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS--NQAPDMAARLHSTRVLG 238
G+ + H +IIHRDIK N+L+ V K+ DF + AP ++ V
Sbjct: 135 -NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---EVYDDEVA- 186
Query: 239 TFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGR 273
T Y APE + + DV++ G ++ E+ G
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 38/260 (14%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVD--ELKEITENFGTNALIGEGSYGRVYYGILKS-GHA 93
++A PKG + + Q + D KE + + +IG G V + ++ GH
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHE 121
Query: 94 AAIKKLDASK--QPDEEFLAQVSMVSR----LK----HENFVQLLGYCVDGTSRVLAYEF 143
A+K ++ + E+ R L+ H + + L+ + L ++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 144 ASNGSLHD--ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201
G L D LS ++ I + + +LH +I+HRD+K
Sbjct: 182 MRKGELFDYLTEKVA-----------LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLK 227
Query: 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLNA 255
N+L+ D+ +++DF S GT GY APE
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEP--GEKLRELC-GTPGYLAPEILKCSMDETHPGYGK 284
Query: 256 KSDVYSFGVVLLELLTGRKP 275
+ D+++ GV+L LL G P
Sbjct: 285 EVDLWACGVILFTLLAGSPP 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 60/216 (27%), Positives = 88/216 (40%), Gaps = 43/216 (19%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEF----LAQVSMVSRLKHENFVQLLG 129
IGEGSYG V+ +G AIKK S+ D L ++ M+ +LKH N V LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHG-RKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
L +E+ H +LH + +G V S + + + + H
Sbjct: 70 VFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT------LQAVNFCH 119
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS------TRVLGTFGY 242
+ + IHRD+K N+LI V K+ DF ARL + + T Y
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGF--------ARLLTGPSDYYDDEVATRWY 168
Query: 243 HAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
+PE + DV++ G V ELL+G
Sbjct: 169 RSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-VSMVSRLK-HENFVQLLGY 130
++GEG++ RV I + A+K ++ + + V M+ + + H N ++L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ L +E GS+ +H R+ + + + A L++LH K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNK 130
Query: 191 ADPHIIHRDIKSSNVLIFD-DDVA--KIADFDLS------NQAPDMAARLHSTRVLGTFG 241
I HRD+K N+L + V+ KI DFDL ++ T G+
Sbjct: 131 ---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186
Query: 242 YHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
Y APE A D++S GV+L LL+G P
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-17
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 22/220 (10%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
+ ++N+ +G+G++ V + K+ G A K ++ K D + L + + +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
L+H N V+L + + L ++ + G L + + R+ S
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQ 112
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHSTR 235
+ + Y H I+HR++K N+L+ K+ADF L+ + D +
Sbjct: 113 QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGF 167
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT GY +PE + D+++ GV+L LL G P
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 54/253 (21%), Positives = 91/253 (35%), Gaps = 40/253 (15%)
Query: 36 ASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAA 94
A G+ P + + +F ++GEGS+ V +
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELATSREY 58
Query: 95 AIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLH 150
AIK L+ + + ++SRL H FV+L D +A NG L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKS 202
+ ++ + LEYLH K IIHRD+K
Sbjct: 119 KYI-----------------RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKP 158
Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSF 262
N+L+ +D +I DF + + + + +GT Y +PE SD+++
Sbjct: 159 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 218
Query: 263 GVVLLELLTGRKP 275
G ++ +L+ G P
Sbjct: 219 GCIIYQLVAGLPP 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 33/228 (14%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
+++ + + +G G + V KS G A K + + + R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+ H N + L + T VL E S G L D L ++ LS ++
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDM 227
G+ YLH K I H D+K N+++ D ++ K+ DF L+ +
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 176 ------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 52/245 (21%), Positives = 99/245 (40%), Gaps = 25/245 (10%)
Query: 40 APKGAQAVKVQPIEVPA-ISVDELKEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIK 97
P A Q + + ++ + ++N+ +G+G++ V + K+ G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 98 KLDASK--QPDEEFLAQ-VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-IL 153
++ K D + L + + +L+H N V+L + + L ++ + G L + I+
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 154 HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DD 210
+ S + + Y H I+HR++K N+L+
Sbjct: 121 --AREF--------YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 167
Query: 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELL 270
K+ADF L+ + D + GT GY +PE + D+++ GV+L LL
Sbjct: 168 AAVKLADFGLAIEVND--SEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
Query: 271 TGRKP 275
G P
Sbjct: 225 VGYPP 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 27/225 (12%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
+++ + + +G G + V KS G A K + + + R
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+ H N + L + T VL E S G L D L ++ LS ++
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEAT 118
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAAR 230
G+ YLH K I H D+K N+++ D ++ K+ DF L+++ +
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDG 172
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ + GT + APE L ++D++S GV+ LL+G P
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 54/231 (23%), Positives = 83/231 (35%), Gaps = 36/231 (15%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQ--------- 112
K + + + + +G G+ G V + AIK + K
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD--ILHGRKGVKGAQPGPVLSW 170
+ ++ +L H +++ + D + E G L D + + R L
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-----------LKE 113
Query: 171 QQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDM 227
++YLHE IIHRD+K NVL+ + + KI DF S +
Sbjct: 114 ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 228 AARLHSTRVLGTFGYHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
L T GT Y APE T N D +S GV+L L+G P
Sbjct: 171 --SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-17
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 43/220 (19%)
Query: 75 IGEGSYGRVYYG--ILKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLK---HEN 123
IGEG+YG+V+ + G A+K+ + + E + +V+++ L+ H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE---EGMPLSTIREVAVLRHLETFEHPN 75
Query: 124 FVQLL----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
V+L D +++ L +E D+ P P + + +
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMF 127
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS----- 233
+GL++LH ++HRD+K N+L+ K+ADF L AR++S
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMAL 176
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
T V+ T Y APE + D++S G + E+ +
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 46/221 (20%), Positives = 83/221 (37%), Gaps = 23/221 (10%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSR 118
TE + +G+G++ V + G A ++ K D + L + +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIA 177
LKH N V+L + L ++ + G L + I+ + S
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AREY--------YSEADASHCI 116
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADFDLSNQAPDMAARLHST 234
+ + + H+ ++HR++K N+L+ K+ADF L+ +
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT GY +PE D+++ GV+L LL G P
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 33/228 (14%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR--- 118
+ + + + T +G G + V KS G A K + + + R
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 119 ----LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
++H N + L + T +L E + G L D L ++ L+ ++
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------SLTEEEAT 117
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDM 227
+ G+ YLH I H D+K N+++ D +V KI DF L+ + +
Sbjct: 118 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 228 AARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 175 ------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 23/231 (9%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRL-K 120
+ T+ + IG GSY I K+ A+K +D SK+ E ++ ++ R +
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQ 74
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H N + L DG + E G L D + +K S ++ +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---------FFSEREASAVLFTI 125
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----VAKIADFDLSNQAPDMAARLHSTRV 236
K +EYLH + ++HRD+K SN+L D+ +I DF + Q L T
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-TPC 181
Query: 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 287
T + APE +A D++S GV+L +LTG P + + +
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV 132
+GEGS+ + K S A A+K + + + + +++ + + H N V+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
D L E + G L + + +K S + I + ++H+
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 193 PHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 249
++HRD+K N+L D++ KI DF + P L + T Y APE
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLN 182
Query: 250 TGQLNAKSDVYSFGVVLLELLTGRKP 275
+ D++S GV+L +L+G+ P
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-16
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 33/226 (14%)
Query: 65 ITENFGTNALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSR----- 118
+ +++ +G G + V K G A K + + + R
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 119 --LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
++H N + L + T VL E S G L D L ++ L+ + +
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---------SLTEDEATQF 113
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLS---NQAPDMAA 229
G+ YLH K I H D+K N+++ D +V K+ DF ++ +
Sbjct: 114 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 169 ----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 22/224 (9%)
Query: 61 ELKEIT-ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV--S 114
E + + + F ++G G +G V+ +K +G A KKL K+ A V
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
+++++ F+ L Y + + + L + G + ++ + P + R
Sbjct: 238 ILAKVHSR-FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY-----NVDEDNPGFQ-EPR 290
Query: 174 VKI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
GLE+LH++ +II+RD+K NVL+ DD +I+D L+ + +
Sbjct: 291 AIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
GT G+ APE + G+ S D ++ GV L E++ R P
Sbjct: 348 -GYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 29/220 (13%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV-----SMVSR 118
+F + +IG G +G VY +G A+K L K E LA S+VS
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 119 LKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI- 176
F+ + Y ++ + + G LH L + ++
Sbjct: 249 GDCP-FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----------EADMRFY 297
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
A GLE++H + +++RD+K +N+L+ + +I+D L+ V
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 351
Query: 237 LGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
GT GY APE G S D +S G +L +LL G P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 43/218 (19%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKK--LDASKQPDEEF----LAQVSMVSRLKHENFVQL 127
+GEG+YG VY I + AIK+ L+ + E + +VS++ L+H N ++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE---EGVPGTAIREVSLLKELQHRNIIEL 98
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
L +E+A N L + V + S+ ++ G+ +
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDV---SMRVIKSFLYQL------INGVNFC 148
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVA-----KIADFDL--SNQAPDMAARLHSTRVLGTF 240
H + +HRD+K N+L+ D + KI DF L + P R + ++ T
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHEII-TL 201
Query: 241 GYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGR 273
Y PE L ++ D++S + E+L
Sbjct: 202 WYRPPEIL----LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-16
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 38/230 (16%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEFLAQVSMVSRL 119
++ + F + G+G++G V G K +G + AIKK D + E L + ++ L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVL 76
Query: 120 KHENFVQLLGYCVDGTSR--------VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
H N VQL + E+ + +LH R + P + +
Sbjct: 77 HHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC--RNYYRRQVAPPPILIK 132
Query: 172 ----QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPD 226
Q + + LH + ++ HRDIK NVL+ + D K+ DF + +
Sbjct: 133 VFLFQ-------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 227 MAARLH--STRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
+ +R Y APE Q + D++S G + E++ G
Sbjct: 185 SEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 43/221 (19%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-H 121
+++ +G G Y V+ I + + +K L K ++ ++ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90
Query: 122 ENFVQLLGYCVDGTSRVLAY--EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
N + L D SR A E +N + L+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYE 138
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLS---NQAPDMAARLHSTR 235
K L+Y H I+HRD+K NV+I + ++ D+ L+ + + R+ ++R
Sbjct: 139 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASR 194
Query: 236 VLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
+ PE + Q+ S D++S G +L ++ ++P
Sbjct: 195 Y-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 61 ELKEIT-ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDEEFLAQV--S 114
E + +T F ++G+G +G V ++ +G A KKL K+ E +A
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 115 MVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSL--HDILHGRKGVKGAQPGPVLSWQ 171
++ ++ FV L Y + + L + G L H G+ G +
Sbjct: 237 ILEKVNSR-FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP----------E 285
Query: 172 QRVKI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230
R A GLE LH + I++RD+K N+L+ D +I+D L+ P+ +
Sbjct: 286 ARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQ 340
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
RV GT GY APE + + S D ++ G +L E++ G+ P
Sbjct: 341 TIKGRV-GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 29/212 (13%)
Query: 74 LIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYC 131
++G G G+V + G A+K L S + +E V + + V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCILDVY 91
Query: 132 VDGTSRVLAY----EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
+ E G L I +G + + ++ +I +++
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQA------FTEREAAEIMRDIGTAIQF 143
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
LH +I HRD+K N+L + V K+ DF + + T T Y
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPC-YTPYYV 196
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + + D++S GV++ LL G P
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 49/236 (20%)
Query: 64 EITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------DEEFLAQ---- 112
+ + I GSYG V G+ G AIK++ + + FL +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 113 -VSMVSRLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKG 158
+ +++ H N + L Y V E L ++H ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLV--------TELMRT-DLAQVIHDQR- 128
Query: 159 VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218
V+S Q GL LHE A ++HRD+ N+L+ D++ I DF
Sbjct: 129 -------IVISPQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDF 178
Query: 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
+L+ + A + T + Y APE M + K D++S G V+ E+ +
Sbjct: 179 NLARED---TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 32/222 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ + + IG G+ G V AIKKL S+ + A+ + ++
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMK 116
Query: 118 RLKHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+ H+N + LL + L E + +L ++ L +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ--------ME---LDHE 164
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ + G+++LH IIHRD+K SN+++ D KI DF L+ A
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SF 218
Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
T + T Y APE + D++S G ++ E++ +
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 44/248 (17%), Positives = 80/248 (32%), Gaps = 52/248 (20%)
Query: 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKK--LDASKQPDEEFLAQVSMVSRLKH 121
++ + +G GS+G V SG A+KK D + E + ++ L H
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE-----LDIMKVLDH 59
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSW----------- 170
N ++L+ Y + + V
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 171 -----QQRVKIAVGAA----------------KGLEYLHEKADPHIIHRDIKSSNVLIF- 208
+ +K + + + + ++H I HRDIK N+L+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176
Query: 209 DDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVV 265
D+ K+ DF + + + +R Y APE + D++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCV 231
Query: 266 LLELLTGR 273
EL+ G+
Sbjct: 232 FGELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 6e-15
Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 4/113 (3%)
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
L+ + + + AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKP 275
+ + APE +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-15
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 32/222 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ + + IG G+ G V AIKKL S+ + A+ + ++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMK 79
Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+ H+N + LL ++ V + E +L ++ L +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ--------ME---LDHE 127
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ + G+++LH IIHRD+K SN+++ D KI DF L A
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSF 181
Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
T + T Y APE + D++S G ++ E++ G
Sbjct: 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
E+ E + + +G G+YG V K+G A+KKL S+ A+ + ++
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLK 83
Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
+KHEN + LL ++ + V L L++I+ +K L+
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDD 132
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARL 231
+ +GL+Y+H IIHRD+K SN+ + +D KI DF L+ D
Sbjct: 133 HVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
+TR Y APE + ++ D++S G ++ ELLTGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 36/224 (16%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
E+ + +G G+YG V + ++G AIKKL + E A+ + ++
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLK 79
Query: 118 RLKHENFVQLLGYCVDGTSRV------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++HEN + LL + L F L ++ + L
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-------HEK---LGED 128
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAAR 230
+ + KGL Y+H IIHRD+K N+ + +D KI DF L+ +M
Sbjct: 129 RIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--- 182
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
T + T Y APE + ++ D++S G ++ E++TG+
Sbjct: 183 ---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
E+ + + + +G G+YG V I +SG AIKKL S+ E A+ + ++
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLK 78
Query: 118 RLKHENFVQLL-----GYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQ 171
++HEN + LL + L F L I+ + S +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-----------FSEE 126
Query: 172 QRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAAR 230
+ + KGL+Y+H ++HRD+K N+ + +D KI DF L+ + +M
Sbjct: 127 KIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
T + T Y APE ++ ++ D++S G ++ E+LTG+
Sbjct: 181 ---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 29/213 (13%)
Query: 75 IGEGSYGRVYYGILKS-GHAAAIKKLDASK--QPDEEFLAQ-VSMVSRLKH-ENFVQLLG 129
+G G + V I KS G A K L + Q + ++++ K + L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 130 YCVDGTSRVLAYEFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + +L E+A+ G + L + ++S +++ +G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCL--------PELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVA---KIADFDLS---NQAPDMAARLHSTRVLGTFGY 242
+ +I+H D+K N+L+ KI DF +S A ++ ++GT Y
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL------REIMGTPEY 199
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
APE + +D+++ G++ LLT P
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-14
Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
++ + +G G G V+ + AIKK+ + + + ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS----VKHALREIKIIR 63
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDI----------LHGRKGVKGAQPGPV 167
RL H+N V++ + + L + S L+ + L V P
Sbjct: 64 RLDHDNIVKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN---VLEQGP--- 116
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLS-NQAP 225
L + +GL+Y+H +++HRD+K +N+ I +D V KI DF L+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
+ + H + L T Y +P ++ K+ D+++ G + E+LTG+
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
++ + + IGEG+YG V + AIKK+ + + Q + ++
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILL 80
Query: 118 RLKHENFVQLLGYCVDGTSRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
R +HEN + + T + + L+ +L Q LS
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK-------TQH---LSNDH 129
Query: 173 RVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-NQAPDMAARL 231
+GL+Y+H A+ ++HRD+K SN+L+ KI DF L+ PD
Sbjct: 130 ICYFLYQILRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 232 HSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
T + T Y APE + + KS D++S G +L E+L+ R
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 50/261 (19%), Positives = 91/261 (34%), Gaps = 28/261 (10%)
Query: 25 KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVY 84
T H P Q + + + I + T+ ++G G G+V
Sbjct: 20 PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79
Query: 85 YGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY- 141
K + A+K L + E V + R + + V+++ + +
Sbjct: 80 QIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLL 135
Query: 142 ---EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIH 197
E G L I + + ++ +I + ++YLH +I H
Sbjct: 136 IVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 184
Query: 198 RDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
RD+K N+L + K+ DF + + +T T Y APE + +
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC-YTPYYVAPEVLGPEKYD 241
Query: 255 AKSDVYSFGVVLLELLTGRKP 275
D++S GV++ LL G P
Sbjct: 242 KSCDMWSLGVIMYILLCGYPP 262
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 51/244 (20%), Positives = 88/244 (36%), Gaps = 39/244 (15%)
Query: 49 VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASK 103
+ + + +L+ E++ +IG G++G V K + A+K L +
Sbjct: 51 LSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 110
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
F + +++ VQL Y F + L+ ++ G
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLF------------YAFQDDRYLYMVMEYMPG----- 153
Query: 164 PGPVLSWQQRVKIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215
G +++ + A+ L+ +H IHRD+K N+L+ K+
Sbjct: 154 -GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL 209
Query: 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLNAKSDVYSFGVVLLELLT 271
ADF + T V GT Y +PE G + D +S GV L E+L
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
Query: 272 GRKP 275
G P
Sbjct: 269 GDTP 272
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 56/300 (18%), Positives = 102/300 (34%), Gaps = 55/300 (18%)
Query: 25 KSSAGTDGAYHASEAAPKGAQAVKVQPIEVPAISVDELK---EITENFGTNALIGEGSYG 81
+ G H + + Q K P S+ +I + + LIG GSYG
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67
Query: 82 RVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVSRLKHENFVQLLGYCVDGT 135
V AIKK+ + ++ + +++++RL H++ V++L +
Sbjct: 68 HVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125
Query: 136 SRV-----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+ E A + + L+ + G++Y+H
Sbjct: 126 VEKFDELYVVLEIADS-DFKKLFRTP------VY---LTELHIKTLLYNLLVGVKYVHS- 174
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---------NQAPDMAARLHSTRVLGTFG 241
A I+HRD+K +N L+ D K+ DF L+ N ++ R ++
Sbjct: 175 AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
Query: 242 YHAPEYAMTGQ------------LNAKS-----DVYSFGVVLLELLTGRKPVDHTLPRGQ 284
+ +TG L ++ DV+S G + ELL K
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L+YL + IIHRD+K N+L+ + I DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 243 HAPE--YAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + G + + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-13
Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 53/238 (22%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
I+ +F +L+GEG+YG V +G AIKK++ D+ A + ++
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILK 64
Query: 118 RLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
KHEN + + Y + E LH ++ Q
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYII--------QELMQT-DLHRVIS-------TQM 108
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
LS + ++ LH ++ +IHRD+K SN+LI + K+ DF L+
Sbjct: 109 ---LSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 225 PDMAARLHSTRVLGTFG--------YHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGR 273
+ AA + Y APE +T +++ DV+S G +L EL R
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 34/222 (15%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
F L+G+G++G+V K +G A+K L K E + V+ EN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL--KK----EVIVAKDEVAHTLTENRV 201
Query: 124 -------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
F+ L Y R+ E+A+ G L H + ++ R +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED--------RAR 251
Query: 176 I-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
L+YLH + + +++RD+K N+++ D KI DF L + A + +
Sbjct: 252 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308
Query: 235 RVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
GT Y APE + ++ D + GVV+ E++ GR P
Sbjct: 309 -FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 8e-12
Identities = 43/248 (17%), Positives = 77/248 (31%), Gaps = 54/248 (21%)
Query: 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKL---------DASKQPDEEFLAQVSMV 116
TE IGEG +G V+ I AIK + + ++ EE L ++ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 117 SRL---------KHENFVQLLG-YCVDGT---SRVLAYEF--ASNGSLHDILHGRKGVKG 161
L + E F+ L +CV G+ + A++ ++ GS +D K +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 162 --------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207
+ S I L HRD+ NVL+
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195
Query: 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP--EYAMTGQLNAKSDVYSFGVV 265
+ K+ + + + G +Y ++ V+ +
Sbjct: 196 KKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 266 LLELLTGR 273
+L TG
Sbjct: 245 DEDLFTGD 252
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 42/238 (17%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEE-FLAQ 112
V +++ E+F +IG G++G V LK + A+K L+ K+ + F +
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 113 VSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQ 172
++ + L Y F + +L+ ++ G G +L+
Sbjct: 125 RDVLVNGDSKWITTLH------------YAFQDDNNLYLVMDYYVG------GDLLTLLS 166
Query: 173 RV--KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
+ ++ A+ ++ +H+ H +HRDIK N+L+ + ++ADF
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-----DVYSFGVVLLELLTGRKP 275
+ + S V GT Y +PE + D +S GV + E+L G P
Sbjct: 224 KLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 52/224 (23%), Positives = 88/224 (39%), Gaps = 42/224 (18%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
+ F +G GS+GRV K SG+ A+K LD KQ E L + ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQAVN 99
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
V+L D ++ + E+ + G + L ++ + +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----------------RRIGRFSEPH 142
Query: 181 AK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
A+ EYLH +I+RD+K N+LI ++ DF + +
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194
Query: 233 STRVL-GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
T L GT APE ++ N D ++ GV++ E+ G P
Sbjct: 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 45/249 (18%), Positives = 89/249 (35%), Gaps = 44/249 (17%)
Query: 49 VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD----ASK 103
+Q E + + E++ ++F +IG G++ V +K +G A+K ++ +
Sbjct: 43 LQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR 102
Query: 104 QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQ 163
F + ++ QL + F L+ ++ G
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQL------------HFAFQDENYLYLVMEYYVG----- 145
Query: 164 PGPVLSWQQRV--KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213
G +L+ + +I A+ ++ +H +HRDIK N+L+
Sbjct: 146 -GDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHI 201
Query: 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVY-------SFGVVL 266
++ADF + + S +GT Y +PE + Y + GV
Sbjct: 202 RLADFGSCLKL-RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 267 LELLTGRKP 275
E+ G+ P
Sbjct: 261 YEMFYGQTP 269
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 7e-11
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L++LH II+RD+K N+L+ ++ K+ DF LS ++ D + +S GT Y
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + + + +S D +SFGV++ E+LTG P
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 53/252 (21%), Positives = 90/252 (35%), Gaps = 63/252 (25%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ +N+ LIG GSYG VY + AIKK+ ++ ++ + +++++
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILN 80
Query: 118 RLKHENFVQLLG-------------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP 164
RLK + ++L Y V E A + L +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIV--------LEIADS-DLKKLFKTP------IF 125
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224
L+ + I G ++HE + IIHRD+K +N L+ D K+ DF L+
Sbjct: 126 ---LTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 225 PDMAARLHSTRVLGTFG--------------------YHAPEYAMTGQLNAKS-DVYSFG 263
+ Y APE + + KS D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
Query: 264 VVLLELLTGRKP 275
+ ELL +
Sbjct: 240 CIFAELLNMLQS 251
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKL--DASKQPDE--------EFLAQVSM 115
+F ++G+GS+G+V K + A+K L D Q D+ LA
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG- 399
Query: 116 VSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
K QL C R+ E+ + G L + H ++ + +P
Sbjct: 400 ----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP--------HA 444
Query: 175 KI-AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
A A GL +L K II+RD+K NV++ + KIADF + + ++ + +
Sbjct: 445 VFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTT 499
Query: 234 TRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
GT Y APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 500 KTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L +LH+K II+RD+K N+++ K+ DF L ++ H+ GT Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + + ++ D +S G ++ ++LTG P
Sbjct: 188 MAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 41/211 (19%), Positives = 73/211 (34%), Gaps = 49/211 (23%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCV 132
+G G G+V K + A+K L + E V + R + + V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYE 81
Query: 133 DGTSRVLAY----EFASNGSLHD-ILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+ + E G L I + + ++ +I + ++YL
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 188 HEKADPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
H +I HRD+K N+L + K+ DF A + G Y
Sbjct: 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTGE-KY-- 175
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ D++S GV++ LL G P
Sbjct: 176 ---------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
++F +IG GSY +V LK + A+K + K E + + ++ E
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV--KK----ELVNDDEDIDWVQTEKHV 62
Query: 124 --------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
F+ L C SR+ E+ + G L H Q++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FH---------------MQRQR 105
Query: 175 KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
K+ A+ L YLHE+ II+RD+K NVL+ + K+ D+ + +
Sbjct: 106 KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
+ GT Y APE + G+ S D ++ GV++ E++ GR P
Sbjct: 163 PGDTTST--FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
LEYLH + +++RDIK N+++ D KI DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + ++ D + GVV+ E++ GR P
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 49/216 (22%), Positives = 77/216 (35%), Gaps = 31/216 (14%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IGEGS+G ++ G L + AIK S P + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFGQ 76
Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+G VL + SL D+L GRK S + A ++ +HEK
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIHEK 125
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAK-----IADFDLSNQAPDMAARLH-----STRVLGTF 240
+++RDIK N LI + + DF + D + H + GT
Sbjct: 126 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 241 GYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
Y G + + + D+ + G V + L G P
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 52/247 (21%), Positives = 94/247 (38%), Gaps = 61/247 (24%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQ-----VSMVS 117
+ + +G+G+YG V+ I ++G A+KK+ AQ + +++
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILT 63
Query: 118 RLK-HENFVQLLG----------YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGP 166
L HEN V LL Y V +++ LH ++ A
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLV--------FDYMET-DLHAVIR-------ANI-- 105
Query: 167 VLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS---NQ 223
L + + K ++YLH ++HRD+K SN+L+ + K+ADF LS
Sbjct: 106 -LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTG------------QLNAKS-----DVYSFGVVL 266
+ + + T + + +T L + D++S G +L
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 267 LELLTGR 273
E+L G+
Sbjct: 222 GEILCGK 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-- 123
++F +IG GSY +V LK + A++ + K E + + ++ E
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV--KK----ELVNDDEDIDWVQTEKHV 105
Query: 124 --------FVQLLGYCVDGTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
F+ L C SR+ E+ + G L H Q++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM--FH---------------MQRQR 148
Query: 175 KIAVGAAK--------GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226
K+ A+ L YLHE+ II+RD+K NVL+ + K+ D+ + +
Sbjct: 149 KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205
Query: 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
+ GT Y APE + G+ S D ++ GV++ E++ GR P
Sbjct: 206 PGDTTST--FCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 29/214 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCV 132
IG GS+G +Y G + +G AIK + K + + + ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+G V+ E SL D+ RK S + + +A +EY+H K
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK----------FSLKTVLLLADQMISRIEYIHSK 124
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAK---IADFDLSNQAPDMAARLH-----STRVLGTFGY 242
+ IHRD+K N L+ I DF L+ + D H + + GT Y
Sbjct: 125 ---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 243 HAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
A G + + + D+ S G VL+ G P
Sbjct: 182 -ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 8e-10
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L +LH+K II+RD+K NVL+ + K+ADF + + + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDY 190
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + L + D ++ GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-10
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 7/94 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
L YLH +I++RD+K N+L+ + DF L + ++ ++ GT Y
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEY 205
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + Q ++ D + G VL E+L G P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL++LH K I++RD+K N+L+ D KIADF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + GQ S D +SFGV+L E+L G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL-GTFG 241
LE+LH+ II+RDIK N+L+ + + DF LS + +A GT
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIE 225
Query: 242 YHAPE---YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y AP+ +G A D +S GV++ ELLTG P
Sbjct: 226 YMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASP 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL +L K II+RD+K NV++ + KIADF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 33/217 (15%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG G++G + G L + AIK S+ P + + Q+ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFGP 75
Query: 133 DGTSRVLAYEFASNG-SLHDI--LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
G + E G SL D+ L R S + + IA+ +EY+H
Sbjct: 76 CGKYNAMVLELL--GPSLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVHS 123
Query: 190 KADPHIIHRDIKSSNVLI-----FDDDVAKIADFDLSNQAPDMAARLH-----STRVLGT 239
K ++I+RD+K N LI V I DF L+ + D + H + GT
Sbjct: 124 K---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 240 FGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
Y G + + + D+ + G + + L G P
Sbjct: 181 ARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 5e-09
Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLD-----ASKQPDEEFLAQVSMVSRLK 120
++F +G GS+GRV+ + +G A+K L KQ E + M+S +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIVT 64
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSL--HDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
H +++ G D + ++ G L L QR V
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-----------------LRKSQRFPNPV 107
Query: 179 G---AAK---GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH 232
AA+ LEYLH K II+RD+K N+L+ + KI DF + PD+
Sbjct: 108 AKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 159
Query: 233 STRVL-GTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKP 275
T L GT Y APE ++ + KS D +SFG+++ E+L G P
Sbjct: 160 -TYTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 40/242 (16%), Positives = 75/242 (30%), Gaps = 63/242 (26%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIK-----KLDASKQPDEEFLAQVSMVSRLKHE-NFVQL 127
IG+G +G +Y + S + K++ S L E F Q
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG------------PLFTELKFYQR 89
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP--------GP----VLSWQQR-- 173
+ + G G G G + +
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 174 -----VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPD 226
+++++ LEY+HE +H DIK+SN+L+ + ++ D+ L+ +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 227 MAARLH-----STRVLGTFGYHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGR 273
GT E+ ++A + D+ G +++ LTG
Sbjct: 207 EGVHKAYAADPKRCHDGT-----IEFT---SIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
Query: 274 KP 275
P
Sbjct: 259 LP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 52/282 (18%), Positives = 91/282 (32%), Gaps = 61/282 (21%)
Query: 31 DGAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LK 89
+H S G + + Q + P V + + IG G +G +Y
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDM-EGNQWVLGKKIGSGGFGLIYLAFPTN 60
Query: 90 SGHAAAIK--KLDASKQP--DEEF-----LAQVSMVSRLKHENFVQLLG-----YC---- 131
A K++ + E +A+ + + + LG
Sbjct: 61 KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120
Query: 132 -VDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ R + E L I +G VL ++ + LEY+H
Sbjct: 121 FKGRSYRFMVMERLGI-DLQKISGQNGTFKKST-----VL------QLGIRMLDVLEYIH 168
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPDMAARLH----STRVL-GTFG 241
E +H DIK++N+L+ + ++ AD+ LS + + GT
Sbjct: 169 EN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT-- 223
Query: 242 YHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGRKP 275
E+ L+A +SDV G +L L G+ P
Sbjct: 224 ---IEFT---SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA------KIADFDLSNQAPDMAARLHSTR 235
GL+Y+H + IIH DIK NVL+ D KIAD + + TR
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
Y +PE + +D++S ++ EL+TG
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCV 132
IG GS+G +Y G +++ AIK + K + L + + L+ + + V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 133 DGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
+G VL + SL D+ RK LS + + +A +E++H K
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK----------LSLKTVLMLADQMINRVEFVHSK 122
Query: 191 ADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLH-----STRVLGTFGY 242
+HRDIK N L+ + I DF L+ + D + H + + GT Y
Sbjct: 123 ---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 243 HAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKP 275
A G + + + D+ S G VL+ L G P
Sbjct: 180 -ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 43/286 (15%), Positives = 88/286 (30%), Gaps = 63/286 (22%)
Query: 32 GAYHASEAAPKGAQAVKVQPIEVPAISVDELKEITENFGTN----ALIGEGSYGRVYYGI 87
+H S G + + Q + ++ +T+ G + + G +Y
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAA 62
Query: 88 -LKSGHAAAIK-------KLDASKQP------------DEEFLAQVSMVSRLKHENFVQL 127
+ + KLDA + + +
Sbjct: 63 PTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122
Query: 128 LGY-CVDGTSRVLAYEFASNGSLHDILH--GRKGVKGAQPGPVLSWQQRVKIAVGAAKGL 184
+G+ R L SL L + VLS + +++A L
Sbjct: 123 MGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKH---------VLSERSVLQVACRLLDAL 172
Query: 185 EYLHEKADPHIIHRDIKSSNVLIFDDDVAKI--ADFDLSNQAPD----MAARLHSTRVL- 237
E+LHE +H ++ + N+ + +D +++ A + + + +A S
Sbjct: 173 EFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE 229
Query: 238 GTFGYHAPEYAMTGQLNA--------KSDVYSFGVVLLELLTGRKP 275
G E+ ++ +SD+ S G +L+ L G P
Sbjct: 230 GD-----LEFI---SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 47/221 (21%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE----- 122
+IG+GS+G+V K A+K + +Q EE + ++ L+ +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNT 158
Query: 123 -NFVQLLGY-------CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
N + +L C + +E S +L++++ K S
Sbjct: 159 MNVIHMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQG-------FSLPLVR 203
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQAPDMAARLH 232
K A + L+ LH IIH D+K N+L+ + K+ DF S
Sbjct: 204 KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
+R F Y APE + + D++S G +L ELLTG
Sbjct: 261 QSR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 26/136 (19%), Positives = 41/136 (30%), Gaps = 46/136 (33%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV----- 236
+GL+YLH K IIH DIK N+L+ ++ + + A S
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 237 ----------------------LGTFG-----------------YHAPEYAMTGQLNAKS 257
+ G Y + E + N +
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 258 DVYSFGVVLLELLTGR 273
D++S + EL TG
Sbjct: 275 DIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 8/94 (8%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA--KIADFDLSNQAPDMAARLHSTRVLGT 239
L +L + IIH D+K N+L+ + + KI DF S Q +
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSR 222
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273
F Y +PE + + D++S G +L+E+ TG
Sbjct: 223 F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 47/245 (19%), Positives = 81/245 (33%), Gaps = 75/245 (30%)
Query: 73 ALIGEGSYGRVYYGI-LKSGHAAAIK----KLDASKQPDEEFLAQVSMVSRLKHE----- 122
+G+G++GRV + + A+K ++ E ++ +++++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96
Query: 123 NFVQLLGY-------CVDGTSRVLAYEFASNGSLHDIL--HGRKGVKGAQPGPVLSWQQR 173
N V+ G C L +E SL++I+ + G +
Sbjct: 97 NIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNG---------FHIEDI 139
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
+ K L YL + + H D+K N+L+ D K +
Sbjct: 140 KLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 234 TRV---LGTFG-----------------YHAPE------YAMTGQLNAKSDVYSFGVVLL 267
L FG Y APE + + SD++SFG VL
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDV------SSDMWSFGCVLA 250
Query: 268 ELLTG 272
EL TG
Sbjct: 251 ELYTG 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 4e-04
Identities = 41/241 (17%), Positives = 81/241 (33%), Gaps = 81/241 (33%)
Query: 49 VQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEE 108
VQ + +S +E+ I + +A+ G+ R+++ +L K ++ + + +
Sbjct: 38 VQDMPKSILSKEEIDHIIMS--KDAV--SGTL-RLFWTLLSKQEEMVQKFVEEVLRINYK 92
Query: 109 FLA--------QVSMVSRL------KHENFVQLLG-YCVDGTSRVLA-----YEFASNGS 148
FL Q SM++R+ + N Q+ Y V L E +
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 149 LHDILHGRKG---------------VKGAQPGPVLSWQQRVKIAVGAA-------KGLEY 186
+ ++ G G V+ + W + + + L+
Sbjct: 153 V--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W-----LNLKNCNSPETVLEMLQK 204
Query: 187 LHEKADP----------HIIHR--DIKSS-----------NVLIFDDDV--AKIAD-FDL 220
L + DP +I R I++ N L+ +V AK + F+L
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL 264
Query: 221 S 221
S
Sbjct: 265 S 265
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 37/115 (32%)
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV-LGTF 240
L +LH + + H D+K N+L + + + + S + + +T + + F
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK----SVKNTSIRVADF 186
Query: 241 G-----------------YHAPE------YAMTGQLNAKSDVYSFGVVLLELLTG 272
G Y PE +A DV+S G +L E G
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGWAQ------PCDVWSIGCILFEYYRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 293 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.82 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.63 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.43 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.32 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 99.08 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.96 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.86 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.79 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.67 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.4 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.31 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 98.13 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 98.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.09 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 98.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.28 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.25 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.66 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 83.49 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=386.08 Aligned_cols=202 Identities=26% Similarity=0.376 Sum_probs=184.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|++++++++||||+++++++++.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999987 8999999999643 345577999999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++||+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 112 Ey~~gG~L~~~i~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 9999999999998654 3999999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+.+............+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 87654433344567889999999999999999999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=386.51 Aligned_cols=200 Identities=29% Similarity=0.475 Sum_probs=181.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
+.|++.+.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999987 79999999996443 34466889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+||+|.+++.+.. +++.+++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.+
T Consensus 154 ~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 154 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 9999999997653 999999999999999999999999 999999999999999999999999999866
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.++
T Consensus 221 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 221 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp CSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 4322 223567899999999999999999999999999999999999999987644
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-56 Score=383.18 Aligned_cols=203 Identities=27% Similarity=0.420 Sum_probs=176.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++++.||+|+||+||+|+++ +|+.||||++....... +.+.+|++++++|+|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999987 79999999997655443 568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
||+||+|.+++..... ..+++.+++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 y~~gg~L~~~i~~~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-------VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp CCTTCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred CCCCCcHHHHHHHcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccce
Confidence 9999999999975542 23799999999999999999999999 9999999999999999999999999998
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 174 ~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 230 (350)
T 4b9d_A 174 VLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230 (350)
T ss_dssp CCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 7654221 23457899999999999999999999999999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=386.36 Aligned_cols=200 Identities=29% Similarity=0.475 Sum_probs=181.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
+.|++.+.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46999999999999999999987 79999999996543 34467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+||+|.++++... +++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++.+
T Consensus 231 ~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 231 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999999997654 999999999999999999999999 999999999999999999999999999866
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++
T Consensus 298 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 298 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp CSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 4322 223567899999999999999999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=361.05 Aligned_cols=198 Identities=28% Similarity=0.419 Sum_probs=164.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||+|.++ +++.||+|++.+.. .....+.+|++++++++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999987 79999999996543 23457899999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+ +|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|
T Consensus 93 Ey~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla 159 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLS 159 (275)
T ss_dssp ECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred eCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCC
Confidence 999 679999887654 3999999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+...... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+
T Consensus 160 ~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 160 NIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 8654322 2355789999999999998776 579999999999999999999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=371.22 Aligned_cols=199 Identities=27% Similarity=0.352 Sum_probs=174.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
+.|.+.+.||+|+||+||+|+++ +|+.||||+++..... .+|+.++++++|||||++++++.+.+..||||||++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 46888899999999999999987 7999999999754432 469999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEeccccCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQA 224 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg~~~~~ 224 (293)
||+|.++++... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+++..
T Consensus 134 gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 134 GGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp TCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999999998654 3999999999999999999999999 99999999999999887 6999999999866
Q ss_pred Cccccc---ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAAR---LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 432211 122346799999999999999999999999999999999999999987654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=368.96 Aligned_cols=201 Identities=25% Similarity=0.343 Sum_probs=172.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|++.+.||+|+||+||+|+.. +++.||+|++.+.. .....+.+|++++++++||||+++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 57889999986532 123467889999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||++||+|.+++.+.. .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 vmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEcCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999999999998654 4999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|+...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 231 (304)
T 3ubd_A 172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231 (304)
T ss_dssp EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence 997654322 223567899999999999999999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=361.34 Aligned_cols=201 Identities=30% Similarity=0.507 Sum_probs=169.1
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+++.+.+.||+|+||+||+|+++ ..||||+++...... +.|.+|++++++++|||||++++++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 57888999999999999999876 359999997554433 568899999999999999999998754 568999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++|+|.+++..... .+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.
T Consensus 113 ~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 113 CEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp CSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred CCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 999999999975542 4999999999999999999999998 99999999999999999999999999987
Q ss_pred CCcccccccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.............+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+..+
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 654433334456789999999999864 3589999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=365.64 Aligned_cols=212 Identities=26% Similarity=0.480 Sum_probs=178.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|.+.+.||+|+||+||+|++. ++..||||+++.... ..++|.+|++++++++|||||++++++.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999864 477899999975432 23578999999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 140 AYEFASNGSLHDILHGRKGV----KGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
||||+++|+|.++++..... ........+++.+++.|+.|++.||+|||+++ |+||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999764210 00011235999999999999999999999998 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.++
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999976544333333345678999999999999999999999999999999999 9999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=356.57 Aligned_cols=196 Identities=29% Similarity=0.446 Sum_probs=169.9
Q ss_pred CCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEe----CCeeEEEE
Q 022706 70 GTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLAY 141 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 141 (293)
++.+.||+|+||+||+|.++ ++..||+|++...... .+.+.+|++++++++|||||++++++.+ ...++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 67778999999999999987 7999999999754433 3568899999999999999999999875 35679999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~ 220 (293)
||++||+|.+++++.. .+++..++.++.||+.||+|||+++ .+|+||||||+|||++. ++.+||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp ECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcC
Confidence 9999999999998654 4899999999999999999999874 34999999999999984 78999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..
T Consensus 179 a~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 179 ATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp GGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 975432 12356789999999998764 69999999999999999999999997643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=364.14 Aligned_cols=212 Identities=25% Similarity=0.446 Sum_probs=172.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|.+.+.||+|+||+||+|+++ +++.||||+++.... ..++|.+|+++|++++|||||++++++.+....+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57888899999999999999864 478899999975432 23678999999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 140 AYEFASNGSLHDILHGRKGVKG------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
||||+++|+|.++++....... ......+++.+++.|+.|++.||+|||+++ |+||||||+|||+++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976542110 111235999999999999999999999998 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999999987654443334456779999999999999999999999999999999999 9999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-53 Score=360.05 Aligned_cols=212 Identities=29% Similarity=0.436 Sum_probs=181.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.++++.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.++++++|||||++++++.+....+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46778889999999999999863 467899999975433 3578999999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 139 LAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
+||||+++|+|.+++..+..... ......+++.+++.|+.||+.||+|||+++ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975432111 011235899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++||+|||+++...............||+.|+|||++.+..++.++|||||||+||||+| |+.||.+.++
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999987654443334456789999999999999999999999999999999998 8999987654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=350.59 Aligned_cols=201 Identities=26% Similarity=0.444 Sum_probs=163.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCC-------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------- 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 135 (293)
.++|++.+.||+|+||+||+|+++ +++.||||++...... .+.+.+|++++++++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 457999999999999999999987 8999999998654432 356889999999999999999999987644
Q ss_pred -----eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC
Q 022706 136 -----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 136 -----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
..|+|||||++|+|.++++..... ...++..++.++.||++||+|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI------EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSG------GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCC------ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence 368999999999999999865421 12566778999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCccccc----------ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 211 DVAKIADFDLSNQAPDMAAR----------LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
+.+||+|||+++........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999999999876433211 12234679999999999999999999999999999999996 8864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=361.01 Aligned_cols=203 Identities=24% Similarity=0.384 Sum_probs=175.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEe------CC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVD------GT 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 135 (293)
.++|++++.||+|+||+||+|.++ +|+.||||+++...... ..+.+|+++|++++||||+++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999987 89999999997655433 467899999999999999999998764 35
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
.+||||||++ |+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence 7899999996 58999987654 4999999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccc--ccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||+++.+.... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 9999998764322 22234567899999999998875 569999999999999999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=350.25 Aligned_cols=202 Identities=25% Similarity=0.389 Sum_probs=163.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCC----eeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 141 (293)
.++|.+.+.||+|+||+||+|+++ |+.||||++...........+|+..+.+++||||+++++++.+.+ ..+|||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 357888999999999999999985 899999999754433333445666677889999999999998654 579999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCceEEcCCCceEEe
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-----DPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
||+++|+|.++++... +++.+++.++.|++.||+|||++. ..+|+||||||+|||++.++++||+
T Consensus 81 Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred cCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 9999999999998654 899999999999999999999861 1139999999999999999999999
Q ss_pred ccccCCCCCcccc--cccccccccCcccccccccccC------CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 217 DFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 217 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
|||+++....... .......+||+.|+|||++.+. .++.++|||||||+||||+||..||..
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 9999875433221 1122346799999999998764 356799999999999999999877654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=352.05 Aligned_cols=221 Identities=23% Similarity=0.379 Sum_probs=183.6
Q ss_pred CHHHHHHHHhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCC-CCceeEE
Q 022706 58 SVDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKH-ENFVQLL 128 (293)
Q Consensus 58 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h-~~i~~~~ 128 (293)
..++.+.-.++|++.+.||+|+||+||+|.+. .++.||||.+...... .+.+.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34444444679999999999999999999864 2357999999765443 3568899999999975 8999999
Q ss_pred EEEEeC-CeeEEEEEcccCCchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 022706 129 GYCVDG-TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200 (293)
Q Consensus 129 ~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di 200 (293)
++|.+. ...++|||||++|+|.++++....... ......+++.+++.++.||+.||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 998764 568999999999999999976432110 111235899999999999999999999998 999999
Q ss_pred CCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 022706 201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 279 (293)
Q Consensus 201 kp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~ 279 (293)
||+|||+++++++||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654443334456778999999999999999999999999999999998 99999876
Q ss_pred CC
Q 022706 280 LP 281 (293)
Q Consensus 280 ~~ 281 (293)
..
T Consensus 292 ~~ 293 (353)
T 4ase_A 292 KI 293 (353)
T ss_dssp CC
T ss_pred CH
Confidence 43
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=369.83 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=175.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHH---HHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLA---QVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
++|.+.+.||+|+||+||+|+++ +|+.||||++.+. ......+.+ ++.+++.++||||+++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999987 8999999999643 223333344 466777889999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||++||+|.+++.... .+++..++.++.||+.||+|||++| ||||||||+|||++.+|++||+||
T Consensus 269 lVmEy~~GGdL~~~l~~~~---------~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DF 336 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 336 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccc
Confidence 9999999999999998654 4999999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
|+|+..... .....+||+.|||||++.+ ..|+.++|+|||||++|||++|++||.+....
T Consensus 337 GlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 337 GLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp TTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred ceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999765432 2356789999999999975 57999999999999999999999999765443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=347.33 Aligned_cols=201 Identities=26% Similarity=0.395 Sum_probs=172.0
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 138 (293)
.+.++|++.+.||+|+||+||+|+++ +++.||+|++.... ...++.+|+++++.+ +||||+++++++.+.++.|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45678999999999999999999864 47889999986543 456788999999998 5999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-CceEEec
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIAD 217 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-~~~kl~D 217 (293)
+||||+++++|.++++ .+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|
T Consensus 97 lvmE~~~g~~L~~~~~------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp EEEECCCCCCHHHHHT------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEeCCCcccHHHHHc------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence 9999999999999984 2899999999999999999999999 9999999999999876 7999999
Q ss_pred cccCCCCCcccc--------------------------cccccccccCcccccccccccC-CCCCccchhhHHHHHHHHH
Q 022706 218 FDLSNQAPDMAA--------------------------RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELL 270 (293)
Q Consensus 218 fg~~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~ 270 (293)
||+|+...+... .......+||+.|+|||++.+. .++.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999975432211 1112346799999999999875 5899999999999999999
Q ss_pred hCCCCCCCCC
Q 022706 271 TGRKPVDHTL 280 (293)
Q Consensus 271 ~g~~Pf~~~~ 280 (293)
+|+.||....
T Consensus 242 ~G~~Pf~~~~ 251 (361)
T 4f9c_A 242 SGRYPFYKAS 251 (361)
T ss_dssp HTCSSSSCCS
T ss_pred HCCCCCCCCC
Confidence 9999996443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=358.86 Aligned_cols=202 Identities=25% Similarity=0.374 Sum_probs=180.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||+||+|.++ +|+.||+|++..... ..+.+.+|+++|+.++||||+++++++.+...+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999987 899999999865433 345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC--CceEEeccccC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--DVAKIADFDLS 221 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~--~~~kl~Dfg~~ 221 (293)
++||+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 236 ~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 236 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp CCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred cCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence 999999999865431 3999999999999999999999999 9999999999999854 89999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+.+..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 305 ~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 305 AHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp EECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 87644322 2456899999999999999999999999999999999999999987644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=318.78 Aligned_cols=219 Identities=42% Similarity=0.733 Sum_probs=188.7
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
....++|++.+.||+|+||+||+|.+++++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3456799999999999999999999888999999998765433 467889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++...... ...+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 115 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp ECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999998754321 124899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccccc
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~~~~~~~ 289 (293)
................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.......+
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 76543333223344568999999999988899999999999999999999999998877665544433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=310.48 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=180.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|++.+.||+|+||+||+|.+. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999976 7999999998644 34456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... +++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 99 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (297)
T ss_dssp CTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCcee
Confidence 99999999997654 899999999999999999999999 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+
T Consensus 166 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 221 (297)
T 3fxz_A 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (297)
T ss_dssp CCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 543222 23456799999999999999999999999999999999999999986543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=316.00 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=179.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||+||+++++ +++.||+|++.+. ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999987 7999999998643 34556788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 99999999999987654 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 152 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 152 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 87543211 12355679999999999999999999999999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=314.91 Aligned_cols=201 Identities=28% Similarity=0.405 Sum_probs=178.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|++.+.||+|+||.||+|.+. +|+.||+|++...... ...+.+|+++++.++||||+++++++.+....++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 458999999999999999999986 8999999999755433 346789999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp CCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred ECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999987654 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 162 NEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp GGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 7543322 23556799999999999887765 789999999999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=315.81 Aligned_cols=201 Identities=27% Similarity=0.415 Sum_probs=179.5
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
+.++|.+.+.||+|+||+||++.++ +|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999987 799999999865432 24678999999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC----c
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~----~ 212 (293)
.++||||+++++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||+++++ .
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 999999999999999997543 4899999999999999999999999 99999999999998877 7
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 158 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp EEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999987654322 2245679999999999998899999999999999999999999997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=318.92 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=175.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|++.+.||+|+||+||+++++ +++.||+|++.+. ......+.+|.++++.+ +||||+++++++.+....++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999987 7999999998643 23446678899999988 69999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 102 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG 169 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG 169 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccc
Confidence 999999999999997654 3899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 170 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 170 MCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp TCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 98754322 1223567899999999999988899999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=325.68 Aligned_cols=202 Identities=22% Similarity=0.314 Sum_probs=177.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||+||+++++ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999987 7899999998642 23334578899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||++|++|.+++.... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 148 ~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp ECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999997653 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.
T Consensus 215 a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 215 CMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp CEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 97654322 11234678999999999998655 78899999999999999999999986543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=310.77 Aligned_cols=198 Identities=28% Similarity=0.422 Sum_probs=178.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||+||+++.+ +++.||+|++... ....+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 368999999999999999999987 7999999998643 24456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 99999999999997654 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+...... ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 8765432 245679999999999999999999999999999999999999997654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=312.82 Aligned_cols=201 Identities=20% Similarity=0.268 Sum_probs=180.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
.++|.+.+.||+|+||+||++.++ +++.+|+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 568999999999999999999987 7899999999766555667889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC--CCceEEeccccCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLSN 222 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~--~~~~kl~Dfg~~~ 222 (293)
++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++.
T Consensus 84 ~g~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 84 SGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp CCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred CCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 9999999997543 23899999999999999999999999 999999999999987 7899999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 153 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 153 QLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp ECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 6543222 245678999999999998888999999999999999999999998654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.82 Aligned_cols=203 Identities=26% Similarity=0.394 Sum_probs=179.7
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 138 (293)
..++|.+.+.||+|+||+||+|+++ +++.||+|++... ......+.+|..++..+ +||||+++++++.+....+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999999987 7999999999753 34456778899999877 8999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+++++|.+++.... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 95 lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEC
Confidence 9999999999999997653 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|+++...... ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+.
T Consensus 163 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 163 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 9987543221 123567899999999999999999999999999999999999999986543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=318.90 Aligned_cols=201 Identities=23% Similarity=0.331 Sum_probs=169.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHH-HhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSM-VSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|++.+.||+|+||.||+++++ +++.||+|++.+... ....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999987 788999999965432 23445666666 567899999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||++|++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 117 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCc
Confidence 999999999999997654 3899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+++..... .......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+
T Consensus 185 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 185 LCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp BCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred cccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 98753221 122356789999999999999999999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=319.20 Aligned_cols=200 Identities=23% Similarity=0.351 Sum_probs=176.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||+||+++++ +++.||+|++++... ....+.+|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999987 788999999875432 224577899999887 79999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|..++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||
T Consensus 131 V~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEcCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecc
Confidence 999999999999987654 3999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 199 la~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 199 MCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp TCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred eeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99753221 12235678999999999999999999999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=312.63 Aligned_cols=205 Identities=29% Similarity=0.435 Sum_probs=178.1
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.++|++.+.||+|+||+||+|.++ +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3468999999999999999999987 899999999864432 2356889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 9999999999997553 3899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
................||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 76543333333345679999999999987765 7789999999999999999999986544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=305.49 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=174.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||.||++.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999977 7999999998544332 24678999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999997654 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 158 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 158 AKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp STTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 986643221 12244678999999999999999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=325.19 Aligned_cols=204 Identities=23% Similarity=0.308 Sum_probs=177.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||+||+++++ +++.||+|++.+. ......+.+|..++..++||||+++++++.+....++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 468999999999999999999987 6889999998642 22233478899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 153 ~Ey~~gg~L~~~l~~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl 221 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFE--------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221 (437)
T ss_dssp ECCCTTCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence 99999999999997643 23999999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 876543221 1224468999999999987 45689999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=317.02 Aligned_cols=201 Identities=24% Similarity=0.370 Sum_probs=178.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||++.++ +++.||+|++... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 368999999999999999999987 7899999998642 34456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+.+++|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||+
T Consensus 94 ~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence 99999999999998653 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+....... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.....
T Consensus 162 a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 162 AAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred eeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 97654322 2356789999999999874 4589999999999999999999999975543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=311.90 Aligned_cols=202 Identities=24% Similarity=0.404 Sum_probs=179.0
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.+.++|.+.+.||+|+||.||++.++ +++.||+|++....... +.+.+|++++++++||||+++++++.+....++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45679999999999999999999987 79999999997654433 467899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC---ceEEe
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIA 216 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~---~~kl~ 216 (293)
||||+++++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 106 v~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence 999999999999887553 4899999999999999999999999 99999999999998654 59999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999977653221 245679999999999999899999999999999999999999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=313.04 Aligned_cols=199 Identities=25% Similarity=0.345 Sum_probs=179.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||+++++ +++.||+|++... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 358999999999999999999987 7999999998643 23456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccc
Confidence 99999999999998654 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 8765432 2456799999999999999999999999999999999999999986543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=311.09 Aligned_cols=200 Identities=24% Similarity=0.354 Sum_probs=177.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||.||+++++ +++.||+|++...... ...+.+|..+++++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 358999999999999999999987 7899999999754332 24577899999888 79999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||
T Consensus 88 v~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 999999999999997653 3899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 156 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp GCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred ccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 987532221 1235568999999999999999999999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=306.60 Aligned_cols=201 Identities=25% Similarity=0.401 Sum_probs=179.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
+.++|.+.+.||+|+||.||++.++ +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4578999999999999999999987 799999999865432 35678999999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC----c
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~----~ 212 (293)
.++||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++ .
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence 999999999999999997543 3899999999999999999999999 99999999999999877 7
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 157 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp EEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999999987654322 1245679999999999998899999999999999999999999997654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=312.26 Aligned_cols=202 Identities=25% Similarity=0.326 Sum_probs=179.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||+||+++++ +++.||+|++... ......+.+|..++..+ +||||+++++++.+....++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999987 6889999998643 34456788999999988 69999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||++|++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 v~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCC
Confidence 999999999999997654 3899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 167 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 167 MCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 987543211 123557899999999999999999999999999999999999999986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=316.77 Aligned_cols=213 Identities=28% Similarity=0.473 Sum_probs=179.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
.++|.+.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999852 3557999999765432 35688999999999 799999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
+..++||||+++++|.+++....... .......+++.+++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999998654210 0111234899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999976554333333344567889999999999999999999999999999999 9999987643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=313.63 Aligned_cols=203 Identities=32% Similarity=0.416 Sum_probs=175.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCC----eeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 141 (293)
.++|++.+.||+|+||+||+|++. ++.||||++...........+|+.++++++||||+++++++.+.. ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 468999999999999999999987 899999999765555556677899999999999999999998754 369999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeCCCCCCceEEcCCC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK----------ADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~~ivH~Dikp~Nilv~~~~ 211 (293)
||+++++|.++++... +++.+++.++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 102 e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 102 AFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred ecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence 9999999999997654 89999999999999999999998 8 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
.+||+|||++................||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999999999765433332233446799999999998863 4556889999999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.90 Aligned_cols=204 Identities=21% Similarity=0.275 Sum_probs=177.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||+||+++++ +++.||+|++.+.. .....+.+|..++..++||||+++++++.+....++|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 478999999999999999999987 79999999986422 1223477899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+
T Consensus 140 mE~~~gg~L~~~l~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFG--------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp ECCCCSCBHHHHHHHHS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EcCCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999997643 13899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccc-------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 876543221 1223468999999999987 35689999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=302.35 Aligned_cols=206 Identities=28% Similarity=0.476 Sum_probs=178.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||+||++.++ +++.+|+|++.... .....+.+|++++++++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 358999999999999999999987 79999999885432 2345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 89 ~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 89 IKGGTLRGIIKSMD--------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp CTTCBHHHHHHHCC--------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 99999999998643 24899999999999999999999999 99999999999999999999999999876
Q ss_pred CCcccccc------------cccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 224 APDMAARL------------HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 224 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 53322111 112467999999999999999999999999999999999999999875543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.29 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=174.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.++|++.+.||+|+||+||+|.+++++.||+|++...... ...+.+|++++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45799999999999999999999988999999999754333 356889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++ +|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp ECCSE-EHHHHHHTCT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCCCC-CHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCc
Confidence 99986 8888776544 23899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
........ ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 167 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 167 RAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp EETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred eecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 76532211 2244578999999999876 56899999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=302.81 Aligned_cols=211 Identities=27% Similarity=0.430 Sum_probs=183.5
Q ss_pred CccCHHHHHHHHh----------cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCC
Q 022706 55 PAISVDELKEITE----------NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHE 122 (293)
Q Consensus 55 ~~~~~~~~~~~~~----------~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~ 122 (293)
+.++.+++....+ .|...+.||+|+||.||+|.++ +|+.||||++..... ..+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 3456666666554 3777789999999999999987 799999999875443 456788999999999999
Q ss_pred CceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 022706 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (293)
Q Consensus 123 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 202 (293)
||+++++++......++||||+++++|.+++.... +++.+++.++.|++.||.|||+.+ |+||||||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp 169 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS 169 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 99999999999999999999999999999987543 899999999999999999999999 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 203 ~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999876543221 2245679999999999999899999999999999999999999997654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=317.31 Aligned_cols=204 Identities=22% Similarity=0.323 Sum_probs=178.5
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
..+.++|.+.+.||+|+||+||++.++ +++.+|+|++...... ...+.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 346789999999999999999999987 7999999998765433 346789999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc---CCCceEE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKI 215 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~---~~~~~kl 215 (293)
+||||+.+++|.+.+.... .+++.++..++.||+.||.|||+.+ |+||||||+|||++ +++.+||
T Consensus 87 lv~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp EEECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEE
T ss_pred EEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEE
Confidence 9999999999999887654 3899999999999999999999999 99999999999998 4678999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 155 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 155 ADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 99999976643221 2245679999999999999899999999999999999999999997654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=312.57 Aligned_cols=205 Identities=21% Similarity=0.246 Sum_probs=175.8
Q ss_pred HhcCCCCceeeccCceEEEEEE------eCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGI------LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~------~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||+||+|. ..+++.||+|++... ...++.+|++++++++ |+||+++++++...+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 4689999999999999999994 337899999998643 4567888888888887 8999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-------
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD------- 209 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~------- 209 (293)
.++||||+++++|.+++...... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 99999999999999999753211 1124999999999999999999999998 999999999999998
Q ss_pred ----CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 210 ----DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 210 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999996543322333345677999999999999999999999999999999999999999644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.56 Aligned_cols=200 Identities=28% Similarity=0.410 Sum_probs=175.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||+||+|.+. +++.||+|++... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 358999999999999999999986 8999999998642 23346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+ +++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 88 ~E~~-~g~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred EECC-CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecc
Confidence 9999 678888886553 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+........ ....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+...
T Consensus 155 s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 155 SNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp TBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred ceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 876543322 245679999999999988775 7899999999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=317.92 Aligned_cols=200 Identities=22% Similarity=0.328 Sum_probs=165.2
Q ss_pred HHhcCCCC-ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHh-cCCCCCceeEEEEEEe----CCee
Q 022706 65 ITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVS-RLKHENFVQLLGYCVD----GTSR 137 (293)
Q Consensus 65 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~ 137 (293)
+.++|.+. +.||+|+||+||++.++ +++.||||++.. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 34577776 68999999999999987 799999999853 356778888874 4479999999999875 5678
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCceE
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK 214 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~k 214 (293)
++||||+++++|.+++..... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++. ++.+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEE
Confidence 999999999999999986532 24899999999999999999999999 999999999999997 78899
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 205 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred EEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999987654322 22456789999999999989999999999999999999999999986543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.82 Aligned_cols=205 Identities=26% Similarity=0.363 Sum_probs=177.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC------CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS------KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
+.++|++.+.||+|+||+||+|.++ +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999987 7999999998532 23467899999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc---eE
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AK 214 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---~k 214 (293)
++||||+++++|.+.+...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEE
T ss_pred EEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEE
Confidence 9999999999998877643211 124899999999999999999999999 999999999999987654 99
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
|+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 174 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 174 LGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp ECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 999999876543221 224567999999999999989999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=305.91 Aligned_cols=201 Identities=26% Similarity=0.377 Sum_probs=169.4
Q ss_pred HhcCCCCceeeccCceEEEEEEe----CCCCeEEEEEcCCCC-----CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||+++. .+++.||+|++.... .....+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999987 378999999997542 223457789999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 999999999999999997654 3899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 999987543221 12245679999999999998899999999999999999999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=311.03 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=169.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
.++|.+.+.||+|+||+||+++++ +++.||+|++.......+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 468999999999999999999987 8999999999877766788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc--eEEeccccCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIADFDLSN 222 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~--~kl~Dfg~~~ 222 (293)
++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 99 ~~~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 99 SGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp CSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 9999999987654 3899999999999999999999999 999999999999987765 9999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCc-cchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAK-SDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 167 SSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred cccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 432221 2244679999999999988877655 899999999999999999998654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=307.38 Aligned_cols=215 Identities=38% Similarity=0.708 Sum_probs=188.1
Q ss_pred cCccCHHHHHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEE
Q 022706 54 VPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYC 131 (293)
Q Consensus 54 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~ 131 (293)
...++..++....++|.+.+.||+|+||.||+|.+++++.||+|++..... ....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788899999999999999999999999999988899999999975432 234688999999999999999999999
Q ss_pred EeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeeeCCCCCCceEEc
Q 022706 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK---ADPHIIHRDIKSSNVLIF 208 (293)
Q Consensus 132 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~~~~ivH~Dikp~Nilv~ 208 (293)
.+....++||||+++++|.+++...... ...+++..++.++.|++.||.|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLD 168 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEEC
Confidence 9999999999999999999999876432 13489999999999999999999999 8 99999999999999
Q ss_pred CCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
+++.++|+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999999999876543222 12244568999999999988889999999999999999999999996
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=297.85 Aligned_cols=204 Identities=27% Similarity=0.504 Sum_probs=182.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||++.+.+++.||+|++.......+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 35899999999999999999999888999999998877778889999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 89 ~~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 89 HGCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp TCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHHhcC--------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999997654 24899999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 158 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp CHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 3221 12234456788999999998899999999999999999999 9999986543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=313.93 Aligned_cols=210 Identities=23% Similarity=0.300 Sum_probs=182.0
Q ss_pred ccCHHHHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-----CCCceeEEE
Q 022706 56 AISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----HENFVQLLG 129 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~ 129 (293)
.++..+...+.++|.+.+.||+|+||+||+|.+. +++.||+|++.........+..|+.+++.+. ||||+++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 3444444456789999999999999999999986 7899999999755444566788999999986 999999999
Q ss_pred EEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 130 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
++...+..++||||+ +++|.+++..... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNY-------NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD 172 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESC
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcc
Confidence 999999999999999 8899999986542 13899999999999999999999999 999999999999975
Q ss_pred -------------------------CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHH
Q 022706 210 -------------------------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264 (293)
Q Consensus 210 -------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 264 (293)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 788999999998754332 24567899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCC
Q 022706 265 VLLELLTGRKPVDHTLP 281 (293)
Q Consensus 265 ~l~el~~g~~Pf~~~~~ 281 (293)
++|+|++|+.||.....
T Consensus 248 il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 248 VLAELYTGSLLFRTHEH 264 (360)
T ss_dssp HHHHHHHSSCSCCCSSH
T ss_pred HHHHHHHCCCCCCCCcH
Confidence 99999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=311.47 Aligned_cols=200 Identities=28% Similarity=0.388 Sum_probs=163.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.++|.+.+.||+|+||+||+|.++ +++.||+|++.... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4678999999999999999999987 68899999987543 345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCceEEecccc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDL 220 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~kl~Dfg~ 220 (293)
+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 130 ~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 130 VTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp CCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred CCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999987653 3899999999999999999999999 999999999999975 88999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 87654321 1245678999999999999899999999999999999999999997654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=300.12 Aligned_cols=199 Identities=31% Similarity=0.430 Sum_probs=169.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---------------------------ChHHHHHHHHHHh
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------------------------PDEEFLAQVSMVS 117 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---------------------------~~~~~~~e~~~l~ 117 (293)
.++|.+.+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999976 789999999864421 1245789999999
Q ss_pred cCCCCCceeEEEEEEe--CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 022706 118 RLKHENFVQLLGYCVD--GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHI 195 (293)
Q Consensus 118 ~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 195 (293)
+++||||+++++++.+ ....++||||+++++|.+++... .+++.+++.++.|++.||.|||+.+ |
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQK---I 158 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 9999999999999986 56889999999999998876543 3899999999999999999999999 9
Q ss_pred eeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCC---CCCccchhhHHHHHHHHHhC
Q 022706 196 IHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELLTG 272 (293)
Q Consensus 196 vH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~~g 272 (293)
+||||||+||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999999999999999999999999876543221 124467899999999987654 37789999999999999999
Q ss_pred CCCCCCC
Q 022706 273 RKPVDHT 279 (293)
Q Consensus 273 ~~Pf~~~ 279 (293)
+.||.+.
T Consensus 237 ~~pf~~~ 243 (298)
T 2zv2_A 237 QCPFMDE 243 (298)
T ss_dssp SCSSCCS
T ss_pred CCCCCCc
Confidence 9999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=322.27 Aligned_cols=202 Identities=23% Similarity=0.370 Sum_probs=179.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||.||++.++ +++.||+|++... ......+.+|++++++++||||+++++++.+....++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57999999999999999999987 7999999998642 344567889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++|++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 264 Ey~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQ-------AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp CCCCSCBHHHHHHSSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EcCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccc
Confidence 99999999999876542 23899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 334 ~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 334 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp EECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred eecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 7654322 12446899999999999998899999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=307.55 Aligned_cols=205 Identities=21% Similarity=0.299 Sum_probs=178.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||+||+|.+. +++.||||++..... ...+.+|+++++++ +||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 468999999999999999999976 799999999865432 34688999999999 899999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc-----eEEecc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-----AKIADF 218 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~-----~kl~Df 218 (293)
+ +++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++. ++|+||
T Consensus 87 ~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 87 L-GPSLEDLFDLCD--------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred C-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9 889999998642 24999999999999999999999999 999999999999998887 999999
Q ss_pred ccCCCCCcccccc-----cccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 219 DLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 219 g~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
|++.......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 9997654322211 1245679999999999999999999999999999999999999999865443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=305.60 Aligned_cols=204 Identities=27% Similarity=0.452 Sum_probs=169.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEeCCe----
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTS---- 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 136 (293)
.++|++.+.||+|+||.||++.+. +++.||+|++....... ..+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 568999999999999999999976 79999999997654332 457899999999999999999999876543
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 158 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 158 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEEC
T ss_pred cEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEe
Confidence 389999999999999997654 3899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..+
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999765443221 222345689999999999999999999999999999999999999987653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=295.52 Aligned_cols=203 Identities=25% Similarity=0.419 Sum_probs=181.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||++.++++..||+|++.........+.+|++++++++||||+++++++.+....++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 46899999999999999999999988899999998877778889999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 87 NGCLLNYLRSHG--------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp TCBHHHHHHHHG--------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecc
Confidence 999999997653 23899999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 156 DDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp TTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred hhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 33221 1233446778999999998889999999999999999999 999997654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=319.70 Aligned_cols=204 Identities=24% Similarity=0.362 Sum_probs=179.8
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||+||+++++ +++.||+|++.+. ......+.+|++++++++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57899999999999999999987 7999999998643 234567889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++|++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||++
T Consensus 265 E~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence 999999999998764321 124899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 76543221 1244689999999999999999999999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.78 Aligned_cols=206 Identities=19% Similarity=0.285 Sum_probs=178.2
Q ss_pred HhcCCCCceeecc--CceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEG--SYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|++.+.||+| +||+||+++++ +++.||||++....... ..+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999987 79999999997654333 457789999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-------DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGG
T ss_pred EEEccCCCCHHHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccc
Confidence 9999999999999976532 13899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc-----ccccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 87644221111 11233478999999999987 5789999999999999999999999987544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=308.76 Aligned_cols=205 Identities=25% Similarity=0.426 Sum_probs=165.8
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCC-CCCceeEEEEEEeCC--
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK-HENFVQLLGYCVDGT-- 135 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-- 135 (293)
..+.++|.+.+.||+|+||+||+|.++ +++.||+|++...... ...+.+|+.+++++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345789999999999999999999987 7999999998654433 345778999999997 999999999997544
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+++ +|.+++.... +++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecccCc-CHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 68999999974 8999987643 899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccc-------------------ccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCC
Q 022706 216 ADFDLSNQAPDMA-------------------ARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKP 275 (293)
Q Consensus 216 ~Dfg~~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~P 275 (293)
+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999987543210 1112244679999999999886 6789999999999999999999999
Q ss_pred CCCCCC
Q 022706 276 VDHTLP 281 (293)
Q Consensus 276 f~~~~~ 281 (293)
|.+.+.
T Consensus 231 f~~~~~ 236 (388)
T 3oz6_A 231 FPGSST 236 (388)
T ss_dssp CCCSSH
T ss_pred CCCCCH
Confidence 987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=308.16 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=177.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
+.++|.+.+.||+|+||+||+|.++ +++.+|+|++..... ....+.+|++++++++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3568999999999999999999987 789999999865432 33568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC--CCceEEecccc
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDL 220 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~--~~~~kl~Dfg~ 220 (293)
|+++++|.+++.... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 129 ~~~gg~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 129 FLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp CCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred cCCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 999999999987543 23899999999999999999999999 999999999999974 46799999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 876543221 234578999999999999899999999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=317.00 Aligned_cols=202 Identities=25% Similarity=0.350 Sum_probs=169.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||.||++.++ +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999987 7999999998643 22335677899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
|||+++++|.+++.... .+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 227 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EeeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCC
Confidence 99999999999987654 38999999999999999999998 88 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 295 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 295 LCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 987643222 223457899999999999999999999999999999999999999976543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=298.06 Aligned_cols=200 Identities=27% Similarity=0.406 Sum_probs=171.1
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|++.+.||+|+||+||+|.+++++.+|+|++..... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47999999999999999999998899999999865432 236788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++ +|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTST--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 976 9998887643 13899999999999999999999999 99999999999999999999999999864
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus 150 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 150 FGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32211 112345689999999998764 58999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=300.09 Aligned_cols=203 Identities=25% Similarity=0.382 Sum_probs=175.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCC--eeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 140 (293)
.++|.+.+.||+|+||+||+|.++ +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 468999999999999999999987 69999999987533 34567889999999999999999999998765 77999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE----cCCCceEEe
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIA 216 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv----~~~~~~kl~ 216 (293)
|||+++++|.+++...... ..+++.+++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEc
Confidence 9999999999999865421 23899999999999999999999999 9999999999999 777889999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccc--------cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++........ .....||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 159 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 159 DFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999976543322 24467899999999886 4678999999999999999999999997543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=296.60 Aligned_cols=204 Identities=27% Similarity=0.488 Sum_probs=178.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||+||++.++++..||+|++.......+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 46899999999999999999999988899999998877778889999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... .+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 103 ~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 103 NGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp TCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999976431 3899999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 172 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 172 DDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp CHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 3221 12233446788999999998899999999999999999998 9999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=298.18 Aligned_cols=207 Identities=35% Similarity=0.508 Sum_probs=171.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
..++|++.+.||+|+||+||+|++. ++.||+|++....... ..+.+|++++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3568999999999999999999875 8899999997665443 46789999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.+||+|||++
T Consensus 114 e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp ECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999765311 13899999999999999999999984 23999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..+
T Consensus 187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 187 RLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7543221 122456789999999999999999999999999999999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=300.59 Aligned_cols=205 Identities=24% Similarity=0.398 Sum_probs=173.0
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCC-----
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----- 135 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 135 (293)
.+.++|++.+.||+|+||.||+|+++ +++.||||++..... ..+.+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 35678999999999999999999987 899999999864433 3467899999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEEcccCCchhhhhhcCCCCCCCC
Q 022706 136 ----------------------------------------------------SRVLAYEFASNGSLHDILHGRKGVKGAQ 163 (293)
Q Consensus 136 ----------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 163 (293)
..++||||+++++|.+++......
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---- 158 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---- 158 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG----
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc----
Confidence 378999999999999999875432
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccccc----------ccc
Q 022706 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR----------LHS 233 (293)
Q Consensus 164 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~----------~~~ 233 (293)
...++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ...
T Consensus 159 --~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 159 --EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp --GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred --cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 23567789999999999999999999 999999999999999999999999998766443211 122
Q ss_pred cccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 234 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
....||+.|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 44579999999999999999999999999999999999988764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=296.89 Aligned_cols=203 Identities=27% Similarity=0.427 Sum_probs=172.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC------CChHHHHHHHHHHhcCC---CCCceeEEEEEEeC
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK------QPDEEFLAQVSMVSRLK---HENFVQLLGYCVDG 134 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~------~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 134 (293)
+.++|++.+.||+|+||+||+|.++ +++.||+|++.... .....+.+|++++++++ ||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999976 79999999986332 22356777887777765 99999999999876
Q ss_pred C-----eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 135 T-----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 135 ~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
. ..++|||++.+ +|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCT-------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 5 57899999975 99999876542 23899999999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp TSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred CCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999997654322 22456789999999999999999999999999999999999999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.14 Aligned_cols=207 Identities=27% Similarity=0.400 Sum_probs=162.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|++.+.||+|+||+||+|.++ +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999977 79999999986443 234678899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++ +|.+++....... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 84 ~~~~-~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 84 FMDN-DLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp CCCC-BHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred ecCC-CHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccce
Confidence 9985 9999887543211 1124899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 157 AFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp ETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 6532211 1234578999999999876 4689999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=294.65 Aligned_cols=196 Identities=23% Similarity=0.389 Sum_probs=169.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|+||+||+|.++ +++.||+|++...... ...+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999987 7999999999754433 3678899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++ +|.+.+.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~-~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSE-EHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCC-CHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9976 5655554432 13899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~Pf 276 (293)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 150 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp ECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred ecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 653221 1224467899999999988765 799999999999999999988775
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.53 Aligned_cols=201 Identities=27% Similarity=0.421 Sum_probs=179.1
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
+.++|.+.+.||+|+||.||++.++ +++.||+|++..... ..+.+.+|++++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4678999999999999999999987 799999999865432 35678999999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC----c
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~----~ 212 (293)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++ .
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999997643 3899999999999999999999999 99999999999999888 7
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 158 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp EEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999987654322 1244568999999999998899999999999999999999999997654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=300.88 Aligned_cols=199 Identities=24% Similarity=0.367 Sum_probs=155.7
Q ss_pred HhcCCCC---ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTN---ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~---~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+. +.||+|+||+||++.++ +++.||+|++... ....+.+|+.+++++. ||||+++++++.+....++|
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 4566654 78999999999999987 7999999998643 3467789999999997 99999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC---ceEEec
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAKIAD 217 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~---~~kl~D 217 (293)
|||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 85 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D 152 (325)
T 3kn6_A 85 MELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIID 152 (325)
T ss_dssp ECCCCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECC
T ss_pred EEccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEec
Confidence 99999999999998654 4899999999999999999999999 99999999999998766 799999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 153 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 153 FGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 99987543322 12245568999999999999999999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.56 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=178.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||+|.++ +|+.||||++... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 358999999999999999999987 8999999998643 23346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp EECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccc
Confidence 99999999999997543 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+...
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 163 SNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp CEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred hhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 87654322 2245679999999999988765 6799999999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=302.69 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=177.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||++.++ +++.+|+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999987 688999999865432 235678999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 120 ~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 187 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 187 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccC
Confidence 99999999999987653 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 188 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 188 ATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 876532221 1244678999999999998889999999999999999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=307.29 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=168.3
Q ss_pred cCCC--CceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 68 NFGT--NALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 68 ~y~~--~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.|.+ .+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 4444 568999999999999976 79999999987544 2346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE--cCCCceEEeccccC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLS 221 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv--~~~~~~kl~Dfg~~ 221 (293)
+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 168 ~~~~~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 168 VDGGELFDRIIDES--------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp CTTCEEHHHHHHTG--------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 99999998886543 13899999999999999999999999 9999999999999 56778999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 237 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 237 RRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp EECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 76543222 234569999999999988889999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=312.07 Aligned_cols=205 Identities=28% Similarity=0.489 Sum_probs=176.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|.+.+.||+|+||.||+|.++ +++.||+|++...... ...+.+|++++++++||||+++++++.+....++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468999999999999999999987 7999999998754322 2357789999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++..... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 193 ~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999976431 3899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
...............+++.|+|||++....++.++||||||+++|||++ |..||.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 6443222211122335678999999998889999999999999999998 9999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.17 Aligned_cols=205 Identities=30% Similarity=0.486 Sum_probs=174.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-C---CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-S---GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~---~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||.||+|.++ + +..||||++...... ...+.+|++++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 468999999999999999999975 3 445999999754332 3568899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 128 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EeeCCCCCcHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999997543 13899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99765433211 11233446778999999998899999999999999999999 9999976543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=289.89 Aligned_cols=201 Identities=24% Similarity=0.377 Sum_probs=177.6
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC-CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.+.++|++.+.||+|+||.||+|.++ ++..+|+|++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 45678999999999999999999987 6889999998654 345678999999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE---cCCCceEEecc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF 218 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv---~~~~~~kl~Df 218 (293)
||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+||
T Consensus 86 e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp ECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 9999999999887654 3899999999999999999999999 9999999999999 77889999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 9987654322 2245578999999998765 48999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=302.83 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=177.4
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---------ChHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCVD 133 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 133 (293)
.+.++|.+.+.||+|+||+||+|.++ +++.||+|++..... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45689999999999999999999976 799999999875532 22356789999999999999999999999
Q ss_pred CCeeEEEEEcccCC-chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 134 GTSRVLAYEFASNG-SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 134 ~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
....++||||+.++ +|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 99999999999766 9999997654 3899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+||+|||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus 169 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 169 IKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp EEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred EEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 9999999987654322 2245678999999999988776 789999999999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=290.33 Aligned_cols=205 Identities=29% Similarity=0.435 Sum_probs=179.3
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.++|++.+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 5678999999999999999999987 799999999864432 3467889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999987543 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
................|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 76543222222345678999999999887665 6789999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=304.40 Aligned_cols=218 Identities=28% Similarity=0.336 Sum_probs=176.1
Q ss_pred HHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC------CCChHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 022706 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS------KQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133 (293)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 133 (293)
++..+.++|++.+.||+|+||+||+|.++ +++.||+|++... ....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34667889999999999999999999986 7889999998642 2334678899999999999999999999999
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHH
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKG-------------------------------AQPGPVLSWQQRVKIAVGAAK 182 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~ 182 (293)
....++||||+++++|.+++........ ......+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999863211000 000112467888999999999
Q ss_pred HHHHHHhCCCCCeeeCCCCCCceEEcCCC--ceEEeccccCCCCCcccc--cccccccccCccccccccccc--CCCCCc
Q 022706 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT--GQLNAK 256 (293)
Q Consensus 183 al~~LH~~~~~~ivH~Dikp~Nilv~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 256 (293)
||+|||+.+ |+||||||+||+++.++ .+||+|||++........ ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 899999999875432211 112245678999999999875 678899
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 257 SDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 257 ~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+||||||+++|+|++|+.||.+...
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh
Confidence 9999999999999999999976543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=305.79 Aligned_cols=221 Identities=23% Similarity=0.387 Sum_probs=182.1
Q ss_pred CHHHHHHHHhcCCCCceeeccCceEEEEEEe-----C-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEE
Q 022706 58 SVDELKEITENFGTNALIGEGSYGRVYYGIL-----K-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLL 128 (293)
Q Consensus 58 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~ 128 (293)
...+.+...++|.+.+.||+|+||.||+|.+ . +++.||||++...... ...+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445555578999999999999999999983 2 5689999999765433 24688999999999 689999999
Q ss_pred EEEEeCCe-eEEEEEcccCCchhhhhhcCCCCCC----------------------------------------------
Q 022706 129 GYCVDGTS-RVLAYEFASNGSLHDILHGRKGVKG---------------------------------------------- 161 (293)
Q Consensus 129 ~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~---------------------------------------------- 161 (293)
+++.+.+. .++||||+++++|.+++........
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987554 8999999999999999986542100
Q ss_pred -----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCccccc
Q 022706 162 -----------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAAR 230 (293)
Q Consensus 162 -----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~ 230 (293)
......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 001123899999999999999999999999 999999999999999999999999999866443333
Q ss_pred ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 231 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.......||+.|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 33445668899999999999999999999999999999998 9999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=304.85 Aligned_cols=199 Identities=28% Similarity=0.426 Sum_probs=172.9
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.+.++|.+.+.||+|+||+||++.++ +++.||+|++...... ..+|++++.++ +||||+++++++.+....++||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45678999999999999999999987 7999999999765433 34678888887 6999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC----CceEEec
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD----DVAKIAD 217 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~----~~~kl~D 217 (293)
||+++++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|
T Consensus 96 E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp CCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999987654 3899999999999999999999999 9999999999998543 3599999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 999876543221 224567899999999998878899999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=305.48 Aligned_cols=214 Identities=28% Similarity=0.439 Sum_probs=178.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
..++|.+.+.||+|+||.||+++++ +++.||+|++...... ...+.+|++++++++||||+++++++.+...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3579999999999999999999975 3478999999755432 3568899999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik 201 (293)
.++||||+++++|.+++........ ......+++.+++.++.|++.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999976431100 001135899999999999999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 202 p~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
|+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999865433322222344567899999999998899999999999999999999 999998654
Q ss_pred C
Q 022706 281 P 281 (293)
Q Consensus 281 ~ 281 (293)
.
T Consensus 282 ~ 282 (343)
T 1luf_A 282 H 282 (343)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=308.07 Aligned_cols=211 Identities=27% Similarity=0.435 Sum_probs=177.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|.+.+.||+|+||+||+|.+. +++.||||++...... ...+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999843 5678999999754333 34688999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC---ceE
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD---VAK 214 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~---~~k 214 (293)
++||||+++++|.+++....... .....+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999997654221 11234899999999999999999999999 99999999999999554 599
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999864432222223345667999999999999999999999999999999998 9999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=315.44 Aligned_cols=197 Identities=24% Similarity=0.307 Sum_probs=166.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC------C
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG------T 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 135 (293)
.++|++.+.||+|+||+||+|.+. +++.||||++...... ...+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999977 7999999999754322 35678999999999999999999999755 3
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+++ +|.+.+.. .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeCCCC-CHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEE
Confidence 56999999976 56666642 2889999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 206 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 206 LDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999765432 12355789999999999999999999999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=316.95 Aligned_cols=202 Identities=25% Similarity=0.373 Sum_probs=158.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC-----Ce
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 136 (293)
.++|.+.+.||+|+||+||+|.++ +++.||||++...... ...+.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999977 7999999999754433 35688999999999999999999998543 56
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccc-cchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence 899999985 69999987653 4999999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc-------------------------ccccccccCcccccccccc-cCCCCCccchhhHHHHHHHHH
Q 022706 217 DFDLSNQAPDMAAR-------------------------LHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELL 270 (293)
Q Consensus 217 Dfg~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~ 270 (293)
|||+++........ ......+||+.|+|||++. ...++.++|||||||++|||+
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 99999865422110 1224567899999999864 567999999999999999999
Q ss_pred h-----------CCCCCCCCC
Q 022706 271 T-----------GRKPVDHTL 280 (293)
Q Consensus 271 ~-----------g~~Pf~~~~ 280 (293)
+ |+++|.+..
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC---
T ss_pred HhccccccccccccccCCCCc
Confidence 9 677776543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=303.62 Aligned_cols=212 Identities=31% Similarity=0.487 Sum_probs=180.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCCCh--HHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQPD--EEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~--~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
.++|.+.+.||+|+||+||+|.+. .+..||+|++....... ..+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999853 23579999997654332 5688999999999 899999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
+..++||||+++++|.+++....... .......+++.+++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999998654211 0111235999999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999987654433333445567889999999999999999999999999999999 999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=301.16 Aligned_cols=200 Identities=22% Similarity=0.401 Sum_probs=168.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCC--CCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||.||++.+++++.||+|++....... ..+.+|++++++++| +||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46799999999999999999999889999999987655443 567899999999986 9999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
||+ .+++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+
T Consensus 88 ~e~-~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp ECC-CSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred EeC-CCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccc
Confidence 995 5779999998654 3899999999999999999999999 99999999999996 67899999999
Q ss_pred CCCCCcccccccccccccCccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 987654433333345679999999999864 56888999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=294.18 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=171.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|++.+.||+|+||+||+|.++ +++.||+|++....... ..+.+|++++++++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999987 69999999987655442 45778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 82 e~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp ECCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 9999999999887554 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
........ ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 150 RLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 76543221 1244578999999999876 5689999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=298.37 Aligned_cols=214 Identities=26% Similarity=0.435 Sum_probs=180.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|.+.+.||+|+||.||++.+. +++.||+|++...... ...+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 578999999999999999999862 4588999999754432 25688999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKG---------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 202 (293)
++||||+++++|.+++........ ......+++.+++.++.|++.||.|||+.+ |+|+||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976542100 001134899999999999999999999999 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 203 ~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876544333333344567889999999998889999999999999999999 9999987654
Q ss_pred c
Q 022706 282 R 282 (293)
Q Consensus 282 ~ 282 (293)
.
T Consensus 259 ~ 259 (314)
T 2ivs_A 259 E 259 (314)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.94 Aligned_cols=202 Identities=25% Similarity=0.326 Sum_probs=179.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||+||++.++ +++.||||++.+. ....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 468999999999999999999987 7889999998642 33456788899999988 59999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||
T Consensus 420 V~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecc
Confidence 999999999999998654 3899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 488 la~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 488 MCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp TCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 987532221 223567899999999999999999999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=291.17 Aligned_cols=218 Identities=42% Similarity=0.698 Sum_probs=186.5
Q ss_pred ccCccCHHHHHHHHhcCCCC------ceeeccCceEEEEEEeCCCCeEEEEEcCCCC-----CChHHHHHHHHHHhcCCC
Q 022706 53 EVPAISVDELKEITENFGTN------ALIGEGSYGRVYYGILKSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKH 121 (293)
Q Consensus 53 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l~h 121 (293)
....++..++..++++|... +.||+|+||+||+|.+ +++.+|+|++.... .....+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678889999998888776 8999999999999987 48899999986432 124678899999999999
Q ss_pred CCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 022706 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIK 201 (293)
Q Consensus 122 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dik 201 (293)
|||+++++++.+....++||||+++++|.+++...... ..+++..++.++.|++.||.|||+.+ |+|+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk 160 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK 160 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 99999999999999999999999999999998754321 24899999999999999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 202 SSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 202 p~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|+||+++.++.++|+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||.....
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 9999999999999999999876544333223345678999999997765 578899999999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=304.29 Aligned_cols=200 Identities=22% Similarity=0.394 Sum_probs=169.2
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCC--CCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+.+.||+|+||+||++.+++++.||||++...... ...+.+|++++++++ ||||+++++++......++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999999765443 256889999999997 599999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
| +.+++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 136 E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp E-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred e-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9 55789999998654 3889999999999999999999999 99999999999995 589999999999
Q ss_pred CCCCcccccccccccccCccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 87654333223345679999999998865 368889999999999999999999997643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=301.50 Aligned_cols=205 Identities=28% Similarity=0.475 Sum_probs=168.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCe----EEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... .....+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 368999999999999999999975 4443 5888875433 34567899999999999999999999998765 77
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+|+|++.+++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence 89999999999999976542 4899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
|++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 226 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence 99875443333222334556889999999999999999999999999999999 99999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=290.28 Aligned_cols=201 Identities=24% Similarity=0.401 Sum_probs=177.2
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
+.++|++.+.||+|+||.||+|.++ +++.||+|++....... ..+.+|++++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999987 79999999987654433 4677899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc---eEEec
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIAD 217 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---~kl~D 217 (293)
|||+++++|.+.+.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+|
T Consensus 84 ~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence 99999999988887654 3899999999999999999999999 999999999999986655 99999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 999866543222 234678999999999999999999999999999999999999997654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=313.98 Aligned_cols=201 Identities=31% Similarity=0.430 Sum_probs=174.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--------------CChHHHHHHHHHHhcCCCCCceeEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--------------QPDEEFLAQVSMVSRLKHENFVQLLG 129 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 129 (293)
+.++|.+.+.||+|+||+||+|.++ +++.+|+|++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 5679999999999999999999987 78999999986543 23467889999999999999999999
Q ss_pred EEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 130 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
++.+....++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLEN 181 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEec
Confidence 9999999999999999999999887654 3899999999999999999999999 999999999999987
Q ss_pred CC---ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 210 DD---VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 210 ~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++ .+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+...
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 76 69999999987654322 224567999999999876 4689999999999999999999999987653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=288.83 Aligned_cols=201 Identities=25% Similarity=0.424 Sum_probs=175.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-------ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-------PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
+.++|++.+.||+|+||.||++.++ +++.+|+|++..... ..+.+.+|++++++++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4568999999999999999999987 799999999864322 35778999999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC----c
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~----~ 212 (293)
.++||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++ .
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred EEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence 999999999999999997643 3899999999999999999999999 99999999999998877 7
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 99999999876543221 244568999999999998899999999999999999999999998654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=289.27 Aligned_cols=202 Identities=27% Similarity=0.499 Sum_probs=180.4
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|.+.+.||+|+||.||++.+.+++.||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 58999999999999999999998889999999988777778899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 88 GCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CcHHHHHhhCc--------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999997653 23899999999999999999999999 99999999999999999999999999876533
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||....
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 157 DQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp HHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 211 11233456788999999998889999999999999999999 999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=289.10 Aligned_cols=199 Identities=34% Similarity=0.571 Sum_probs=165.0
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC-----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||.||++.+. ++.+|+|++..... ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 58999999999999999999986 89999999875432 2367889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC--------CCce
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--------DDVA 213 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~--------~~~~ 213 (293)
||+++++|.+++.... +++..++.++.|++.||.|||+.+..+++||||||+||+++. ++.+
T Consensus 86 e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 86 EFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp ECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 9999999999986443 899999999999999999999987445889999999999986 6789
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+..
T Consensus 156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 156 KITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp EECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred EEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654322 234568999999999998899999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=312.46 Aligned_cols=204 Identities=27% Similarity=0.477 Sum_probs=178.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|.+.+.||+|+||.||+|.++++..||||+++......+.+.+|++++++++||||+++++++. ....++||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 5689999999999999999999988899999999877777889999999999999999999999986 667899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 266 ~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 266 KGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp TCBHHHHHHSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred CCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999975431 13888999999999999999999999 9999999999999999999999999997654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... ......+++.|+|||++....++.++||||||+++|||++ |+.||.+...
T Consensus 336 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 336 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp CHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 32211 1223345778999999998899999999999999999999 9999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=300.90 Aligned_cols=204 Identities=28% Similarity=0.460 Sum_probs=171.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCe----EEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|++.+.||+|+||+||+|.+. +++. +++|.+.... .....+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 58999999999999999999976 5554 7788775432 22346778999999999999999999886 456889
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCS
T ss_pred EEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCC
Confidence 9999999999999976531 3888999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
++................+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+....
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 224 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence 9987654433333345667889999999998899999999999999999999 99999876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=302.23 Aligned_cols=204 Identities=27% Similarity=0.477 Sum_probs=164.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||.||+|+++ ++..||||+++..... ...+.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999865 5778999999765432 3568899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 124 v~e~~~~~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCc
Confidence 999999999999997653 24899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccc-cccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 220 LSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++.......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 998664332111 1122335778999999999999999999999999999998 999997654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=315.55 Aligned_cols=206 Identities=30% Similarity=0.458 Sum_probs=181.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
..+|.+.+.||+|+||.||+|.++ ++..||||++.......+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 467899999999999999999987 5889999999887777889999999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 299 ~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 299 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp TTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999976432 23899999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
...... ......+++.|+|||++....++.++||||||+++|||++ |..||.+.+..
T Consensus 369 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 369 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp TTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred cCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 432211 1223345778999999998889999999999999999999 99999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=292.53 Aligned_cols=203 Identities=21% Similarity=0.269 Sum_probs=176.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ....+.+|+.+++++ +|+|++++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 468999999999999999999975 79999999986433 334678899999999 699999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc-----eEEecc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV-----AKIADF 218 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~-----~kl~Df 218 (293)
+ +++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+||
T Consensus 88 ~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 88 L-GPSLEDLLDLCG--------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 9 889999998653 23899999999999999999999999 999999999999987765 999999
Q ss_pred ccCCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 219 DLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 998765433221 123456799999999999998999999999999999999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=298.08 Aligned_cols=205 Identities=24% Similarity=0.420 Sum_probs=178.6
Q ss_pred HHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---------hHHHHHHHHHHhcC-CCCCceeEEE
Q 022706 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---------DEEFLAQVSMVSRL-KHENFVQLLG 129 (293)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---------~~~~~~e~~~l~~l-~h~~i~~~~~ 129 (293)
....+.++|.+.+.||+|+||.||+|.++ +|+.||||++...... .+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34556789999999999999999999987 7999999998654421 24577899999999 7999999999
Q ss_pred EEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 130 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
++......++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| |+|+||||+||+++.
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999997543 3899999999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCcccccccccccccCccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 236 ~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp TCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999987654322 2245679999999998863 357889999999999999999999997643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=299.14 Aligned_cols=200 Identities=23% Similarity=0.375 Sum_probs=166.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|++.+.||+|+||+||+|.+. +++.||+|++...... ...+.+|++++++++||||+++++++.+....++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 568999999999999999999977 7999999999754433 245778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc-----CCCceEEe
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-----DDDVAKIA 216 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~-----~~~~~kl~ 216 (293)
||+++ +|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 113 e~~~~-~L~~~~~~~~---------~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP---------DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp ECCSE-EHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred ecCCC-CHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence 99975 9999987654 3899999999999999999999999 99999999999994 45569999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus 180 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 180 DFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 999986543211 122445689999999998874 48999999999999999999999997654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=298.66 Aligned_cols=213 Identities=28% Similarity=0.467 Sum_probs=177.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++++ +||||+++++++.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 478999999999999999999962 46689999997543 2346789999999999 89999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKG--------------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~--------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 202 (293)
.++||||+++++|.+++........ ......+++.+++.++.|++.||.|||+.+ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 9999999999999999976542100 001124899999999999999999999999 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 203 ~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999976544333223344567889999999998899999999999999999998 9999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=289.09 Aligned_cols=199 Identities=32% Similarity=0.480 Sum_probs=174.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||+||++.++ +++.||+|++... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999987 6889999998543 23346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 88 ~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCE
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccc
Confidence 99999999999987654 3899999999999999999999998 99999999999999999999999998
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 156 SVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp ESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 86543322 244578999999999999889999999999999999999999998654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=290.98 Aligned_cols=204 Identities=28% Similarity=0.405 Sum_probs=172.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.++|.+.+.||+|+||+||++.++ ++..+|+|++.... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4578999999999999999999987 78999999986543 34578899999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc---CCCceEEecc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADF 218 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~---~~~~~kl~Df 218 (293)
||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.++|+||
T Consensus 100 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEee
Confidence 999999999988543210 024899999999999999999999999 99999999999994 4678999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||.+..
T Consensus 172 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 172 GLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 9997654322 224567899999999875 568899999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=298.64 Aligned_cols=204 Identities=30% Similarity=0.499 Sum_probs=172.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEe------CCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD------GTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~ 136 (293)
..++|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.+++++ +||||+++++++.. ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 4678999999999999999999986 799999999987766778899999999999 79999999999987 467
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 8999999999999999976532 13899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++........ ......|++.|+|||++. +..++.++||||||+++|+|++|..||.+..
T Consensus 172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999876543211 124457899999999987 4568899999999999999999999997654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=310.60 Aligned_cols=202 Identities=29% Similarity=0.439 Sum_probs=176.4
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCC---CCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA---SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.+.++|++.+.||+|+||+||++.++ +++.||+|++.. .......+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 45689999999999999999999987 899999999853 23456788999999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc---CCCceEEe
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIA 216 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~---~~~~~kl~ 216 (293)
||||+.+++|.+.+.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 99 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEE
Confidence 999999999998886654 3899999999999999999999999 99999999999995 45679999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999997654322 2245679999999998875 589999999999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=301.17 Aligned_cols=197 Identities=27% Similarity=0.405 Sum_probs=167.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 135 (293)
.++|.+.+.||+|+||.||+|.++ +|+.||||++...... ...+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999986 7999999999654433 356789999999999999999999987653
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+ +++|.++++... +++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence 459999999 779999997643 899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||++...... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 170 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Eeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999998764321 245678999999999887 6799999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=297.53 Aligned_cols=210 Identities=26% Similarity=0.396 Sum_probs=160.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCC---eEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCee-
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR- 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~---~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~- 137 (293)
.++|.+.+.||+|+||+||+|.++ ++. .||+|++..... ..+.+.+|++++++++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 468999999999999999999976 333 799999975432 235788999999999999999999999877665
Q ss_pred -----EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 138 -----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 138 -----~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
++||||+++++|.+++....... ....+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 89999999999999986543211 1124899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 99999999986644333333344556889999999999999999999999999999999 9999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=294.04 Aligned_cols=204 Identities=25% Similarity=0.386 Sum_probs=170.5
Q ss_pred HhcCCCC-ceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|.+. +.||+|+||+||+|.+. +++.||||++.... .....+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999976 79999999996543 3457789999999885 6999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc---eEEecc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---AKIADF 218 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---~kl~Df 218 (293)
||+++++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 91 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 9999999999997654 3899999999999999999999999 999999999999988776 999999
Q ss_pred ccCCCCCcccc-----cccccccccCccccccccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 219 DLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMT-----GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|++........ ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 99876532211 111234568999999998875 4578999999999999999999999987653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=287.47 Aligned_cols=202 Identities=31% Similarity=0.456 Sum_probs=157.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||+|.+. +++.||+|++... ......+.+|++++++++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 468999999999999999999986 7999999998643 23346788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 90 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--------KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp EECCTTEEHHHHHHTCS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 99999999999998653 24899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 159 ATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred eeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 876543221 1234568999999999998889999999999999999999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=312.33 Aligned_cols=201 Identities=30% Similarity=0.471 Sum_probs=177.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
+.++|++.+.||+|+||.||++.++ +++.||||++... ......+.+|++++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5678999999999999999999987 8999999998643 3345778999999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE---cCCCceEEe
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIA 216 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv---~~~~~~kl~ 216 (293)
||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 104 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 999999999999887654 3899999999999999999999999 9999999999999 467889999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..+
T Consensus 172 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 172 DFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp CTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 999986543322 2244679999999998866 689999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=293.59 Aligned_cols=205 Identities=31% Similarity=0.462 Sum_probs=182.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
.++|.+.+.||+|+||+||+|.++ ++..||+|++.......+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 568999999999999999999987 6889999999877766788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 92 ~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 92 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp TTEEHHHHHHHCCT-------TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCCcHHHHHHhccc-------CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999976432 24899999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 43221 12233456888999999998899999999999999999999 9999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=297.87 Aligned_cols=201 Identities=24% Similarity=0.400 Sum_probs=167.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh--HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|.+.+.||+|+||+||+|.++ +++.||+|++....... ..+.+|++++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999987 79999999986543222 2355799999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++ +|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LDK-DLKQYLDDCG--------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp CSE-EHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred ccc-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 975 8988887654 24899999999999999999999999 99999999999999999999999999875
Q ss_pred CCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 150 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 150 KSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 43322 12234568999999999876 5689999999999999999999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=301.34 Aligned_cols=202 Identities=19% Similarity=0.300 Sum_probs=167.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC------CCeEEEEEcCCCCCC------------hHHHHHHHHHHhcCCCCCceeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFVQL 127 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~avK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~ 127 (293)
.++|.+.+.||+|+||+||+|.++. ++.||+|++...... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999999763 478999998654321 1123345566777889999999
Q ss_pred EEEEEeC----CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 022706 128 LGYCVDG----TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (293)
Q Consensus 128 ~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~ 203 (293)
++++.+. ...++||||+ +++|.+++.... ..+++.+++.++.||+.||.|||+.+ |+||||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~ 181 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--------KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKAS 181 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHH
Confidence 9998764 4589999999 899999997653 24999999999999999999999999 999999999
Q ss_pred ceEEc--CCCceEEeccccCCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 022706 204 NVLIF--DDDVAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 204 Nilv~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf 276 (293)
|||++ .++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 182 Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 182 NLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp GEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999 8899999999999765433211 1113455999999999999989999999999999999999999999
Q ss_pred CCC
Q 022706 277 DHT 279 (293)
Q Consensus 277 ~~~ 279 (293)
.+.
T Consensus 262 ~~~ 264 (364)
T 3op5_A 262 EDN 264 (364)
T ss_dssp GGG
T ss_pred ccc
Confidence 864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=292.94 Aligned_cols=203 Identities=22% Similarity=0.326 Sum_probs=167.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
..++|++.+.||+|+||.||++.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3579999999999999999999987 7899999998754332 2568899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 112 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred EEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 999999999999997653 3899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++........ .......+++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 180 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 180 IASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred cCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 9876543221 12234568999999999998889999999999999999999999997643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.04 Aligned_cols=212 Identities=21% Similarity=0.346 Sum_probs=179.9
Q ss_pred ccCHHHHHHHHhcCCCC-ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCC-CCCceeEEE
Q 022706 56 AISVDELKEITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLK-HENFVQLLG 129 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~ 129 (293)
.+.+...+.+.++|.+. +.||+|+||+||++.++ +++.||+|++..... ....+.+|+.+++++. ||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34444556778889888 89999999999999987 799999999875432 3467889999999995 699999999
Q ss_pred EEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC
Q 022706 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 130 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~ 209 (293)
++.+....++||||+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS 166 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEec
Confidence 99999999999999999999999865422 24899999999999999999999999 999999999999987
Q ss_pred ---CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 210 ---DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 210 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 78999999999876543222 244678999999999999999999999999999999999999997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.19 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=172.9
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC---CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK---QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
+.++|++.+.||+|+||+||+|.++ ++..+|+|++.... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5678999999999999999999987 78999999986542 3356789999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC---CceEEec
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKIAD 217 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~---~~~kl~D 217 (293)
|||+++++|.+.+.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|
T Consensus 115 ~e~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 99999999998887654 3899999999999999999999999 9999999999999764 4599999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|..||.+..+
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99987654322 224567999999999875 5689999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=306.34 Aligned_cols=200 Identities=32% Similarity=0.547 Sum_probs=174.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCC-eeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT-SRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~ 144 (293)
.++|.+.+.||+|+||.||++.++ ++.||||+++... ..+.+.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 367899999999999999999987 7899999997654 5578999999999999999999999987665 789999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 270 ~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp TTCBHHHHHHHHCT-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999999986542 23789999999999999999999999 999999999999999999999999998754
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
.... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||.+....
T Consensus 340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 340 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred cccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 3211 22356889999999999999999999999999999998 99999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=305.18 Aligned_cols=202 Identities=25% Similarity=0.410 Sum_probs=166.0
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---------ChHHHHHHHHHHhcCCCCCceeEEEEEE
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCV 132 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 132 (293)
..+.++|.+.+.||+|+||+||+|.++ +++.||+|++..... ....+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456789999999999999999999987 789999999864321 1124789999999999999999999975
Q ss_pred eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-
Q 022706 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD- 211 (293)
Q Consensus 133 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~- 211 (293)
....++||||+++++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred -cCceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 455799999999999999887553 3899999999999999999999999 99999999999997544
Q ss_pred --ceEEeccccCCCCCcccccccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 212 --VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 212 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 59999999998764322 2245679999999998863 567889999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=304.83 Aligned_cols=202 Identities=26% Similarity=0.344 Sum_probs=173.7
Q ss_pred HhcCCCCceeeccCceEEEEEEe----CCCCeEEEEEcCCCC-----CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL----KSGHAAAIKKLDASK-----QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGT 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 135 (293)
.++|.+.+.||+|+||+||+++. .+++.||||++.... .....+.+|+++++++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 378999999986432 3345677899999999 6999999999999999
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence 9999999999999999997654 3899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 201 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 201 TDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp SCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 99999876543222 22345679999999999885 347889999999999999999999997543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.26 Aligned_cols=197 Identities=30% Similarity=0.500 Sum_probs=172.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.+.|.+.+.||+|+||+||+|.+. +++.||||++....... ..+.+|++++++++||||+++++++.+....++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 456999999999999999999975 79999999987554332 4678999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+. ++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~e~~~-g~l~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp EECCS-EEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred EecCC-CCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 99997 48888775433 23899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+...... ....||+.|+|||++. ...++.++|||||||++|||++|+.||.+..
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765431 3457899999999885 4678999999999999999999999997654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.92 Aligned_cols=200 Identities=27% Similarity=0.401 Sum_probs=168.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC-----Ce
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 136 (293)
.++|.+.+.||+|+||.||+|.++ +++.||||++...... ...+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999987 7899999999765433 35688999999999999999999998766 56
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEc
Confidence 899999996 49999997653 4899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc--------------------ccccccccCcccccccccc-cCCCCCccchhhHHHHHHHHHhCCCC
Q 022706 217 DFDLSNQAPDMAAR--------------------LHSTRVLGTFGYHAPEYAM-TGQLNAKSDVYSFGVVLLELLTGRKP 275 (293)
Q Consensus 217 Dfg~~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~g~~P 275 (293)
|||++......... ......+||+.|+|||++. ...++.++|||||||++|||++|..|
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99999765432211 1235678999999999864 56699999999999999999986666
Q ss_pred CCC
Q 022706 276 VDH 278 (293)
Q Consensus 276 f~~ 278 (293)
|..
T Consensus 252 ~~~ 254 (432)
T 3n9x_A 252 HIN 254 (432)
T ss_dssp TCS
T ss_pred ccc
Confidence 543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=309.23 Aligned_cols=204 Identities=32% Similarity=0.537 Sum_probs=174.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||+|.++.+..||||++.......+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 46899999999999999999999877889999998777777889999999999999999999999876 67899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 262 ~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 262 KGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp TCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999975321 13899999999999999999999999 9999999999999999999999999998654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... .......+++.|+|||++....++.++||||||+++|||++ |+.||.+...
T Consensus 332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 332 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 3221 11223446788999999998899999999999999999999 9999987643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=288.53 Aligned_cols=197 Identities=23% Similarity=0.290 Sum_probs=165.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChH---HHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDE---EFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~---~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 139 (293)
+.++|++.+.||+|+||+||+|.++ +++.||||++........ ...+|+..+.++ +||||+++++++.+....++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4578999999999999999999987 799999999876544432 344555555555 89999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 135 v~e~~-~~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG--------ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEECC-CCBHHHHHHHHC--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEecc-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence 99999 569988887654 24999999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 987654322 2244568999999998776 78999999999999999999976654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=290.59 Aligned_cols=201 Identities=27% Similarity=0.419 Sum_probs=176.3
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.+.++|.+.+.||+|+||.||++.++ +++.||+|++..... ....+.+|+.++++++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45679999999999999999999987 799999999975433 3456889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE---cCCCceEEecc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF 218 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv---~~~~~~kl~Df 218 (293)
||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+|+||||+||++ +.++.++|+||
T Consensus 86 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 86 QLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp CCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EcCCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999999887553 3899999999999999999999999 9999999999999 77889999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|++...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp STTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 998754322 1234568999999999998899999999999999999999999997654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=287.34 Aligned_cols=199 Identities=30% Similarity=0.466 Sum_probs=177.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||++.+. +++.||+|++... ......+.+|++++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999987 6889999998542 33456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 93 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccc
Confidence 99999999999987653 3899999999999999999999999 99999999999999999999999998
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 161 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 161 SVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp CEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 86543321 244578999999999999899999999999999999999999997653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=288.36 Aligned_cols=204 Identities=29% Similarity=0.490 Sum_probs=178.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||+|.++++..||+|++.......+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4689999999999999999999888889999999877777788999999999999999999999876 456899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 91 ~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 91 NGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp TCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999975421 13899999999999999999999999 9999999999999999999999999987654
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred Cccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 3221 11233456788999999988889999999999999999999 9999986543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=296.02 Aligned_cols=205 Identities=28% Similarity=0.474 Sum_probs=167.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCe----EEEEEcCCC--CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHA----AAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----~avK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.++|++.+.||+|+||+||+|.+. +++. +++|.+... ......+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 368999999999999999999976 5554 477776533 345578999999999999999999999998765 78
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+|+|++.+++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccC
Confidence 89999999999999976542 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
|++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 99987654433333344557889999999999999999999999999999999 99999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=298.19 Aligned_cols=198 Identities=24% Similarity=0.306 Sum_probs=164.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCC------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGT------ 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 135 (293)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999977 7899999998754433 246789999999999999999999997665
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+++ +|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEcCCC-CHHHHHhh-----------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEE
Confidence 67999999975 78888752 2889999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 169 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp CCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999987654321 22456789999999999998999999999999999999999999987543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.53 Aligned_cols=213 Identities=25% Similarity=0.426 Sum_probs=180.2
Q ss_pred HhcCCCCceeeccCceEEEEEEe------CCCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 25789999999765432 35688999999999 89999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVK---------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
.++||||+++++|.+++....... .......+++.+++.++.|++.||.|||+.+ |+|+||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 999999999999999997654210 0011224899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999987654433323344557889999999998899999999999999999999 9999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=288.16 Aligned_cols=200 Identities=30% Similarity=0.460 Sum_probs=178.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.+.|.+.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 357999999999999999999976 79999999986543 335788999999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++.... +++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 101 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 101 YLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp CCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999987543 899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 6543221 2245678999999999999899999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=296.32 Aligned_cols=216 Identities=26% Similarity=0.417 Sum_probs=179.9
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG 134 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 134 (293)
+...++|.+.+.||+|+||.||+|.++ +++.||+|++...... ...+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 334679999999999999999999854 3778999999754432 24588999999999999999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
...++||||+++++|.+++....... .......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999987532100 0000123789999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999876544333333344567889999999998899999999999999999999 8999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=296.42 Aligned_cols=204 Identities=26% Similarity=0.401 Sum_probs=169.2
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGT 135 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 135 (293)
....++|.+.+.||+|+||.||+|.++ +++.||+|++...... ...+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344679999999999999999999987 7999999999753321 246789999999999999999999999999
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++||||+++ +|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred ceEEEEEcCCC-CHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEE
Confidence 99999999986 8888886543 23888899999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+..
T Consensus 154 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 154 ADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp CCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 99999987643221 22456789999999998764 58899999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=292.99 Aligned_cols=201 Identities=28% Similarity=0.439 Sum_probs=171.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|++.+.||+|+||.||++.++ +++.||+|++....... ..+.+|++++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999987 69999999986554443 45778999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 104 e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp ECCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCc
Confidence 9999988888866443 3899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
........ ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 76543221 22445689999999998875 68999999999999999999999998664
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=286.97 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=177.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||++.++ +++.+|+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999987 688999999865432 235678899999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 94 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp EECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccC
Confidence 99999999999887653 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 162 ATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876532211 1244568999999999998889999999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=288.14 Aligned_cols=201 Identities=30% Similarity=0.555 Sum_probs=162.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|++.+.||+|+||+||++.++ ..+|+|++....... +.+.+|++++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999865 359999997655443 5688999999999999999999965 5566899999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 100 ~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ecCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 999999999996543 24899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...............||+.|+|||++. +..++.++||||||+++|+|++|+.||.+..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 654333333334567899999999886 5668889999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=292.84 Aligned_cols=201 Identities=27% Similarity=0.449 Sum_probs=166.7
Q ss_pred HHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhc--CCCCCceeEEEEEEe----CCeeE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVD----GTSRV 138 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~ 138 (293)
+.++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.+ ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 357899999999999999999988 5899999998653 33455666666665 789999999998654 34578
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCceEEcCC
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--------EKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
+||||+++++|.++++... +++..++.++.|++.||+||| +.+ |+||||||+|||++.+
T Consensus 83 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred EehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence 9999999999999996543 899999999999999999999 888 9999999999999999
Q ss_pred CceEEeccccCCCCCccccc--ccccccccCcccccccccccC------CCCCccchhhHHHHHHHHHhC----------
Q 022706 211 DVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG------QLNAKSDVYSFGVVLLELLTG---------- 272 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~~g---------- 272 (293)
+.+||+|||++......... .......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999998654322111 112345799999999998876 345789999999999999999
Q ss_pred CCCCCCCCC
Q 022706 273 RKPVDHTLP 281 (293)
Q Consensus 273 ~~Pf~~~~~ 281 (293)
..||....+
T Consensus 230 ~~pf~~~~~ 238 (301)
T 3q4u_A 230 KPPFYDVVP 238 (301)
T ss_dssp CCTTTTTSC
T ss_pred cccccccCC
Confidence 888876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=294.40 Aligned_cols=212 Identities=28% Similarity=0.474 Sum_probs=177.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
.++|.+.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999863 4678999999765432 35688999999999 899999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
+..++||||+++++|.+++........ ......+++.+++.++.|++.||.|||+.+ |+|+||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999986542110 001124899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999876554333223344567889999999988889999999999999999999 999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=292.11 Aligned_cols=202 Identities=29% Similarity=0.444 Sum_probs=169.7
Q ss_pred HhcCCCCceeeccCceEEEEEEe----C-CCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL----K-SGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~----~-~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 137 (293)
.++|++.+.||+|+||+||++++ . +++.||+|++...... ...+.+|++++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 57899999999999999999983 2 6899999998754322 3568899999999999999999999864 3568
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 999999999999999976542 3899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 218 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 9999876433221 122334567789999999999999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=303.85 Aligned_cols=203 Identities=25% Similarity=0.382 Sum_probs=174.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCC--eeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 140 (293)
.++|.+.+.||+|+||+||+|.++ +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 468999999999999999999987 69999999997533 34567889999999999999999999998765 67999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE----cCCCceEEe
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAKIA 216 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv----~~~~~~kl~ 216 (293)
|||+++++|.+++...... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEe
Confidence 9999999999999765421 13899999999999999999999999 9999999999999 777789999
Q ss_pred ccccCCCCCcccccccccccccCccccccccccc--------CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--------GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 159 DFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999976544322 245679999999998865 457789999999999999999999997543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=293.58 Aligned_cols=204 Identities=26% Similarity=0.412 Sum_probs=172.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEe--------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-------- 133 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 133 (293)
.++|++.+.||+|+||+||+|.++ +++.||+|++..... ....+.+|++++++++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999986 899999999865433 23578899999999999999999999887
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
....++||||+++ +|.+.+.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 4468999999976 7777776543 13899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccc--ccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999987653221 1122245678999999998876 4589999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=298.98 Aligned_cols=199 Identities=28% Similarity=0.432 Sum_probs=175.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|.+.+.||+|+||+||++.++ +++.||+|++...... ...+.+|++++++++||||+++++++.+....++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 358999999999999999999987 7999999998765332 3568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|+++++|.+++.... .+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+|||++
T Consensus 112 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp CCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999999999997654 389999999999999999999996 8 999999999999999999999999988
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 180 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 180 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred ccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54322 12245678999999999999999999999999999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=296.83 Aligned_cols=208 Identities=25% Similarity=0.397 Sum_probs=170.9
Q ss_pred CHHHHHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC------------hHHHHHHHHHHhcCCCCCce
Q 022706 58 SVDELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFV 125 (293)
Q Consensus 58 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~ 125 (293)
...++..+.++|.+.+.||+|+||.||+|.+.+++.||||++...... .+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 345667778999999999999999999999888999999998643322 16788999999999999999
Q ss_pred eEEEEEEe-----CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 022706 126 QLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200 (293)
Q Consensus 126 ~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di 200 (293)
++++++.. ....++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 160 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--------IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDL 160 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCC
Confidence 99999854 3367999999974 8888876543 24899999999999999999999999 999999
Q ss_pred CCCceEEcCCCceEEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 201 kp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||+||+++.++.++|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 161 HPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987543322 2245678999999998887 67899999999999999999999999875
Q ss_pred C
Q 022706 280 L 280 (293)
Q Consensus 280 ~ 280 (293)
.
T Consensus 238 ~ 238 (362)
T 3pg1_A 238 T 238 (362)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.47 Aligned_cols=197 Identities=30% Similarity=0.450 Sum_probs=156.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeC------C
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDG------T 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 135 (293)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... ...+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999976 7999999999764433 35678999999999999999999998754 5
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..++|||++ +++|.+++.... +++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEE
Confidence 679999999 679999887543 899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 174 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 174 LDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999998764332 245678999999999887 6789999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=286.72 Aligned_cols=203 Identities=30% Similarity=0.442 Sum_probs=163.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC----CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|++.+.||+|+||.||+|.+.. +..+|+|++...... .+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 5689999999999999999998752 456999998754332 35688999999999999999999997 4567899
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 93 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EEECCTTEEHHHHHHHTT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence 999999999999997653 23899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 162 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 9876543221 11233456789999999998899999999999999999997 9999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.22 Aligned_cols=194 Identities=19% Similarity=0.339 Sum_probs=171.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEe--CCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVD--GTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~ 141 (293)
.++|++.+.||+|+||+||+|.+. +++.||+|++.. .....+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 368999999999999999999976 799999999863 34578899999999997 9999999999987 66789999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg~ 220 (293)
||+.+++|.+++. .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++ .++|+|||+
T Consensus 113 e~~~~~~l~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ECCCCCCHHHHGG------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eccCchhHHHHHH------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 9999999999884 2789999999999999999999999 99999999999999776 899999999
Q ss_pred CCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 178 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 178 AEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 876543222 244578999999999887 67899999999999999999999999543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=291.18 Aligned_cols=203 Identities=26% Similarity=0.402 Sum_probs=171.2
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---------ChHHHHHHHHHHhcCCCCCceeEEEEEE
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLKHENFVQLLGYCV 132 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 132 (293)
..+.++|.+.+.||+|+||.||+|.++ +++.||||++..... ....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 345679999999999999999999987 789999999865421 1234789999999999999999999987
Q ss_pred eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 133 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
... .++||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSS
T ss_pred CCc-eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCC
Confidence 655 899999999999999886543 4899999999999999999999999 999999999999987664
Q ss_pred ---eEEeccccCCCCCcccccccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 213 ---AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 213 ---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+||+|||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp SCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred CCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 99999999876543221 23456899999999874 45688999999999999999999999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.61 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=174.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeC-----Cee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 137 (293)
.++|++.+.||+|+||.||++.+. +++.||+|++...... ...+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999977 7889999999754433 25688999999999999999999998755 368
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++|||++.+ +|.+++.... +++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence 999999975 9999987653 899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-ccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 218 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 9999765433221 11244679999999998765 4589999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.92 Aligned_cols=204 Identities=32% Similarity=0.537 Sum_probs=179.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||.||+|.++.+..||||++.......+.+.+|++++++++||||+++++++.+ ...++||||+.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 56899999999999999999999877889999998777777889999999999999999999999866 67899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+++|.+++..... ..+++.+++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 345 ~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 345 KGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp TEEHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred CCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999975321 13899999999999999999999999 9999999999999999999999999998765
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... .......++..|+|||++....++.++||||||+++|||++ |+.||.+...
T Consensus 415 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 415 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp CHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred CCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3221 11223446788999999998899999999999999999999 9999987643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=283.92 Aligned_cols=200 Identities=32% Similarity=0.537 Sum_probs=170.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh--------HHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--------EEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
.++|++.+.||+|+||+||+|.+. +++.||+|++....... ..+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 368999999999999999999986 89999999986543321 57889999999999999999999986655
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc----
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---- 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---- 212 (293)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ .+|+|+||||+||+++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSC
T ss_pred -eEEEEecCCCCHHHHHhccc--------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCce
Confidence 69999999999998886544 24899999999999999999999984 23999999999999988776
Q ss_pred -eEEeccccCCCCCcccccccccccccCcccccccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 213 -AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 213 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++|+|||++...... .....||+.|+|||++. ...++.++||||||+++|+|++|+.||.....
T Consensus 167 ~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 167 CAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 999999998754332 24467899999999884 45578899999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=302.57 Aligned_cols=200 Identities=23% Similarity=0.308 Sum_probs=174.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC------CCCCceeEEEEEEeCCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL------KHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 138 (293)
..+|++.+.||+|+||+||+|.+. +++.||||++.........+.+|+++++.+ +|+||+++++++......+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 468999999999999999999977 689999999976544446677888887776 4779999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc--eEEe
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV--AKIA 216 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~--~kl~ 216 (293)
+||||+. ++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 176 lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF-------QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred EEEeccC-CCHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence 9999996 589998876542 13899999999999999999999999 999999999999999887 9999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 245 DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 245 DFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999865332 12456789999999999999999999999999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=287.68 Aligned_cols=202 Identities=32% Similarity=0.494 Sum_probs=173.4
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
..++|.+.+.||+|+||.||+|.++ +++.||+|++.... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 4578999999999999999999987 69999999987543 446789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 106 ~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 106 CGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp CTTEEHHHHHHHHT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 99999999987432 23899999999999999999999999 99999999999999999999999999876
Q ss_pred CCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 175 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 543221 2244578999999999998889999999999999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=289.77 Aligned_cols=204 Identities=25% Similarity=0.395 Sum_probs=164.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-C---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-P---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||.||++.+. +++.||+|++..... . ...+.+|++++++++||||+++++++.+....++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 468999999999999999999976 799999999975332 2 35678999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred EecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 9999999999998653211 124899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+........ ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 183 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 183 GRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred eeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 876543221 123456899999999999889999999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=291.02 Aligned_cols=203 Identities=28% Similarity=0.463 Sum_probs=168.1
Q ss_pred HHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcC--CCCCceeEEEEEEeC----C
Q 022706 62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL--KHENFVQLLGYCVDG----T 135 (293)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~ 135 (293)
...+.++|++.+.||+|+||.||+|+++ ++.||+|++.... .....+|.+++..+ +||||+++++++.+. .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3456789999999999999999999987 8999999985432 34445555555554 899999999999887 7
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeCCCCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK--------ADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~~ivH~Dikp~Nilv 207 (293)
..++||||+++++|.++++... +++.+++.++.|++.||.|||+. + |+||||||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill 175 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILV 175 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEE
T ss_pred ceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEE
Confidence 8899999999999999997653 89999999999999999999998 8 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccc--ccccccccCcccccccccccCCCCCc------cchhhHHHHHHHHHhC-------
Q 022706 208 FDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAK------SDVYSFGVVLLELLTG------- 272 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~~l~el~~g------- 272 (293)
+.++.+||+|||++......... .......||+.|+|||++.+...... +|||||||++|||++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999998655332221 11234579999999999987766655 9999999999999999
Q ss_pred ---CCCCCCCC
Q 022706 273 ---RKPVDHTL 280 (293)
Q Consensus 273 ---~~Pf~~~~ 280 (293)
+.||....
T Consensus 256 ~~~~~p~~~~~ 266 (337)
T 3mdy_A 256 EEYQLPYHDLV 266 (337)
T ss_dssp CCCCCTTTTTS
T ss_pred ccccccHhhhc
Confidence 77776543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=297.61 Aligned_cols=204 Identities=22% Similarity=0.340 Sum_probs=167.4
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe--------
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-------- 133 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 133 (293)
+...++|.+.+.||+|+||+||+|.+. +++.||+|++..+... ..+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 345679999999999999999999976 8999999998654332 3479999999999999999999854
Q ss_pred ------------------------------CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 022706 134 ------------------------------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183 (293)
Q Consensus 134 ------------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 183 (293)
....++||||+++ +|.+.+...... ...+++..++.++.|++.|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS-----GRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHH
Confidence 3347899999985 877776542110 1248999999999999999
Q ss_pred HHHHHhCCCCCeeeCCCCCCceEEc-CCCceEEeccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhh
Q 022706 184 LEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYS 261 (293)
Q Consensus 184 l~~LH~~~~~~ivH~Dikp~Nilv~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws 261 (293)
|.|||+.| |+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++||||
T Consensus 154 L~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 154 VGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 99999999 99999999999998 688999999999976533222 2456789999999988875 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCC
Q 022706 262 FGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 262 lG~~l~el~~g~~Pf~~~~~ 281 (293)
+||++|+|++|+.||.+.+.
T Consensus 228 lG~il~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETS 247 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999987643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=286.43 Aligned_cols=205 Identities=25% Similarity=0.382 Sum_probs=170.9
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC-----CCChHHHHHHHHHHhcCCCCCceeEEEEEE--eCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS-----KQPDEEFLAQVSMVSRLKHENFVQLLGYCV--DGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 136 (293)
+.++|.+.+.||+|+||.||++.++ +++.+|+|++... ......+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4579999999999999999999986 7899999998643 233467899999999999999999999984 4567
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||++++ |.+++..... ..+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-------KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEehhccCC-HHHHHHhCcc-------cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEee
Confidence 89999999875 7777665432 24899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++................|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.+..
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 999987654333332334566899999999887643 4779999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=286.18 Aligned_cols=199 Identities=28% Similarity=0.482 Sum_probs=174.1
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe--------
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-------- 133 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 133 (293)
..+.++|++.+.||+|+||.||++.++ +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 346789999999999999999999987 89999999986543 457789999999999999999998864
Q ss_pred --------CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCce
Q 022706 134 --------GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (293)
Q Consensus 134 --------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Ni 205 (293)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Ni 153 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-------EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNI 153 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHE
Confidence 4457899999999999999975432 23899999999999999999999999 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 206 LIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 206 lv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
++++++.++|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999999999876543221 244568999999999998889999999999999999999998875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=304.67 Aligned_cols=204 Identities=11% Similarity=0.184 Sum_probs=162.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHH---HHHhcCCCCCceeEE-------EEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQV---SMVSRLKHENFVQLL-------GYC 131 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~ 131 (293)
++|.+.+.||+|+||+||+|.++ +++.||||++... ....+.+.+|+ +.+++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 57888999999999999999975 7999999998643 22346788999 455555799999988 776
Q ss_pred EeCCe-----------------eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 022706 132 VDGTS-----------------RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194 (293)
Q Consensus 132 ~~~~~-----------------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 194 (293)
.+.+. .++||||+ +|+|.+++....... .....+++..++.++.||+.||+|||+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 65542 78999999 579999997643211 01122446888899999999999999999
Q ss_pred eeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccC-----------CCCCccchhhHH
Q 022706 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----------QLNAKSDVYSFG 263 (293)
Q Consensus 195 ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG 263 (293)
|+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999875432 2244567 999999999877 799999999999
Q ss_pred HHHHHHHhCCCCCCCCCCc
Q 022706 264 VVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 264 ~~l~el~~g~~Pf~~~~~~ 282 (293)
|++|||++|+.||.+....
T Consensus 301 ~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp HHHHHHHHSSCCC------
T ss_pred HHHHHHHHCCCCCcccccc
Confidence 9999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=291.51 Aligned_cols=220 Identities=23% Similarity=0.393 Sum_probs=181.1
Q ss_pred CHHHHHHHHhcCCCCceeeccCceEEEEEEe------CCCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEE
Q 022706 58 SVDELKEITENFGTNALIGEGSYGRVYYGIL------KSGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLL 128 (293)
Q Consensus 58 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~ 128 (293)
...+.....++|++.+.||+|+||+||+|.+ .+++.||+|++...... ...+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444567999999999999999999984 25789999999765433 24688999999999 699999999
Q ss_pred EEEEeCC-eeEEEEEcccCCchhhhhhcCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 022706 129 GYCVDGT-SRVLAYEFASNGSLHDILHGRKGVKGA-------QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200 (293)
Q Consensus 129 ~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di 200 (293)
+++.+.+ ..++||||+++++|.+++......... .....+++.+++.++.|++.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987654 489999999999999999865421000 00123889999999999999999999999 999999
Q ss_pred CCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 022706 201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHT 279 (293)
Q Consensus 201 kp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~ 279 (293)
||+||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986644333333345567889999999999999999999999999999998 99999865
Q ss_pred C
Q 022706 280 L 280 (293)
Q Consensus 280 ~ 280 (293)
.
T Consensus 255 ~ 255 (316)
T 2xir_A 255 K 255 (316)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=292.77 Aligned_cols=209 Identities=22% Similarity=0.315 Sum_probs=163.1
Q ss_pred HHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe---
Q 022706 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS--- 136 (293)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 136 (293)
......++|.+.+.||+|+||+||+|.++ +++.||||++...........++++.++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 34555689999999999999999999987 79999999987666555677788899999999999999999875433
Q ss_pred ----eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCceEEcC-
Q 022706 137 ----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--EKADPHIIHRDIKSSNVLIFD- 209 (293)
Q Consensus 137 ----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~ivH~Dikp~Nilv~~- 209 (293)
.++||||+++ +|...+...... ...+++..++.++.|++.||.||| +.+ |+||||||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEA 167 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETT
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCC
Confidence 7899999987 554443321100 124889999999999999999999 888 999999999999997
Q ss_pred CCceEEeccccCCCCCcccccccccccccCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 89999999999987654322 24557899999999987654 89999999999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=299.53 Aligned_cols=200 Identities=24% Similarity=0.301 Sum_probs=170.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC--------CCCceeEEEEEE----
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK--------HENFVQLLGYCV---- 132 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 132 (293)
.++|++.+.||+|+||+||+|.+. +++.||+|++.......+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999976 7899999999765444567889999999885 788999999987
Q ss_pred eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCC
Q 022706 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 133 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~ 211 (293)
+....++||||+. ++|.+.+..... ..+++.+++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 116 NGTHICMVFEVLG-HHLLKWIIKSNY-------QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TEEEEEEEECCCC-CBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCceEEEEEeccC-ccHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 5567899999995 466655544321 2389999999999999999999998 8 99999999999998775
Q ss_pred -------------------------------------------------ceEEeccccCCCCCcccccccccccccCccc
Q 022706 212 -------------------------------------------------VAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242 (293)
Q Consensus 212 -------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 242 (293)
.+||+|||++...... .....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999998765332 2445789999
Q ss_pred ccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 243 ~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 999999999999999999999999999999999986553
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=292.30 Aligned_cols=199 Identities=30% Similarity=0.463 Sum_probs=171.8
Q ss_pred hcC-CCCceeeccCceEEEEEEeC-----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCe
Q 022706 67 ENF-GTNALIGEGSYGRVYYGILK-----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTS 136 (293)
Q Consensus 67 ~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 136 (293)
++| ++.+.||+|+||+||++.++ +++.||+|++...... ...+.+|++++++++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 455 99999999999999988642 6889999999765432 3568899999999999999999999987 467
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+++++|.+++.... +++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEEC
Confidence 899999999999999997654 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 217 DFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 217 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 99999766443221 122445678889999999988899999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=282.16 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=168.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|.+.+.||+|+||.||++.++ +++.||+|++... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999987 7999999998643 23456788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 90 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred EeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccc
Confidence 99999999999997653 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+........ .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 158 SNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp GGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 876543221 234568999999999887765 679999999999999999999997643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=285.24 Aligned_cols=206 Identities=22% Similarity=0.333 Sum_probs=169.4
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEE-EEeCCeeEEEE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY-CVDGTSRVLAY 141 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~ 141 (293)
.+.++|.+.+.||+|+||+||+|.+. +++.||+|++...... ..+.+|+++++.++|++++..+.. +.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 35679999999999999999999975 7999999986543322 357889999999998776665554 46788889999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE---cCCCceEEecc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADF 218 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv---~~~~~~kl~Df 218 (293)
||+ +++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||++ ++++.+||+||
T Consensus 85 e~~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Df 152 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp ECC-CCBHHHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred Ecc-CCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecC
Confidence 999 889999997543 13899999999999999999999999 9999999999999 78899999999
Q ss_pred ccCCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 219 DLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 219 g~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
|++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 998765433221 1223567899999999999999999999999999999999999999876544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.40 Aligned_cols=213 Identities=28% Similarity=0.463 Sum_probs=177.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CC-----CeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SG-----HAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-----~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||+|.+. ++ ..||+|.+...... ...+.+|+++++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 468999999999999999999975 33 47999998765432 35688999999999 89999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCC-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVK-----GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
.++||||+++++|.+++....... .......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 999999999999999987542100 0001124899999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999976543332222334557889999999998899999999999999999998 9999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.42 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=172.1
Q ss_pred HhcCCCCceeeccCceEEEEEEe-----CCCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeC--Ce
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDG--TS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 136 (293)
.++|++.+.||+|+||.||++.+ .+++.||+|++.... .....+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45789999999999999999983 268999999997543 3347789999999999999999999999876 66
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK--------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT--------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEEC
Confidence 899999999999999996543 23899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 217 DFDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 217 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99998765433221 22344567888999999998889999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=293.61 Aligned_cols=200 Identities=20% Similarity=0.271 Sum_probs=166.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCC------------hHHHHHHHHHHhcCCCCCceeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP------------DEEFLAQVSMVSRLKHENFVQLLG 129 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~ 129 (293)
.++|.+.+.||+|+||+||+|.+. ++..+|+|++...... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999976 5788999998755321 133567888899999999999999
Q ss_pred EEEe----CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCce
Q 022706 130 YCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNV 205 (293)
Q Consensus 130 ~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Ni 205 (293)
++.+ ....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 182 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANL 182 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHE
Confidence 9988 78899999999 899999997654 3899999999999999999999999 99999999999
Q ss_pred EEcCCC--ceEEeccccCCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 206 LIFDDD--VAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 206 lv~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
|++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999887 9999999999765432211 112445789999999999998999999999999999999999999965
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=285.28 Aligned_cols=202 Identities=29% Similarity=0.395 Sum_probs=175.6
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---C-------hHHHHHHHHHHhcCC-CCCceeEEEEE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---P-------DEEFLAQVSMVSRLK-HENFVQLLGYC 131 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~-------~~~~~~e~~~l~~l~-h~~i~~~~~~~ 131 (293)
.+.++|.+.+.||+|+||.||+|.++ +++.||+|++..... . .+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34679999999999999999999987 789999999865431 1 245778999999996 99999999999
Q ss_pred EeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 132 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
.+....++||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM 161 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence 99999999999999999999997653 3899999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.++|+|||++....... ......+++.|+|||++. ...++.++||||||+++|+|++|+.||....
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 99999999987654322 124456899999999885 4568889999999999999999999997653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=299.75 Aligned_cols=212 Identities=23% Similarity=0.375 Sum_probs=159.3
Q ss_pred HHhcCCC-CceeeccCceEEEEEEeC---CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeE
Q 022706 65 ITENFGT-NALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRV 138 (293)
Q Consensus 65 ~~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 138 (293)
+.+.|.+ ++.||+|+||+||+|.++ +++.||+|++..... ...+.+|++++++++||||+++++++.+ ....+
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4456776 558999999999999965 588999999975443 3578899999999999999999999964 67889
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE----cCCCceE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI----FDDDVAK 214 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv----~~~~~~k 214 (293)
+||||+.+ +|.+++..............+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 88877753321111111124899999999999999999999999 9999999999999 6778999
Q ss_pred EeccccCCCCCcccc-cccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999999986543211 1223456789999999998874 589999999999999999999999976543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=286.88 Aligned_cols=196 Identities=31% Similarity=0.575 Sum_probs=164.7
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|.+.+.||+|+||+||++.+. ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 58999999999999999999986 788999998643 34567889999999999999999999876 347899999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeeeCCCCCCceEEcCCCc-eEEeccccCC
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE---KADPHIIHRDIKSSNVLIFDDDV-AKIADFDLSN 222 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~~~~ivH~Dikp~Nilv~~~~~-~kl~Dfg~~~ 222 (293)
++|.+++...... +.+++..++.++.|+++||.|||+ .+ |+||||||+||+++.++. +||+|||++.
T Consensus 84 ~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 84 GSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp CBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred CCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccc
Confidence 9999999865421 237889999999999999999999 66 999999999999998886 7999999987
Q ss_pred CCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 155 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 155 DIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 54322 133468999999999999899999999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=285.83 Aligned_cols=197 Identities=27% Similarity=0.484 Sum_probs=171.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CC-------CeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SG-------HAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-------~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||+||+|.++ ++ ..||+|++.... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999876 34 469999986543 334678999999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc----
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---- 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---- 212 (293)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred CEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence 9999999999999999986542 3899999999999999999999999 999999999999998887
Q ss_pred ----eEEeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 022706 213 ----AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLT-GRKPVDHT 279 (293)
Q Consensus 213 ----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~-g~~Pf~~~ 279 (293)
++|+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|+|++ |.+||...
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 999999998765332 23457889999999987 678999999999999999999 55666554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=299.98 Aligned_cols=200 Identities=27% Similarity=0.344 Sum_probs=164.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeC------CeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG------TSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~ 138 (293)
..+|.+.+.||+|+||+||+|.++ +++.||||++..... ...+|++++++++||||+++++++... ...+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 347999999999999999999987 799999999865432 234799999999999999999988542 2367
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-CceEEec
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-DVAKIAD 217 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-~~~kl~D 217 (293)
+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence 89999976 666655431110 124899999999999999999999999 9999999999999965 5789999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+..
T Consensus 201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999976533221 2446789999999998765 78999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=284.15 Aligned_cols=204 Identities=28% Similarity=0.485 Sum_probs=173.2
Q ss_pred HhcCCCCc-eeeccCceEEEEEEeC---CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNA-LIGEGSYGRVYYGILK---SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+ .||+|+||.||+|.++ ++..||+|++..... ..+.+.+|++++++++||||+++++++ .....++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677766 9999999999999854 578899999976543 235688999999999999999999998 5566899
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred EEEeCCCCCHHHHHHhCC--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccc
Confidence 999999999999996543 24899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccc-cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9876543221 111233456889999999988889999999999999999998 9999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.00 Aligned_cols=204 Identities=22% Similarity=0.333 Sum_probs=172.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEE-EEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY-CVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~ 143 (293)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+|+.+++.++|++++..+.. ..+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 568999999999999999999975 899999999865443 3468899999999998776655554 4677888999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE---cCCCceEEecccc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDL 220 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv---~~~~~~kl~Dfg~ 220 (293)
+ +++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+
T Consensus 87 ~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred c-CCCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 9 889999997443 13899999999999999999999999 9999999999999 4888999999999
Q ss_pred CCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 221 SNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 221 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
+......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence 8765433221 1124567899999999999989999999999999999999999999876543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.33 Aligned_cols=210 Identities=28% Similarity=0.419 Sum_probs=164.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCe--
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTS-- 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 136 (293)
.++|.+.+.||+|+||.||+|.+. ++..||+|++....... ..+.+|+.++++++||||+++++++.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 568999999999999999999854 34589999997655443 457899999999999999999999887553
Q ss_pred ---eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 137 ---RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 137 ---~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
.++||||+++++|.+++....... ....+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 489999999999999985432111 1134899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 9999999876644332223344557889999999999899999999999999999999 9999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=289.65 Aligned_cols=208 Identities=31% Similarity=0.490 Sum_probs=171.4
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeE--EEEEcCCCC--CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAA--AIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~--avK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|.+.+.||+|+||.||+|.++ ++..+ ++|.+.... .....+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999976 56654 999886432 2345688999999999 899999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 141 YEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
|||+++++|.+++........ ......+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 999999999999976530000 001124899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+..
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 999999986433221 1234456889999999988889999999999999999998 999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=314.04 Aligned_cols=203 Identities=28% Similarity=0.470 Sum_probs=167.9
Q ss_pred cCCCCc-eeeccCceEEEEEEeC---CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 68 NFGTNA-LIGEGSYGRVYYGILK---SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 68 ~y~~~~-~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++.+.+ .||+|+||.||+|.++ ++..||||+++... ...+.+.+|++++++++||||+++++++.+ ...++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333444 7999999999999864 46679999997643 345789999999999999999999999876 5689999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++++|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 415 E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp ECCTTCBHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred EeCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 9999999999996543 24899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 222 NQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 222 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
+........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 876432211 11122345688999999998999999999999999999998 99999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.78 Aligned_cols=200 Identities=24% Similarity=0.300 Sum_probs=164.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCC------eeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT------SRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~l 139 (293)
..+|.+.+.||+|+||+||+|++..+..+|+|++...... ..+|+++++.++||||+++++++.... ..++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4589999999999999999999986677999988543322 236999999999999999999986543 3789
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc-CCCceEEecc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADF 218 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~-~~~~~kl~Df 218 (293)
||||++++.+......... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+||
T Consensus 116 v~e~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKL------KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp EEECCSEEHHHHHHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EeeccCccHHHHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 9999987444333221110 024899999999999999999999999 99999999999999 7999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+
T Consensus 187 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 187 GSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp TTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876533222 2456789999999998765 58999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=290.18 Aligned_cols=210 Identities=27% Similarity=0.440 Sum_probs=171.8
Q ss_pred HhcCCCCceeeccCceEEEEEEe-----C-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL-----K-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~-----~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|.+.+.||+|+||.||+|.+ . +++.||+|++...... ...+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46999999999999999999983 2 5789999999654332 35688999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCceE
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK 214 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~k 214 (293)
++||||+++++|.+++....... .....+++.+++.++.|++.||.|||+.+ |+||||||+||+++. +..++
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999998654221 11134899999999999999999999999 999999999999984 44699
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 999998764322222222344567899999999998899999999999999999998 999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=279.93 Aligned_cols=201 Identities=20% Similarity=0.316 Sum_probs=171.3
Q ss_pred HHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeE
Q 022706 64 EITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 64 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 138 (293)
.+.++|++.+.||+|+||+||+|.++ +++.||+|++..... ....+.+|+..+.++ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35678999999999999999999987 899999999875433 235678899999999 8999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC--------
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-------- 210 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-------- 210 (293)
+||||+++++|.+++....... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIM-----SYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------
T ss_pred EEEEecCCCcHHHHHHhhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccc
Confidence 9999999999999997642110 13899999999999999999999999 9999999999999844
Q ss_pred -----------CceEEeccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 211 -----------DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 211 -----------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
..++|+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+..
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 47999999998765432 234589999999998875 566899999999999999999987754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=278.34 Aligned_cols=200 Identities=24% Similarity=0.358 Sum_probs=172.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeC--CeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDG--TSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 140 (293)
.++|.+.+.||+|+||+||+|.++ ++.+|+|++....... +.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 368999999999999999999986 8899999998665443 4688999999999999999999999877 778999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ ..++|+||||+||+++.++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccc
Confidence 999999999999986542 24899999999999999999999873 2499999999999999999999999988
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCC---ccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNA---KSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... ....+|+.|+|||++.+..++. ++||||||+++|+|++|+.||.+...
T Consensus 160 ~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 160 KFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp CCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred eeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 654322 3356899999999998765544 79999999999999999999986543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=290.08 Aligned_cols=203 Identities=22% Similarity=0.353 Sum_probs=164.8
Q ss_pred HHHHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-------hHHHHHHHHHHhcC----CCCCceeEE
Q 022706 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-------DEEFLAQVSMVSRL----KHENFVQLL 128 (293)
Q Consensus 61 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-------~~~~~~e~~~l~~l----~h~~i~~~~ 128 (293)
+.+.+.++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34556789999999999999999999976 7899999999754332 22355788888888 899999999
Q ss_pred EEEEeCCeeEEEEEc-ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 129 GYCVDGTSRVLAYEF-ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 129 ~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
+++.+.+..++|||+ +.+++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILI 172 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEE
Confidence 999999999999999 78899999997654 3899999999999999999999999 9999999999999
Q ss_pred c-CCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCC
Q 022706 208 F-DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN-AKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 208 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+ .++.++|+|||++....... .....|++.|+|||++.+..+. .++||||||+++|+|++|+.||...
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9 88999999999987654322 2445689999999998876664 5899999999999999999999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=286.50 Aligned_cols=203 Identities=28% Similarity=0.448 Sum_probs=170.3
Q ss_pred HhcCCCCc-eeeccCceEEEEEEe--C-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 66 TENFGTNA-LIGEGSYGRVYYGIL--K-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 66 ~~~y~~~~-~lg~G~~g~V~~~~~--~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
.++|.+.+ .||+|+||+||++.+ + +++.||+|++...... .+.+.+|++++++++||||+++++++ .....+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46888888 999999999999964 3 5788999999755432 35788999999999999999999998 567789
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 9999999999999997653 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 219 DLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 998765432221 11233446788999999988889999999999999999999 9999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=291.76 Aligned_cols=196 Identities=29% Similarity=0.446 Sum_probs=169.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCee---
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR--- 137 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 137 (293)
+.++|.+.+.||+|+||+||+|.++ +++.||+|++....... ..+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999987 79999999997654443 5678999999999999999999999877665
Q ss_pred ---EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceE
Q 022706 138 ---VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (293)
Q Consensus 138 ---~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~k 214 (293)
++||||+. ++|.+++.. .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEEcccc-ccHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 99999997 488887742 2899999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998764322 244678999999999887 678999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.60 Aligned_cols=200 Identities=22% Similarity=0.334 Sum_probs=174.2
Q ss_pred HhcCCCCceeeccCceEEEEEEe-C-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC------CceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL-K-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE------NFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~ 137 (293)
.++|++.+.||+|+||+||++.+ + +++.||+|++.......+.+.+|+++++.++|+ +++++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999987 3 688999999976544456788899999888755 499999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC--------
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-------- 209 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-------- 209 (293)
++||||+ +++|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF-------LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEcCC-CCCHHHHHHhcCC-------CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence 9999999 7899999876542 23889999999999999999999999 999999999999987
Q ss_pred -----------CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 210 -----------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 210 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 667999999998754322 2446789999999999998999999999999999999999999987
Q ss_pred CCC
Q 022706 279 TLP 281 (293)
Q Consensus 279 ~~~ 281 (293)
.+.
T Consensus 237 ~~~ 239 (339)
T 1z57_A 237 HDS 239 (339)
T ss_dssp SCH
T ss_pred CCh
Confidence 653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=300.98 Aligned_cols=204 Identities=24% Similarity=0.365 Sum_probs=174.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC-CCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+|+++++.+.| +++..+..++.+....++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 478999999999999999999976 799999998764433 2357889999999986 6666777777888999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE---cCCCceEEecccc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---FDDDVAKIADFDL 220 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv---~~~~~~kl~Dfg~ 220 (293)
+ +++|.+++.... ..+++.+++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~-g~sL~~ll~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred C-CCCHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9 889999997543 23999999999999999999999999 9999999999999 6889999999999
Q ss_pred CCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 221 SNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 221 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch
Confidence 9765443221 1123567999999999999999999999999999999999999999886653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=288.29 Aligned_cols=203 Identities=29% Similarity=0.477 Sum_probs=167.6
Q ss_pred hcCCCCceeeccCceEEEEEEeCC-----CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKS-----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
++|.+.+.||+|+||+||+|.++. +..||+|++...... ...+.+|++++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 578888999999999999998652 235999999755432 3468899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 124 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999997643 23899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 220 LSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 98765433211 11223346788999999998899999999999999999999 999997654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.84 Aligned_cols=204 Identities=28% Similarity=0.443 Sum_probs=170.1
Q ss_pred hcCCCCceeeccCceEEEEEEeCC----CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEE-eCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCV-DGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 139 (293)
.+|++.+.||+|+||+||+|.+.. ...+|+|.+...... ...+.+|+.++++++||||+++++++. .....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 478999999999999999998652 235899988754332 356889999999999999999999864 5567899
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||
T Consensus 105 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp EEECCTTCBHHHHHHCTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred EEeCCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence 999999999999997643 23899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc--ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 99876443321 12234557889999999999999999999999999999999 6778876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=293.57 Aligned_cols=200 Identities=18% Similarity=0.246 Sum_probs=171.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC---------CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCcee----------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS---------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ---------- 126 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------- 126 (293)
.++|.+.+.||+|+||.||+|.++. ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3689999999999999999999763 789999998644 46788999999999999887
Q ss_pred -----EEEEEEe-CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 022706 127 -----LLGYCVD-GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDI 200 (293)
Q Consensus 127 -----~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Di 200 (293)
+++++.. ....++||||+ +++|.+++..... ..+++.+++.++.|++.||.|||+.+ |+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 185 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLHENE---YVHGNV 185 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCC
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 6777766 78889999999 8999999986521 13999999999999999999999999 999999
Q ss_pred CCCceEEcCCC--ceEEeccccCCCCCccccc-----ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCC
Q 022706 201 KSSNVLIFDDD--VAKIADFDLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR 273 (293)
Q Consensus 201 kp~Nilv~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~ 273 (293)
||+||+++.++ .++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999998 8999999999876543221 1123457899999999999989999999999999999999999
Q ss_pred CCCCCCC
Q 022706 274 KPVDHTL 280 (293)
Q Consensus 274 ~Pf~~~~ 280 (293)
.||....
T Consensus 266 ~pf~~~~ 272 (352)
T 2jii_A 266 LPWTNCL 272 (352)
T ss_dssp CTTGGGT
T ss_pred CCcccCC
Confidence 9998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.29 Aligned_cols=203 Identities=26% Similarity=0.418 Sum_probs=171.3
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
..++|++.+.||+|+||.||+|.++ +++.+|+|++.... .....+.+|++++++++||||+++++++.+....++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3568999999999999999999987 68999999987543 345788999999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 97 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--------RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp CCTTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred eCCCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 999999999887533 13899999999999999999999999 9999999999999999999999999864
Q ss_pred CCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... ........|++.|+|||++. ...++.++||||||+++|+|++|..||....
T Consensus 166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 166 KNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 32111 11123456899999999884 5678899999999999999999999998654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=282.54 Aligned_cols=199 Identities=32% Similarity=0.543 Sum_probs=166.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeC-CeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG-TSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~ 144 (293)
.++|++.+.||+|+||+||++.++ ++.||+|++.... ..+.+.+|++++++++||||+++++++.+. ...++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468999999999999999999886 8899999997543 456789999999999999999999987654 4789999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 98 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp TTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 99999999975431 12789999999999999999999999 999999999999999999999999998754
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3321 23456889999999998899999999999999999998 9999986543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=282.45 Aligned_cols=202 Identities=28% Similarity=0.335 Sum_probs=157.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|++.+.||+|+||+||++.+. +++.||+|++....... ..+.++...++.++||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999986 79999999997654332 22334455578889999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
||+++ +|.+++...... ...+++..++.++.|++.||.|||+. + ++||||||+||+++.++.++|+|||+
T Consensus 86 e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp ECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred ehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCC
Confidence 99975 887777542111 12499999999999999999999998 8 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCccccccccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+........ .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 157 SGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 876543222 2344689999999996 4557889999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=287.86 Aligned_cols=212 Identities=28% Similarity=0.397 Sum_probs=159.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|.+.+.||+|+||+||++.+. +++.||+|++.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468999999999999999999976 78999999986543 234568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++....... ......+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp CCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999987421100 001124899999999999999999999999 9999999999999999999999999876
Q ss_pred CCCccc---ccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMA---ARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... .........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 543221 1112234578999999998875 5689999999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.52 Aligned_cols=198 Identities=11% Similarity=0.076 Sum_probs=154.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHH---HHHhcCCCCCceeEE-------EEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQV---SMVSRLKHENFVQLL-------GYC 131 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~---~~l~~l~h~~i~~~~-------~~~ 131 (293)
.+|.+.+.||+|+||+||+|.++ +++.||+|++...... .+.+.+|+ +.++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 46999999999999999999987 7999999999875542 24566775 45555 699988755 455
Q ss_pred EeC-----------------CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHH
Q 022706 132 VDG-----------------TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR------VKIAVGAAKGLEYLH 188 (293)
Q Consensus 132 ~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH 188 (293)
... ...++||||++ ++|.+++..... .+.+..+ +.++.||+.||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--------VYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--------SCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--------ccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 433 33799999998 799999986531 2444455 678899999999999
Q ss_pred hCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCccccccccccc--CCCCCccchhhHHHHH
Q 022706 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVL 266 (293)
Q Consensus 189 ~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l 266 (293)
+++ |+||||||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 999 9999999999999999999999999987654322 24456799999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCc
Q 022706 267 LELLTGRKPVDHTLPR 282 (293)
Q Consensus 267 ~el~~g~~Pf~~~~~~ 282 (293)
|||++|+.||.+..+.
T Consensus 284 ~elltg~~Pf~~~~~~ 299 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPG 299 (371)
T ss_dssp HHHHHSSCSTTBCCTT
T ss_pred HHHHhCCCCCCCcCcc
Confidence 9999999999877543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.19 Aligned_cols=203 Identities=28% Similarity=0.446 Sum_probs=162.1
Q ss_pred cCCCCceeeccCceEEEEEEeC--C--CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEe-CCeeEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK--S--GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~--~--~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 140 (293)
.|.+.+.||+|+||+||+|.+. + +..+|+|.+...... ...+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5777899999999999999864 2 236899998754333 3578899999999999999999998754 5678999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 170 ~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 238 (373)
T ss_dssp EECCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EECCCCCCHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccc
Confidence 99999999999997654 23889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccc--ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 221 SNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+......... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||.....
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 9765432211 11233456789999999999999999999999999999999 7889987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=278.40 Aligned_cols=199 Identities=29% Similarity=0.437 Sum_probs=170.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEe----CCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 138 (293)
+.|.+.+.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.++++++||||+++++++.+ ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45788899999999999999986 7889999998754433 3568899999999999999999999875 45689
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc-CCCceEEec
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIAD 217 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~-~~~~~kl~D 217 (293)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ .+|+|+||||+||+++ +++.++|+|
T Consensus 106 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEecCCCCHHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEee
Confidence 9999999999999997643 3899999999999999999999973 2399999999999997 788999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||....
T Consensus 176 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 176 LGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 9998654322 124456899999999776 458999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.82 Aligned_cols=201 Identities=21% Similarity=0.359 Sum_probs=175.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC----h--------------HHHHHHHHHHhcCCCCCceeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP----D--------------EEFLAQVSMVSRLKHENFVQL 127 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~----~--------------~~~~~e~~~l~~l~h~~i~~~ 127 (293)
.++|.+.+.||+|+||.||+|.+ +++.||+|++...... . ..+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998643211 1 788999999999999999999
Q ss_pred EEEEEeCCeeEEEEEcccCCchhhh------hhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCC
Q 022706 128 LGYCVDGTSRVLAYEFASNGSLHDI------LHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDI 200 (293)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Di 200 (293)
++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .+ ++|+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl 178 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-------TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV 178 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-------CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence 9999999999999999999999998 44321 1349999999999999999999999 88 999999
Q ss_pred CCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccC-CCCC-ccchhhHHHHHHHHHhCCCCCCC
Q 022706 201 KSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNA-KSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 201 kp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
||+||+++.++.++|+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|+.||..
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998765332 22456789999999999877 5666 99999999999999999999986
Q ss_pred CCC
Q 022706 279 TLP 281 (293)
Q Consensus 279 ~~~ 281 (293)
...
T Consensus 255 ~~~ 257 (348)
T 2pml_X 255 KIS 257 (348)
T ss_dssp SSC
T ss_pred CCc
Confidence 544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.84 Aligned_cols=202 Identities=28% Similarity=0.419 Sum_probs=171.2
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeC-----Ce
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 136 (293)
+.++|.+.+.||+|+||.||+|.++ +++.||||++...... ...+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999987 7999999999654332 34677999999999999999999987654 67
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.++||||+. ++|.+++.... +++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccC-ccHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 899999997 49999887643 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccccc--------cccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARL--------HSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987654322110 1233578999999998765 678999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=288.92 Aligned_cols=203 Identities=26% Similarity=0.386 Sum_probs=174.4
Q ss_pred HhcCCCCceeeccCceEEEEEEe-----CCCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEE--eCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCV--DGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 137 (293)
.++|++.+.||+|+||.||++++ .+++.||+|++...... .+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999984 26889999998755332 356889999999999999999999887 45678
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcc
Confidence 999999999999999976431 3899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccc-cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 218 FDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 218 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||++........ ........+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 999876543221 12234456788899999999888999999999999999999999998643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=280.77 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=170.1
Q ss_pred cCCCCceeeccCceEEEEEEeC-CC---CeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee-EEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SG---HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR-VLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~---~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv 140 (293)
.|.+.+.||+|+||+||+|.+. ++ ..+|+|.+...... .+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5667799999999999999854 22 37999998754432 35688999999999999999999999876665 899
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+.+++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 102 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--------RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EecccCCCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCC
Confidence 99999999999997643 24899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccc--cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 221 SNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 986544321 122234567889999999999899999999999999999999 5566655443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=279.10 Aligned_cols=202 Identities=28% Similarity=0.431 Sum_probs=175.7
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC---CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS---KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
..+.++|++.+.||+|+||.||++.++ +++.||+|++... ......+.+|++++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 556789999999999999999999987 7999999998543 334578899999999999999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC---CceEE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD---DVAKI 215 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~---~~~kl 215 (293)
+||||+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+ +.++|
T Consensus 98 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEE
Confidence 9999999999998886543 3899999999999999999999999 9999999999999754 46999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+..
T Consensus 166 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99999876533221 233458899999998765 48899999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=279.96 Aligned_cols=203 Identities=25% Similarity=0.407 Sum_probs=170.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC----CCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||+||+|.+.. +..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ...++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4689999999999999999998542 34599999876533 23568899999999999999999999765 45689
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 90 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEecCCCCCHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence 999999999999997653 23899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 159 LSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred CCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 9876543221 11233456889999999988899999999999999999998 9999976543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=291.17 Aligned_cols=197 Identities=28% Similarity=0.458 Sum_probs=160.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHH--HHHHhcCCCCCceeEEEEEEe-----CCeeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQ--VSMVSRLKHENFVQLLGYCVD-----GTSRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e--~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 138 (293)
.++|++.+.||+|+||.||+|+. +++.||+|++.... ...+..| +..+..++||||+++++.+.. ....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46899999999999999999987 48999999986443 2334444 444556889999999986542 23568
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeCCCCCCceEEcC
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK---------ADPHIIHRDIKSSNVLIFD 209 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~~ivH~Dikp~Nilv~~ 209 (293)
+||||+++++|.+++.... .++..++.++.|++.||.|||+. + |+||||||+|||++.
T Consensus 89 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKN 155 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECT
T ss_pred EEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcC
Confidence 9999999999999997664 68899999999999999999999 8 999999999999999
Q ss_pred CCceEEeccccCCCCCccc------ccccccccccCccccccccccc-------CCCCCccchhhHHHHHHHHHhCCCCC
Q 022706 210 DDVAKIADFDLSNQAPDMA------ARLHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLTGRKPV 276 (293)
Q Consensus 210 ~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~g~~Pf 276 (293)
++.+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999999997654321 1112234579999999999876 34567899999999999999997766
Q ss_pred CC
Q 022706 277 DH 278 (293)
Q Consensus 277 ~~ 278 (293)
..
T Consensus 236 ~~ 237 (336)
T 3g2f_A 236 FP 237 (336)
T ss_dssp ST
T ss_pred CC
Confidence 43
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=280.94 Aligned_cols=208 Identities=25% Similarity=0.376 Sum_probs=173.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 139 (293)
.++|++.+.||+|+||.||++.++ +++.||+|++...... .+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999987 7999999999765443 3468899999999999999999998754 578899
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCceEEcCCCceEEec
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ..+++|+||||+||+++.++.++|+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 99999999999999754321 124899999999999999999999975 12399999999999999999999999
Q ss_pred cccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 160 FGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp CCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 999865433211 1234568999999999998889999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=285.73 Aligned_cols=204 Identities=26% Similarity=0.453 Sum_probs=172.9
Q ss_pred HHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhc--CCCCCceeEEEEEEeCC----
Q 022706 62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSR--LKHENFVQLLGYCVDGT---- 135 (293)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~---- 135 (293)
...+.++|.+.+.||+|+||.||++.+. ++.||+|++... ....+.+|.++++. ++||||+++++++.+..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3556789999999999999999999985 899999998643 34567788888877 68999999999998776
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH--------EKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~ivH~Dikp~Nilv 207 (293)
..++||||+++++|.+++.... +++.+++.++.|++.||.||| +.+ |+||||||+||++
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred eeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 7899999999999999997653 899999999999999999999 787 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccc--ccccccccCcccccccccccCC------CCCccchhhHHHHHHHHHhC-------
Q 022706 208 FDDDVAKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQ------LNAKSDVYSFGVVLLELLTG------- 272 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el~~g------- 272 (293)
+.++.+||+|||++......... .......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999998654322211 1224457899999999987652 33689999999999999999
Q ss_pred ---CCCCCCCCC
Q 022706 273 ---RKPVDHTLP 281 (293)
Q Consensus 273 ---~~Pf~~~~~ 281 (293)
..||....+
T Consensus 261 ~~~~~p~~~~~~ 272 (342)
T 1b6c_B 261 EDYQLPYYDLVP 272 (342)
T ss_dssp CCCCCTTTTTSC
T ss_pred cccccCccccCc
Confidence 889976543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=283.92 Aligned_cols=202 Identities=25% Similarity=0.414 Sum_probs=171.8
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC--CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcC---CCCCceeEEEEEE----
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRL---KHENFVQLLGYCV---- 132 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---- 132 (293)
..++|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3578999999999999999999984 688999999864322 223566777776666 8999999999987
Q ss_pred -eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC
Q 022706 133 -DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 133 -~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
.....++||||+. ++|.+++..... ..+++.+++.++.|++.||.|||+.| |+|+||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 157 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCC
Confidence 5567899999997 599999876542 23899999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 212 VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 158 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 158 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999987664322 2245678999999999998899999999999999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=278.15 Aligned_cols=201 Identities=30% Similarity=0.459 Sum_probs=169.9
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
+|.....||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3445559999999999999976 788999999875433 34678899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCceEEeccccCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVAKIADFDLSNQA 224 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~kl~Dfg~~~~~ 224 (293)
+++|.+++...... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++...
T Consensus 103 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 103 GGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred CCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999765321 23678999999999999999999999 999999999999987 899999999998765
Q ss_pred CcccccccccccccCcccccccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
..... ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 43221 124457899999999987643 788999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=282.29 Aligned_cols=202 Identities=22% Similarity=0.388 Sum_probs=167.7
Q ss_pred HHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCC--CCCceeEEEEEEeCCeeEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---DEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 139 (293)
..++|.+.+.||+|+||.||++.+++++.||+|++...... ...+.+|++++++++ |+||+++++++.+....++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 35689999999999999999999888999999999755443 356789999999997 5999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||| +.+++|.+++.... .+++.+++.++.|++.||.|||+.+ |+|+||||+||++++ +.+||+|||
T Consensus 106 v~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred EEe-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999 55779999998654 3899999999999999999999999 999999999999964 899999999
Q ss_pred cCCCCCcccccccccccccCccccccccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++................|++.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 9987654333222345678999999998875 467889999999999999999999997653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=281.29 Aligned_cols=196 Identities=26% Similarity=0.434 Sum_probs=163.7
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe----------
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD---------- 133 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------- 133 (293)
+.++|++.+.||+|+||.||+|.+. +++.||+|++.........+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 5678999999999999999999986 79999999996554445678899999999999999999998865
Q ss_pred ---CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC
Q 022706 134 ---GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 134 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
....++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence 356789999999999999997543 23788999999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCcccc------------cccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHh
Q 022706 211 DVAKIADFDLSNQAPDMAA------------RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLT 271 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~ 271 (293)
+.++|+|||++........ ........|++.|+|||++.+. .++.++||||||+++|+|++
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999876543210 1122345689999999998864 68999999999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=283.20 Aligned_cols=202 Identities=23% Similarity=0.366 Sum_probs=164.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEE-----------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCV----------- 132 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~----------- 132 (293)
.++|.+.+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999987 699999999864432 2356889999999999999999999873
Q ss_pred ---eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc-
Q 022706 133 ---DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF- 208 (293)
Q Consensus 133 ---~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~- 208 (293)
+....++||||+. ++|.+++.... +++..++.++.|++.||+|||+.+ |+|+||||+||+++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINT 155 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEET
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 4467899999997 59999986543 899999999999999999999999 99999999999997
Q ss_pred CCCceEEeccccCCCCCcccc-cccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 209 DDDVAKIADFDLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+++.+||+|||++........ ........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 567999999999986543211 112234567999999998875 6789999999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=286.32 Aligned_cols=195 Identities=29% Similarity=0.440 Sum_probs=167.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCe-----
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTS----- 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 136 (293)
.++|.+.+.||+|+||.||+|.++ +|+.||||++....... ..+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999987 79999999997654432 467899999999999999999999987654
Q ss_pred -eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 137 -RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 137 -~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
.++||||+. ++|.+++.. .+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 499999997 488887742 2899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 168 ~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 168 LDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred eecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998764322 234578999999999887 678999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=290.55 Aligned_cols=201 Identities=24% Similarity=0.317 Sum_probs=172.2
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CC-----CceeEEEEEEeCCee
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HE-----NFVQLLGYCVDGTSR 137 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~ 137 (293)
+.++|.+.+.||+|+||+||+|.++ +++.||||++.........+.+|+++++.++ |+ +|+++++++......
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 4579999999999999999999987 7889999999755444456778888888775 44 499999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeCCCCCCceEEc--CCCce
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE--KADPHIIHRDIKSSNVLIF--DDDVA 213 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~~~~ivH~Dikp~Nilv~--~~~~~ 213 (293)
++||||+.+ +|.+++..... ..+++..++.++.|++.||.|||. .+ |+||||||+|||++ .++.+
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNF-------RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCE
T ss_pred EEEEecCCC-CHHHHHhhcCc-------CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcE
Confidence 999999965 99999876532 138999999999999999999994 56 99999999999995 47789
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998765332 2456789999999999999999999999999999999999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=284.25 Aligned_cols=205 Identities=27% Similarity=0.403 Sum_probs=169.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEe----CCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 139 (293)
.++|++.+.||+|+||.||++.++ +++.||+|++.... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999985 79999999886433 234568899999999999999999999873 347789
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++++|.+++...... ...+++.+++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 99999999999998763211 124899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc-------ccccccccCcccccccccccCC---CCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 220 LSNQAPDMAAR-------LHSTRVLGTFGYHAPEYAMTGQ---LNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 220 ~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
++......... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 88654322111 0112345799999999887654 68899999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=286.31 Aligned_cols=200 Identities=20% Similarity=0.333 Sum_probs=171.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CC-CeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC------ceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SG-HAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN------FVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~ 137 (293)
.++|++.+.||+|+||+||+|.++ ++ +.||+|++.........+.+|++++++++|++ ++.+++++......
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 579999999999999999999976 44 68999999765444567888999999987655 89999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE----------
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI---------- 207 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv---------- 207 (293)
++||||+ +++|.+++..... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF-------QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred EEEEecc-CCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence 9999999 5567666654431 23899999999999999999999998 9999999999999
Q ss_pred ---------cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 208 ---------FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 208 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999998754322 2446789999999999999999999999999999999999999987
Q ss_pred CCC
Q 022706 279 TLP 281 (293)
Q Consensus 279 ~~~ 281 (293)
...
T Consensus 242 ~~~ 244 (355)
T 2eu9_A 242 HEN 244 (355)
T ss_dssp SSH
T ss_pred CCH
Confidence 543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=286.65 Aligned_cols=200 Identities=23% Similarity=0.328 Sum_probs=147.8
Q ss_pred HHhcCCCCc-eeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe----CCeeE
Q 022706 65 ITENFGTNA-LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRV 138 (293)
Q Consensus 65 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 138 (293)
+.++|.+.+ .||+|+||+||+|.++ +++.||+|++... .....+....++.++||||+++++++.. ....+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 457899855 6999999999999987 7999999998643 2222233344667789999999999876 45589
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCceEE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKI 215 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~kl 215 (293)
+||||+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++. ++.++|
T Consensus 103 lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEE
Confidence 99999999999999986542 24899999999999999999999999 999999999999976 455999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||++....... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 173 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 173 TDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 9999987543221 2345689999999999888899999999999999999999999976543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=291.59 Aligned_cols=199 Identities=21% Similarity=0.278 Sum_probs=169.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-----------CCCceeEEEEEEe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----------HENFVQLLGYCVD 133 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 133 (293)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.........+.+|+++++++. |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 358999999999999999999986 7999999999765545567888999988886 7899999999886
Q ss_pred CC----eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEc
Q 022706 134 GT----SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIF 208 (293)
Q Consensus 134 ~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~ 208 (293)
.. ..++|||++ +++|.+++..... ..+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 166 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc-------cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEe
Confidence 54 788999999 8899999976432 1389999999999999999999998 8 99999999999995
Q ss_pred C------CCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 209 D------DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 209 ~------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
. .+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3 347999999998765432 244578999999999999999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.55 Aligned_cols=201 Identities=24% Similarity=0.400 Sum_probs=173.3
Q ss_pred HHHHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-------hHHHHHHHHHHhcCC--CCCceeEEEEEE
Q 022706 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-------DEEFLAQVSMVSRLK--HENFVQLLGYCV 132 (293)
Q Consensus 63 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 132 (293)
..+.++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445679999999999999999999976 7899999998654322 245678999999996 599999999999
Q ss_pred eCCeeEEEEEcccC-CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc-CC
Q 022706 133 DGTSRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DD 210 (293)
Q Consensus 133 ~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~-~~ 210 (293)
+.+..++|||++.+ ++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++ ++
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 99999999999976 89999987653 3899999999999999999999999 99999999999999 78
Q ss_pred CceEEeccccCCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 899999999987654322 234568999999999887665 67899999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.68 Aligned_cols=196 Identities=28% Similarity=0.454 Sum_probs=164.5
Q ss_pred ceeeccCceEEEEEEeC---CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||.||+|.+. +++.||||+++..... .+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 5688999999754332 4679999999999999999999999864 457899999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
++|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 454 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 99999997553 3899999999999999999999999 99999999999999999999999999876543
Q ss_pred ccc-cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 221 112233456788999999999999999999999999999998 9999987654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=280.68 Aligned_cols=203 Identities=31% Similarity=0.414 Sum_probs=151.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHH-HHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVS-MVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|.+.+.||+|+||.||++.++ +++.||+|++...... ...+.+|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368999999999999999999987 7999999999755432 234555555 677789999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
||+.+ +|.+++...... ....+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||+
T Consensus 101 e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp CCCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred eecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99986 887777531100 012489999999999999999999998 8 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCccccccccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+........ .....||+.|+|||++ .+..++.++||||||+++|+|++|+.||...
T Consensus 173 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 173 SGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp SCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 976543222 2344689999999998 4566899999999999999999999999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=283.13 Aligned_cols=202 Identities=29% Similarity=0.448 Sum_probs=172.3
Q ss_pred HhcCCCCceeeccCceEEEEEEe-----CCCCeEEEEEcCCCCCC-hHHHHHHHHHHhcCCCCCceeEEEEEEeCC--ee
Q 022706 66 TENFGTNALIGEGSYGRVYYGIL-----KSGHAAAIKKLDASKQP-DEEFLAQVSMVSRLKHENFVQLLGYCVDGT--SR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~avK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 137 (293)
.++|++.+.||+|+||.||++++ .+++.||+|++...... ...+.+|++++++++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46899999999999999999983 26899999999764432 357889999999999999999999987644 78
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++..... .+++.+++.++.|++.||.+||+.+ |+|+||||+||+++.++.++|+|
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 999999999999999976542 3899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 218 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 9998765433221 112334567789999999888899999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=277.78 Aligned_cols=203 Identities=30% Similarity=0.469 Sum_probs=162.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--CCC--eEEEEEcCCCCC----ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--SGH--AAAIKKLDASKQ----PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~~avK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|++.+.||+|+||+||+|.+. +++ .||+|++..... ..+.+.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999854 333 689998875432 2357889999999999999999999988765 8
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEec
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~D 217 (293)
++||||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcc
Confidence 899999999999999876431 3899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 218 FDLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 218 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 9998765433221 12234457888999999988889999999999999999999 999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=280.65 Aligned_cols=207 Identities=23% Similarity=0.358 Sum_probs=154.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCC-CCCceeEEEEEE--------eC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLK-HENFVQLLGYCV--------DG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~ 134 (293)
..+|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 358999999999999999999986 799999998854432 2356789999999996 999999999984 33
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~k 214 (293)
...+++|||+. ++|.+++...... ..+++.+++.++.|++.||.|||+.+ .+|+|+||||+|||++.++.+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEE
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEE
Confidence 45789999996 5998888652211 24899999999999999999999873 2399999999999999999999
Q ss_pred EeccccCCCCCcccccc----------cccccccCccccccccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARL----------HSTRVLGTFGYHAPEYA---MTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+|||++.......... ......+|+.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999998764432110 11245689999999988 45678889999999999999999999997643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.42 Aligned_cols=191 Identities=21% Similarity=0.224 Sum_probs=161.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---------ChHHHHHHHHHHhcCC---------CCCceeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---------PDEEFLAQVSMVSRLK---------HENFVQL 127 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~i~~~ 127 (293)
.++|.+.+.||+|+||+||+|++ +++.||||++..... ..+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999998 589999999975432 2367888998888885 7888887
Q ss_pred EEEEE------------------------------eCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHH
Q 022706 128 LGYCV------------------------------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177 (293)
Q Consensus 128 ~~~~~------------------------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~ 177 (293)
.+++. +....++||||+++|++.+.+... .+++.+++.++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHH
Confidence 77643 267899999999999777666432 28999999999
Q ss_pred HHHHHHHHHHH-hCCCCCeeeCCCCCCceEEcCCC--------------------ceEEeccccCCCCCccccccccccc
Q 022706 178 VGAAKGLEYLH-EKADPHIIHRDIKSSNVLIFDDD--------------------VAKIADFDLSNQAPDMAARLHSTRV 236 (293)
Q Consensus 178 ~qi~~al~~LH-~~~~~~ivH~Dikp~Nilv~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~ 236 (293)
.||+.||.||| +.+ |+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 168 ~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~ 237 (336)
T 2vuw_A 168 HQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred HHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence 99999999999 898 99999999999999887 899999999875432 234
Q ss_pred ccCcccccccccccCCCCCccchhhHHHH-HHHHHhCCCCCCC
Q 022706 237 LGTFGYHAPEYAMTGQLNAKSDVYSFGVV-LLELLTGRKPVDH 278 (293)
Q Consensus 237 ~gt~~y~aPE~~~~~~~~~~~DvwslG~~-l~el~~g~~Pf~~ 278 (293)
.||+.|+|||++.+.. +.++||||++++ .+++++|..||.+
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 7999999999988766 889999998777 7788999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=299.62 Aligned_cols=204 Identities=29% Similarity=0.431 Sum_probs=170.9
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
..++|.+.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.++++++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3568999999999999999999875 2457999998754433 256889999999999999999999985 45689
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 467 lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT--------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEcCCCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 9999999999999997553 23899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999876443221 2233456789999999998899999999999999999997 9999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=282.45 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=166.8
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|.+.+.||+|+||.||+|.++. .+++|++..... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4689999999999999999999863 599999875432 23457789999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++++|.+++.... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++ ++.++|+|||++.
T Consensus 110 ~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp CCCSEEHHHHTTSSC--------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred cccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999997643 24889999999999999999999999 99999999999998 6799999999986
Q ss_pred CCCcccc---cccccccccCccccccccccc---------CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAA---RLHSTRVLGTFGYHAPEYAMT---------GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... ........|++.|+|||++.. ..++.++||||||+++|+|++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432211 112234558999999998864 347889999999999999999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.63 Aligned_cols=199 Identities=27% Similarity=0.415 Sum_probs=152.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.++|.+.+.||+|+||.||++.++ +++.||+|++....... ..+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999987 79999999997654332 22334455678889999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
||+ ++.+..+..... ..+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||+
T Consensus 104 e~~-~~~~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--------GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp CCC-SEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCC
Confidence 999 556666554322 1389999999999999999999995 8 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
+........ .....+++.|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 172 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 172 SGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp C-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred chhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 876543221 23456899999999984 456888999999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=269.68 Aligned_cols=174 Identities=16% Similarity=0.152 Sum_probs=154.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... ..+.+|+..+.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 468999999999999999999987 69999999998665443 5788999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||++|++|.++++.. ....++..++.|++.||+|||+.| |+||||||+|||+++++.++|++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred EEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-
Confidence 9999999999998542 355678899999999999999999 9999999999999999999998554
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
|++ .++.++|||||||++|+|++|+.||.+.+..
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 222 3688999999999999999999999876553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=287.89 Aligned_cols=206 Identities=22% Similarity=0.321 Sum_probs=158.9
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+....++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 456667899999999998776668999999998643 235678899999876 79999999999999999999999996
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC-------------Cc
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD-------------DV 212 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~-------------~~ 212 (293)
++|.+++......... ....++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.
T Consensus 93 -gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 93 -LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp -EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred -CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 5999999865421110 011234456789999999999999999 9999999999999754 47
Q ss_pred eEEeccccCCCCCccccc--ccccccccCccccccccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-------GQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+..
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999999866433211 11234579999999999875 568899999999999999999 999997653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=302.58 Aligned_cols=192 Identities=20% Similarity=0.364 Sum_probs=165.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC--CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCe-----
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK--SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTS----- 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 136 (293)
.++|++.+.||+|+||+||++.++ +++.||||++...... ...+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999976 6899999998754332 2467899999999999999999999987665
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.|+||||+++++|.+++.. .+++.+++.++.||+.+|.|||+++ |+||||||+|||++.+ .+||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred eEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 6999999999999887754 2899999999999999999999999 9999999999999875 89999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 99998765432 445789999999988765 488999999999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=297.34 Aligned_cols=201 Identities=26% Similarity=0.394 Sum_probs=171.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEe------CCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD------GTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 136 (293)
.++|++.+.||+|+||.||+|.++ +++.||+|++...... ...+.+|++++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999986 7999999998754332 3568899999999999999999998765 677
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc---e
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV---A 213 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~---~ 213 (293)
.++||||+++++|.+++...... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEE
T ss_pred EEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeE
Confidence 89999999999999999865421 23888899999999999999999999 999999999999997765 8
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
+|+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 164 KL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 164 KIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp EECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999999998764332 22456789999999999989999999999999999999999999964
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.12 Aligned_cols=200 Identities=23% Similarity=0.316 Sum_probs=159.7
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.+|.+.+.||+|+||+|+.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....++||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 47899999999999997765556799999999865332 2356899999999 79999999999999999999999996
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---C--CceEEecccc
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---D--DVAKIADFDL 220 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~--~~~kl~Dfg~ 220 (293)
+ +|.+++..... .+.+.+++.++.||+.||.|||+.+ |+||||||+|||++. + ..++|+|||+
T Consensus 102 g-~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 102 A-TLQEYVEQKDF--------AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp E-EHHHHHHSSSC--------CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred C-CHHHHHHhcCC--------CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 4 99999976542 2444566789999999999999999 999999999999953 2 3578999999
Q ss_pred CCCCCcccc-cccccccccCcccccccccc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 221 SNQAPDMAA-RLHSTRVLGTFGYHAPEYAM---TGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 221 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
+........ ........||+.|+|||++. ...++.++|||||||++|||++ |..||....
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 876643221 12234567999999999987 3567889999999999999999 999997543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.54 Aligned_cols=204 Identities=12% Similarity=0.178 Sum_probs=155.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC----ChHHHHHHHHHHhcCCC-CCc---------e------
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ----PDEEFLAQVSMVSRLKH-ENF---------V------ 125 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~----~~~~~~~e~~~l~~l~h-~~i---------~------ 125 (293)
++|...+.||+|+||+||+|.+. +|+.||||++..... ..+.+.+|+.+++.+.| .|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35778899999999999999976 799999999873322 24678899999999976 221 1
Q ss_pred ------eEEEEEEe-----CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 022706 126 ------QLLGYCVD-----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194 (293)
Q Consensus 126 ------~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 194 (293)
.+..++.. ....+++|+++ +++|.++++...... .....+++..++.++.|++.||+|||+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11111111 22456777776 569998885211000 00124788899999999999999999999
Q ss_pred eeeCCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCccccccccc----------ccCCCCCccchhhHHH
Q 022706 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYA----------MTGQLNAKSDVYSFGV 264 (293)
Q Consensus 195 ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~ 264 (293)
|+||||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998765432 245567 999999998 4456888999999999
Q ss_pred HHHHHHhCCCCCCCCCCc
Q 022706 265 VLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 265 ~l~el~~g~~Pf~~~~~~ 282 (293)
++|||++|+.||....+.
T Consensus 306 il~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAAL 323 (413)
T ss_dssp HHHHHHHSSCCCCTTGGG
T ss_pred HHHHHHHCCCCCCCcchh
Confidence 999999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.36 Aligned_cols=178 Identities=21% Similarity=0.374 Sum_probs=152.6
Q ss_pred HHhcCCCC-ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHH-hcCCCCCceeEEEEEEe----CCee
Q 022706 65 ITENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMV-SRLKHENFVQLLGYCVD----GTSR 137 (293)
Q Consensus 65 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~ 137 (293)
+.++|.+. +.||+|+||.||++.++ +++.||+|++.. ...+.+|+.++ +.++||||+++++++.+ ....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 34678777 78999999999999986 799999999853 35677888887 55689999999999887 6778
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCceE
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAK 214 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~k 214 (293)
++||||+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++. ++.++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEE
Confidence 999999999999999986542 24899999999999999999999999 999999999999998 78899
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+|||++.... +..++.++|||||||++|+|++|+.||....
T Consensus 161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 99999874321 2346788999999999999999999997654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=270.99 Aligned_cols=183 Identities=16% Similarity=0.079 Sum_probs=129.0
Q ss_pred eeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-----------hHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEE
Q 022706 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-----------DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 75 lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-----------~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
.+.|+.|.+..++.. .|+.+++|++...... .+++.+|+++|+++ .|+||+++++++++....||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 445666665555433 6899999998654321 24588999999999 5999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++|++|.+++.... .++.. .|+.||+.||+|+|++| ||||||||+|||++++|.+||+|||++
T Consensus 322 Eyv~G~~L~d~i~~~~---------~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---------EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp ECCCSEEHHHHHHTTC---------CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred ecCCCCcHHHHHHhCC---------CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccC
Confidence 9999999999998654 35554 57899999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~P 275 (293)
+....... .....+||+.|+|||++.+ .+...+|+||+|+++++|.++..|
T Consensus 387 r~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 86643222 2355789999999998875 456789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=240.87 Aligned_cols=185 Identities=16% Similarity=0.144 Sum_probs=145.8
Q ss_pred CCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC---------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP---------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
...+.||+|+||+||++.. .++.+++|+....... .+.+.+|++++++++||||+++..++.+....++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4566899999999999954 4788999986543322 13478999999999999999666666677888999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++++|.+++.. ++.++.|++++|+|||+++ |+||||||+|||+++ .+||+|||+
T Consensus 418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 999999999999864 3489999999999999999 999999999999998 999999999
Q ss_pred CCCCCcccccc-----cccccccCccccccccccc--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 221 SNQAPDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 221 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
++......... ......||+.|+|||++.. ..|+...|+|+..+-..+-..++-+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 98765432221 1245779999999999886 567788899999998888888888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=198.17 Aligned_cols=156 Identities=14% Similarity=0.108 Sum_probs=122.1
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC-------------------ChHHHHHHHHHHhcCCCCCceeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-------------------PDEEFLAQVSMVSRLKHENFVQL 127 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~ 127 (293)
..|.+.+.||+|+||.||+|.+.+|+.||+|++..... ....+.+|++++++++| +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 34566799999999999999997799999999864321 13457899999999984 555
Q ss_pred EEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 128 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
.+++.. +..++||||++|++|.+ +.. .+...++.|++.||.+||+.| |+||||||+|||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 554433 55699999999999988 421 123479999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCccccccccccc----------CCCCCccchhh
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----------GQLNAKSDVYS 261 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws 261 (293)
+ ++.++|+|||++.. +..+.|||.+.+ ..++..+|+|.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9 99999999998753 344678887643 34556667765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.9e-23 Score=170.11 Aligned_cols=135 Identities=19% Similarity=0.195 Sum_probs=105.3
Q ss_pred CCCCceeeccCceEEEEEEe-CCCCe--EEEEEcCCCCCC-------------------------hHHHHHHHHHHhcCC
Q 022706 69 FGTNALIGEGSYGRVYYGIL-KSGHA--AAIKKLDASKQP-------------------------DEEFLAQVSMVSRLK 120 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~-~~~~~--~avK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 120 (293)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ...+.+|++++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56889999999999999998 57889 999987543211 125788999999998
Q ss_pred CCCc--eeEEEEEEeCCeeEEEEEcccC-C----chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCC
Q 022706 121 HENF--VQLLGYCVDGTSRVLAYEFASN-G----SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH-EKAD 192 (293)
Q Consensus 121 h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~ 192 (293)
|+++ +.++.. ...++||||+.+ | +|.++... .++.++..++.|++.+|.+|| +.|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 7754 444443 356899999942 3 56555421 224467789999999999999 998
Q ss_pred CCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 193 ~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
|+||||||+|||+++ .++|+|||++...
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.6e-20 Score=162.14 Aligned_cols=133 Identities=13% Similarity=0.209 Sum_probs=100.3
Q ss_pred CCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---------------ChHH--------HHHHHHHHhcCCCCCce
Q 022706 69 FGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---------------PDEE--------FLAQVSMVSRLKHENFV 125 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---------------~~~~--------~~~e~~~l~~l~h~~i~ 125 (293)
|.+.+.||+|+||.||+|.+.+|+.||||+++.... .... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 889999999999999999999999999998753210 0111 23566777777554442
Q ss_pred --eEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 022706 126 --QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (293)
Q Consensus 126 --~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~ 203 (293)
..++. . ..+|||||++|.+|..+.. . .....++.|++.+|.+||+.| ||||||||.
T Consensus 177 vp~p~~~--~--~~~LVME~i~G~~L~~l~~-------------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 177 VPEPIAQ--S--RHTIVMSLVDALPMRQVSS-------------V--PDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp CCCEEEE--E--TTEEEEECCSCEEGGGCCC-------------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred CCeeeec--c--CceEEEEecCCccHhhhcc-------------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 23322 2 2379999999988876542 1 124568899999999999999 999999999
Q ss_pred ceEEcCCC----------ceEEeccccCCC
Q 022706 204 NVLIFDDD----------VAKIADFDLSNQ 223 (293)
Q Consensus 204 Nilv~~~~----------~~kl~Dfg~~~~ 223 (293)
|||+++++ .+.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99998776 389999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-15 Score=126.54 Aligned_cols=146 Identities=18% Similarity=0.122 Sum_probs=114.6
Q ss_pred HHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCC-CChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEE
Q 022706 62 LKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 62 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 139 (293)
+......|.+...++.|+.+.||++... ++.+++|...... .....+.+|+++++.+. +..+.++++++.+....|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567988888999999999999865 7899999986421 22346889999999885 6778899999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA---------------------------- 191 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------- 191 (293)
|||+++|.+|.+.+. +......++.+++++|..||+..
T Consensus 88 v~e~i~G~~l~~~~~--------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE--------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEECCSSEEHHHHCC--------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEecCCeehhhccC--------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 999999999987632 11123477889999999999810
Q ss_pred ----------------------------CCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 192 ----------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 192 ----------------------------~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0238999999999999876667799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-13 Score=112.67 Aligned_cols=136 Identities=13% Similarity=0.059 Sum_probs=99.2
Q ss_pred cCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC--ceeEEEEEEeCCeeEEEEEccc
Q 022706 68 NFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--FVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.|.+....+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++.+..+.+..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 44443333456669999998777888999997654 2345778899888886434 5678888888788899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA---------------------------------- 191 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 191 (293)
|.+|. ... .+ ...++.+++..|..||+..
T Consensus 99 G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 99 GQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp SEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 98884 211 11 1256677777777777642
Q ss_pred ---------------------CCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 192 ---------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 192 ---------------------~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.43 E-value=9.2e-13 Score=114.82 Aligned_cols=141 Identities=17% Similarity=0.235 Sum_probs=105.7
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcC--CCC--CChHHHHHHHHHHhcCC--CCCceeEEEEEEeC---CeeEEEE
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLD--ASK--QPDEEFLAQVSMVSRLK--HENFVQLLGYCVDG---TSRVLAY 141 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~--~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~ 141 (293)
..+.|+.|.++.||+.... +..+++|+.. ... .....+.+|..+++.+. +..+++++.++.+. ...|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567889999999999876 4688899776 332 22356788999999987 45678899888766 3478999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------------------------------ 191 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------ 191 (293)
||++|..+.+..- ..++..+...++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp ECCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 9999987754211 12678888999999999999999731
Q ss_pred -------------------------CCCeeeCCCCCCceEEcCCCc--eEEeccccCCC
Q 022706 192 -------------------------DPHIIHRDIKSSNVLIFDDDV--AKIADFDLSNQ 223 (293)
Q Consensus 192 -------------------------~~~ivH~Dikp~Nilv~~~~~--~kl~Dfg~~~~ 223 (293)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997753 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.32 E-value=8.4e-13 Score=112.41 Aligned_cols=184 Identities=17% Similarity=0.160 Sum_probs=121.6
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCC--ceeEEEEEEeCC---eeEEEEEccc
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HEN--FVQLLGYCVDGT---SRVLAYEFAS 145 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~ 145 (293)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++....... ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 56899986432 22457889999998874 332 445555443333 3478999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA---------------------------------- 191 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 191 (293)
|.+|.+.... .++..+...++.|++..|..||+..
T Consensus 100 G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 100 GVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred CeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 9888753321 2677888888889988888888621
Q ss_pred ---------------------CCCeeeCCCCCCceEEcC--CCceEEeccccCCCCCcccccccccccccCccc---ccc
Q 022706 192 ---------------------DPHIIHRDIKSSNVLIFD--DDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY---HAP 245 (293)
Q Consensus 192 ---------------------~~~ivH~Dikp~Nilv~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aP 245 (293)
...++|+|++|.||++++ +..+.|+||+.+...... .+ ....... ..|
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~D-----l~~~~~~~~~~~~ 242 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-ND-----FISLMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HH-----HHTTCCTTTSCCH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HH-----HHHHHhhccccCH
Confidence 134899999999999998 456889999986532111 00 0001111 222
Q ss_pred ccccc-----CCC---------CCccchhhHHHHHHHHHhCCCCCC
Q 022706 246 EYAMT-----GQL---------NAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 246 E~~~~-----~~~---------~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
+.... ... ....+.|+++.++|.+.+|..+|-
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 21110 001 122589999999999999998874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-09 Score=91.08 Aligned_cols=134 Identities=14% Similarity=0.093 Sum_probs=99.4
Q ss_pred eeeccCce-EEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEcccCCchh
Q 022706 74 LIGEGSYG-RVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (293)
Q Consensus 74 ~lg~G~~g-~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 150 (293)
.+..|..+ .||+...+ ++..+++|+-... ....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 45556555 69988866 5678999986432 3456788999988885 334778899999999999999999998887
Q ss_pred hhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 022706 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--------------------------------------- 191 (293)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------------- 191 (293)
+..... ......+..++...|..||...
T Consensus 109 ~~~~~~-------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 109 QVLEEY-------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp HHHHHC-------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccCC-------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 765422 1223456677777777777531
Q ss_pred ----------------CCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 192 ----------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 192 ----------------~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
...++|+|+.+.||++++++.+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999988777899999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=6.8e-09 Score=88.28 Aligned_cols=136 Identities=18% Similarity=0.149 Sum_probs=94.6
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCC---CceeEEEEEE-eCCeeEEEEEcccCC
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHE---NFVQLLGYCV-DGTSRVLAYEFASNG 147 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~ 147 (293)
.+.++.|....||+. +..+++|+.. .......+.+|.++++.+.+. .+.+++.+.. ..+..++|||+++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 356788888899988 5778999842 222235788999999998742 3667777764 345678999999998
Q ss_pred chhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 022706 148 SLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA------------------------------------ 191 (293)
Q Consensus 148 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------ 191 (293)
+|.+..-. .++..+...++.++...|..||+..
T Consensus 99 ~l~~~~~~-----------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 99 ILGEDGMA-----------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp ECHHHHHT-----------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred ECchhhhh-----------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 88663211 1455555566666666666666432
Q ss_pred ---------------------CCCeeeCCCCCCceEEcC---CCc-eEEeccccCCC
Q 022706 192 ---------------------DPHIIHRDIKSSNVLIFD---DDV-AKIADFDLSNQ 223 (293)
Q Consensus 192 ---------------------~~~ivH~Dikp~Nilv~~---~~~-~kl~Dfg~~~~ 223 (293)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123699999999999987 355 58999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=1.3e-08 Score=88.21 Aligned_cols=79 Identities=8% Similarity=0.026 Sum_probs=55.8
Q ss_pred cee-eccCceEEEEEEeC-------CCCeEEEEEcCCCC---C-ChHHHHHHHHHHhcCC-C--CCceeEEEEEEeC---
Q 022706 73 ALI-GEGSYGRVYYGILK-------SGHAAAIKKLDASK---Q-PDEEFLAQVSMVSRLK-H--ENFVQLLGYCVDG--- 134 (293)
Q Consensus 73 ~~l-g~G~~g~V~~~~~~-------~~~~~avK~~~~~~---~-~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~--- 134 (293)
+.| +.|..+.+|+.... +++.+++|...... . ....+.+|..+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988754 26789999875432 1 2245778888888775 3 3567788877655
Q ss_pred CeeEEEEEcccCCchhh
Q 022706 135 TSRVLAYEFASNGSLHD 151 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~ 151 (293)
...++|||+++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.9e-07 Score=81.00 Aligned_cols=74 Identities=18% Similarity=0.040 Sum_probs=50.1
Q ss_pred CceeeccCceEEEEEEeC-CCCeEEEEEcCCCC--------CChHHHHHHHHHHhcCCC--C-CceeEEEEEEeCCeeEE
Q 022706 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDASK--------QPDEEFLAQVSMVSRLKH--E-NFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~--------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~l 139 (293)
.+.||.|..+.||++... +++.+++|...... ....++..|.++++.+.. + .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999765 57889999865321 123456778888887742 3 34556644 4556789
Q ss_pred EEEcccCC
Q 022706 140 AYEFASNG 147 (293)
Q Consensus 140 v~e~~~~~ 147 (293)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.58 E-value=9e-07 Score=75.95 Aligned_cols=152 Identities=16% Similarity=0.281 Sum_probs=82.1
Q ss_pred hcCCCC----ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC--CCceeEEE------EEEeC
Q 022706 67 ENFGTN----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH--ENFVQLLG------YCVDG 134 (293)
Q Consensus 67 ~~y~~~----~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~------~~~~~ 134 (293)
+.|.+. +.|+.|..+.||+....++ .+++|+... ....+..|..+++.|.. -.+.+++. +....
T Consensus 28 ~~~~~~~~~~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~ 103 (346)
T 2q83_A 28 QGWDVQAEKIDVIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHG 103 (346)
T ss_dssp GGSCCCCCEEEECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEET
T ss_pred HHcCCceEEeeeccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEEC
Confidence 566542 3455567899999987644 599998865 23445555555555531 12333332 12346
Q ss_pred CeeEEEEEcccCCchh--------------hhhhcC-CCCCCCCC----CCCCCHHH-----------------------
Q 022706 135 TSRVLAYEFASNGSLH--------------DILHGR-KGVKGAQP----GPVLSWQQ----------------------- 172 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~--------------~~l~~~-~~~~~~~~----~~~l~~~~----------------------- 172 (293)
+..+++|+|++|.++. ..++.. ........ .....+..
T Consensus 104 ~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 183 (346)
T 2q83_A 104 SFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDP 183 (346)
T ss_dssp TEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCH
T ss_pred CEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCc
Confidence 6788999999986542 011111 10000000 00112211
Q ss_pred --------HHHHHHHHHHHHHHHHh--------C--CCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 173 --------RVKIAVGAAKGLEYLHE--------K--ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 173 --------~~~i~~qi~~al~~LH~--------~--~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
...+..++..++.+|+. . ....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 184 FSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11112233445666652 0 12249999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.42 E-value=2.1e-06 Score=72.89 Aligned_cols=75 Identities=13% Similarity=0.060 Sum_probs=59.9
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEEEEcccCCc
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGYCVDGTSRVLAYEFASNGS 148 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~s 148 (293)
.+.|+.|....+|+.... +..+++|+.... ....+.+|.+.|+.|. ...+++++.+....+..++|||+++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 356889999999999864 778999987543 3566888988888874 3568889988888888999999999876
Q ss_pred h
Q 022706 149 L 149 (293)
Q Consensus 149 L 149 (293)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.40 E-value=5.7e-06 Score=70.61 Aligned_cols=95 Identities=8% Similarity=0.104 Sum_probs=63.9
Q ss_pred cCccCHHHHHHHHhcCCCC-----ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC--cee
Q 022706 54 VPAISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--FVQ 126 (293)
Q Consensus 54 ~~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~ 126 (293)
...++.+.+......|.+. ..|+ |....||+....+|+.+++|...........+..|..+++.+.... +++
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecc
Confidence 4466777777776766542 3466 7888999988777778999998755455667778888877774211 333
Q ss_pred EEEE-----EEeCCeeEEEEEcccCCch
Q 022706 127 LLGY-----CVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 127 ~~~~-----~~~~~~~~lv~e~~~~~sL 149 (293)
++.. ....+..+++|++++|.++
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCC
Confidence 3332 1234566789999988554
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.39 E-value=3.4e-06 Score=70.77 Aligned_cols=79 Identities=23% Similarity=0.240 Sum_probs=57.3
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCC-C--CCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLK-H--ENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv~e 142 (293)
.+..-.+.+|.|..+.||+.+..+|+.+++|+...... ....+.+|.+.|+.|. . -.+++++.+ + ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 34555677999999999999999999999998764432 2345788998888884 2 234556654 2 2478999
Q ss_pred cccCCch
Q 022706 143 FASNGSL 149 (293)
Q Consensus 143 ~~~~~sL 149 (293)
++++...
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.36 E-value=5.1e-06 Score=70.73 Aligned_cols=166 Identities=16% Similarity=0.230 Sum_probs=90.2
Q ss_pred CccCHHHHHHHHhcCCCC-----ceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC--ceeE
Q 022706 55 PAISVDELKEITENFGTN-----ALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN--FVQL 127 (293)
Q Consensus 55 ~~~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 127 (293)
+.++.+++..+..+|.+. +.|+.|....+|+....++ .+++|..... .....+..|..+++.+...+ +.++
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 356778888888888763 3355677889999987654 7889988653 12235566777776664211 2333
Q ss_pred EE------EEEeCCeeEEEEEcccCCchhh--------------hhhcC-CCCCCCCCC--CCCCHHHHHH---------
Q 022706 128 LG------YCVDGTSRVLAYEFASNGSLHD--------------ILHGR-KGVKGAQPG--PVLSWQQRVK--------- 175 (293)
Q Consensus 128 ~~------~~~~~~~~~lv~e~~~~~sL~~--------------~l~~~-~~~~~~~~~--~~l~~~~~~~--------- 175 (293)
+. +....+..+++|++++|..+.. .++.. ......... ....+.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 21 1123456789999999865421 01111 100000000 0001111000
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 176 ---IAVGAAKGLEYLHEK----ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 176 ---i~~qi~~al~~LH~~----~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
+...+...++.+... ....++|+|+.+.||++++++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011133444555421 11249999999999999887666899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.31 E-value=3.1e-06 Score=71.48 Aligned_cols=71 Identities=7% Similarity=0.031 Sum_probs=45.9
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcc-cCCch
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFA-SNGSL 149 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~~~sL 149 (293)
.+.|+.|....+|+. +.+++|+.........+..+|..+++.+...++ .+++.+ +....++++||+ +|.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 678989999999998 669999876532221223567777776652222 455543 444557899999 76555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=4.4e-06 Score=72.83 Aligned_cols=142 Identities=15% Similarity=0.172 Sum_probs=83.3
Q ss_pred ceeeccCceEEEEEEeC--------CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEc
Q 022706 73 ALIGEGSYGRVYYGILK--------SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~--------~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.|..|-...+|++... +++.+++|+..........+.+|.++++.|. +.-..++++.+.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45667888889999864 2578999986443334566778999988885 3333566665533 289999
Q ss_pred ccCCchhhh-----------------hhcCCCCCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHH
Q 022706 144 ASNGSLHDI-----------------LHGRKGVKGAQPGPVL--SWQQRVKIAVGAAK-------------------GLE 185 (293)
Q Consensus 144 ~~~~sL~~~-----------------l~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~-------------------al~ 185 (293)
++|.+|..- ++... ... +... -+.++.++..++.. .+.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~---~~~-~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGME---MPF-TKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCC---CSS-CCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCC---CCC-CCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 998665321 01111 000 1112 23455555544322 122
Q ss_pred H----HHhC-CCCCeeeCCCCCCceEEcCC----CceEEeccccCC
Q 022706 186 Y----LHEK-ADPHIIHRDIKSSNVLIFDD----DVAKIADFDLSN 222 (293)
Q Consensus 186 ~----LH~~-~~~~ivH~Dikp~Nilv~~~----~~~kl~Dfg~~~ 222 (293)
. |... ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 3221 12358999999999999876 689999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.29 E-value=6e-06 Score=73.15 Aligned_cols=72 Identities=14% Similarity=0.159 Sum_probs=45.3
Q ss_pred CceeeccCceEEEEEEeCCCCeEEEEEcCCC-----CC-----ChHHHHHHHHHHh-cCCCCCceeEEEEEEeCCeeEEE
Q 022706 72 NALIGEGSYGRVYYGILKSGHAAAIKKLDAS-----KQ-----PDEEFLAQVSMVS-RLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~-----~~-----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
.+.||.|..+.||++.. +++.+++|...+. .. ....+..|+..+. ......+.+++.+. ....++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45788999999999965 4678999954321 11 2223334433322 22234567777664 5677899
Q ss_pred EEcc-cC
Q 022706 141 YEFA-SN 146 (293)
Q Consensus 141 ~e~~-~~ 146 (293)
||++ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=98.13 E-value=1.4e-05 Score=71.08 Aligned_cols=73 Identities=12% Similarity=0.131 Sum_probs=50.1
Q ss_pred CceeeccCceEEEEEEeCC--------CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEEEEE
Q 022706 72 NALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 142 (293)
.+.|+.|-...+|++...+ ++.+++|+.... .....+.+|..+++.+...+ ..++++.+. + .+|||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 3467778889999998652 578999987432 22256678998888886333 356666543 2 38999
Q ss_pred cccCCch
Q 022706 143 FASNGSL 149 (293)
Q Consensus 143 ~~~~~sL 149 (293)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.7e-05 Score=70.95 Aligned_cols=73 Identities=12% Similarity=0.001 Sum_probs=47.2
Q ss_pred ceeeccCceEEEEEEeCC-CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEEEcccCCch
Q 022706 73 ALIGEGSYGRVYYGILKS-GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF-VQLLGYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~-~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~sL 149 (293)
+.|+.|-...+|++...+ +..+++|+........-+..+|..+++.|...++ .++++.+ .+ .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 456778889999998764 5789999875432221123578888888874444 5677665 22 359999998655
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.09 E-value=4.9e-05 Score=64.95 Aligned_cols=76 Identities=9% Similarity=0.068 Sum_probs=39.7
Q ss_pred eeeccCceE-EEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC--CCceeEEEEEEeCCeeEEEEEcccCCchh
Q 022706 74 LIGEGSYGR-VYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH--ENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (293)
Q Consensus 74 ~lg~G~~g~-V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 150 (293)
.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+.. ..-+++||++.+.++.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcchH
Confidence 455555544 6677654467788887654321 233456666665542 23556666532 2237899999776665
Q ss_pred hhh
Q 022706 151 DIL 153 (293)
Q Consensus 151 ~~l 153 (293)
+.+
T Consensus 101 ~~l 103 (333)
T 3csv_A 101 EVI 103 (333)
T ss_dssp HHH
T ss_pred HHh
Confidence 443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.3e-05 Score=69.63 Aligned_cols=74 Identities=12% Similarity=0.022 Sum_probs=44.4
Q ss_pred CceeeccCceEEEEEEeCC---------CCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEEEE
Q 022706 72 NALIGEGSYGRVYYGILKS---------GHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~---------~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 141 (293)
.+.|+.|....+|+....+ ++.+++|+.........+...|.++++.+...+ ..+++... . -++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 3457778888999998653 268889987543211112356777777775333 44666543 2 36899
Q ss_pred EcccCCch
Q 022706 142 EFASNGSL 149 (293)
Q Consensus 142 e~~~~~sL 149 (293)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00029 Score=60.43 Aligned_cols=64 Identities=14% Similarity=0.055 Sum_probs=41.2
Q ss_pred ceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC---CCCceeEEEE------EEeCCeeEEEEEcccCCch
Q 022706 80 YGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK---HENFVQLLGY------CVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 80 ~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~------~~~~~~~~lv~e~~~~~sL 149 (293)
...||+....+| .+++|+...... ..|+..++.|. -|++++++.. .......+++|+|++|..+
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred ccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 678999987766 999998765442 24455554442 2324444422 2335677899999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00016 Score=63.94 Aligned_cols=73 Identities=8% Similarity=-0.023 Sum_probs=48.0
Q ss_pred ceeeccCceEEEEEEeCC--------CCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEEc
Q 022706 73 ALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.|..|-...+|+....+ ++.+++|+........-+..+|..+++.+. +.-..++++.+ . -++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 456667788999998653 588999987543322223457888887775 33345566532 2 3789999
Q ss_pred ccCCch
Q 022706 144 ASNGSL 149 (293)
Q Consensus 144 ~~~~sL 149 (293)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 999764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0022 Score=56.27 Aligned_cols=28 Identities=25% Similarity=0.502 Sum_probs=23.9
Q ss_pred eeeCCCCCCceEE------cCCCceEEeccccCC
Q 022706 195 IIHRDIKSSNVLI------FDDDVAKIADFDLSN 222 (293)
Q Consensus 195 ivH~Dikp~Nilv------~~~~~~kl~Dfg~~~ 222 (293)
++|+|+.+.|||+ ++++.+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345679999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0041 Score=49.27 Aligned_cols=99 Identities=16% Similarity=0.175 Sum_probs=65.5
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
-+|.++|+... .++++++++.++.|.+.+|..+-.... -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~--------~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---- 97 (229)
T 2yle_A 33 LSLEEILRLYN--------QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---- 97 (229)
T ss_dssp EEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred ccHHHHHHHcC--------CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----
Confidence 38999998776 369999999999999999877622110 12334457999999999988764 2110
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT 271 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~ 271 (293)
.....+.+||.+. ...+.+.=|||||+++|..+-
T Consensus 98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0123466888653 344567889999999998876
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.11 Score=40.94 Aligned_cols=117 Identities=8% Similarity=0.123 Sum_probs=78.3
Q ss_pred CCCCceeEEEEEEeCCeeEEEEEccc-CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 022706 120 KHENFVQLLGYCVDGTSRVLAYEFAS-NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHR 198 (293)
Q Consensus 120 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~ 198 (293)
.||+++.. .+-.+.+.+.+.++.-+ +.++.. ++ ..+....++++.+|+....+++. -+|-
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------------SFTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------------GSCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------------hcCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 58888876 45566776666666544 223333 22 27889999999999998855554 3688
Q ss_pred CCCCCceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 199 DIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 199 Dikp~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
-|.|+||+++.++.+++.=-|+-..+ +|. ..+...=+-++=+++..+++++..|+.
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999999999877653221 121 111112223466788888888888864
Q ss_pred C
Q 022706 279 T 279 (293)
Q Consensus 279 ~ 279 (293)
.
T Consensus 160 l 160 (215)
T 4ann_A 160 L 160 (215)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.25 E-value=0.43 Score=37.69 Aligned_cols=83 Identities=6% Similarity=-0.054 Sum_probs=60.4
Q ss_pred CCCCceeEEEEEEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeC
Q 022706 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE-YLHEKADPHIIHR 198 (293)
Q Consensus 120 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~ivH~ 198 (293)
.||++ -..+-.+.+.+.+.++.-++..-...++ .++..++++++.+|+.... +++. -+|-
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf 108 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIF 108 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------------TSCHHHHHHHHHHHHHHHSSCCSS-----SEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeE
Confidence 47888 4444467777777777654332223332 2788999999999988777 5544 5788
Q ss_pred CCCCCceEEcCCCceEEeccccC
Q 022706 199 DIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 199 Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
-|.|+||+++.++.+++.-.|+-
T Consensus 109 ~l~P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 109 IVCPENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp CCCGGGEEECTTCCEEESCCEET
T ss_pred EEeCceEEEeCCCcEEEEEcCCc
Confidence 99999999999999999977753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.66 E-value=0.12 Score=46.11 Aligned_cols=59 Identities=5% Similarity=0.052 Sum_probs=17.5
Q ss_pred CCceeeccCceEEEEEEeCC-CCeEEE------EEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEE
Q 022706 71 TNALIGEGSYGRVYYGILKS-GHAAAI------KKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCV 132 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~-~~~~av------K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~ 132 (293)
+.+.|| ||.||++.++. ..+||+ |..+..... ...+.+|..+++.++|||+++.+.+..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345665 99999999763 467888 665432222 235677888888899999999988765
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=83.49 E-value=3 Score=35.10 Aligned_cols=138 Identities=12% Similarity=0.118 Sum_probs=70.2
Q ss_pred CCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEE--------------------
Q 022706 71 TNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGY-------------------- 130 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-------------------- 130 (293)
.++..-.|. +.||.+.. ++..++||-. .....+-+-.++...-.+..|+..-+...
T Consensus 73 ~I~~s~~Gs-tgvff~~t-d~~~~VVK~s--~~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~~~~~~ 148 (342)
T 1cja_A 73 GIERSEKGT-EGLFFVET-ESGVFIVKRS--TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKSFRV 148 (342)
T ss_dssp EEEECCSTT-SCEEEEEE-SSCEEEEECC--TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSSSCH
T ss_pred EEEeccCCC-CCeEEEEe-CCCEEEEeCc--HHHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhhhhhHH
Confidence 334444555 45665555 4789999944 22222333344444445555553322211
Q ss_pred --EEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHH--HHHHHHHHhCCC-CCeee-CCCCCCc
Q 022706 131 --CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA--AKGLEYLHEKAD-PHIIH-RDIKSSN 204 (293)
Q Consensus 131 --~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi--~~al~~LH~~~~-~~ivH-~Dikp~N 204 (293)
.......+++|+|.+|..|.+.-...-. ..+... ...++ +-++..+..+.+ .+.+. .--.+.|
T Consensus 149 l~~l~~~~~~l~meyv~G~~L~e~~~~~~~-------~~f~~~----~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~N 217 (342)
T 1cja_A 149 ITTLANQANILLMELVRGITLNKLTTTSAP-------EVLTKS----TMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDN 217 (342)
T ss_dssp HHHHTTCSEEEEEECCCEEESTTCCSSSHH-------HHSCHH----HHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGG
T ss_pred HHHhhcccceehhhhcCCCccccchhhhhh-------hhcCHH----HHHhhchhheehhhhcCCccCcccccCCCChhh
Confidence 0012245699999998777654321100 013222 22332 234555555431 12222 2347889
Q ss_pred eEEcCCCc-eEEeccccCCC
Q 022706 205 VLIFDDDV-AKIADFDLSNQ 223 (293)
Q Consensus 205 ilv~~~~~-~kl~Dfg~~~~ 223 (293)
||+++++. +.++|-+++..
T Consensus 218 IL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 218 IMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp EEEESBTTCEEECSCCCCCC
T ss_pred eEEeCCCCeEEEEcCCcccc
Confidence 99987554 88999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 293 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 8e-63
Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 20/235 (8%)
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVS 117
ELK+ ++F + +G G+ G V+ K SG A K + +P + + ++ ++
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
V G + E GSL +L + Q K++
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVS 110
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
+ KGL YL EK I+HRD+K SN+L+ K+ DF +S Q D + +
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 164
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
GT Y +PE + +SD++S G+ L+E+ GR P+ + + + +
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-62
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDA-SKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
IG GS+G VY G A + + A + Q + F +V ++ + +H N + +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 73
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ ++ SL+ LH + + + IA A+G++YLH K
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-- 250
IIHRD+KS+N+ + +D KI DF L+ + ++ G+ + APE
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 251 -GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
+ +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-61
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
E +G G +G V+ G A+K L + FLA+ +++ +L+H+ V+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L + E+ NGSL D L G+K L+ + + +A A+G+ +
Sbjct: 73 LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAF 124
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ E+ + IHRD++++N+L+ D KIADF L+ D + APE
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 180
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
G KSDV+SFG++L E++T +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-58
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
+G G +G V YG + + AIK + ++EF+ + ++ L HE VQL G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
+ E+ +NG L + L + QQ +++ + +EYL K
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
+HRD+ + N L+ D V K++DF LS D S + PE M + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFS 179
Query: 255 AKSDVYSFGVVLLELLTGRKP 275
+KSD+++FGV++ E+ + K
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKM 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-57
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG G +G V+ G + AIK + +E+F+ + ++ +L H VQL G C++
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 135 TSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPH 194
L +EF +G L D L ++G+ + + + + + +G+ YL E
Sbjct: 73 APICLVFEFMEHGCLSDYLRTQRGLF--------AAETLLGMCLDVCEGMAYLEEA---C 121
Query: 195 IIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLN 254
+IHRD+ + N L+ ++ V K++DF ++ D ST + +PE + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYS 180
Query: 255 AKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
+KSDV+SFGV++ E+ + K +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-55
Identities = 57/261 (21%), Positives = 101/261 (38%), Gaps = 23/261 (8%)
Query: 43 GAQAVKVQPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK------SGHAAAI 96
G V + P ++P E +G G++G+V + A+
Sbjct: 1 GNNYVYIDPTQLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAV 58
Query: 97 KKLDASKQPD--EEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDIL 153
K L S E ++++ ++S L H N V LLG C G ++ E+ G L + L
Sbjct: 59 KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 154 HGRKG---------VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSN 204
++ L + + + AKG+ +L K + IHRD+ + N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175
Query: 205 VLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGV 264
+L+ + KI DF L+ + + + + APE +SDV+S+G+
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 265 VLLELLTGRKPVDHTLPRGQQ 285
L EL + +P +
Sbjct: 236 FLWELFSLGSSPYPGMPVDSK 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 1e-54
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD 133
IG+G +G V G + G+ A+K + + FLA+ S++++L+H N VQLLG V+
Sbjct: 14 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 134 GTSRV-LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ + E+ + GSL D L R VL +K ++ + +EYL
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN-- 122
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
+ +HRD+ + NVL+ +D+VAK++DF L+ +A + APE +
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKK 176
Query: 253 LNAKSDVYSFGVVLLELLTGRKPVDHTLP 281
+ KSDV+SFG++L E+ + + +P
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIP 205
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-54
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQ 126
E+ +G+G +G V+ G AIK L E FL + ++ +L+HE VQ
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L + + E+ S GSL D L G G L Q V +A A G+ Y
Sbjct: 77 LYAVVSEE-PIYIVTEYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAY 128
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
+ + +HRD++++N+L+ ++ V K+ADF L+ D + APE
Sbjct: 129 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPE 184
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
A+ G+ KSDV+SFG++L EL T +
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-54
Identities = 61/259 (23%), Positives = 105/259 (40%), Gaps = 27/259 (10%)
Query: 51 PIEVPAISVDELKEIT-ENFGTNALIGEGSYGRVYYGILKS------GHAAAIKKLDASK 103
++ D E EN ++G G++G+V A+K L
Sbjct: 20 YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 79
Query: 104 QPDE--EFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG-- 158
E ++++ M+++L HEN V LLG C L +E+ G L + L ++
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 159 ------------VKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVL 206
++ + VL+++ + A AKG+E+L K +HRD+ + NVL
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVL 196
Query: 207 IFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVL 266
+ V KI DF L+ + + + APE G KSDV+S+G++L
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256
Query: 267 LELLTGRKPVDHTLPRGQQ 285
E+ + +P
Sbjct: 257 WEIFSLGVNPYPGIPVDAN 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-54
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-EEFLAQVSMVSRLKHENFVQLLGYCV 132
+G+G++G+VY K + AA K +D + + E+++ ++ +++ H N V+LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 133 DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKAD 192
+ + EF + G++ ++ + L+ Q + L YLH+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNYLHDN-- 129
Query: 193 PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ 252
IIHRD+K+ N+L D K+ADF +S + R S +GT + APE M
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCET 186
Query: 253 L-----NAKSDVYSFGVVLLELLTGRKP 275
+ K+DV+S G+ L+E+ P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-54
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE---FLAQVSMVSRLKHE 122
E++ IG GSYGR K G K+LD + E +++V+++ LKH
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 123 NFVQLLGYCVDGTSRVL--AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
N V+ +D T+ L E+ G L ++ KG + L + +++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMTQL 118
Query: 181 AKGLEYLHEKAD--PHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
L+ H ++D ++HRD+K +NV + K+ DF L+ + + +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVG 176
Query: 239 TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
T Y +PE N KSD++S G +L EL P
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (444), Expect = 7e-54
Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 28/250 (11%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPD--EEFLAQVSMVSR 118
N IGEG++GRV+ A+K L D +F + ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---------------GAQ 163
+ N V+LLG C G L +E+ + G L++ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 164 PGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223
P LS +++ IA A G+ YL E +HRD+ + N L+ ++ V KIADF LS
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283
+ PE + +SDV+++GVVL E+ + + +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 247
Query: 284 QQSLVTWVLD 293
+ ++ +V D
Sbjct: 248 HEEVIYYVRD 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-53
Identities = 64/227 (28%), Positives = 94/227 (41%), Gaps = 21/227 (9%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKH 121
E+F +G+G +G VY K S A+K L ++ + +V + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
N ++L GY D T L E+A G+++ L Q+ A
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
L Y H K +IHRDIK N+L+ KIADF S AP T + GT
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
Y PE + K D++S GV+ E L G+ P + + +
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 4e-53
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 16/223 (7%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHEN 123
E++ +GEG+YG V + + + A A+K +D + D E ++ + L HEN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
V+ G+ +G + L E+ S G L D + G + + G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAG 115
Query: 184 LEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYH 243
+ YLH I HRDIK N+L+ + D KI+DF L+ ++ GT Y
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 244 APEYAMTGQLNA-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
APE + +A DV+S G+VL +L G P D Q+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 4e-53
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 29/236 (12%)
Query: 58 SVDELKEITENFGTNA---------LIGEGSYGRVYYGILKS----GHAAAIKKL--DAS 102
+ ++ E F +IG G +G V G LK AIK L +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 103 KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGA 162
++ +FL++ S++ + H N + L G T ++ EF NGSL L G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125
Query: 163 QPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222
+ Q V + G A G++YL D + +HRD+ + N+L+ + V K++DF LS
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 223 QAPDMAARLHSTRVLG---TFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
D + T LG + APE + + SDV+S+G+V+ E+++ +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-53
Identities = 69/238 (28%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 51 PIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILKSGH---AAAIKKLD--ASKQP 105
P P + +++K +IGEG++G+V +K AAIK++ ASK
Sbjct: 1 PTIYPVLDWNDIKFQD-------VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53
Query: 106 DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVK---- 160
+F ++ ++ +L H N + LLG C LA E+A +G+L D L + ++
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 161 ---GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIAD 217
LS QQ + A A+G++YL +K IHRD+ + N+L+ ++ VAKIAD
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170
Query: 218 FDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
F LS + T + A E SDV+S+GV+L E+++
Sbjct: 171 FGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 7e-53
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 12/219 (5%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFV 125
+ +G G YG VY G+ K A+K L EEFL + +++ +KH N V
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 126 QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLE 185
QLLG C + EF + G+L D L + +S + +A + +E
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAME 129
Query: 186 YLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
YL +K + IHRD+ + N L+ ++ + K+ADF LS H + AP
Sbjct: 130 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAP 185
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
E + + KSDV++FGV+L E+ T + Q
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-52
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 58 SVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE-FLAQVSM 115
S+ + + + + IG+G+ G VY + + +G AI++++ +QP +E + ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+ K+ N V L + G + E+ + GSL D++ Q
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAA 120
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
+ + LE+LH +IHRDIKS N+L+ D K+ DF Q + +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRST 175
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
++GT + APE K D++S G++ +E++ G P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 2e-52
Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 28/231 (12%)
Query: 53 EVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE--- 108
+V + + + + F IG GS+G VY+ +++ AIKK+ S + E
Sbjct: 3 DVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 109 -FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
+ +V + +L+H N +Q G + + L E+ + + +K
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--------- 111
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDM 227
L + + GA +GL YLH ++IHRD+K+ N+L+ + + K+ DF ++
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 228 AARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKP 275
+GT + APE + GQ + K DV+S G+ +EL + P
Sbjct: 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-52
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 24/219 (10%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLD---ASKQPDEEFLAQVSMVSRLKHENFVQLLGY 130
IG GS+ VY G+ + A +L +K + F + M+ L+H N V+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 131 CVDGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
VL E ++G+L L K V+ + KGL++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
LH + P IIHRD+K N+ I KI D L+ + V+GT + AP
Sbjct: 128 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
E + + DVY+FG+ +LE+ T P Q
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-52
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDG 134
IG+G +G V+ G + G A+K + ++ A++ L+HEN + +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 135 TSRV----LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
L ++ +GSL D L+ ++ + +K+A+ A GL +LH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHME 119
Query: 191 A-----DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLH--STRVLGTFGYH 243
P I HRD+KS N+L+ + IAD L+ + + +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 244 APEYAMT------GQLNAKSDVYSFGVVLLELLTGRKP 275
APE + ++D+Y+ G+V E+
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-52
Identities = 56/243 (23%), Positives = 103/243 (42%), Gaps = 32/243 (13%)
Query: 52 IEVPAISVDELKEITE----------NFGTNALIGEGSYGRVYYGILK----SGHAAAIK 97
I++ A++ + ++ + +F +IG G +G VY+G L A+K
Sbjct: 4 IDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 98 KLDASKQPDE--EFLAQVSMVSRLKHENFVQLLGYCVDGTSRV-LAYEFASNGSLHDILH 154
L+ E +FL + ++ H N + LLG C+ + + +G L + +
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 155 GRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214
+ + + + AKG+++L +HRD+ + N ++ + K
Sbjct: 122 NETHN--------PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVK 170
Query: 215 IADFDLSNQAPD--MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG 272
+ADF L+ D + + T + A E T + KSDV+SFGV+L EL+T
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
Query: 273 RKP 275
P
Sbjct: 231 GAP 233
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-52
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 75 IGEGSYGRVYYGILK---SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLG 129
+G G++G V G+ + AIK L + EE + + ++ +L + V+L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 130 YCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE 189
C + +L E A G LH L G++ + ++ + G++YL E
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 127
Query: 190 KADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTRVLGTFGYHAPEYA 248
K + +HRD+ + NVL+ + AKI+DF LS D + + ++APE
Sbjct: 128 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 249 MTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ +++SDV+S+GV + E L+ +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-50
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 20/230 (8%)
Query: 64 EI-TENFGTNALIGEGSYGRVYYGILKSGHAA-----AIKKLDASKQPDE--EFLAQVSM 115
EI +IG G +G VY G+LK+ AIK L A + +FL + +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 116 VSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVK 175
+ + H N ++L G ++ E+ NG+L L + G S Q V
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVG 114
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST- 234
+ G A G++YL + +HRD+ + N+L+ + V K++DF LS D ++T
Sbjct: 115 MLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
+ APE + + SDV+SFG+V+ E++T + L +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-49
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 75 IGEGSYGRVYYGIL---KSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLL 128
+G G++G V G K A+K L +E LA+ +++ +L + V+++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 129 GYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
G C S +L E A G L+ L + + + +++ + G++YL
Sbjct: 75 GICEAE-SWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124
Query: 189 EKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ-APDMAARLHSTRVLGTFGYHAPEY 247
E + +HRD+ + NVL+ AKI+DF LS D T ++APE
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ ++KSDV+SFGV++ E + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-49
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 17/218 (7%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQV----SMVS 117
K+ E+F ++GEGS+ V L + AIK L+ E + V ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
RL H FV+L D +A NG L +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYT 114
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
LEYLH IIHRD+K N+L+ +D +I DF + + + + +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT Y +PE SD+++ G ++ +L+ G P
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-49
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 74 LIGEGSYGRVYYGILKSGH-----AAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQ 126
++G G++G VY G+ AIK+L + P +E L + +++ + + + +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LLG C+ T +++ + G L D + K Q + V AKG+ Y
Sbjct: 76 LLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLLNWCVQIAKGMNY 126
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
L ++ ++HRD+ + NVL+ KI DF L+ H+ + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ +SDV+S+GV + EL+T
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 12/218 (5%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPDE--EFLAQVSMVSR 118
E + +G+GS+G VY G+ K AIK ++ + E EFL + S++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQP-GPVLSWQQRVKIA 177
+ V+LLG G ++ E + G L L + P S + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
A G+ YL+ +HRD+ + N ++ +D KI DF ++ + + L
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ +PE G SDV+SFGVVL E+ T +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (410), Expect = 3e-48
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 50 QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD-E 107
QP+E+ + +++ + +G G++G V+ +G+ A K + + D E
Sbjct: 15 QPVEIKH------DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68
Query: 108 EFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
++ +S L+H V L D V+ YEF S G L + +
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--------K 120
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAP 225
+S + V+ KGL ++HE + +H D+K N++ K+ DF L+
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ +T GT + APE A + +D++S GV+ LL+G P
Sbjct: 178 PKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-48
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 74 LIGEGSYGRVYYGILKS--------GHAAAIKKL--DASKQPDEEFLAQVSMVSRL-KHE 122
+GEG++G+V A+K L DA+++ + ++++ M+ + KH+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLSWQQRVK 175
N + LLG C + E+AS G+L + L R+ P LS + V
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 176 IAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTR 235
A A+G+EYL K IHRD+ + NVL+ +D+V KIADF L+ + +T
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 236 VLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 284
+ APE +SDV+SFGV+L E+ T +P +
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 2e-47
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 50 QPIEVPAISVDELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE 108
QP+EV SV + +I E +G G++G V+ + +G K ++ D+
Sbjct: 18 QPVEVKQGSVYDYYDILE------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 109 -FLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPV 167
++S++++L H + L D VL EF S G L D +
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--------K 123
Query: 168 LSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI--FDDDVAKIADFDLSNQAP 225
+S + + A +GL+++HE I+H DIK N++ KI DF L+ +
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
Query: 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+T T + APE + +D+++ GV+ LL+G P
Sbjct: 181 PDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-47
Identities = 42/219 (19%), Positives = 85/219 (38%), Gaps = 17/219 (7%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH 121
KE+ E + +G G +G V+ + S K + ++S+++ +H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
N + L V+ +EF S + + ++ L+ ++ V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVC 112
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDD--VAKIADFDLSNQAPDMAARLHSTRVLGT 239
+ L++LH +I H DI+ N++ KI +F + Q + +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278
Y+APE ++ +D++S G ++ LL+G P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-47
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 74 LIGEGSYGRVYYGILKS----GHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQL 127
IGEG +G V+ GI S A AIK E+FL + + + H + V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 128 LGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYL 187
+G + + E + G L L RK L + A + L YL
Sbjct: 74 IGVITENP-VWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYL 124
Query: 188 HEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEY 247
K +HRDI + NVL+ +D K+ DF LS D +++ + APE
Sbjct: 125 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPES 180
Query: 248 AMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ + SDV+ FGV + E+L
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVK 208
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 9e-46
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 75 IGEGSYGRVYYGILKS----GHAAAIKKLD----ASKQPDEEFLAQVSMVSRLKHENFVQ 126
+G+GS+G V G + + A+K L + + ++F+ +V+ + L H N ++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L G + + + E A GSL D L +G + AV A+G+ Y
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 126
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP-DMAARLHSTRVLGTFGYHAP 245
L K IHRD+ + N+L+ D+ KI DF L P + + F + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
E T + SD + FGV L E+ T +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 1e-45
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 22/223 (9%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE----FLAQVSMVS 117
+++ + ++G G V+ L+ A+K L A D F + +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 118 RLKHENFVQLLGYCVD----GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQR 173
L H V + G + E+ +L DI+H ++ ++
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRA 113
Query: 174 VKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHS 233
+++ A + L + H+ IIHRD+K +N++I + K+ DF ++ D +
Sbjct: 114 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 234 T-RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
T V+GT Y +PE A ++A+SDVYS G VL E+LTG P
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 4e-44
Identities = 47/236 (19%), Positives = 91/236 (38%), Gaps = 20/236 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKL--DASKQPDEEFLAQVSMVSR 118
+ +G G++G+V + A+K L A+ ++++ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 119 LKHENFVQLLGYCV--DGTSRVLAYEFASNGSLHDILHGRKG-------VKGAQPGPVLS 169
+ H V L G ++ EF G+L L ++ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
+ + + AKG+E+L + IHRD+ + N+L+ + +V KI DF L+
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 285
+ + APE +SDV+SFGV+L E+ + + ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (376), Expect = 5e-44
Identities = 58/241 (24%), Positives = 93/241 (38%), Gaps = 33/241 (13%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD----------EEFLAQVSM 115
EN+ ++G G V I + A+K +D + E L +V +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 116 VSRLK-HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
+ ++ H N +QL T L ++ G L D L + LS ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETR 113
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
KI + + LH+ +I+HRD+K N+L+ DD K+ DF S Q
Sbjct: 114 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 167
Query: 235 RVLGTFGYHAPEYAMTGQLNA------KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
V GT Y APE + + D++S GV++ LL G P H ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 289 T 289
Sbjct: 228 M 228
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 7e-44
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 20/215 (9%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQV-----SMVSRLK 120
E+F + ++G+GS+G+V+ K + AIK L ++ + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 121 HENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
H + + E+ + G L + + A
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEI 112
Query: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
GL++LH K I++RD+K N+L+ D KIADF + + A+ + GT
Sbjct: 113 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 167
Query: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y APE + + N D +SFGV+L E+L G+ P
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 1e-43
Identities = 44/218 (20%), Positives = 83/218 (38%), Gaps = 15/218 (6%)
Query: 61 ELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEE--FLAQVSMVS 117
+ ++I + + ++G G++ V ++ AIK + +E +++++
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 118 RLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIA 177
++KH N V L G L + S G L D + + + + ++
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLI 113
Query: 178 VGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVL 237
++YLH+ H + + +D I+DF LS + +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STAC 170
Query: 238 GTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
GT GY APE + D +S GV+ LL G P
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (377), Expect = 3e-43
Identities = 50/236 (21%), Positives = 88/236 (37%), Gaps = 25/236 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQ-------VSMVSR 118
+F + +IG G +G VY +G A+K LD + ++ +S+VS
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 119 LKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAV 178
V + + + G LH L A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAA 114
Query: 179 GAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLG 238
GLE++H + +++RD+K +N+L+ + +I+D L+ +G
Sbjct: 115 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG 167
Query: 239 TFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLD 293
T GY APE G ++ +D +S G +L +LL G P + + + L
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-42
Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 22/238 (9%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD--EEFLAQVSMVSRLK 120
++ + + IGEG+YG V + AIKK+ + + L ++ ++ R +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 121 HENFVQLLGYCVDGTSRVLAYEF----ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
HEN + + T + + L+ +L + LS
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYF 114
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA-PDMAARLHSTR 235
+GL+Y+H +++HRD+K SN+L+ KI DF L+ A PD T
Sbjct: 115 LYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 236 VLGTFGYHAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
+ T Y APE + + KS D++S G +L E+L+ R Q + + +L
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (361), Expect = 2e-41
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 22/227 (9%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKH 121
++F +G GS+GRV+ + +G A+K L E + M+S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
+++ G D + ++ G L +L + A
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
LEYLH K II+RD+K N+L+ + KI DF + PD+ + + GT
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPD 166
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
Y APE T N D +SFG+++ E+L G P + +
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-41
Identities = 46/226 (20%), Positives = 83/226 (36%), Gaps = 17/226 (7%)
Query: 75 IGEGSYGRVYYGILK--SGHAAAIKKLDASKQPDEEFLAQV------SMVSRLKHENFVQ 126
IGEG+YG+V+ G A+K++ + L+ + + +H N V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
L C + + P P + + + +GL++
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH ++HRD+K N+L+ K+ADF L+ T V+ T Y APE
Sbjct: 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 185
Query: 247 YAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
+ D++S G + E+ + + Q + V+
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-40
Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 22/227 (9%)
Query: 74 LIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD------EEFLAQVSMVSRLKHENFVQ 126
+GEG + VY K + AIKK+ + + L ++ ++ L H N +
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 127 LLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEY 186
LL ++ L ++F I L+ + +GLEY
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115
Query: 187 LHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPE 246
LH+ I+HRD+K +N+L+ ++ V K+ADF L+ T + T Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPE 170
Query: 247 YAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
++ D+++ G +L ELL + Q + + L
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 7e-40
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 16/221 (7%)
Query: 75 IGEGSYGRVYYGILKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYC 131
IGEG+YG VY G A+KK+ K+ + + ++S++ LKH N V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
VL +E + G L + G+ Y H++
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR- 119
Query: 192 DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 251
++HRD+K N+LI + KIADF L+ + ++ + +
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSK 176
Query: 252 QLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
+ + D++S G + E++ G Q + +L
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-39
Identities = 56/249 (22%), Positives = 89/249 (35%), Gaps = 24/249 (9%)
Query: 52 IEVPAISVDELKEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFL 110
+ P D +E+ ++ +IG GS+G VY L SG AIKK+ K
Sbjct: 7 VATPGQGPDRPQEV--SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKN 61
Query: 111 AQVSMVSRLKHENFVQLLGYCVDGTSR------VLAYEFASNGSLHDILHGRKGVKGAQP 164
++ ++ +L H N V+L + + L ++ H +
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------ 115
Query: 165 GPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQ 223
L + L Y+H I HRDIK N+L+ D V K+ DF + Q
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 224 APDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283
+ + + + + DV+S G VL ELL G+
Sbjct: 173 LVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 284 QQSLVTWVL 292
Q + VL
Sbjct: 231 QLVEIIKVL 239
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-39
Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 16/213 (7%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHE 122
ENF IGEG+YG VY K +G A+KK+ + + + ++S++ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
N V+LL L +EF + + +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQ 113
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
GL + H ++HRD+K N+LI + K+ADF L+ +A + R ++ V+ +
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTLWYR 169
Query: 243 HAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ D++S G + E++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 4e-38
Identities = 43/225 (19%), Positives = 81/225 (36%), Gaps = 23/225 (10%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYC- 131
IG GS+G +Y G + +G AIK + + + + ++ + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 132 VDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA 191
+G V+ E + S + + +A +EY+H K
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTVLLLADQMISRIEYIHSK- 122
Query: 192 DPHIIHRDIKSSNVLIFDDD---VAKIADFDLSNQAPD-----MAARLHSTRVLGTFGYH 243
+ IHRD+K N L+ + I DF L+ + D + + GT Y
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 244 APEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
+ + + + + D+ S G VL+ G P ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 9e-38
Identities = 48/217 (22%), Positives = 83/217 (38%), Gaps = 27/217 (12%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD-------EEFLAQVSMVSRLK--HEN 123
L+G G +G VY GI + AIK ++ + D +V ++ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 124 FVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKG 183
++LL + S VL E +G L + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEA 122
Query: 184 LEYLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGY 242
+ + H ++HRDIK N+LI + K+ DF D T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175
Query: 243 HAPEYAMTGQLNAKS-DVYSFGVVLLELLTGRKPVDH 278
PE+ + + +S V+S G++L +++ G P +H
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-37
Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 24/210 (11%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
++G G G+V ++ A+K L + E + + V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL---HWRASQCPHIVRIVDVYE 75
Query: 133 DGTSR----VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLH 188
+ + ++ E G L + R + ++ +I + ++YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQYLH 128
Query: 189 EKADPHIIHRDIKSSNVLI---FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP 245
+I HRD+K N+L + + K+ DF + + + T Y AP
Sbjct: 129 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP 182
Query: 246 EYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
E + + D++S GV++ LL G P
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-37
Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 63 KEITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD-------EEFLAQVS 114
+ + + + T +G G + V K +G A K + + E+ +VS
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 115 MVSRLKHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
++ ++H N + L + T +L E + G L D L ++ L+ ++
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEAT 116
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA----KIADFDLSNQAPDMAAR 230
+ G+ YLH I H D+K N+++ D +V KI DF L+++
Sbjct: 117 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-- 171
Query: 231 LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
+ GT + APE L ++D++S GV+ LL+G P
Sbjct: 172 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (326), Expect = 2e-36
Identities = 41/241 (17%), Positives = 82/241 (34%), Gaps = 25/241 (10%)
Query: 65 ITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN 123
+ ++ IGEGS+G ++ G L + AIK + + + L
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCT 61
Query: 124 FV-QLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+ + + +G VL + + G S + A
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLA 112
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLI-----FDDDVAKIADFDLSNQAPDMAARLH----- 232
++ +HEK +++RDIK N LI + ++ + DF + D + H
Sbjct: 113 RVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 233 STRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
+ GT Y + + + + + D+ + G V + L G P + +
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 293 D 293
+
Sbjct: 230 E 230
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-36
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 19/214 (8%)
Query: 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEE----FLAQVSMVSRLKH 121
+F L+G+G++G+V K +G A+K L ++ + + ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 122 ENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAA 181
L E+A+ G L L + + ++
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIV 115
Query: 182 KGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
LEYLH + +++RDIK N+++ D KI DF L + A + GT
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPE 170
Query: 242 YHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
Y APE D + GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-36
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 27/233 (11%)
Query: 75 IGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
IG+G++G V+ K+G A+KK+ + + L ++ ++ LKHEN V L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 131 CVDGTSRV--------LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
C S L ++F + + + + + ++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---------FTLSEIKRVMQMLLN 128
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ--APDMAARLHSTRVLGTF 240
GL Y+H I+HRD+K++NVLI D V K+ADF L+ + T + T
Sbjct: 129 GLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 241 GYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
Y PE + + D++ G ++ E+ T + + Q +L++ +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-35
Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 16/233 (6%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
E+ + +G G+YG V + ++G AIKKL Q + + ++ ++ +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVG 179
+HEN + LL + +F G+ L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQ 129
Query: 180 AAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGT 239
KGL Y+H IIHRD+K N+ + +D KI DF L+ QA + V+
Sbjct: 130 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTR 182
Query: 240 FGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 292
+ + D++S G ++ E++TG+ + Q + V
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 5e-35
Identities = 58/253 (22%), Positives = 97/253 (38%), Gaps = 32/253 (12%)
Query: 37 SEAAPKGAQAVKVQPIEVPAISVDELKEIT---------ENFGTNALIGEGSYGRVYYGI 87
+ AA KG++ V+ A D LK+ + F +G GS+GRV
Sbjct: 3 AAAAKKGSEQESVKEFLAKA-KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 88 -LKSGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142
+SG+ A+K LD K E L + ++ + V+L D ++ + E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202
+ + G + L S A EYLH +I+RD+K
Sbjct: 122 YVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKP 169
Query: 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSF 262
N+LI ++ DF + + + + GT APE ++ N D ++
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 263 GVVLLELLTGRKP 275
GV++ E+ G P
Sbjct: 225 GVLIYEMAAGYPP 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 1e-34
Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 17/205 (8%)
Query: 75 IGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGY 130
IGEG+YG V+ + + A+K++ + L ++ ++ LKH+N V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEK 190
L +EF + + KGL + H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120
Query: 191 ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT 250
+++HRD+K N+LI + K+A+F L+ +A + R +S V+ +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 251 GQLNAKSDVYSFGVVLLELLTGRKP 275
+ D++S G + EL +P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-32
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 26/221 (11%)
Query: 64 EITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSMVSRL 119
E+ E + + +G G+YG V K+G A+KKL Q + ++ ++ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 120 KHENFVQLLGYCVDGTS-----RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRV 174
KHEN + LL S V L++I+ +K L+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQ 124
Query: 175 KIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHST 234
+ +GL+Y+H IIHRD+K SN+ + +D KI DF L+ D +
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTG 177
Query: 235 RVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 275
V + N D++S G ++ ELLTGR
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-31
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 25/234 (10%)
Query: 67 ENFGTNALIGEGSYGRVYYGILKSGHAA----AIKKLDASKQPD-----EEFLAQVSMVS 117
ENF ++G G+YG+V+ SGH A+K L + E + ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 118 RLKHENF-VQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKI 176
++ F V L T L ++ + G L L R+ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIY 134
Query: 177 AVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRV 236
LE+LH+ II+RDIK N+L+ + + DF LS + +
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDF 190
Query: 237 LGTFGYHAPEYAMTGQ--LNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 288
GT Y AP+ G + D +S GV++ ELLTG P + Q+ +
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (288), Expect = 1e-30
Identities = 40/215 (18%), Positives = 83/215 (38%), Gaps = 26/215 (12%)
Query: 67 ENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENF 124
+++ +G G Y V+ I + + +K L K+ ++ ++ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 125 VQLLGYCVDGTSR--VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+ L D SR L +E +N + L+ K
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILK 140
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLSNQAPDMAARLHSTRVLGTFG 241
L+Y H I+HRD+K NV+I + ++ D+ L+ + +
Sbjct: 141 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRY 194
Query: 242 YHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKP 275
+ PE + Q+ + D++S G +L ++ ++P
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 3e-30
Identities = 39/213 (18%), Positives = 80/213 (37%), Gaps = 11/213 (5%)
Query: 74 LIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCV 132
+G G + V+ + + A+K + K E ++ ++ R+ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 133 DGTSRVLAY--EFASNGSLHDILHGRKGVKG-----AQPGPVLSWQQRVKIAVGAAKGLE 185
+ ++L + NG ++ G + +I+ GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 186 YLHEKADPHIIHRDIKSSNVLI-FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHA 244
Y+H + IIH DIK NVL+ D + +++ H T + T Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 245 PEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277
PE + +D++S ++ EL+TG +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-29
Identities = 49/243 (20%), Positives = 83/243 (34%), Gaps = 28/243 (11%)
Query: 60 DELKEITENFGTNALIGEGSYGRVYYGI-LKSGHAAAIKKLDASKQPD---EEFLAQVSM 115
D + + + IG G+ G V AIKKL Q + ++ +
Sbjct: 10 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 116 VSRLKHENFVQLLGYCV------DGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLS 169
+ + H+N + LL + L E I
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------D 117
Query: 170 WQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAA 229
++ + G+++LH IIHRD+K SN+++ D KI DF L+
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGT 171
Query: 230 RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 289
T + T Y APE + D++S G ++ E++ + Q + V
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 290 WVL 292
L
Sbjct: 232 EQL 234
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.4 bits (182), Expect = 1e-16
Identities = 26/173 (15%), Positives = 54/173 (31%), Gaps = 32/173 (18%)
Query: 74 LIGEGSYGRVYYGILKSGHAAAIKKLDASK-----------QPDEEFLAQVSMVSRLKHE 122
L+GEG V+ + +K D F +R +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 123 NFVQLLGYCVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAK 182
+L G V Y + N L +++ + + + ++ +
Sbjct: 67 ALQKLQGLAV-----PKVYAWEGNAVLMELIDA-------KELYRVRVENPDEVLDMILE 114
Query: 183 GLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS-----NQAPDMAAR 230
+ + + I+H D+ NVL+ ++ + I DF S ++ R
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILER 163
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 293 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.14 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.73 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.04 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=362.78 Aligned_cols=204 Identities=29% Similarity=0.435 Sum_probs=179.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|++.+.||+|+||+||+|.++ +|+.||||++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999987 799999999865432 23568899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++|+|.+++.... .+++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 84 y~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 999999999997543 4999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 7654443334466789999999999988776 5789999999999999999999976543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=357.84 Aligned_cols=200 Identities=26% Similarity=0.445 Sum_probs=180.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
++|++.+.||+|+||+||+|.++ +|+.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999976 79999999986543 44577899999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
+|++|.+++.... +++.+++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 100 AGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9999999887653 899999999999999999999999 999999999999999999999999999865
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+
T Consensus 167 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 167 TPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp CSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 4322 223556799999999999999999999999999999999999999986543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=354.16 Aligned_cols=199 Identities=32% Similarity=0.475 Sum_probs=180.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCC----CCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDA----SKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||+|+++ +++.||+|++.+ .......+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999987 799999999863 2344577899999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 86 Ey~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a 153 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS 153 (263)
T ss_dssp ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred eecCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeeccccee
Confidence 9999999999997654 3899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 154 ~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 154 VHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp SCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 8764322 2456799999999999999999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=359.44 Aligned_cols=203 Identities=26% Similarity=0.373 Sum_probs=178.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||+|.++ +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999987 7999999998642 344567899999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 88 Ey~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccc
Confidence 9999999999987664 3999999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 876544433344567899999999999999999999999999999999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=362.16 Aligned_cols=199 Identities=27% Similarity=0.427 Sum_probs=177.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|++.+.||+|+||+||+|+++ +|+.||+|+++..... ...+.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999987 7999999998754333 4678899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
|+++++|.+++.+.. .+++..++.++.|++.||.|||+ ++ |+||||||+|||+++++++||+|||+|
T Consensus 85 y~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp CCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred cCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999999999997654 38999999999999999999997 48 999999999999999999999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....+ ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus 153 ~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 153 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 75432 22356789999999999999999999999999999999999999997654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=351.70 Aligned_cols=202 Identities=27% Similarity=0.434 Sum_probs=177.6
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
+.|++.+.||+|+||+||+|.++ +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999987 79999999986543 33467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++|+|.+++.+.. ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~g~L~~~~~~~~--------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 92 AGGAVDAVMLELE--------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 9999999876543 13999999999999999999999999 999999999999999999999999998765
Q ss_pred CcccccccccccccCcccccccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAM-----TGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
.... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.+.++
T Consensus 161 ~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 161 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp HHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred CCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 3321 1234578999999999884 45688999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=348.96 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=166.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVD--GTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 140 (293)
++|++.+.||+|+||+||+|+++ +|+.||+|++....... +.+.+|++++++++||||+++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 58999999999999999999987 79999999997665443 457899999999999999999999865 4568999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--DPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
|||+++|+|.+++...... ...+++.+++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+||
T Consensus 84 mEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 9999999999998643211 124999999999999999999999864 124999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 159 G~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 159 GLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp HHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 9987654322 123457899999999999999999999999999999999999999987644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=353.47 Aligned_cols=201 Identities=25% Similarity=0.356 Sum_probs=181.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|.+++.||+|+||+||+|+++ +|+.||+|++.+. ......+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 58999999999999999999987 8999999998643 344577889999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++||+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++
T Consensus 85 ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp ECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eccCCCchhhhhhccc---------CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccc
Confidence 9999999999998765 3899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 153 ~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 153 KEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp BCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 8654322 223557899999999999999999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=344.60 Aligned_cols=202 Identities=30% Similarity=0.504 Sum_probs=169.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
.++|.+.+.||+|+||+||+|+++ ..||||+++.... ..+.+.+|++++++++||||+++++++. ....++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 368999999999999999999865 3599999975433 2367889999999999999999999875 456899999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+++|+|.+++..... .+++.+++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred cCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999975542 3899999999999999999999998 9999999999999999999999999998
Q ss_pred CCCcccccccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.++
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 7654444434456789999999999864 3578899999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-52 Score=352.90 Aligned_cols=201 Identities=25% Similarity=0.399 Sum_probs=164.2
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC--ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ--PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.+.|++.+.||+|+||+||+|+++ +++.||||++..... ....+.+|++++++++||||+++++++.+.+..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999987 799999999865432 2356789999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc---CCCceEEecc
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF---DDDVAKIADF 218 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~---~~~~~kl~Df 218 (293)
||++|++|.+++.... .+++.++..++.||+.||+|||+++ |+||||||+||++. +++.+||+||
T Consensus 87 E~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp CCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 9999999999997654 4999999999999999999999999 99999999999995 5789999999
Q ss_pred ccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 9998654322 2245679999999999999999999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-51 Score=350.67 Aligned_cols=198 Identities=28% Similarity=0.424 Sum_probs=180.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++.+.||+|+||+||+|+++ +|+.||||++... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 58999999999999999999987 7999999998642 344577899999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||++|++|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 84 E~~~gg~l~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp CCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eecCCccccccccccc---------cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccc
Confidence 9999999999988765 3889999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 152 ~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 152 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 876442 2457899999999999999999999999999999999999999987543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=341.99 Aligned_cols=202 Identities=27% Similarity=0.512 Sum_probs=171.5
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|.+.+.||+|+||+||+|.+++++.||||++.......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 47889999999999999999998888999999988888888999999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 g~L~~~l~~~~--------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 85 GCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CcHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccC
Confidence 99999987654 24899999999999999999999998 99999999999999999999999999986644
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTL 280 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~ 280 (293)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||....
T Consensus 154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 3221 2234568999999999999999999999999999999999 567776543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-51 Score=352.93 Aligned_cols=202 Identities=25% Similarity=0.372 Sum_probs=179.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|++.+.||+|+||+||+|+++ +|+.||||++..... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999987 799999999975433 245688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC--CCceEEeccccC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD--DDVAKIADFDLS 221 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~--~~~~kl~Dfg~~ 221 (293)
++||+|.+++..... .+++.+++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 105 ~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 105 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp CCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 999999999865431 3999999999999999999999999 999999999999964 578999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 174 ~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 230 (350)
T d1koaa2 174 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230 (350)
T ss_dssp EECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 7664332 23457899999999999999999999999999999999999999986543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=348.24 Aligned_cols=201 Identities=30% Similarity=0.452 Sum_probs=179.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFA 144 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 144 (293)
.++|++.+.||+|+||+||+|.++ +++.||||+++.+....+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 468999999999999999999987 6899999999888878889999999999999999999999999999999999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 96 ~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 96 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp TTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred cCcchHHHhhhccc-------cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999876532 24899999999999999999999998 999999999999999999999999999876
Q ss_pred CcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 225 PDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
...... ......|++.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 166 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp CSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 443221 2233457899999999999999999999999999999999665543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9e-51 Score=351.99 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=179.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC-ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ-PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|++.+.||+|+||+||+|.++ +|+.||||++..... ....+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999986 899999999865432 235678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc--CCCceEEeccccC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF--DDDVAKIADFDLS 221 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~--~~~~~kl~Dfg~~ 221 (293)
++|++|.+++.... ..+++.+++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~gg~L~~~~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 108 LSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp CCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CCCChHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 99999998876543 24999999999999999999999999 99999999999998 5789999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 8764322 23556789999999999999999999999999999999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=345.39 Aligned_cols=197 Identities=28% Similarity=0.470 Sum_probs=174.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh----HHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD----EEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
+.|++.+.||+|+||+||+|+++ +++.||||++....... +.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999977 78999999997655432 45789999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+.+++|..++.... .+++.+++.++.||+.||.|||+++ |+||||||+|||+++++++||+|||++
T Consensus 95 E~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp ECCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred EecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccc
Confidence 9999999987765543 3999999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCccccccccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
..... .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+..+
T Consensus 163 ~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 163 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp BSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 76543 244679999999999864 4588999999999999999999999986543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=335.49 Aligned_cols=203 Identities=28% Similarity=0.490 Sum_probs=184.1
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|++.+.||+|+||+||+|++++++.||||+++......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 58999999999999999999999888999999998888889999999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
|+|.+++..... .+++..+++++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 84 GCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred CcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999998766542 3889999999999999999999998 99999999999999999999999999986654
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 153 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 153 DEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp SSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred CCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 322 22344668999999999999999999999999999999998 8999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=341.79 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=179.6
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC-------CChHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK-------QPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTS 136 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 136 (293)
+.++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3468999999999999999999986 79999999986432 124678999999999999999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC----c
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD----V 212 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~----~ 212 (293)
.++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++ .
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred EEEEEEcCCCccccchhcccc---------ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence 999999999999999997654 3999999999999999999999999 99999999999998776 4
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+||+|||++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.
T Consensus 156 vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 221 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221 (293)
T ss_dssp EEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH
Confidence 9999999987654322 22456789999999999999999999999999999999999999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=336.97 Aligned_cols=197 Identities=29% Similarity=0.447 Sum_probs=169.2
Q ss_pred CCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEe----CCeeEEE
Q 022706 69 FGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVD----GTSRVLA 140 (293)
Q Consensus 69 y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 140 (293)
|++.+.||+|+||+||+|.++ +++.||+|++...... .+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367778999999999999987 7889999998755433 3468899999999999999999999875 3567899
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc-CCCceEEeccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF-DDDVAKIADFD 219 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~-~~~~~kl~Dfg 219 (293)
|||+++++|.+++.... .+++.+++.++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||
T Consensus 91 mE~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EeCCCCCcHHHHHhccc---------cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 99999999999997654 3899999999999999999999873 3499999999999996 47899999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+++..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+..
T Consensus 161 la~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 161 LATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp GGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 99754322 2245689999999998765 69999999999999999999999997654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-50 Score=350.59 Aligned_cols=198 Identities=25% Similarity=0.348 Sum_probs=180.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAY 141 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 141 (293)
++|++++.||+|+||+||+|.++ +|+.||||++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999987 8999999998632 344567899999999999999999999999999999999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccC
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLS 221 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~ 221 (293)
||+.+++|.+++.... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||++
T Consensus 121 e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceee
Confidence 9999999999987654 3999999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 189 ~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 189 KRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp EECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 876432 2456799999999999999999999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=338.30 Aligned_cols=202 Identities=29% Similarity=0.497 Sum_probs=177.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEccc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFAS 145 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 145 (293)
.++|++.+.||+|+||+||+|.+++++.||||++.......+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 46899999999999999999999988899999998877778899999999999999999999998754 56799999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+|+|.+++...... .+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 91 ~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 91 NGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp TCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 99999987654321 3899999999999999999999998 9999999999999999999999999998765
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RKPVDHT 279 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g-~~Pf~~~ 279 (293)
.... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...
T Consensus 161 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 4322 223445689999999999988999999999999999999995 5555543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=342.75 Aligned_cols=203 Identities=20% Similarity=0.270 Sum_probs=181.0
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
+.++|.+.+.||+|+||+||+|.++ +++.||+|+++....+...+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 3468999999999999999999987 799999999987665666788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC--CceEEeccccC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD--DVAKIADFDLS 221 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~--~~~kl~Dfg~~ 221 (293)
++|++|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ ..++|+|||++
T Consensus 83 ~~gg~L~~~i~~~~--------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 83 ISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 99999999997654 13899999999999999999999999 9999999999999854 47999999998
Q ss_pred CCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
....... ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.++
T Consensus 152 ~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 152 RQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 7654322 22456789999999999999999999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-50 Score=339.79 Aligned_cols=204 Identities=29% Similarity=0.473 Sum_probs=165.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC---eEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH---AAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~---~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|++.+.||+|+||+||+|+++ +++ .||||.+...... .+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56788899999999999999976 333 5889988654443 35689999999999999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++|+|.+++.... ..+++.+++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+
T Consensus 106 ~Ey~~~g~L~~~~~~~~--------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EECCTTEEHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEecCCCcceeeecccc--------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence 99999999999887654 24899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccccc---cccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 221 SNQAPDMAARL---HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+..+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 98765432221 1123457899999999999999999999999999999998 8999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8e-50 Score=347.67 Aligned_cols=201 Identities=26% Similarity=0.383 Sum_probs=174.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCC----CChHHHHH---HHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASK----QPDEEFLA---QVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~----~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
++|++.+.||+|+||+||+|+++ +|+.||||++.+.. .....+.+ |+++++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 58999999999999999999987 79999999985322 22233444 467778888999999999999999999
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||++|++|.+++.... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCC
T ss_pred EEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeee
Confidence 9999999999999997654 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 022706 219 DLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRG 283 (293)
Q Consensus 219 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~~ 283 (293)
|+++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.....
T Consensus 152 Gla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 152 GLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp TTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred ceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999765432 2245679999999999875 568999999999999999999999998765443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=340.01 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=178.0
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCC----CCChHHHHHHHHHHh-cCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDAS----KQPDEEFLAQVSMVS-RLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~----~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|.+.+.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|..++. .++||||+++++++.+....|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999987 8999999999643 334456667777655 68999999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+
T Consensus 82 mEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeecCCCcHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccch
Confidence 99999999999997654 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 221 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++
T Consensus 150 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 150 CKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 98654322 223556799999999999999999999999999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=342.62 Aligned_cols=212 Identities=28% Similarity=0.466 Sum_probs=177.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CC-----CeEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SG-----HAAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~-----~~~avK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 137 (293)
++|.+.+.||+|+||+||+|+++ .+ ..||+|.+.... .....+.+|+.++.++ +||||+++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 58999999999999999999875 22 268999886433 3346788999999998 799999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 022706 138 VLAYEFASNGSLHDILHGRKGVK--------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSS 203 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~ 203 (293)
++||||+++|+|.++++...... .......+++.+++.++.|++.||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 99999999999999997654211 0111235899999999999999999999998 999999999
Q ss_pred ceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 204 NVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 204 Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|||++.++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987654443333445678999999999999999999999999999999998 8999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-49 Score=332.81 Aligned_cols=201 Identities=29% Similarity=0.392 Sum_probs=177.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----------hHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----------DEEFLAQVSMVSRLK-HENFVQLLGYCVD 133 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 133 (293)
.++|++.+.||+|+||+||+|+++ +++.||||++...... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999986 7999999998654322 135778999999997 9999999999999
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
++..|+||||+++++|.++++.+. .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 999999999999999999997654 3999999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCccccccccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
||+|||++....... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.++
T Consensus 150 kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 150 KLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 999999998764422 2255679999999998863 3478899999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-49 Score=334.90 Aligned_cols=204 Identities=26% Similarity=0.431 Sum_probs=170.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCC----e
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGT----S 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 136 (293)
.++|++.+.||+|+||+||+|.++ +++.||||+++..... ...+.+|++++++++||||+++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999986 8999999999765443 245889999999999999999999987654 3
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.|+||||++|++|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+|+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEECCCCCEehhhhcccC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence 789999999999999887654 3899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccc-ccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 217 DFDLSNQAPDMA-ARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|||.+....... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.++
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 999886543322 22233556799999999999999999999999999999999999999987643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=332.00 Aligned_cols=203 Identities=28% Similarity=0.492 Sum_probs=173.1
Q ss_pred hcCCCCce-eeccCceEEEEEEeC---CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNAL-IGEGSYGRVYYGILK---SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~-lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|.+.+. ||+|+||+||+|.++ ++..||||+++..... .+++.+|++++++++||||+++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45667774 999999999999865 3557999999755433 3578999999999999999999999865 467899
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDL 220 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~ 220 (293)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCcHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence 99999999999876543 24899999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCcccc-cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 221 SNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 221 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
++....... ........||+.|+|||++....++.++|||||||++|||+| |+.||.+...
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 986644322 222334568999999999998999999999999999999998 9999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=330.68 Aligned_cols=196 Identities=28% Similarity=0.454 Sum_probs=165.5
Q ss_pred ceeeccCceEEEEEEeC---CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 73 ALIGEGSYGRVYYGILK---SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 73 ~~lg~G~~g~V~~~~~~---~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
+.||+|+||+||+|.++ +++.||||+++....+ .+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 3568999999754332 3578999999999999999999999865 457899999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence 99999997654 4999999999999999999999998 99999999999999999999999999976543
Q ss_pred ccc-cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 227 MAA-RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 227 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 322 222344668999999999999999999999999999999998 9999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=338.40 Aligned_cols=199 Identities=22% Similarity=0.335 Sum_probs=172.0
Q ss_pred HhcCCCC-ceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcC-CCCCceeEEEEEEe----CCeeE
Q 022706 66 TENFGTN-ALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRL-KHENFVQLLGYCVD----GTSRV 138 (293)
Q Consensus 66 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~ 138 (293)
.++|.+. ++||+|+||+||+|+++ +++.||||+++. ...+.+|+.++.++ +||||+++++++.+ ....|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4689876 46999999999999986 799999999853 35678899887655 79999999999876 46689
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCceEE
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKI 215 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~kl 215 (293)
+|||||+||+|.+++..... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||+++ ++.+||
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccc
Confidence 99999999999999976532 24999999999999999999999999 999999999999985 457999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.
T Consensus 156 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 156 TDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp CCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred cccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 99999976544322 3556799999999999998999999999999999999999999976543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=329.70 Aligned_cols=201 Identities=32% Similarity=0.522 Sum_probs=170.7
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEcccC
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEFASN 146 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 146 (293)
++|++.+.||+|+||+||+|++++++.||||++.......+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 6899999999999999999999988889999998888888899999999999999999999999854 567999999999
Q ss_pred CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCCc
Q 022706 147 GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPD 226 (293)
Q Consensus 147 ~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~~ 226 (293)
|+|..++..... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 96 g~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 96 GSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred Cchhhhhhhccc-------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999988865432 23899999999999999999999999 99999999999999999999999999986643
Q ss_pred ccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCC
Q 022706 227 MAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR-KPVDHT 279 (293)
Q Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~-~Pf~~~ 279 (293)
... .......||+.|+|||.+....++.++|||||||++|||++|. +||...
T Consensus 166 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 166 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 322 2234466899999999999999999999999999999999954 555543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=330.24 Aligned_cols=197 Identities=26% Similarity=0.372 Sum_probs=167.9
Q ss_pred CCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC------hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 71 TNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP------DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 71 ~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.+++||+|+||+||+|+++ +|+.||||+++..... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999987 7999999999754322 24688999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+.++++..+..... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 82 METDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred hcchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 99887776665443 4888999999999999999999999 99999999999999999999999999987
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
...... .....+||+.|+|||++... .++.++|||||||++|||++|.+||.+.++
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 150 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 644322 22456799999999988754 579999999999999999999999986543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=332.27 Aligned_cols=204 Identities=28% Similarity=0.474 Sum_probs=169.9
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC----eEEEEEcCCC--CCChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH----AAAIKKLDAS--KQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~avK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.+|++.+.||+|+||+||+|.+. +|+ .||+|++... ....+.+.+|++++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 36999999999999999999976 444 5888888643 33457899999999999999999999999865 4678
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
+||++.+++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK--------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp EEECCTTCBHHHHHHHTS--------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred EEEeccCCcccccccccc--------cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccc
Confidence 889999999998887654 24899999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.+....
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 9886654433333445568999999999999999999999999999999998 89999876543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=324.85 Aligned_cols=200 Identities=29% Similarity=0.457 Sum_probs=164.3
Q ss_pred hcCCCCceeeccCceEEEEEEeCC-C----CeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKS-G----HAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~-~----~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
+.|.+.++||+|+||+||+|.++. + ..||||++...... ..++.+|++++++++||||+++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468889999999999999998763 2 36999998754433 2468899999999999999999999999999999
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+.++++.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecccCcchhhhhccc--------ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 999999999998876554 24899999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCccccc-ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 022706 220 LSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVD 277 (293)
Q Consensus 220 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~ 277 (293)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 99876443222 12234568999999999999999999999999999999999655443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=327.75 Aligned_cols=198 Identities=24% Similarity=0.386 Sum_probs=170.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC-------hHHHHHHHHHHhcCC--CCCceeEEEEEEeCC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP-------DEEFLAQVSMVSRLK--HENFVQLLGYCVDGT 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~ 135 (293)
.++|++.+.||+|+||+||+|.++ +++.||||++...... ..++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999987 7999999998643221 234678999999997 899999999999999
Q ss_pred eeEEEEEcccC-CchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-CCce
Q 022706 136 SRVLAYEFASN-GSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-DDVA 213 (293)
Q Consensus 136 ~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-~~~~ 213 (293)
..++||||+.+ +++.+++.... .+++.+++.++.|++.||+|||+++ |+||||||+|||++. ++.+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred eEEEEEEeccCcchHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence 99999999976 57777776554 3999999999999999999999999 999999999999985 4789
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-NAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.
T Consensus 151 kl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp EECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 99999998754332 2245679999999999987665 56789999999999999999999764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=326.70 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=170.3
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++.+.||+|+||+||+|.++ +++.||||+++.... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999986 799999999965432 34678899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
|+.+ .+.+++..... ..+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~-~~~~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp CCSE-EHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ecCC-chhhhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence 9976 44444433221 24999999999999999999999999 9999999999999999999999999986
Q ss_pred CCCcccccccccccccCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
...... .......||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+
T Consensus 151 ~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 151 AFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp HHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 543222 2234567999999999877655 5789999999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=320.55 Aligned_cols=204 Identities=30% Similarity=0.439 Sum_probs=164.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC----CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 139 (293)
.++|.+.+.||+|+||+||+|.+.. +..||||.++..... .+.+.+|++++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3689999999999999999998752 346889988654433 356889999999999999999999985 567899
Q ss_pred EEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccc
Q 022706 140 AYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFD 219 (293)
Q Consensus 140 v~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg 219 (293)
||||+++|+|.+++..... .+++.+++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||
T Consensus 85 v~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence 9999999999998765442 4899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLPR 282 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~~ 282 (293)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+..+.
T Consensus 154 ~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 154 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred hheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 9986543222 22345668999999999999999999999999999999998 89999876553
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=318.35 Aligned_cols=198 Identities=32% Similarity=0.547 Sum_probs=166.2
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe-CCeeEEEEEccc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYEFAS 145 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 145 (293)
++|++.+.||+|+||.||+|.++ |+.||||+++.+ ...+.+.+|++++++++||||+++++++.+ .+..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 57889999999999999999986 789999999654 345779999999999999999999999865 456899999999
Q ss_pred CCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCCC
Q 022706 146 NGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAP 225 (293)
Q Consensus 146 ~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~~ 225 (293)
+|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 85 KGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp TEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC
Confidence 9999999865432 13899999999999999999999998 9999999999999999999999999987653
Q ss_pred cccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 226 DMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 226 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
.. .....+++.|+|||.+.+..++.++|||||||++|||+| |++||...+.
T Consensus 155 ~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 155 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred CC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 32 234567899999999999999999999999999999998 7999987644
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=325.13 Aligned_cols=214 Identities=27% Similarity=0.435 Sum_probs=178.2
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|++.+.||+|+||+||+|+++ +++.||||++...... .+++.+|++++++++||||+++++++.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 568999999999999999999864 3578999999765443 35689999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 022706 138 VLAYEFASNGSLHDILHGRKGVK---------------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKS 202 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp 202 (293)
+++|||+++++|.+++....... .......+++.+++.++.|++.||+|||+++ |+||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999986533110 0111234899999999999999999999998 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCCC
Q 022706 203 SNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR-KPVDHTLP 281 (293)
Q Consensus 203 ~Nilv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~-~Pf~~~~~ 281 (293)
+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++|. +||.+..+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999987654443333345567899999999999999999999999999999999985 68877654
Q ss_pred c
Q 022706 282 R 282 (293)
Q Consensus 282 ~ 282 (293)
.
T Consensus 249 ~ 249 (301)
T d1lufa_ 249 E 249 (301)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-47 Score=320.86 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=171.5
Q ss_pred hcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEEc
Q 022706 67 ENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
++|++.+.||+|+||+||+|++++|+.||||++..... ....+.+|+.++++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999999999999999965432 346889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
+.++.+..+..... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 98876666655443 4999999999999999999999998 99999999999999999999999999865
Q ss_pred CCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 224 APDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
..... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+
T Consensus 150 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 150 FGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 43221 122445689999999998764 56899999999999999999999998654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=320.89 Aligned_cols=202 Identities=24% Similarity=0.391 Sum_probs=168.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-C-CCeEEEEEcCCCC---CChHHHHHHHHHHhcC---CCCCceeEEEEEEe----
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-S-GHAAAIKKLDASK---QPDEEFLAQVSMVSRL---KHENFVQLLGYCVD---- 133 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~~avK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---- 133 (293)
.++|++++.||+|+||+||+|++. + ++.||||++.... .....+.+|+++++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999975 4 5679999986432 2233566777776665 79999999999863
Q ss_pred -CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCc
Q 022706 134 -GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDV 212 (293)
Q Consensus 134 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~ 212 (293)
....+++||++.++.+........ ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 346789999998877655444332 24899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 213 AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 213 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
+||+|||++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.++
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 9999999987654332 23567899999999999999999999999999999999999999987643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=317.58 Aligned_cols=203 Identities=30% Similarity=0.463 Sum_probs=163.2
Q ss_pred hcCCCCceeeccCceEEEEEEeC--CC--CeEEEEEcCCCCCC----hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK--SG--HAAAIKKLDASKQP----DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRV 138 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~--~~--~~~avK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 138 (293)
++|++.+.||+|+||+||+|+++ ++ ..||||++...... .+++.+|++++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999854 22 36899998754321 3578999999999999999999999966 4678
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
+||||+++++|.+++..+.. .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred eeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccc
Confidence 99999999999988765542 3899999999999999999999998 999999999999999999999999
Q ss_pred ccCCCCCcccccc-cccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 219 DLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
|++.......... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.+.+.
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 9998765443222 2234457889999999999999999999999999999998 8999986543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=317.82 Aligned_cols=213 Identities=31% Similarity=0.476 Sum_probs=176.4
Q ss_pred HhcCCCCceeeccCceEEEEEEeCC--------CCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG 134 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 134 (293)
.++|.+++.||+|+||.||+|+... +..||||+++.+... ..++.+|...+.++ +||||+++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998542 247999999765543 35678898888888 799999999999999
Q ss_pred CeeEEEEEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 135 TSRVLAYEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 135 ~~~~lv~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
...++||||+++|+|.+++..+.... .......+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997654211 1112245899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |.+||.+.+.
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999999999999987765554444566778999999999999999999999999999999998 7999986654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=319.57 Aligned_cols=212 Identities=24% Similarity=0.391 Sum_probs=166.9
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeC-C
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDG-T 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 135 (293)
.++|++.+.||+|+||+||+|.++ +++.||||+++..... ...+.+|...+.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 468999999999999999999864 3468999998754433 34577788877777 589999999988754 4
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEc
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKG-------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIF 208 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~ 208 (293)
..++||||+++|+|.+++........ ......+++.+++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999976532110 011235899999999999999999999998 99999999999999
Q ss_pred CCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCC
Q 022706 209 DDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RKPVDHTL 280 (293)
Q Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g-~~Pf~~~~ 280 (293)
+++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++| .+||.+..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999876554444444567899999999999999999999999999999999986 57887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-46 Score=315.25 Aligned_cols=204 Identities=21% Similarity=0.266 Sum_probs=175.6
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC-CCceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.+.| +|++.+++++.+....++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468999999999999999999987 79999999875433 33457788999999975 8999999999999999999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC-----CCceEEecc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD-----DDVAKIADF 218 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~-----~~~~kl~Df 218 (293)
+ +++|.+++.... ..++..++..++.|++.+|+|||++| |+||||||+|||++. ++.++|+||
T Consensus 83 ~-~~~l~~~~~~~~--------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 83 L-GPSLEDLLDLCG--------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp C-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHhhc--------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence 9 679999887654 24899999999999999999999999 999999999999964 568999999
Q ss_pred ccCCCCCcccc-----cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 219 DLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 219 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
|+++...+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 99976543221 11234567999999999999999999999999999999999999999876554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=319.83 Aligned_cols=203 Identities=25% Similarity=0.381 Sum_probs=164.0
Q ss_pred HhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEeCC----eeEEEE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRVLAY 141 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 141 (293)
.++|.+.+.||+|+||+||+|+++ |+.||||++..+.........|+..+.+++||||+++++++.+.+ ..++||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 357888999999999999999975 899999999654332223344555667789999999999998654 578999
Q ss_pred EcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCceEEcCCCceEEe
Q 022706 142 EFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-----DPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 142 e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
||+++|+|.+++++.. +++.+++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+
T Consensus 81 Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp ECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred ecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 9999999999998654 899999999999999999999730 1139999999999999999999999
Q ss_pred ccccCCCCCcccc--cccccccccCcccccccccccCC------CCCccchhhHHHHHHHHHhCCCCCCCC
Q 022706 217 DFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQ------LNAKSDVYSFGVVLLELLTGRKPVDHT 279 (293)
Q Consensus 217 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~~l~el~~g~~Pf~~~ 279 (293)
|||+++....... ........||+.|+|||++.+.. ++.++|||||||+||||+||..||...
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 9999876533221 12234567999999999887542 566899999999999999999988643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=321.28 Aligned_cols=203 Identities=26% Similarity=0.349 Sum_probs=169.1
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEeCC----eeE
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVDGT----SRV 138 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 138 (293)
+.+|++++.||+|+||+||+|.++ +|+.||||++.+.... .+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 468999999999999999999976 8999999999754432 346789999999999999999999987543 234
Q ss_pred EEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEecc
Q 022706 139 LAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADF 218 (293)
Q Consensus 139 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Df 218 (293)
++++++.+++|.+++.... +++.+++.++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 87 ~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 5555666899999997653 899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccc-cccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 219 DLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 219 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
|++........ .......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+...
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 99976544322 222355679999999998854 5678899999999999999999999986543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=316.46 Aligned_cols=213 Identities=25% Similarity=0.420 Sum_probs=180.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCC--hHHHHHHHHHHhcC-CCCCceeEEEEEEeCCe
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQP--DEEFLAQVSMVSRL-KHENFVQLLGYCVDGTS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 136 (293)
.++|.+.+.||+|+||.||+|+++ +++.||||+++..... ...+.+|+.+++++ +||||+++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368999999999999999999852 4678999999765443 34688999999999 59999999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEE
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKG---------AQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLI 207 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv 207 (293)
.++||||+++++|.+++........ ......+++..++.++.||+.||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999976542111 011235899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 022706 208 FDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLT-GRKPVDHTLP 281 (293)
Q Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-g~~Pf~~~~~ 281 (293)
+.++.++++|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |.+||.....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999988765544444556788999999999999999999999999999999999 6677765544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=320.05 Aligned_cols=197 Identities=27% Similarity=0.417 Sum_probs=167.1
Q ss_pred HHhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeCC-----
Q 022706 65 ITENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDGT----- 135 (293)
Q Consensus 65 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 135 (293)
+.++|++++.||+|+||+||+|.++ +|+.||||++....... +.+.+|+++|++++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3568999999999999999999987 79999999997654443 46789999999999999999999998654
Q ss_pred -eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceE
Q 022706 136 -SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAK 214 (293)
Q Consensus 136 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~k 214 (293)
..++||||+ +.+|..+++... +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 469999999 568888876543 999999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 215 IADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 215 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|+|||++...... .+...||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 9999999765432 2556799999999998764 57899999999999999999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=313.99 Aligned_cols=204 Identities=25% Similarity=0.381 Sum_probs=168.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCC---ChHHHHHHHHHHhcCCCCCceeEEEEEEe--------
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQ---PDEEFLAQVSMVSRLKHENFVQLLGYCVD-------- 133 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 133 (293)
.++|++++.||+|+||+||+|+++ +|+.||||++..... ....+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 369999999999999999999986 899999999865432 34678899999999999999999998765
Q ss_pred CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 134 GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 134 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
....++|||++.++.+..+..... .+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 346789999998766655544332 4899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccc--cccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~~ 281 (293)
||+|||++........ .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.++
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 9999999976543221 1222445799999999998865 689999999999999999999999986543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=314.53 Aligned_cols=209 Identities=31% Similarity=0.472 Sum_probs=171.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCC--eEEEEEcCCCC--CChHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGH--AAAIKKLDASK--QPDEEFLAQVSMVSRL-KHENFVQLLGYCVDGTSRVLA 140 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~~avK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 140 (293)
++|++.+.||+|+||+||+|.++ ++. .||||++.... ...+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 68899999999999999999977 554 46778775332 2345789999999999 699999999999999999999
Q ss_pred EEcccCCchhhhhhcCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCce
Q 022706 141 YEFASNGSLHDILHGRKGVK-------GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVA 213 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~ 213 (293)
|||+++|+|.+++....... .......+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997542100 0011235999999999999999999999998 9999999999999999999
Q ss_pred EEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCCC
Q 022706 214 KIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGR-KPVDHTLP 281 (293)
Q Consensus 214 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~-~Pf~~~~~ 281 (293)
||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|. +||.+.+.
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 9999999876543322 23456899999999999999999999999999999999965 67876543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=318.64 Aligned_cols=198 Identities=27% Similarity=0.342 Sum_probs=164.3
Q ss_pred cCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCceeEEEEEEe------CCeeEEE
Q 022706 68 NFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENFVQLLGYCVD------GTSRVLA 140 (293)
Q Consensus 68 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv 140 (293)
+|+..++||+|+||+||+|+++ +|+.||||++...... ..+|++++++++||||+++++++.. ..+.++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 7899999999999999999987 7999999999654432 3479999999999999999999864 3357899
Q ss_pred EEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEeccc
Q 022706 141 YEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFD 219 (293)
Q Consensus 141 ~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg 219 (293)
|||++++.+..+...... ...+++.+++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||
T Consensus 98 ~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence 999987544443321110 124999999999999999999999999 99999999999999775 89999999
Q ss_pred cCCCCCcccccccccccccCccccccccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 220 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
++....... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 169 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 169 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp TCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred chhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 987654322 2245679999999998875 468999999999999999999999997654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=315.14 Aligned_cols=213 Identities=26% Similarity=0.418 Sum_probs=180.3
Q ss_pred HhcCCCCceeeccCceEEEEEEeC------CCCeEEEEEcCCCCCCh--HHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK------SGHAAAIKKLDASKQPD--EEFLAQVSMVSRLKHENFVQLLGYCVDGTSR 137 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~avK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 137 (293)
.++|.+.+.||+|+||+||+|.++ +++.||||+++...... ..+.+|++++++++||||+++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 468999999999999999999864 35789999997544332 3588999999999999999999999999999
Q ss_pred EEEEEcccCCchhhhhhcCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 138 VLAYEFASNGSLHDILHGRKGVK-GAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
++||||+++|+|.+++....... .......+++..+..++.|+++||.|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999886432100 0011124789999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTG-RKPVDHTLP 281 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g-~~Pf~~~~~ 281 (293)
|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+|| .+||.+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 99999876555444445566789999999999999999999999999999999997 588876654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-44 Score=310.78 Aligned_cols=194 Identities=19% Similarity=0.331 Sum_probs=169.1
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEe--CCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVD--GTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e 142 (293)
++|++++.||+|+||+||+|+++ +++.||||+++. ...+.+.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 58999999999999999999986 799999999864 34577899999999996 9999999999974 456899999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCC-ceEEeccccC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDD-VAKIADFDLS 221 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~-~~kl~Dfg~~ 221 (293)
|+.+++|..+.+ .+++.+++.++.||+.||+|||++| |+||||||+|||++.++ .++|+|||++
T Consensus 113 ~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 113 HVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp CCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred ecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccc
Confidence 999999977642 3899999999999999999999999 99999999999998655 6999999999
Q ss_pred CCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 222 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
....... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 178 EFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp EECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred eeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 7654322 23556789999999998765 57999999999999999999999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=313.78 Aligned_cols=203 Identities=26% Similarity=0.362 Sum_probs=175.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC----CCCeEEEEEcCCCC-----CChHHHHHHHHHHhcCCC-CCceeEEEEEEeCCe
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK----SGHAAAIKKLDASK-----QPDEEFLAQVSMVSRLKH-ENFVQLLGYCVDGTS 136 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~avK~~~~~~-----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 136 (293)
++|++++.||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 68999999999999999999852 58899999986432 334568899999999976 899999999999999
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++|||+.+++|.+++.... .+.+..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---------~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred eeeeeecccccHHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEe
Confidence 999999999999999997665 3789999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
|||+++........ ......|++.|++||.+.+. .++.++|||||||+||+|++|+.||.+....
T Consensus 172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 172 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred eccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999766443322 23456789999999998764 4678999999999999999999999876543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=307.10 Aligned_cols=196 Identities=28% Similarity=0.457 Sum_probs=166.8
Q ss_pred CceeeccCceEEEEEEeCC----CCeEEEEEcCCCCCC--hHHHHHHHHHHhcCCCCCceeEEEEEEe-CCeeEEEEEcc
Q 022706 72 NALIGEGSYGRVYYGILKS----GHAAAIKKLDASKQP--DEEFLAQVSMVSRLKHENFVQLLGYCVD-GTSRVLAYEFA 144 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~----~~~~avK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 144 (293)
.++||+|+||+||+|++.. ...||||+++..... .+++.+|++++++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5689999999999999753 225899998753332 3568999999999999999999999875 46789999999
Q ss_pred cCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCCCC
Q 022706 145 SNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQA 224 (293)
Q Consensus 145 ~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~~ 224 (293)
++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99999999876542 3788899999999999999999998 999999999999999999999999999876
Q ss_pred Cccccc--ccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 225 PDMAAR--LHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 225 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
...... .......||+.|+|||.+....++.++||||||+++|||++|..||..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 443221 222345689999999999999999999999999999999997777754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=304.18 Aligned_cols=198 Identities=22% Similarity=0.350 Sum_probs=173.5
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCC---hHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEE
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQP---DEEFLAQVSMVSRLKHENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++|++++.||+|+||+||+|+++ +++.||||+++..... ...+.+|+.++++++||||+++++++.+....+++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999987 8999999998654432 3678899999999999999999999999999999999
Q ss_pred cccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 143 FASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 143 ~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
++.+++|..++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+.
T Consensus 82 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhh
Confidence 999999888877554 4889999999999999999999998 9999999999999999999999999997
Q ss_pred CCCcccccccccccccCcccccccccccCC-CCCccchhhHHHHHHHHHhCCCCCCC
Q 022706 223 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LNAKSDVYSFGVVLLELLTGRKPVDH 278 (293)
Q Consensus 223 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~g~~Pf~~ 278 (293)
....... ......+++.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp ECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 6543222 223455788999999887654 68999999999999999999999743
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-44 Score=304.82 Aligned_cols=204 Identities=22% Similarity=0.308 Sum_probs=168.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEEEEEc
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHEN-FVQLLGYCVDGTSRVLAYEF 143 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 143 (293)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++++++++|+| |+.+..++.+.+..++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 468999999999999999999986 799999998765433 345788999999998665 55566667788899999999
Q ss_pred ccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcC---CCceEEecccc
Q 022706 144 ASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFD---DDVAKIADFDL 220 (293)
Q Consensus 144 ~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~---~~~~kl~Dfg~ 220 (293)
+. ++|...+.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++. +..++|+|||+
T Consensus 85 ~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp CC-CBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred cC-Cchhhhhhhcc--------CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCc
Confidence 95 46666655433 24899999999999999999999999 999999999999863 55799999999
Q ss_pred CCCCCcccc-----cccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 022706 221 SNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPR 282 (293)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~~~ 282 (293)
++...+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 987644322 12234567999999999999999999999999999999999999999876543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=311.96 Aligned_cols=197 Identities=30% Similarity=0.435 Sum_probs=167.7
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEeC-----Ce
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVDG-----TS 136 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 136 (293)
.++|++.+.||+|+||+||+|+++ +|+.||||++....... +.+.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999976 89999999998665443 4678999999999999999999998643 33
Q ss_pred eEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEEe
Q 022706 137 RVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIA 216 (293)
Q Consensus 137 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl~ 216 (293)
.+++|+++.+++|.+++.... +++.+++.++.||+.||+|||++| |+||||||+|||++.++.+|++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccc
Confidence 466677788999999996543 999999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccCcccccccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 217 DFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 217 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
|||++...... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus 164 dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 164 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 99998765332 2456789999999987765 46889999999999999999999997654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=311.38 Aligned_cols=197 Identities=23% Similarity=0.283 Sum_probs=161.5
Q ss_pred HhcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCCh---HHHHHHHHHHhcCCCCCceeEEEEEEe------CC
Q 022706 66 TENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPD---EEFLAQVSMVSRLKHENFVQLLGYCVD------GT 135 (293)
Q Consensus 66 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 135 (293)
.++|++++.||+|+||+||+|.++ +|+.||||++....... .++.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999987 79999999997654443 457899999999999999999999864 46
Q ss_pred eeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCCCceEE
Q 022706 136 SRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKI 215 (293)
Q Consensus 136 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~~~~kl 215 (293)
..|+||||+.++.+ +.+.. .+++.+++.++.||+.||.|||++| |+||||||+|||++.++.+++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchHHH-Hhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 78999999977544 44432 3899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 216 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
+|||++....... ......+|+.|+|||++.+..+++++||||+||++|+|++|++||.+.+
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 9999987654322 2355678999999999999999999999999999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.7e-39 Score=278.16 Aligned_cols=200 Identities=22% Similarity=0.251 Sum_probs=159.7
Q ss_pred hcCCCCceeeccCceEEEEEEeC-CCCeEEEEEcCCCCCChHHHHHHHHHHhcCC-----------CCCceeEEEEEEe-
Q 022706 67 ENFGTNALIGEGSYGRVYYGILK-SGHAAAIKKLDASKQPDEEFLAQVSMVSRLK-----------HENFVQLLGYCVD- 133 (293)
Q Consensus 67 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~- 133 (293)
++|++++.||+|+||+||+|+++ +|+.||||+++.+....+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 36999999999999999999986 8999999999866545567788998888775 5789999988754
Q ss_pred -CCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCceEEcCCC
Q 022706 134 -GTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHE-KADPHIIHRDIKSSNVLIFDDD 211 (293)
Q Consensus 134 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~ivH~Dikp~Nilv~~~~ 211 (293)
....+++|+++.............. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYE------HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 163 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTT------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred cccceeeeeeeccccccccccccccc------ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccC
Confidence 4566677777655443322221111 1248999999999999999999998 77 99999999999998665
Q ss_pred c------eEEeccccCCCCCcccccccccccccCcccccccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 022706 212 V------AKIADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTL 280 (293)
Q Consensus 212 ~------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~g~~Pf~~~~ 280 (293)
. ++++|||.+...... .....||+.|+|||++....++.++|+||+||++++|++|+.||....
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 3 899999998654322 245679999999999999999999999999999999999999998653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=2.5e-28 Score=193.06 Aligned_cols=162 Identities=14% Similarity=0.135 Sum_probs=118.8
Q ss_pred CCCceeeccCceEEEEEEeCCCCeEEEEEcCCCCCC-------------------hHHHHHHHHHHhcCCCCCceeEEEE
Q 022706 70 GTNALIGEGSYGRVYYGILKSGHAAAIKKLDASKQP-------------------DEEFLAQVSMVSRLKHENFVQLLGY 130 (293)
Q Consensus 70 ~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~i~~~~~~ 130 (293)
.+++.||+|+||+||+|.+.+|+.||||+++..... .....+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999888999999987532110 1234567888999999999998865
Q ss_pred EEeCCeeEEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCceEEcCC
Q 022706 131 CVDGTSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKADPHIIHRDIKSSNVLIFDD 210 (293)
Q Consensus 131 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ivH~Dikp~Nilv~~~ 210 (293)
. ..+++|||+++..+.+ ++...+..++.|++.+|.|||+.| |+||||||+|||++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 3 2379999998865543 233445688999999999999999 9999999999999865
Q ss_pred CceEEeccccCCCCCcccccccccccccCcccccc--c---ccccCCCCCccchhhHHHH
Q 022706 211 DVAKIADFDLSNQAPDMAARLHSTRVLGTFGYHAP--E---YAMTGQLNAKSDVYSFGVV 265 (293)
Q Consensus 211 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DvwslG~~ 265 (293)
+ ++|+|||++......... .|... + .+..+.|+.++|+||+.--
T Consensus 140 ~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 140 G-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp E-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred C-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 4 899999998654322111 11110 0 1224567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.14 E-value=2.1e-10 Score=93.18 Aligned_cols=149 Identities=18% Similarity=0.139 Sum_probs=105.0
Q ss_pred HHHHHHHhcCCCCceeeccCceEEEEEEeCCCCeEEEEEcCCCC-CChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCee
Q 022706 60 DELKEITENFGTNALIGEGSYGRVYYGILKSGHAAAIKKLDASK-QPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSR 137 (293)
Q Consensus 60 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~avK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 137 (293)
.++......|++.+..+.++.+.||+.... ++.+++|...... .....+.+|...++.+. +-.+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 456677778888776555556789988754 6678888875432 33445778888887775 43467888888888999
Q ss_pred EEEEEcccCCchhhhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 022706 138 VLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA-------------------------- 191 (293)
Q Consensus 138 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------- 191 (293)
++||++++|.++.+..... .....++.++...+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEEEEeccccccccccccc--------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 9999999998886544211 112234556666666666421
Q ss_pred ------------------------------CCCeeeCCCCCCceEEcCCCceEEeccccCCC
Q 022706 192 ------------------------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQ 223 (293)
Q Consensus 192 ------------------------------~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~~ 223 (293)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999877778999987653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.73 E-value=6.8e-08 Score=77.54 Aligned_cols=130 Identities=14% Similarity=0.061 Sum_probs=88.2
Q ss_pred eeeccCc-eEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCC--CCCceeEEEEEEeCCeeEEEEEcccCCchh
Q 022706 74 LIGEGSY-GRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLK--HENFVQLLGYCVDGTSRVLAYEFASNGSLH 150 (293)
Q Consensus 74 ~lg~G~~-g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 150 (293)
.+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++||++++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3445543 679999988888899998754432 34667777777664 233677888888888899999999987664
Q ss_pred hhhhcCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 022706 151 DILHGRKGVKGAQPGPVLSWQQRVKIAVGAAKGLEYLHEKA--------------------------------------- 191 (293)
Q Consensus 151 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------------- 191 (293)
+.. .... ..+.++...|..||+..
T Consensus 95 ~~~--------------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 95 SSH--------------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp TSC--------------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ccc--------------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence 421 1111 12234444444444311
Q ss_pred ----------------CCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 192 ----------------DPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 192 ----------------~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.42 E-value=7.5e-07 Score=76.19 Aligned_cols=76 Identities=18% Similarity=0.079 Sum_probs=50.5
Q ss_pred CceeeccCceEEEEEEeC-CCCeEEEEEcCCC--------CCChHHHHHHHHHHhcCC-C--CCceeEEEEEEeCCeeEE
Q 022706 72 NALIGEGSYGRVYYGILK-SGHAAAIKKLDAS--------KQPDEEFLAQVSMVSRLK-H--ENFVQLLGYCVDGTSRVL 139 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~-~~~~~avK~~~~~--------~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l 139 (293)
.+.||.|....||++... +++.+++|.-.+. +....+...|.+.|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999876 4778999975321 123345667887777663 2 345666654 5666789
Q ss_pred EEEcccCCch
Q 022706 140 AYEFASNGSL 149 (293)
Q Consensus 140 v~e~~~~~sL 149 (293)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.09 E-value=1.1e-05 Score=68.78 Aligned_cols=73 Identities=12% Similarity=0.119 Sum_probs=50.8
Q ss_pred CceeeccCceEEEEEEeCC--------CCeEEEEEcCCCCCChHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEEEE
Q 022706 72 NALIGEGSYGRVYYGILKS--------GHAAAIKKLDASKQPDEEFLAQVSMVSRLK-HENFVQLLGYCVDGTSRVLAYE 142 (293)
Q Consensus 72 ~~~lg~G~~g~V~~~~~~~--------~~~~avK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 142 (293)
++.|+.|-.-.+|++...+ .+.+++++.- ......+..+|..+++.+. +.-..++++++.+ .+|||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 3567778889999998653 3457777765 3444556778999988886 4334577776532 68999
Q ss_pred cccCCch
Q 022706 143 FASNGSL 149 (293)
Q Consensus 143 ~~~~~sL 149 (293)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9998655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.07 E-value=1.2e-05 Score=66.70 Aligned_cols=70 Identities=9% Similarity=0.055 Sum_probs=50.3
Q ss_pred ceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCCCCc--eeEE-----EEEEeCCeeEEEEEcccCCch
Q 022706 80 YGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKHENF--VQLL-----GYCVDGTSRVLAYEFASNGSL 149 (293)
Q Consensus 80 ~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~lv~e~~~~~sL 149 (293)
-..||+++..+|+.+++|+..+.....+.+..|...+..|...++ +..+ ..+......+.+++++.|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 468999999999999999998877778888899988877752221 1111 122346667889999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.04 E-value=2e-05 Score=64.81 Aligned_cols=165 Identities=14% Similarity=0.133 Sum_probs=86.5
Q ss_pred ccCHHHHHHHHhcCCCCceee-----ccCceEEEEEEeCCCCeEEEEEcCCCCCChHHHHHHHHHHhcCCC-----CCce
Q 022706 56 AISVDELKEITENFGTNALIG-----EGSYGRVYYGILKSGHAAAIKKLDASKQPDEEFLAQVSMVSRLKH-----ENFV 125 (293)
Q Consensus 56 ~~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~~avK~~~~~~~~~~~~~~e~~~l~~l~h-----~~i~ 125 (293)
.++.+++..+..+|.+++... .|--.+.|+.+..+| .+++|+..... +.+++..|++++..|.. |..+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccc
Confidence 467889999999999876544 455678899987754 59999986532 33455566767666642 2221
Q ss_pred eEE---EEEEeCCeeEEEEEcccCCchhh--------------hhhc-CCCCCCCCCCCCCCH-----------------
Q 022706 126 QLL---GYCVDGTSRVLAYEFASNGSLHD--------------ILHG-RKGVKGAQPGPVLSW----------------- 170 (293)
Q Consensus 126 ~~~---~~~~~~~~~~lv~e~~~~~sL~~--------------~l~~-~~~~~~~~~~~~l~~----------------- 170 (293)
... .+..-......++.++.+..... .++. ...............
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 01122445556677766643321 0000 000000000000000
Q ss_pred HHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCceEEcCCCceEEeccccCC
Q 022706 171 QQRVKIAVGAAKGLEYLHEK-ADPHIIHRDIKSSNVLIFDDDVAKIADFDLSN 222 (293)
Q Consensus 171 ~~~~~i~~qi~~al~~LH~~-~~~~ivH~Dikp~Nilv~~~~~~kl~Dfg~~~ 222 (293)
......+..+...+...+.. -..++||+|+.++||+++.+...-++||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01112222222333332221 01239999999999999988877899999864
|